Citrus Sinensis ID: 044155
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 239 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LMP1 | 732 | Wall-associated receptor | yes | no | 0.928 | 0.303 | 0.380 | 9e-39 | |
| Q9LSV3 | 433 | Putative wall-associated | no | no | 0.937 | 0.517 | 0.375 | 9e-39 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.924 | 0.301 | 0.391 | 1e-38 | |
| Q0WNY5 | 793 | Wall-associated receptor | no | no | 0.958 | 0.288 | 0.365 | 4e-38 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.937 | 0.302 | 0.379 | 4e-38 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.933 | 0.302 | 0.373 | 5e-38 | |
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.958 | 0.291 | 0.357 | 8e-38 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.928 | 0.302 | 0.376 | 6e-36 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.941 | 0.300 | 0.379 | 1e-34 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.933 | 0.291 | 0.358 | 2e-34 |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 160 bits (404), Expect = 9e-39, Method: Compositional matrix adjust.
Identities = 89/234 (38%), Positives = 140/234 (59%), Gaps = 12/234 (5%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H +++K++GCCLET +P+LV+E + GTL+D + G+ + L +HRL+IA ++
Sbjct: 454 QINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSL--YDSSLTWEHRLRIATEVA 511
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+LAYLH PI+ R+ KT+ IL ++ AK+ DF S IP + +T V GTLGY
Sbjct: 512 GSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGY 571
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD--VHDLVCPFSEYLKNCFEDN 178
PEY TG+ NEKS+V+SF V L ELL+G + +LV F+ KN N
Sbjct: 572 LDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPHCPKNLVSCFASATKN----N 627
Query: 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
RF EI+D V+ + + ++++ +A++ EC + +RP M +VA +L +
Sbjct: 628 RFHEIIDGQVMNE----DNQREIQEAARIAAECTRLMGEERPRMKEVAAELEAL 677
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (404), Expect = 9e-39, Method: Compositional matrix adjust.
Identities = 87/232 (37%), Positives = 137/232 (59%), Gaps = 8/232 (3%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H +++KL+GCCLET +P+LV+E + G+L+D + G+ L +HRL+IA+++
Sbjct: 158 QINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGSM--FVSSLTWEHRLEIAIEVA 215
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
A+AYLH G PI+ R+ KT IL +E AK+ DF S P + +T V GTLGY
Sbjct: 216 GAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQLTTMVQGTLGY 275
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PEY T + NEKS+V+SF V L EL++G L + + Y ++NR
Sbjct: 276 LDPEYYTTWLLNEKSDVYSFGVVLMELISGQKA--LCFERPETSKHLVSYFVLATKENRL 333
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
EI+D V+ + E ++++H +A+V EC + +RP M++VA +L +
Sbjct: 334 HEIIDDQVLNE----ENQREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (403), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 92/235 (39%), Positives = 141/235 (60%), Gaps = 14/235 (5%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP-LLLKHRLKIAMDI 59
Q++H +++KL+GCCLET +P+LV+E + GTL+D + G+ F+ L +HRL+IA+++
Sbjct: 458 QINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGS---MFDSSLTWEHRLRIAIEV 514
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
LAYLH PI+ R+ KT+ IL +E AK+ DF S IP + +T V GTLG
Sbjct: 515 AGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLG 574
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS--DLVKDVHDLVCPFSEYLKNCFED 177
Y PEY TG+ NEKS+V+SF V L ELL+G + + LV F +K +
Sbjct: 575 YLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMK----E 630
Query: 178 NRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
NR EI+D V+ + + ++++ SA++ EC + +RPSM +VA +L +
Sbjct: 631 NRLHEIIDGQVMNEYN----QREIQESARIAVECTRIMGEERPSMKEVAAELEAL 681
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0WNY5|WAKLN_ARATH Wall-associated receptor kinase-like 18 OS=Arabidopsis thaliana GN=WAKL18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 86/235 (36%), Positives = 139/235 (59%), Gaps = 6/235 (2%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H H++KL+GCCLET +P+LV+E + G L+ I + +L RL+IA+DI
Sbjct: 503 QINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDY-TMLWGMRLRIAVDIA 561
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL+YLH PI R+ K++ IL +E+ AK+ DF S S+ +TH T + GT+GY
Sbjct: 562 GALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGY 621
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PEY ++ + EKS+V+SF V L EL+TG +V++ ++V +E+ + ++ R
Sbjct: 622 VDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIV-ALAEHFRVAMKEKRL 680
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
T+I+D + D K +Q+ A A+V +C+ RP+M +V +L +I S
Sbjct: 681 TDIIDARIRNDC----KPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERICTS 731
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 88/232 (37%), Positives = 135/232 (58%), Gaps = 8/232 (3%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H +++K++GCCLET +P+LV+E + GTL+D + G+ L +HRL+IA+++
Sbjct: 465 QINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFD--SSLTWEHRLRIAIEVA 522
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
LAYLH PI+ R+ KT+ IL +E AK+ DF S IP + +T V GTLGY
Sbjct: 523 GTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGY 582
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PEY TG+ NEKS+V+SF V L ELL+G L + Y + E+NR
Sbjct: 583 LDPEYYTTGLLNEKSDVYSFGVVLMELLSGQKA--LCFERPQASKHLVSYFVSATEENRL 640
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
EI+D V+ + + +++ +A++ EC + +RP M +VA KL +
Sbjct: 641 HEIIDDQVLNE----DNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 87/233 (37%), Positives = 137/233 (58%), Gaps = 10/233 (4%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP-LLLKHRLKIAMDI 59
Q++H +++KL+GCCLET +P+LV+E + GTL+D + G+ F+ L +HRL++A++I
Sbjct: 460 QINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGS---MFDSSLTWEHRLRMAVEI 516
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
LAYLH PI+ R+ KT+ IL +E AK+ DF S IP + + V GTLG
Sbjct: 517 AGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLG 576
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y PEY TG+ NEKS+V+SF V L ELL+G L + Y + ++NR
Sbjct: 577 YLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKA--LCFERPQTSKHIVSYFASATKENR 634
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
EI+D V+ + ++++ +A++ EC + + +RP M +VA +L +
Sbjct: 635 LHEIIDGQVMNE----NNQREIQKAARIAVECTRLTGEERPGMKEVAAELEAL 683
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 157 bits (396), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 84/235 (35%), Positives = 140/235 (59%), Gaps = 6/235 (2%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H H++KL+GCCLET +PILV+E + G L+ I + ++ RL+IA+DI
Sbjct: 494 QINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDY-TMIWGMRLRIAVDIA 552
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL+YLH PI R+ K++ IL +E+ AK+ DF S S+ +TH T + GT+GY
Sbjct: 553 GALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGY 612
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PEY R+ + EKS+V+SF V L EL+TG +V++ +++ +E+ + ++ R
Sbjct: 613 VDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEII-ALAEHFRVAMKERRL 671
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
++I+D + +D K +Q+ A A + +C+ +RP+M +V +L +I S
Sbjct: 672 SDIMDARIRDD----SKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERICTS 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 150 bits (380), Expect = 6e-36, Method: Compositional matrix adjust.
Identities = 88/234 (37%), Positives = 133/234 (56%), Gaps = 12/234 (5%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H +++KL+GCCLET +P+LV+E + GTL+D + G+ L +HRLKIA+++
Sbjct: 459 QINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMID--SSLTWEHRLKIAIEVA 516
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
LAYLH PI+ R+ KT+ IL + AK+ DF S IP + + V GTLGY
Sbjct: 517 GTLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGY 576
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK--DVHDLVCPFSEYLKNCFEDN 178
PEY TG+ NEKS+V+SF V L ELL+G + LV F+ K +N
Sbjct: 577 LDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSKHLVSYFATATK----EN 632
Query: 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
R EI+ V+ + + +++ +A++ EC + +RP M +VA KL +
Sbjct: 633 RLDEIIGGEVMNE----DNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 682
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (369), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 90/237 (37%), Positives = 133/237 (56%), Gaps = 12/237 (5%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H +I+KL+GCCLET +P+LV+E V G L R+ + + + RL IA++I
Sbjct: 466 QINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDY--TMTWEVRLHIAIEIA 523
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL+YLH PI R+ KT+ IL +E N AK+ DF S S+ +TH+T V GT GY
Sbjct: 524 GALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGY 583
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD--LVCPFSEYLKNCFEDN 178
PEY ++ F EKS+V+SF V L ELLTG S V+ + L F E +K +N
Sbjct: 584 VDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVK----EN 639
Query: 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
R +IVD + ++ + Q+ + A + C+ RP+M +V+ +L I S
Sbjct: 640 RVLDIVDDRIKDECNM----DQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (368), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 84/234 (35%), Positives = 130/234 (55%), Gaps = 11/234 (4%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE--PLLLKHRLKIAMD 58
Q++H H++KL+GCCLET +PILV+E + G L+ + F+ L R++IA+D
Sbjct: 504 QINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHL----HEEFDDYTALWGVRMRIAVD 559
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
I A +YLH PI R+ K++ IL +E+ AK+ DF S S+ TH T + GT+
Sbjct: 560 ISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTV 619
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDN 178
GY PEY + F EKS+V+SF V L EL+TG + + ++ ++Y + +N
Sbjct: 620 GYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEIT-GLADYFRLAMREN 678
Query: 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
R EI+D + D K +Q+ A A + C+K + RP M +V+ L +I
Sbjct: 679 RLFEIIDARIRNDC----KLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 239 | ||||||
| 255582635 | 331 | receptor protein kinase, putative [Ricin | 0.970 | 0.700 | 0.497 | 1e-58 | |
| 224123144 | 344 | predicted protein [Populus trichocarpa] | 0.974 | 0.677 | 0.470 | 2e-55 | |
| 255542662 | 330 | serine-threonine protein kinase, plant-t | 0.979 | 0.709 | 0.472 | 7e-52 | |
| 255542656 | 331 | serine-threonine protein kinase, plant-t | 0.933 | 0.673 | 0.478 | 8e-50 | |
| 255542658 | 356 | serine-threonine protein kinase, plant-t | 0.916 | 0.615 | 0.429 | 5e-48 | |
| 255542668 | 307 | serine-threonine protein kinase, plant-t | 0.958 | 0.745 | 0.460 | 3e-46 | |
| 359495254 | 331 | PREDICTED: wall-associated receptor kina | 0.958 | 0.691 | 0.413 | 1e-40 | |
| 297740943 | 321 | unnamed protein product [Vitis vinifera] | 0.949 | 0.707 | 0.412 | 2e-40 | |
| 297845102 | 735 | hypothetical protein ARALYDRAFT_889580 [ | 0.933 | 0.303 | 0.394 | 1e-38 | |
| 224065631 | 323 | predicted protein [Populus trichocarpa] | 0.933 | 0.690 | 0.420 | 3e-38 |
| >gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 231 bits (590), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 116/233 (49%), Positives = 158/233 (67%), Gaps = 1/233 (0%)
Query: 1 QMS-HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
QMS H + LKL+GCCLET IP+LVFE ++YGTL R+ G + ++PLL +HRLKIA++I
Sbjct: 97 QMSKHKNFLKLLGCCLETQIPVLVFEPIEYGTLAGRLYGPNKTLYQPLLWRHRLKIAVEI 156
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
+A++YLH F RPIVFRN K I +E +VAKL DFSL++SIPEGE+H+ D + G G
Sbjct: 157 ANAVSYLHTAFSRPIVFRNIKPLNIFLDECHVAKLSDFSLAVSIPEGESHVKDMLAGAWG 216
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
APEY +T FNE +V++F VFL LLTG V D + +++K D+R
Sbjct: 217 LIAPEYAKTSCFNESQDVYNFGVFLLMLLTGQKVVDSYRPQAGEELGLVDHVKKFIADDR 276
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
F E VD I++ + S EK+QQL A ++F CI ++ DRP M+DVAK+LR+I
Sbjct: 277 FYETVDSIILGEGSLPEKDQQLQAFTLLSFRCISEADEDRPMMIDVAKELRKI 329
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 221 bits (563), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 111/236 (47%), Positives = 158/236 (66%), Gaps = 3/236 (1%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
H +KL+GCCLE IPILVFE V TL D + G+ + +PLL R KIAMD+ +A+
Sbjct: 108 HKSFMKLLGCCLEARIPILVFEYVGDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAV 167
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123
A+LH F +PIVFRN K IL ++ + AKL DFS+SISIP+GE+H+ D+V G G AP
Sbjct: 168 AFLHAAFSKPIVFRNIKPLNILLDDNHEAKLSDFSISISIPKGESHVRDSVAGATGLIAP 227
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEI 183
EY+ TG FNEK +VF+F VFL LL+G V D + +++ +++K C ED+RF ++
Sbjct: 228 EYLTTGNFNEKQDVFNFGVFLLVLLSGQMVVDFSRPEKEIL--LQDHVKKCIEDDRFNKV 285
Query: 184 VDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS-LSC 238
+D ++ + + KEQQL A ++ CI + DRP+M+DV+K+LR+IY S +SC
Sbjct: 286 IDSTIIAEGTWPGKEQQLQAYTALSLRCISELAEDRPTMIDVSKELRKIYWSAISC 341
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 209 bits (532), Expect = 7e-52, Method: Compositional matrix adjust.
Identities = 111/235 (47%), Positives = 146/235 (62%), Gaps = 1/235 (0%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
H + +KL+GCCLETP PILVFES + TL DRI+ HFEP+ K RLKI DI + +
Sbjct: 95 HINSIKLLGCCLETPSPILVFESAKEKTLADRIIDRNDDHFEPVKWKLRLKIVADIANVV 154
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123
Y+H FPRPIV RN K S IL +E+ VAKL DFSL +SIPEG++ + D + GT+G A
Sbjct: 155 VYIHTAFPRPIVHRNIKASNILLDEDYVAKLSDFSLCVSIPEGKSRVRDIMAGTMGLIAS 214
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEI 183
E + TG FNEKS+V+SF V L +LTG D + ++K E F E+
Sbjct: 215 ESLATGYFNEKSDVYSFGVVLLVVLTGQRSFDFSRTETGEQFLLVNHVKKHIETGGFKEM 274
Query: 184 VDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLSC 238
VD I+V + + K Q+L + CI DS +RP+M++VAK+LR IY S SC
Sbjct: 275 VDPIIVAEEAGNRKGQELEDFRDLALRCIHDSAEERPTMIEVAKQLRHIYLS-SC 328
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 202 bits (514), Expect = 8e-50, Method: Compositional matrix adjust.
Identities = 113/236 (47%), Positives = 143/236 (60%), Gaps = 13/236 (5%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
H ++LKL+GCCLE+ IPI VFE + GTL D + LL K RLKIA+D+ +
Sbjct: 102 HRNVLKLLGCCLESEIPIPVFEYAEKGTLEDYVQKTA------LLWKDRLKIAVDVASVI 155
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123
AYLH FPRPIV R+ + IL +E+ AK+ FSLSISIPEGETHI D V GT+GY AP
Sbjct: 156 AYLHTAFPRPIVHRDISLASILLDEDCAAKVTGFSLSISIPEGETHIEDEVAGTIGYVAP 215
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLTGWD---VSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
EY +FNEK +V+SF V L LLTG S + H LV +KN RF
Sbjct: 216 EYFMKRMFNEKIDVYSFGVVLLVLLTGHGPILRSPTTNESHALVVFVEAKIKN----ERF 271
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236
EI+D ++E+ EKEQQL + + +C + DRP + DVAK+LR IY SL
Sbjct: 272 NEIIDPAILEEGPWPEKEQQLKSFLTLAMQCTRKDEEDRPEITDVAKQLRHIYHSL 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 196 bits (499), Expect = 5e-48, Method: Compositional matrix adjust.
Identities = 113/263 (42%), Positives = 144/263 (54%), Gaps = 44/263 (16%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
H ++LKL+GCCLE+ IPILVFE + G L D I F PLL K RLKIA+D + +
Sbjct: 105 HKNVLKLLGCCLESEIPILVFEYAEKGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVI 164
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123
AYLH PRP+V R+ S I +E+ VAK+ DF++S+SI EGETHI D V+GT GY AP
Sbjct: 165 AYLHTACPRPVVHRDITLSNIWLDEDYVAKVTDFTVSMSILEGETHIEDFVLGTCGYAAP 224
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEI 183
EY+R+G+FNEK +VFSF V L LLT PF +N +D RF EI
Sbjct: 225 EYVRSGIFNEKIDVFSFGVLLLVLLTDQK-------------PFQGNWENILKDARFDEI 271
Query: 184 -------------------------------VDHIVVEDVSSIEKEQQLHASAQVTFECI 212
+D I+VE+ EKEQQL A + +CI
Sbjct: 272 IGSLIVEKGLWSEKEQLETFLTRTRQKLDLTIDPIIVEEGPWPEKEQQLKAFLMLGVQCI 331
Query: 213 KDSPADRPSMVDVAKKLRQIYRS 235
+RP + DVAK+LR Y S
Sbjct: 332 DPDEENRPEITDVAKQLRHFYLS 354
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542668|ref|XP_002512397.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548358|gb|EEF49849.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 190 bits (483), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 110/239 (46%), Positives = 147/239 (61%), Gaps = 10/239 (4%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
H ++LKL+GCCLE+ IPILVFE Q G L D LL + RL+IA+D+ +
Sbjct: 75 HKNVLKLLGCCLESKIPILVFECAQKGILKDYFYKTDSAS---LLWQIRLRIAVDVASVI 131
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123
+YLH FPRPIV R+ S IL +E+ +AK+ FSLS+SIPEG+THI D V+GT GY AP
Sbjct: 132 SYLHSAFPRPIVHRDITLSNILLDEDYIAKVTGFSLSMSIPEGKTHIEDEVVGTPGYLAP 191
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLTGWDV---SDLVKDVHDLVCPFSEYLKNCFEDNRF 180
Y +T +FNEK +V+SF V L LLTG S + LV ++K ED RF
Sbjct: 192 AYFKTLMFNEKIDVYSFGVLLLVLLTGQQPILHSPTTTARYSLV----NFVKEKIEDERF 247
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLSCN 239
EI+D +++E+ EKE+QL + +C ++ DRP + DVAK+LR IY SL N
Sbjct: 248 DEIIDPVILEEGPWPEKERQLEIFLTLAMQCTHENEEDRPEITDVAKQLRHIYHSLISN 306
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495254|ref|XP_002271826.2| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 172 bits (435), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 98/237 (41%), Positives = 140/237 (59%), Gaps = 8/237 (3%)
Query: 1 QMS-HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
QMS H + LKL+GCCLET IPILV+E G+L DRI P P L K RL+IA DI
Sbjct: 99 QMSAHKNALKLLGCCLETRIPILVYEFPSGGSLIDRIFSPPNP----LSWKSRLRIAYDI 154
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
+ +AYLH FPR I+ + K S +++ AKL DFSLSI++PEGE H+ D + GT G
Sbjct: 155 ANVIAYLHIAFPRSIIHTDIKPSSFFLDQDCAAKLSDFSLSITLPEGEMHVEDEIRGTFG 214
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y APE + +GV+ EK++VFSF + L ELL G ++ + + +++ N ++ N
Sbjct: 215 YLAPETLISGVYTEKNDVFSFGILLLELLIGKRAHSIMHEERASIQDYAQSFVNTYDIN- 273
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236
IVD I++ I +E Q A + C +RP++V+ AK++R+I L
Sbjct: 274 --GIVDPIILAQPRGIHEELQFQAIFDLAMRCSMKDMDERPTIVNAAKEVRRIQNYL 328
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740943|emb|CBI31255.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 172 bits (435), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 97/235 (41%), Positives = 140/235 (59%), Gaps = 8/235 (3%)
Query: 1 QMS-HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
QMS H + LKL+GCCLET IPILV+E G+L DRI P P L K RL+IA DI
Sbjct: 91 QMSAHKNALKLLGCCLETRIPILVYEFPSGGSLIDRIFSPPNP----LSWKSRLRIAYDI 146
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
+ +AYLH FPR I+ + K S +++ AKL DFSLSI++PEGE H+ D + GT G
Sbjct: 147 ANVIAYLHIAFPRSIIHTDIKPSSFFLDQDCAAKLSDFSLSITLPEGEMHVEDEIRGTFG 206
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y APE + +GV+ EK++VFSF + L ELL G ++ + + +++ N ++ N
Sbjct: 207 YLAPETLISGVYTEKNDVFSFGILLLELLIGKRAHSIMHEERASIQDYAQSFVNTYDIN- 265
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234
IVD I++ I +E Q A + C +RP++V+ AK++R+I +
Sbjct: 266 --GIVDPIILAQPRGIHEELQFQAIFDLAMRCSMKDMDERPTIVNAAKEVRRIQK 318
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297845102|ref|XP_002890432.1| hypothetical protein ARALYDRAFT_889580 [Arabidopsis lyrata subsp. lyrata] gi|297336274|gb|EFH66691.1| hypothetical protein ARALYDRAFT_889580 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 166 bits (419), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 92/233 (39%), Positives = 141/233 (60%), Gaps = 10/233 (4%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP-LLLKHRLKIAMDI 59
Q++H +++KL+GCCLET +P+LV+E + GTL+D + G+ F+ L +HRL+IA++I
Sbjct: 460 QINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGS---MFDSSLTWEHRLRIAIEI 516
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
LAYLH PI+ R+ KT+ IL +E AK+ DF S IP + +T TV GTLG
Sbjct: 517 AGTLAYLHSSASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTTVQGTLG 576
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y PEY TG+ NEKS+V+SF V L ELL+G L + Y + ++NR
Sbjct: 577 YLDPEYYNTGLLNEKSDVYSFGVILMELLSGEKA--LCFERPQTSKHLVSYFVSAMKENR 634
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
EI+D V+ + + ++++ SA++ EC + + +RPSM +VA +L +
Sbjct: 635 LHEIIDGQVMNEYN----QREIRESARIALECTRITGEERPSMKEVATELEAL 683
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065631|ref|XP_002301893.1| predicted protein [Populus trichocarpa] gi|222843619|gb|EEE81166.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 164 bits (414), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 100/238 (42%), Positives = 142/238 (59%), Gaps = 15/238 (6%)
Query: 3 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
SHN++LKL+GCCLE P P LV+E + +L DR + H+ L RLKIA +I +
Sbjct: 97 SHNNVLKLLGCCLEIPEGPALVYEYPENRSL-DRHI-----HYGSLPWGTRLKIAKEIAN 150
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM-GTLGY 120
A+AYLH FPRPI+ R+ K + I N+ AKL DFS SISIPEGE+ + D ++ GT G+
Sbjct: 151 AVAYLHTAFPRPIIHRDIKPANIFLNQNYAAKLSDFSFSISIPEGESKVGDDLLVGTFGF 210
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
P+Y T EK++VFSF V L LLTG ++H E++K E +R
Sbjct: 211 LDPDYTMTNFVTEKTDVFSFGVLLLVLLTGRATRQ--GEIH-----LIEHVKLLVEQDRV 263
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLSC 238
E VD ++ + +QQL AS ++ C DS DRP M++VAK++++I RS++
Sbjct: 264 HEAVDPMIRGNGGEAIDQQQLEASIELALRCTDDSGEDRPLMIEVAKEIQRIERSITA 321
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 239 | ||||||
| TAIR|locus:2094468 | 433 | AT3G25490 [Arabidopsis thalian | 0.937 | 0.517 | 0.344 | 2.9e-32 | |
| TAIR|locus:2014912 | 732 | WAK2 "wall-associated kinase 2 | 0.920 | 0.300 | 0.347 | 1.3e-31 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.924 | 0.301 | 0.353 | 1.3e-31 | |
| TAIR|locus:2076671 | 355 | AT3G57730 [Arabidopsis thalian | 0.945 | 0.636 | 0.357 | 3.3e-31 | |
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.933 | 0.300 | 0.347 | 6.1e-31 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.958 | 0.288 | 0.336 | 1.2e-30 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.933 | 0.302 | 0.339 | 1.6e-30 | |
| TAIR|locus:2076596 | 340 | AT3G57700 [Arabidopsis thalian | 0.962 | 0.676 | 0.348 | 1.8e-30 | |
| TAIR|locus:2076586 | 351 | AT3G57710 [Arabidopsis thalian | 0.958 | 0.652 | 0.350 | 2.3e-30 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.958 | 0.291 | 0.327 | 2.5e-30 |
| TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 353 (129.3 bits), Expect = 2.9e-32, P = 2.9e-32
Identities = 80/232 (34%), Positives = 128/232 (55%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H +++KL+GCCLET +P+LV+E + G+L+D + G+ L +HRL+IA+++
Sbjct: 158 QINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGSM--FVSSLTWEHRLEIAIEVA 215
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
A+AYLH G PI+ R+ KT IL +E AK+ DF S P + +T V GTLGY
Sbjct: 216 GAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQLTTMVQGTLGY 275
Query: 121 CAPEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PEY T + NEKS+ +G L + + Y ++NR
Sbjct: 276 LDPEYYTTWLLNEKSDVYSFGVVLMELISGQKA--LCFERPETSKHLVSYFVLATKENRL 333
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
EI+D V+ + E ++++H +A+V EC + +RP M++VA +L +
Sbjct: 334 HEIIDDQVLNE----ENQREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381
|
|
| TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 355 (130.0 bits), Expect = 1.3e-31, P = 1.3e-31
Identities = 82/236 (34%), Positives = 134/236 (56%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H +++K++GCCLET +P+LV+E + GTL+D + G+ + L +HRL+IA ++
Sbjct: 454 QINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSL--YDSSLTWEHRLRIATEVA 511
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+LAYLH PI+ R+ KT+ IL ++ AK+ DF S IP + +T V GTLGY
Sbjct: 512 GSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGY 571
Query: 121 CAPEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVSDLVKDVHDLVCPFSEYLKNCF----E 176
PEY TG+ NEKS+ +G + H CP + L +CF +
Sbjct: 572 LDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERP-H---CP--KNLVSCFASATK 625
Query: 177 DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
+NRF EI+D V+ + + ++++ +A++ EC + +RP M +VA +L +
Sbjct: 626 NNRFHEIIDGQVMNE----DNQREIQEAARIAAECTRLMGEERPRMKEVAAELEAL 677
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 355 (130.0 bits), Expect = 1.3e-31, P = 1.3e-31
Identities = 83/235 (35%), Positives = 132/235 (56%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL-KHRLKIAMDI 59
Q++H +++KL+GCCLET +P+LV+E + GTL+D + G+ F+ L +HRL+IA+++
Sbjct: 458 QINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSM---FDSSLTWEHRLRIAIEV 514
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
LAYLH PI+ R+ KT+ IL +E AK+ DF S IP + +T V GTLG
Sbjct: 515 AGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLG 574
Query: 120 YCAPEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVS--DLVKDVHDLVCPFSEYLKNCFED 177
Y PEY TG+ NEKS+ +G + + LV Y + ++
Sbjct: 575 YLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLV----SYFVSAMKE 630
Query: 178 NRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
NR EI+D V+ + + ++++ SA++ EC + +RPSM +VA +L +
Sbjct: 631 NRLHEIIDGQVMNEYN----QREIQESARIAVECTRIMGEERPSMKEVAAELEAL 681
|
|
| TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 343 (125.8 bits), Expect = 3.3e-31, P = 3.3e-31
Identities = 83/232 (35%), Positives = 127/232 (54%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDIVH 61
+HN+ LKL+GCCLE P P+LVFE ++G L R G E LL L RLKI +I +
Sbjct: 121 NHNNFLKLLGCCLEFPFPVLVFEFAEHGVLNYRG-GITVNGEESLLPLSLRLKIGKEIAN 179
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLGY 120
ALAYLH FP+ I++R+ K + + AKL D S SIS+ EG++ I + V+GT GY
Sbjct: 180 ALAYLHMAFPKIIIYRDVKPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEAEDVLGTYGY 239
Query: 121 CAPEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
P Y T + E ++ TG V D + + Y+K E+ +
Sbjct: 240 LDPLYFATRIVTEYTDVYSFGVFLMVVITGISVYFTGSDGYPV--GILGYMKGLAENGKL 297
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
EIV +++++++S ++ Q+ A + C ++ DRP M+ VAK+L++I
Sbjct: 298 NEIVYPMIMKEMTSAQR-LQVEACVLLALRCCEERVEDRPKMIQVAKELKRI 348
|
|
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 349 (127.9 bits), Expect = 6.1e-31, P = 6.1e-31
Identities = 81/233 (34%), Positives = 128/233 (54%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL-KHRLKIAMDI 59
Q++H +++K++GCCLET +P+LV+E + GTL+D + G+ F+ L +HRL+IA+++
Sbjct: 465 QINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSI---FDSSLTWEHRLRIAIEV 521
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
LAYLH PI+ R+ KT+ IL +E AK+ DF S IP + +T V GTLG
Sbjct: 522 AGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLG 581
Query: 120 YCAPEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y PEY TG+ NEKS+ +G L + Y + E+NR
Sbjct: 582 YLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQKA--LCFERPQASKHLVSYFVSATEENR 639
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
EI+D V+ + + +++ +A++ EC + +RP M +VA KL +
Sbjct: 640 LHEIIDDQVLNE----DNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 347 (127.2 bits), Expect = 1.2e-30, P = 1.2e-30
Identities = 79/235 (33%), Positives = 130/235 (55%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H H++KL+GCCLET +P+LV+E + G L+ I + +L RL+IA+DI
Sbjct: 503 QINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYT-MLWGMRLRIAVDIA 561
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL+YLH PI R+ K++ IL +E+ AK+ DF S S+ +TH T + GT+GY
Sbjct: 562 GALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGY 621
Query: 121 CAPEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PEY ++ + EKS+ TG +V++ ++V +E+ + ++ R
Sbjct: 622 VDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIVA-LAEHFRVAMKEKRL 680
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
T+I+D + D K +Q+ A A+V +C+ RP+M +V +L +I S
Sbjct: 681 TDIIDARIRNDC----KPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERICTS 731
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 345 (126.5 bits), Expect = 1.6e-30, P = 1.6e-30
Identities = 79/233 (33%), Positives = 128/233 (54%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLL-KHRLKIAMDI 59
Q++H +++KL+GCCLET +P+LV+E + GTL+D + G+ F+ L +HRL++A++I
Sbjct: 460 QINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSM---FDSSLTWEHRLRMAVEI 516
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
LAYLH PI+ R+ KT+ IL +E AK+ DF S IP + + V GTLG
Sbjct: 517 AGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLG 576
Query: 120 YCAPEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y PEY TG+ NEKS+ +G L + Y + ++NR
Sbjct: 577 YLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKA--LCFERPQTSKHIVSYFASATKENR 634
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
EI+D V+ + ++++ +A++ EC + + +RP M +VA +L +
Sbjct: 635 LHEIIDGQVMNE----NNQREIQKAARIAVECTRLTGEERPGMKEVAAELEAL 683
|
|
| TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 336 (123.3 bits), Expect = 1.8e-30, P = 1.8e-30
Identities = 83/238 (34%), Positives = 123/238 (51%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
SH ++LKL+GCCLE P P+LV E ++G L + + RL+IA +I A
Sbjct: 107 SHKNVLKLLGCCLEFPRPVLVCEYPEHGAL--NCIRCGKEGVRSFPWNVRLRIAKEIADA 164
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCA 122
+AYLH FPR I+ R+ K + I +E AKL FSLSI +PEGET + D V T Y
Sbjct: 165 VAYLHTEFPRTIIHRDLKLANIFLDENWSAKLSSFSLSIVLPEGETGVNDMVCRTSSYIE 224
Query: 123 PEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTE 182
P+Y TG+ E + TG + V+ V P Y+ E TE
Sbjct: 225 PDYFNTGLVTENVDIYSLGIIMLIILTGKSEYNSEVAVYLPVLPV--YVGKFLERGLLTE 282
Query: 183 IVDHIVVEDVSS-IEKEQQLHASA--QVTFECIKDSPADR-PSMVDVAKKLRQIYRSL 236
++D +++ S I K +L A ++ F C++ P + P M+DVAK+L++I + +
Sbjct: 283 LIDPSILDSTSDDIPKHSRLQMEAFIELAFRCVRFRPGENVPRMIDVAKELKKIEKHI 340
|
|
| TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 335 (123.0 bits), Expect = 2.3e-30, P = 2.3e-30
Identities = 83/237 (35%), Positives = 129/237 (54%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKH--RLKIAMDIV 60
+H++ L+L+GCCLE P P+LVFE ++G + R G + E LL RLKI +I
Sbjct: 116 NHSNFLQLLGCCLEFPFPVLVFEFAEHGAMNQR--GGVIVNGEESLLPWSVRLKIGKEIA 173
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLG 119
+A+ YLH FP+ I+ R+ K + ++ AKL D S SIS+PEG++ I + V+GT G
Sbjct: 174 NAVTYLHTAFPKIIIHRDVKPMHVFLDKNWTAKLSDLSFSISLPEGKSRIEAEWVLGTFG 233
Query: 120 YCAPEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y P Y +T E ++ TG + D DL S + C E+ +
Sbjct: 234 YIDPLYHKTCFVTEYTDVYSFGICLLVIITGKPAIMTISD-GDLQGILSLVRELC-ENGK 291
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236
E++D +++D++S ++ Q+ A + C K+ DRP M+ VAK+L+QI SL
Sbjct: 292 LDEVIDPRLMKDITSGQR-LQVEACVVLALRCCKERDEDRPKMIQVAKELKQIEASL 347
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 344 (126.2 bits), Expect = 2.5e-30, P = 2.5e-30
Identities = 77/235 (32%), Positives = 131/235 (55%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q++H H++KL+GCCLET +PILV+E + G L+ I + ++ RL+IA+DI
Sbjct: 494 QINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYT-MIWGMRLRIAVDIA 552
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL+YLH PI R+ K++ IL +E+ AK+ DF S S+ +TH T + GT+GY
Sbjct: 553 GALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGY 612
Query: 121 CAPEYMRTGVFNEKSNXXXXXXXXXXXXTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PEY R+ + EKS+ TG +V++ +++ +E+ + ++ R
Sbjct: 613 VDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIA-LAEHFRVAMKERRL 671
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
++I+D + +D K +Q+ A A + +C+ +RP+M +V +L +I S
Sbjct: 672 SDIMDARIRDD----SKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERICTS 722
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| fgenesh4_pm.C_LG_XIII000087 | hypothetical protein (344 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 239 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-23 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-22 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-18 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-13 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-09 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-06 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-05 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-04 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.001 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 0.001 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.001 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.001 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.001 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.001 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 0.001 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.001 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 0.001 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.001 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.001 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 0.002 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.002 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 0.002 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.002 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.003 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.003 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.004 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.004 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-25
Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 30/230 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +++KL+G C E +V E ++ G L L +P L L L A+ I
Sbjct: 57 KLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL-LSYLRKNRPK---LSLSDLLSFALQIA 112
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+ YL + + R+ L E V K+ DF LS + + + + + +
Sbjct: 113 RGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
APE ++ G F KS+V+SF V L+E+ T + +++ EYLKN R
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL----EYLKN---GYR- 221
Query: 181 TEIVDHIVVEDVSSIEKEQQLHAS-AQVTFECIKDSPADRPSMVDVAKKL 229
+ + + +C + P DRP+ ++ + L
Sbjct: 222 --------------LPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-25
Identities = 58/249 (23%), Positives = 100/249 (40%), Gaps = 57/249 (22%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWD----RILGAPQPHFEPLLLKHRLKIA 56
++ H ++++L+G C E LV E ++ G L D P P L LK L A
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 116
+ I + YL + V R+ L E+ V K+ DF LS + + +
Sbjct: 112 IQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD----YYRKK 164
Query: 117 TLG-----YCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD-- 162
T G + APE ++ G+F KS+V+SF V L+E+ T G ++++ +
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY 224
Query: 163 -LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221
L P + C ++ E++ C + P DRP+
Sbjct: 225 RLPKP-----EYCPDE--LYELM------------------------LSCWQLDPEDRPT 253
Query: 222 MVDVAKKLR 230
++ ++L
Sbjct: 254 FSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 9e-25
Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 29/230 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +I+KL+G C E ++V E + G L L +P L L L A+ I
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL-LDYLRKNRPKE--LSLSDLLSFALQIA 113
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+ YL + + R+ L E V K+ DF LS + + + + + +
Sbjct: 114 RGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRW 170
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
APE ++ G F KS+V+SF V L+E+ T + +++ EYLK R
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL----EYLKK---GYR- 222
Query: 181 TEIVDHIVVEDVSSIEKEQQLHAS-AQVTFECIKDSPADRPSMVDVAKKL 229
+ K ++ +C + P DRP+ ++ + L
Sbjct: 223 --------------LPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 9e-23
Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 16/155 (10%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++SH +I++L+G C + +V E + G L D + + H E L LK L++A+ I
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIA 112
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+ YL + V R+ L E V K+ DF LS I E + G
Sbjct: 113 KGMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY----YRKRGGGK 165
Query: 121 -----CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE ++ G F KS+V+SF V L+E+ T
Sbjct: 166 LPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 1e-22
Identities = 47/149 (31%), Positives = 77/149 (51%), Gaps = 10/149 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+++H +I+KL G + LV E + G+L D + + + L L+I + I+
Sbjct: 47 KLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQIL 102
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLG 119
L YLH I+ R+ K IL + +N KL DF LS + + + T++GT
Sbjct: 103 EGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPA 158
Query: 120 YCAPE-YMRTGVFNEKSNVFSFSVFLFEL 147
Y APE + G ++EKS+++S V L+EL
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 3e-18
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +I++L + LV E + G L+D + + + I+
Sbjct: 53 KLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARF---YLRQIL 107
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL YLH + IV R+ K IL +E+ KL DF L+ + GE T +GT Y
Sbjct: 108 SALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEY 162
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE + + + +++S V L+ELLTG
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 8e-16
Identities = 49/150 (32%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
+SH +I++LI + LV E + G L+D + K KIA+ I+
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAK---KIALQILR 109
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYC 121
L YLH I+ R+ K IL +E V K+ DF L+ + T +GT Y
Sbjct: 110 GLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLA-KKLLKSSSSLTTFVGTPWYM 165
Query: 122 APEYMRTG-VFNEKSNVFSFSVFLFELLTG 150
APE + G + K +V+S V L+ELLTG
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTG 195
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 73.6 bits (179), Expect = 3e-15
Identities = 54/237 (22%), Positives = 85/237 (35%), Gaps = 30/237 (12%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
+I+KL + LV E V G+L D + PL L I I+ A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSA 113
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDFSLSISIPEGETH-----ITDTVMG 116
L YLH + I+ R+ K IL + + V KL DF L+ +P+ + + T +G
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 117 TLGYCAPEYMRTGVFNE---KSNVFSFSVFLFELLTG---WDVSDLVKDVHDLVCPFSEY 170
T GY APE + S+++S + L+ELLTG ++ + E
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230
Query: 171 LKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227
+ I ++K + P +R S
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKK-------------LLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-15
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 2 MSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
+ H +I+K G C + L+ E + G+L D + Q H + + LK L + I
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQI 118
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
+ YL + + R+ IL E++ K+ DF L+ +PE + + G
Sbjct: 119 CKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 120 --YCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ APE +RT F+ S+V+SF V L+EL T
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 19/237 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +I+KLIG C L+ E ++ L + + L + R KIA+ I
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIA 790
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL +LH +V N I+ + ++ L +S+P G + Y
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-----RLSLP-GLLCTDTKCFISSAY 844
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
APE T EKS+++ F + L ELLTG +D VH + ++ Y C+ D
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY---CYSDCHL 901
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237
+D + DV S+ + + + + C P RP DV K L RS S
Sbjct: 902 DMWIDPSIRGDV-SVNQNEIVEV-MNLALHCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-14
Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
+ H ++++L G L P+ ++V E G+L DR+ + L+ A+ I +
Sbjct: 53 LDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIAN 108
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL--G 119
+ YL + + R+ IL ++ K+ DF L ++P+ E H +
Sbjct: 109 GMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+CAPE +RT F+ S+V+ F V L+E+ T
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-13
Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H +I+K G L+ +V E G+L D + Q E + + +++
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY----VCKELL 108
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
L YLH I+ R+ K + IL + KL DF LS + + + +T++GT +
Sbjct: 109 KGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYW 163
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE + ++ K++++S + EL G
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-13
Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 33/203 (16%)
Query: 30 GTLWDRILGAPQPHFEPLLLKHRLKIAM--DIVHALAYLHFGFPRPIVFRNFKTSCILFN 87
GTL+D+I+ FE + + IV A++Y+H I+ R+ KT I
Sbjct: 84 GTLYDKIVRQKGQLFE-----EEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLT 135
Query: 88 EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFEL 147
+ + KL DF +S I E + +TV+GT Y +PE + +N KS++++ L+EL
Sbjct: 136 KAGLIKLGDFGIS-KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYEL 194
Query: 148 LTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQV 207
LT LK F+ +V I V+ + +
Sbjct: 195 LT---------------------LKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISL 232
Query: 208 TFECIKDSPADRPSMVDVAKKLR 230
++ P RP+ +V +
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-13
Identities = 56/246 (22%), Positives = 97/246 (39%), Gaps = 46/246 (18%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWD---------RILGAPQPHFEPLLLKHR 52
H +I+K G C E PI+VFE +++G L L +P L L
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 53 LKIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 109
L+IA+ I + YL HF V R+ T L + V K+ DF +S + + +
Sbjct: 125 LQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 110 -ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFS 168
+ M + + PE + F +S+V+SF V L+E+ T
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT------------------- 219
Query: 169 EYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASA---QVTFECIKDSPADRPSMVDV 225
Y K + E+++ I ++ + + C K P R ++ D+
Sbjct: 220 -YGKQPWYGLSNEEVIECI----TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274
Query: 226 AKKLRQ 231
++L++
Sbjct: 275 HERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 9e-13
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 11/153 (7%)
Query: 1 QMSHNHILKLIGCCL-ETPIPILVF-ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
+ H +I++ G E + +F E V G+L + +++ +
Sbjct: 55 SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTR---Q 109
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGT 117
I+ LAYLH IV R+ K + IL + + V KL DF + + + ET T +V GT
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE +R + ++++S + E+ TG
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 38/147 (25%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H ++++L+G L+ +V E + G+L D + + L +L A+D+
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVIT---LAQQLGFALDVC 112
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+ YL + V R+ +L +E+ VAK+ DF L+ + + D+ + +
Sbjct: 113 EGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLA----KEASQGQDSGKLPVKW 165
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFEL 147
APE +R F+ KS+V+SF + L+E+
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 17/162 (10%)
Query: 6 HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAY 65
+I+ G L + E + G+L DRI P+ ++ KIA+ +V L Y
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSL-DRIY----KKGGPIPVEILGKIAVAVVEGLTY 118
Query: 66 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGTLGYCAP 123
L+ I+ R+ K S IL N KL DF +S GE I DT +GT Y +P
Sbjct: 119 LYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSP 171
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLTG---WDVSDLVKDVHD 162
E ++ G + KS+V+S + + EL G + S++ D D
Sbjct: 172 ERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-12
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 13/155 (8%)
Query: 2 MSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
+ H +I+K GCC E L+ E V G+L D + P+ L L L A I
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PK---HKLNLAQLLLFAQQI 116
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGT 117
+AYLH + + R+ +L + + + K+ DF L+ ++PEG + + +
Sbjct: 117 CEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWD 152
+ + A E ++ F+ S+V+SF V L+ELLT D
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELLTHCD 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-12
Identities = 50/158 (31%), Positives = 74/158 (46%), Gaps = 19/158 (12%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP--LLLKHRLKIAMDIVH 61
H +I+KL+G CL ++ E ++ G L + A F P L LK L I +D+
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 62 ALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-------PEGETHIT 111
YL HF R + RN S ++ + V K+ DF L+ I EGE +
Sbjct: 118 GCVYLEQMHF-IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 112 DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
M APE + G F +S+V+SF V ++E+LT
Sbjct: 177 VRWM------APESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 9e-12
Identities = 59/250 (23%), Positives = 96/250 (38%), Gaps = 60/250 (24%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMDI 59
Q+ H I++LIG C P+ +LV E G L + + P + L H++ + M
Sbjct: 52 QLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM-- 108
Query: 60 VHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 116
AYL HF V R+ +L + AK+ DF +S ++ G + T G
Sbjct: 109 ----AYLESKHF------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158
Query: 117 T--LGYCAPEYMRTGVFNEKSNVFSFSVFLFEL----------LTGWDVSDLVKDVHDLV 164
L + APE + G F+ KS+V+S+ V L+E + G +V +++ L
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP 218
Query: 165 CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224
P + C I + C K P DRP+ +
Sbjct: 219 RP-----EEC---------PQEIY-----------------SIMLSCWKYRPEDRPTFSE 247
Query: 225 VAKKLRQIYR 234
+ R+
Sbjct: 248 LESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-11
Identities = 54/264 (20%), Positives = 101/264 (38%), Gaps = 68/264 (25%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTL-----WDRILGAP--------------Q 41
Q++H H++KL G C + +L+ E +YG+L R +G
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 42 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101
P L + + A I + YL +V R+ +L E K+ DF LS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 102 SIPEGETHIT---DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--------- 149
+ E ++++ + + + A E + ++ +S+V+SF V L+E++T
Sbjct: 176 DVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233
Query: 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVT 208
+ +L+K + + P +NC E +
Sbjct: 234 APERLFNLLKTGYRMERP-----ENCSE--------------------------EMYNLM 262
Query: 209 FECIKDSPADRPSMVDVAKKLRQI 232
C K P RP+ D++K+L ++
Sbjct: 263 LTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-11
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 22/163 (13%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLK 50
+ H HI++ G C E ++VFE +++G L +R L + P + L L
Sbjct: 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 51 HRLKIAMDIVHALAY---LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 107
L IA I + Y LHF V R+ T L + V K+ DF +S I +
Sbjct: 123 QMLAIASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 108 TH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + M + + PE + F +S+++SF V L+E+ T
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
Q+ H+++++L+G +E + +V E + G+L D + + L LK ++D+
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDV 111
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
A+ YL V R+ +L +E+NVAK+ DF L+ + + DT +
Sbjct: 112 CEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVK 164
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFEL 147
+ APE +R F+ KS+V+SF + L+E+
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 1 QMSHNHILKLIGCCLE-TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
++SH +++L G C E +PI LVFE +++G L D L A + F L L + +D+
Sbjct: 55 KLSHPKLVQLYGVCTERSPI-CLVFEFMEHGCLSD-YLRAQRGKFSQETL---LGMCLDV 109
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
+AYL ++ R+ L E V K+ DF ++ + + + + +
Sbjct: 110 CEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
+ +PE ++ KS+V+SF V ++E+ FSE K +E+
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEV-------------------FSEG-KTPYENRS 206
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFE----CIKDSPADRPS 221
+E VVE +++ + + ++Q +E C K+ P DRPS
Sbjct: 207 NSE-----VVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 3e-10
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 4/96 (4%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
A +IV AL YLH I++R+ K IL + + KL DF L+ + + T+T
Sbjct: 98 YAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTF 153
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE + + + + +S V L+E+LTG
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-10
Identities = 38/101 (37%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 52 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
R+ IA +IV AL +LH I++R+ K IL + E L DF LS E
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 112 DTVMGTLGYCAPEYMRTGVFNEKSNV--FSFSVFLFELLTG 150
+ GT+ Y APE +R G V +S V FELLTG
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-09
Identities = 37/153 (24%), Positives = 74/153 (48%), Gaps = 13/153 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI---LGAPQPHFEPLLLKHRLKIAM 57
++ ++I++ L+ +V E + G L + G P P E + + +
Sbjct: 55 KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLP--EDQVWR----FFI 108
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
I+ LA+LH + I+ R+ K+ + + + K+ D ++ + + T+ +T++GT
Sbjct: 109 QILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGT 164
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
Y +PE +NEKS+V++ V L+E TG
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 35/168 (20%), Positives = 76/168 (45%), Gaps = 19/168 (11%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
+ H H+++L+G CL + L+ + + G L D + + H + + ++ L + I
Sbjct: 66 VDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYV----RNHKDNIGSQYLLNWCVQIAK 120
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGY 120
++YL + +V R+ +L K+ DF L+ + E + + +
Sbjct: 121 GMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVK 158
A E + ++ KS+V+S+ V ++EL+T ++ DL++
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 21/154 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILG---APQPHFEPLLLKHRLKI 55
++ H ++++L+G L + I V E + G L + R G L+
Sbjct: 55 KLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQL--------LQF 105
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
++D+ + YL + +V R+ IL +E+ VAK+ DF L+ G D
Sbjct: 106 SLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSK 158
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + APE ++ F+ KS+V+S+ V L+E+ +
Sbjct: 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 16/158 (10%)
Query: 1 QMSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
Q H +I+KLIG C++ PI I V E V G+L + L +K L++++D
Sbjct: 48 QYDHPNIVKLIGVCVQKQPIYI-VMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDA 102
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-- 117
+ YL + + R+ L E NV K+ DF +S G ++D G
Sbjct: 103 AAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD---GLKQ 156
Query: 118 --LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153
+ + APE + G + +S+V+S+ + L+E + D
Sbjct: 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDT 194
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 52/221 (23%)
Query: 13 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYL--HFGF 70
C LE PI I V E ++YG+L + + G L L + +A + +AYL
Sbjct: 70 CTLEEPIYI-VTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV 130
R + RN +L E N+ K+ DF L+ I E + + + APE
Sbjct: 126 HRDLAARN-----VLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR 180
Query: 131 FNEKSNVFSFSVFLFEL----------LTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
F+ KS+V+SF + L E+ +T +V V + + CP C
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP-----PGC------ 229
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221
++L+ + +C K+ P DRP+
Sbjct: 230 -----------------PKELY---DIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 4e-09
Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL--GAPQPHF-EPLLLKHRLKIAM 57
+++H +I+K E +V E G L +I F E +L +++ +
Sbjct: 55 KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
AL YLH R I+ R+ K I + KL DF +S + + TV+GT
Sbjct: 115 ----ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGIS-KVLSSTVDLAKTVVGT 166
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
Y +PE + +N KS+++S L+EL T
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-09
Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
IV AL YLH + I+ R+ K IL +E+ + DF+++ + +T + GT
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTP 163
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GY APE + ++ + +S V +E L G
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-09
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 10/96 (10%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THIT 111
KIA ++ L+YLH R I+ R+ K S IL + KL DF +S GE +
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLA 160
Query: 112 DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFEL 147
T GT Y APE ++ ++ S+V+S + L E+
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 23/238 (9%)
Query: 2 MSHNHILKLIGCCLETPIP--ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
+ H++I+K G C LV E + YG+L D + Q H E L + L A I
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQI 117
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-- 117
+ YL + V R+ T IL EN K+ DF L+ +P+ + + G
Sbjct: 118 CKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFED 177
+ + APE + F+ S+V+SF V L+EL T D S P +E+++ D
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC---------SPPAEFMRMMGND 225
Query: 178 NRFTEIVDHIVVEDVSSIEKEQQLHASAQV---TFECIKDSPADRPSMVDVAKKLRQI 232
+ IV H++ ++ A++ EC + P+ RPS ++A ++ I
Sbjct: 226 KQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 7/149 (4%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H +I+KLIG C + +V E V G L + + L K +K A+D
Sbjct: 48 QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF----LSFLRKKKDELKTKQLVKFALDAA 103
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+AYL + + R+ L E NV K+ DF +S +G + + +
Sbjct: 104 AGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW 160
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
APE + G ++ +S+V+S+ + L+E +
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 8/148 (5%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H HI+KLIG E P+ I V E G L + Q + L L + + +
Sbjct: 63 QFDHPHIVKLIGVITENPVWI-VMELAPLGELRSYL----QVNKYSLDLASLILYSYQLS 117
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
ALAYL + V R+ +L + + KL DF LS + + + + +
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELL 148
APE + F S+V+ F V ++E+L
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 33/101 (32%), Positives = 45/101 (44%), Gaps = 14/101 (13%)
Query: 59 IVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS--------ISIPEGETH 109
IV AL YLH G I+ R+ K IL + KL DF LS I++ + E
Sbjct: 102 IVLALEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157
Query: 110 ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
V GT Y APE + ++ + +S L+E L G
Sbjct: 158 DKRIV-GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 13/156 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL----GAPQPHFEPLLLKHRLKIA 56
++SH ++++L+G C E ++ E G L + + PL K ++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 57 MDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
I + +L F R + RN C++ ++ K+ SLS + E +
Sbjct: 124 TQIALGMDHLSNARF-VHRDLAARN----CLVSSQ-REVKVSLLSLSKDVYNSEYYKLRN 177
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ L + APE ++ F+ KS+V+SF V ++E+ T
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-08
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 37/209 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H ++++L+G C P ++ E + YG L D + + ++L L +A I
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQIS 114
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT-VMGTLG 119
A+ YL + + R+ L E ++ K+ DF LS + G+T+ +
Sbjct: 115 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK 170
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHDLV-------- 164
+ APE + F+ KS+V++F V L+E+ T G D+S V++L+
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEKGYRMER 226
Query: 165 ---CPFSEY--LKNCFEDN-----RFTEI 183
CP Y ++ C++ N F EI
Sbjct: 227 PEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 40/215 (18%)
Query: 22 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81
+V E + G+L D + +L IA I+ L YLH R I+ R+ K
Sbjct: 76 IVLEYMDGGSLADLL--KKVGKIPEPVLA---YIARQILKGLDYLH--TKRHIIHRDIKP 128
Query: 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFS 141
S +L N + K+ DF +S + E +T +GT+ Y +PE ++ ++ ++++S
Sbjct: 129 SNLLINSKGEVKIADFGISKVL-ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLG 187
Query: 142 VFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQL 201
+ L E G PF F E++ I S+ E
Sbjct: 188 LTLLECALG-------------KFPFLPP-----GQPSFFELMQAICDGPPPSLPAE--- 226
Query: 202 HASAQVTFE-----CIKDSPADRPSMVDVAKKLRQ 231
S + F C++ P RPS A +L Q
Sbjct: 227 EFSPE--FRDFISACLQKDPKKRPS----AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 53 LKIAMDIVHALAYLHFG-FPRPIVF-RNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 110
+I ++ AL H P V R+ K + I + N KL DF L+ + +
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSF 166
Query: 111 TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T +GT Y +PE + ++EKS+++S ++EL
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 23/164 (14%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRIL------------GAPQPHFEPLLL 49
+ H HI+K G C + I+VFE +++G L ++ L G P+ L L
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 50 KHRLKIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 106
L IA I + YL HF V R+ T L + K+ DF +S +
Sbjct: 123 SQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 107 ETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + + M + + PE + F +S+V+SF V L+E+ T
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 25/163 (15%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRI-----------LGAPQPHFEPLLLKHR 52
H +I+ L+G C + +V E +G L D + P+P E L K
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 53 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
+ A + + +L + + R+ +L E++V K+ DF L+ I H D
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHID 186
Query: 113 ----TVMGTLGY--CAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
T G L APE + V+ +S+V+SF V L+E+ T
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 22/160 (13%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHF-------EPLLLKH 51
H +I+ L+G C + E YG L D R+L P F L +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVL-ETDPAFAKEHGTASTLTSQQ 120
Query: 52 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
L+ A D+ + YL + + R+ +L E +K+ DF LS GE
Sbjct: 121 LLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYV 173
Query: 112 DTVMGTLG--YCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
MG L + A E + V+ KS+V+SF V L+E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-08
Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 7/149 (4%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ H +++L + PI I + E ++ G+L D L P+ L + + +A I
Sbjct: 57 QLQHPRLVRLYAVVTQEPIYI-ITEYMENGSLVD-FLKTPEGI--KLTINKLIDMAAQIA 112
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+A++ + + R+ + + IL +E K+ DF L+ I + E + + +
Sbjct: 113 EGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
APE + G F KS+V+SF + L E++T
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-08
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 13/154 (8%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
+ H +I++ +G CL+ + E V G++ IL P EP+ K+ I+
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKY----TKQILD 113
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM-----G 116
+AYLH +V R+ K + ++ + KL DF + + H T + M G
Sbjct: 114 GVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T + APE + + KS+++S +FE+ TG
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-08
Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q SH +I++LIG C + +V E VQ G L P L +K +++ +
Sbjct: 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGPR---LKVKELIQMVENAA 104
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-LG 119
+ YL + + R+ L E+NV K+ DF +S +G T + +
Sbjct: 105 AGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK 161
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFE 146
+ APE + G ++ +S+V+SF + L+E
Sbjct: 162 WTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-08
Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 9/99 (9%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THIT 111
KIA+ ++ L YLH I+ R+ K S IL N KL DF +S G+ +
Sbjct: 104 KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLA 156
Query: 112 DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T +GT Y APE ++ ++ KS+++S + L EL TG
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-08
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 37/213 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H +I++L G ++ +++ E ++ G+L D+ L F L + + I
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQL---VGMLRGIA 116
Query: 61 HALAYL--HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 116
+ YL R + RN IL N V K+ DF LS + + E T T G
Sbjct: 117 SGMKYLSEMNYVHRDLAARN-----ILVNSNLVCKVSDFGLSRRLEDSEA--TYTTKGGK 169
Query: 117 -TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD------ 162
+ + APE + F S+V+SF + ++E+++ D++K V D
Sbjct: 170 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP 229
Query: 163 -LVCPFSEY--LKNCFEDNR-----FTEIVDHI 187
+ CP + Y + +C++ +R F++IV +
Sbjct: 230 PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-08
Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 18/160 (11%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTL--------WDRILGAPQPHFEPLLLKHRL 53
+ H HI+K G C+E I+VFE +++G L D +L A L L
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 54 KIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH- 109
IA I + YL HF V R+ T L E + K+ DF +S + + +
Sbjct: 124 HIAQQIAAGMVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 110 ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ M + + PE + F +S+V+S V L+E+ T
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-08
Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 7/146 (4%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
H H++ L C ++ E ++ G+L L +P+ + L + + +A + +
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLA-FLRSPEG--QVLPVASLIDMACQVAEGM 117
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123
AYL + + R+ IL E+ V K+ DF L+ I E + +++ + AP
Sbjct: 118 AYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAP 173
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLT 149
E G F+ KS+V+SF + L+E+ T
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
+V A YLH R I++R+ K +L + KL DF + + G+ T T GT
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTP 156
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
Y APE + ++ + +S + L+ELLTG
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 26/95 (27%), Positives = 48/95 (50%), Gaps = 5/95 (5%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A I+ L +LH R IV+R+ K +L ++ ++ D L++ + G+
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT GY APE ++ V++ + F+ L+E++ G
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 24/163 (14%)
Query: 1 QMSHNHILKLI--GCCLETPIPIL--VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
++ H +I+ L+ G E P +L VFE V TL + + A +
Sbjct: 34 RLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVL--AADGALPAGETGRLMLQV 88
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV---AKLFDFSLSISIP----EGETH 109
+D ALA H + IV R+ K I+ ++ V AK+ DF + +P
Sbjct: 89 LD---ALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142
Query: 110 ITDT--VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+T T V+GT YCAPE +R S+++++ + E LTG
Sbjct: 143 LTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 57/261 (21%), Positives = 95/261 (36%), Gaps = 72/261 (27%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTL-----------------WDRILGAPQPHFEP 46
H +I+KL+G C L+FE + YG L + P
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 47 LLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 106
L +L IA + +AYL R V R+ T L E V K+ DF LS +I
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI--- 180
Query: 107 ETHITDTVMGT------LGYCAPEYMRTGVFNEKSNVFSFSVFLFEL----------LTG 150
+ D + + + PE + + +S+V+++ V L+E+ +
Sbjct: 181 --YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238
Query: 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFE 210
+V V+D + L CP DN E+ + + +
Sbjct: 239 EEVIYYVRDGNVLSCP----------DNCPLELYNLMRL--------------------- 267
Query: 211 CIKDSPADRPSMVDVAKKLRQ 231
C P+DRPS + + L++
Sbjct: 268 CWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-07
Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 13/152 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRLKIA--M 57
++ H +++L E PI I V E + G+L D + G + P L+ +IA M
Sbjct: 57 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 115
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
V + Y+H R+ + + IL E V K+ DF L+ I + E
Sbjct: 116 AYVERMNYVH---------RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + APE G F KS+V+SF + L EL T
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 10/98 (10%)
Query: 53 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
L +A+D +H+L I++R+ K IL +EE KL DF LS + E
Sbjct: 107 LALALDHLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AY 156
Query: 113 TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ GT+ Y APE + + ++ +SF V +FE+LTG
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +I+ L ++H F +V+R+ K + IL +E ++ D L+ + + H + +
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 156
Query: 116 GTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTG 150
GT GY APE ++ G ++ ++ FS LF+LL G
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 38/212 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK-IA--M 57
Q SH++I++L G + +++ E ++ G L D+ L F L L+ IA M
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGM 120
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI---PEGETHITDTV 114
+ + Y+H R + RN IL N K+ DF LS + PEG T+ T
Sbjct: 121 KYLSDMNYVH----RDLAARN-----ILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGG 170
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-----GWDVS--DLVKDVHD----- 162
+ + APE + F S+V+SF + ++E+++ WD+S +++K ++D
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230
Query: 163 --LVCPFSEY--LKNCFEDNR-----FTEIVD 185
+ CP + Y + C++ +R F +IV+
Sbjct: 231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 46/192 (23%), Positives = 87/192 (45%), Gaps = 30/192 (15%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPL---LLKHRLKIAMD 58
+ H +I+K IG + ++ E + G+L I F P L+ +
Sbjct: 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQII-----KKFGPFPESLVAVYVY---Q 107
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
++ LAYLH + ++ R+ K + IL ++ V KL DF ++ + + + +V+GT
Sbjct: 108 VLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTP 163
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG----WDVSDL------VKDVH-----DL 163
+ APE + + S+++S + ELLTG +D++ + V+D H +
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGI 223
Query: 164 VCPFSEYLKNCF 175
++L CF
Sbjct: 224 SPELKDFLMQCF 235
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +I+ L ++H F +V+R+ K + IL +E ++ D L+ + + H + +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---V 156
Query: 116 GTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTG 150
GT GY APE ++ GV ++ ++ FS LF+LL G
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 1 QMSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
++ H+ +++L C E PI I V E + G+L D L + + L L + +A I
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYI-VTEYMSKGSLLD-FLKSGEGKK--LRLPQLVDMAAQI 112
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-- 117
+AYL R + R+ IL E V K+ DF L+ I E G
Sbjct: 113 AEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKF 166
Query: 118 -LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + APE G F KS+V+SF + L E++T
Sbjct: 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-07
Identities = 44/160 (27%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHF-------EPLLLKH 51
H +I+ L+G C L E +G L D R+L P F L +
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL-ETDPAFAIANSTASTLSSQQ 113
Query: 52 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
L A D+ + YL + + R+ IL E VAK+ DF LS G+
Sbjct: 114 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYV 166
Query: 112 DTVMGTLG--YCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
MG L + A E + V+ S+V+S+ V L+E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-07
Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 48/237 (20%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAP-QPHFEPLLLKH------RL 53
Q+ H +I++ LE +V + ++ GAP HF L K R+
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIE---------GAPLGEHFNSLKEKKQRFTEERI 115
Query: 54 -KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
I + +V AL YLH + IV R+ + I+ E++ + DF L+ +
Sbjct: 116 WNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLT 171
Query: 113 TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLK 172
+V+GT+ Y PE ++ + EK++V++F L+++ T L PF Y
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-------------LQPPF--YST 216
Query: 173 NCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTF---ECIKDSPADRPSMVDVA 226
N + T+IV+ + E + S VT C+ RP ++ V+
Sbjct: 217 NML--SLATKIVE-------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-07
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 13/152 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRLKIA--M 57
++ H+ ++ L E PI I V E + G+L D + + + P L+ +IA M
Sbjct: 57 KLRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGM 115
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
+ + Y+H R+ + + IL + V K+ DF L+ I + E
Sbjct: 116 AYIERMNYIH---------RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + APE G F KS+V+SF + L EL+T
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +I+ L +LH + I++R+ K +L +++ K+ DF + GE T
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-KASTFC 157
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE ++ +NE + +SF V L+E+L G
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-07
Identities = 43/171 (25%), Positives = 80/171 (46%), Gaps = 20/171 (11%)
Query: 1 QMSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
++SH ++++L G C + PI I V E + G L + + + L + L + D+
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFI-VTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDV 109
Query: 60 VHALAYL--HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
A+ YL + R + RN C L E+NV K+ DF L+ + + + +
Sbjct: 110 CEAMEYLESNGFIHRDLAARN----C-LVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP 164
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVH 161
+ + PE F+ KS+V+SF V ++E+ + + S++V+ V
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 39/148 (26%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
+ H+ ++KL + PI I+ E + G+L D L + + +PL + + I
Sbjct: 58 LQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLD-FLKSDEGSKQPL--PKLIDFSAQIAE 113
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYC 121
+A++ R + R+ + + IL + V K+ DF L+ I + E + + +
Sbjct: 114 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170
Query: 122 APEYMRTGVFNEKSNVFSFSVFLFELLT 149
APE + G F KS+V+SF + L E++T
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-07
Identities = 37/145 (25%), Positives = 71/145 (48%), Gaps = 11/145 (7%)
Query: 7 ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYL 66
I K G L+ P ++ E + G++ R L P E K+ I +++ AL Y+
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAE----KYISVIIREVLVALKYI 117
Query: 67 HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYM 126
H ++ R+ K + IL KL DF ++ + + + + T +GT + APE +
Sbjct: 118 H---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS-TFVGTPYWMAPEVI 173
Query: 127 RTGV-FNEKSNVFSFSVFLFELLTG 150
G ++ K++++S + ++E+ TG
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 15/159 (9%)
Query: 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGA---PQPHFEPLLLKH 51
+ H ++++LIG CL+T P P+++ +++G L +L + P + P +
Sbjct: 56 EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QM 113
Query: 52 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
+K DI + YL + + R+ + NE + DF LS I G+ +
Sbjct: 114 LVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170
Query: 112 DTVMGT-LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + + A E + V+ KS+V+SF V ++E+ T
Sbjct: 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-07
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 25/164 (15%)
Query: 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTL-----WDRILGAPQPHFEPLLL 49
H +++KLIG C E P P+++ +++G L + R+ G P E L L
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP----EKLPL 112
Query: 50 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG--- 106
+ LK +DI + YL R + R+ + E+ + DF LS I G
Sbjct: 113 QTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY 169
Query: 107 -ETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ I + + A E + V+ KS+V++F V ++E+ T
Sbjct: 170 RQGRIAKM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-07
Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 13/155 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMD 58
+ H +I++ +G E + E V G+L R P E ++ +
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY----TKQ 116
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGT 117
I+ L YLH IV R+ K +L N V K+ DF S + G T+T GT
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGT 172
Query: 118 LGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLTG 150
L Y APE + G + ++++S + E+ TG
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-07
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 9/153 (5%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE---PLLLKHRLKIAMDI 59
+H +I++LIG E ++ E + G L L +P E L +K L A D+
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 60 VHALAYLH-FGF-PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMG 116
YL F R I RN +C VAK+ DF ++ I + M
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCK--GPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + PE G+F K++V+SF V L+E+ +
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-07
Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 2 MSHNH-ILKLIGCCLETPIPIL-VFESVQYGTLW-----DRILGAPQPHFEPLLLKHRLK 54
++ NH L + CC +TP + V E V G L R + F
Sbjct: 51 LARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF---------- 100
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDT 113
A +I AL +LH + I++R+ K +L + E KL DF + I G+T T T
Sbjct: 101 YAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TST 155
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE ++ ++ + ++ V L+E+L G
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-07
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
+I+ AL +LH IV+R+ K IL + E L DF LS E T + GT
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169
Query: 118 LGYCAPEYMRTGVFNEKS-NVFSFSVFLFELLTG 150
+ Y APE +R + K+ + +S + +FELLTG
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-07
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 9/149 (6%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
+SH +I++ LE ++V E GTL + I + L + I+
Sbjct: 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE---DTILHFFVQILL 112
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL ++H + I+ R+ KT IL ++ + V K+ DF +S + TV+GT Y
Sbjct: 113 ALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCY 167
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+PE +N+KS++++ L+EL +
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 5 NHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPLLLKHRLKIAMDI 59
+H+++L+G ++V E + G L R P P L+ +++A +I
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTL 118
+AYL + V R+ + E+ K+ DF ++ I E + + + +
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ APE ++ GVF KS+V+SF V L+E+ T
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI-SIPEGETHITDTV 114
A +IV L +LH R I++R+ K +L + E K+ DF + I G T T T
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE + + + ++ V L+E+L G
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 34/120 (28%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +I L LH IV+R+ K IL ++ ++ D L++ +PEG+T I V
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV- 162
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW-------------DVSDLVKDVHD 162
GT+GY APE ++ + + ++ L+E++ G +V LVK+V +
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 36/232 (15%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDI 59
+M H +I+ E +V E G L RI F E +L ++I++ +
Sbjct: 55 KMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTL 118
H +H R I+ R+ K+ I ++ VAKL DF ++ + + + T +GT
Sbjct: 115 KH----IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTP 166
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDN 178
Y +PE + +N K++++S L+EL T LK+ FE N
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCT---------------------LKHPFEGN 205
Query: 179 RFTEIVDHIVVEDVSSIEK--EQQLHASAQVTFECIKDSPADRPSMVDVAKK 228
++V I + I + L + F K SP DRPS+ + K+
Sbjct: 206 NLHQLVLKICQGYFAPISPNFSRDLRSLISQLF---KVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 38/126 (30%), Positives = 58/126 (46%), Gaps = 14/126 (11%)
Query: 49 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 108
LK +LK A+ I + YL R V R+ +L E+ K+ DF L+ +I +
Sbjct: 108 LKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164
Query: 109 HIT--DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCP 166
+ T D + + + APE + F S+V+SF V L+ELLT D P
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE---------SSP 215
Query: 167 FSEYLK 172
+ +LK
Sbjct: 216 MTLFLK 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 5/95 (5%)
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
+IV AL +LH I++R+ K IL + L DF LS E E + GT
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 118 LGYCAPEYMRTGVFNEKSNV--FSFSVFLFELLTG 150
+ Y AP+ +R G V +S V ++ELLTG
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 37/129 (28%), Positives = 59/129 (45%), Gaps = 8/129 (6%)
Query: 22 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81
LV + G L I P FE + L A +I+ L LH V+R+ K
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLH---RENTVYRDLKP 130
Query: 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFS 141
IL ++ ++ D L++ IPEGE+ I V GT+GY APE + + + +
Sbjct: 131 ENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQRYTLSPDYWGLG 188
Query: 142 VFLFELLTG 150
++E++ G
Sbjct: 189 CLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 1e-06
Identities = 41/129 (31%), Positives = 56/129 (43%), Gaps = 19/129 (14%)
Query: 1 QMSHNHILKLIG-CCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAM 57
++ H +I+KL+ E + LVFE D + L P L+K I
Sbjct: 54 ELKHPNIVKLLDVIHTERKL-YLVFEYCDM----DLKKYLDKRPGPLSPNLIKS---IMY 105
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVM 115
++ LAY H I+ R+ K IL N + V KL DF L+ IP T V+
Sbjct: 106 QLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVV 160
Query: 116 GTLGYCAPE 124
TL Y APE
Sbjct: 161 -TLWYRAPE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-06
Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 4 HNHILKLIGCCL-ETPIPILVFESVQYGTLWD--RILGAPQP---------HFEPLLLKH 51
H +I+ L+G C E P+ ++V E G L + R P P E L K
Sbjct: 77 HKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 52 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
+ A + + YL R + R+ +L E+NV K+ DF L+ + + + +
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID-YYK 191
Query: 112 DTVMGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
T G L + APE + V+ +S+V+SF + ++E+ T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMG 116
+I AL +LH + I++R+ K IL + + KL DF L SI EG +T T G
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCG 162
Query: 117 TLGYCAPE-YMRTGVFNEKSNVFSFSVFLFELLTG 150
T+ Y APE MR+G + + +S ++++LTG
Sbjct: 163 TIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 21/221 (9%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLW---DRILGAPQPHFEPLLLKHRLKIA 56
Q S N L + C +T + LV E V G L R P+ +H A
Sbjct: 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPE--------EHARFYA 102
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGETHITDTVM 115
+I AL +LH R I++R+ K +L + + KL D+ + + G+T T T
Sbjct: 103 AEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFC 157
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCP---FSEYLK 172
GT Y APE +R + + ++ V +FE++ G D++ D D+ F L+
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE 217
Query: 173 NCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIK 213
RF + V++ + + +++L Q F IK
Sbjct: 218 KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIK 258
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 4/96 (4%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
I + L YLH + R+ K IL NEE AKL DF +S +TV
Sbjct: 104 ILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTV 159
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GT + APE ++ +N K++++S + E+ G
Sbjct: 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 25/158 (15%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-------RILGAPQPHFEPLLLKHRL 53
++ H+ +++L E PI I V E + G+L D R L P L+
Sbjct: 57 KLRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPN------LVDMAA 109
Query: 54 KIA--MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
++A M + + Y+H R+ +++ IL + V K+ DF L+ I + E
Sbjct: 110 QVAAGMAYIERMNYIH---------RDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160
Query: 112 DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + APE G F KS+V+SF + L EL+T
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
KIA+ IV AL YLH ++ R+ K S +L N KL DF +S ++ D+
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDS 157
Query: 114 VMGTLG-----YCAPEY----MRTGVFNEKSNVFSFSVFLFELLTG 150
V T+ Y APE + ++ KS+V+S + + EL TG
Sbjct: 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +I+ L +LH + IV+R+ K IL + + K+ DF + G+ T T
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFC 157
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE + +N + +SF V L+E+L G
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 8/149 (5%)
Query: 2 MSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H+ +++L E PI I+ E + G+L D + +LL + + I
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIIT-EYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQIA 113
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+AY+ + + R+ + + +L +E + K+ DF L+ I + E + + +
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
APE + G F KS+V+SF + L+E++T
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 44/160 (27%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHF-------EPLLLKH 51
H +I+ L+G C L E +G L D R+L P F L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL-ETDPAFAIANSTASTLSSQQ 125
Query: 52 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
L A D+ + YL + + R+ IL E VAK+ DF LS G+
Sbjct: 126 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYV 178
Query: 112 DTVMGTLG--YCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
MG L + A E + V+ S+V+S+ V L+E+++
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-06
Identities = 39/157 (24%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 5 NHILKLIGCCLETPIPILVFESVQYGTL--WDRIL--------GAPQPHFEPLLLKHRLK 54
+H+++L+G + ++V E + +G L + R L G P P L+ ++
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT-----LQEMIQ 123
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+A +I +AYL+ + V R+ + + K+ DF ++ I E + +
Sbjct: 124 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-YYRKGG 179
Query: 115 MGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
G L + APE ++ GVF S+++SF V L+E+ +
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 15/98 (15%)
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
+ L +H + ++ R+ K++ IL + KL DF S TV +G
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS-------KMYAATVSDDVG 202
Query: 120 --------YCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
Y APE R +++K+++FS V L+ELLT
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-06
Identities = 44/233 (18%), Positives = 92/233 (39%), Gaps = 36/233 (15%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++SH +++L G C + +V E ++ G L + L Q +L L + D+
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN-YLRQRQGKLSKDML---LSMCQDVC 110
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+ YL + R+ L + V K+ DF ++ + + E + + +
Sbjct: 111 EGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PE ++ KS+V+SF V ++E+ T + PF +
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKM------------PFEKK---------- 205
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFE----CIKDSPADRPSMVDVAKKL 229
++ VVE +S + + ++ +E C + P RP+ ++ + +
Sbjct: 206 ---SNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 32/142 (22%), Positives = 62/142 (43%), Gaps = 38/142 (26%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+A+D +H++ ++H R+ K +L ++ KL DF + + + DT
Sbjct: 153 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 115 MGTLGYCAPEYMRT----GVFNEKSNVFSFSVFLFELLTG-------------------- 150
+GT Y +PE +++ G + + + +S VFL+E+L G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263
Query: 151 -----WDVSDLVKDVHDLVCPF 167
D +D+ K+ +L+C F
Sbjct: 264 NSLTFPDDNDISKEAKNLICAF 285
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-06
Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 53 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
++IAM AL YLH + I+ R+ KT + N+ K+ D ++ + E + +
Sbjct: 109 VQIAM----ALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA-RVLENQCDMAS 160
Query: 113 TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
T++GT Y +PE +N KS+V++ ++E+ T
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-06
Identities = 39/160 (24%), Positives = 78/160 (48%), Gaps = 23/160 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI--LGAPQPHFEPLLLKHRLKIAMD 58
++ H +I++ +G L+ + E V G++ + GA FE L+++ ++
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVR---Q 114
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT----- 113
I+ L YLH R I+ R+ K + IL + + K+ DF +S + E + T
Sbjct: 115 ILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGA 168
Query: 114 ---VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ G++ + APE ++ + K++++S + E+LTG
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 23/77 (29%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNE 133
IV+R+ K IL ++ ++ D L++ IPEGET +GT+GY APE + +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKYTF 180
Query: 134 KSNVFSFSVFLFELLTG 150
+ + ++E++ G
Sbjct: 181 SPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-06
Identities = 23/90 (25%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
I+ L +LH R I++R+ K +L + + ++ D L++ + +G++ T GT
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTP 161
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148
G+ APE ++ ++ + F+ V L+E++
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 7e-06
Identities = 32/150 (21%), Positives = 67/150 (44%), Gaps = 8/150 (5%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
H +I+ L +V E + G+L D I +F + + +++
Sbjct: 71 DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVL 126
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
L YLH + ++ R+ K+ IL +++ KL DF + + + ++ +V+GT +
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN-SVVGTPYW 182
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE ++ + K +++S + E+ G
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 4 HNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHF-----------EPLLLKH 51
H +I+ L+G C + P+ +LV E G L + + P E L K
Sbjct: 77 HKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 52 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
+ A + + YL + + R+ +L E+NV K+ DF L+ + + +
Sbjct: 136 LVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID-YYK 191
Query: 112 DTVMGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
T G L + APE + V+ +S+V+SF V L+E+ T
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-06
Identities = 39/153 (25%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 1 QMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
++SH +++L G C + PI I V E + G L + L F+P L L++ D+
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYI-VTEYMSNGCLLN-YLREHGKRFQPSQL---LEMCKDV 109
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT-- 117
+AYL + + R+ L +++ K+ DF LS + + E + +G+
Sbjct: 110 CEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKF 163
Query: 118 -LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + PE + F+ KS+V++F V ++E+ +
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-06
Identities = 36/159 (22%), Positives = 66/159 (41%), Gaps = 17/159 (10%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 52
H +I+ L+G C + ++ E G L + + P E + K
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 53 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
+ + + YL + + R+ +L E NV K+ DF L+ + + +
Sbjct: 140 VSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID-YYKK 195
Query: 113 TVMGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
T G L + APE + V+ +S+V+SF V ++E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 13/100 (13%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+A+D +H++ +H R+ K +L ++ KL DF + + E DT
Sbjct: 153 LALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203
Query: 115 MGTLGYCAPEYMRT----GVFNEKSNVFSFSVFLFELLTG 150
+GT Y +PE +++ G + + + +S VFLFE+L G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-06
Identities = 45/180 (25%), Positives = 85/180 (47%), Gaps = 25/180 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL--LKHRLKIAMD 58
Q+ + +I+++IG C E +LV E + G L ++ L + E + L H++ + M
Sbjct: 52 QLDNPYIVRMIGIC-EAESWMLVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMK 109
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT- 117
+ ++H R + RN +L ++ AK+ DF LS ++ E + G
Sbjct: 110 YLEETNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160
Query: 118 -LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDVHDLVCP 166
+ + APE M F+ KS+V+SF V ++E + G +V+ +++ + CP
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 6/105 (5%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 114
+ +I AL +LH R I++R+ K +L + E KL D+ + I G+T T T
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTF 156
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159
GT Y APE +R + + ++ V +FE++ G D+V
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 17/159 (10%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-----------PLLLKHR 52
H +I+ L+G C + ++ E G L + + P E L K
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 53 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
+ A + + YL + + R+ +L E+NV K+ DF L+ I + +
Sbjct: 143 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-YYKK 198
Query: 113 TVMGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
T G L + APE + ++ +S+V+SF V L+E+ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 1e-05
Identities = 36/129 (27%), Positives = 57/129 (44%), Gaps = 16/129 (12%)
Query: 1 QMSHNHILKLIGCCLETPIP--ILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIA 56
++ H +I++L +VFE + + D +L +P+ F +K +K
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH----DLTGLLDSPEVKFTESQIKCYMK-- 107
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDTVM 115
++ L YLH I+ R+ K S IL N + V KL DF L+ T+ V+
Sbjct: 108 -QLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 116 GTLGYCAPE 124
TL Y PE
Sbjct: 164 -TLWYRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 33/148 (22%), Positives = 58/148 (39%), Gaps = 27/148 (18%)
Query: 22 LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81
V E G L I + + A +I+ AL YLH + I+ R+ K
Sbjct: 79 FVLEYAPNGELLQYIR--KYGSLDEKCTRF---YAAEILLALEYLH---SKGIIHRDLKP 130
Query: 82 SCILFNEENVAKLFDF---------SLSISIPEGETHI----------TDTVMGTLGYCA 122
IL +++ K+ DF S S T+I + +GT Y +
Sbjct: 131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVS 190
Query: 123 PEYMRTGVFNEKSNVFSFSVFLFELLTG 150
PE + + S++++ ++++LTG
Sbjct: 191 PELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 5 NHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPLLLKHRLKIAMDI 59
+H+++L+G + +++ E + G L R P P LK +++A +I
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD-TVMGTL 118
+AYL+ V R+ + E+ K+ DF ++ I E + + + +
Sbjct: 129 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ +PE ++ GVF S+V+SF V L+E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 10/111 (9%)
Query: 40 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 99
P +E LL +++ +A+D VH+ +H R+ K++ I + KL DF
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVHSRKMMH---------RDLKSANIFLMPTGIIKLGDFGF 215
Query: 100 SISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
S + + + + GT Y APE +++K++++S V L+ELLT
Sbjct: 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +IV AL YLH + IV+R+ K IL ++E KL DF + + + T T+
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLC 159
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
GT Y APE +++ N+ + ++ + ++E+L G+
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 36/154 (23%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ---PHFEPLLLKHRLKIAM 57
Q+ + +I+++IG C E +LV E G L ++ L + + L H++ + M
Sbjct: 51 QLDNPYIVRMIGVC-EAEALMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGM 108
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
+ ++H R + RN +L ++ AK+ DF LS ++ +++ G
Sbjct: 109 KYLEGKNFVH----RDLAARN-----VLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159
Query: 118 --LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
L + APE + F+ +S+V+S+ + ++E +
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 39/170 (22%), Positives = 69/170 (40%), Gaps = 32/170 (18%)
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYC 121
AL ++H R I+ R+ K+ I ++ KL DF ++ + + T +GT Y
Sbjct: 113 ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIA-RVLNSTVELARTCIGTPYYL 168
Query: 122 APEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFT 181
+PE +N KS++++ L+E+ T LK+ FE
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCT---------------------LKHAFEAGNMK 207
Query: 182 EIVDHIVVEDVSSIEKEQQLHASA---QVTFECIKDSPADRPSMVDVAKK 228
+V I+ + H S + + K +P DRPS+ + +K
Sbjct: 208 NLVLKIIRGSYPPVS----SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-05
Identities = 35/151 (23%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE-PLLLKHRLKIAMDI 59
Q ++ K G L+ ++ E + G+ D + P F+ +LK LK +D
Sbjct: 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK-GLDY 116
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
+H+ +H R+ K + +L +E+ KL DF ++ + + + +T +GT
Sbjct: 117 LHSEKKIH---------RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNTFVGTPF 166
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE ++ ++ K++++S + EL G
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK-IA--M 57
Q H +I+ L G ++ ++V E ++ G+L D L F + L L+ IA M
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
+ + Y+H R + RN IL N V K+ DF LS + + T G
Sbjct: 120 KYLSDMGYVH----RDLAARN-----ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 118 LG--YCAPEYMRTGVFNEKSNVFSFSVFLFELLT-----GWDVS--DLVKDVHD------ 162
+ + APE + F S+V+S+ + ++E+++ W++S D++K + +
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA 230
Query: 163 -LVCPFSEY--LKNCFEDNR-----FTEIV 184
+ CP + + + +C++ +R F +IV
Sbjct: 231 PMDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 6/97 (6%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+IA+ +V L YL + I+ R+ K S +L N KL DF +S + I T
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKT 152
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GT Y APE + + S+V+S + EL G
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-05
Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 6/109 (5%)
Query: 50 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGET 108
+H + +I AL YLH R I++R+ K +L + E KL D+ + + G+T
Sbjct: 96 EHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152
Query: 109 HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157
T T GT Y APE +R + + ++ V +FE++ G D+V
Sbjct: 153 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 26/100 (26%), Positives = 50/100 (50%), Gaps = 13/100 (13%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+A+D +H++ ++H R+ K +L ++ KL DF + + DT
Sbjct: 153 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203
Query: 115 MGTLGYCAPEYMRT----GVFNEKSNVFSFSVFLFELLTG 150
+GT Y +PE +++ G + + + +S VFL+E+L G
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
M H H+++L+G CL +P LV + + +G L D + H + + + L + I
Sbjct: 66 MDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYV----HEHKDNIGSQLLLNWCVQIAK 120
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL--G 119
+ YL R +V R+ +L N K+ DF L+ + EG+ + G +
Sbjct: 121 GMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKMPIK 176
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ A E + F +S+V+S+ V ++EL+T
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 30/107 (28%), Positives = 54/107 (50%), Gaps = 6/107 (5%)
Query: 45 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 104
EPL L+ + + + + +L R + R+ IL +E NV K+ DF L+ I
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 105 EGETHIT--DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ ++ D + L + APE + V+ +S+V+SF V L+E+ +
Sbjct: 225 KDPDYVRKGDARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 18/230 (7%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ H +++ LI LVFE V + T+ D + P L K I+
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG----LDESRVRKYLFQIL 110
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+ + H I+ R+ K IL ++ V KL DF + ++ TD V T Y
Sbjct: 111 RGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWY 166
Query: 121 CAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDV----SDLVKDVHDLVC--PFSEYLKN 173
APE + + ++++ + E+LTG + SD+ + H + C +
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226
Query: 174 CFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTF--ECIKDSPADRPS 221
F+ N + V+++ +EK + + +C++ P DRPS
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 34/150 (22%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
+ + H+ +L+G CL + + L+ + + +G L D + + H + + ++ L + I
Sbjct: 66 VDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 120
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTLG 119
+ YL R +V R+ +L K+ DF L+ + E E H + +
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH-AEGGKVPIK 176
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ A E + ++ +S+V+S+ V ++EL+T
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 29/137 (21%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 114
A +I L +LH + I++R+ K ++ + E K+ DF + +I G+T T T
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTF 161
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG---WDVSDLVKDVHDLVCPFSEYL 171
GT Y APE + + + + ++F V L+E+L G +D D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---------------- 205
Query: 172 KNCFEDNRFTEIVDHIV 188
ED F I++H V
Sbjct: 206 ----EDELFQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
K+++ ++ LAYL I+ R+ K S IL N KL DF +S + + + ++
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GT Y +PE ++ ++ +S+++S + L EL G
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-05
Identities = 37/158 (23%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR-- 52
+ H +++KLIG L + PIP+++ +++G L +L + EP L +
Sbjct: 57 EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTL 115
Query: 53 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
++ +DI + YL + + R+ + NE + DF LS I G+ +
Sbjct: 116 VRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 113 TVMG-TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + A E + V+ S+V++F V ++E++T
Sbjct: 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-05
Identities = 20/77 (25%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNE 133
IV+R+ K +L +++ +L D L++ + +G+T GT GY APE ++ ++
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173
Query: 134 KSNVFSFSVFLFELLTG 150
+ F+ ++E++ G
Sbjct: 174 PVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-05
Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 19/102 (18%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +I L LH IV+R+ K IL ++ ++ D L++ IPEGET I V
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV- 162
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSV-------FLFELLTG 150
GT+GY APE ++ NE+ ++FS ++E++ G
Sbjct: 163 GTVGYMAPEVVK----NER---YTFSPDWWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG---ETHITDTVMGTL 118
L YLH + R+ K IL E+ K+ DF +S S+ +G + T +GT
Sbjct: 114 GLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 119 GYCAPEYM--RTGVFNEKSNVFSFSVFLFELLTG 150
+ APE M G ++ K++++SF + EL TG
Sbjct: 171 CWMAPEVMEQVHG-YDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-05
Identities = 34/172 (19%), Positives = 69/172 (40%), Gaps = 28/172 (16%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+I + ++ L LH + I+ R+ K++ IL ++ K+ D +S + + + T
Sbjct: 107 RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKT 160
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKN 173
+GT Y APE + ++ KS+++S L+E+ T + + DL K
Sbjct: 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF-APPFEARSMQDL------RYKV 213
Query: 174 CFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
++ I I +D+ ++ P RP+ +
Sbjct: 214 Q--RGKYPPI-PPIYSQDLQ------------NFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-05
Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 51 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETH 109
H + A +I L +LH + I++R+ K ++ + E K+ DF + ++ +G T
Sbjct: 102 HAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT- 157
Query: 110 ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T T GT Y APE + + + + ++F V L+E+L G
Sbjct: 158 -TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 14/104 (13%)
Query: 54 KIAMDIVHALAYL---HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI 110
K+ + IV AL YL H ++ R+ K S IL + KL DF +S + + +
Sbjct: 118 KMTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171
Query: 111 TDTVMGTLGYCAPEYM----RTGVFNEKSNVFSFSVFLFELLTG 150
G Y APE + ++ +++V+S + L EL TG
Sbjct: 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 25/94 (26%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
++V A YLH + I++R+ K +L + + K+ DF + +P+ T T+ GT
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGT 178
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
Y APE +++ + + ++ V L+E + G+
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY 212
|
Length = 329 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 1e-04
Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 12/149 (8%)
Query: 4 HNHILKLIGCCLETPIPILVF-ESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
H I++ GC L + +F E + G++ D++ + L K I+
Sbjct: 63 HERIVQYYGC-LRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEG 116
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTLGY 120
+ YLH IV R+ K + IL + KL DF S + + T +V GT +
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+PE + + K++V+S + E+LT
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 26/169 (15%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK-IA--M 57
Q H +I+ L G ++ +++ E ++ G L D L F + L L+ IA M
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
+ + Y+H R + RN IL N V K+ DF LS + + + T T +
Sbjct: 120 KYLSEMNYVH----RDLAARN-----ILVNSNLVCKVSDFGLSRFLEDDTSDPTYT--SS 168
Query: 118 LG------YCAPEYMRTGVFNEKSNVFSFSVFLFELLT-----GWDVSD 155
LG + APE + F S+V+S+ + ++E+++ WD+S+
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +IV L +LH + I++R+ K ++ + + K+ DF + G+ + T
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS-TFC 157
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE ++ + + +SF V L+E+L G
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 52 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHI 110
+ IA ++V AL +LH IV+R+ K IL + L DF LS ++ + +T
Sbjct: 99 KFYIA-ELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152
Query: 111 TDTVMGTLGYCAPE-YMRTGVFNEKSNVFSFSVFLFELLTGW 151
T+T GT Y APE + + + + +S V +FE+ GW
Sbjct: 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW 194
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 14/98 (14%)
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD----- 112
+IV AL YLH G IV+R+ K ++ +++ K+ DF L EG ITD
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLC---KEG---ITDAATMK 153
Query: 113 TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T GT Y APE + + + + V ++E++ G
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 28/99 (28%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--IT 111
KI++ ++ L YL I+ R+ K S IL N KL DF +S G+ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155
Query: 112 DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
++ +GT Y +PE ++ + +S+++S + L E+ G
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 22/70 (31%), Positives = 36/70 (51%), Gaps = 4/70 (5%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ + ++ L YLH F I+ R+ K S +L ++ K+ DF L+ + +T V
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 115 MGTLGYCAPE 124
+ TL Y APE
Sbjct: 170 V-TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 16/102 (15%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
I +++ L YLH + R+ K + IL +EE KL DF +S +T T+
Sbjct: 103 ILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTM 152
Query: 115 ------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GT + APE ++ ++EK++++S + EL G
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGETHITDTVMG 116
+IV AL YLH + +V+R+ K ++ +++ K+ DF L I +G T T G
Sbjct: 103 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCG 158
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T Y APE + + + + V ++E++ G
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 3 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPL---LLKHRLKIA-- 56
SH ++L L+G CL + P++V +++G L + I P L+ L++A
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKG 110
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE---THITDT 113
M+ + + ++H R + RN C+L +E K+ DF L+ I + E H
Sbjct: 111 MEYLASKKFVH----RDLAARN----CML-DESFTVKVADFGLARDIYDKEYYSVHNHTG 161
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + A E ++T F KS+V+SF V L+EL+T
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 41/173 (23%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H++I++L G ++V E + G L D L + H L+ + + +
Sbjct: 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFL---RKHEGQLVAGQLMGMLPGLA 117
Query: 61 HALAYL-HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG--- 116
+ YL G+ V + +L N + V K+ F + E ++ T M
Sbjct: 118 SGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKS 170
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-----GWDVS--DLVKDVHD 162
+ + APE ++ F+ S+V+SF + ++E+++ WD+S D++K V D
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 22/154 (14%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYG--TLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
+SH I+ LI +V + T DR PL L+ + I +
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS--------GPLPLEQAITIQRRL 194
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV----- 114
+ ALAYLH R I+ R+ KT I +E A L DF + + DT
Sbjct: 195 LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH----PDTPQCYGW 247
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148
GTL +PE + + K++++S + LFE+
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 34/151 (22%), Positives = 69/151 (45%), Gaps = 13/151 (8%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
+H +I+ L+G C +++ E YG L + L + F L L+ L + +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLN-FLRRKRESF--LTLEDLLSFSYQVAKG 153
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT----L 118
+A+L + + R+ +L + K+ DF L+ I ++ V G +
Sbjct: 154 MAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPV 207
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ APE + V+ +S+V+S+ + L+E+ +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 27/105 (25%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 46 PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 105
PL + I +I+ L YLH + R+ K + +L +E+ KL DF ++ + +
Sbjct: 97 PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153
Query: 106 GETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ +T +GT + APE ++ ++ K++++S + EL G
Sbjct: 154 TQIK-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 8/98 (8%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+ ++V + LH R I+ R+ K +L ++ KL DF LS +
Sbjct: 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKK 152
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
+GT Y APE + ++ S+ +S +FE L G+
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGY 190
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 114
A +I L +LH R I++R+ K ++ + E K+ DF + + +G T T T
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTF 161
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE + + + + +++ V L+E+L G
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 25/85 (29%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 66 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD-TVMGTLGYCAPE 124
+ F R + R+ IL +E NV K+ DF L+ I + ++ + L + APE
Sbjct: 187 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246
Query: 125 YMRTGVFNEKSNVFSFSVFLFELLT 149
+ V+ +S+V+SF V L+E+ +
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 28/107 (26%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 45 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 104
+ L L+ + + + + +L R + R+ IL +E NV K+ DF L+ I
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 105 EGETHIT--DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ ++ D + L + APE + V+ +S+V+SF V L+E+ +
Sbjct: 231 KDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A ++ A+ YLH I++R+ K IL + + L DF L E E T T
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFC 157
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE +R ++ + + L+E+L G
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 4e-04
Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 28/164 (17%)
Query: 66 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEY 125
+H+ R I+ R+ K I F + N+ K+ DF +S + G + T GT Y +PE
Sbjct: 119 VHYMHQRRILHRDLKAKNI-FLKNNLLKIGDFGVS-RLLMGSCDLATTFTGTPYYMSPEA 176
Query: 126 MRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVD 185
++ ++ KS+++S L+E + C L + FE F +V
Sbjct: 177 LKHQGYDSKSDIWSLGCILYE----------------MCC-----LAHAFEGQNFLSVVL 215
Query: 186 HIVVEDVSSIEK--EQQLHASAQVTFECIKDSPADRPSMVDVAK 227
IV S+ + +QL++ Q KD P+ RPS ++ +
Sbjct: 216 RIVEGPTPSLPETYSRQLNSIMQSMLN--KD-PSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQ-YGTLWD-----RILGAPQPHFEPLLLKHRL-K 54
+SH +IL ++ C+E P V +G L R+ A P L +L
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ---ALSTQQLVH 121
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKT-SCILFNEENVAKLFDFSLSISIPEGETH-ITD 112
+A+ I ++YLH R ++ ++ +C++ E V K+ D +LS + + H + D
Sbjct: 122 MAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQV-KITDNALSRDLFPMDYHCLGD 177
Query: 113 TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + A E + ++ S+V+SF V L+EL+T
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 19/155 (12%)
Query: 1 QMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM-- 57
++ H +I++ +G E + I + E V G+L ++L EP+ I +
Sbjct: 58 KLQHPNIVQYLGTEREEDNLYIFL-ELVPGGSL-AKLLKKYGSFPEPV-------IRLYT 108
Query: 58 -DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 116
I+ L YLH R V R+ K + IL + V KL DF ++ + E + G
Sbjct: 109 RQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKG 163
Query: 117 TLGYCAPEY-MRTGVFNEKSNVFSFSVFLFELLTG 150
+ + APE + G + ++++S + E+ TG
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGETHITDTV 114
A +I AL YLH IV+R+ K IL + + L DF L I + +T T T
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTF 156
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE +R ++ + + L+E+L G
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGETHITDTVMG 116
+IV AL YLH R +V+R+ K ++ +++ K+ DF L I +G T T G
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 157
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T Y APE + + + + V ++E++ G
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 26/97 (26%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
K+++ ++ L YL I+ R+ K S IL N KL DF +S + + + ++
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GT Y +PE ++ ++ +S+++S + L E+ G
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 5e-04
Identities = 38/165 (23%), Positives = 69/165 (41%), Gaps = 29/165 (17%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTL-------WDRILGAPQPHFEPLLLKHRLK 54
++H ++L+ +G C+E+ +LV E G L + Q +L + +
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD---VLQRMACE 108
Query: 55 IAMDI--VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS-IPEGETHIT 111
+A + +H ++H RN C L + +V K+ D+ L++ PE
Sbjct: 109 VASGLLWLHQADFIHSDL----ALRN----CQLTADLSV-KIGDYGLALEQYPEDYYITK 159
Query: 112 DTVMGTLGYCAPEYM-------RTGVFNEKSNVFSFSVFLFELLT 149
D L + APE + +KSN++S V ++EL T
Sbjct: 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLL 49
++S +I +L+G C P ++ E ++ G L + F LL
Sbjct: 75 RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS-TLL 133
Query: 50 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 109
+IA + + L L+F V R+ T L + K+ DF +S ++ + +
Sbjct: 134 YMATQIASGMRY-LESLNF------VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186
Query: 110 -ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + + A E + G F KS+V++F V L+E+LT
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 36/125 (28%), Positives = 54/125 (43%), Gaps = 10/125 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ H +I+ L LVFE V+ L +L A P ++ ++
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVR---SYIWQLL 110
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG-ETHITDTVMGTLG 119
A+AY H I+ R+ K IL +E V KL DF + ++ + +TD V T
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRW 166
Query: 120 YCAPE 124
Y APE
Sbjct: 167 YRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 6e-04
Identities = 30/95 (31%), Positives = 43/95 (45%), Gaps = 4/95 (4%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +I AL YLH I++R+ K IL + + L DF L E T T
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTSTFC 157
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE +R ++ + + L+E+L G
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 7e-04
Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
I +I+ L YLH + R+ K + +L +E KL DF ++ + + + +T
Sbjct: 106 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTF 161
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GT + APE ++ ++ K++++S + EL G
Sbjct: 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTVMG 116
+IV AL YLH +V+R+ K ++ +++ K+ DF L I +G T T G
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 157
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T Y APE + + + + V ++E++ G
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 33/191 (17%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH------------FEPLLL 49
+ H +I+ L+G C + ++FE + +G L + L PH L
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE-FLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 50 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 109
L IA+ I + YL V R+ L E K+ DF LS I + +
Sbjct: 124 SDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 110 ITDTVMGT----LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GW---DVSD 155
V + + PE + G F +S+++SF V L+E+ + G+ +V +
Sbjct: 181 ---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237
Query: 156 LVKDVHDLVCP 166
+++ L CP
Sbjct: 238 MIRSRQLLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 26/95 (27%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +V AL YLH IV+R+ K +L + + K+ DF + + T T+
Sbjct: 107 AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLC 159
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE + + + + + ++ + ++E+L G
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL-SISIPEGETHITDTV 114
A ++ AL +LH +++R+ K IL + E KL DF + I G T T T
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTF 156
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE ++ + + ++ V ++E++ G
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 37/146 (25%), Positives = 70/146 (47%), Gaps = 11/146 (7%)
Query: 6 HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAY 65
++ +L+G CL + + LV + + YG L D + + + + + + L + I ++Y
Sbjct: 70 YVCRLLGICLTSTVQ-LVTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQIAKGMSY 124
Query: 66 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS--ISIPEGETHITDTVMGTLGYCAP 123
L +V R+ +L N K+ DF L+ + I E E H D + + A
Sbjct: 125 LE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADGGKVPIKWMAL 180
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLT 149
E + F +S+V+S+ V ++EL+T
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 6/97 (6%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDT 113
+ + + AL +LH ++ R+ K+ +L + KL DF I PE T
Sbjct: 120 VCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--ST 174
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
++GT + APE + + K +++S + E++ G
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 30/95 (31%), Positives = 42/95 (44%), Gaps = 4/95 (4%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
A +I AL YLH IV+R+ K IL + + L DF L E T T
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTSTFC 157
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE + ++ + + L+E+L G
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 24/154 (15%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA---M 57
Q+ H + ++ GC L LV E G+ D + + H +PL ++IA
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDIL----EVHKKPL---QEVEIAAICH 122
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF-SLSISIPEGETHITDTVMG 116
+ LAYLH + R+ K IL E KL DF S S+ P ++ +G
Sbjct: 123 GALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVG 173
Query: 117 TLGYCAPEY---MRTGVFNEKSNVFSFSVFLFEL 147
T + APE M G ++ K +V+S + EL
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 33/147 (22%), Positives = 66/147 (44%), Gaps = 5/147 (3%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ H +++K + +E +V E G L R++ + + + K + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL ++H + I+ R+ K + + V KL D L +T +++GT Y
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPYY 172
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFEL 147
+PE + +N KS+++S L+E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 28/101 (27%), Positives = 47/101 (46%), Gaps = 14/101 (13%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
IA+D VH L Y+H R+ K IL + +L DF + + E T +
Sbjct: 113 IAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163
Query: 115 MGTLGYCAPEYMRT-----GVFNEKSNVFSFSVFLFELLTG 150
+GT Y +PE ++ G + + + +S V ++E+L G
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 31/149 (20%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
++ AL++LH + ++ R+ K+ IL + KL DF + + E +++GT
Sbjct: 124 VLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTP 179
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG----WDVSDL--VKDVHDLVCPFSEYLK 172
+ APE + + + +++S + + E++ G ++ L +K + D + P + L
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLH 239
Query: 173 NCFEDNRFTEIVDHIVVEDVSSIEKEQQL 201
R +D ++V D + +L
Sbjct: 240 KV--SPRLRSFLDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 17/105 (16%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
KIA+ V AL YL I+ R+ K S IL + KL DF +S + D+
Sbjct: 111 KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLVDS 161
Query: 114 VMGTLG-----YCAPEYMRTGV---FNEKSNVFSFSVFLFELLTG 150
+ T Y APE + ++ +S+V+S + L+E+ TG
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 16/150 (10%)
Query: 2 MSHNHILKLIGCCLETPIPILV---FESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
++H ++++ + I +V + S Y L R PL + L I
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS--------RPLPIDQALIIEKQ 165
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
I+ L YLH + I+ R+ KT I N+ + + D + P + GT+
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLG-LAGTV 220
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148
APE + +N K++++S + LFE+L
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 32/149 (21%), Positives = 71/149 (47%), Gaps = 9/149 (6%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
+ H +I++L+G C + LV + G+L D + + H + L + L + I
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHV----RQHRDSLDPQRLLNWCVQIAK 120
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGTLGY 120
+ YL +V RN IL +++ ++ DF ++ + P+ + + + +
Sbjct: 121 GMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
A E + G + +S+V+S+ V ++E+++
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 9/101 (8%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+A I+ +AYLH R IV R+ K S +L N K+ DF +S + + +V
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229
Query: 115 MGTLGYCAPEYMRTGVFNEK-----SNVFSFSVFLFELLTG 150
GT+ Y +PE + T + + +++S V + E G
Sbjct: 230 -GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 22/96 (22%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ + ++ AL+YLH + ++ R+ K+ IL + KL DF + + E ++
Sbjct: 123 VCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSL 178
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GT + APE + + + +++S + + E++ G
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 38.2 bits (88), Expect = 0.002
Identities = 25/97 (25%), Positives = 45/97 (46%), Gaps = 6/97 (6%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDT 113
+ + + AL +LH ++ R+ K+ IL + KL DF I PE T
Sbjct: 120 VCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--ST 174
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
++GT + APE + + K +++S + E++ G
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 38.2 bits (88), Expect = 0.002
Identities = 23/96 (23%), Positives = 44/96 (45%), Gaps = 4/96 (4%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ + + AL +LH ++ R+ K+ IL + KL DF I ++ + V
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT + APE + + K +++S + E++ G
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 54/236 (22%), Positives = 95/236 (40%), Gaps = 35/236 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF--EPLLLKHRL--KIA 56
Q++H +++K +E +V E G L I HF + L+ + K
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPEKTVWKYF 112
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 116
+ + AL ++H R ++ R+ K + + V KL D L +T +++G
Sbjct: 113 VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVG 168
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFE 176
T Y +PE + +N KS+++S L+E+ L PF N +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-------------LQSPFYGDKMNLYS 215
Query: 177 DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV---DVAKKL 229
+ E D+ + S ++L Q+ CI P RP + DVAK++
Sbjct: 216 LCKKIEQCDY---PPLPSDHYSEELR---QLVNMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.003
Identities = 25/94 (26%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDTVMG 116
+ + AL +LH ++ R+ K+ IL + KL DF I PE T++G
Sbjct: 123 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVG 177
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T + APE + + K +++S + E++ G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 14/96 (14%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG-- 116
I+ L Y+H I+ R+ K S + NE+ K+ DF L+ H D + G
Sbjct: 129 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGYV 178
Query: 117 -TLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTG 150
T Y APE M + +N+ +++S + ELLTG
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.2 bits (88), Expect = 0.003
Identities = 31/119 (26%), Positives = 54/119 (45%), Gaps = 25/119 (21%)
Query: 55 IAMDIVHALAYLHFGFPRP----IVFRNFKTSCIL-----------------FNEENVAK 93
I ++HALAY H P ++ R+ K I N +AK
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 94 LFDFSLSISIPEGETHITDTVMGTLGYCAPEYM--RTGVFNEKSNVFSFSVFLFELLTG 150
+ DF LS +I G + + +GT Y +PE + T +++KS++++ ++EL +G
Sbjct: 183 IGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
|
Length = 1021 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.004
Identities = 35/151 (23%), Positives = 68/151 (45%), Gaps = 13/151 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF--EPLLLKHRL--KIA 56
Q++H +++K + +E +V E G L I +F + L+ R K
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK-----YFKKQKRLIPERTVWKYF 112
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 116
+ + A+ ++H R ++ R+ K + + V KL D L +T +++G
Sbjct: 113 VQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVG 168
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFEL 147
T Y +PE + +N KS+++S L+E+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.004
Identities = 21/96 (21%), Positives = 48/96 (50%), Gaps = 4/96 (4%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ + ++ AL+ LH + ++ R+ K+ IL + KL DF + + E ++
Sbjct: 121 VCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSL 176
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GT + APE + + + +++S + + E++ G
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 26/91 (28%), Positives = 43/91 (47%), Gaps = 9/91 (9%)
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYC 121
AL +LH ++ R+ K IL + KL DF +S + + DT +GT +
Sbjct: 115 ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQKRDTFIGTPYWM 170
Query: 122 APEYMRTGVF-----NEKSNVFSFSVFLFEL 147
APE + F + K++++S + L EL
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 239 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.67 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.62 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.58 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.47 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.45 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.4 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.4 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.39 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.24 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.2 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.11 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.7 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.68 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.58 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.51 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.31 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.08 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.26 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.12 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.01 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.0 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.69 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.34 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.97 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.69 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.09 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.06 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.77 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.48 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.41 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.24 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.24 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.94 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 93.87 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.83 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.82 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.51 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.43 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.36 | |
| PF10140 | 359 | YukC: WXG100 protein secretion system (Wss), prote | 93.03 | |
| PLN02236 | 344 | choline kinase | 92.54 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.21 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.08 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.6 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 90.56 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 89.5 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 89.41 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 88.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 87.8 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 87.5 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 87.02 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 85.77 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 85.76 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 83.24 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=306.33 Aligned_cols=200 Identities=24% Similarity=0.294 Sum_probs=175.0
Q ss_pred CCCcccceeeEEEEeCCC-ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MSHNHILKLIGCCLETPI-PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~-~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.+|||||.+||.|+.++. ..|+||||++|||.++++.. +++++....+++.++++||.|||. +++|+|||||
T Consensus 134 ~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIK 206 (364)
T KOG0581|consen 134 CQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIK 206 (364)
T ss_pred CCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCC
Confidence 479999999999999995 99999999999999999876 679999999999999999999994 4999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|+|++..|++||+|||.+..+..+ ...++.||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...
T Consensus 207 PsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--- 280 (364)
T KOG0581|consen 207 PSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--- 280 (364)
T ss_pred HHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---
Confidence 99999999999999999999876544 456889999999999999999999999999999999999999998543
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......+.++...++.+.........+++++.+||..||++||.+|||+.|+++
T Consensus 281 -------------~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 281 -------------NPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -------------CCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112335567777777755443333358999999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=302.98 Aligned_cols=209 Identities=29% Similarity=0.457 Sum_probs=174.1
Q ss_pred CCCCcccceeeEEEEeCC-CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC-eeecc
Q 044155 1 QMSHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP-IVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~-~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~-i~H~d 78 (239)
+++|||||+++|++.+.. ..++||||+++|+|.++++.... ..++...+.+++.||+.|+.||| +.+ |+|||
T Consensus 95 ~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~---~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrD 168 (362)
T KOG0192|consen 95 RLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRK---RKLPLKVRLRIALDIARGMEYLH---SEGPIIHRD 168 (362)
T ss_pred hCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecc
Confidence 489999999999999887 78999999999999999987422 67999999999999999999999 888 99999
Q ss_pred ccCcceeecCCC-ceeEcccccccccCCCCcceeecccccccccCccccc--cCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 79 FKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR--TGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 79 lk~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|||+|+|++.++ .+||+|||+++...... ...+...||+.|||||++. ...++.++||||||+++|||+||..||.
T Consensus 169 LK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~ 247 (362)
T KOG0192|consen 169 LKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE 247 (362)
T ss_pred cChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence 999999999997 99999999997654321 1122367999999999999 5689999999999999999999999886
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.... ............++..+...++.+..+|.+||..||+.||++.+++..|+.+...
T Consensus 248 ~~~~---------------------~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 248 DLAP---------------------VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCH---------------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 5442 2222233333333333445778899999999999999999999999999998875
Q ss_pred hc
Q 044155 236 LS 237 (239)
Q Consensus 236 ~~ 237 (239)
..
T Consensus 307 ~~ 308 (362)
T KOG0192|consen 307 IS 308 (362)
T ss_pred hc
Confidence 54
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=304.76 Aligned_cols=207 Identities=26% Similarity=0.396 Sum_probs=176.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|+|||+++|+|..+...+|||||++.|+|.++++...+ ..+...+.+.++.|||+|++||. ++++|||||.
T Consensus 257 ~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLA 330 (468)
T KOG0197|consen 257 KLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLA 330 (468)
T ss_pred hCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHH---hCCccchhhh
Confidence 58999999999999998899999999999999999998444 67889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
++|||++++..+||+|||+++...+..........-|..|+|||.+..++++.+||||||||++||++| |+.||..
T Consensus 331 ARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--- 407 (468)
T KOG0197|consen 331 ARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--- 407 (468)
T ss_pred hhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC---
Confidence 999999999999999999999655444444445556889999999999999999999999999999999 5455533
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
....+.+.. +...++-+.+..+++.+.++|..||+.+|++|||++.+...|+.+...
T Consensus 408 ------------------msn~ev~~~-le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 408 ------------------MSNEEVLEL-LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ------------------CCHHHHHHH-HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 333344433 333444455568899999999999999999999999999999988764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=302.14 Aligned_cols=195 Identities=22% Similarity=0.353 Sum_probs=172.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||+++++|++.+++|||.|+|..++|..++++. +.+++.+++.++.||+.||.||| +++|+|||||
T Consensus 74 ~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLK 145 (592)
T KOG0575|consen 74 SLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLK 145 (592)
T ss_pred hcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccc
Confidence 589999999999999999999999999999999999865 78999999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
..|++++++.++||+|||+|..... ..+...+.+|||-|.|||++.....+..+||||+||++|.++.|++||+
T Consensus 146 LGNlfL~~~~~VKIgDFGLAt~le~-~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe----- 219 (592)
T KOG0575|consen 146 LGNLFLNENMNVKIGDFGLATQLEY-DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE----- 219 (592)
T ss_pred hhheeecCcCcEEecccceeeeecC-cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc-----
Confidence 9999999999999999999987642 2244567889999999999999999999999999999999999999985
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.....+....+....+.-+ ...+.+.++||..+|+.||.+|||+++|+.
T Consensus 220 ----------------tk~vkety~~Ik~~~Y~~P--~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 220 ----------------TKTVKETYNKIKLNEYSMP--SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----------------cchHHHHHHHHHhcCcccc--cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3345566666666655433 367778899999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=290.98 Aligned_cols=197 Identities=21% Similarity=0.338 Sum_probs=164.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||+++++|+.....||||||++||.|.+++-.+ ..+.+..-+.++.|++.|+.||| ++||+|||||
T Consensus 232 kL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiK 303 (475)
T KOG0615|consen 232 KLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIK 303 (475)
T ss_pred hcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHH---HcCcccccCC
Confidence 589999999999999999999999999999999999876 56778888999999999999999 9999999999
Q ss_pred CcceeecCC---CceeEcccccccccCCCCcceeecccccccccCccccccCC---cccccchhhhhhHHHHHhcCCCCc
Q 044155 81 TSCILFNEE---NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV---FNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 81 ~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+|||+..+ ..+||+|||+|+.... .....+++||+.|.|||++.+.. +..+.||||+||++|-+++|..||
T Consensus 304 PeNILl~~~~e~~llKItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPF 381 (475)
T KOG0615|consen 304 PENILLSNDAEDCLLKITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPF 381 (475)
T ss_pred cceEEeccCCcceEEEecccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCc
Confidence 999999887 4689999999987643 33456889999999999998655 334789999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... .+.+.+++..+.+. +..-...+++..++|.+||..||++|||++|+++
T Consensus 382 S~~~~--------------------~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 382 SEEYT--------------------DPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccccC--------------------CccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 64321 11122333333332 2333577888999999999999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=290.23 Aligned_cols=224 Identities=40% Similarity=0.669 Sum_probs=182.6
Q ss_pred CCCCcccceeeEEEEeCC-CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~-~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++|||+|+++|||.+.+ ..++|+||+++|||.+.++..... .++|..+.+|+.++|.||+|||+.+...|+||||
T Consensus 127 ~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDi 203 (361)
T KOG1187|consen 127 RLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDI 203 (361)
T ss_pred cCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCC
Confidence 579999999999999988 499999999999999999876431 7899999999999999999999876778999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecc-cccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTV-MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
||.|||+|.+.++||+|||+++..+.... ..... .||.+|+|||+...+..+.++||||||+++.|++||+.+.+...
T Consensus 204 KssNILLD~~~~aKlsDFGLa~~~~~~~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 204 KSSNILLDEDFNAKLSDFGLAKLGPEGDT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred CHHHeeECCCCCEEccCccCcccCCcccc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 99999999999999999999966543111 11122 79999999999999999999999999999999999998876544
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhh-cCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV-EDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
..... .+.+|...........++++..+. ..+... .....+..+..+|++.+|.+||++.||++.|..+.
T Consensus 283 ~~~~~--~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~---~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 283 PRGEL--SLVEWAKPLLEEGKLREIVDPRLKEGEYPDE---KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred Ccccc--cHHHHHHHHHHCcchhheeCCCccCCCCChH---HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 21111 145555556666677777777765 232211 45566889999999999999999999999996654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=277.79 Aligned_cols=207 Identities=21% Similarity=0.305 Sum_probs=174.5
Q ss_pred CCCCcccceeeE-EEEeCCC-ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC--eee
Q 044155 1 QMSHNHILKLIG-CCLETPI-PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~-~~~~~~~-~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--i~H 76 (239)
||+|||||++++ .|.+.+. ..||||+|.+|+|...++...... ..++++++.+++.|++.||.++|+-. .+ |.|
T Consensus 74 QL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmH 151 (375)
T KOG0591|consen 74 QLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMH 151 (375)
T ss_pred hcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccc-cccceee
Confidence 689999999999 5656655 789999999999999888654322 67899999999999999999999311 34 999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||||.||+++.+|.+||+|||+++.+. +.........|||.||+||.+...+|+.+|||||+||++|||..-..||.
T Consensus 152 RDIKPaNIFl~~~gvvKLGDfGL~r~l~-s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~- 229 (375)
T KOG0591|consen 152 RDIKPANIFLTANGVVKLGDFGLGRFLS-SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY- 229 (375)
T ss_pred ccCcchheEEcCCCceeeccchhHhHhc-chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc-
Confidence 9999999999999999999999998874 34445667889999999999999999999999999999999999988775
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
......+..++..+++.+......+..+..+|..|+..||..||+.-.+++.++.
T Consensus 230 --------------------g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 230 --------------------GDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------------------cccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3355566777777777655556889999999999999999999986556655544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=289.52 Aligned_cols=196 Identities=20% Similarity=0.289 Sum_probs=166.1
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.+|+|||.+++.|.-++..|+||||++||+|.|.+.. ..+++.+++.++.++++||+||| .++|+|||||.
T Consensus 327 ~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKS 397 (550)
T KOG0578|consen 327 LHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKS 397 (550)
T ss_pred ccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHH---hcceeeecccc
Confidence 5899999999999989999999999999999999976 45889999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+|||++.+|.+||+|||++....... .......||+.|||||+.....|.++.||||||++++||+.|.+||-.
T Consensus 398 DnILL~~~g~vKltDFGFcaqi~~~~-~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----- 471 (550)
T KOG0578|consen 398 DNILLTMDGSVKLTDFGFCAQISEEQ-SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----- 471 (550)
T ss_pred ceeEeccCCcEEEeeeeeeecccccc-CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-----
Confidence 99999999999999999987664333 256678899999999999999999999999999999999999999732
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+.....+..-...+......+...+..+++|+.+||..|+.+|+||.|||+
T Consensus 472 ---------------E~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 472 ---------------ENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ---------------CChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111111111111222222334577889999999999999999999999997
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=296.90 Aligned_cols=210 Identities=25% Similarity=0.397 Sum_probs=178.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCC---------CCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH---------FEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
.|+|||||+++|+|..++..++|+|||.+|+|.++++...... +.++...+.+.|+.||+.|+.||- +
T Consensus 545 ~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~ 621 (774)
T KOG1026|consen 545 ELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---S 621 (774)
T ss_pred hccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 4799999999999999999999999999999999998653311 234889999999999999999999 9
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcceee-cccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD-TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
+.+|||||..+|+||+++..|||+|||+++..-....+... ...-+++|||||.+..++|+++|||||+||++||+++
T Consensus 622 ~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsy 701 (774)
T KOG1026|consen 622 HHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSY 701 (774)
T ss_pred CcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhcc
Confidence 99999999999999999999999999999765444444333 4456899999999999999999999999999999998
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||.++ ...+++.-+..+.. ...+..++.++.+||.+||+..|++|||+.|+-.+|
T Consensus 702 G~QPy~gl---------------------Sn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 702 GKQPYYGL---------------------SNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred ccCccccc---------------------chHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 65665433 34456655555555 455668899999999999999999999999999999
Q ss_pred HHHHHh
Q 044155 230 RQIYRS 235 (239)
Q Consensus 230 ~~l~~~ 235 (239)
+.....
T Consensus 760 ~~~~~~ 765 (774)
T KOG1026|consen 760 QAWAQA 765 (774)
T ss_pred HHHHhc
Confidence 987654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=285.17 Aligned_cols=203 Identities=23% Similarity=0.374 Sum_probs=171.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|+||+.|.|+|.....+|||||||..|-|..+++.. ..++......|..+|+.|+.||| .+.|+|||||
T Consensus 168 kLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLK 239 (904)
T KOG4721|consen 168 KLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLK 239 (904)
T ss_pred hccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccC
Confidence 589999999999999999999999999999999999987 67888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
.-||||+.+..+||+|||.++...+- .-...+.||..|||||++...+.++|.|||||||++|||+||..||......
T Consensus 240 SPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 240 SPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred CCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence 99999999999999999998765432 2234678999999999999999999999999999999999999998644422
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
--..+ +. .+....+.+..+++.++-||.+||+-.|..|||+.+++.-|+-+..
T Consensus 318 AIIwG-----------------VG----sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 318 AIIWG-----------------VG----SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred eeEEe-----------------cc----CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 11111 00 1112233345677889999999999999999999999998875443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=274.05 Aligned_cols=201 Identities=25% Similarity=0.315 Sum_probs=159.4
Q ss_pred CCCCcccceeeEEEEeCC--CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLETP--IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~--~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+|+|||||+++|...... .+++.|||+.+|||.+++.+.. ..+++..++.+..|+++||+||| +++++|+|
T Consensus 70 ~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g----~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~D 142 (313)
T KOG0198|consen 70 RLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYG----GKLPEPLVRRYTRQILEGLAYLH---SKGIVHCD 142 (313)
T ss_pred hCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccC
Confidence 478999999999754444 5889999999999999998863 25899999999999999999999 99999999
Q ss_pred ccCcceeecC-CCceeEcccccccccCC--CCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCc
Q 044155 79 FKTSCILFNE-ENVAKLFDFSLSISIPE--GETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 79 lk~~nil~~~-~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|||+|||++. ++.+||+|||.+..... ..........||+.|||||++..+ ....++|||||||++.||+||+.||
T Consensus 143 iK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW 222 (313)
T KOG0198|consen 143 IKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPW 222 (313)
T ss_pred cccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcc
Confidence 9999999999 69999999999876642 112224467899999999999853 3445999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
.... ......-.+......+..+...+...++|+..|+.+||++||||+++++.
T Consensus 223 ~~~~--------------------~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 223 SEFF--------------------EEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred hhhc--------------------chHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 6430 00011111111112223344677889999999999999999999999973
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=271.20 Aligned_cols=145 Identities=27% Similarity=0.444 Sum_probs=134.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.|+|||||.+++++++.+..|+|||||.||+|.+++++. ..+++...+.++.|++.||++|| +++|+|||||
T Consensus 65 el~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLK 136 (429)
T KOG0595|consen 65 ELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLH---ENNIIHRDLK 136 (429)
T ss_pred hcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCC
Confidence 378999999999999999999999999999999999987 67999999999999999999999 9999999999
Q ss_pred CcceeecCC------CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 81 TSCILFNEE------NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 81 ~~nil~~~~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+|||++.. -.+||+|||+++.+..+. ...+.+|++.|||||++....|+.|+|+||+|+++|++++|+.||
T Consensus 137 PQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf 214 (429)
T KOG0595|consen 137 PQNILLSTTARNDTSPVLKIADFGFARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPF 214 (429)
T ss_pred cceEEeccCCCCCCCceEEecccchhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCc
Confidence 999999875 458999999999886443 355778999999999999999999999999999999999999998
Q ss_pred c
Q 044155 155 D 155 (239)
Q Consensus 155 ~ 155 (239)
+
T Consensus 215 ~ 215 (429)
T KOG0595|consen 215 D 215 (429)
T ss_pred c
Confidence 6
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=268.74 Aligned_cols=207 Identities=21% Similarity=0.300 Sum_probs=164.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||++++..|..+...|+||.||.+||+.++++.... ..+.+..++.++.++++||.||| .+|.+|||+|+
T Consensus 81 ~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKA 154 (516)
T KOG0582|consen 81 IDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLH---QNGHIHRDVKA 154 (516)
T ss_pred cCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHH---hcCceeccccc
Confidence 6899999999999999999999999999999999998754 56899999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcce--e-ecccccccccCcccccc--CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHI--T-DTVMGTLGYCAPEYMRT--GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~-~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
.|||++.+|.+||+|||.+..+..+..+. . ..+.|+++|||||++.. ..|+.|+||||||++..|+.+|..||..
T Consensus 155 gnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 155 GNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred ccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 99999999999999999876664443221 2 56789999999999543 4699999999999999999999999875
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...+..+.. .. ++..+.... ...........+..+.++|..||.+||.+||||++++.
T Consensus 235 ~pPmkvLl~--------tL-qn~pp~~~t----~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 235 YPPMKVLLL--------TL-QNDPPTLLT----SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHHHHH--------Hh-cCCCCCccc----ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 553322211 00 011110000 00111122345568999999999999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=269.97 Aligned_cols=201 Identities=19% Similarity=0.264 Sum_probs=161.4
Q ss_pred CCCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCee
Q 044155 1 QMSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~ 75 (239)
+++||||++++|++.+ ....++||||+++|+|.+++... ..+++.....++.|++.||.||| . .+++
T Consensus 74 ~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ 145 (283)
T PHA02988 74 RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLY---KYTNKP 145 (283)
T ss_pred hcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHH---hcCCCC
Confidence 4799999999999877 34678999999999999999865 56788899999999999999999 6 4889
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc--CCcccccchhhhhhHHHHHhcCCCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT--GVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
||||||+||+++.++.+||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|||++|..|
T Consensus 146 Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~P 221 (283)
T PHA02988 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP 221 (283)
T ss_pred CCcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCC
Confidence 99999999999999999999999987543221 23457889999999976 6789999999999999999999999
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
|..... .+..............+...+..+.+++.+||+.||.+|||++++++.|+++.
T Consensus 222 f~~~~~---------------------~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 222 FENLTT---------------------KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCH---------------------HHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 864321 11111111111111111245677999999999999999999999999999875
Q ss_pred H
Q 044155 234 R 234 (239)
Q Consensus 234 ~ 234 (239)
.
T Consensus 281 ~ 281 (283)
T PHA02988 281 F 281 (283)
T ss_pred h
Confidence 3
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=275.70 Aligned_cols=194 Identities=25% Similarity=0.369 Sum_probs=163.3
Q ss_pred CC-CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MS-HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~-H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++ ||||+++++++......++||||+.+|+|.+++... .++.+..+++++.|++.|++|+| .++|+|||||
T Consensus 76 ~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK 147 (370)
T KOG0583|consen 76 LRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLK 147 (370)
T ss_pred hccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCC
Confidence 45 999999999999999999999999999999999884 67888999999999999999999 9999999999
Q ss_pred CcceeecCC-CceeEcccccccccCCCCcceeecccccccccCccccccCC-cc-cccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEE-NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FN-EKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+|+|++.+ +.+||+|||++.... .......+..||+.|+|||++.+.. |+ .++||||+|+++|.|++|..||+.
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d- 225 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD- 225 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-
Confidence 999999999 999999999998763 2223456788999999999999876 75 789999999999999999888853
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHH-HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQ-LHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.........+..+.+.-+ ... +.++.+++.+|+..||.+|+|+.++++
T Consensus 226 --------------------~~~~~l~~ki~~~~~~~p--~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 226 --------------------SNVPNLYRKIRKGEFKIP--SYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --------------------ccHHHHHHHHhcCCccCC--CCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 222333333333332211 122 778899999999999999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=279.00 Aligned_cols=207 Identities=26% Similarity=0.388 Sum_probs=174.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++||++....+.++|||+|.||+|.++++... ..++..++..++.+.+.||+||| .++++||||.
T Consensus 217 ~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIA 289 (474)
T KOG0194|consen 217 QLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIA 289 (474)
T ss_pred hCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHh
Confidence 5899999999999999999999999999999999999864 35999999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
.+|+|++.++.+||+|||+++... ..........-+..|+|||.+....++.++|||||||++||+++ |..||.+..
T Consensus 290 ARNcL~~~~~~vKISDFGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~- 367 (474)
T KOG0194|consen 290 ARNCLYSKKGVVKISDFGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK- 367 (474)
T ss_pred HHHheecCCCeEEeCccccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-
Confidence 999999999999999999987653 11111112346889999999999999999999999999999999 666765433
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
..++...+....++...+...+..+..++.+||..+|++|||+.++.+.|+.+....
T Consensus 368 --------------------~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 368 --------------------NYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred --------------------HHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 224444444444444444567788899999999999999999999999999987653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=273.47 Aligned_cols=214 Identities=18% Similarity=0.242 Sum_probs=165.3
Q ss_pred CCC-CcccceeeEEEEeCC-CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMS-HNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~-H~niv~l~~~~~~~~-~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+|+ |||||++.+++.++. ..++|||||+ .+|+++++..+ ..+++..++.|+.||++||+|+| .+|+.|||
T Consensus 64 kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH---k~GfFHRD 135 (538)
T KOG0661|consen 64 KLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRD 135 (538)
T ss_pred hcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH---hcCccccc
Confidence 467 999999999999888 8999999998 89999999873 78999999999999999999999 99999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
+||+|||+..+..+||+|||+++...... +-+....|.+|+|||++.. +.|+.+.|+|++||+++|+.+-++.|.+.
T Consensus 136 lKPENiLi~~~~~iKiaDFGLARev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 136 LKPENILISGNDVIKIADFGLAREVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred CChhheEecccceeEecccccccccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 99999999988899999999998763322 2346678999999998875 56999999999999999999999888776
Q ss_pred cccccccccchhhhhhhhhccchhhhh--hhhhh--------cCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIV--DHIVV--------EDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+.+..... .+.+..+. ...+.+.. ...+. .+..... ...+.+..++|.+|+.+||.+||||.|.++
T Consensus 214 sE~Dqi~KI-c~VLGtP~-~~~~~eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 214 SEIDQIYKI-CEVLGTPD-KDSWPEGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred cHHHHHHHH-HHHhCCCc-cccchhHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 554433221 01111111 11111111 11100 0001111 247788899999999999999999999987
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=271.83 Aligned_cols=199 Identities=23% Similarity=0.311 Sum_probs=175.6
Q ss_pred CCCCcccceeeEEEEeCCC-ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPI-PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~-~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++|||||.+++.|+.++. .+|||+||+||++.+.+.+..+ ..++++.+..|+.|++.|+.||| +.+|+||||
T Consensus 59 ~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDl 132 (426)
T KOG0589|consen 59 KLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH---ENRVLHRDL 132 (426)
T ss_pred hccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccc
Confidence 5799999999999999888 8999999999999999998865 67899999999999999999999 999999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+.||+++.++.++|+|||+++.+.... .......||+.|++||.+.+.+|+.|+|||||||++|||++-+++|
T Consensus 133 K~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF----- 206 (426)
T KOG0589|consen 133 KCANIFLTKDKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAF----- 206 (426)
T ss_pred hhhhhhccccCceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhccccc-----
Confidence 9999999999999999999998875432 2456778999999999999999999999999999999999996665
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
.......++.++....+.+ .+...+.++..+|..|+..+|..||++.+|+..
T Consensus 207 ----------------~a~~m~~Li~ki~~~~~~P-lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 207 ----------------KASNMSELILKINRGLYSP-LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----------------CccchHHHHHHHhhccCCC-CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 4455566666666666433 345778899999999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=269.44 Aligned_cols=194 Identities=21% Similarity=0.282 Sum_probs=163.6
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.||.|++||--|.+...+|+|+||+++|+|.++|++. ..+++...+.++.+|+.||+||| .+||+||||||+
T Consensus 132 ~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPE 203 (604)
T KOG0592|consen 132 GHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPE 203 (604)
T ss_pred CCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChh
Confidence 8999999999999999999999999999999999987 67999999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCc------------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcC
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGET------------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g 150 (239)
|||++.++.++|+|||.++.+..... .....++||-.|.+||++.....+..+|||+|||++|+|+.|
T Consensus 204 NILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 204 NILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred heeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcC
Confidence 99999999999999999987743211 112568999999999999999999999999999999999999
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+||.... -.-..+.++.-.+.. +...++...+||...|..||++|+|+.++.+
T Consensus 284 ~PPFra~N---------------------eyliFqkI~~l~y~f--p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 284 QPPFRAAN---------------------EYLIFQKIQALDYEF--PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCCcccc---------------------HHHHHHHHHHhcccC--CCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 99985322 111222222222211 1245577889999999999999999988865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=255.55 Aligned_cols=218 Identities=21% Similarity=0.281 Sum_probs=171.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
||+|+|+|.++++|......++|+|||+. ++.+-+.... ..++.....+++.|++.|+.|+| .++++|||||
T Consensus 57 qLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIK 128 (396)
T KOG0593|consen 57 QLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIK 128 (396)
T ss_pred hcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCC
Confidence 68999999999999999999999999984 6666676654 56888999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+|||++.+|.+||+|||+|+.+... ...-+....|.+|+|||.+.+ ..|....||||+||++.||++|.+.|.+-++
T Consensus 129 PENILit~~gvvKLCDFGFAR~L~~p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 129 PENILITQNGVVKLCDFGFARTLSAP-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred hhheEEecCCcEEeccchhhHhhcCC-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 99999999999999999999887532 222346678999999999988 6799999999999999999999999988777
Q ss_pred ccccc------ccchhhhhhhhhccchhhhhhhhhhcCCCcHHH--HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLV------CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEK--EQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+.+. +.+.......|..+....-+.--..++..+... ...+..+.+++..|++.||.+|+|-+|++.
T Consensus 208 iDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 208 IDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 65442 233333444454444333222111122221111 244567889999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=259.82 Aligned_cols=189 Identities=24% Similarity=0.336 Sum_probs=161.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||+||+++-.|.+....++|+||+.||.|.-.+.+. ..+++..++-++..|+.||.||| +++|+|||||
T Consensus 81 ~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlK 152 (357)
T KOG0598|consen 81 KIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLK 152 (357)
T ss_pred hCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCC
Confidence 479999999999999999999999999999999999876 67999999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.+|.++|+|||+++..... ...+..++||+.|||||++....++..+|-||||+++|+|++|.+||.
T Consensus 153 PENILLd~~GHi~LtDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~----- 226 (357)
T KOG0598|consen 153 PENILLDEQGHIKLTDFGLCKEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY----- 226 (357)
T ss_pred HHHeeecCCCcEEEeccccchhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc-----
Confidence 99999999999999999999754322 223556899999999999999999999999999999999999988874
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP 220 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 220 (239)
.....+.++++..+.... .+...+.+.++++...+..||.+|.
T Consensus 227 ----------------~~~~~~~~~~I~~~k~~~-~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 227 ----------------AEDVKKMYDKILKGKLPL-PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----------------CccHHHHHHHHhcCcCCC-CCccCCHHHHHHHHHHhccCHHHhc
Confidence 333345555555544221 1223667889999999999999996
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=268.69 Aligned_cols=209 Identities=21% Similarity=0.390 Sum_probs=159.7
Q ss_pred CCcccceeeEEEEeCC-CceEEEEEccCCChhhhhhcCCCC---------------------------------------
Q 044155 3 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQP--------------------------------------- 42 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~-~~~iv~e~~~~~sL~~~l~~~~~~--------------------------------------- 42 (239)
+||||+++++++...+ ..++||||+++|+|.+++......
T Consensus 69 ~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (338)
T cd05102 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSR 148 (338)
T ss_pred cCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccc
Confidence 7999999999987644 578999999999999998753210
Q ss_pred ------------------CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccC
Q 044155 43 ------------------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 104 (239)
Q Consensus 43 ------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~ 104 (239)
....++...+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||+++...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~ 225 (338)
T cd05102 149 FQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225 (338)
T ss_pred cccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccc
Confidence 0134777888999999999999999 8999999999999999999999999999987543
Q ss_pred CCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccccccccccchhhhhhhhhccchhh
Q 044155 105 EGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTE 182 (239)
Q Consensus 105 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (239)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |..||........ . ..
T Consensus 226 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-------~-~~--------- 288 (338)
T cd05102 226 KDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------F-CQ--------- 288 (338)
T ss_pred cCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-------H-HH---------
Confidence 22111 1223345678999999998889999999999999999997 8888754321100 0 00
Q ss_pred hhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 183 IVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.+........+...++.+.+++.+||+.||.+|||+.|+++.|+++..+
T Consensus 289 ----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 289 ----RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred ----HHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000000011123456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=288.34 Aligned_cols=211 Identities=24% Similarity=0.421 Sum_probs=173.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC--CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP--HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++|||||+++|++.+....+|++|||++|+|..++++.+.. ....+..+..+.++.|||.|+.||+ ++++||||
T Consensus 751 ~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRD 827 (1025)
T KOG1095|consen 751 KFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRD 827 (1025)
T ss_pred cCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcc
Confidence 479999999999999999999999999999999999986331 1257889999999999999999999 99999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCccee-ecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~ 156 (239)
|..+|+|++....+||+|||+++..-....+.. ....-+..|||||.+....++.++|||||||++||++| |..||..
T Consensus 828 LAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 828 LAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred hhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999984433333322 23356789999999999999999999999999999999 5456543
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
. ...++......+- +...+..++..+.++|..||+.+|++||++..+++.+.++.+..
T Consensus 908 ~---------------------~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 908 R---------------------SNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred c---------------------chHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 2 2223333233322 33344577888999999999999999999999999998887643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=255.54 Aligned_cols=203 Identities=17% Similarity=0.245 Sum_probs=160.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..++..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+|||
T Consensus 62 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dik 134 (266)
T cd05064 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLA 134 (266)
T ss_pred cCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccc
Confidence 4689999999999999999999999999999999987642 46889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++++|||.+...............++..|+|||.+.+..++.++||||||+++|++++ |..||.....
T Consensus 135 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 135 AHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred HhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 999999999999999999865432221111122334678999999998899999999999999999775 8888854321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
. +........ .....+...+..+.+++.+||..+|.+|||++++.+.|.++
T Consensus 215 ~---------------------~~~~~~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 215 Q---------------------DVIKAVEDG-FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred H---------------------HHHHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 111111111 01111224566789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=248.23 Aligned_cols=194 Identities=23% Similarity=0.333 Sum_probs=165.5
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.||||+++.++++.+...++|+|.|+.|.|.|++.+. ..++++..++++.|+.+|+.||| .++||||||||+
T Consensus 81 GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpE 152 (411)
T KOG0599|consen 81 GHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPE 152 (411)
T ss_pred CCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChh
Confidence 7999999999999999999999999999999999876 77899999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc------CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT------GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||++++.+++|+|||++.....+. .....+|||+|+|||.+.. ..|+...|+|++|+++|.++.|.+||.-
T Consensus 153 NILlddn~~i~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 153 NILLDDNMNIKISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred heeeccccceEEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 9999999999999999998876654 3557789999999999853 3488899999999999999999999742
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
-. -.-....+..+.+ .+++=.+.+...+++|++||..||.+|.|++|.++
T Consensus 231 Rk---------------------QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 231 RK---------------------QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HH---------------------HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11 1112223333333 23333577888999999999999999999999986
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=268.99 Aligned_cols=196 Identities=20% Similarity=0.296 Sum_probs=164.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++++||.++||.+..+...|++||||.||++.+.++.. ..+.+.....++.+++.|+.||| ..+.+|||||
T Consensus 67 ~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIK 138 (467)
T KOG0201|consen 67 QCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIK 138 (467)
T ss_pred hcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhh---hcceeccccc
Confidence 468899999999999999999999999999999999876 34577888889999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+.||++..+|.+|++|||.+.++..- .....++.||+.|||||++.+..|+.++||||||++.+||.+|.+|+...-.+
T Consensus 139 aanil~s~~g~vkl~DfgVa~ql~~~-~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm 217 (467)
T KOG0201|consen 139 AANILLSESGDVKLADFGVAGQLTNT-VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM 217 (467)
T ss_pred ccceeEeccCcEEEEecceeeeeech-hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc
Confidence 99999999999999999998776432 33347889999999999999889999999999999999999999997533321
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+...++ .+...+.....+++.+++||..||++||+.||||.+++.
T Consensus 218 ------------------rvlflI----pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 218 ------------------RVLFLI----PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ------------------eEEEec----cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 111111 122222233367788999999999999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=263.62 Aligned_cols=217 Identities=18% Similarity=0.208 Sum_probs=167.5
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+|+||||++|.+...+. +.+|+|+|||+ -+|.-++.... -.++..+++.++.|++.||.|+| .++++|||
T Consensus 172 ~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRD 243 (560)
T KOG0600|consen 172 RLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRD 243 (560)
T ss_pred hcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHh---hcCeeecc
Confidence 58999999999998866 68999999998 58988886543 57899999999999999999999 99999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
||..||||+++|.+||+|||+++.........-+..+.|.+|+|||.+++. .|+...|+||.|||+.||+.|++++++-
T Consensus 244 IK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~ 323 (560)
T KOG0600|consen 244 IKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR 323 (560)
T ss_pred ccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc
Confidence 999999999999999999999998766555556677889999999999985 5999999999999999999999999876
Q ss_pred cccccccccchhhhhhhhhccchh--hhhhhhhhc---CCCcH---HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFT--EIVDHIVVE---DVSSI---EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+...+...|.-.... ....|. ++-...... .+... .....+....+|+..+|..||.+|.||.++++
T Consensus 324 tEveQl~kIfklcGSP--~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 324 TEVEQLHKIFKLCGSP--TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cHHHHHHHHHHHhCCC--ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 6554443322111100 011111 000000000 11111 11245567789999999999999999999886
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=268.66 Aligned_cols=194 Identities=24% Similarity=0.357 Sum_probs=172.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.|+|||||.++++|++..+.|+|+||+. |+|..++... ..+++..+..++.++..||.||| +.+|.|||+|
T Consensus 57 ~lkHpniv~m~esfEt~~~~~vVte~a~-g~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~k 127 (808)
T KOG0597|consen 57 SLKHPNIVEMLESFETSAHLWVVTEYAV-GDLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMK 127 (808)
T ss_pred hcCCcchhhHHHhhcccceEEEEehhhh-hhHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCC
Confidence 4799999999999999999999999998 5999999876 67999999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||+...+.+|++|||+++.+..+ +...+...|||-|||||...+.+|+..+|+||+||++||+++|++||.
T Consensus 128 PqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~----- 201 (808)
T KOG0597|consen 128 PQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY----- 201 (808)
T ss_pred cceeeecCCCceeechhhhhhhcccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-----
Confidence 99999999999999999999887553 334556679999999999999999999999999999999999988873
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...+..++..+..++...+ ...+..+.+++...|.+||..|.|+.+++.
T Consensus 202 ----------------a~si~~Lv~~I~~d~v~~p--~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 202 ----------------ARSITQLVKSILKDPVKPP--STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----------------HHHHHHHHHHHhcCCCCCc--ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 4455567777777666544 377888999999999999999999999986
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=269.96 Aligned_cols=193 Identities=23% Similarity=0.341 Sum_probs=167.8
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
|.||||+++|+++++...+++|.||+++|-|.+++.+. +++++.++++++.||+.|+.|+| ..+|+||||||
T Consensus 69 i~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKp 140 (786)
T KOG0588|consen 69 IEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKP 140 (786)
T ss_pred hcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCc
Confidence 58999999999999999999999999999999999887 67999999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+|+|++..+.+||+|||+|.....+ ....+.+|++.|.|||++.+.+| +.++||||.|||+|.++||+.||+
T Consensus 141 ENlLLd~~~nIKIADFGMAsLe~~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd----- 213 (786)
T KOG0588|consen 141 ENLLLDVKNNIKIADFGMASLEVPG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD----- 213 (786)
T ss_pred hhhhhhcccCEeeeccceeecccCC--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----
Confidence 9999999999999999998664333 33556789999999999999885 578999999999999999988775
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
++....+..++..+.+.-+ ...+.+.++|+++|+..||++|.|.+||+.
T Consensus 214 ----------------DdNir~LLlKV~~G~f~MP--s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 214 ----------------DDNIRVLLLKVQRGVFEMP--SNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred ----------------CccHHHHHHHHHcCcccCC--CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 3344455555555554322 467788999999999999999999999986
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=253.58 Aligned_cols=204 Identities=22% Similarity=0.369 Sum_probs=161.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......+++|||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++|+|||
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlk 131 (263)
T cd05052 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLA 131 (263)
T ss_pred hCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccC
Confidence 47899999999999999999999999999999999976532 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+................+..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 132 p~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 211 (263)
T cd05052 132 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211 (263)
T ss_pred cceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999987654332211122234567999999988889999999999999999998 8777653211
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
.+...... .......+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 212 ---------------------~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 212 ---------------------SQVYELLE-KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---------------------HHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00000000 0001111123457789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=254.96 Aligned_cols=206 Identities=24% Similarity=0.399 Sum_probs=163.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCC-----------CcCCHHHHHHHHHHHHHHHhHHhhC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF-----------EPLLLKHRLKIAMDIVHALAYLHFG 69 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~ 69 (239)
+++||||+++++++......+++|||+++++|.+++........ ..++...+..++.|++.||.|||
T Consensus 64 ~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH-- 141 (283)
T cd05048 64 DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS-- 141 (283)
T ss_pred hcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 47899999999999988899999999999999999976432111 35778889999999999999999
Q ss_pred CCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 70 FPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 70 ~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
+.+++|+||||+||++++++.++|+|||++........ .......+++.|+|||.+.+..++.++|+||||+++|||+
T Consensus 142 -~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~ 220 (283)
T cd05048 142 -SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF 220 (283)
T ss_pred -hCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHH
Confidence 89999999999999999999999999999865432211 1223344678899999998888999999999999999999
Q ss_pred c-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 149 T-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 149 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+ |..||..... .+....+..... ...+...+.++.+++.+||+.||.+|||+.++++
T Consensus 221 ~~g~~p~~~~~~---------------------~~~~~~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 221 SYGLQPYYGFSN---------------------QEVIEMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHT 278 (283)
T ss_pred cCCCCCCCCCCH---------------------HHHHHHHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8 8888753221 111111111111 1122356788999999999999999999999999
Q ss_pred HHHH
Q 044155 228 KLRQ 231 (239)
Q Consensus 228 ~L~~ 231 (239)
.|+.
T Consensus 279 ~l~~ 282 (283)
T cd05048 279 RLRS 282 (283)
T ss_pred HHhc
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=260.36 Aligned_cols=217 Identities=21% Similarity=0.273 Sum_probs=160.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC-Ceeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-~i~H~dl 79 (239)
+++||||+++++++...+..++||||+++++|.+++... ..++...+..++.|++.||.||| +. +++|+||
T Consensus 59 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dl 130 (331)
T cd06649 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDV 130 (331)
T ss_pred HCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCC
Confidence 478999999999999999999999999999999999765 56889999999999999999999 64 6999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+||+++.++.++|+|||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 131 kp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 131 KPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred ChhhEEEcCCCcEEEccCccccccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999998654322 12345688999999999988899999999999999999999999864221
Q ss_pred cccc---cccc-----------h---h-----hhhh---hhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCC
Q 044155 160 VHDL---VCPF-----------S---E-----YLKN---CFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKD 214 (239)
Q Consensus 160 ~~~~---~~~~-----------~---~-----~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 214 (239)
..-. ..+. . . .... ........+..................+.++.+||.+||+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 287 (331)
T cd06649 208 KELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIK 287 (331)
T ss_pred HHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccC
Confidence 1000 0000 0 0 0000 00000011111111111111111123567799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 044155 215 SPADRPSMVDVAKK 228 (239)
Q Consensus 215 dp~~Rps~~ell~~ 228 (239)
||++|||++++++.
T Consensus 288 ~P~~Rpt~~ell~h 301 (331)
T cd06649 288 NPAERADLKMLMNH 301 (331)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999873
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=261.49 Aligned_cols=195 Identities=18% Similarity=0.262 Sum_probs=158.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..++..++||||+++++|.+.+... ..+++..+..++.|++.||+||| +.+|+|||||
T Consensus 51 ~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlk 122 (323)
T cd05571 51 NTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLK 122 (323)
T ss_pred hCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCC
Confidence 468999999999999999999999999999999998765 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 123 p~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~- 200 (323)
T cd05571 123 LENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH- 200 (323)
T ss_pred HHHEEECCCCCEEEeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-
Confidence 999999999999999999986532211 123345689999999999988899999999999999999999999853210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
............. .+...+..+.+++.+||+.||++|| ++.++++
T Consensus 201 --------------------~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 201 --------------------EKLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --------------------HHHHHHHHcCCCC--CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1111111111111 1123456788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=255.62 Aligned_cols=201 Identities=31% Similarity=0.479 Sum_probs=152.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||++++|++...+..++|+||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+
T Consensus 57 ~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~ 130 (259)
T PF07714_consen 57 KLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLS 130 (259)
T ss_dssp THSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-S
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccc---cccccccccc
Confidence 46899999999999988889999999999999999998633 57889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCC-CcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEG-ETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
++||+++.++.+||+|||++...... ..........+..|+|||.+....++.++||||||+++||+++ |..|+....
T Consensus 131 ~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 131 PSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp GGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999998765222 1122334456788999999998889999999999999999999 566654321
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
..+......... ....+...+..+.++|.+||+.||.+|||+.++++.|
T Consensus 211 ---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 211 ---------------------NEEIIEKLKQGQ-RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---------------------HHHHHHHHHTTE-ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---------------------cccccccccccc-cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111111111111 1111124466788999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=271.73 Aligned_cols=201 Identities=21% Similarity=0.245 Sum_probs=160.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..++..++||||+++|+|.+.+...... ...++...+..++.|++.||.||| +++|+|||||
T Consensus 121 ~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlk 196 (478)
T PTZ00267 121 ACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLK 196 (478)
T ss_pred hCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcC
Confidence 478999999999999999999999999999999888643211 146788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 197 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~- 275 (478)
T PTZ00267 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS- 275 (478)
T ss_pred HHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 9999999999999999999876543221 12334568999999999998889999999999999999999999875321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+.......+.... .+...+..+.++|.+||..||++|||+++++.
T Consensus 276 --------------------~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 276 --------------------QREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --------------------HHHHHHHHHhCCCCC-CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111122222222111 11234567899999999999999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=265.47 Aligned_cols=205 Identities=25% Similarity=0.363 Sum_probs=175.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++.|||||+++|+|.+. ..|||||+++-|-|..+++.+. ..++......++.||+.||+||| +.+.|||||.
T Consensus 447 nfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIA 518 (974)
T KOG4257|consen 447 NFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIA 518 (974)
T ss_pred hCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhh
Confidence 47899999999999655 4799999999999999998764 57889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
.+|||+.+...+|++|||+++.......+..+...-++.|||||.++...++.++|+|.||+.+||++. |..||++..+
T Consensus 519 aRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN 598 (974)
T KOG4257|consen 519 ARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN 598 (974)
T ss_pred hhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc
Confidence 999999999999999999999887776666666667889999999999999999999999999999876 7788876553
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.+-.. . +.+..+.+.++++++.+..++.+||.+||.+||++.++...|.+++..
T Consensus 599 sDVI~---------------------~-iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 599 SDVIG---------------------H-IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred cceEE---------------------E-ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 22221 1 122223445568889999999999999999999999999999988763
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=257.84 Aligned_cols=219 Identities=19% Similarity=0.190 Sum_probs=157.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||++++++..+.... ..++...++.++.|++.||.||| +.+++|+|||
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlk 127 (287)
T cd07848 56 TLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIK 127 (287)
T ss_pred hCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 478999999999999999999999999976665444322 46888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++...............+++.|+|||++.+..++.++|+||||+++|+|++|+.||......
T Consensus 128 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~ 207 (287)
T cd07848 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI 207 (287)
T ss_pred HHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999998765433222233456889999999998888999999999999999999999999754322
Q ss_pred cccc------ccchhhhhhhhhccc-hhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLV------CPFSEYLKNCFEDNR-FTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... .+........+.... ............. ........+..+.+++.+||+.||++|||++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 208 DQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1110 000000000000000 0000000000000 00011234677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=263.16 Aligned_cols=218 Identities=17% Similarity=0.194 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+||||+++++++..+...++|+|++. ++|.+++... ..++...++.++.|++.||.||| +++|+|||||
T Consensus 139 ~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiK 209 (391)
T PHA03212 139 AINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIK 209 (391)
T ss_pred hCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 4799999999999999999999999996 7998888765 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++...............||+.|+|||++.+..++.++||||||+++|+|++|..|+......
T Consensus 210 P~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~ 289 (391)
T PHA03212 210 AENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGL 289 (391)
T ss_pred hHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccc
Confidence 99999999999999999998653222222223456899999999999888999999999999999999999876432211
Q ss_pred ccccc---cchhhhhhh--------hhc-cchhhhhhhhhhc----CC-C--cHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 161 HDLVC---PFSEYLKNC--------FED-NRFTEIVDHIVVE----DV-S--SIEKEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 161 ~~~~~---~~~~~~~~~--------~~~-~~~~~~~~~~~~~----~~-~--~~~~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
..... ......... ... ............. .. . .......+.++.+++.+||+.||.+|||
T Consensus 290 ~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt 369 (391)
T PHA03212 290 DGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS 369 (391)
T ss_pred cccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC
Confidence 11000 000000000 000 0000000000000 00 0 0111245678899999999999999999
Q ss_pred HHHHHH
Q 044155 222 MVDVAK 227 (239)
Q Consensus 222 ~~ell~ 227 (239)
++|+++
T Consensus 370 a~elL~ 375 (391)
T PHA03212 370 AEALLD 375 (391)
T ss_pred HHHHhc
Confidence 999986
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=250.61 Aligned_cols=204 Identities=20% Similarity=0.346 Sum_probs=161.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++.+...+..+++|||+++++|.+++..... ..++...+..++.|++.||+||| +.+++|+|||
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~ 130 (261)
T cd05072 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLR 130 (261)
T ss_pred hCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccc
Confidence 47899999999999998999999999999999999976533 46788889999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............++..|+|||.+....++.++|+||||+++|+|++ |..||.....
T Consensus 131 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred hhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 999999999999999999987654332222223345678999999988889999999999999999998 8888753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
. +........ .........+..+.+++.+||+.+|++|||++++.+.|+++
T Consensus 211 ~---------------------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 211 S---------------------DVMSALQRG-YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred H---------------------HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 000000000 00001113456788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=263.42 Aligned_cols=206 Identities=18% Similarity=0.342 Sum_probs=158.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCC---------------------------------------
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH--------------------------------------- 43 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~--------------------------------------- 43 (239)
+||||+++++++.++...++||||+++|+|.+++.......
T Consensus 97 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (375)
T cd05104 97 NHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVS 176 (375)
T ss_pred CCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcc
Confidence 79999999999999999999999999999999987532100
Q ss_pred -------------------------------CCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCce
Q 044155 44 -------------------------------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA 92 (239)
Q Consensus 44 -------------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~ 92 (239)
...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~ 253 (375)
T cd05104 177 YVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRIT 253 (375)
T ss_pred cccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcE
Confidence 024678888999999999999999 8999999999999999999999
Q ss_pred eEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccccccccccchhh
Q 044155 93 KLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKDVHDLVCPFSEY 170 (239)
Q Consensus 93 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~ 170 (239)
+|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 254 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-------- 325 (375)
T cd05104 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-------- 325 (375)
T ss_pred EEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--------
Confidence 9999999876533221 11122335667999999998899999999999999999998 7777754321100
Q ss_pred hhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 171 LKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
....+ ........+...+.++.+++.+||..||++|||+.|+++.|++.
T Consensus 326 ---------~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 326 ---------FYKMI----KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---------HHHHH----HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00000 10000001112346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=258.73 Aligned_cols=195 Identities=20% Similarity=0.268 Sum_probs=156.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +++++|||||
T Consensus 49 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlk 120 (312)
T cd05585 49 QVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLK 120 (312)
T ss_pred hCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCC
Confidence 478999999999999999999999999999999999765 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 121 p~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-- 197 (312)
T cd05585 121 PENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-- 197 (312)
T ss_pred HHHeEECCCCcEEEEECcccccCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--
Confidence 999999999999999999986532221 12334568999999999998889999999999999999999999985321
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS---MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ell~ 227 (239)
..+........... .+...+..+.+++.+||+.||.+||+ +.+++.
T Consensus 198 -------------------~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 198 -------------------VNEMYRKILQEPLR--FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -------------------HHHHHHHHHcCCCC--CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 11111111111111 11245567889999999999999985 555553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=252.53 Aligned_cols=200 Identities=21% Similarity=0.311 Sum_probs=158.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.+.+..++||||+++|+|.+.+..... ..+++..+..++.|++.||.||| +.+++|||||
T Consensus 56 ~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dik 129 (285)
T cd05631 56 KVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLK 129 (285)
T ss_pred hcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCC
Confidence 46899999999999999999999999999999888765422 45889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 130 p~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 130 PENILLDDRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred HHHEEECCCCCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 999999999999999999987653322 123446899999999999889999999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
.. .+.+........ .......+..+.+++.+||+.||.+||| ++++++
T Consensus 208 ~~------------------~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 208 VK------------------REEVDRRVKEDQ-EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hh------------------HHHHHHHhhccc-ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00 001111111100 0111235567899999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=263.22 Aligned_cols=207 Identities=19% Similarity=0.355 Sum_probs=159.6
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----------------------------------------
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ----------------------------------------- 41 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~----------------------------------------- 41 (239)
+|+||+++++++...+..++||||+++|+|.+++.....
T Consensus 100 ~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (374)
T cd05106 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSD 179 (374)
T ss_pred cCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccc
Confidence 799999999999999999999999999999998864311
Q ss_pred ------------------------CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEccc
Q 044155 42 ------------------------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF 97 (239)
Q Consensus 42 ------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~df 97 (239)
....++++..+..++.|++.||.||| +++++||||||+||+++.++.++|+||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~Df 256 (374)
T cd05106 180 TYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDF 256 (374)
T ss_pred cccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeec
Confidence 00124678888999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccccccccccchhhhhhhh
Q 044155 98 SLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCF 175 (239)
Q Consensus 98 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 175 (239)
|++......... ......++..|+|||++....++.++||||||+++|+|++ |..||........
T Consensus 257 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------------- 323 (374)
T cd05106 257 GLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------------- 323 (374)
T ss_pred eeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-------------
Confidence 998655332211 1122334567999999988889999999999999999997 9888754321100
Q ss_pred hccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 176 EDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
..... ........+...+.++.+++.+||..||.+|||+.++++.|+++.
T Consensus 324 ----~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 324 ----FYKMV----KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----HHHHH----HcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00000 000000111123567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=250.50 Aligned_cols=210 Identities=23% Similarity=0.356 Sum_probs=164.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFG 69 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~ 69 (239)
+++||||+++++++......++||||+++++|.+++...... ....+++..+..++.|++.||+|||
T Consensus 63 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-- 140 (291)
T cd05094 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA-- 140 (291)
T ss_pred cCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 478999999999999999999999999999999999764320 1134788999999999999999999
Q ss_pred CCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 70 FPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 70 ~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
+++++|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 141 -~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 219 (291)
T cd05094 141 -SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219 (291)
T ss_pred -hCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999999865432211 1122344578899999999888999999999999999999
Q ss_pred c-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 149 T-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 149 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+ |..||...... +........... ......+..+.+++.+||..||++|||+.++++
T Consensus 220 t~g~~p~~~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 220 TYGKQPWFQLSNT---------------------EVIECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCCCHH---------------------HHHHHHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 8 88887543210 000001111100 001134567899999999999999999999999
Q ss_pred HHHHHHHh
Q 044155 228 KLRQIYRS 235 (239)
Q Consensus 228 ~L~~l~~~ 235 (239)
.|.++.+.
T Consensus 278 ~l~~~~~~ 285 (291)
T cd05094 278 ILHALGKA 285 (291)
T ss_pred HHHHHHhh
Confidence 99998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=250.60 Aligned_cols=210 Identities=23% Similarity=0.361 Sum_probs=164.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC--------CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ--------PHFEPLLLKHRLKIAMDIVHALAYLHFGFPR 72 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 72 (239)
+++||||+++++++...+..++||||+++++|.+++..... .....+++..+..++.|++.||+||| +.
T Consensus 63 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~ 139 (288)
T cd05093 63 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQ 139 (288)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 47899999999999999999999999999999999975431 11135899999999999999999999 99
Q ss_pred CeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-C
Q 044155 73 PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-G 150 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g 150 (239)
+++|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++|+||||+++|+|++ |
T Consensus 140 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g 219 (288)
T cd05093 140 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 219 (288)
T ss_pred CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999865432211 11223345678999999998889999999999999999998 8
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
..||...... +............ .....+.++.+++.+||+.||.+|||+.+++..|+
T Consensus 220 ~~p~~~~~~~---------------------~~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 220 KQPWYQLSNN---------------------EVIECITQGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred CCCCCCCCHH---------------------HHHHHHHcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 7777533210 0111111111000 01133467899999999999999999999999999
Q ss_pred HHHHh
Q 044155 231 QIYRS 235 (239)
Q Consensus 231 ~l~~~ 235 (239)
++...
T Consensus 278 ~~~~~ 282 (288)
T cd05093 278 NLAKA 282 (288)
T ss_pred HHHHh
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=254.57 Aligned_cols=218 Identities=17% Similarity=0.191 Sum_probs=155.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||++ ++|.+++.... ..++...+..++.|++.||+||| +++++|||||
T Consensus 59 ~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlk 130 (288)
T cd07871 59 NLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLK 130 (288)
T ss_pred hCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 4789999999999999888999999997 69999887542 45788899999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++....... .......+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||.....
T Consensus 131 p~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 131 PQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred HHHEEECCCCCEEECcCcceeeccCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999986543221 11233457889999998875 5688999999999999999999999864332
Q ss_pred cccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... +..+.+........+....................+.+..+++.+||..||.+|||++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 210 KEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111100 00000000000000000000000000000000123466889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=255.92 Aligned_cols=192 Identities=23% Similarity=0.323 Sum_probs=156.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++......++.|++.||+||| +++++|+|||
T Consensus 57 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 128 (291)
T cd05612 57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLK 128 (291)
T ss_pred hCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCC
Confidence 478999999999999999999999999999999999765 56888999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 129 p~NIli~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~- 203 (291)
T cd05612 129 PENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP- 203 (291)
T ss_pred HHHeEECCCCCEEEEecCcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 99999999999999999998765332 1234688999999999988899999999999999999999998853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
......+...... .+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 204 --------------------~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 204 --------------------FGIYEKILAGKLE--FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred --------------------HHHHHHHHhCCcC--CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1111111111111 11123567889999999999999995 888775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=247.26 Aligned_cols=200 Identities=19% Similarity=0.350 Sum_probs=157.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......+++|||+.+++|.+++.... ..+++..+..++.|++.||+||| +.+++|+|||
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 127 (256)
T cd05113 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127 (256)
T ss_pred cCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccC
Confidence 4789999999999998888999999999999999997643 35789999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||.++..............++..|+|||...+..++.++|+||||+++|+|++ |..||.....
T Consensus 128 p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred cceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 999999999999999999887553332211122335677999999988889999999999999999998 8888753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
. +.......... .......+..+.+++.+||+.+|.+|||+.++++.|
T Consensus 208 ~---------------------~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 208 S---------------------ETVEKVSQGLR-LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred H---------------------HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 0 01111111100 000112356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=258.59 Aligned_cols=192 Identities=19% Similarity=0.309 Sum_probs=155.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||+.+++|.+.+... ..++...+..++.|++.||+||| +++++|+|||
T Consensus 74 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlk 145 (329)
T PTZ00263 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLK 145 (329)
T ss_pred hCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCC
Confidence 478999999999999999999999999999999999765 56788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||++....... ....|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 146 p~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~- 220 (329)
T PTZ00263 146 PENLLLDNKGHVKVTDFGFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP- 220 (329)
T ss_pred HHHEEECCCCCEEEeeccCceEcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-
Confidence 999999999999999999987653322 234689999999999988899999999999999999999999853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
.+....+...... .+...+..+.+++.+||+.||.+||+ +++++.
T Consensus 221 --------------------~~~~~~i~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 221 --------------------FRIYEKILAGRLK--FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --------------------HHHHHHHhcCCcC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0111111111110 01123456889999999999999997 577663
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=256.31 Aligned_cols=216 Identities=20% Similarity=0.262 Sum_probs=158.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dl 79 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..++......++.|++.||.||| + .+++|+||
T Consensus 59 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dl 130 (333)
T cd06650 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDV 130 (333)
T ss_pred HCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCC
Confidence 478999999999999999999999999999999999765 55788999999999999999999 6 47999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||||+++|++++|..||.....
T Consensus 131 kp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 131 KPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred ChhhEEEcCCCCEEEeeCCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 999999999999999999998654222 12344688999999999988899999999999999999999999864321
Q ss_pred cccc--c------cc-----------chhhhhhhh-h---ccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCC
Q 044155 160 VHDL--V------CP-----------FSEYLKNCF-E---DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSP 216 (239)
Q Consensus 160 ~~~~--~------~~-----------~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 216 (239)
.... . .+ ......... . ........................+.++.+++.+||+.||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 287 (333)
T cd06650 208 KELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNP 287 (333)
T ss_pred hHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCc
Confidence 1000 0 00 000000000 0 0000011111111111111111245678999999999999
Q ss_pred CCCCCHHHHHH
Q 044155 217 ADRPSMVDVAK 227 (239)
Q Consensus 217 ~~Rps~~ell~ 227 (239)
++|||+.|++.
T Consensus 288 ~~Rpt~~ell~ 298 (333)
T cd06650 288 AERADLKQLMV 298 (333)
T ss_pred ccCcCHHHHhh
Confidence 99999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=247.16 Aligned_cols=204 Identities=23% Similarity=0.396 Sum_probs=160.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..+++||++++++|.+++....+ ..+++..+..++.|++.|+.+|| +.+++|+|||
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 130 (261)
T cd05068 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLA 130 (261)
T ss_pred HCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCC
Confidence 47899999999999999999999999999999999976532 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++................+..|+|||...+..++.++|+||||++++++++ |..||.....
T Consensus 131 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 131 ARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred cceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999987654322111112223457999999988889999999999999999999 8778753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
........ ...........+..+.+++.+||+.+|.+||++.++.+.|+++
T Consensus 211 ---------------------~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 211 ---------------------AEVLQQVD-QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---------------------HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00110110 0000011123456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=239.01 Aligned_cols=216 Identities=19% Similarity=0.180 Sum_probs=169.4
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|+||+.++++|-+.....+|+||++ .+|+..++... ..+....++.++.++++|++|+| .+.|+|||+||
T Consensus 58 l~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKP 129 (318)
T KOG0659|consen 58 LKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKP 129 (318)
T ss_pred ccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCc
Confidence 689999999999999999999999998 89999998764 56788999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
.|+|++.+|.+||+|||+++.+..... .......|.+|+|||.+.+.+ |+...||||.||++.|++-|.+.|.+..+.
T Consensus 130 nNLLis~~g~lKiADFGLAr~f~~p~~-~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 130 NNLLISSDGQLKIADFGLARFFGSPNR-IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred cceEEcCCCcEEeecccchhccCCCCc-ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 999999999999999999988754322 222336789999999998865 899999999999999999999999888877
Q ss_pred ccccccchhhhhhhhhccchhhhhh-----hh--hhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVD-----HI--VVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
+.....|+....... ..|++... .. .............+....+++..|+.+||.+|+|+.|+++.
T Consensus 209 dQL~~If~~LGTP~~--~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 209 DQLSKIFRALGTPTP--DQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHHHHHHcCCCCc--ccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 666555443322111 11222111 00 01111111122455667999999999999999999998863
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=253.92 Aligned_cols=212 Identities=21% Similarity=0.312 Sum_probs=157.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC--------------CCCcCCHHHHHHHHHHHHHHHhHH
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP--------------HFEPLLLKHRLKIAMDIVHALAYL 66 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~L 66 (239)
+++||||+++++++.+.+..++||||+++++|.+++...... ....+++.....++.|++.||.||
T Consensus 75 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 154 (304)
T cd05096 75 RLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154 (304)
T ss_pred hcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999999999999999988653210 112467788899999999999999
Q ss_pred hhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHH
Q 044155 67 HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLF 145 (239)
Q Consensus 67 H~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 145 (239)
| +.+++|+||||+||+++.++.+||+|||++........ .......++..|+|||++....++.++||||||+++|
T Consensus 155 H---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 231 (304)
T cd05096 155 S---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231 (304)
T ss_pred H---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence 9 89999999999999999999999999999875533221 1122334578899999998888999999999999999
Q ss_pred HHhcC--CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 146 ELLTG--WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 146 ~~~~g--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
+|+++ ..||......... .. .......... ......+...+..+.+++.+||..||.+|||+.
T Consensus 232 el~~~~~~~p~~~~~~~~~~--------~~------~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 232 EILMLCKEQPYGELTDEQVI--------EN------AGEFFRDQGR-QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred HHHHccCCCCCCcCCHHHHH--------HH------HHHHhhhccc-cccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 99874 4566543211000 00 0000000000 000000113456789999999999999999999
Q ss_pred HHHHHHH
Q 044155 224 DVAKKLR 230 (239)
Q Consensus 224 ell~~L~ 230 (239)
++.+.|+
T Consensus 297 ~i~~~l~ 303 (304)
T cd05096 297 DIHAFLT 303 (304)
T ss_pred HHHHHHh
Confidence 9988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=246.59 Aligned_cols=200 Identities=20% Similarity=0.361 Sum_probs=157.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 127 (256)
T cd05114 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127 (256)
T ss_pred HCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccC
Confidence 4789999999999999999999999999999999987542 35788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............++..|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 128 p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 128 ARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred cceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999887553322222222335668999999988889999999999999999999 8778753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
.+.......... ...+...+..+.+++.+||..+|.+|||++++++.|
T Consensus 208 ---------------------~~~~~~i~~~~~-~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 208 ---------------------YEVVEMISRGFR-LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---------------------HHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111111111100 000112345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=248.24 Aligned_cols=204 Identities=18% Similarity=0.328 Sum_probs=158.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++.||||+++++++. +...++++||+++|+|.+++.... ..+++..+..++.|++.||.||| +++++|+|||
T Consensus 65 ~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlk 136 (279)
T cd05111 65 SLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLA 136 (279)
T ss_pred cCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccC
Confidence 468999999999875 445678999999999999997643 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.+||+|||.++........ ......++..|+|||.+.+..++.++|+||||+++||+++ |..||....
T Consensus 137 p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 137 ARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred cceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999998765332211 1223346678999999988889999999999999999998 888875432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
.. ...+.+. .......+...+..+.+++.+||..||++|||+.|+++.|..+..
T Consensus 217 ~~------------------~~~~~~~----~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 217 PH------------------EVPDLLE----KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HH------------------HHHHHHH----CCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 10 0001111 000000011223457889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=258.76 Aligned_cols=192 Identities=19% Similarity=0.257 Sum_probs=157.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++|||||
T Consensus 87 ~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLk 158 (340)
T PTZ00426 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLK 158 (340)
T ss_pred hCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCC
Confidence 478999999999999999999999999999999999765 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.++|+|||++...... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 159 p~NILl~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~- 233 (340)
T PTZ00426 159 PENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP- 233 (340)
T ss_pred HHHEEECCCCCEEEecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999998765322 2245689999999999988899999999999999999999999853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
......+...... .+...+..+.+++.+||+.||.+|+ |++++++
T Consensus 234 --------------------~~~~~~i~~~~~~--~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 234 --------------------LLIYQKILEGIIY--FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --------------------HHHHHHHhcCCCC--CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 0111111111110 0113345678999999999999995 8888875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=256.60 Aligned_cols=195 Identities=19% Similarity=0.273 Sum_probs=156.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||+++++|..++... ..+++..+..++.|++.||.||| +++++|+|||
T Consensus 51 ~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlk 122 (323)
T cd05595 51 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIK 122 (323)
T ss_pred hCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCC
Confidence 478999999999999999999999999999999888765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 123 p~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~- 200 (323)
T cd05595 123 LENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH- 200 (323)
T ss_pred HHHEEEcCCCCEEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-
Confidence 999999999999999999876432211 112345689999999999988899999999999999999999999853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
............. .+...++.+.+++.+||+.||.+|| ++.++++
T Consensus 201 --------------------~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 201 --------------------ERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --------------------HHHHHHHhcCCCC--CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1111111111111 0123456788999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=251.34 Aligned_cols=215 Identities=19% Similarity=0.257 Sum_probs=156.1
Q ss_pred CCCcccceeeEEEEe-----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 2 MSHNHILKLIGCCLE-----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 2 l~H~niv~l~~~~~~-----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++||||+++++++.. ....++|||++. ++|.+++..... ..+++..+..++.|++.||.||| +.+++|
T Consensus 61 ~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH 133 (290)
T cd07862 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVH 133 (290)
T ss_pred cCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeee
Confidence 479999999999852 345789999997 799999876533 45889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||||+||+++.++.++|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 134 RDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred CCCCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 999999999999999999999998765332 123345688999999999888899999999999999999999999875
Q ss_pred ccccccccccchhhhhhhhhccchhhhhh---hhhhc-CCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVD---HIVVE-DVSS--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+........ .....+ ....+..... ..... .... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 212 ~~~~~~~~~i~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 212 SSDVDQLGKIL-DVIGLP-GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCHHHHHHHHH-HHhCCC-ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 44322111000 000000 0000000000 00000 0000 011134567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=245.83 Aligned_cols=208 Identities=20% Similarity=0.270 Sum_probs=163.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++++||+++++|.+++...... ...++...+..++.|++.||.||| +.+++|+|||
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~ 133 (267)
T cd08228 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIK 133 (267)
T ss_pred hCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCC
Confidence 478999999999999999999999999999999888643211 145788899999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 134 ~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~ 212 (267)
T cd08228 134 PANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212 (267)
T ss_pred HHHEEEcCCCCEEECccccceeccchh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc
Confidence 999999999999999999887653222 1122345788999999998888899999999999999999999887432110
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
..............+......+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 213 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 213 -------------------LFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -------------------HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00111111111111112234567789999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=267.19 Aligned_cols=201 Identities=25% Similarity=0.356 Sum_probs=168.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|.|||+++|.+.+++.+-|.||-.+||||.++++..+++ -.-.+.+...+..||++||.||| +..|||||||
T Consensus 628 ~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGP--lKDNEstm~fYtkQILeGLkYLH---en~IVHRDIK 702 (1226)
T KOG4279|consen 628 TLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGP--LKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIK 702 (1226)
T ss_pred HHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCC--CccchhHHHHHHHHHHHHhhhhh---hcceeecccc
Confidence 479999999999999999999999999999999999988753 22367888899999999999999 9999999999
Q ss_pred Ccceeec-CCCceeEcccccccccCCCCcceeecccccccccCccccccCC--cccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFN-EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
.+|+|++ ..|.+||+|||.++.+ .+...++.++.||.-|||||++..++ |..++|||||||++.||.||++||.++
T Consensus 703 GDNVLvNTySGvlKISDFGTsKRL-AginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 703 GDNVLVNTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred CCcEEEeeccceEEecccccchhh-ccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 9999996 4689999999998876 45566788899999999999997654 889999999999999999999999766
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
++... ..|.-+- -...++.+...+.+.+.+|.+|+..||.+||||.++++
T Consensus 782 gspqA----------AMFkVGm----------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 782 GSPQA----------AMFKVGM----------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CChhH----------hhhhhcc----------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 53211 1111100 01224455688889999999999999999999999986
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=249.13 Aligned_cols=201 Identities=19% Similarity=0.299 Sum_probs=157.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.+++|+|||
T Consensus 49 ~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dik 122 (277)
T cd05607 49 KVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE---RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMK 122 (277)
T ss_pred hcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCC
Confidence 47899999999999999999999999999999988865432 45788888999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 123 p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~ 200 (277)
T cd05607 123 PENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200 (277)
T ss_pred hHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch
Confidence 999999999999999999987653322 122345788999999998888999999999999999999999998543210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. ..+............ .....+.++.+++..||+.||.+||+++|+++
T Consensus 201 ~~-----------------~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 201 VA-----------------KEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred hh-----------------HHHHHHHhhcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 00 001111111111111 11234667899999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=245.86 Aligned_cols=203 Identities=20% Similarity=0.313 Sum_probs=161.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..+++|||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++|+|||
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~ 133 (266)
T cd05033 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLA 133 (266)
T ss_pred hCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 4789999999999999999999999999999999997643 46789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||....
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 99999999999999999998766421111 1112234578999999988889999999999999999998 877774322
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
. .+........ .....+...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus 214 ~---------------------~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 214 N---------------------QDVIKAVEDG-YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred H---------------------HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 0111111110 00011123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=271.63 Aligned_cols=206 Identities=20% Similarity=0.298 Sum_probs=175.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
|+.||||++|.|+.......+||+|||++|+|..+|+.++ ..++..+..-++..|+.|++||. +.++|||||.
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLA 758 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLA 758 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhh
Confidence 6899999999999999999999999999999999999876 45888888999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce--eecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI--TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
.+|||++.+-.+|++|||+++.+.+..... ...-.-+..|.|||.+...+++.+||+||+|+++||.++ |..||.
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW-- 836 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW-- 836 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc--
Confidence 999999999999999999999774332111 122233678999999999999999999999999999776 766764
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
++..++.+.++ ...++.+.+-+++..+.+||..||++|-.+||.+.+++..|+++..+
T Consensus 837 -------------------dmSNQdVIkaI-e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 837 -------------------DMSNQDVIKAI-EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -------------------ccchHHHHHHH-HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 34445555444 44455555668899999999999999999999999999999998754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=256.56 Aligned_cols=195 Identities=19% Similarity=0.269 Sum_probs=157.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||+++++|.+.+... ..+++..+..++.||+.||+||| +++++|||||
T Consensus 51 ~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDik 122 (328)
T cd05593 51 NTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLK 122 (328)
T ss_pred hCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccC
Confidence 368999999999999999999999999999999888765 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 123 p~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~- 200 (328)
T cd05593 123 LENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH- 200 (328)
T ss_pred HHHeEECCCCcEEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-
Confidence 999999999999999999986532211 122345689999999999988899999999999999999999999853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.+........... .+...+..+.+++.+||..||.+|| ++.++++
T Consensus 201 --------------------~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 201 --------------------EKLFELILMEDIK--FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred --------------------HHHHHHhccCCcc--CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 0111111111110 1123456788999999999999997 8898875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=244.20 Aligned_cols=201 Identities=24% Similarity=0.368 Sum_probs=156.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 49 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~ 121 (252)
T cd05084 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLA 121 (252)
T ss_pred hCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccc
Confidence 4789999999999999999999999999999999987542 45789999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce-eecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.++|+|||.+.......... ......+..|+|||.+.+..++.++|+||||+++|++++ |..||....
T Consensus 122 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred hheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 999999999999999999986543221110 111223456999999988889999999999999999998 777765322
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
.. ........ ......+...+..+.+++.+||..+|++|||+.++++.|+
T Consensus 202 ~~------------------~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 202 NQ------------------QTREAIEQ----GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HH------------------HHHHHHHc----CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 10 00001100 0001111234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=245.05 Aligned_cols=202 Identities=22% Similarity=0.328 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++.||||+++++++. ....++||||+++++|.+++... ..++...+..++.|++.||.||| +++++|+|||
T Consensus 52 ~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlk 122 (257)
T cd05116 52 QLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLA 122 (257)
T ss_pred hCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccc
Confidence 368999999999885 45678999999999999999764 46889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce--eecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI--TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|.||+++.++.++|+|||++.......... .....++..|+|||.+....++.++|+||||+++||+++ |..||...
T Consensus 123 p~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 123 ARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred hhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999987654332211 122234578999999988888999999999999999998 88887543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
... ...+.+.. ... ...+...+..+.++|.+||+.||.+|||+++|.+.|++.+
T Consensus 203 ~~~------------------~~~~~i~~---~~~-~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 203 KGN------------------EVTQMIES---GER-MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred CHH------------------HHHHHHHC---CCC-CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 210 00111111 000 0111235567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=244.37 Aligned_cols=203 Identities=21% Similarity=0.352 Sum_probs=157.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++. ....++||||+++++|.+++.... ..+++..++.++.|++.||.||| +++++|+|||
T Consensus 51 ~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk 122 (257)
T cd05115 51 QLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLA 122 (257)
T ss_pred hcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccc
Confidence 478999999999885 456789999999999999987532 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce--eecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI--TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++.......... .....++..|+|||.+....++.++|+||||+++|++++ |..||...
T Consensus 123 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 123 ARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred hheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 999999999999999999986543222111 111223568999999988889999999999999999996 88887543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
... +......... ....+...+.++.+++.+||..+|++||++.++.+.|+.++
T Consensus 203 ~~~---------------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 203 KGP---------------------EVMSFIEQGK-RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CHH---------------------HHHHHHHCCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 210 0111110100 00111234577889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=253.87 Aligned_cols=198 Identities=24% Similarity=0.301 Sum_probs=162.5
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++|||||+++++..+. ..+|+|+|||..|.+...-... ..+...++++++.++..||.||| .++|+|||
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~-----~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRD 235 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-----PELSEQQARKYLRDVVLGLEYLH---YQGIIHRD 235 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc-----ccccHHHHHHHHHHHHHHHHHHH---hcCeeccc
Confidence 58999999999998765 4789999999988885433221 33889999999999999999999 99999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCC----cceeecccccccccCccccccCC----cccccchhhhhhHHHHHhcC
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGE----THITDTVMGTLGYCAPEYMRTGV----FNEKSNVFSFSVFLFELLTG 150 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~~~~g 150 (239)
|||+|+|++.+|++||+|||.+..+..+. ........|||+|+|||...++. .+.+.||||+||++|.++.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 99999999999999999999987663322 11223467999999999987733 45789999999999999999
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+.|| -.+...++.++++......+...+..+.++++|.+||.+||..|.+..+|..
T Consensus 316 ~~PF---------------------~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 316 QLPF---------------------FDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred cCCc---------------------ccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 7776 3445567777777777665555567788999999999999999999988753
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=245.90 Aligned_cols=203 Identities=24% Similarity=0.402 Sum_probs=162.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 58 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~ 131 (261)
T cd05148 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLA 131 (261)
T ss_pred cCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccC
Confidence 47899999999999999999999999999999999986543 56789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+........ ......++..|+|||......++.++|+||||+++|++++ |..||.....
T Consensus 132 ~~nilv~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 132 ARNILVGEDLVCKVADFGLARLIKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred cceEEEcCCceEEEccccchhhcCCccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999999999866533221 1223345678999999988889999999999999999998 7788753321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
.+....... ......+...+..+.+++.+||+.||.+|||++++++.|+.+
T Consensus 211 ---------------------~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 211 ---------------------HEVYDQITA-GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---------------------HHHHHHHHh-CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011111111 011111124456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=249.20 Aligned_cols=193 Identities=22% Similarity=0.317 Sum_probs=165.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
|+||||+.+|++|++.....|||||..+|.|+|++... ..+++.+.+.++.||..|+.|+| .++++|||||.
T Consensus 110 LNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKL 181 (668)
T KOG0611|consen 110 LNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKL 181 (668)
T ss_pred cCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh---hccceecccch
Confidence 79999999999999999999999999999999999887 67999999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcc-cccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFN-EKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+|||++.++++||+|||++..+... ...++++|++-|.+||+.++.+|. +..|.||||+++|.++.|..||++..
T Consensus 182 ENILLD~N~NiKIADFGLSNly~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-- 257 (668)
T KOG0611|consen 182 ENILLDQNNNIKIADFGLSNLYADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-- 257 (668)
T ss_pred hheeecCCCCeeeeccchhhhhccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--
Confidence 9999999999999999998766433 235688999999999999998864 67999999999999999988876433
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
...++.++-.+.+..+ ..+....-||+.||..+|.+|-|+.++...
T Consensus 258 -------------------hk~lvrQIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 258 -------------------HKRLVRQISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -------------------HHHHHHHhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 3345555555555433 233445679999999999999999998763
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=248.04 Aligned_cols=209 Identities=23% Similarity=0.373 Sum_probs=162.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-------------------CCCcCCHHHHHHHHHHHHH
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-------------------HFEPLLLKHRLKIAMDIVH 61 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~~~~~~~~~i~~ 61 (239)
+++||||+++++.+...+..++++||+.+++|.+++...... ....+++..+..++.|++.
T Consensus 59 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 138 (290)
T cd05045 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISR 138 (290)
T ss_pred hCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHH
Confidence 478999999999999999999999999999999998753210 1135778899999999999
Q ss_pred HHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhh
Q 044155 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSF 140 (239)
Q Consensus 62 ~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 140 (239)
||.||| +.+++|+||||+||++++++.++|+|||++......... ......++..|+|||.+.+..++.++|||||
T Consensus 139 ~l~~LH---~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 215 (290)
T cd05045 139 GMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215 (290)
T ss_pred HHHHHH---HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHH
Confidence 999999 899999999999999999999999999998754322211 1123345678999999988889999999999
Q ss_pred hhHHHHHhc-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 141 SVFLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 141 G~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
|+++++|++ |..||...... ... ... ........+...+..+.+++.+||+.+|.+|
T Consensus 216 G~~l~el~t~g~~p~~~~~~~---------~~~---------~~~----~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~R 273 (290)
T cd05045 216 GVLLWEIVTLGGNPYPGIAPE---------RLF---------NLL----KTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273 (290)
T ss_pred HHHHHHHHhcCCCCCCCCCHH---------HHH---------HHH----hCCCCCCCCCCCCHHHHHHHHHHccCCcccC
Confidence 999999998 88887532210 000 011 0000111112345678899999999999999
Q ss_pred CCHHHHHHHHHHHHH
Q 044155 220 PSMVDVAKKLRQIYR 234 (239)
Q Consensus 220 ps~~ell~~L~~l~~ 234 (239)
||+.++++.|++++.
T Consensus 274 p~~~~i~~~l~~~~~ 288 (290)
T cd05045 274 PTFADISKELEKMMV 288 (290)
T ss_pred CCHHHHHHHHHHHHh
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=248.94 Aligned_cols=206 Identities=22% Similarity=0.357 Sum_probs=160.1
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----------CCCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+|+||+++++++..++..+++|||+++++|.+++..... .....+++..+..++.|++.||+||| +
T Consensus 74 ~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~ 150 (293)
T cd05053 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---S 150 (293)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---H
Confidence 799999999999999999999999999999999975321 11256889999999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
.+++|+||||+||+++.++.++|+|||.+......... ......++..|+|||++.+..++.++||||||+++|++++
T Consensus 151 ~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 230 (293)
T cd05053 151 KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 230 (293)
T ss_pred CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcC
Confidence 99999999999999999999999999998765432211 1122234677999999988889999999999999999997
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||..... .+.......... ...+...+..+.+++.+||..||.+|||+.++++.|
T Consensus 231 g~~p~~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 231 GGSPYPGIPV---------------------EELFKLLKEGYR-MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred CCCCCCCCCH---------------------HHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 8777643221 011111111100 001113346788999999999999999999999999
Q ss_pred HHHH
Q 044155 230 RQIY 233 (239)
Q Consensus 230 ~~l~ 233 (239)
.++.
T Consensus 289 ~~~~ 292 (293)
T cd05053 289 DRML 292 (293)
T ss_pred HHhh
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=243.62 Aligned_cols=204 Identities=24% Similarity=0.343 Sum_probs=159.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+ ...++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.+++|+|||
T Consensus 57 ~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~ 129 (262)
T cd05071 57 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 129 (262)
T ss_pred hCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccC
Confidence 4789999999998754 557899999999999999976432 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............++..|+|||+.....++.++|+||||+++|++++ |..||.....
T Consensus 130 p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred cccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 999999999999999999987654332222223345678999999988889999999999999999999 7667643221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
.+....... ..........+..+.+++.+||+.||.+|||+.++++.|++.+
T Consensus 210 ---------------------~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 210 ---------------------REVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ---------------------HHHHHHHhc-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 011111100 0011112245677899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=244.68 Aligned_cols=200 Identities=22% Similarity=0.395 Sum_probs=157.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+|||
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~ 127 (256)
T cd05059 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127 (256)
T ss_pred hCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccc
Confidence 4789999999999999899999999999999999997643 45789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.++..............++..|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 128 p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred HhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 999999999999999999886553322111122234457999999988889999999999999999999 7777753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
. +...... .......+...+..+.+++.+||..+|.+|||+.|+++.|
T Consensus 208 ~---------------------~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 208 S---------------------EVVESVS-AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred H---------------------HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1 0000000 0000011113456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=256.45 Aligned_cols=200 Identities=20% Similarity=0.240 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 57 ~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlk 128 (333)
T cd05600 57 TTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLK 128 (333)
T ss_pred hCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 367999999999999999999999999999999999765 56888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||++..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 129 p~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 204 (333)
T cd05600 129 PENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204 (333)
T ss_pred HHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH
Confidence 9999999999999999999865432 223456899999999999889999999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... ..... +.. ..............+.++.+++.+||..+|.+|||+++++.
T Consensus 205 ~~~--------~~i~~---~~~----~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 205 ETW--------ENLKY---WKE----TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred HHH--------HHHHh---ccc----cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 000 00000 000 00000000000134677899999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=245.45 Aligned_cols=199 Identities=20% Similarity=0.259 Sum_probs=158.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++|+|++++++|.+.+... ..++...+..++.|++.||.||| +.+++|+||+
T Consensus 60 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~ 131 (263)
T cd06625 60 NLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIK 131 (263)
T ss_pred hCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 478999999999999999999999999999999999765 56788999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCccee--ecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+||+++.++.++|+|||.+........... ....++..|+|||.+.+..++.++||||||+++|++++|+.||....
T Consensus 132 p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 132 GANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred HHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 9999999999999999999865432211111 23457788999999998889999999999999999999999875321
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
.. ...............+...+..+.+++.+||..+|.+|||+.++++.
T Consensus 212 ~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 212 AM---------------------AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred hH---------------------HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 10 00001111111111122455678899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=255.21 Aligned_cols=195 Identities=21% Similarity=0.297 Sum_probs=156.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..++..++||||+.+++|.+.+... ..+....+..++.|++.||.||| +.+++|+|||
T Consensus 56 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlk 127 (323)
T cd05584 56 AVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLK 127 (323)
T ss_pred hCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 478999999999999999999999999999999999765 45778888899999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 128 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~- 205 (323)
T cd05584 128 PENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR- 205 (323)
T ss_pred HHHeEECCCCCEEEeeCcCCeecccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999999986432221 122345689999999999988899999999999999999999999854221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
............. .+...++.+.+++.+||+.||++|| +++++++
T Consensus 206 --------------------~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 206 --------------------KKTIDKILKGKLN--LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --------------------HHHHHHHHcCCCC--CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0111111111111 1113456788999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=247.97 Aligned_cols=217 Identities=23% Similarity=0.360 Sum_probs=160.4
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++... ...+++|||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+|
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~d 132 (283)
T cd05080 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRD 132 (283)
T ss_pred hCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccc
Confidence 47899999999988754 357899999999999999865 35889999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||++......... ......++..|+|||.+....++.++||||||+++|+|++|..|+..
T Consensus 133 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 133 LAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred cChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998765432211 11223356679999999888899999999999999999999988754
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
....... ............... ...........+...+..+.+++..||+.+|++|||++++++.|+++.
T Consensus 213 ~~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 213 PPKKFEE------MIGPKQGQMTVVRLI-ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred Ccchhhh------hhcccccccchhhhh-hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 3221000 000000000000000 001111111111244578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=255.84 Aligned_cols=191 Identities=21% Similarity=0.278 Sum_probs=154.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.||| +++++|||||
T Consensus 52 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dik 123 (323)
T cd05575 52 NVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLK 123 (323)
T ss_pred hCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCC
Confidence 378999999999999999999999999999999988765 56888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 124 p~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-- 200 (323)
T cd05575 124 PENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-- 200 (323)
T ss_pred HHHeEECCCCcEEEeccCCCcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--
Confidence 999999999999999999986532211 12334568999999999998889999999999999999999999985321
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
..+............ ....+..+.+++.+||+.||.+||++.
T Consensus 201 -------------------~~~~~~~i~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 201 -------------------TAEMYDNILNKPLRL--KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -------------------HHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111111111111110 113356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=238.34 Aligned_cols=183 Identities=23% Similarity=0.353 Sum_probs=161.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
+.||+++++++.|.+....++||||.+||-|.+++++. .++++..++-++.||+.||.||| ..+|++|||||
T Consensus 101 v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKP 172 (355)
T KOG0616|consen 101 VSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKP 172 (355)
T ss_pred ccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCCh
Confidence 57999999999999999999999999999999999887 67999999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+|||++.+|-+||+|||+++..... +-+.+|||.|+|||++.+.+++.++|-||||+++|||+.|..||..
T Consensus 173 ENiLlD~~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~----- 243 (355)
T KOG0616|consen 173 ENLLLDQNGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD----- 243 (355)
T ss_pred HHeeeccCCcEEEEeccceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-----
Confidence 9999999999999999999876543 4477899999999999999999999999999999999999888753
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
........+++...+.- +...+.++++|+...|+.|-++|
T Consensus 244 ----------------~~~~~iY~KI~~~~v~f--P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 244 ----------------DNPIQIYEKILEGKVKF--PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------------CChHHHHHHHHhCcccC--CcccCHHHHHHHHHHHhhhhHhh
Confidence 22355666666666542 23566788999999999999888
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=249.72 Aligned_cols=204 Identities=18% Similarity=0.361 Sum_probs=160.6
Q ss_pred C-CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 M-SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l-~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+ +||||+++++++...+..+++|||+.+++|.++++.... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 95 l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlk 168 (302)
T cd05055 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA 168 (302)
T ss_pred ccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhc
Confidence 5 799999999999999999999999999999999976432 34789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.++++|||++........ .......++..|+|||.+.+..++.++||||||+++|++++ |..||....
T Consensus 169 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 169 ARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred cceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 9999999999999999999875533221 11223345678999999988889999999999999999998 888875332
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
... ......... .....+...+..+.+++.+||..+|++|||+.|+++.|.++
T Consensus 249 ~~~-----------------~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 249 VDS-----------------KFYKLIKEG----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred chH-----------------HHHHHHHcC----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 100 000011000 00001112346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=251.24 Aligned_cols=205 Identities=19% Similarity=0.324 Sum_probs=159.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||++++|++... ..++++||+++|+|.+++.... ..++......++.|++.||+||| +.+++|+|||
T Consensus 65 ~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlk 136 (316)
T cd05108 65 SVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLA 136 (316)
T ss_pred hCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccc
Confidence 47899999999999765 4678999999999999998653 45788899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce-eecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.+||+|||++.......... .....++..|+|||.+....++.++||||||+++|++++ |..||....
T Consensus 137 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 137 ARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred hhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999999987654322211 112234668999999998889999999999999999997 888875322
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.. +. . .. .......+.+...+..+.+++.+||..+|.+|||+.+++..+..+...
T Consensus 217 ~~--------~~-~---------~~----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 217 AS--------EI-S---------SI----LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HH--------HH-H---------HH----HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 10 00 0 00 000000011112345678999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=254.71 Aligned_cols=198 Identities=23% Similarity=0.313 Sum_probs=154.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.+||||+++++++...+..++||||+++++|.+++... ..++...+..++.|++.||.||| +++++||||||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp 124 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKL 124 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCH
Confidence 37999999999999999999999999999999888765 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 125 ~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 203 (329)
T cd05618 125 DNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203 (329)
T ss_pred HHEEECCCCCEEEeeCCccccccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcC
Confidence 99999999999999999986532211 12234568999999999998889999999999999999999999986433211
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
..... ............... .+...+..+.+++.+||+.||.+|||+
T Consensus 204 ~~~~~------------~~~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 204 NPDQN------------TEDYLFQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred Ccccc------------cHHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11100 000011111111111 112345678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=254.14 Aligned_cols=193 Identities=23% Similarity=0.317 Sum_probs=154.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+++..++||||+++++|...+.. ..+++..+..++.|++.||.||| +.+++||||||
T Consensus 59 l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp 129 (324)
T cd05589 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKL 129 (324)
T ss_pred cCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCH
Confidence 5799999999999999999999999999999888754 45889999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.+||+|||++...... ........|++.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 130 ~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-- 206 (324)
T cd05589 130 DNLLLDTEGFVKIADFGLCKEGMGF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-- 206 (324)
T ss_pred HHeEECCCCcEEeCcccCCccCCCC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--
Confidence 9999999999999999987643221 1123345689999999999988899999999999999999999999853221
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.+........... .+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 207 -------------------~~~~~~i~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 207 -------------------EEVFDSIVNDEVR--YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -------------------HHHHHHHHhCCCC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111111111111 1123456788999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=246.64 Aligned_cols=205 Identities=25% Similarity=0.405 Sum_probs=160.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC---------CCCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ---------PHFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+++||||+++++++......++||||+++++|.+++..... .....+++..+..++.|++.|+.+|| +
T Consensus 64 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~ 140 (280)
T cd05049 64 NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---S 140 (280)
T ss_pred hcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---h
Confidence 36899999999999999999999999999999999976532 11145788899999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
.+++|+||||+||+++.++.++|+|||.+........ .......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 141 ~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~ 220 (280)
T cd05049 141 QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220 (280)
T ss_pred CCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999865422211 11223345678999999998899999999999999999998
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||...... +............ .+...+..+.+++.+||..||.+|||+.|+++.|
T Consensus 221 g~~p~~~~~~~---------------------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 221 GKQPWYGLSNE---------------------EVIECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred CCCCCCCCCHH---------------------HHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 98887532210 1111111111111 1124557789999999999999999999999988
Q ss_pred H
Q 044155 230 R 230 (239)
Q Consensus 230 ~ 230 (239)
.
T Consensus 279 ~ 279 (280)
T cd05049 279 Q 279 (280)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=261.78 Aligned_cols=207 Identities=22% Similarity=0.365 Sum_probs=171.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
|+|||+|+++|+|..+..+|||+|||..|+|.|++++.+. ..++.-..++++.||..|+.||. .++++||||..
T Consensus 320 ikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAA 393 (1157)
T KOG4278|consen 320 IKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAA 393 (1157)
T ss_pred hcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHH---Hhhhhhhhhhh
Confidence 7899999999999999999999999999999999998866 67888999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~~ 160 (239)
+|+|++.+..+|++|||+++.+..-.........-++.|.|||.+....++.++|+|+||+++||+.| |..||.+..-
T Consensus 394 RNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl- 472 (1157)
T KOG4278|consen 394 RNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL- 472 (1157)
T ss_pred hhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-
Confidence 99999999999999999999875433222223345789999999999999999999999999999987 6567654331
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
..++ ..+.+.++-..+..+++.+.+||+.||++.|++||+++|+-+.++.+..+-
T Consensus 473 --------------------SqVY-~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 473 --------------------SQVY-GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred --------------------HHHH-HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 1111 112222222223477889999999999999999999999999999876543
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=248.40 Aligned_cols=207 Identities=21% Similarity=0.327 Sum_probs=159.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++...+..++++||+++++|.+++...... ....++...+..++.|++.||+||| +
T Consensus 61 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~ 137 (297)
T cd05089 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---E 137 (297)
T ss_pred CCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 7999999999999989999999999999999999764210 1135788999999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-C
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-G 150 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g 150 (239)
++++|+||||+||+++.++.+||+|||++....... .......+..|+|||+..+..++.++||||||+++|+|++ |
T Consensus 138 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g 215 (297)
T cd05089 138 KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLG 215 (297)
T ss_pred CCcccCcCCcceEEECCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999875432111 1111223557999999988889999999999999999997 8
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
..||..... .+........ .....+...+..+.+++.+||+.+|.+|||++++++.|.
T Consensus 216 ~~pf~~~~~---------------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 216 GTPYCGMTC---------------------AELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred CCCCCCCCH---------------------HHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 888753221 0011111110 000111234567889999999999999999999999999
Q ss_pred HHHHhh
Q 044155 231 QIYRSL 236 (239)
Q Consensus 231 ~l~~~~ 236 (239)
++....
T Consensus 274 ~~~~~~ 279 (297)
T cd05089 274 RMLEAR 279 (297)
T ss_pred HHHHhh
Confidence 887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=255.46 Aligned_cols=195 Identities=18% Similarity=0.268 Sum_probs=156.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dl 79 (239)
+++||||+++++++......++||||+++++|.+++... ..+++..+..++.|++.||.||| + .+++||||
T Consensus 51 ~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDi 122 (325)
T cd05594 51 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDL 122 (325)
T ss_pred hCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCC
Confidence 368999999999999999999999999999999888765 56889999999999999999999 6 79999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 123 kp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 123 KLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred CCCeEEECCCCCEEEecCCCCeecCCCC-cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 9999999999999999999986532211 122345689999999999988899999999999999999999999853221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
............. .+...++.+.+++.+||+.||.+|+ ++.++++
T Consensus 202 ---------------------~~~~~~i~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 202 ---------------------EKLFELILMEEIR--FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ---------------------HHHHHHHhcCCCC--CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 0111111111110 0113456788999999999999997 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=241.84 Aligned_cols=201 Identities=23% Similarity=0.365 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.|+| +.+++|+|||
T Consensus 48 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~ 120 (250)
T cd05085 48 QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLA 120 (250)
T ss_pred hCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccC
Confidence 4689999999999999999999999999999999886543 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++++|||++...............++..|+|||++.+..++.++|+||||+++|++++ |..||.....
T Consensus 121 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~ 200 (250)
T cd05085 121 ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200 (250)
T ss_pred hheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 999999999999999999986543332222223344677999999988889999999999999999998 8888753321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
.. ....... ......+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus 201 ~~---------------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 201 QQ---------------------AREQVEK-GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HH---------------------HHHHHHc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00 0000000 0000001134567899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=254.48 Aligned_cols=198 Identities=22% Similarity=0.282 Sum_probs=155.6
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||+||| +++++||||||+
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~ 134 (332)
T cd05614 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLE 134 (332)
T ss_pred CCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHH
Confidence 5999999999999999999999999999999998765 56889999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
|||++.++.++|+|||++...............|++.|+|||++.+. .++.++||||||+++|+|++|..||.......
T Consensus 135 Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 135 NILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred HeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 99999999999999999876533322233345689999999998765 47889999999999999999999986332110
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.. ........... ...+...+..+.+++.+||+.||++|| +++++++
T Consensus 215 ~~-----------------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 215 TQ-----------------SEVSRRILKCD--PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CH-----------------HHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00 00111111111 011123456788999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=242.30 Aligned_cols=202 Identities=22% Similarity=0.314 Sum_probs=157.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++. .+..+++|||+.+++|.+++..... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 57 ~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~ 129 (260)
T cd05069 57 KLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLR 129 (260)
T ss_pred hCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccC
Confidence 478999999999875 4567899999999999999976432 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||++++++.++|+|||.+...............++..|+|||...+...+.++|+||||+++|++++ |..||....+
T Consensus 130 ~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred cceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987653332222223345678999999988889999999999999999999 7778753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
. +....... ......+...+..+.+++.+||..||.+|||++++++.|++
T Consensus 210 ~---------------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 210 R---------------------EVLEQVER-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred H---------------------HHHHHHHc-CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 00001100 00111112456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=244.08 Aligned_cols=204 Identities=22% Similarity=0.317 Sum_probs=157.6
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----------CCCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++...+..+++|||+++++|.+++..... .....++...+..++.|++.||+||| +
T Consensus 54 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~ 130 (270)
T cd05047 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---Q 130 (270)
T ss_pred cCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 799999999999999999999999999999999976431 01135788999999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-C
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-G 150 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g 150 (239)
.+++|+||||+||+++.++.++++|||++....... .......+..|+|||++....++.++|+||||+++|+|++ |
T Consensus 131 ~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g 208 (270)
T cd05047 131 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 208 (270)
T ss_pred CCEeecccccceEEEcCCCeEEECCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999875322111 1111223567999999988889999999999999999997 8
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
..||..... . +........ .........+..+.+++.+||..+|.+|||+.+++..|.
T Consensus 209 ~~pf~~~~~--------~-------------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 209 GTPYCGMTC--------A-------------ELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred CCCccccCH--------H-------------HHHHHHhCC-CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 888753221 0 000000000 000001134456889999999999999999999999999
Q ss_pred HHH
Q 044155 231 QIY 233 (239)
Q Consensus 231 ~l~ 233 (239)
++.
T Consensus 267 ~~~ 269 (270)
T cd05047 267 RML 269 (270)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=254.16 Aligned_cols=202 Identities=22% Similarity=0.313 Sum_probs=156.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +++++||||||+
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~ 125 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLD 125 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHH
Confidence 7999999999999999999999999999999888765 56899999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||+.......
T Consensus 126 Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~ 204 (329)
T cd05588 126 NVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204 (329)
T ss_pred HeEECCCCCEEECcCccccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc
Confidence 9999999999999999986432111 122345689999999999988899999999999999999999999964332211
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS------MVDVAK 227 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps------~~ell~ 227 (239)
....... ............ .+...+..+.+++.+||+.||.+||| ++++++
T Consensus 205 ~~~~~~~------------~~~~~~~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 205 PDQNTED------------YLFQVILEKQIR--IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ccccchH------------HHHHHHHcCCCC--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1100000 111111111111 11234567889999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=253.54 Aligned_cols=188 Identities=22% Similarity=0.327 Sum_probs=153.1
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.||| +++++||||||+
T Consensus 54 ~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~ 125 (320)
T cd05590 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLD 125 (320)
T ss_pred CCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHH
Confidence 7999999999999999999999999999999988765 56889999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 126 NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--- 201 (320)
T cd05590 126 NVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--- 201 (320)
T ss_pred HeEECCCCcEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---
Confidence 9999999999999999986532221 123345689999999999988899999999999999999999999864221
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
.+....+...... .+...+..+.+++.+||+.||.+||++
T Consensus 202 ------------------~~~~~~i~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 202 ------------------DDLFEAILNDEVV--YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ------------------HHHHHHHhcCCCC--CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111111111111 111345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=253.16 Aligned_cols=194 Identities=22% Similarity=0.324 Sum_probs=155.5
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++..+...++||||+++++|.+++... ..++...+..++.|++.||.||| +++++||||||
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp 124 (316)
T cd05592 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKL 124 (316)
T ss_pred cCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCH
Confidence 47999999999999999999999999999999998765 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 125 ~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-- 201 (316)
T cd05592 125 DNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-- 201 (316)
T ss_pred HHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--
Confidence 99999999999999999986543222 223355689999999999988899999999999999999999999864321
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV-DVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell~ 227 (239)
.+.......... ..+...+..+.+++.+||+.||.+||++. ++++
T Consensus 202 -------------------~~~~~~i~~~~~--~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 202 -------------------DELFDSILNDRP--HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -------------------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 011111111110 01123456678999999999999999865 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=251.64 Aligned_cols=217 Identities=18% Similarity=0.225 Sum_probs=154.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+. ++|.+++.... ..++...+..++.|++.||+||| +.+++|+|||
T Consensus 59 ~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlk 130 (303)
T cd07869 59 GLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLK 130 (303)
T ss_pred hCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 4789999999999999999999999996 78888887543 45788899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+
T Consensus 131 p~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 131 PQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred HHHEEECCCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 999999999999999999986532211 11233457889999999865 4578899999999999999999999975433
Q ss_pred cccccccchhhhhhhhhccchhhhh-----hh-hhhcCCCcHHH-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIV-----DH-IVVEDVSSIEK-----EQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..............+ ....+.... .. ........... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 210 IQDQLERIFLVLGTP-NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHHHHHHHHhCCC-ChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 211100000000000 000000000 00 00000000000 012356789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=252.84 Aligned_cols=217 Identities=19% Similarity=0.256 Sum_probs=154.0
Q ss_pred CCCCcccceeeEEEEeCC-----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETP-----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~-----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++.... ..++||||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++
T Consensus 55 ~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~iv 125 (338)
T cd07859 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH---TANVF 125 (338)
T ss_pred hCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence 478999999999886432 4689999996 7999988765 56889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCC--cceeecccccccccCcccccc--CCcccccchhhhhhHHHHHhcCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGTLGYCAPEYMRT--GVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|+||||+||+++.++.+||+|||++....... ........+++.|+|||++.+ ..++.++||||||+++|+|++|+
T Consensus 126 H~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~ 205 (338)
T cd07859 126 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205 (338)
T ss_pred cCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999986542211 111234568999999999865 56889999999999999999999
Q ss_pred CCccccccccccc-------ccchhhhhhhhhccchhhhhhhhhhcCCCcHH--HHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 152 DVSDLVKDVHDLV-------CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE--KEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 152 ~p~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
.||.......... .+....... ...................... ....++.+.+++.+||+.||++|||+
T Consensus 206 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 284 (338)
T cd07859 206 PLFPGKNVVHQLDLITDLLGTPSPETISR-VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA 284 (338)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHH-hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH
Confidence 9986533211000 000000000 0000000111111110000000 01234667899999999999999999
Q ss_pred HHHHH
Q 044155 223 VDVAK 227 (239)
Q Consensus 223 ~ell~ 227 (239)
+|+++
T Consensus 285 ~e~l~ 289 (338)
T cd07859 285 EEALA 289 (338)
T ss_pred HHHhc
Confidence 99986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=248.36 Aligned_cols=207 Identities=21% Similarity=0.300 Sum_probs=159.8
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++...+..++||||+++++|.++++..... ....++...++.++.|++.||+||| +
T Consensus 66 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~ 142 (303)
T cd05088 66 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---Q 142 (303)
T ss_pred CCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---h
Confidence 7999999999999999999999999999999999764310 0135788999999999999999999 9
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-C
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-G 150 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g 150 (239)
.+++|+||||+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++||||||+++|+++| |
T Consensus 143 ~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 220 (303)
T cd05088 143 KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 220 (303)
T ss_pred CCccccccchheEEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcC
Confidence 999999999999999999999999999875321111 1112234567999999988888999999999999999998 8
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
..||...... +... .... ......+...+..+.+++.+||+.+|.+|||++++++.|.
T Consensus 221 ~~p~~~~~~~--------~~~~-------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 221 GTPYCGMTCA--------ELYE-------------KLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred CCCcccCChH--------HHHH-------------HHhc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 8887532210 0000 0000 0000001123456889999999999999999999999999
Q ss_pred HHHHhh
Q 044155 231 QIYRSL 236 (239)
Q Consensus 231 ~l~~~~ 236 (239)
++....
T Consensus 279 ~~~~~~ 284 (303)
T cd05088 279 RMLEER 284 (303)
T ss_pred HHHHhh
Confidence 877654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=245.22 Aligned_cols=208 Identities=20% Similarity=0.245 Sum_probs=152.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.+....++||||+++++|.+++...........+......++.|++.||+||| +.+++|+|||
T Consensus 51 ~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlk 127 (269)
T cd05042 51 ELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLA 127 (269)
T ss_pred hCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEeccccc
Confidence 3689999999999999999999999999999999998754322234567788899999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCcccccc-------CCcccccchhhhhhHHHHHhc-CC
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRT-------GVFNEKSNVFSFSVFLFELLT-GW 151 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~~~~-g~ 151 (239)
|+||+++.++.+||+|||++........ .......+++.|+|||++.. ..++.++||||||+++|+|++ |.
T Consensus 128 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~ 207 (269)
T cd05042 128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD 207 (269)
T ss_pred HhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999998764322211 11123345677999998742 346789999999999999999 66
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
.||....+... .. ............+......+..+.+++..|| .||.+|||+++|++.|
T Consensus 208 ~p~~~~~~~~~--------~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 208 QPYPDLSDEQV--------LK---------QVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCcCCHHHH--------HH---------HHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 67643321100 00 0000000000011112245566788999999 5999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=242.22 Aligned_cols=202 Identities=22% Similarity=0.340 Sum_probs=157.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++. ....+++|||+++++|.+++..... ..++...+..++.|++.||+||| +.+++|+|||
T Consensus 57 ~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~ 129 (260)
T cd05070 57 KLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLR 129 (260)
T ss_pred hcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCc
Confidence 478999999999885 4557899999999999999976432 45789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||++++++.++|+|||.+...............++..|+|||...+..++.++|+||||+++|++++ |..||.....
T Consensus 130 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 130 SANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred cceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999987654332222223345678999999988889999999999999999999 7777753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
. +....... ......+...+..+.+++.+||..+|.+|||++++.+.|++
T Consensus 210 ~---------------------~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 210 R---------------------EVLEQVER-GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred H---------------------HHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 01111100 00111122445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=251.49 Aligned_cols=194 Identities=23% Similarity=0.319 Sum_probs=155.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||+++|+|.+++... ..++...+..++.|++.||.||| +.+++||||||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp 124 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKL 124 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCH
Confidence 48999999999999999999999999999999999764 46888999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-- 201 (316)
T cd05619 125 DNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-- 201 (316)
T ss_pred HHEEECCCCCEEEccCCcceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--
Confidence 99999999999999999986432211 122345689999999999988899999999999999999999999853221
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV-DVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell~ 227 (239)
.+.......... ..+...+..+.+++.+||+.||.+||++. ++++
T Consensus 202 -------------------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 202 -------------------EELFQSIRMDNP--CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -------------------HHHHHHHHhCCC--CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 011111111110 01113456688999999999999999996 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=232.92 Aligned_cols=196 Identities=23% Similarity=0.355 Sum_probs=162.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.|+|||||++.+.+......++|+|+++|++|..-+-.. .-..+..+-.++.||+++|.|+| .++|||||+|
T Consensus 66 ~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvk 137 (355)
T KOG0033|consen 66 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLK 137 (355)
T ss_pred hcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCC
Confidence 479999999999999999999999999999997655443 34567778889999999999999 9999999999
Q ss_pred CcceeecCCC---ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|.|+++-+.. -+|++|||++..... ......+.|+|.|+|||++...+++..+|||+.|+++|-++.|..||..
T Consensus 138 P~nllLASK~~~A~vKL~~FGvAi~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~- 214 (355)
T KOG0033|consen 138 PENLLLASKAKGAAVKLADFGLAIEVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD- 214 (355)
T ss_pred hhheeeeeccCCCceeecccceEEEeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-
Confidence 9999986533 479999999988762 2345577899999999999999999999999999999999999988743
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+...++..+..+.+. +++-+..+++.+++|++||..||++|.|+.|.+.
T Consensus 215 --------------------~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 215 --------------------EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --------------------ccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2334455555555443 3233467788999999999999999999999874
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=242.07 Aligned_cols=202 Identities=24% Similarity=0.402 Sum_probs=158.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++.||||+++++++. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| ..+++|+|||
T Consensus 52 ~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~ 122 (257)
T cd05060 52 QLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLA 122 (257)
T ss_pred hcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcc
Confidence 468999999999876 45679999999999999999865 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCccee--ecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.++|+|||.+........... ....++..|+|||...+..++.++||||||+++|++++ |..||...
T Consensus 123 p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 123 ARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred cceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999876543322111 11223467999999988889999999999999999998 88887543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
... +......... ....+...+..+.+++.+||..+|.+|||+.++++.|+++.
T Consensus 203 ~~~---------------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 203 KGA---------------------EVIAMLESGE-RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CHH---------------------HHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 210 0000000000 00111234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=254.01 Aligned_cols=193 Identities=22% Similarity=0.281 Sum_probs=154.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++...+..++||||+++++|.+++... ..+.......++.|++.||.||| +.+++||||||
T Consensus 53 ~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp 124 (325)
T cd05602 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKP 124 (325)
T ss_pred CCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCH
Confidence 68999999999999999999999999999999999765 45778888889999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 125 ~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-- 201 (325)
T cd05602 125 ENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-- 201 (325)
T ss_pred HHeEECCCCCEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999986532211 123345689999999999988899999999999999999999999853221
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
.+........... .....+..+.+++.+||+.||.+||++.+.+
T Consensus 202 -------------------~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 202 -------------------AEMYDNILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -------------------HHHHHHHHhCCcC--CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1111111111111 0113456788999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=251.26 Aligned_cols=193 Identities=21% Similarity=0.298 Sum_probs=154.5
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+.+..++||||+.+++|.+++... ..++...+..++.|++.||+||| +++++||||||
T Consensus 53 ~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp 124 (316)
T cd05620 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKL 124 (316)
T ss_pred cCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCH
Confidence 48999999999999999999999999999999998765 56888999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-- 201 (316)
T cd05620 125 DNVMLDRDGHIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-- 201 (316)
T ss_pred HHeEECCCCCEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--
Confidence 99999999999999999876432211 123355689999999999988999999999999999999999999853221
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV-DVA 226 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell 226 (239)
.+.......... ..+...+..+.+++.+||+.||.+||++. +++
T Consensus 202 -------------------~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 202 -------------------DELFESIRVDTP--HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -------------------HHHHHHHHhCCC--CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 001111110100 00112345688999999999999999974 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=229.95 Aligned_cols=195 Identities=21% Similarity=0.343 Sum_probs=166.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.|+||||+++|++|.+....|+++||...|++...+..+.. .++++.....++.|++.|+.|+| .++++|||+|
T Consensus 78 ~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiK 151 (281)
T KOG0580|consen 78 HLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIK 151 (281)
T ss_pred ccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc---cCCcccCCCC
Confidence 37999999999999999999999999999999999986544 67888999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|+|++.++.+||+|||-+...+. ....+.+||..|.+||+..+...+...|+|++|++.||++.|.+||+...
T Consensus 152 penlLlg~~~~lkiAdfGwsV~~p~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-- 226 (281)
T KOG0580|consen 152 PENLLLGSAGELKIADFGWSVHAPS---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-- 226 (281)
T ss_pred HHHhccCCCCCeeccCCCceeecCC---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--
Confidence 9999999999999999998876542 23567889999999999999999999999999999999999999885322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+.+..+..-.... +...+...+++|.+|+..+|.+|.+..|+++
T Consensus 227 -------------------~~etYkrI~k~~~~~--p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 227 -------------------HSETYKRIRKVDLKF--PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -------------------hHHHHHHHHHccccC--CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 223333333322222 1466778899999999999999999999876
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=251.94 Aligned_cols=194 Identities=20% Similarity=0.289 Sum_probs=156.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.+||||+++++++.+++..++||||+++++|.+.+... ..+++..+..++.|++.||.||| +++++||||||
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp 124 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKL 124 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence 37999999999999999999999999999999988765 56888999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 125 ~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-- 201 (321)
T cd05591 125 DNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-- 201 (321)
T ss_pred HHeEECCCCCEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999886532221 122345689999999999988899999999999999999999999864321
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-------CHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-------SMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-------s~~ell~ 227 (239)
.+....+...... .+...+..+.+++.+||+.||.+|| +++++++
T Consensus 202 -------------------~~~~~~i~~~~~~--~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 202 -------------------DDLFESILHDDVL--YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -------------------HHHHHHHHcCCCC--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1111111111111 0112346788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=242.24 Aligned_cols=217 Identities=19% Similarity=0.203 Sum_probs=162.1
Q ss_pred CCCcccceeeEEEEe-----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 2 MSHNHILKLIGCCLE-----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 2 l~H~niv~l~~~~~~-----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++|+||+.+++++.. -+..++|+|+|+ .+|...++.+ +.++......+++|++.||.|+| +.+++|
T Consensus 78 ~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiH---SAnViH 148 (359)
T KOG0660|consen 78 LRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIH---SANVIH 148 (359)
T ss_pred hcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhh---cccccc
Confidence 689999999999875 246799999996 8999999886 55999999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCC-cceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|||||.|++++.+..+||+|||+++...... ....+....|.+|+|||.+.. ..|+...||||.|||+.||++|+..|
T Consensus 149 RDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF 228 (359)
T KOG0660|consen 149 RDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF 228 (359)
T ss_pred cccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence 9999999999999999999999998875431 112356678999999998765 56999999999999999999999998
Q ss_pred cccccccccccc------chhhhhhhhhccchhhhhhhhhhcCCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 155 DLVKDVHDLVCP------FSEYLKNCFEDNRFTEIVDHIVVEDVSS--IEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 155 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
.+....+..... -.+.......+......+.+.-..+..+ ......++...+|+.+||..||.+|+|++|++
T Consensus 229 pG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 229 PGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred CCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 765543322111 1111111111111111111111111111 11125567788999999999999999999988
Q ss_pred H
Q 044155 227 K 227 (239)
Q Consensus 227 ~ 227 (239)
+
T Consensus 309 ~ 309 (359)
T KOG0660|consen 309 A 309 (359)
T ss_pred c
Confidence 6
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=247.84 Aligned_cols=211 Identities=22% Similarity=0.355 Sum_probs=162.8
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++...+..++||||+.+++|.+++...... ....++...++.++.|++.||+||| +
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~ 158 (307)
T cd05098 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---S 158 (307)
T ss_pred CCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---H
Confidence 7999999999999999999999999999999999764321 0134788899999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
.+++|+||||+||+++.++.++|+|||.+......... ......+++.|+|||++.+..++.++|+||||+++|+|++
T Consensus 159 ~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 159 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred CCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999998654322111 1112234568999999988889999999999999999998
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||.... ..+......... ....+...+..+.+++.+||..+|.+|||+.++++.|
T Consensus 239 g~~p~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 239 GGSPYPGVP---------------------VEELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred CCCCCCcCC---------------------HHHHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 767764221 001111100111 0011123456788999999999999999999999999
Q ss_pred HHHHHhhcC
Q 044155 230 RQIYRSLSC 238 (239)
Q Consensus 230 ~~l~~~~~~ 238 (239)
.++....++
T Consensus 297 ~~~~~~~~~ 305 (307)
T cd05098 297 DRILALTSN 305 (307)
T ss_pred HHHHHHhhc
Confidence 998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=241.40 Aligned_cols=198 Identities=21% Similarity=0.330 Sum_probs=160.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~ 128 (256)
T cd08529 55 KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIK 128 (256)
T ss_pred hcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 47899999999999999999999999999999999987533 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++........ ......+++.|+|||+..+..++.++|+||||+++++|++|..||.....
T Consensus 129 ~~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 206 (256)
T cd08529 129 SLNLFLDAYDNVKIGDLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ- 206 (256)
T ss_pred cceEEEeCCCCEEEcccccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-
Confidence 9999999999999999998876543321 12334578899999999988899999999999999999999998853321
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+............ .....+..+.+++.+||+.+|++||++.++++
T Consensus 207 --------------------~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 207 --------------------GALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --------------------HHHHHHHHcCCCCC-CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 01111111111111 11245677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=244.05 Aligned_cols=209 Identities=22% Similarity=0.244 Sum_probs=153.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++...........+....+.++.|++.|+.||| +.+++|+|||
T Consensus 51 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlk 127 (269)
T cd05087 51 SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLA 127 (269)
T ss_pred hCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccC
Confidence 4789999999999998888999999999999999997643221134567788889999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce-eecccccccccCccccccC-------CcccccchhhhhhHHHHHhc-CC
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLGYCAPEYMRTG-------VFNEKSNVFSFSVFLFELLT-GW 151 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~~~~-g~ 151 (239)
|+||+++.++.++|+|||.+.......... .....++..|+|||++... .++.++|+||||+++|+|++ |.
T Consensus 128 p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~ 207 (269)
T cd05087 128 LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207 (269)
T ss_pred cceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCC
Confidence 999999999999999999986543222111 1234467889999988532 35789999999999999996 98
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
.||.......... ..+.........+......+..+.+++..|| .+|.+|||++||+..|.
T Consensus 208 ~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 208 QPYRHLSDEQVLT-----------------YTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCChHHHHH-----------------HHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 8885432111000 0000000000001111123456788999999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=242.41 Aligned_cols=205 Identities=24% Similarity=0.324 Sum_probs=160.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++.||||+++++++.+ ...++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 63 ~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~ 134 (270)
T cd05056 63 QFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIA 134 (270)
T ss_pred hCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccC
Confidence 4689999999999875 45689999999999999997642 45789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++++|||++...............++..|+|||.+....++.++||||||+++|++++ |..||.....
T Consensus 135 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred hheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999999999999987654332222223334568999999988889999999999999999886 9888754321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.. ......... ....+...+..+.+++.+||..+|.+|||+.++++.|.++.++
T Consensus 215 ~~---------------------~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 215 ND---------------------VIGRIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HH---------------------HHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 10 000000000 0001123456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=242.58 Aligned_cols=209 Identities=21% Similarity=0.276 Sum_probs=164.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..++..+++|||+++++|.+++...... ...+++.....++.|++.||.||| +.+++|+|||
T Consensus 58 ~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~ 133 (267)
T cd08229 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIK 133 (267)
T ss_pred HccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 368999999999999999999999999999999988743221 146789999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 212 (267)
T cd08229 134 PANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212 (267)
T ss_pred HHHEEEcCCCCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch
Confidence 9999999999999999998766533221 122345788999999998888999999999999999999999987532210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
..............+......+..+.+++.+||..||.+|||+.+|++.++++.
T Consensus 213 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 213 -------------------LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -------------------HHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000111111111111112245678999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=251.13 Aligned_cols=193 Identities=23% Similarity=0.320 Sum_probs=155.8
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++|+||||+
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~ 125 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLD 125 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHH
Confidence 6999999999999999999999999999999988765 46889999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 126 Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-- 202 (318)
T cd05570 126 NVLLDSEGHIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-- 202 (318)
T ss_pred HeEECCCCcEEecccCCCeecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--
Confidence 9999999999999999886432211 1223446889999999999989999999999999999999999998543210
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM-----VDVAK 227 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~ell~ 227 (239)
............ .+...+..+.++|.+||..||.+|||+ .+++.
T Consensus 203 -------------------~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 203 -------------------ELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -------------------HHHHHHHcCCCC--CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111111111110 112345678899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=245.02 Aligned_cols=205 Identities=20% Similarity=0.345 Sum_probs=156.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCC-----CCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH-----FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++..+...++||||+++++|.+++....... ...++...+..++.|++.||.||| +.+++
T Consensus 65 ~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~v 141 (277)
T cd05062 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFV 141 (277)
T ss_pred hCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 3689999999999999999999999999999999987642210 123567888899999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDV 153 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p 153 (239)
|+||||+||+++.++.++|+|||++......... ......+++.|+|||++.+..++.++|+||||+++|++++ |..|
T Consensus 142 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p 221 (277)
T cd05062 142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221 (277)
T ss_pred cCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999998654332211 1122345678999999988889999999999999999999 5677
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
|..... .+........... ..+...+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 222 ~~~~~~---------------------~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 222 YQGMSN---------------------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCH---------------------HHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 643221 0111111111100 001234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=246.43 Aligned_cols=203 Identities=18% Similarity=0.280 Sum_probs=158.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++.+++..+...++||||+++++|.+.+..... ....+++..+..++.|++.||.||| +.+++|+|||
T Consensus 49 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 124 (280)
T cd05608 49 KVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLK 124 (280)
T ss_pred hCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 47899999999999999999999999999999887754221 1146889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 125 p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 203 (280)
T cd05608 125 PENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 203 (280)
T ss_pred HHHEEECCCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 9999999999999999999866533221 223456889999999999989999999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.. ............. ..+...+..+.+++.+||+.||++|| +++++++
T Consensus 204 ~~-----------------~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 204 VE-----------------NKELKQRILNDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred hh-----------------HHHHHHhhcccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 00 0011111111111 11124567789999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=241.01 Aligned_cols=220 Identities=18% Similarity=0.203 Sum_probs=163.3
Q ss_pred CCCCcc-cceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 1 QMSHNH-ILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 1 ~l~H~n-iv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
+|+|+| |+.+++++.+.+ ..++|+||.+ -+|.+++....... ..++...++.++.||+.||+||| +++
T Consensus 66 ~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~ 140 (323)
T KOG0594|consen 66 RLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHG 140 (323)
T ss_pred HhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 478999 999999998877 7789999997 89999999865321 34677899999999999999999 999
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCC
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|+||||||.|+|++.+|.+||+|||+++...-.. ..-....+|.+|+|||++.+. .|+...||||+||++.||++++.
T Consensus 141 IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~ 219 (323)
T KOG0594|consen 141 ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP 219 (323)
T ss_pred eecccCCcceEEECCCCcEeeeccchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence 9999999999999999999999999998653221 123455689999999999987 69999999999999999999999
Q ss_pred Ccccccccccccccchhhhhhhhhccchhhhhhhhh-----hcCC-CcHHH---HHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIV-----VEDV-SSIEK---EQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
.|.+..+.......|..... .....|+....-.. .... ..... ........+++..|++++|.+|.||+
T Consensus 220 LFpG~se~~ql~~If~~lGt--P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~ 297 (323)
T KOG0594|consen 220 LFPGDSEIDQLFRIFRLLGT--PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAK 297 (323)
T ss_pred CCCCCcHHHHHHHHHHHcCC--CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHH
Confidence 88876663332222111100 01122222221110 0000 00011 12224678999999999999999999
Q ss_pred HHHHH
Q 044155 224 DVAKK 228 (239)
Q Consensus 224 ell~~ 228 (239)
.+++.
T Consensus 298 ~al~h 302 (323)
T KOG0594|consen 298 GALTH 302 (323)
T ss_pred HHhcC
Confidence 99874
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=241.52 Aligned_cols=200 Identities=26% Similarity=0.395 Sum_probs=156.3
Q ss_pred CCCCcccceeeEEEE-eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~-~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++|+||+++++++. .+...++++||+++++|.++++.... ..+++..+..++.|++.||+||| +++++|+||
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl 128 (256)
T cd05082 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDL 128 (256)
T ss_pred hCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccc
Confidence 478999999999765 44568899999999999999976532 45788999999999999999999 999999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
||+||+++.++.++++|||++....... ....++..|+|||++....++.++|+||||+++|+|++ |..||....
T Consensus 129 kp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 129 AARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred chheEEEcCCCcEEecCCccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999886543221 12334567999999988889999999999999999997 877764221
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
..+........ .........+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 205 ---------------------~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 205 ---------------------LKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---------------------HHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00111111000 01111124456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=240.40 Aligned_cols=209 Identities=20% Similarity=0.284 Sum_probs=164.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++...+..++||||+++++|.+++...... ...++...+..++.+++.||.||| +.+++|+||+
T Consensus 58 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~ 133 (267)
T cd08224 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIK 133 (267)
T ss_pred hCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcC
Confidence 468999999999999999999999999999999988653211 145789999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|++++|..||.....
T Consensus 134 p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 211 (267)
T cd08224 134 PANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM- 211 (267)
T ss_pred hhhEEECCCCcEEEeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-
Confidence 9999999999999999999865533221 12234578889999999888899999999999999999999988743220
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
...+...........+......+..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 212 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 212 ------------------NLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ------------------cHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0011111111111111111245667899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=256.77 Aligned_cols=208 Identities=17% Similarity=0.337 Sum_probs=160.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC----------------------------------------
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP---------------------------------------- 42 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~---------------------------------------- 42 (239)
.||||+++++++.+....++||||+++|+|.+++......
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (400)
T cd05105 99 PHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYM 178 (400)
T ss_pred CCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccc
Confidence 4999999999999999999999999999999988653210
Q ss_pred ---------------------------------------------------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 43 ---------------------------------------------------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 43 ---------------------------------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
....+++..+..++.|++.||.||| .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~ 255 (400)
T cd05105 179 DMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---S 255 (400)
T ss_pred ccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 0024677888899999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
.+++|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 256 ~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 256 KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999999999999999875432211 11223446778999999988889999999999999999997
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||....... ..... +........+...+..+.+++.+||..||++|||+.+|.+.|
T Consensus 336 g~~P~~~~~~~~-----------------~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 336 GGTPYPGMIVDS-----------------TFYNK----IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred CCCCCcccchhH-----------------HHHHH----HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 878875321100 00000 001111111124567789999999999999999999999999
Q ss_pred HHHHH
Q 044155 230 RQIYR 234 (239)
Q Consensus 230 ~~l~~ 234 (239)
+++..
T Consensus 395 ~~l~~ 399 (400)
T cd05105 395 ESLLP 399 (400)
T ss_pred HHHcC
Confidence 98754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=254.29 Aligned_cols=192 Identities=24% Similarity=0.291 Sum_probs=155.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 54 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 125 (318)
T cd05582 54 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLK 125 (318)
T ss_pred hCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCC
Confidence 478999999999999999999999999999999999764 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 126 p~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~- 203 (318)
T cd05582 126 PENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR- 203 (318)
T ss_pred HHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-
Confidence 999999999999999999986543221 123345689999999999988889999999999999999999999853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
.+........... .+...+..+.+++.+||+.||.+|||+.+
T Consensus 204 --------------------~~~~~~i~~~~~~--~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 204 --------------------KETMTMILKAKLG--MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --------------------HHHHHHHHcCCCC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0111111111110 11234567889999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=245.70 Aligned_cols=208 Identities=20% Similarity=0.348 Sum_probs=160.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++......++||||+.+++|.+++...... ....++...+..++.|++.||.||| +
T Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~ 155 (304)
T cd05101 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---S 155 (304)
T ss_pred cCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---H
Confidence 7999999999999999999999999999999999764221 0135778889999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
++++|+||||+||+++.++.++|+|||.+......... ......+++.|+|||++.+..++.++||||||+++|++++
T Consensus 156 ~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999998765332211 1222345678999999988889999999999999999998
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||.... ..+......... ....+...+..+.+++.+||..+|.+|||+.++++.|
T Consensus 236 g~~p~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 236 GGSPYPGIP---------------------VEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred CCCCcccCC---------------------HHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 666653221 111111111100 0001123456788999999999999999999999999
Q ss_pred HHHHHh
Q 044155 230 RQIYRS 235 (239)
Q Consensus 230 ~~l~~~ 235 (239)
+++..-
T Consensus 294 ~~~~~~ 299 (304)
T cd05101 294 DRILTL 299 (304)
T ss_pred HHHHHh
Confidence 987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=242.06 Aligned_cols=203 Identities=19% Similarity=0.281 Sum_probs=160.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||+++++|.+++.... ..++......++.|++.||++|| +.+++|+|||
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlk 133 (267)
T cd05066 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLA 133 (267)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhc
Confidence 4789999999999999999999999999999999997643 45788999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCccee--ecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.++++|||.+........... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred hhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 9999999999999999999876543322111 11223567999999988889999999999999999886 88887543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
... +........ .........+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 214 ~~~---------------------~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 214 SNQ---------------------DVIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CHH---------------------HHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 210 000000000 00011113456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=256.39 Aligned_cols=197 Identities=18% Similarity=0.247 Sum_probs=155.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++||||+++|+|.+++.. ..++...+..++.|++.||.||| +++++|||||
T Consensus 99 ~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLk 169 (370)
T cd05596 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVK 169 (370)
T ss_pred hCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 36899999999999999999999999999999999865 34778889999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC----CcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG----VFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+|||++.++.+||+|||++...............|++.|+|||++.+. .++.++|+|||||++|+|++|..||..
T Consensus 170 p~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred HHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 9999999999999999999876533222222345689999999998653 378899999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPAD--RPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~ 227 (239)
... ......+.... ...+.....+..+.++|.+||+.+|.+ |+|++++++
T Consensus 250 ~~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 250 DSL---------------------VGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCH---------------------HHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 221 01111111100 000111134577889999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=240.63 Aligned_cols=199 Identities=25% Similarity=0.413 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.+....++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 56 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~ 129 (256)
T cd05039 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLA 129 (256)
T ss_pred hcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcc
Confidence 46899999999999988899999999999999999976532 36889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+........ ....+..|+|||.+....++.++|+||||++++++++ |..||.....
T Consensus 130 p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 130 ARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred cceEEEeCCCCEEEcccccccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999876532211 2334567999999988889999999999999999997 8888743221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.+...... .......+...++.+.+++.+||..+|.+|||++++++.|++
T Consensus 206 ---------------------~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 206 ---------------------KDVVPHVE-KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---------------------HHHHHHHh-cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00110000 000111112345778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=241.30 Aligned_cols=193 Identities=24% Similarity=0.352 Sum_probs=149.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||+++++|..++.... ..++...+..++.|++.||+||| +.+++|+|||
T Consensus 60 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlk 132 (262)
T cd05077 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVC 132 (262)
T ss_pred hCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCC
Confidence 4789999999999999889999999999999988886542 45888999999999999999999 9999999999
Q ss_pred CcceeecCCCc-------eeEcccccccccCCCCcceeecccccccccCccccc-cCCcccccchhhhhhHHHHHh-cCC
Q 044155 81 TSCILFNEENV-------AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-TGVFNEKSNVFSFSVFLFELL-TGW 151 (239)
Q Consensus 81 ~~nil~~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~-~g~ 151 (239)
|+||+++.++. ++++|||.+...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|.
T Consensus 133 p~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~ 207 (262)
T cd05077 133 TKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207 (262)
T ss_pred cccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 99999987664 899999987554221 2334678899999886 456889999999999999997 576
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
.|+...... +. .. +.. ... ... ...+..+.+++.+||+.||.+||++.++++.+
T Consensus 208 ~p~~~~~~~--------~~-~~-~~~--------~~~-~~~-----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 208 IPLKDKTLA--------EK-ER-FYE--------GQC-MLV-----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCCcchh--------HH-HH-HHh--------cCc-cCC-----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 665432100 00 00 000 000 000 11235688999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=244.21 Aligned_cols=217 Identities=24% Similarity=0.346 Sum_probs=159.9
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++... ...++||||+++++|.+++.+.. ..+++..+..++.|++.||+||| +++++|+|
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~d 134 (284)
T cd05079 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRD 134 (284)
T ss_pred hCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecc
Confidence 47899999999998865 56789999999999999986542 45789999999999999999999 99999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|++++++.|...
T Consensus 135 lkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~ 214 (284)
T cd05079 135 LAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESS 214 (284)
T ss_pred cchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcc
Confidence 999999999999999999999876543221 112234567789999999888899999999999999999998765321
Q ss_pred cc-ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 157 VK-DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 157 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
.. .......+. ............. ............+..+.+++.+||+.+|.+|||++++++.|+++
T Consensus 215 ~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 215 PMTLFLKMIGPT-------HGQMTVTRLVRVL-EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccchhhhhcccc-------cccccHHHHHHHH-HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11 000000000 0000001111111 11111111123567799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=256.85 Aligned_cols=197 Identities=20% Similarity=0.272 Sum_probs=157.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||+++++|.+++... ..++...+..++.|++.||.||| ..+++|+|||
T Consensus 57 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlk 128 (350)
T cd05573 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIK 128 (350)
T ss_pred hcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 368999999999999999999999999999999999865 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC----------------------------cceeecccccccccCccccccCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE----------------------------THITDTVMGTLGYCAPEYMRTGVFN 132 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~ 132 (239)
|+||+++.++.++|+|||++....... ........|++.|+|||++.+..++
T Consensus 129 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (350)
T cd05573 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG 208 (350)
T ss_pred HHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC
Confidence 999999999999999999987553322 0122345689999999999998999
Q ss_pred cccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhh--cCCCcHHHHHHHHHHHHHHhh
Q 044155 133 EKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV--EDVSSIEKEQQLHASAQVTFE 210 (239)
Q Consensus 133 ~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ 210 (239)
.++|||||||++|+|++|..||...... .....+.. .....+.....++.+.++|.+
T Consensus 209 ~~~DiwSlG~il~ell~g~~Pf~~~~~~---------------------~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ 267 (350)
T cd05573 209 LECDWWSLGVILYEMLYGFPPFYSDTLQ---------------------ETYNKIINWKESLRFPPDPPVSPEAIDLICR 267 (350)
T ss_pred CceeeEecchhhhhhccCCCCCCCCCHH---------------------HHHHHHhccCCcccCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999998643210 00000100 000000011246778899999
Q ss_pred hcCCCCCCCCC-HHHHHH
Q 044155 211 CIKDSPADRPS-MVDVAK 227 (239)
Q Consensus 211 cl~~dp~~Rps-~~ell~ 227 (239)
|+. ||.+||+ ++++++
T Consensus 268 ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 268 LLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred Hcc-ChhhcCCCHHHHhc
Confidence 997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=249.94 Aligned_cols=225 Identities=18% Similarity=0.191 Sum_probs=158.0
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++..++..++||||+++++|.+++..... ..+++..++.++.|++.||+||| +.+++|+||||
T Consensus 56 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp 129 (327)
T cd08227 56 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKA 129 (327)
T ss_pred cCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCh
Confidence 6899999999999999999999999999999999976432 45889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCc------ceeecccccccccCcccccc--CCcccccchhhhhhHHHHHhcCCCC
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRT--GVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+||+++.++.++++||+.......... .......++..|+|||++.+ ..++.++||||||+++|++++|..|
T Consensus 130 ~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 209 (327)
T cd08227 130 SHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209 (327)
T ss_pred hhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999986543221110 01122346678999999876 4588999999999999999999999
Q ss_pred cccccccccccc----cch----------hhhhhhh-hccchhhhhh--------hhhhcCCCcHHHHHHHHHHHHHHhh
Q 044155 154 SDLVKDVHDLVC----PFS----------EYLKNCF-EDNRFTEIVD--------HIVVEDVSSIEKEQQLHASAQVTFE 210 (239)
Q Consensus 154 ~~~~~~~~~~~~----~~~----------~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~ 210 (239)
|........... ... +...... .......... ...............++.+.+++.+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 289 (327)
T cd08227 210 FKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQ 289 (327)
T ss_pred CCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHH
Confidence 975332110000 000 0000000 0000000000 0000000011122456788999999
Q ss_pred hcCCCCCCCCCHHHHHH--HHHHH
Q 044155 211 CIKDSPADRPSMVDVAK--KLRQI 232 (239)
Q Consensus 211 cl~~dp~~Rps~~ell~--~L~~l 232 (239)
||+.||++|||++|+++ +++++
T Consensus 290 ~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 290 CLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred HHhhCchhcCCHHHHhcChhhhhc
Confidence 99999999999999987 45444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=246.46 Aligned_cols=210 Identities=22% Similarity=0.368 Sum_probs=161.7
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++......+++|||+++++|.+++...... ....++...+..++.|++.||.||| +
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~ 152 (314)
T cd05099 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---S 152 (314)
T ss_pred CCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---H
Confidence 6999999999999888899999999999999999764210 1135788899999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
++++|+||||+||+++.++.++|+|||.++........ ......++..|+|||++.+..++.++||||||+++|++++
T Consensus 153 ~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 153 RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 99999999999999999999999999998765322111 1112234567999999988889999999999999999999
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||..... .+.......... ...+...+.++.+++.+||..+|++|||+.++++.|
T Consensus 233 g~~p~~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 233 GGSPYPGIPV---------------------EELFKLLREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred CCCCCCCCCH---------------------HHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 7777643221 001111101100 000113345788999999999999999999999999
Q ss_pred HHHHHhhc
Q 044155 230 RQIYRSLS 237 (239)
Q Consensus 230 ~~l~~~~~ 237 (239)
.++...++
T Consensus 291 ~~~~~~~~ 298 (314)
T cd05099 291 DKVLAAVS 298 (314)
T ss_pred HHHHHHhc
Confidence 99887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=240.38 Aligned_cols=205 Identities=24% Similarity=0.396 Sum_probs=155.4
Q ss_pred CCCCcccceeeEEEE-eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~-~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||+++++++. .++..++++||+.+++|.+++.... ..........++.|++.||.||| +.+++|+||
T Consensus 52 ~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl 124 (262)
T cd05058 52 DFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDL 124 (262)
T ss_pred cCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccc
Confidence 478999999999876 4556789999999999999997642 34567778889999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCc---ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCC-Ccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWD-VSD 155 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~-p~~ 155 (239)
||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++|.. ||.
T Consensus 125 k~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 125 AARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred CcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999865422111 01112235678999999988889999999999999999999654 443
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
.... .+.......... ...+...+..+.+++.+||..+|++||++.+++..|+++..
T Consensus 205 ~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 205 DVDS---------------------FDITVYLLQGRR-LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCH---------------------HHHHHHHhcCCC-CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 2110 011111111110 01111335678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=240.73 Aligned_cols=202 Identities=26% Similarity=0.458 Sum_probs=159.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.. ...++|+||+++++|.+.+..... ..+++.....++.|++.||+||| +.+++|+|||
T Consensus 52 ~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~ 124 (257)
T cd05040 52 SLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLA 124 (257)
T ss_pred hcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccC
Confidence 4789999999999988 888999999999999999987532 35789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 125 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 125 ARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998765432211 1223456788999999988889999999999999999998 98887532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
... +..............+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus 205 ~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 205 SGS---------------------QILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CHH---------------------HHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 210 0000000000000011234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=242.93 Aligned_cols=206 Identities=22% Similarity=0.367 Sum_probs=158.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC------------CCCCcCCHHHHHHHHHHHHHHHhHHhh
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ------------PHFEPLLLKHRLKIAMDIVHALAYLHF 68 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~LH~ 68 (239)
+++||||+++++++..+...++||||+.+++|.+++..... .....+++.....++.|++.||+|||
T Consensus 63 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH- 141 (283)
T cd05090 63 ELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS- 141 (283)
T ss_pred hCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-
Confidence 47899999999999999999999999999999999864321 00134778889999999999999999
Q ss_pred CCCCCeeeccccCcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHH
Q 044155 69 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFEL 147 (239)
Q Consensus 69 ~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~ 147 (239)
+++++|+||||+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++|+||||+++|+|
T Consensus 142 --~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 219 (283)
T cd05090 142 --SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219 (283)
T ss_pred --hcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHH
Confidence 8999999999999999999999999999987653222 1122333456789999999888899999999999999999
Q ss_pred hc-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 148 LT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 148 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
++ |..||..... .+.......... ...+...+..+.+++.+||+.||.+||++.+++
T Consensus 220 ~~~g~~p~~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 277 (283)
T cd05090 220 FSFGLQPYYGFSN---------------------QEVIEMVRKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIH 277 (283)
T ss_pred HcCCCCCCCCCCH---------------------HHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 98 8777753221 001111100110 011123456788999999999999999999999
Q ss_pred HHHHH
Q 044155 227 KKLRQ 231 (239)
Q Consensus 227 ~~L~~ 231 (239)
+.|..
T Consensus 278 ~~l~~ 282 (283)
T cd05090 278 TRLRS 282 (283)
T ss_pred HHhhc
Confidence 88763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=240.69 Aligned_cols=203 Identities=21% Similarity=0.282 Sum_probs=159.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++.+++...+..++||||+++++|.+++.... ..+++.....++.|++.|+.||| +.+++|+|||
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlk 134 (268)
T cd05063 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLA 134 (268)
T ss_pred cCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccc
Confidence 4789999999999999999999999999999999987643 46788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCccee--ecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.++++|||++........... .....+..|+|||.+....++.++|+||||+++|++++ |..||...
T Consensus 135 p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 135 ARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred hhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999875533221111 11123457999999988889999999999999999997 88887532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
... +......... ..+.....+..+.+++.+||..+|.+||++.++++.|+++
T Consensus 215 ~~~---------------------~~~~~i~~~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 215 SNH---------------------EVMKAINDGF-RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CHH---------------------HHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 210 0111110000 0001113456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=242.77 Aligned_cols=205 Identities=21% Similarity=0.365 Sum_probs=157.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC--CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP--HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++|+||+++++++.+....++||||+++++|.+++...... ....+++..+..++.|++.||.||| +.+++|+|
T Consensus 65 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~d 141 (277)
T cd05036 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRD 141 (277)
T ss_pred hCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecc
Confidence 478999999999999988999999999999999999765321 1135889999999999999999999 89999999
Q ss_pred ccCcceeecCCC---ceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCC
Q 044155 79 FKTSCILFNEEN---VAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDV 153 (239)
Q Consensus 79 lk~~nil~~~~~---~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p 153 (239)
|||+||+++.++ .++|+|||+++........ .......+..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 142 lkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~p 221 (277)
T cd05036 142 IAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221 (277)
T ss_pred cchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 999999998765 5899999998765322111 1112233567999999988889999999999999999997 8778
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
|..... .+......... ....+...+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 222 f~~~~~---------------------~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 222 YPGRTN---------------------QEVMEFVTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCH---------------------HHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 753221 01111110000 00011234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=243.89 Aligned_cols=216 Identities=25% Similarity=0.369 Sum_probs=157.3
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++... ...++|+||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+|
T Consensus 61 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~d 133 (284)
T cd05081 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG---SKRYVHRD 133 (284)
T ss_pred hCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecc
Confidence 47899999999987543 46789999999999999997542 45789999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||++......... ......++..|+|||++.+..++.++||||||++++||++|..++..
T Consensus 134 lkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 134 LATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 9999999999999999999998765432211 11112234569999999888899999999999999999998766432
Q ss_pred ccccccccccchhhhhhhhhccc---hhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNR---FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
.... +......... ........+............+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 214 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 214 PPAE---------FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cchh---------hhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 2110 0000000000 00000011111111111123456799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=252.90 Aligned_cols=191 Identities=22% Similarity=0.275 Sum_probs=153.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++...+..++||||+.+++|...+... ..+++..+..++.||+.||.||| +.+++||||||
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp 124 (325)
T cd05604 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKP 124 (325)
T ss_pred CCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCH
Confidence 68999999999999999999999999999999888764 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++|+|||++...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 125 ~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-- 201 (325)
T cd05604 125 ENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-- 201 (325)
T ss_pred HHeEECCCCCEEEeecCCcccCCCC-CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--
Confidence 9999999999999999998643221 1122345689999999999988899999999999999999999999853221
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
.+........... .....+..+.+++.+|++.+|.+||++.+
T Consensus 202 -------------------~~~~~~~~~~~~~--~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 202 -------------------AEMYDNILHKPLV--LRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred -------------------HHHHHHHHcCCcc--CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1111111111110 01134456789999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=243.44 Aligned_cols=206 Identities=17% Similarity=0.306 Sum_probs=159.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----------CCCCcCCHHHHHHHHHHHHHHHhHHhhC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHFG 69 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 69 (239)
+++||||+++++++.+....++++||+.+++|.+++..... .....++...+..++.|++.||.|||
T Consensus 64 ~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH-- 141 (283)
T cd05091 64 RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS-- 141 (283)
T ss_pred cCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--
Confidence 47899999999999999999999999999999999853211 01135788889999999999999999
Q ss_pred CCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 70 FPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 70 ~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
+++++|+||||+||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+
T Consensus 142 -~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 220 (283)
T cd05091 142 -SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220 (283)
T ss_pred -HcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 89999999999999999999999999999876533221 1123334567899999998888999999999999999999
Q ss_pred c-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 149 T-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 149 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+ |..||..... .+........... ..+...+..+.+++.+||+.+|.+|||+++++.
T Consensus 221 ~~g~~p~~~~~~---------------------~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 221 SYGLQPYCGYSN---------------------QDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred cCCCCCCCCCCH---------------------HHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 8 7667643211 1111111111111 112245667889999999999999999999999
Q ss_pred HHHH
Q 044155 228 KLRQ 231 (239)
Q Consensus 228 ~L~~ 231 (239)
.|+.
T Consensus 279 ~l~~ 282 (283)
T cd05091 279 RLRT 282 (283)
T ss_pred HhhC
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=241.32 Aligned_cols=208 Identities=21% Similarity=0.244 Sum_probs=151.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.+....++||||+++++|.+++.+.... ....+......++.|++.||+||| +.+++|+|||
T Consensus 51 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dik 126 (268)
T cd05086 51 ILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLA 126 (268)
T ss_pred ccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCc
Confidence 378999999999999999999999999999999999764221 145677788899999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-cceeecccccccccCcccccc-------CCcccccchhhhhhHHHHHhcC-C
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRT-------GVFNEKSNVFSFSVFLFELLTG-W 151 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~~~~g-~ 151 (239)
|+||+++.++.++|+|||++....... ........++..|+|||++.. ..++.++||||||+++|+|+++ .
T Consensus 127 p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~ 206 (268)
T cd05086 127 LRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206 (268)
T ss_pred cceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCC
Confidence 999999999999999999875322111 111234457889999998743 2357899999999999999975 5
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
.||...... +........ .......+......++.+.+++..|| .+|.+|||++++++.|.
T Consensus 207 ~p~~~~~~~--------~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 207 QPYSHLSDR--------EVLNHVIKD---------QQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCCHH--------HHHHHHHhh---------cccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 566432210 000000000 00000011111134466788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=241.17 Aligned_cols=207 Identities=25% Similarity=0.369 Sum_probs=156.7
Q ss_pred CCCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCC-CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
+++||||+++++++... ...+++|||+++++|.+++..... .....+++.....++.|++.||+||| +++
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~ 132 (272)
T cd05075 56 EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKS 132 (272)
T ss_pred hCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 47899999999987532 246899999999999988753321 11245789999999999999999999 899
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCcce-eecccccccccCccccccCCcccccchhhhhhHHHHHhc-CC
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GW 151 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~ 151 (239)
++|+||||+||+++.++.++|+|||++.......... .....+++.|+|||......++.++|+||||+++|++++ |.
T Consensus 133 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~ 212 (272)
T cd05075 133 FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212 (272)
T ss_pred eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999987654332211 122345678999999998889999999999999999999 67
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||...... +........... ......+..+.+++.+||..||.+|||+.++++.|++
T Consensus 213 ~p~~~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 213 TPYPGVENS---------------------EIYDYLRQGNRL-KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCCCCHH---------------------HHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 777532210 000000000000 0011344668999999999999999999999999987
Q ss_pred H
Q 044155 232 I 232 (239)
Q Consensus 232 l 232 (239)
+
T Consensus 271 ~ 271 (272)
T cd05075 271 A 271 (272)
T ss_pred h
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=241.54 Aligned_cols=204 Identities=20% Similarity=0.315 Sum_probs=158.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++... ..++++|++++|+|.+++.... ..++...+..++.|++.||+||| +.+++|+|||
T Consensus 65 ~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlk 136 (279)
T cd05109 65 GVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLA 136 (279)
T ss_pred hcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccc
Confidence 36899999999998754 4678999999999999997642 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||++++++.++|+|||+++........ ......++..|+|||...+..++.++||||||+++||+++ |..||+...
T Consensus 137 p~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 137 ARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred cceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999998765432211 1112234677999999988889999999999999999998 878875322
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
.. .....+. ...........+..+.+++.+||..||++|||+.++++.|.++..
T Consensus 217 ~~------------------~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 217 AR------------------EIPDLLE----KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HH------------------HHHHHHH----CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 10 0001111 000001112345678899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=243.67 Aligned_cols=205 Identities=21% Similarity=0.366 Sum_probs=159.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCC-----CCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH-----FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++......++||||+++++|.+++....... ...+++..+..++.|++.||.||| +.+++
T Consensus 65 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~ 141 (277)
T cd05032 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFV 141 (277)
T ss_pred hCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 3689999999999999999999999999999999997543211 124678889999999999999999 99999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDV 153 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p 153 (239)
|+||||+||+++.++.++|+|||+++....... .......++..|+|||.+....++.++||||||+++|++++ |..|
T Consensus 142 H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 221 (277)
T cd05032 142 HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221 (277)
T ss_pred ccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCC
Confidence 999999999999999999999999875533221 12233446778999999988889999999999999999998 8777
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
|..... .+.......... ...+...+..+.+++.+||..+|++|||+.++++.|+
T Consensus 222 ~~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 222 YQGLSN---------------------EEVLKFVIDGGH-LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CccCCH---------------------HHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 743221 000001111100 0011133567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=239.70 Aligned_cols=202 Identities=21% Similarity=0.347 Sum_probs=158.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++. ....+++|||+.+++|.+++..... ..++......++.|++.||.||| +.+++|+|||
T Consensus 57 ~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~ 129 (260)
T cd05067 57 QLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLR 129 (260)
T ss_pred hcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccccc
Confidence 478999999999874 4568999999999999999876543 46788999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............++..|+|||++....++.++||||||+++|++++ |..||.....
T Consensus 130 p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 130 AANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred HHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 999999999999999999987654332222233345678999999988889999999999999999998 8888753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
. +..... ............+.++.+++.+||+.+|++|||++++++.|+.
T Consensus 210 ~---------------------~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 210 P---------------------EVIQNL-ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred H---------------------HHHHHH-HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 000000 0000111112345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=248.91 Aligned_cols=208 Identities=23% Similarity=0.416 Sum_probs=159.3
Q ss_pred CCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcCCCCC--------------------------------------
Q 044155 3 SHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPH-------------------------------------- 43 (239)
Q Consensus 3 ~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~~~-------------------------------------- 43 (239)
+|+||+++++++... ...++++||+++++|.+++.......
T Consensus 69 ~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (337)
T cd05054 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFI 148 (337)
T ss_pred cCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccc
Confidence 799999999988754 56789999999999999886532100
Q ss_pred ------------------CCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCC
Q 044155 44 ------------------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 105 (239)
Q Consensus 44 ------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~ 105 (239)
...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 149 EDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred cCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 025788899999999999999999 89999999999999999999999999999876533
Q ss_pred CCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccccccccccchhhhhhhhhccchhhh
Q 044155 106 GETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEI 183 (239)
Q Consensus 106 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (239)
.... ......++..|+|||++.+..++.++|||||||++|+|++ |..||........ ....
T Consensus 226 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-----------------~~~~ 288 (337)
T cd05054 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----------------FCRR 288 (337)
T ss_pred CcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-----------------HHHH
Confidence 2211 1223345678999999999999999999999999999997 8888753211000 0000
Q ss_pred hhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 184 VDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
+........+...+.++.+++.+||+.+|.+|||+.|+++.|++++.
T Consensus 289 ----~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 289 ----LKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ----HhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000001112345678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=240.67 Aligned_cols=207 Identities=26% Similarity=0.413 Sum_probs=159.7
Q ss_pred CCCCcccceeeEEEEeCCC------ceEEEEEccCCChhhhhhcCCC-CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 1 QMSHNHILKLIGCCLETPI------PILVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~------~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
+++||||+++++++..... .++++||+++++|..++..... .....++......++.|++.||.||| +.+
T Consensus 57 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~ 133 (273)
T cd05035 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRN 133 (273)
T ss_pred hCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 3689999999998876543 7899999999999998865432 11246889999999999999999999 899
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCcce-eecccccccccCccccccCCcccccchhhhhhHHHHHhc-CC
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GW 151 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~ 151 (239)
++|+||||+||++++++.++|+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |.
T Consensus 134 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~ 213 (273)
T cd05035 134 FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213 (273)
T ss_pred eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999987654332211 122234678999999988889999999999999999999 77
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||..... .+..+....... ...+...+..+.+++.+||+.||.+|||+.|+++.|++
T Consensus 214 ~p~~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 214 TPYPGVEN---------------------HEIYDYLRHGNR-LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCCCCCH---------------------HHHHHHHHcCCC-CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 77643221 011111111111 11122455678999999999999999999999999988
Q ss_pred H
Q 044155 232 I 232 (239)
Q Consensus 232 l 232 (239)
+
T Consensus 272 ~ 272 (273)
T cd05035 272 I 272 (273)
T ss_pred h
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=242.55 Aligned_cols=205 Identities=23% Similarity=0.340 Sum_probs=158.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC----------CCCcCCHHHHHHHHHHHHHHHhHHhhCC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP----------HFEPLLLKHRLKIAMDIVHALAYLHFGF 70 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 70 (239)
+++|+||+++++++.+....+++|||+++++|.+++...... ....+++..++.++.|++.|++|||
T Consensus 63 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--- 139 (280)
T cd05092 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--- 139 (280)
T ss_pred cCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---
Confidence 478999999999999999999999999999999999764320 1134788999999999999999999
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 149 (239)
+.+++|+||||+||++++++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 140 ~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 219 (280)
T cd05092 140 SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219 (280)
T ss_pred HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHc
Confidence 99999999999999999999999999999865432221 11122334678999999998889999999999999999998
Q ss_pred -CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 150 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
|..||...... +.......... ...+...+..+.+++.+||+.||.+|||+++|++.
T Consensus 220 ~g~~p~~~~~~~---------------------~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~ 277 (280)
T cd05092 220 YGKQPWYQLSNT---------------------EAIECITQGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSR 277 (280)
T ss_pred CCCCCCccCCHH---------------------HHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 87887432211 01111111100 00011345678899999999999999999999998
Q ss_pred HH
Q 044155 229 LR 230 (239)
Q Consensus 229 L~ 230 (239)
|+
T Consensus 278 l~ 279 (280)
T cd05092 278 LQ 279 (280)
T ss_pred Hh
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=250.42 Aligned_cols=191 Identities=21% Similarity=0.294 Sum_probs=153.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+.+... ..++......++.|++.||.||| +.+++|||||
T Consensus 52 ~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlk 123 (321)
T cd05603 52 NLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLK 123 (321)
T ss_pred hCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCC
Confidence 368999999999999999999999999999998888654 56788889999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 124 p~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-- 200 (321)
T cd05603 124 PENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-- 200 (321)
T ss_pred HHHeEECCCCCEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--
Confidence 999999999999999999886532211 12234568999999999988889999999999999999999999985321
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
.......+...... .+...+..+.+++.+||+.||.+||++.
T Consensus 201 -------------------~~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 201 -------------------VSQMYDNILHKPLQ--LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -------------------HHHHHHHHhcCCCC--CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11111111111111 1123455688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=240.89 Aligned_cols=210 Identities=21% Similarity=0.329 Sum_probs=162.4
Q ss_pred CCCCcccceeeEEEEe-CCCceEEEEEccCCChhhhhhcCCCC---CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLE-TPIPILVFESVQYGTLWDRILGAPQP---HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+++||||+++++++.. +...+++++|+++++|.+++...... ....++...+..++.|++.||.||| +.+++|
T Consensus 64 ~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H 140 (280)
T cd05043 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIH 140 (280)
T ss_pred hCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEee
Confidence 4789999999998776 46788999999999999998764321 1145889999999999999999999 999999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVS 154 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~ 154 (239)
+||||+||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|++++ |..||
T Consensus 141 ~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 220 (280)
T cd05043 141 KDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220 (280)
T ss_pred cccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCc
Confidence 999999999999999999999998765332221 1123345678999999988889999999999999999999 88887
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
...... +..... ............++.+.+++.+||..||++|||+.++++.|.++.+
T Consensus 221 ~~~~~~---------------------~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 221 VEIDPF---------------------EMAAYL-KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CcCCHH---------------------HHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 532210 000000 0000000111345678999999999999999999999999999876
Q ss_pred h
Q 044155 235 S 235 (239)
Q Consensus 235 ~ 235 (239)
.
T Consensus 279 ~ 279 (280)
T cd05043 279 Q 279 (280)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=251.57 Aligned_cols=195 Identities=20% Similarity=0.285 Sum_probs=149.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++...+..++||||+++++|.+. .......+..++.||+.||.||| +.+++|+|||
T Consensus 128 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlk 195 (353)
T PLN00034 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIK 195 (353)
T ss_pred hCCCCCcceeeeEeccCCeEEEEEecCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCC
Confidence 47899999999999999999999999999998542 23456778889999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-----CcccccchhhhhhHHHHHhcCCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-----VFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+||+++.++.+||+|||++....... .......|+..|+|||++... ..+.++|||||||++|+|++|+.||.
T Consensus 196 p~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 196 PSNLLINSAKNVKIADFGVSRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred HHHEEEcCCCCEEEcccccceeccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999987653221 112345689999999987532 24568999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ..+........... ........+..+.++|.+||+.||++|||+.|+++
T Consensus 275 ~~~~------------------~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 275 VGRQ------------------GDWASLMCAICMSQ-PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCC------------------ccHHHHHHHHhccC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2211 01111111111100 01111245567899999999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=230.34 Aligned_cols=210 Identities=18% Similarity=0.255 Sum_probs=160.3
Q ss_pred CCCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC--
Q 044155 1 QMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP-- 73 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~-- 73 (239)
+++||||++++++...+ ...|++++|...|||.+.+....... ..+++.+.++|+.+++.||.+|| +..
T Consensus 74 kf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH---~~~~~ 149 (302)
T KOG2345|consen 74 KFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALH---EKEPP 149 (302)
T ss_pred hhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHh---ccCCc
Confidence 47899999999987643 34799999999999999887643321 56899999999999999999999 665
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCC---c-c----eeecccccccccCcccccc---CCcccccchhhhhh
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE---T-H----ITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSV 142 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~-~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~ 142 (239)
+.||||||.||++++++.+++.|||.+....-.. . . .......|..|+|||.+.. ...++++|||||||
T Consensus 150 yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGC 229 (302)
T KOG2345|consen 150 YAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGC 229 (302)
T ss_pred ccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhH
Confidence 9999999999999999999999999876543111 0 0 1122347899999999864 34789999999999
Q ss_pred HHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 143 FLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 143 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
++|.|+.|..||+......+... - ++....+.-+.....+..+.++|..|++.||.+||++
T Consensus 230 tLYa~mf~~sPfe~~~~~GgSla----------------L---Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i 290 (302)
T KOG2345|consen 230 TLYAMMFGESPFERIYQQGGSLA----------------L---AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTI 290 (302)
T ss_pred HHHHHHHcCCcchHHhhcCCeEE----------------E---eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCH
Confidence 99999999999874433111110 0 1111111112222467788999999999999999999
Q ss_pred HHHHHHHHHHH
Q 044155 223 VDVAKKLRQIY 233 (239)
Q Consensus 223 ~ell~~L~~l~ 233 (239)
.+++..++.+.
T Consensus 291 ~~ll~~~d~Li 301 (302)
T KOG2345|consen 291 PELLSKLDDLI 301 (302)
T ss_pred HHHHHHHHhhc
Confidence 99999998764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=253.57 Aligned_cols=197 Identities=19% Similarity=0.254 Sum_probs=153.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++||||+++|+|.+++.. ..++...+..++.|++.||+||| +.+|+|||||
T Consensus 99 ~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLK 169 (370)
T cd05621 99 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVK 169 (370)
T ss_pred hCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCC
Confidence 36899999999999999999999999999999999965 34788899999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC----cccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV----FNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+|||++.++.+||+|||++...............||+.|+|||++.... ++.++|+||||+++|+|++|..||..
T Consensus 170 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred HHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 99999999999999999998765433222233556899999999987543 77899999999999999999999854
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPAD--RPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~ 227 (239)
... ......+.... ...+.....+..+++++..|+..++.+ |+|+.|+++
T Consensus 250 ~~~---------------------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 250 DSL---------------------VGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred CCH---------------------HHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 221 01111111100 111111234667889999999855543 889999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=243.46 Aligned_cols=200 Identities=21% Similarity=0.302 Sum_probs=158.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.++...++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlk 129 (285)
T cd05605 56 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLK 129 (285)
T ss_pred hcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCC
Confidence 47899999999999998999999999999999988865422 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||++++++.++|+|||++........ .....|++.|+|||++.+..++.++||||+|+++|++++|..||......
T Consensus 130 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~ 207 (285)
T cd05605 130 PENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207 (285)
T ss_pred HHHEEECCCCCEEEeeCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh
Confidence 9999999999999999999876533221 12346789999999998888999999999999999999999998642210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
. ............. ...+...+..+.+++.+||..||.+|| ++++++.
T Consensus 208 ~-----------------~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 208 V-----------------KREEVERRVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred h-----------------HHHHHHHHhhhcc--cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0 0001111111111 111124567789999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=239.26 Aligned_cols=199 Identities=18% Similarity=0.237 Sum_probs=158.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++.+.+++..+++|||+++++|.+++..... ..++......++.|++.||.+|| +.+++|+|||
T Consensus 54 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~ 127 (255)
T cd08219 54 KMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIK 127 (255)
T ss_pred hCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCC
Confidence 47899999999999999999999999999999998875432 45788999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++++|||.+........ ......+++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 128 p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-- 204 (255)
T cd08219 128 SKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-- 204 (255)
T ss_pred cceEEECCCCcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--
Confidence 9999999999999999999865532211 1223457888999999988889999999999999999999999985321
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
............... .+...+..+.+++.+||+.||.+|||+.+++.+
T Consensus 205 -------------------~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 205 -------------------WKNLILKVCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------------------HHHHHHHHhcCCCCC-CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011111111111111 112345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=252.41 Aligned_cols=197 Identities=16% Similarity=0.157 Sum_probs=155.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp 130 (330)
T cd05601 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKP 130 (330)
T ss_pred CCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCch
Confidence 689999999999999999999999999999999997653 46889999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc------cCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR------TGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
+||+++.++.++|+|||++...............|++.|+|||++. ...++.++||||||+++|+|++|..||.
T Consensus 131 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 131 ENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred HheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 9999999999999999998765433322233456899999999986 3457789999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhc--CCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE--DVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... ....+... ....+.....+..+.+++..||. +|.+|||+++++.
T Consensus 211 ~~~~~~---------------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 211 EGTSAK---------------------TYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCHHH---------------------HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 432110 00000000 00000011345678899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=243.93 Aligned_cols=197 Identities=18% Similarity=0.236 Sum_probs=155.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+..+...++||||+++++|.+++.. ..++......++.|++.||.||| ..+++|+|||
T Consensus 73 ~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLk 143 (296)
T cd06654 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIK 143 (296)
T ss_pred hCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 36899999999999999999999999999999999864 34778899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 144 p~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~ 222 (296)
T cd06654 144 SDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (296)
T ss_pred HHHEEEcCCCCEEECccccchhccccc-cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999876543221 1122345788999999998888899999999999999999999998532210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .............+...+..+.+++.+||..+|.+|||+.++++
T Consensus 223 ~~~--------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 223 RAL--------------------YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HhH--------------------HHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 00000000000111244567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=239.67 Aligned_cols=203 Identities=24% Similarity=0.375 Sum_probs=159.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++|||++++++|.+++..... ..++...+..++.|++.|+.||| +.+++|+|||
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~ 130 (261)
T cd05034 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLA 130 (261)
T ss_pred hCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcc
Confidence 47899999999999988889999999999999999977543 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++++|||.+................+..|+|||.+.+...+.++|+||||++++++++ |+.||.....
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 131 ARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred hheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654322111222234568999999998889999999999999999998 8888743221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
. ......... .....+...+..+.+++.+||..+|.+|||++++.+.|+.
T Consensus 211 ~---------------------~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 211 R---------------------EVLEQVERG-YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred H---------------------HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 001111100 0001111235678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=239.01 Aligned_cols=203 Identities=20% Similarity=0.308 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 61 ~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~ 133 (269)
T cd05065 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLA 133 (269)
T ss_pred hCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccC
Confidence 4789999999999999999999999999999999987643 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce--eeccc--ccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI--TDTVM--GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~--~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~ 155 (239)
|+||+++.++.++++|||.+.......... ..... .+..|+|||.+.+..++.++|+||||+++||+++ |..||.
T Consensus 134 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~ 213 (269)
T cd05065 134 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213 (269)
T ss_pred hheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence 999999999999999999886553322111 11111 2357999999988889999999999999999886 888875
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
..... +...... ...........+..+.+++.+||..+|.+||++++++..|+++
T Consensus 214 ~~~~~---------------------~~~~~i~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 214 DMSNQ---------------------DVINAIE-QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCHH---------------------HHHHHHH-cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 33210 0011100 0011111123456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=244.87 Aligned_cols=216 Identities=21% Similarity=0.289 Sum_probs=159.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dl 79 (239)
+++||||+++++.+..++..++||||+++++|.+++... ..++...+..++.|++.||.||| + .+++|+||
T Consensus 55 ~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl 126 (308)
T cd06615 55 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDV 126 (308)
T ss_pred hCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCC
Confidence 478999999999999999999999999999999999765 56889999999999999999999 6 58999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|++++|..||.....
T Consensus 127 ~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 127 KPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred ChHHEEEecCCcEEEccCCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 9999999999999999999876543221 2345678899999999888889999999999999999999999853321
Q ss_pred cccccccchhhhhhh------------h----hccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 160 VHDLVCPFSEYLKNC------------F----EDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~------------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
.. ....+....... . ......+..+...............+..+.+++.+||..+|++|||+.
T Consensus 204 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 282 (308)
T cd06615 204 KE-LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLK 282 (308)
T ss_pred hh-HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHH
Confidence 11 000000000000 0 000011111111111100000112456789999999999999999999
Q ss_pred HHHHH
Q 044155 224 DVAKK 228 (239)
Q Consensus 224 ell~~ 228 (239)
++++.
T Consensus 283 ~ll~~ 287 (308)
T cd06615 283 ELTKH 287 (308)
T ss_pred HHhcC
Confidence 99874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=241.83 Aligned_cols=206 Identities=22% Similarity=0.330 Sum_probs=158.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCC----CCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH----FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+++||||+++++++.+....++||||+++++|.+++....... ...+++..+..++.|++.||+||| +.+++|
T Consensus 64 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H 140 (275)
T cd05046 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVH 140 (275)
T ss_pred hcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCccc
Confidence 4789999999999998889999999999999999997653210 125889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSD 155 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~ 155 (239)
+||||+||+++.++.++++|||++...............++..|+|||.+.+...+.++||||||+++|++++ |..||.
T Consensus 141 ~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 141 RDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred CcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999876443222222233456778999999988888899999999999999998 666764
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
..... ...................+..+.+++.+||+.+|.+|||+.|++..|.
T Consensus 221 ~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 221 GLSDE---------------------EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ccchH---------------------HHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 32210 0111111000000011234567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=237.47 Aligned_cols=218 Identities=18% Similarity=0.206 Sum_probs=161.9
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++|||||.+.++.... +..++|||||+ -+|..++..-. +++...+++.+..|++.|++||| ...|+|||
T Consensus 131 ~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH---~~wilHRD 202 (419)
T KOG0663|consen 131 KARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRD 202 (419)
T ss_pred hcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh---hceeEecc
Confidence 36899999999887744 46899999998 69999998653 57889999999999999999999 99999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCcccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
||++|+|++..|.+||+|||+|+..... ...-+....|.+|+|||.+.+.+ |+++.|+||+|||+.|++++++.|.+.
T Consensus 203 LK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 203 LKTSNLLLSHKGILKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred cchhheeeccCCcEEecccchhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999887433 22344566899999999999865 999999999999999999999998876
Q ss_pred cccccccccchhhh---hhhhhccchhhhhhhh-hhc-CCCcH---HH-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYL---KNCFEDNRFTEIVDHI-VVE-DVSSI---EK-EQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~-~~~~~---~~-~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.........|.... ...|..-.....+... ... ++... .. ...++.-.+|+..++.+||.+|.||+|.+.
T Consensus 282 sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 282 SEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 66544332221110 0001100000000000 000 00000 00 014466789999999999999999999875
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=239.29 Aligned_cols=205 Identities=20% Similarity=0.334 Sum_probs=160.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.. ...++|+||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+|||
T Consensus 65 ~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~ 136 (279)
T cd05057 65 SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLA 136 (279)
T ss_pred hCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccC
Confidence 4789999999999987 77899999999999999997653 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCccee-ecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.++|+|||.+........... ....++..|+|||.+....++.++|+||||+++|++++ |..||....
T Consensus 137 p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 137 ARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 9999999999999999999876543322111 11223567999999988889999999999999999998 888875322
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
. .+.......... ...+...+..+.+++.+||..+|++|||+.++++.|.++.+.
T Consensus 217 ~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 217 A---------------------VEIPDLLEKGER-LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred H---------------------HHHHHHHhCCCC-CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1 011111111100 011112335678999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=247.63 Aligned_cols=195 Identities=24% Similarity=0.333 Sum_probs=153.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||+||| +++++||||||+
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~ 125 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLD 125 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 6999999999999999999999999999999888765 56899999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 126 Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~ 204 (327)
T cd05617 126 NVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204 (327)
T ss_pred HEEEeCCCCEEEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc
Confidence 9999999999999999886432211 122345689999999999988999999999999999999999999964332111
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
.. ............... .+...+..+.+++.+||+.||.+|+++
T Consensus 205 ~~--------------~~~~~~~~~~~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 205 MN--------------TEDYLFQVILEKPIR--IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred cc--------------cHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 10 000111111111111 112345668899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=255.12 Aligned_cols=218 Identities=17% Similarity=0.229 Sum_probs=156.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|+||+++++++..++..++|||++. ++|.+++.... ..+++..++.++.|++.||.||| +++|+|||||
T Consensus 216 ~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLK 287 (461)
T PHA03211 216 RLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIK 287 (461)
T ss_pred HCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCC
Confidence 4799999999999999999999999996 79988886542 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+|||++.++.++|+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|..++-....
T Consensus 288 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~ 367 (461)
T PHA03211 288 TENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASR 367 (461)
T ss_pred HHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCc
Confidence 9999999999999999999876533221 112245689999999999988899999999999999999998765432221
Q ss_pred cccccccchhhhhhhhhc-------------cchhhhhhhhhhcCCC----c---HHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 160 VHDLVCPFSEYLKNCFED-------------NRFTEIVDHIVVEDVS----S---IEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~----~---~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
... ..++.......... ................ . ......+..+.+||.+||+.||.+|
T Consensus 368 ~~~-~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~R 446 (461)
T PHA03211 368 GDE-RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARR 446 (461)
T ss_pred ccc-cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhC
Confidence 110 00000000000000 0000000000000000 0 0001234568899999999999999
Q ss_pred CCHHHHHH
Q 044155 220 PSMVDVAK 227 (239)
Q Consensus 220 ps~~ell~ 227 (239)
||+.|+++
T Consensus 447 Psa~elL~ 454 (461)
T PHA03211 447 PSAAELLR 454 (461)
T ss_pred cCHHHHhh
Confidence 99999986
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=252.84 Aligned_cols=217 Identities=21% Similarity=0.240 Sum_probs=159.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+||||+++++++......+++||++. ++|.+++... ..+++..+..++.|++.||.||| ..+|+|||||
T Consensus 142 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlk 212 (392)
T PHA03207 142 TISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVK 212 (392)
T ss_pred hcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 4799999999999999999999999996 7898888543 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++........ .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 213 p~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 213 TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred HHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 9999999999999999999876543322 122345689999999999988899999999999999999999999865432
Q ss_pred cccccccchhhhhhh------hhccchhhh---hhhh---hhcCCCcH---HHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 160 VHDLVCPFSEYLKNC------FEDNRFTEI---VDHI---VVEDVSSI---EKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~------~~~~~~~~~---~~~~---~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
.... .......+.. +........ .... ........ .....+.++.++|.+||..||.+|||+.|
T Consensus 293 ~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e 371 (392)
T PHA03207 293 KSSS-SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD 371 (392)
T ss_pred CCcH-HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHH
Confidence 1100 0000000000 000000000 0000 00000000 01123567889999999999999999999
Q ss_pred HHH
Q 044155 225 VAK 227 (239)
Q Consensus 225 ll~ 227 (239)
++.
T Consensus 372 ~l~ 374 (392)
T PHA03207 372 ILS 374 (392)
T ss_pred Hhh
Confidence 986
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=237.50 Aligned_cols=205 Identities=25% Similarity=0.431 Sum_probs=161.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC----CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP----HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+++|+||+++++++......+++|||+++++|.+++...... ....+++..+..++.|++.||.+|| +.+++|
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H 128 (262)
T cd00192 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVH 128 (262)
T ss_pred hcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCccc
Confidence 368999999999999989999999999999999999875210 0156899999999999999999999 999999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVS 154 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~ 154 (239)
+||||+||+++.++.++|+|||.+........ .......++..|+|||.+....++.++||||||+++|++++ |..||
T Consensus 129 ~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 129 RDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred CccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999876643321 12234456788999999988889999999999999999999 57887
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
..... .+........ .....+...+..+.+++.+||+.+|.+|||+.|++..|+
T Consensus 209 ~~~~~---------------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 209 PGLSN---------------------EEVLEYLRKG-YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCH---------------------HHHHHHHHcC-CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 54321 0111111111 111112234678899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=240.07 Aligned_cols=198 Identities=20% Similarity=0.256 Sum_probs=154.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++|+||+++++|..++.+.. ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 58 ~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlk 130 (282)
T cd06643 58 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLK 130 (282)
T ss_pred HCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCC
Confidence 3789999999999999999999999999999988876532 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+||+++.++.++++|||++....... .......++..|+|||++. ...++.++|+||||+++|+|++|..||.
T Consensus 131 p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 209 (282)
T cd06643 131 AGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209 (282)
T ss_pred cccEEEccCCCEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence 999999999999999999986543221 1223456788999999874 3457789999999999999999998875
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhc-CCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE-DVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... ........ ......+...+..+.++|.+||+.||.+|||+.++++
T Consensus 210 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 210 ELNPMR---------------------VLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ccCHHH---------------------HHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 432100 00000000 0000111234567899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=250.77 Aligned_cols=194 Identities=22% Similarity=0.277 Sum_probs=152.7
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||+||| +.+++||||||+
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~ 125 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPE 125 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHH
Confidence 6999999999999999999999999999999988765 56889999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
||+++.++.++|+|||++....... .......|++.|+|||++.+. .++.++||||||+++|+|++|..||.....
T Consensus 126 Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-- 202 (330)
T cd05586 126 NILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-- 202 (330)
T ss_pred HeEECCCCCEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--
Confidence 9999999999999999986532221 122345689999999998754 478999999999999999999999853211
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC----CHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP----SMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp----s~~ell~ 227 (239)
.+....+........ ....+..+.+++.+||+.||.+|| ++.++++
T Consensus 203 -------------------~~~~~~i~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 203 -------------------QQMYRNIAFGKVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -------------------HHHHHHHHcCCCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 111111111111100 012456778999999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=235.50 Aligned_cols=201 Identities=23% Similarity=0.390 Sum_probs=157.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+.+++|.+++.... ..++......++.+++.||.||| +.+++|+|||
T Consensus 48 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~ 120 (251)
T cd05041 48 QYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLA 120 (251)
T ss_pred hCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcC
Confidence 4789999999999999999999999999999999987643 45788899999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCccee-ecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.++|+|||.+........... .....+..|+|||.+.+..++.++|+||||+++|++++ |..||....
T Consensus 121 p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 121 ARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 9999999999999999999865432211111 12233567999999988889999999999999999999 667764322
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
.. ........ ......+...+..+.+++.+||..+|.+|||+.|+++.|+
T Consensus 201 ~~------------------~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 201 NQ------------------QTRERIES----GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HH------------------HHHHHHhc----CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 10 00001100 0011111244567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=238.19 Aligned_cols=193 Identities=20% Similarity=0.353 Sum_probs=150.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++.||||+++++++..+...++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++|+|||
T Consensus 55 ~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlk 127 (258)
T cd05078 55 QLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVC 127 (258)
T ss_pred hCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCc
Confidence 4689999999999999899999999999999999997653 35788999999999999999999 9999999999
Q ss_pred CcceeecCCCc--------eeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCC
Q 044155 81 TSCILFNEENV--------AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 81 ~~nil~~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|+||+++.++. ++++|||.+..... .....++..|+|||.+.+. .++.++|+||||+++|++++|.
T Consensus 128 p~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 202 (258)
T cd05078 128 AKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG 202 (258)
T ss_pred cceEEEecccccccCCCceEEecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCC
Confidence 99999988765 58999998754422 2234577889999999864 4788999999999999999995
Q ss_pred -CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 152 -DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 152 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
.|+....... ....... .... +.....++.+++.+||+.||.+|||++++++.|
T Consensus 203 ~~~~~~~~~~~------------------~~~~~~~--~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 203 DKPLSALDSQK------------------KLQFYED--RHQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCChhhccHHH------------------HHHHHHc--cccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 4433211000 0000000 0001 112235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=238.51 Aligned_cols=193 Identities=21% Similarity=0.309 Sum_probs=149.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++.... ..++...+..++.|++.||+||| +++++|+|||
T Consensus 72 ~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlk 144 (274)
T cd05076 72 QVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVC 144 (274)
T ss_pred cCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCC
Confidence 4789999999999999999999999999999988886542 46788999999999999999999 9999999999
Q ss_pred CcceeecCCC-------ceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHh-cCC
Q 044155 81 TSCILFNEEN-------VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELL-TGW 151 (239)
Q Consensus 81 ~~nil~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~-~g~ 151 (239)
|+||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|.
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~ 219 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219 (274)
T ss_pred cccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999997643 3799999987543211 12346788999998865 56889999999999999984 687
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
.||........ . ...... .... ......+.+++.+||+.+|++|||+.++++.|
T Consensus 220 ~p~~~~~~~~~---------~---------~~~~~~--~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 220 VPLKERTPSEK---------E---------RFYEKK--HRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCccccChHHH---------H---------HHHHhc--cCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 77753221000 0 000000 0000 01234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=237.28 Aligned_cols=202 Identities=21% Similarity=0.357 Sum_probs=158.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.+ ...+++|||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 57 ~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~ 129 (260)
T cd05073 57 TLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLR 129 (260)
T ss_pred hcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHH---hCCccccccC
Confidence 4789999999999877 678999999999999999976533 45778889999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............++..|+|||++....++.++|+||||+++|++++ |..||.....
T Consensus 130 p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred cceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999887654332222223345677999999988889999999999999999998 8888753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
. ....... ...........+..+.+++.+||..+|.+||++.++++.|+.
T Consensus 210 ~---------------------~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 210 P---------------------EVIRALE-RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred H---------------------HHHHHHh-CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0000000 000001112445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=252.11 Aligned_cols=195 Identities=20% Similarity=0.297 Sum_probs=160.6
Q ss_pred CCCcccceeeEEEEeCCC--ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 2 MSHNHILKLIGCCLETPI--PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~--~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
|+||||+++|.+|.+... ..+|+|++..|+|+.+.++. .++..+..+.|+.||++||.|||+. ..+|+||||
T Consensus 98 L~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDL 171 (632)
T KOG0584|consen 98 LKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDL 171 (632)
T ss_pred CCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCcccccc
Confidence 799999999999987654 67899999999999999987 6788899999999999999999964 668999999
Q ss_pred cCcceeecCC-CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 80 KTSCILFNEE-NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 80 k~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|.+||+|+.+ |.|||+|+|+|.....+. .....|||.|||||+.. ..|++..||||||+.++||+|+..||.+-.
T Consensus 172 KCDNIFinG~~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 172 KCDNIFVNGNLGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred ccceEEEcCCcCceeecchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence 9999999875 799999999998765432 22467999999999998 889999999999999999999999985432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. ...++.++..+........-..+++++||..|+.. .++|||+.|+|.
T Consensus 248 n--------------------~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 248 N--------------------PAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred C--------------------HHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1 12333344443332222223357789999999999 999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=254.23 Aligned_cols=207 Identities=23% Similarity=0.390 Sum_probs=164.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+|.||+-+.|+|...+. .||+.+|+|.+|+.+++... ..+.....+.|+.|+++|+.||| +++|+|+|||..
T Consensus 446 RH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSn 517 (678)
T KOG0193|consen 446 RHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSN 517 (678)
T ss_pred chhhheeeehhhcCCce-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhcccc
Confidence 79999999999987776 99999999999999998764 67889999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCC-CcceeecccccccccCcccccc---CCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEG-ETHITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
||++.+++.|||+|||++...... .........|...|||||++.. .+|++.+||||||+++|||++|..||. ..
T Consensus 518 NIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~ 596 (678)
T KOG0193|consen 518 NIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQ 596 (678)
T ss_pred ceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CC
Confidence 999999999999999997543221 1222345567889999998864 469999999999999999999999986 22
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.-+.... .-+. .....-......+.+.++++|+..||.+++++||++.+|+..|+++...
T Consensus 597 ~~dqIif----------mVGr-------G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 597 NRDQIIF----------MVGR-------GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ChhheEE----------Eecc-------cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111110 0000 0000111122346778999999999999999999999999999988764
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=237.90 Aligned_cols=201 Identities=23% Similarity=0.406 Sum_probs=156.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++++||+++++|.+++.... ..+++..+..++.|++.|+++|| +.+++|+|||
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~ 127 (256)
T cd05112 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127 (256)
T ss_pred hCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccc
Confidence 4789999999999999999999999999999999987543 35788899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............++..|+|||.+.+..++.++|+||||+++|++++ |..||.....
T Consensus 128 p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05112 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207 (256)
T ss_pred cceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999999999886543322111122334678999999988889999999999999999998 8888753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
.+........ .....+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus 208 ---------------------~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 208 ---------------------SEVVETINAG-FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---------------------HHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0011110000 000001123467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=252.87 Aligned_cols=197 Identities=15% Similarity=0.230 Sum_probs=154.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.+++|||||
T Consensus 57 ~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlk 128 (364)
T cd05599 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIK 128 (364)
T ss_pred hCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCC
Confidence 368999999999999999999999999999999999765 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc-------------------------------------eeecccccccccCc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH-------------------------------------ITDTVMGTLGYCAP 123 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~-------------------------------------~~~~~~~~~~y~aP 123 (239)
|+|||++.++.++|+|||++......... ......||+.|+||
T Consensus 129 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 208 (364)
T cd05599 129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAP 208 (364)
T ss_pred HHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCH
Confidence 99999999999999999998654211100 00123589999999
Q ss_pred cccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhc--CCCcHHHHHHH
Q 044155 124 EYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE--DVSSIEKEQQL 201 (239)
Q Consensus 124 E~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 201 (239)
|++....++.++|||||||++|+|++|..||...... +........ ....+.....+
T Consensus 209 E~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~---------------------~~~~~i~~~~~~~~~~~~~~~s 267 (364)
T cd05599 209 EVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ---------------------ETYRKIINWKETLQFPDEVPLS 267 (364)
T ss_pred HHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH---------------------HHHHHHHcCCCccCCCCCCCCC
Confidence 9999888999999999999999999999998643211 000001000 00000001335
Q ss_pred HHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 044155 202 HASAQVTFECIKDSPADRPS---MVDVAK 227 (239)
Q Consensus 202 ~~~~~li~~cl~~dp~~Rps---~~ell~ 227 (239)
+.+.++|.+|+. +|.+|++ ++++++
T Consensus 268 ~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 268 PEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 678899999997 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=236.08 Aligned_cols=201 Identities=21% Similarity=0.262 Sum_probs=157.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...+++|||+.+++|.+++.... ..++...+..++.|++.||.||| +.+++|+||+
T Consensus 56 ~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~ 128 (262)
T cd06613 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIK 128 (262)
T ss_pred hCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCC
Confidence 4799999999999999999999999999999999887642 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC---CcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG---VFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.++|+|||.+....... .......++..|+|||...+. .++.++|+||||+++|+|++|..||...
T Consensus 129 p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 129 GANILLTEDGDVKLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred hhhEEECCCCCEEECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999886543221 112334578889999998776 7889999999999999999999987532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... ......... ..........+..+.+++.+||..+|.+|||+.+++.
T Consensus 208 ~~~~~~-----------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 208 HPMRAL-----------------FLISKSNFP-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CHHHHH-----------------HHHHhccCC-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 211000 000000000 0001112345677899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=240.72 Aligned_cols=202 Identities=19% Similarity=0.237 Sum_probs=155.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|+|
T Consensus 62 ~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~ 133 (267)
T cd06646 62 ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIK 133 (267)
T ss_pred hcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 468999999999999999999999999999999988754 56789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++....... .......+++.|+|||.+. ...++.++|+||||+++|+|++|..||...
T Consensus 134 p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 134 GANILLTDNGDVKLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred HHHEEECCCCCEEECcCccceeecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999999999999999987653221 1123345788999999875 344778999999999999999999887533
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
......... .. ...... ........+..+.+++.+||..+|++|||++++++.|
T Consensus 213 ~~~~~~~~~---------~~--------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 213 HPMRALFLM---------SK--------SNFQPP-KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred chhhhheee---------ec--------CCCCCC-CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 211110000 00 000000 0000113456788999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=242.33 Aligned_cols=212 Identities=22% Similarity=0.333 Sum_probs=158.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCC------CCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++..+...+++||++++++|.+++....... ...+++..+..++.|++.||+||| +.++
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i 151 (296)
T cd05051 75 RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNF 151 (296)
T ss_pred hcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCc
Confidence 4789999999999999999999999999999999997653211 126889999999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc--CC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--GW 151 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~--g~ 151 (239)
+|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|++++ +.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999999865433221 11223345778999999988889999999999999999998 55
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
.||......... ......+.... .......+...+.++.+++.+||+.||.+|||+.++++.|+
T Consensus 232 ~p~~~~~~~~~~-----~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 232 QPYEHLTDQQVI-----ENAGHFFRDDG----------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCcChHHHH-----HHHHhcccccc----------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 666432210000 00000000000 00000001133467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=244.03 Aligned_cols=218 Identities=21% Similarity=0.248 Sum_probs=160.3
Q ss_pred CCCCcccceeeEEEEeCC-----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETP-----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~-----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
++.|||||++.-+|.... ...+||||++ .+|.++++..... ...++...++-+..||..||+||| ..+|+
T Consensus 73 ~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh---~~~Ic 147 (364)
T KOG0658|consen 73 KLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLH---SHGIC 147 (364)
T ss_pred hcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHH---hcCcc
Confidence 478999999988887443 2358999998 8999999853211 167888888899999999999999 89999
Q ss_pred eccccCcceeecCC-CceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCC
Q 044155 76 FRNFKTSCILFNEE-NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 76 H~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
||||||.|+|++.+ |.+||+|||.|+....+.. ......|..|+|||.+.+. .|+.+.||||.||++.||+-|++.
T Consensus 148 HRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~pl 225 (364)
T KOG0658|consen 148 HRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPL 225 (364)
T ss_pred cCCCChheEEEcCCCCeEEeccCCcceeeccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcc
Confidence 99999999999987 8999999999988765543 3466688999999999875 599999999999999999999999
Q ss_pred ccccccccccccc-------chhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 154 SDLVKDVHDLVCP-------FSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 154 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
|.+.......... -.+.....-. ...+.-.+.+.... ........+++..+|+.+++.++|.+|.|+.|+
T Consensus 226 FpG~s~~dQL~eIik~lG~Pt~e~I~~mn~--~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~ 303 (364)
T KOG0658|consen 226 FPGDSSVDQLVEIIKVLGTPTREDIKSMNP--NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA 303 (364)
T ss_pred cCCCCHHHHHHHHHHHhCCCCHHHHhhcCc--ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH
Confidence 9875443222111 1111110000 00000001111111 111233556788999999999999999999998
Q ss_pred HH
Q 044155 226 AK 227 (239)
Q Consensus 226 l~ 227 (239)
+.
T Consensus 304 l~ 305 (364)
T KOG0658|consen 304 LA 305 (364)
T ss_pred hc
Confidence 85
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=236.44 Aligned_cols=199 Identities=24% Similarity=0.343 Sum_probs=161.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.+....+++|||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+||+
T Consensus 55 ~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~ 128 (256)
T cd08221 55 LLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIK 128 (256)
T ss_pred hCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCC
Confidence 47899999999999999999999999999999999976532 46789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||.+........ ......+++.|.|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 129 p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-- 205 (256)
T cd08221 129 TLNIFLTKAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-- 205 (256)
T ss_pred hHhEEEeCCCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--
Confidence 9999999999999999999876533221 2334567899999999988888999999999999999999988874321
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
..+............ .....+..+.+++.+||..+|.+|||+.++++.
T Consensus 206 -------------------~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 206 -------------------PLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -------------------HHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 111111111121111 113456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=241.89 Aligned_cols=215 Identities=20% Similarity=0.246 Sum_probs=153.4
Q ss_pred CCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 2 MSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 2 l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++||||+++++++... ...+++||++. ++|.+++..... ..++...+..++.|++.||.||| +.+++|
T Consensus 59 ~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH 131 (288)
T cd07863 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVH 131 (288)
T ss_pred cCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 5799999999988643 34689999997 689888876432 45889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||||+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 132 ~dikp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 132 RDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred CCCCHHHEEECCCCCEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 9999999999999999999999987553221 12234578899999999888899999999999999999999998854
Q ss_pred ccccccccccchhhhhhhhhccchhhhhh---hhhh-cCCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVD---HIVV-EDVSS--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
............ .... .....+..... .... ..... ......+..+.+++.+||+.||.+|||+.|++.
T Consensus 210 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 210 NSEADQLGKIFD-LIGL-PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCHHHHHHHHHH-HhCC-CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 322111000000 0000 00000000000 0000 00000 011134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=252.65 Aligned_cols=142 Identities=23% Similarity=0.268 Sum_probs=127.5
Q ss_pred cccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcce
Q 044155 5 NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 84 (239)
Q Consensus 5 ~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ni 84 (239)
-|+|+++++|...++.|||+|++. -+|+++++.+.. ..++...++.++.||+.||.+|| +.+|+|+||||+||
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENI 320 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENI 320 (586)
T ss_pred eeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhhe
Confidence 489999999999999999999997 899999998865 77999999999999999999999 99999999999999
Q ss_pred eecCCC--ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 85 LFNEEN--VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 85 l~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+.+.+ .+||+|||.+........ ....+..|+|||++++.+|+.+.||||||||+.||++|.+.|.+-
T Consensus 321 LL~~~~r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 321 LLKDPKRSRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred eeccCCcCceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 997654 689999999876543322 566788999999999999999999999999999999998777643
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=235.60 Aligned_cols=198 Identities=23% Similarity=0.387 Sum_probs=155.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+ .+++|||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 55 ~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~ 127 (254)
T cd05083 55 KLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLA 127 (254)
T ss_pred hCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccC
Confidence 478999999999986654 6899999999999999976532 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 128 p~nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 128 ARNILVSEDGVAKVSDFGLARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred cceEEEcCCCcEEECCCccceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 999999999999999999886543221 12234567999999988889999999999999999997 8888753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.+........ .........+..+.+++.+||+.+|.+|||++++++.|++
T Consensus 204 ---------------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 204 ---------------------KEVKECVEKG-YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---------------------HHHHHHHhCC-CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0000010001 0000112445678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=250.19 Aligned_cols=208 Identities=17% Similarity=0.309 Sum_probs=158.8
Q ss_pred CC-CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC--------------------------------------
Q 044155 2 MS-HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-------------------------------------- 42 (239)
Q Consensus 2 l~-H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-------------------------------------- 42 (239)
+. ||||+++++++...+..++||||+++|+|.++++.....
T Consensus 97 l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (401)
T cd05107 97 LGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDG 176 (401)
T ss_pred cCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCc
Confidence 55 999999999999999999999999999999999754210
Q ss_pred -------------------------------------------------------CCCcCCHHHHHHHHHHHHHHHhHHh
Q 044155 43 -------------------------------------------------------HFEPLLLKHRLKIAMDIVHALAYLH 67 (239)
Q Consensus 43 -------------------------------------------------------~~~~~~~~~~~~~~~~i~~~l~~LH 67 (239)
....+++.....++.|++.||.|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 256 (401)
T cd05107 177 GYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA 256 (401)
T ss_pred cccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 0023566678889999999999999
Q ss_pred hCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHH
Q 044155 68 FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFE 146 (239)
Q Consensus 68 ~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 146 (239)
+.+++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+....++.++|+||||+++||
T Consensus 257 ---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e 333 (401)
T cd05107 257 ---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333 (401)
T ss_pred ---cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHH
Confidence 89999999999999999999999999999875422111 11123346788999999988889999999999999999
Q ss_pred Hhc-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 147 LLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 147 ~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
|++ |..||....... .....+........+...+..+.+++.+||..+|.+|||+++|
T Consensus 334 ~l~~g~~P~~~~~~~~---------------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 334 IFTLGGTPYPELPMNE---------------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred HHHcCCCCCCCCCchH---------------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 998 777774322100 0000000000001111345678999999999999999999999
Q ss_pred HHHHHHHH
Q 044155 226 AKKLRQIY 233 (239)
Q Consensus 226 l~~L~~l~ 233 (239)
++.|++++
T Consensus 393 l~~L~~~~ 400 (401)
T cd05107 393 VHLVGDLL 400 (401)
T ss_pred HHHHHHHh
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=237.14 Aligned_cols=206 Identities=25% Similarity=0.417 Sum_probs=158.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC--CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP--HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++......++||||+++++|.+++...... ....+++..+..++.|++.||.||| +.+++|+|
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~d 131 (269)
T cd05044 55 NFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRD 131 (269)
T ss_pred hcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence 478999999999999888999999999999999999754221 1134678899999999999999999 89999999
Q ss_pred ccCcceeecCCC-----ceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CC
Q 044155 79 FKTSCILFNEEN-----VAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GW 151 (239)
Q Consensus 79 lk~~nil~~~~~-----~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~ 151 (239)
|||+||+++.++ .++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 132 l~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~ 211 (269)
T cd05044 132 LAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ 211 (269)
T ss_pred CChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCC
Confidence 999999999887 899999999865432211 11223345678999999998889999999999999999998 88
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||...... +......... ........+..+.+++.+||..+|.+|||++++++.|++
T Consensus 212 ~p~~~~~~~---------------------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 212 QPYPALNNQ---------------------EVLQHVTAGG-RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCCcccCHH---------------------HHHHHHhcCC-ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 887532210 0000000000 001112445778999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=249.94 Aligned_cols=148 Identities=19% Similarity=0.307 Sum_probs=129.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.+....++||||+++|+|.+++... ..++...++.++.|++.||.||| +++|+|||||
T Consensus 57 ~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlK 128 (363)
T cd05628 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIK 128 (363)
T ss_pred hCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCC
Confidence 368999999999999999999999999999999999765 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc----------------------------------ceeecccccccccCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET----------------------------------HITDTVMGTLGYCAPEYM 126 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~~ 126 (239)
|+|||++.++.++|+|||++........ .......||+.|+|||++
T Consensus 129 p~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 208 (363)
T cd05628 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF 208 (363)
T ss_pred HHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH
Confidence 9999999999999999999865321100 001234689999999999
Q ss_pred ccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 127 RTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 127 ~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
.+..++.++|+|||||++|+|++|..||..
T Consensus 209 ~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 209 MQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred cCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 988899999999999999999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=241.69 Aligned_cols=213 Identities=20% Similarity=0.313 Sum_probs=157.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-------CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
+++||||+++++++......++||||+++++|.+++...... ....+++..++.++.|++.||+||| +.+
T Consensus 73 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ 149 (295)
T cd05097 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLN 149 (295)
T ss_pred hCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcC
Confidence 478999999999999999999999999999999998653210 0124678889999999999999999 999
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc--C
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--G 150 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~--g 150 (239)
++|+||||+||+++.++.+||+|||++........ .......++..|+|||.+....++.++|+||||+++++|++ +
T Consensus 150 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~ 229 (295)
T cd05097 150 FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229 (295)
T ss_pred eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999865433221 11223345678999999988889999999999999999998 4
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
..||......... ... .+........... ......+..+.+++.+||..||++|||++++++.|+
T Consensus 230 ~~p~~~~~~~~~~--------~~~------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 230 EQPYSLLSDEQVI--------ENT------GEFFRNQGRQIYL-SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCcccChHHHH--------HHH------HHhhhhccccccC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 4565432211000 000 0000000000000 001123467999999999999999999999999886
Q ss_pred H
Q 044155 231 Q 231 (239)
Q Consensus 231 ~ 231 (239)
+
T Consensus 295 ~ 295 (295)
T cd05097 295 E 295 (295)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=243.19 Aligned_cols=216 Identities=18% Similarity=0.228 Sum_probs=155.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..++..++||||++ ++|.+++.... ..++...+..++.|++.||+||| +.+++|||||
T Consensus 60 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlk 131 (309)
T cd07872 60 DLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLK 131 (309)
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 4789999999999999999999999997 68888886542 45788889999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.....
T Consensus 132 p~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 132 PQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred HHHEEECCCCCEEECccccceecCCCc-cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999986543221 11223456889999998865 4588999999999999999999999865432
Q ss_pred cccccccchhhhhhhhhccchhhhhh-----hhhhcCCC--c--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVD-----HIVVEDVS--S--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~--~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... ....+ ....+..... ........ . ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 211 ~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 211 EDELHLIFR-LLGTP-TEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHHHHHH-HhCCC-CHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 111100000 00000 0000000000 00000000 0 011134567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=240.00 Aligned_cols=208 Identities=18% Similarity=0.337 Sum_probs=158.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++......++||||+++|+|.+++...... .....+...+..++.|++.||.||| +++++
T Consensus 65 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~ 141 (288)
T cd05061 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFV 141 (288)
T ss_pred hCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCc
Confidence 468999999999999888999999999999999999753211 1134567788899999999999999 99999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDV 153 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p 153 (239)
|+||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus 142 H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p 221 (288)
T cd05061 142 HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221 (288)
T ss_pred CCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998654322211 1122334677999999988889999999999999999998 6667
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
|..... .+............ .+...+..+.+++.+||+.||.+|||+.++++.|++..
T Consensus 222 ~~~~~~---------------------~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 222 YQGLSN---------------------EQVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCH---------------------HHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 643221 01111111111000 01133467999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=241.94 Aligned_cols=205 Identities=22% Similarity=0.349 Sum_probs=158.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++... ..++++||+++|+|.+++.... ..++...+..++.|++.||.||| +++++|+|||
T Consensus 65 ~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dik 136 (303)
T cd05110 65 SMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLA 136 (303)
T ss_pred hCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccc
Confidence 47899999999998754 4678999999999999987643 45788899999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||....
T Consensus 137 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 137 ARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998765332211 1122335678999999988889999999999999999997 878875321
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.. ...+... ...........+..+.+++..||..+|.+|||++++++.|.++...
T Consensus 217 ~~------------------~~~~~~~----~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 217 TR------------------EIPDLLE----KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HH------------------HHHHHHH----CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 0001110 0000000112345678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=235.27 Aligned_cols=192 Identities=23% Similarity=0.379 Sum_probs=151.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.. ...++||||+++++|.+++.... ..++...+..++.|++.||+||| +++++|+|||
T Consensus 57 ~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlk 128 (259)
T cd05037 57 QLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVC 128 (259)
T ss_pred cCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCc
Confidence 4789999999999988 77899999999999999998653 36889999999999999999999 9999999999
Q ss_pred CcceeecCCC-------ceeEcccccccccCCCCcceeecccccccccCccccccC--CcccccchhhhhhHHHHHhcC-
Q 044155 81 TSCILFNEEN-------VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG--VFNEKSNVFSFSVFLFELLTG- 150 (239)
Q Consensus 81 ~~nil~~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~g- 150 (239)
|+||+++.++ .++|+|||++..... .....++..|+|||++.+. .++.++|+||||+++|++++|
T Consensus 129 p~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 129 GKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred cceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence 9999999887 799999999876533 1233466789999999876 688999999999999999995
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
..|+...... .. ..... .....+ ......+.+++.+||..+|.+|||+.++++.|
T Consensus 204 ~~p~~~~~~~-~~--------~~~~~------------~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 204 EEPLSTLSSS-EK--------ERFYQ------------DQHRLP---MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCcccCCch-hH--------HHHHh------------cCCCCC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 5555432210 00 00000 000000 01116788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=249.68 Aligned_cols=197 Identities=17% Similarity=0.252 Sum_probs=152.8
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++.+.++...++||||+++|+|.+++.. ..++...+..++.|++.||.||| +++|+||||||
T Consensus 100 ~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp 170 (371)
T cd05622 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKP 170 (371)
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCH
Confidence 6899999999999999999999999999999999865 34788889999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC----cccccchhhhhhHHHHHhcCCCCcccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV----FNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
+||+++.++.+||+|||++...............||+.|+|||++.... ++.++||||||+++|+|++|..||...
T Consensus 171 ~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred HHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 9999999999999999998765433222233556899999999987543 788999999999999999999998632
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhc--CCCcHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE--DVSSIEKEQQLHASAQVTFECIKDSPAD--RPSMVDVAKK 228 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~~ 228 (239)
.. ......+... ....+.....+..++++|..|+..++.+ |++++++++.
T Consensus 251 ~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 251 SL---------------------VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CH---------------------HHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 21 0111111110 0011111245667889999999844433 7789888873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=237.19 Aligned_cols=200 Identities=19% Similarity=0.245 Sum_probs=154.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||+++++|.+++... ..++...+..++.|++.|+.||| +.+++|+|||
T Consensus 62 ~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk 133 (267)
T cd06645 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIK 133 (267)
T ss_pred hCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 368999999999999999999999999999999998765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++....... .......|+..|+|||++. ...++.++|+||||+++|+|++|..||...
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~ 212 (267)
T cd06645 134 GANILLTDNGHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred HHHEEECCCCCEEECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccc
Confidence 999999999999999999986543221 1223456889999999874 345788999999999999999999887533
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
....... .. .... .... ........+..+.+++.+||..+|++|||++++++
T Consensus 213 ~~~~~~~-------~~--~~~~--------~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 213 HPMRALF-------LM--TKSN--------FQPP-KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cchhhHH-------hh--hccC--------CCCC-cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 2111000 00 0000 0000 00000123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=238.35 Aligned_cols=217 Identities=24% Similarity=0.368 Sum_probs=161.7
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.. +...+++|||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+|
T Consensus 62 ~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~d 134 (284)
T cd05038 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRD 134 (284)
T ss_pred hCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 4789999999999887 557899999999999999997653 35889999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++++|++|..|+..
T Consensus 135 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 135 LAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred CCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 9999999999999999999998766432211 11123345679999999888899999999999999999999988653
Q ss_pred ccccc-cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 157 VKDVH-DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 157 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
..... ....+ ........... ..+........+...+..+.+++.+||+.+|.+|||+.|+++.|+++
T Consensus 215 ~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 215 PPAEFLRMIGI-------AQGQMIVTRLL-ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccchhcccccc-------ccccccHHHHH-HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22111 00000 00000011111 11111111111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=237.65 Aligned_cols=203 Identities=20% Similarity=0.326 Sum_probs=159.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++..++..+++|||+++++|.+++...... ...++...+..++.|++.||.|||. ..+++|+||+|
T Consensus 66 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~ 142 (269)
T cd08528 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTP 142 (269)
T ss_pred CCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCH
Confidence 68999999999999999999999999999999987542111 1468889999999999999999993 36899999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++|+|||.+....... ......++..|+|||...+..++.++|+||||+++|++++|..||.....
T Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-- 218 (269)
T cd08528 143 NNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-- 218 (269)
T ss_pred HHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--
Confidence 99999999999999999987653322 23345678899999999988899999999999999999999988753211
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
.............+......+..+.+++.+||+.||.+|||+.|+.+++.
T Consensus 219 -------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 219 -------------------LSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -------------------HHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01111111111111111134567889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=243.39 Aligned_cols=207 Identities=22% Similarity=0.355 Sum_probs=160.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----------CCCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++...+..++++||+++++|.+++..... .....++...+..++.|++.||.||| +
T Consensus 76 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~ 152 (334)
T cd05100 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---S 152 (334)
T ss_pred CCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---H
Confidence 799999999999998899999999999999999976421 01135778889999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
++++|+||||+||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 153 ~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 153 QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999998755332211 1122234567999999998889999999999999999998
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||.... ..+.......... ...+...+..+.+++.+||+.+|.+|||+.|+++.|
T Consensus 233 g~~p~~~~~---------------------~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 233 GGSPYPGIP---------------------VEELFKLLKEGHR-MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CCCCCCCCC---------------------HHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 767764321 0111111111110 001113456788999999999999999999999999
Q ss_pred HHHHH
Q 044155 230 RQIYR 234 (239)
Q Consensus 230 ~~l~~ 234 (239)
+++..
T Consensus 291 ~~~~~ 295 (334)
T cd05100 291 DRVLT 295 (334)
T ss_pred HHHhh
Confidence 98874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=260.20 Aligned_cols=203 Identities=21% Similarity=0.256 Sum_probs=160.5
Q ss_pred CCcccceeeEE-EEe------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 3 SHNHILKLIGC-CLE------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 3 ~H~niv~l~~~-~~~------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
.|+|||.+++. ... ...+.+.||||.+|+|-|++..... ..|++.++++|++|+++|+++||.. ..+|+
T Consensus 93 gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiI 168 (738)
T KOG1989|consen 93 GHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPII 168 (738)
T ss_pred CCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccc
Confidence 49999999993 221 1246789999999999999986544 5699999999999999999999943 44699
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCc--------ceeecccccccccCccccc---cCCcccccchhhhhhHH
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGET--------HITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFL 144 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l 144 (239)
|||||.+|||++.++..||||||.+..-..... ...-...-|+.|+|||++. +.+.++|+|||+|||+|
T Consensus 169 HRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclL 248 (738)
T KOG1989|consen 169 HRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLL 248 (738)
T ss_pred hhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHH
Confidence 999999999999999999999998753221110 0111233578899999874 56789999999999999
Q ss_pred HHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 145 FELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 145 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
|-++....||+..... +++...+.-+.....+..+++||..||+.||.+||++-+
T Consensus 249 YkLCy~t~PFe~sg~l-------------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 249 YKLCYFTTPFEESGKL-------------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred HHHHHhCCCcCcCcce-------------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 9999999998753211 233334443333578889999999999999999999999
Q ss_pred HHHHHHHHHH
Q 044155 225 VAKKLRQIYR 234 (239)
Q Consensus 225 ll~~L~~l~~ 234 (239)
|++.+.++..
T Consensus 304 v~~~~~~l~~ 313 (738)
T KOG1989|consen 304 VLEEIFELAN 313 (738)
T ss_pred HHHHHHHHhc
Confidence 9999988754
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=247.60 Aligned_cols=144 Identities=22% Similarity=0.353 Sum_probs=125.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++|+|++. ++|.+++.... ..+++..+..++.|++.||.||| +++|+|||||
T Consensus 113 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlk 184 (357)
T PHA03209 113 NVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVK 184 (357)
T ss_pred hCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 4799999999999999999999999996 79988887543 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||+++.++.++|+|||+++...... ......|++.|+|||++.+..++.++||||||+++|+|+++..++
T Consensus 185 p~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 185 TENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred HHHEEECCCCCEEEecCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999999999999999986432211 122445889999999999889999999999999999999866544
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=239.57 Aligned_cols=213 Identities=18% Similarity=0.290 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCC------CCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++|+||+++++++......+++|||+++++|.+++....... ...++...+..++.|++.||+||| +.++
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i 151 (296)
T cd05095 75 RLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNF 151 (296)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 4789999999999999999999999999999999987643211 124677889999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc--CC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--GW 151 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~--g~ 151 (239)
+|+||||+||+++.++.++|+|||++........ .......+++.|+|||...+..++.++|+||||+++|||++ |.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~ 231 (296)
T cd05095 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231 (296)
T ss_pred ecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999875433221 11222334678999999888889999999999999999998 55
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||......... ... ............. ..+...+..+.+++.+||+.||.+|||+.++.+.|++
T Consensus 232 ~p~~~~~~~~~~--------~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 232 QPYSQLSDEQVI--------ENT------GEFFRDQGRQVYL-PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCccccChHHHH--------HHH------HHHHhhccccccC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 676533211100 000 0000000000000 0011344678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=245.02 Aligned_cols=188 Identities=21% Similarity=0.320 Sum_probs=151.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+|++|+++++++.+.+..++||||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+++||||||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~ 130 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLD 130 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHH
Confidence 6899999999999999999999999999999988765 56888999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
|||++.++.+||+|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 131 Nill~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--- 206 (323)
T cd05616 131 NVMLDSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--- 206 (323)
T ss_pred HeEECCCCcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---
Confidence 9999999999999999986432111 122345689999999999988999999999999999999999999854221
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
......+...... .+...+..+.+++.+||+.||.+|++.
T Consensus 207 ------------------~~~~~~i~~~~~~--~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 207 ------------------DELFQSIMEHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ------------------HHHHHHHHhCCCC--CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111111111111 112345678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=250.35 Aligned_cols=200 Identities=16% Similarity=0.203 Sum_probs=152.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++|+|.+++.+. ..+++..++.++.|++.||.||| ..+|+|||||
T Consensus 57 ~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlK 128 (381)
T cd05626 57 EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIK 128 (381)
T ss_pred hcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCc
Confidence 468999999999999999999999999999999999765 56888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC----------------------------------------------cceeecc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE----------------------------------------------THITDTV 114 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~----------------------------------------------~~~~~~~ 114 (239)
|+||+++.++.++|+|||++....... .......
T Consensus 129 p~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (381)
T cd05626 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSL 208 (381)
T ss_pred HHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccc
Confidence 999999999999999999875321000 0001234
Q ss_pred cccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCc
Q 044155 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSS 194 (239)
Q Consensus 115 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (239)
.||+.|+|||++.+..++.++|||||||++|||++|..||......... ...... ......
T Consensus 209 ~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----------------~~i~~~--~~~~~~ 269 (381)
T cd05626 209 VGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ-----------------LKVINW--ENTLHI 269 (381)
T ss_pred cCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHH-----------------HHHHcc--ccccCC
Confidence 6899999999999888999999999999999999999998542210000 000000 000000
Q ss_pred HHHHHHHHHHHHHHhhh--cCCCCCCCCCHHHHHH
Q 044155 195 IEKEQQLHASAQVTFEC--IKDSPADRPSMVDVAK 227 (239)
Q Consensus 195 ~~~~~~~~~~~~li~~c--l~~dp~~Rps~~ell~ 227 (239)
+.....++++.++|.+| +..+|..||++++++.
T Consensus 270 ~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 270 PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 01113456778899884 4556666999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=251.27 Aligned_cols=197 Identities=17% Similarity=0.239 Sum_probs=151.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++|+|.+++... ..++...++.++.|++.||.||| +.+++|||||
T Consensus 57 ~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlk 128 (377)
T cd05629 57 ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIK 128 (377)
T ss_pred hCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCC
Confidence 468999999999999999999999999999999999765 56888999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc------------c----------------------------------eeecc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET------------H----------------------------------ITDTV 114 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~------------~----------------------------------~~~~~ 114 (239)
|+||+++.++.++|+|||++........ . .....
T Consensus 129 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (377)
T cd05629 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYST 208 (377)
T ss_pred HHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc
Confidence 9999999999999999999853211000 0 00124
Q ss_pred cccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhh--cCC
Q 044155 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV--EDV 192 (239)
Q Consensus 115 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 192 (239)
.||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+.. ...
T Consensus 209 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------------------~~~~i~~~~~~~ 267 (377)
T cd05629 209 VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE---------------------TYRKIINWRETL 267 (377)
T ss_pred CCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH---------------------HHHHHHccCCcc
Confidence 58999999999998889999999999999999999999985322100 0000000 000
Q ss_pred CcHHHHHHHHHHHHHHhhhcCCCCCCC---CCHHHHHH
Q 044155 193 SSIEKEQQLHASAQVTFECIKDSPADR---PSMVDVAK 227 (239)
Q Consensus 193 ~~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~ell~ 227 (239)
..+.....+..+.+++.+|+. +|.+| +|+.|+++
T Consensus 268 ~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 268 YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 000001234678899999998 66665 59999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=242.93 Aligned_cols=221 Identities=19% Similarity=0.244 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......+++|||+++++|.+++..... ..++......++.|++.||+||| +.+++|+|||
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk 128 (314)
T cd08216 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVK 128 (314)
T ss_pred hcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 47899999999999999999999999999999999986533 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc------ceeecccccccccCcccccc--CCcccccchhhhhhHHHHHhcCCC
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRT--GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|+||+++.++.++++|||.+........ .......++..|+|||++.. ..++.++|+||||+++|+|++|..
T Consensus 129 ~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 129 ASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred cceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999998765432111 11223346778999999875 357889999999999999999999
Q ss_pred Ccccccccccccccchhhhhhhhhccchhhh-----------hhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEI-----------VDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
||............................. .................+..+.+++.+||..||++|||
T Consensus 209 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 288 (314)
T cd08216 209 PFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288 (314)
T ss_pred CCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC
Confidence 9875432211100000000000000000000 00000011111222355678899999999999999999
Q ss_pred HHHHHH
Q 044155 222 MVDVAK 227 (239)
Q Consensus 222 ~~ell~ 227 (239)
++++++
T Consensus 289 ~~~ll~ 294 (314)
T cd08216 289 ASQLLN 294 (314)
T ss_pred HHHHhc
Confidence 999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=240.15 Aligned_cols=197 Identities=17% Similarity=0.260 Sum_probs=155.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++|+||+++++|.+++.. ..+++..+..++.|++.|+.||| +.+++|+|||
T Consensus 72 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~ 142 (296)
T cd06655 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIK 142 (296)
T ss_pred hcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 47899999999999999999999999999999998864 45789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|++++|..||......
T Consensus 143 p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~ 221 (296)
T cd06655 143 SDNVLLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (296)
T ss_pred HHHEEECCCCCEEEccCccchhccccc-ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999876543221 1122345788999999998888999999999999999999999988542211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... . . ... ........+...+..+.++|.+||..||.+|||+.+++.
T Consensus 222 ~~~--------~---------~-~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 222 RAL--------Y---------L-IAT--NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHH--------H---------H-HHh--cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 0 0 000 000000011234567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=234.22 Aligned_cols=199 Identities=23% Similarity=0.328 Sum_probs=158.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++++|++.+++|.+++.... ..+++..+..++.|++.|+.||| +.+++|+||+
T Consensus 54 ~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~ 126 (256)
T cd06612 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIK 126 (256)
T ss_pred hCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 3689999999999999999999999999999999987543 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......++..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 127 ~~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 127 AGNILLNEEGQAKLADFGVSGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred cceEEECCCCcEEEcccccchhcccCc-cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 999999999999999999987653322 1223445788999999998888999999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ........ ........+..+.+++.+||+.||++|||+.|+++
T Consensus 206 ~~~~------------------~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 206 RAIF------------------MIPNKPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhh------------------hhccCCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1000 00000000 00111234567899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=249.67 Aligned_cols=213 Identities=22% Similarity=0.262 Sum_probs=155.1
Q ss_pred CCCCcccceeeEEEEeCC-----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETP-----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~-----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++.... ..++|+||+. ++|.+.+... ..++...+..++.|++.||.||| +.+++
T Consensus 55 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~iv 125 (372)
T cd07853 55 FFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLH---SAGIL 125 (372)
T ss_pred hCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 378999999999998766 6789999997 7888888654 56889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||||+||+++.++.+||+|||++...............+++.|+|||.+.+. .++.++|||||||++|+|++|+.||
T Consensus 126 H~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 205 (372)
T cd07853 126 HRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF 205 (372)
T ss_pred CCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC
Confidence 999999999999999999999999876433222222334578899999998874 4789999999999999999999999
Q ss_pred ccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcH-------HHHHHHHHHHHHHhhhcCCCCCCCC
Q 044155 155 DLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSI-------EKEQQLHASAQVTFECIKDSPADRP 220 (239)
Q Consensus 155 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~dp~~Rp 220 (239)
........... +..+...... ............... .....++.+.++|.+||+.||.+||
T Consensus 206 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 280 (372)
T cd07853 206 QAQSPIQQLDLITDLLGTPSLEAMRSAC-----EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280 (372)
T ss_pred CCCCHHHHHHHHHHHcCCCCHHHHHHhh-----HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc
Confidence 65432211100 0000000000 000000001110000 0012356788999999999999999
Q ss_pred CHHHHHH
Q 044155 221 SMVDVAK 227 (239)
Q Consensus 221 s~~ell~ 227 (239)
|+.|+++
T Consensus 281 t~~e~l~ 287 (372)
T cd07853 281 SAADALA 287 (372)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=255.52 Aligned_cols=223 Identities=18% Similarity=0.285 Sum_probs=153.0
Q ss_pred CCCCcccceeeEEEEeC--------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC
Q 044155 1 QMSHNHILKLIGCCLET--------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR 72 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 72 (239)
+++||||+++++++... ...++||||++ ++|.+++..... ....++...+..++.|++.||+||| +.
T Consensus 115 ~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH---~~ 189 (440)
T PTZ00036 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIH---SK 189 (440)
T ss_pred hcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 47899999999987542 13568999997 688777754211 1156889999999999999999999 89
Q ss_pred CeeeccccCcceeecCCC-ceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcC
Q 044155 73 PIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTG 150 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g 150 (239)
+|+||||||+||+++.++ .+||+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 190 ~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG 267 (440)
T PTZ00036 190 FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267 (440)
T ss_pred CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999998665 699999999976543221 2234678999999998764 689999999999999999999
Q ss_pred CCCcccccccccccc-------cchhhhhhhhhccchhhh-hhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 151 WDVSDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEI-VDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
..||........... +..+..... ...+.+. .............+...+.++.+|+.+||..||.+|||+
T Consensus 268 ~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta 345 (440)
T PTZ00036 268 YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM--NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345 (440)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHh--chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH
Confidence 999865432211100 000000000 0000000 000000000000112345678999999999999999999
Q ss_pred HHHHH--HHHHH
Q 044155 223 VDVAK--KLRQI 232 (239)
Q Consensus 223 ~ell~--~L~~l 232 (239)
.|+++ ++..+
T Consensus 346 ~e~l~hp~f~~~ 357 (440)
T PTZ00036 346 IEALADPFFDDL 357 (440)
T ss_pred HHHhCChhHHhh
Confidence 99985 44443
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=240.32 Aligned_cols=220 Identities=16% Similarity=0.179 Sum_probs=155.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||++ ++|.+++...... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~ 128 (285)
T cd07861 55 ELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLK 128 (285)
T ss_pred hcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCC--CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCC
Confidence 4689999999999999999999999997 7898888654321 46889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.....
T Consensus 129 p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 129 PQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred HHHEEEcCCCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999999986543221 112233567889999988654 478899999999999999999999864332
Q ss_pred cccccccchhh---hhhhhhccchhhhhhhhhhcCCC---cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEY---LKNCFEDNRFTEIVDHIVVEDVS---SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......+... ....+.................. .......++++.++|.+||..||.+|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 208 IDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 11110000000 00000000000000000000000 0001134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=239.22 Aligned_cols=206 Identities=24% Similarity=0.369 Sum_probs=157.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----------------CCCCcCCHHHHHHHHHHHHHHH
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----------------PHFEPLLLKHRLKIAMDIVHAL 63 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-----------------~~~~~~~~~~~~~~~~~i~~~l 63 (239)
+++||||+++++++.++...++++||+++++|.+++..... .....++...+..++.|++.||
T Consensus 64 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL 143 (288)
T cd05050 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGM 143 (288)
T ss_pred hcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 46899999999999999999999999999999999975321 0113467888999999999999
Q ss_pred hHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhh
Q 044155 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSV 142 (239)
Q Consensus 64 ~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 142 (239)
.||| +.+++|+||||+||+++.++.++|+|||.+........ ........+..|+|||.+.+..++.++|+||||+
T Consensus 144 ~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (288)
T cd05050 144 AYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGV 220 (288)
T ss_pred HHHH---hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHH
Confidence 9999 89999999999999999999999999998765422211 1112223467799999998888999999999999
Q ss_pred HHHHHhc-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 143 FLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 143 ~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
++|+|++ |..||..... .+........... ..+...+..+.+++.+||..||.+|||
T Consensus 221 il~el~~~~~~p~~~~~~---------------------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt 278 (288)
T cd05050 221 VLWEIFSYGMQPYYGMAH---------------------EEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPS 278 (288)
T ss_pred HHHHHHhCCCCCCCCCCH---------------------HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 9999997 7667643211 0111111111111 011234567899999999999999999
Q ss_pred HHHHHHHHHH
Q 044155 222 MVDVAKKLRQ 231 (239)
Q Consensus 222 ~~ell~~L~~ 231 (239)
+.|+++.|++
T Consensus 279 ~~el~~~l~~ 288 (288)
T cd05050 279 FASINRILQR 288 (288)
T ss_pred HHHHHHHhhC
Confidence 9999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=245.95 Aligned_cols=189 Identities=18% Similarity=0.248 Sum_probs=153.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
..|+||+||-.|.+...+|+||||++||++..+|... ..+++.+++.++.+++.|+..+| ..|++||||||+
T Consensus 199 ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPd 270 (550)
T KOG0605|consen 199 DSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPD 270 (550)
T ss_pred CCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChh
Confidence 5789999999999999999999999999999999876 67999999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCC----------------------CCcc------------------------eeecccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPE----------------------GETH------------------------ITDTVMG 116 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~----------------------~~~~------------------------~~~~~~~ 116 (239)
|+||+..|.+||+|||++..+.. .... .....+|
T Consensus 271 NlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVG 350 (550)
T KOG0605|consen 271 NLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVG 350 (550)
T ss_pred heeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccC
Confidence 99999999999999999753211 0000 0113579
Q ss_pred cccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcC--CCc
Q 044155 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSS 194 (239)
Q Consensus 117 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 194 (239)
||.|+|||++.+..++..+|.||||||+|||+.|.+||..- ...+....++... ...
T Consensus 351 TPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~---------------------tp~~T~rkI~nwr~~l~f 409 (550)
T KOG0605|consen 351 TPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSE---------------------TPQETYRKIVNWRETLKF 409 (550)
T ss_pred CccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCC---------------------CHHHHHHHHHHHhhhccC
Confidence 99999999999999999999999999999999999998532 2222222222211 111
Q ss_pred HHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 195 IEKEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 195 ~~~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
+.....+.+.++||.+|+. ||.+|.-
T Consensus 410 P~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 410 PEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred CCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 2222445788999999999 9999985
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=270.97 Aligned_cols=218 Identities=28% Similarity=0.430 Sum_probs=164.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|+|.+....++||||+++|+|.++++ .+++..+.+++.|++.|++|||..+..+++|||+|
T Consensus 739 ~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk 810 (968)
T PLN00113 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810 (968)
T ss_pred hCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCC
Confidence 4789999999999999999999999999999999994 37788999999999999999996556799999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+++. ++....... .....+++.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 811 p~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~ 884 (968)
T PLN00113 811 PEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884 (968)
T ss_pred HHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC
Confidence 999999998887765 554322211 11235788999999999889999999999999999999999998533221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~~ 237 (239)
. ....++.+............+..+..... .......++.+++.+||+.||++|||++|+++.|+++....+
T Consensus 885 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 885 H---GSIVEWARYCYSDCHLDMWIDPSIRGDVS--VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred C---CcHHHHHHHhcCccchhheeCccccCCCC--ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 1 11122222222222222222222222111 112445678899999999999999999999999999877543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=256.56 Aligned_cols=200 Identities=21% Similarity=0.264 Sum_probs=156.7
Q ss_pred CCCcccceeeEEEEeCC--------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 2 MSHNHILKLIGCCLETP--------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~--------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
++|+||+++++.+.... ..++||||+++|+|.++++..... ...++...+..++.|++.||.||| +.+
T Consensus 88 ~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH---~~~ 163 (496)
T PTZ00283 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVH---SKH 163 (496)
T ss_pred CCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 68999999988775432 257999999999999998754321 156889999999999999999999 899
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCC
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
++||||||+||+++.++.+||+|||+++...... ........|++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 164 IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~ 243 (496)
T PTZ00283 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243 (496)
T ss_pred EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999987653221 112335568999999999998889999999999999999999999
Q ss_pred CcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
||.... ..+........... ..+...++.+.+++.+||+.||.+|||+.+++.
T Consensus 244 Pf~~~~---------------------~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 244 PFDGEN---------------------MEEVMHKTLAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCCCC---------------------HHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 985321 11112222221111 112245677899999999999999999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=273.93 Aligned_cols=197 Identities=18% Similarity=0.255 Sum_probs=161.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
|+|||+|++||+=.+....+|.||||++|+|.+.+..+ ...++.....+-.|++.|++||| ++||||||+||
T Consensus 1291 lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~ 1362 (1509)
T KOG4645|consen 1291 LNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKP 1362 (1509)
T ss_pred ccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCc
Confidence 79999999999999999999999999999999999876 45677777888999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcc---eeecccccccccCccccccCC---cccccchhhhhhHHHHHhcCCCCcc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRTGV---FNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
.||+++.+|.+|++|||.+.....+... -.....||+.|||||++.+.. ...++|||||||++.||+||+.||.
T Consensus 1363 aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1363 ANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred cceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence 9999999999999999999877554311 134668999999999997644 5678999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+...... +. ++-.++.. ..+...+.+-.+|+..||..||+.|.++.|+++
T Consensus 1443 ~~dne~aI-----------------My---~V~~gh~P-q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1443 ELDNEWAI-----------------MY---HVAAGHKP-QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hccchhHH-----------------Hh---HHhccCCC-CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 55421111 11 12222222 223347788899999999999999999988876
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=237.95 Aligned_cols=195 Identities=21% Similarity=0.322 Sum_probs=156.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..++..++|+||+++++|.+++.. ..+++..+..++.|++.|+.||| +.+++|+||+
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~ 128 (277)
T cd06642 58 QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIK 128 (277)
T ss_pred cCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCC
Confidence 47899999999999999999999999999999998864 45788899999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++++|||++....... .......++..|+|||++.+..++.++|+||||+++|++++|..|+......
T Consensus 129 p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06642 129 AANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM 207 (277)
T ss_pred hheEEEeCCCCEEEccccccccccCcc-hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh
Confidence 999999999999999999986553321 1122345788899999999888999999999999999999999987533211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... . . .............+..+.+++.+||..+|.+|||+.+++.
T Consensus 208 ~~~--------~----------~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 208 RVL--------F----------L----IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred hHH--------h----------h----hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 0 0 0000000111234567889999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=256.99 Aligned_cols=221 Identities=14% Similarity=0.202 Sum_probs=154.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++|++++. ++|.+++................+.++.|++.||.||| +++|+|||||
T Consensus 219 ~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLK 294 (501)
T PHA03210 219 RLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIK 294 (501)
T ss_pred hCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 4799999999999999999999999996 78888776543211123345677889999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC-cccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV-SDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p-~~~~~~ 159 (239)
|+|||++.++.+||+|||++...............|+..|+|||++.+..++.++|||||||++|||++|..+ +.....
T Consensus 295 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred HHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 9999999999999999999976644332223345689999999999988999999999999999999998754 332211
Q ss_pred cccccccchhhhh------hhhhc--cchhhhhhhhhhcCC-C---cH-HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 160 VHDLVCPFSEYLK------NCFED--NRFTEIVDHIVVEDV-S---SI-EKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 160 ~~~~~~~~~~~~~------~~~~~--~~~~~~~~~~~~~~~-~---~~-~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
... ....+... ..+.. ....+.+........ . .. .....+..+.+++.+||..||.+|||+.|++
T Consensus 375 ~~~--~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 375 KPG--KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred CHH--HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 000 00000000 00000 000000100000000 0 00 0112345678899999999999999999998
Q ss_pred H
Q 044155 227 K 227 (239)
Q Consensus 227 ~ 227 (239)
.
T Consensus 453 ~ 453 (501)
T PHA03210 453 A 453 (501)
T ss_pred h
Confidence 6
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=236.30 Aligned_cols=197 Identities=19% Similarity=0.291 Sum_probs=157.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++++||+++++|.+++... ..++...+..++.|++.||+||| +.+++|+||+
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~ 133 (267)
T cd06628 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIK 133 (267)
T ss_pred hcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCC
Confidence 478999999999999999999999999999999999765 56788899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-----ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-----HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+||+++.++.++|+|||.++....... .......++..|+|||.+.+..++.++|+||||+++|++++|..||.
T Consensus 134 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 213 (267)
T cd06628 134 GANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213 (267)
T ss_pred HHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 9999999999999999998876542111 11123457889999999988888999999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... .+..... ...+..+...+..+.+++.+||+.||.+||++.++++
T Consensus 214 ~~~~~~---------------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 214 DCTQLQ---------------------AIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CccHHH---------------------HHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 422100 0000000 0011111244567889999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=239.61 Aligned_cols=200 Identities=20% Similarity=0.305 Sum_probs=157.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++.+.+.+..++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 56 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dik 129 (285)
T cd05630 56 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLK 129 (285)
T ss_pred hCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCC
Confidence 47899999999999999999999999999999998865432 45889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 130 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~ 207 (285)
T cd05630 130 PENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207 (285)
T ss_pred HHHEEECCCCCEEEeeccceeecCCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc
Confidence 9999999999999999998865432221 12346889999999999888999999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
... . ......... . .......++.+.+++.+||+.||.+||| ++|+++
T Consensus 208 ~~~-----~---------~~~~~~~~~-~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 208 IKR-----E---------EVERLVKEV-Q----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred chH-----H---------HHHhhhhhh-h----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 0 000000000 0 0011234566889999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=229.63 Aligned_cols=200 Identities=22% Similarity=0.311 Sum_probs=161.5
Q ss_pred CCcccceeeEEEEeC----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 3 SHNHILKLIGCCLET----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 3 ~H~niv~l~~~~~~~----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
.|||||.+++++++. ..+.+|||.++||.|.+.+...+. ..++++++..|..||+.|+.||| +.+|.|||
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH---~~nIAHRD 186 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLH---SMNIAHRD 186 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHH---hcchhhcc
Confidence 599999999998753 356799999999999999988755 67999999999999999999999 99999999
Q ss_pred ccCcceeecCC---CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 79 FKTSCILFNEE---NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 79 lk~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|||+|+|.... ..+||+|||+++...... ...+.+.|+.|.|||++-..+++...|+||+|+++|-|+.|.+||.
T Consensus 187 lKpENLLyt~t~~na~lKLtDfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 187 LKPENLLYTTTSPNAPLKLTDFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred CChhheeeecCCCCcceEecccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 99999998754 468999999998754332 2445667999999999999999999999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..-. . ... +.....+..+.+. .++=+..++..+++|+.+|+.+|++|.|+.+++.
T Consensus 265 S~hg---~----------ais----pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 265 SNHG---L----------AIS----PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCC---c----------cCC----hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 4321 0 000 1111222333332 2233577889999999999999999999999875
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=250.22 Aligned_cols=197 Identities=15% Similarity=0.228 Sum_probs=151.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.++...++||||+++|+|.+++.+. ..+++..+..++.|++.||.||| +.+|+|||||
T Consensus 57 ~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlK 128 (382)
T cd05625 57 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIK 128 (382)
T ss_pred hCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 468999999999999999999999999999999998765 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC----------------------------------------------cceeecc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE----------------------------------------------THITDTV 114 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~----------------------------------------------~~~~~~~ 114 (239)
|+|||++.++.++|+|||++....... .......
T Consensus 129 p~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (382)
T cd05625 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSL 208 (382)
T ss_pred HHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccc
Confidence 999999999999999999874321000 0001134
Q ss_pred cccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhh--cCC
Q 044155 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV--EDV 192 (239)
Q Consensus 115 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 192 (239)
.||+.|+|||++.+..++.++|||||||++|||++|..||...... +....+.. ...
T Consensus 209 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---------------------~~~~~i~~~~~~~ 267 (382)
T cd05625 209 VGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPL---------------------ETQMKVINWQTSL 267 (382)
T ss_pred ccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHH---------------------HHHHHHHccCCCc
Confidence 6899999999999889999999999999999999999998643210 00000100 000
Q ss_pred CcHHHHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 044155 193 SSIEKEQQLHASAQVTFECIKDSPADRPS---MVDVAK 227 (239)
Q Consensus 193 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ell~ 227 (239)
..+.....+++..++|.+|+ .+|.+|++ ++++++
T Consensus 268 ~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 268 HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 11111234566788888876 49999997 887764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=243.96 Aligned_cols=187 Identities=24% Similarity=0.343 Sum_probs=149.2
Q ss_pred CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcc
Q 044155 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 83 (239)
Q Consensus 4 H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~n 83 (239)
|++|+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +++++||||||+|
T Consensus 60 ~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~N 131 (324)
T cd05587 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDN 131 (324)
T ss_pred CCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHH
Confidence 456889999999999999999999999999998765 56788999999999999999999 8999999999999
Q ss_pred eeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccc
Q 044155 84 ILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDL 163 (239)
Q Consensus 84 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~ 163 (239)
|+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 132 ill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---- 206 (324)
T cd05587 132 VMLDAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---- 206 (324)
T ss_pred eEEcCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----
Confidence 999999999999999876432211 122345689999999999988899999999999999999999999853221
Q ss_pred cccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 164 VCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
.+........... .+...+..+.+++.+||..||.+|+++
T Consensus 207 -----------------~~~~~~i~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 207 -----------------DELFQSIMEHNVS--YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----------------HHHHHHHHcCCCC--CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0111111111110 111345678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=237.84 Aligned_cols=208 Identities=24% Similarity=0.306 Sum_probs=160.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||+++++|.+++... ..++......++.+++.||.|||. ..+++|+|||
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~ 131 (284)
T cd06620 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIK 131 (284)
T ss_pred HcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCC
Confidence 368999999999999999999999999999999988764 568899999999999999999993 3689999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .....++..|+|||++.+..++.++|+||||+++|++++|..||......
T Consensus 132 p~nil~~~~~~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 132 PSNILVNSRGQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred HHHEEECCCCcEEEccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 999999999999999999875432221 22456889999999998888999999999999999999999998754322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
.+... ......+..................+..+.+++.+||..||.+|||+.|++..
T Consensus 209 ~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 209 DDGQD----------DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhhhh----------hhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11000 00011122222222111111112356678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=251.47 Aligned_cols=199 Identities=15% Similarity=0.211 Sum_probs=152.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.+++..++||||+++|+|.+++... ..++...+..++.||+.||+||| +.+|+|||||
T Consensus 57 ~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlk 128 (376)
T cd05598 57 EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIK 128 (376)
T ss_pred hCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCC
Confidence 478999999999999999999999999999999999765 45788899999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCC------------------------------------------Ccceeecccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEG------------------------------------------ETHITDTVMGTL 118 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~------------------------------------------~~~~~~~~~~~~ 118 (239)
|+||+++.++.++|+|||++..+... .........|++
T Consensus 129 p~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 208 (376)
T cd05598 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTP 208 (376)
T ss_pred HHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCc
Confidence 99999999999999999987432100 000011346899
Q ss_pred cccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHH
Q 044155 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKE 198 (239)
Q Consensus 119 ~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (239)
.|+|||++.+..++.++|||||||++|+|++|..||......... . ..... ..........
T Consensus 209 ~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~--------~---------~i~~~--~~~~~~~~~~ 269 (376)
T cd05598 209 NYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQ--------L---------KVINW--ETTLHIPSQA 269 (376)
T ss_pred cccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHH--------H---------HHhcc--CccccCCCCC
Confidence 999999999888999999999999999999999998643211000 0 00000 0000000011
Q ss_pred HHHHHHHHHHhhhcCCCCCCCC---CHHHHHH
Q 044155 199 QQLHASAQVTFECIKDSPADRP---SMVDVAK 227 (239)
Q Consensus 199 ~~~~~~~~li~~cl~~dp~~Rp---s~~ell~ 227 (239)
..+..+.+++.+|+ .+|.+|+ |+.+++.
T Consensus 270 ~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 270 KLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 34556778888876 4999999 8898875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=241.68 Aligned_cols=222 Identities=16% Similarity=0.197 Sum_probs=157.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||++ ++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 60 ~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlk 131 (301)
T cd07873 60 DLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLK 131 (301)
T ss_pred hcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCC
Confidence 4789999999999999999999999997 69988887543 45788999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++....... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.....
T Consensus 132 p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 132 PQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred HHHEEECCCCcEEECcCcchhccCCCC-CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999986543221 112233568899999988654 478899999999999999999999864332
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhh-----cCCC----cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--H
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVV-----EDVS----SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK--K 228 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~--~ 228 (239)
...... .......+ ....+......... .... .......+..+.++|.+||+.||.+|||++|+++ +
T Consensus 211 ~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 211 EEQLHF-IFRILGTP-TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred HHHHHH-HHHHcCCC-ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 110000 00000000 00011111000000 0000 0011134567889999999999999999999987 4
Q ss_pred HHHHH
Q 044155 229 LRQIY 233 (239)
Q Consensus 229 L~~l~ 233 (239)
++.+.
T Consensus 289 f~~~~ 293 (301)
T cd07873 289 FHCLG 293 (301)
T ss_pred ccccc
Confidence 44443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=247.72 Aligned_cols=213 Identities=18% Similarity=0.255 Sum_probs=151.2
Q ss_pred CCCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++.... ..++||||++ ++|.+.+. ..++...+..++.|++.||.||| ++++
T Consensus 76 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH---~~~i 144 (359)
T cd07876 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH-------MELDHERMSYLLYQMLCGIKHLH---SAGI 144 (359)
T ss_pred hCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 478999999999986443 4689999997 67777664 34778888999999999999999 9999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
+||||||+||+++.++.++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 145 vHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 222 (359)
T cd07876 145 IHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222 (359)
T ss_pred ccCCCCHHHEEECCCCCEEEecCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986542221 123456789999999999889999999999999999999999999
Q ss_pred cccccccccc-------ccchhhhhhh-------hhcc------chhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCC
Q 044155 155 DLVKDVHDLV-------CPFSEYLKNC-------FEDN------RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKD 214 (239)
Q Consensus 155 ~~~~~~~~~~-------~~~~~~~~~~-------~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 214 (239)
.......... .+..++.... .... ...+....... ..........+..+.+++.+||..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~ 301 (359)
T cd07876 223 QGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIF-PSESERDKLKTSQARDLLSKMLVI 301 (359)
T ss_pred CCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccc-ccccccccccchhHHHHHHHHhcc
Confidence 7543211100 0000000000 0000 00000000000 000000112346688999999999
Q ss_pred CCCCCCCHHHHHH
Q 044155 215 SPADRPSMVDVAK 227 (239)
Q Consensus 215 dp~~Rps~~ell~ 227 (239)
||.+|||+.|+++
T Consensus 302 dP~~R~t~~e~l~ 314 (359)
T cd07876 302 DPDKRISVDEALR 314 (359)
T ss_pred CcccCCCHHHHhc
Confidence 9999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=239.56 Aligned_cols=154 Identities=20% Similarity=0.275 Sum_probs=124.0
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCCC----CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQP----HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++.. +...+++|||+. ++|.+++...... ....++...+..++.|++.||.||| +.++
T Consensus 54 ~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~i 129 (317)
T cd07868 54 ELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWV 129 (317)
T ss_pred hcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence 4789999999999864 345789999996 7898887643211 1135889999999999999999999 8999
Q ss_pred eeccccCcceee----cCCCceeEcccccccccCCCCc--ceeecccccccccCccccccC-CcccccchhhhhhHHHHH
Q 044155 75 VFRNFKTSCILF----NEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFEL 147 (239)
Q Consensus 75 ~H~dlk~~nil~----~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~ 147 (239)
+||||||+|||+ +.++.+||+|||++........ .......+|+.|+|||++.+. .++.++||||+||++|+|
T Consensus 130 vHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (317)
T cd07868 130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred EcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHH
Confidence 999999999999 4557899999999876533221 122345678999999998764 588999999999999999
Q ss_pred hcCCCCccccc
Q 044155 148 LTGWDVSDLVK 158 (239)
Q Consensus 148 ~~g~~p~~~~~ 158 (239)
++|..||....
T Consensus 210 ~~g~~~f~~~~ 220 (317)
T cd07868 210 LTSEPIFHCRQ 220 (317)
T ss_pred HhCCCCccCCc
Confidence 99999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=253.16 Aligned_cols=193 Identities=23% Similarity=0.368 Sum_probs=163.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||++.+.|.|......|+|||||- ||-.|++.... +++.+.++..|+.+.+.||+||| +++.+|||||
T Consensus 82 ~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiK 153 (948)
T KOG0577|consen 82 QLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIK 153 (948)
T ss_pred hccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhcc
Confidence 5899999999999999999999999997 78889888764 67889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc---CCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
..|||+++.|.|||+|||.+... .+...+.|||.|||||++.. +.|+-++||||||++..|+...++|+-.+
T Consensus 154 AGNILLse~g~VKLaDFGSAsi~-----~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 154 AGNILLSEPGLVKLADFGSASIM-----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred ccceEecCCCeeeeccccchhhc-----CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 99999999999999999987554 33558899999999999874 45999999999999999999998886332
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. ....++ ++..+.........++..|.+||..||..-|.+|||.++++.
T Consensus 229 N--------------------AMSALY-HIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 229 N--------------------AMSALY-HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred h--------------------HHHHHH-HHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2 222222 233333333334588999999999999999999999998875
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=234.66 Aligned_cols=196 Identities=19% Similarity=0.314 Sum_probs=157.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.+++..++||||+++++|.+++.. .+++......++.|++.||++|| ..+++|+||+
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~ 128 (277)
T cd06640 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIK 128 (277)
T ss_pred hCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCC
Confidence 46899999999999999999999999999999999864 35778888999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++++|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 129 p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06640 129 AANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM 207 (277)
T ss_pred hhhEEEcCCCCEEEcccccceeccCCc-cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH
Confidence 999999999999999999986653322 1223345778899999998888999999999999999999999987543211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
... ... ............+..+.+++.+||+.+|.+||++.+++..
T Consensus 208 ~~~------------------~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 208 RVL------------------FLI----PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHh------------------hhh----hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000 000 0000111123456778999999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=242.73 Aligned_cols=194 Identities=24% Similarity=0.350 Sum_probs=164.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|||||++|++..+....|+|+|+=++|+|.|++-++. ..+.+....+++.||..|+.|+| ...+|||||||
T Consensus 74 VQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKP 146 (864)
T KOG4717|consen 74 VQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKP 146 (864)
T ss_pred hcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCc
Confidence 489999999999999999999999999999999998765 56889999999999999999999 89999999999
Q ss_pred cceeecC-CCceeEcccccccccCCCCcceeecccccccccCccccccCCcc-cccchhhhhhHHHHHhcCCCCcccccc
Q 044155 82 SCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFN-EKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 82 ~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
+|+++.. -|-+||.|||++..+..+. ...+.+|+.+|-|||++.+..|. ++.||||||+|+|.++.|+.||+...+
T Consensus 147 ENVVFFEKlGlVKLTDFGFSNkf~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 147 ENVVFFEKLGLVKLTDFGFSNKFQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred ceeEEeeecCceEeeeccccccCCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 9998765 5789999999998776554 35677899999999999998876 578999999999999999999875432
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. +....++.-.+. .+...+.+.++||.+||.+||.+|.|.+|+..
T Consensus 225 S---------------------ETLTmImDCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 225 S---------------------ETLTMIMDCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred h---------------------hhhhhhhccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2 222233333332 23467788999999999999999999999875
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=236.73 Aligned_cols=198 Identities=20% Similarity=0.252 Sum_probs=153.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+...+..++||||+++++|..++.+.. ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 65 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlk 137 (292)
T cd06644 65 TCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLK 137 (292)
T ss_pred hCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCC
Confidence 4789999999999999999999999999999988876543 45789999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+. ...++.++|+||||+++|+|++|..||.
T Consensus 138 p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 216 (292)
T cd06644 138 AGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216 (292)
T ss_pred cceEEEcCCCCEEEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence 999999999999999999876432221 1122445788999999885 3446789999999999999999998875
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... .......... ....+...+..+.+++.+||..+|++||+++++++
T Consensus 217 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 217 ELNPMR---------------------VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cccHHH---------------------HHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 422100 0000000000 00011234456889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=252.34 Aligned_cols=187 Identities=23% Similarity=0.355 Sum_probs=161.7
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||.++.++..|.+..+.++||||+.||++...++. ..+++..++-++..|+.||+||| +++|++||||.+
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLd 497 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLD 497 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchh
Confidence 699999999999999999999999999996544433 56889999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
|||++.+|.+||+|||+++... .....+++++||+.|+|||++.+..|+...|-|||||++|||+.|..||.
T Consensus 498 NiLLD~eGh~kiADFGlcKe~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~------- 569 (694)
T KOG0694|consen 498 NLLLDTEGHVKIADFGLCKEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP------- 569 (694)
T ss_pred heEEcccCcEEecccccccccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC-------
Confidence 9999999999999999998653 23346789999999999999999999999999999999999999987774
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
.++-.++.++++...+. .+...+.+..+++.++|.++|++|.-+
T Consensus 570 --------------gddEee~FdsI~~d~~~--yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 570 --------------GDDEEEVFDSIVNDEVR--YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --------------CCCHHHHHHHHhcCCCC--CCCcccHHHHHHHHHHhccCcccccCC
Confidence 34445666666655533 234677889999999999999999954
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=232.95 Aligned_cols=201 Identities=25% Similarity=0.429 Sum_probs=157.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.+.+..+++||++++++|.+++..... ..+++..+..++.|++.||++|| +.+++|+|||
T Consensus 57 ~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~ 130 (258)
T smart00219 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLA 130 (258)
T ss_pred hcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccc
Confidence 36899999999999999999999999999999999976532 22899999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............+++.|+|||.+.+..++.++|+||||+++++|++ |..||.....
T Consensus 131 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~ 210 (258)
T smart00219 131 ARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN 210 (258)
T ss_pred cceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654332222212236788999999988889999999999999999998 6677643110
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
............ .......+..+.+++.+||..||.+|||+.++++.|
T Consensus 211 ---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 211 ---------------------EEVLEYLKKGYR-LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---------------------HHHHHHHhcCCC-CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011111111110 011113566789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=233.45 Aligned_cols=198 Identities=21% Similarity=0.300 Sum_probs=159.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++|+||+.+++|.+.+..... ..++...+..++.|++.|+.||| +.+++|+||+
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~ 128 (256)
T cd08218 55 NMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH---DRKILHRDIK 128 (256)
T ss_pred hCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCC
Confidence 47899999999999999999999999999999999876432 35788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++++|||.+........ ......+++.|+|||++.+...+.++|+||||++++++++|..||....
T Consensus 129 ~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-- 205 (256)
T cd08218 129 SQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-- 205 (256)
T ss_pred HHHEEEcCCCCEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--
Confidence 9999999999999999999876533221 1223347788999999988888999999999999999999988874211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+.......+... ..+...+..+.++|.+||+.+|.+||++.++++
T Consensus 206 -------------------~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 206 -------------------MKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -------------------HHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11122222222111 112245677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=235.79 Aligned_cols=197 Identities=21% Similarity=0.294 Sum_probs=151.8
Q ss_pred CCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 3 SHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 3 ~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+||||+++++++... ...+++|||+.+++|.+++..... ..+++..+..++.|++.|++||| +++++|
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh 134 (272)
T cd06637 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIH 134 (272)
T ss_pred CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence 699999999998753 347899999999999999886432 46889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-----CCcccccchhhhhhHHHHHhcCC
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-----GVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
+|+||+||+++.++.++|+|||++....... .......|+..|+|||++.+ ..++.++|+||||+++|+|++|.
T Consensus 135 ~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~ 213 (272)
T cd06637 135 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 213 (272)
T ss_pred CCCCHHHEEECCCCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999986543221 12234568889999998863 35778999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.||.......... . ..............+..+.+++.+||..+|.+|||+.++++
T Consensus 214 ~p~~~~~~~~~~~-------~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 214 PPLCDMHPMRALF-------L--------------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCccccCHHHHHH-------H--------------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 9885322110000 0 00000000011134467889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=235.67 Aligned_cols=198 Identities=23% Similarity=0.315 Sum_probs=153.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||+++++|..+ ..+++.....++.|++.||.||| +.+++|+|||
T Consensus 55 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 122 (279)
T cd06619 55 KCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVK 122 (279)
T ss_pred hCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCC
Confidence 47899999999999999999999999999988543 24678888899999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 123 p~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~ 199 (279)
T cd06619 123 PSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199 (279)
T ss_pred HHHEEECCCCCEEEeeCCcceeccccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccc
Confidence 999999999999999999986553221 23456888999999999888999999999999999999999998653322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.....+ ....................+.++.+++.+||..+|.+||+++|+++
T Consensus 200 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 200 QGSLMP--------------LQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred ccccch--------------HHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111100 00000000010000001134567899999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=249.19 Aligned_cols=212 Identities=20% Similarity=0.276 Sum_probs=164.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
||+||||++++|+|......++|+||+++|+|.+++.++.. ..+.......++.||+.|++||. +.++||||+.
T Consensus 591 qLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a 664 (807)
T KOG1094|consen 591 RLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLA 664 (807)
T ss_pred ccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHH---hhchhhcccc
Confidence 68999999999999999999999999999999999988643 22345556679999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce-eecccccccccCccccccCCcccccchhhhhhHHHHHhc--CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~--g~~p~~~~ 157 (239)
++|+|++.++.+||+|||+++.+-.+..+. .+...-+..|||||.+..++++.++|+|+||+++||+++ ...||+.+
T Consensus 665 ~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 665 TRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred ccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 999999999999999999998665554443 344556889999999999999999999999999999876 45666544
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
.+...... ....+..... ..-...+.-++..+.++|.+||++|-.+|||++++...|++..
T Consensus 745 t~e~vven-----~~~~~~~~~~----------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 745 TDEQVVEN-----AGEFFRDQGR----------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hHHHHHHh-----hhhhcCCCCc----------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 32110000 0000000000 0001112245677889999999999999999999999988753
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=234.69 Aligned_cols=201 Identities=24% Similarity=0.318 Sum_probs=159.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dl 79 (239)
+++||||+++++++...+..++++||+++++|.+++.... ..++......++.|++.|+.||| + .+++|+||
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl 127 (265)
T cd06605 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDV 127 (265)
T ss_pred HCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCC
Confidence 3689999999999999999999999999999999997653 46788999999999999999999 7 99999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+||+++.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||||++++++++|..||.....
T Consensus 128 ~~~ni~~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 204 (265)
T cd06605 128 KPSNILVNSRGQIKLCDFGVSGQLVNSL---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND 204 (265)
T ss_pred CHHHEEECCCCCEEEeecccchhhHHHH---hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999876542221 1125678899999999888899999999999999999999999864322
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. ....+..................+..+.++|.+||..||.+|||+.+++.
T Consensus 205 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 205 PP----------------DGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cc----------------ccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 00 01111111111111111111125677899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=237.60 Aligned_cols=153 Identities=20% Similarity=0.273 Sum_probs=123.2
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCC----CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQ----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++.. +...++|+||+. ++|.+++..... .....+++..+..++.|++.||.||| +.++
T Consensus 54 ~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~i 129 (317)
T cd07867 54 ELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWV 129 (317)
T ss_pred hCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence 4789999999999864 456789999997 688888754321 11135788899999999999999999 8999
Q ss_pred eeccccCcceee----cCCCceeEcccccccccCCCCc--ceeecccccccccCccccccC-CcccccchhhhhhHHHHH
Q 044155 75 VFRNFKTSCILF----NEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFEL 147 (239)
Q Consensus 75 ~H~dlk~~nil~----~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~ 147 (239)
+|+||||+||++ +.++.+||+|||+++....... .......+++.|+|||++.+. .++.++||||||+++|+|
T Consensus 130 vH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 209 (317)
T cd07867 130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred EcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHH
Confidence 999999999999 4567899999999876533221 122345678999999998764 578999999999999999
Q ss_pred hcCCCCcccc
Q 044155 148 LTGWDVSDLV 157 (239)
Q Consensus 148 ~~g~~p~~~~ 157 (239)
++|..||...
T Consensus 210 ~tg~~~f~~~ 219 (317)
T cd07867 210 LTSEPIFHCR 219 (317)
T ss_pred HhCCCCcccc
Confidence 9999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=234.60 Aligned_cols=199 Identities=20% Similarity=0.318 Sum_probs=156.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.+.+..++++||+++++|.+++.+. ..++......++.|++.||+||| +.+++|+||+
T Consensus 58 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~ 129 (265)
T cd06631 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIK 129 (265)
T ss_pred hcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcC
Confidence 468999999999999999999999999999999999765 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-----cceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-----THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+||+++.++.++|+|||.+....... ........++..|+|||++.+..++.++|+||||+++|++++|..||.
T Consensus 130 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 209 (265)
T cd06631 130 GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209 (265)
T ss_pred HHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence 999999999999999999886542111 111223457889999999998888999999999999999999999985
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........ .............+...+..+.+++.+||..+|.+||++.+++.
T Consensus 210 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 210 SMDRLAAM--------------------FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cCChHHHH--------------------HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 43211000 00000000000111234567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=239.18 Aligned_cols=197 Identities=18% Similarity=0.238 Sum_probs=155.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..+...++||||+++++|.+++.. ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 72 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~ 142 (297)
T cd06656 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIK 142 (297)
T ss_pred hCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 36899999999999999999999999999999999865 35788899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++|++++|..||......
T Consensus 143 p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~ 221 (297)
T cd06656 143 SDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (297)
T ss_pred HHHEEECCCCCEEECcCccceEccCCc-cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 999999999999999999886543221 1122345788899999998888999999999999999999999998532211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... .. .........+...+..+.+++.+||..+|.+|||++++++
T Consensus 222 ~~~~~--------~~------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 222 RALYL--------IA------------TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred hheee--------ec------------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10000 00 0000000011234566789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=235.67 Aligned_cols=198 Identities=20% Similarity=0.289 Sum_probs=155.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..+...++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~ 130 (280)
T cd06611 58 ECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLK 130 (280)
T ss_pred hCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 4789999999999999999999999999999999887643 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+. ...++.++|+||||+++|+|++|..||.
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~ 209 (280)
T cd06611 131 AGNILLTLDGDVKLADFGVSAKNKSTL-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209 (280)
T ss_pred hhhEEECCCCCEEEccCccchhhcccc-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc
Confidence 999999999999999999876543221 1223445788999999874 3446789999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... .......... ....+...+..+.+++..||..+|.+|||+.++++
T Consensus 210 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 210 ELNPMR---------------------VLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred cCCHHH---------------------HHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 432110 0000000000 00011234567889999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=239.14 Aligned_cols=198 Identities=16% Similarity=0.271 Sum_probs=155.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+..++..++||||+++++|.+++.. ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 75 ~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlk 145 (292)
T cd06658 75 DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIK 145 (292)
T ss_pred hCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCC
Confidence 36899999999999999999999999999999988854 45788899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|++++|..||......
T Consensus 146 p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 224 (292)
T cd06658 146 SDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224 (292)
T ss_pred HHHEEEcCCCCEEEccCcchhhccccc-ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999886543221 1122345788999999998888999999999999999999999987532210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
.. ............. .....+..+.+++..||..||++|||++++++.
T Consensus 225 ~~------------------~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 225 QA------------------MRRIRDNLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HH------------------HHHHHhcCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0000000111100 111345678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=235.10 Aligned_cols=201 Identities=27% Similarity=0.431 Sum_probs=156.6
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++......++|||++++++|.+++... ..++...+..++.|++.||.+|| +.+++|+||||
T Consensus 55 l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp 126 (260)
T PF00069_consen 55 LRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKP 126 (260)
T ss_dssp HTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSG
T ss_pred cccccccccccccccccccccccccccccccccccccc-----ccccccccccccccccccccccc---ccccccccccc
Confidence 58999999999999999999999999988999999843 67899999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-cCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-TGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+||+++.++.++|+|||.+.... ..........++..|+|||.+. +...+.++|+||||+++++|++|..||......
T Consensus 127 ~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~ 205 (260)
T PF00069_consen 127 ENILLDENGEVKLIDFGSSVKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD 205 (260)
T ss_dssp GGEEESTTSEEEESSGTTTEEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 99999999999999999987531 1122334556788999999998 788999999999999999999999988643100
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... . ................ .......+.+++.+||+.||++|||+.++++
T Consensus 206 ~~~--------~------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 206 DQL--------E------IIEKILKRPLPSSSQQ--SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHH--------H------HHHHHHHTHHHHHTTS--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhh--------h------hhhhcccccccccccc--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0 0000000000000000 0011267899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=246.41 Aligned_cols=212 Identities=17% Similarity=0.223 Sum_probs=151.5
Q ss_pred CCCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++... ...++||||++ +++.+.+. ..++...+..++.|++.||.||| ++++
T Consensus 72 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~gi 140 (355)
T cd07874 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGI 140 (355)
T ss_pred HhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 36899999999988643 24689999997 67777774 34778888999999999999999 9999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
+||||||+||+++.++.+||+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 141 vHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 218 (355)
T cd07874 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_pred ccCCCChHHEEECCCCCEEEeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987543221 123456889999999999888999999999999999999999998
Q ss_pred cccccccccc-------ccchhhhhhhhhccchhhhhhh-----------hhhcC---CCcHHHHHHHHHHHHHHhhhcC
Q 044155 155 DLVKDVHDLV-------CPFSEYLKNCFEDNRFTEIVDH-----------IVVED---VSSIEKEQQLHASAQVTFECIK 213 (239)
Q Consensus 155 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~---~~~~~~~~~~~~~~~li~~cl~ 213 (239)
.......... .+..++..... ......... ..... .........+..+.+++.+||.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 296 (355)
T cd07874 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQ--PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhc--HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhc
Confidence 6533211110 00000000000 000000000 00000 0000111234567899999999
Q ss_pred CCCCCCCCHHHHHH
Q 044155 214 DSPADRPSMVDVAK 227 (239)
Q Consensus 214 ~dp~~Rps~~ell~ 227 (239)
.||.+|||+.|+++
T Consensus 297 ~dP~~Rps~~ell~ 310 (355)
T cd07874 297 IDPAKRISVDEALQ 310 (355)
T ss_pred CCchhcCCHHHHhc
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=246.29 Aligned_cols=213 Identities=17% Similarity=0.238 Sum_probs=151.8
Q ss_pred CCCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++... ...++||||++ ++|.+.+. ..++...+..++.|++.||+||| ++++
T Consensus 79 ~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i 147 (364)
T cd07875 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGI 147 (364)
T ss_pred hcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHh---hCCe
Confidence 36899999999987643 34689999997 68877774 34678888999999999999999 9999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
+||||||+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 148 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 148 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred ecCCCCHHHEEECCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987543221 123456889999999999989999999999999999999999999
Q ss_pred cccccccccc-------ccchhhhhhhh-------hcc------chhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCC
Q 044155 155 DLVKDVHDLV-------CPFSEYLKNCF-------EDN------RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKD 214 (239)
Q Consensus 155 ~~~~~~~~~~-------~~~~~~~~~~~-------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 214 (239)
.......... .+..++..... ... .......... ..............+.+++.+||..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dll~~mL~~ 304 (364)
T cd07875 226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL-FPADSEHNKLKASQARDLLSKMLVI 304 (364)
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccc-ccccccccccccHHHHHHHHHhcCc
Confidence 7543221110 00000000000 000 0000000000 0000000112345688999999999
Q ss_pred CCCCCCCHHHHHH
Q 044155 215 SPADRPSMVDVAK 227 (239)
Q Consensus 215 dp~~Rps~~ell~ 227 (239)
||.+|||+.|+++
T Consensus 305 dP~~R~t~~e~L~ 317 (364)
T cd07875 305 DASKRISVDEALQ 317 (364)
T ss_pred CcccCCCHHHHhc
Confidence 9999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=239.72 Aligned_cols=200 Identities=20% Similarity=0.274 Sum_probs=157.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.++...++||||+.+++|.+++..... ..+++.....++.|++.||+||| +.+++|+|||
T Consensus 57 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 130 (316)
T cd05574 57 TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLK 130 (316)
T ss_pred hCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 46899999999999999999999999999999999876533 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc----------------------------ceeecccccccccCccccccCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET----------------------------HITDTVMGTLGYCAPEYMRTGVFN 132 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 132 (239)
|+||+++.++.++|+|||++........ .......|+..|+|||++.+..++
T Consensus 131 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 210 (316)
T cd05574 131 PENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG 210 (316)
T ss_pred hHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC
Confidence 9999999999999999998765422110 011234578889999999988899
Q ss_pred cccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhc
Q 044155 133 EKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECI 212 (239)
Q Consensus 133 ~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 212 (239)
.++||||||+++|++++|..||....... ..................+..+.+++.+||
T Consensus 211 ~~~Di~slG~ll~~l~~g~~pf~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 269 (316)
T cd05574 211 SAVDWWTLGILLYEMLYGTTPFKGSNRDE---------------------TFSNILKKEVTFPGSPPVSSSARDLIRKLL 269 (316)
T ss_pred chHHHHHHHHHHHHHhhCCCCCCCCchHH---------------------HHHHHhcCCccCCCccccCHHHHHHHHHHc
Confidence 99999999999999999999986432110 000111111111111125678999999999
Q ss_pred CCCCCCCCC----HHHHHH
Q 044155 213 KDSPADRPS----MVDVAK 227 (239)
Q Consensus 213 ~~dp~~Rps----~~ell~ 227 (239)
..||.+||| +++++.
T Consensus 270 ~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 270 VKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred cCCHhHCCCchhhHHHHHc
Confidence 999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=232.94 Aligned_cols=199 Identities=23% Similarity=0.330 Sum_probs=152.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcC--CHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPL--LLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++|+||+++++++..++..++|+||+++++|.+++.... ..+ +...+..++.|++.||+||| +.+++|+|
T Consensus 61 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~d 133 (268)
T cd06624 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRD 133 (268)
T ss_pred hcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecC
Confidence 4789999999999999999999999999999999997643 233 77888889999999999999 89999999
Q ss_pred ccCcceeecC-CCceeEcccccccccCCCCcceeecccccccccCccccccCC--cccccchhhhhhHHHHHhcCCCCcc
Q 044155 79 FKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 79 lk~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|||+||+++. ++.++|+|||.+....... .......+++.|+|||.+.... ++.++|+||||+++|++++|..||.
T Consensus 134 l~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~ 212 (268)
T cd06624 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212 (268)
T ss_pred CCHHHEEEcCCCCeEEEecchhheecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence 9999999976 6689999999876543221 1122345788999999986543 7889999999999999999999875
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... ....... .....+...++.+.+++.+||..+|.+|||+.++++
T Consensus 213 ~~~~~~~~~-------------------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 213 ELGEPQAAM-------------------FKVGMFK-IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccChhhhH-------------------hhhhhhc-cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 432110000 0000000 001112244567889999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=231.18 Aligned_cols=198 Identities=19% Similarity=0.306 Sum_probs=156.1
Q ss_pred CCCCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++|+||+++++.+... ...++++||+++++|.+++..... ..+++.++..++.|++.|+.+|| +.+++|+||
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di 128 (257)
T cd08223 55 QLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---EKHILHRDL 128 (257)
T ss_pred hCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCC
Confidence 46899999999987643 457899999999999999976432 45889999999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+||+++.++.++|+|||++....... .......+++.|+|||+..+..++.++|+||||++++++++|..||.....
T Consensus 129 ~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 207 (257)
T cd08223 129 KTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 207 (257)
T ss_pred CchhEEEecCCcEEEecccceEEecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999999999999999999987653221 222344578899999999988899999999999999999999888753210
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
............. ..+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 208 ---------------------~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 208 ---------------------NSLVYRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---------------------HHHHHHHHhcCCC-CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111111111111 112245677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=239.32 Aligned_cols=228 Identities=19% Similarity=0.217 Sum_probs=160.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||++++++|..+...++|+||+.+++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||
T Consensus 56 l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp 129 (328)
T cd08226 56 FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKA 129 (328)
T ss_pred CCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 7899999999999999999999999999999999876532 45888999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcc------eeecccccccccCccccccC--CcccccchhhhhhHHHHHhcCCCC
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETH------ITDTVMGTLGYCAPEYMRTG--VFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+||+++.++.++++||+........... ......++..|+|||++.+. .++.++||||||+++|++++|..|
T Consensus 130 ~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p 209 (328)
T cd08226 130 SHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209 (328)
T ss_pred HHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999754322111100 01122345679999998763 478999999999999999999999
Q ss_pred ccccccccccccc-------------chhhhhhhhhcc-chh----hhh-h-----hhhhcCCCcHHHHHHHHHHHHHHh
Q 044155 154 SDLVKDVHDLVCP-------------FSEYLKNCFEDN-RFT----EIV-D-----HIVVEDVSSIEKEQQLHASAQVTF 209 (239)
Q Consensus 154 ~~~~~~~~~~~~~-------------~~~~~~~~~~~~-~~~----~~~-~-----~~~~~~~~~~~~~~~~~~~~~li~ 209 (239)
|............ +........... ... +.. . ...............+..+.+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 289 (328)
T cd08226 210 FQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE 289 (328)
T ss_pred CCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHH
Confidence 8754321110000 000000000000 000 000 0 000011112223456788999999
Q ss_pred hhcCCCCCCCCCHHHHHH--HHHHHHHh
Q 044155 210 ECIKDSPADRPSMVDVAK--KLRQIYRS 235 (239)
Q Consensus 210 ~cl~~dp~~Rps~~ell~--~L~~l~~~ 235 (239)
+||..||++|||++|+++ ++.++.++
T Consensus 290 ~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 290 LCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred HHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 999999999999999985 56665554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=234.75 Aligned_cols=200 Identities=21% Similarity=0.314 Sum_probs=156.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++.+.+..++..+++|||+++++|.+.+..... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 56 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dik 129 (285)
T cd05632 56 KVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLH---RENTVYRDLK 129 (285)
T ss_pred HcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCC
Confidence 47899999999999999999999999999999988865432 46899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++........ .....|+..|+|||.+.+..++.++|+||||+++|++++|..||......
T Consensus 130 p~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~ 207 (285)
T cd05632 130 PENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207 (285)
T ss_pred HHHEEECCCCCEEEecCCcceecCCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999998865432211 12346889999999998888999999999999999999999998643210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
... +.......... .......+..+.+++..||+.||.+||+ +.+++.
T Consensus 208 ~~~------------------~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 208 VKR------------------EEVDRRVLETE-EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHH------------------HHHHHhhhccc-cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 000 00001000000 0011234566789999999999999999 667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=237.92 Aligned_cols=197 Identities=17% Similarity=0.273 Sum_probs=155.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..++..++|+||+++++|.+++.. ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 74 ~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~ 144 (297)
T cd06659 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIK 144 (297)
T ss_pred hCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 37899999999999999999999999999999987754 45788999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||||+++++|++|..||......
T Consensus 145 p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 223 (297)
T cd06659 145 SDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV 223 (297)
T ss_pred HHHeEEccCCcEEEeechhHhhccccc-ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999886543221 1223455788999999998888999999999999999999999988532211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .. ..... ..........+..+.+++.+||..+|.+|||++++++
T Consensus 224 ~~~--------~~----------~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 224 QAM--------KR----------LRDSP--PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHH--------HH----------HhccC--CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000 00 00000 0000001133456889999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=232.24 Aligned_cols=197 Identities=21% Similarity=0.272 Sum_probs=152.0
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.+. ...++++||+++++|.+++... ..++......++.|++.||+||| +.+++|+|
T Consensus 60 ~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~ 131 (266)
T cd06651 60 NLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLH---SNMIVHRD 131 (266)
T ss_pred HcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCC
Confidence 47899999999988753 4678999999999999999765 45788899999999999999999 99999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCC--cceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++|+||||+++|++++|..||..
T Consensus 132 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 132 IKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred CCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 99999999999999999999986543211 1112234578889999999888899999999999999999999999853
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ...............+...++.+.+++ +||..+|++|||++|+++
T Consensus 212 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 212 YEAM---------------------AAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cchH---------------------HHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 2110 000111111111111223456677887 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=234.75 Aligned_cols=218 Identities=20% Similarity=0.217 Sum_probs=156.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||+++++|..++... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 56 ~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~ 127 (286)
T cd07847 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVK 127 (286)
T ss_pred hCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCC
Confidence 478999999999999999999999999988887766543 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 128 p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 128 PENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred hhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999999876543221 1223456788999999876 4578899999999999999999999865432
Q ss_pred cccccc------cchhhhhhhhhccchhhhhhhhhhcCCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVC------PFSEYLKNCFEDNRFTEIVDHIVVEDVSS--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... .........+....+.............. ......+..+.+++.+||..+|++|||+.|++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 207 VDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 211100 00000000000000000000000000000 011234577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=240.79 Aligned_cols=202 Identities=18% Similarity=0.204 Sum_probs=152.1
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|+||+++++++.+++..++||||+++++|.+++.... ..++...+..++.|++.||+||| +++++||||||
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp 130 (331)
T cd05597 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKP 130 (331)
T ss_pred CCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCH
Confidence 689999999999999999999999999999999997532 46889999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-----CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-----GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||+++.++.++|+|||++...............|++.|+|||++.. ..++.++||||||+++|+|++|..||..
T Consensus 131 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred HHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 99999999999999999986554332222234568999999999863 3467899999999999999999999853
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCC--CCCCHHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPA--DRPSMVDVAKK 228 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~--~Rps~~ell~~ 228 (239)
.... +.... ........... ......+..+.+++.+|+..++. .|++++++++.
T Consensus 211 ~~~~--------~~~~~---------i~~~~~~~~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 211 ESLV--------ETYGK---------IMNHKEHFQFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCHH--------HHHHH---------HHcCCCcccCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 2110 00000 00000000000 01113456788999998865444 37899888763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=237.98 Aligned_cols=215 Identities=15% Similarity=0.163 Sum_probs=154.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++|+||++ ++|.+++.... ..+++..++.++.|++.||.||| +.+++|+|||
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~ 126 (284)
T cd07839 55 ELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLK 126 (284)
T ss_pred hcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCC
Confidence 4789999999999999999999999997 68888876543 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++|+|++|..|+....+
T Consensus 127 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~ 205 (284)
T cd07839 127 PQNLLINKNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205 (284)
T ss_pred HHHEEEcCCCcEEECccchhhccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence 999999999999999999987543221 112234567889999988764 478999999999999999999988643222
Q ss_pred cccccccchhhhhhhh--hccchhhhhh---hhhhcCCC-----cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCF--EDNRFTEIVD---HIVVEDVS-----SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... ........ ....+..... ........ .......+..+.+++.+||..||.+|||+++++.
T Consensus 206 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 206 VDDQL---KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHH---HHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 11100 00000000 0000000000 00000000 0011134567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=239.63 Aligned_cols=194 Identities=24% Similarity=0.325 Sum_probs=163.3
Q ss_pred CC-CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MS-HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~-H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
|. |||||.+++.|++....++|||++.||.|.+.+... .+++..+..++.|++.++.||| ..|++|||+|
T Consensus 92 l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlK 162 (382)
T KOG0032|consen 92 LSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLK 162 (382)
T ss_pred ccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCC
Confidence 55 999999999999999999999999999999999764 2889999999999999999999 9999999999
Q ss_pred CcceeecCC----CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEE----NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+|+|+... +.++++|||++..... ........||+.|+|||++....++..+||||+|+++|.|++|..||..
T Consensus 163 pEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 163 PENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred HHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 999998754 3699999999988755 3446677899999999999999999999999999999999999999865
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
....... ..+.... +....-+..+...+++|..|+..||.+|+|+.++++
T Consensus 241 ~~~~~~~---------------------~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 241 ETEFEIF---------------------LAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CChhHHH---------------------HHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 4421111 1111111 122222466788999999999999999999999987
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=232.14 Aligned_cols=193 Identities=20% Similarity=0.257 Sum_probs=155.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++.+...+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~ 138 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLE 138 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHH
Confidence 6999999999999999999999999999999999765 46889999999999999999999 899999999999
Q ss_pred ceeecCCC-ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 83 CILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 83 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
||+++.++ .++|+|||.+...... ....++..|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 139 nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 139 NVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred HEEEeCCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 99999998 9999999988655322 13457889999999998889999999999999999999999986322111
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-MVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~ell~ 227 (239)
. ......... .... ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus 214 -~---------------~~~~~~~~~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 214 -L---------------DLESLLKRQ-QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -h---------------hHHHHHHhh-cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 000000000 1110 111245677899999999999999996 588874
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=233.11 Aligned_cols=196 Identities=23% Similarity=0.306 Sum_probs=157.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.++...++|+||+++++|.+++.. ..++...+..++.|++.|+.||| +.+++|+||+
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~ 125 (274)
T cd06609 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIK 125 (274)
T ss_pred HcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 36899999999999999999999999999999999875 36789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||++++++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|++++|..||......
T Consensus 126 p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~ 204 (274)
T cd06609 126 AANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM 204 (274)
T ss_pred HHHEEECCCCCEEEcccccceeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH
Confidence 999999999999999999987664321 2233445778899999999888999999999999999999999998532210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...................+..+.+++.+||..+|.+|||+++++.
T Consensus 205 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 205 ---------------------RVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---------------------HHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0000000011111111114567889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=241.08 Aligned_cols=199 Identities=18% Similarity=0.187 Sum_probs=153.5
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|+||+++++.+.+....++||||+++|+|.+++.+.. ..+++..++.++.|++.||.||| +.+++||||||
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp 130 (332)
T cd05623 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKP 130 (332)
T ss_pred CCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCH
Confidence 689999999999999999999999999999999997642 46888999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-----CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-----GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||+++.++.++|+|||++...............|++.|+|||++.. ..++.++|+||||+++|+|++|+.||..
T Consensus 131 ~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 131 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred HHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 99999999999999999986543332222334568999999999863 4578899999999999999999999853
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCC---CcHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV---SSIEKEQQLHASAQVTFECIKDSPAD--RPSMVDVAKK 228 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~~ 228 (239)
... .+....+..... .+......+..+.+++.+|+..++.+ |++++++++.
T Consensus 211 ~~~---------------------~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 211 ESL---------------------VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCH---------------------HHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 221 011111111000 01111234677889999988665444 6889988764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=239.75 Aligned_cols=188 Identities=22% Similarity=0.317 Sum_probs=151.1
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+|++|+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +++++||||||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~ 130 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLD 130 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 5688889999999999999999999999999998765 56889999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 131 Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--- 206 (323)
T cd05615 131 NVMLDSEGHIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--- 206 (323)
T ss_pred HeEECCCCCEEEeccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---
Confidence 9999999999999999986532211 122345589999999999988899999999999999999999999864321
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
......+...... .+...+..+.+++.+||+.+|.+|++.
T Consensus 207 ------------------~~~~~~i~~~~~~--~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 207 ------------------DELFQSIMEHNVS--YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------------------HHHHHHHHhCCCC--CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111111111111 112345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=234.07 Aligned_cols=201 Identities=20% Similarity=0.285 Sum_probs=155.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+...+..++||||+++++|..++..... ...+++..+..++.|++.||.|||. ..+++|+|||
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~ 130 (286)
T cd06622 55 KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVK 130 (286)
T ss_pred hcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCC
Confidence 47899999999999999999999999999999888876321 1468899999999999999999993 3599999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC------cccccchhhhhhHHHHHhcCCCCc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV------FNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||+++.++.++|+|||.+....... .....++..|+|||.+.+.. ++.++|+||||+++|++++|..||
T Consensus 131 p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 207 (286)
T cd06622 131 PTNVLVNGNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207 (286)
T ss_pred HHHEEECCCCCEEEeecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCC
Confidence 999999999999999999986543221 22345778899999986543 478999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... ................ ..+...+..+.+++.+||..+|.+||++++++.
T Consensus 208 ~~~~~------------------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 208 PPETY------------------ANIFAQLSAIVDGDPP-TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCcch------------------hhHHHHHHHHhhcCCC-CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 53210 0000111111111111 112246677899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=232.10 Aligned_cols=201 Identities=20% Similarity=0.346 Sum_probs=157.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.+++..++|+||+++++|.+++... ..+++.....++.|++.||.||| +++++|+||+
T Consensus 59 ~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~ 130 (268)
T cd06630 59 RLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVK 130 (268)
T ss_pred HcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 478999999999999999999999999999999999764 56788999999999999999999 9999999999
Q ss_pred CcceeecCCC-ceeEcccccccccCCCCc---ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEEN-VAKLFDFSLSISIPEGET---HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~-~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||+++.++ .++|+|||.+........ .......++..|+|||.+.+..++.++|+||+|++++++++|..||..
T Consensus 131 ~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 131 GANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred HHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 9999998775 589999999866533211 112234578899999999888889999999999999999999988752
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ..................+...+..+.+++.+||..+|.+|||+.+++.
T Consensus 211 ~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 211 EKHS------------------NHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCc------------------chHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2110 0001111111111111222356678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=232.68 Aligned_cols=202 Identities=16% Similarity=0.279 Sum_probs=156.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||+
T Consensus 64 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~ 135 (272)
T cd06629 64 DLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLK 135 (272)
T ss_pred hcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCC
Confidence 468999999999999999999999999999999999765 46888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCC--cccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.++++|||++........ .......++..|+|||.+.... ++.++|+||||++++++++|..||...
T Consensus 136 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 136 ADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred hhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 9999999999999999999865432211 1123445788999999987654 789999999999999999999987432
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... + +..................+..+.+++.+||..+|.+|||++++++
T Consensus 216 ~~~~~~-----------~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 216 EAIAAM-----------F------KLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred chHHHH-----------H------HhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 211000 0 0000000000000111134577899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=240.48 Aligned_cols=208 Identities=22% Similarity=0.378 Sum_probs=155.5
Q ss_pred CCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcCCCCC--------------------------------------
Q 044155 3 SHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPH-------------------------------------- 43 (239)
Q Consensus 3 ~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~~~-------------------------------------- 43 (239)
+||||+++++++... ...+++|||+++|+|.+++.......
T Consensus 69 ~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (343)
T cd05103 69 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSA 148 (343)
T ss_pred CCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccc
Confidence 689999999988654 46789999999999999987532100
Q ss_pred ------------------------CCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEccccc
Q 044155 44 ------------------------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 99 (239)
Q Consensus 44 ------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~ 99 (239)
...+++.....++.|++.||+||| +++++|+||||+||+++.++.++|+|||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~ 225 (343)
T cd05103 149 SSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGL 225 (343)
T ss_pred cccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEeccc
Confidence 023577788899999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccccccccccchhhhhhhhhc
Q 044155 100 SISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFED 177 (239)
Q Consensus 100 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 177 (239)
+........ .......+++.|+|||.+.+..++.++||||||+++|++++ |..||....... .. .
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~-~----- 292 (343)
T cd05103 226 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EF-C----- 292 (343)
T ss_pred ccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------HH-H-----
Confidence 865422211 11222335677999999988889999999999999999997 777774321100 00 0
Q ss_pred cchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 178 NRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
.. .........+...++.+.+++..||..||.+|||+.++++.|+.+..
T Consensus 293 ----~~----~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 293 ----RR----LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ----HH----HhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 00000000011234568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=232.01 Aligned_cols=198 Identities=23% Similarity=0.320 Sum_probs=158.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++++||+++++|.+++.+. ..++...+..++.|++.||.||| +.+++|+||+
T Consensus 49 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~ 120 (262)
T cd05572 49 ECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLK 120 (262)
T ss_pred hCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCC
Confidence 478999999999999999999999999999999999765 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... ......++..|+|||.+....++.++|+||||+++|++++|..||......
T Consensus 121 ~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 198 (262)
T cd05572 121 PENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198 (262)
T ss_pred HHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC
Confidence 999999999999999999987654332 122345788899999998888899999999999999999999998643310
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
..+..............+...+..+.+++.+||..+|.+||| ++|+++
T Consensus 199 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 199 -------------------PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -------------------HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 011111111111111111233678999999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=259.08 Aligned_cols=211 Identities=18% Similarity=0.236 Sum_probs=159.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC------CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++.+++..++||||++|++|.+++...... .....+......++.|++.||+||| +.++
T Consensus 58 ~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GI 134 (932)
T PRK13184 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGV 134 (932)
T ss_pred hCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence 478999999999999999999999999999999988753210 0123556778899999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCC-----------------cceeecccccccccCccccccCCcccccch
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-----------------THITDTVMGTLGYCAPEYMRTGVFNEKSNV 137 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 137 (239)
+||||||+||+++.++.++|+|||++....... ........||+.|+|||++.+..++.++||
T Consensus 135 IHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDI 214 (932)
T PRK13184 135 LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI 214 (932)
T ss_pred cccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHH
Confidence 999999999999999999999999987551110 001123468999999999998899999999
Q ss_pred hhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCC
Q 044155 138 FSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPA 217 (239)
Q Consensus 138 ~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~ 217 (239)
||||+++|+|++|..||......... . . ...............++.+.+++.+||+.||+
T Consensus 215 WSLGVILyELLTG~~PF~~~~~~ki~-----------~-~--------~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~ 274 (932)
T PRK13184 215 YALGVILYQMLTLSFPYRRKKGRKIS-----------Y-R--------DVILSPIEVAPYREIPPFLSQIAMKALAVDPA 274 (932)
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhhh-----------h-h--------hhccChhhccccccCCHHHHHHHHHHccCChh
Confidence 99999999999999998542110000 0 0 00000000000124456788999999999999
Q ss_pred CCC-CHHHHHHHHHHHHH
Q 044155 218 DRP-SMVDVAKKLRQIYR 234 (239)
Q Consensus 218 ~Rp-s~~ell~~L~~l~~ 234 (239)
+|| +++++.+.|+....
T Consensus 275 kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 275 ERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hCcCHHHHHHHHHHHHHh
Confidence 997 57778888877655
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=245.22 Aligned_cols=197 Identities=15% Similarity=0.237 Sum_probs=151.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.+....++||||+++|+|.+++... ..++...+..++.|++.||.||| +.+++|||||
T Consensus 57 ~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLk 128 (360)
T cd05627 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIK 128 (360)
T ss_pred hCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCC
Confidence 468999999999999999999999999999999999765 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc----------------------------------ceeecccccccccCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET----------------------------------HITDTVMGTLGYCAPEYM 126 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~~ 126 (239)
|+||+++.++.++|+|||++........ .......||+.|+|||++
T Consensus 129 p~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 208 (360)
T cd05627 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF 208 (360)
T ss_pred HHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH
Confidence 9999999999999999998764321100 001134689999999999
Q ss_pred ccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHH
Q 044155 127 RTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHAS 204 (239)
Q Consensus 127 ~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 204 (239)
.+..++.++|+|||||++|+|++|..||...... .....+.... ...+.....+...
T Consensus 209 ~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~---------------------~~~~~i~~~~~~~~~p~~~~~s~~~ 267 (360)
T cd05627 209 MQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ---------------------ETYRKVMNWKETLVFPPEVPISEKA 267 (360)
T ss_pred cCCCCCCcceeccccceeeecccCCCCCCCCCHH---------------------HHHHHHHcCCCceecCCCCCCCHHH
Confidence 9889999999999999999999999998543211 0111111000 0000001234567
Q ss_pred HHHHhhhcCCCCCCCCC---HHHHHH
Q 044155 205 AQVTFECIKDSPADRPS---MVDVAK 227 (239)
Q Consensus 205 ~~li~~cl~~dp~~Rps---~~ell~ 227 (239)
+++|.+|+. ||.+|++ ++++++
T Consensus 268 ~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 268 KDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred HHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 889988774 9999995 556554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=233.81 Aligned_cols=195 Identities=19% Similarity=0.252 Sum_probs=154.7
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.+||||+.+++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp 125 (279)
T cd05633 54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKP 125 (279)
T ss_pred CCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCH
Confidence 37999999999999989999999999999999988765 56899999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+||+++.++.++++|||++....... .....++..|+|||.+.. ..++.++|+||+|+++|++++|..||......
T Consensus 126 ~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 202 (279)
T cd05633 126 ANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202 (279)
T ss_pred HHEEECCCCCEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc
Confidence 99999999999999999986543221 123458899999998864 55889999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
... ........ .....+...+..+.+++.+||..||++|| |+.++++
T Consensus 203 ~~~------------------~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 203 DKH------------------EIDRMTLT--VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CHH------------------HHHHHhhc--CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 000 00000000 01111224567889999999999999999 5888877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=230.02 Aligned_cols=201 Identities=22% Similarity=0.309 Sum_probs=161.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dl 79 (239)
+++|+||+++++++...+..++|+||+++++|.+++... ..++...+..++.|++.|++||| + .+++|+||
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l 126 (264)
T cd06623 55 SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDI 126 (264)
T ss_pred hcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCC
Confidence 368999999999999999999999999999999999865 56889999999999999999999 8 99999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
+|+||+++.++.++|+|||.+........ ......++..|+|||.+....++.++|+||||+++|++++|..||.....
T Consensus 127 ~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 205 (264)
T cd06623 127 KPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ 205 (264)
T ss_pred CHHHEEECCCCCEEEccCccceecccCCC-cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 99999999999999999998876533221 12234578889999999888899999999999999999999999865432
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
....+..................+..+.+++.+||+.+|++|||+.++++.
T Consensus 206 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 206 ------------------PSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ------------------cCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011111111111111111111156789999999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=234.63 Aligned_cols=197 Identities=21% Similarity=0.288 Sum_probs=151.7
Q ss_pred CCcccceeeEEEEe------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 3 SHNHILKLIGCCLE------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 3 ~H~niv~l~~~~~~------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+|+||+++++++.. ....+++|||+.+++|.+++..... ..+++..+..++.|++.|+.||| +.+++|
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~ivH 144 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH---AHKVIH 144 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 69999999999863 3467899999999999999976543 45788889999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCC
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
+|++|+||+++.++.++|+|||++........ ......++..|+|||.+. ...++.++|+||||+++|+|++|.
T Consensus 145 ~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 145 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred CCCCHHHEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 99999999999999999999998765432211 123455788999999876 345778999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.||.......... ...............+..+.++|.+||..||.+|||+.|+++
T Consensus 224 ~p~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 224 PPLCDMHPMRALF---------------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCccccCHHhhhh---------------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 9985432111000 000000111111245567999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=237.00 Aligned_cols=201 Identities=19% Similarity=0.216 Sum_probs=155.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+..+...++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 57 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 128 (305)
T cd05609 57 FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLK 128 (305)
T ss_pred hCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCc
Confidence 368999999999999999999999999999999999765 46888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc--------------ceeecccccccccCccccccCCcccccchhhhhhHHHH
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET--------------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFE 146 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 146 (239)
|+||+++.++.++++|||+++....... .......++..|+|||.+....++.++|+||||+++|+
T Consensus 129 p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~e 208 (305)
T cd05609 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208 (305)
T ss_pred hHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHH
Confidence 9999999999999999998763211000 01112346788999999988889999999999999999
Q ss_pred HhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCC-cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 147 LLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS-SIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 147 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
+++|..||.... ..+........... +......+..+.+++.+||+.||.+|||+.++
T Consensus 209 l~~g~~pf~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 267 (305)
T cd05609 209 FLVGCVPFFGDT---------------------PEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGA 267 (305)
T ss_pred HHhCCCCCCCCC---------------------HHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCH
Confidence 999998874321 01111111111110 01111355678999999999999999996555
Q ss_pred HHHHH
Q 044155 226 AKKLR 230 (239)
Q Consensus 226 l~~L~ 230 (239)
.+.|+
T Consensus 268 ~~ll~ 272 (305)
T cd05609 268 FEVKQ 272 (305)
T ss_pred HHHHh
Confidence 55444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=233.82 Aligned_cols=217 Identities=18% Similarity=0.254 Sum_probs=156.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..+...++|+||+ +++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 126 (286)
T cd07832 55 ACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLK 126 (286)
T ss_pred hCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcC
Confidence 468999999999999999999999999 899999987643 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............++..|+|||.+.+. .++.++||||+|++++++++|..+|....+
T Consensus 127 p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 206 (286)
T cd07832 127 PANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206 (286)
T ss_pred HHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence 9999999999999999999876543321122344578899999988654 468899999999999999999777754332
Q ss_pred cccccccchhhhhhhhhccchhhhh-----hhhhh-cCCCc---HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIV-----DHIVV-EDVSS---IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........... ..+. ...+++.. ..... ..... ......+..+.+++.+||..+|.+|||++++++
T Consensus 207 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 207 IEQLAIVFRTL-GTPN-EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHHHHHHHHHc-CCCC-hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11110000000 0000 00000000 00000 00000 001133578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=231.72 Aligned_cols=200 Identities=24% Similarity=0.321 Sum_probs=164.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++.||.+..+|+.|+.....|++||||+||+|..+.+++.+ +.+++..++-++..++.||.||| ..|||.||||
T Consensus 133 ~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLK 206 (459)
T KOG0610|consen 133 LLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLK 206 (459)
T ss_pred hcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHH---hhceeeccCC
Confidence 37899999999999999999999999999999999988766 78999999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCC---------------------------------C-C-------------------
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPE---------------------------------G-E------------------- 107 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~---------------------------------~-~------------------- 107 (239)
|+|||+.++|.+-|+||.++..... . .
T Consensus 207 PENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ae 286 (459)
T KOG0610|consen 207 PENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAE 286 (459)
T ss_pred cceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcC
Confidence 9999999999999999987542110 0 0
Q ss_pred --cceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhh
Q 044155 108 --THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVD 185 (239)
Q Consensus 108 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (239)
......+.||-.|.|||++.+...+.++|-|+|||++|||+.|..||.+.. ..+...
T Consensus 287 p~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~---------------------~~~Tl~ 345 (459)
T KOG0610|consen 287 PTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN---------------------NKETLR 345 (459)
T ss_pred CCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC---------------------chhhHH
Confidence 011234678999999999999999999999999999999999988885322 223333
Q ss_pred hhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC----HHHHHH
Q 044155 186 HIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS----MVDVAK 227 (239)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~ell~ 227 (239)
.++..+...+.....+...++||++.|.+||++|.- |.||-+
T Consensus 346 NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 346 NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 444444433333366678899999999999999997 666643
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=245.51 Aligned_cols=197 Identities=19% Similarity=0.281 Sum_probs=162.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
..||+||++++.|+..+.+||..|||.||....++-.-+ ..+++.++..+++|++.||.||| +++|+|||||.
T Consensus 86 CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKA 158 (1187)
T KOG0579|consen 86 CDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKA 158 (1187)
T ss_pred CCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccc
Confidence 369999999999999999999999999999977776643 57899999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
.|||+.-+|.++|+|||.+... .........+.|||.|||||+.. ..+|+.++||||||+++.||.-+.+|-..
T Consensus 159 GNiL~TldGdirLADFGVSAKn-~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 159 GNILLTLDGDIRLADFGVSAKN-KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred cceEEEecCcEeeecccccccc-hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 9999999999999999987543 22233456889999999999874 35689999999999999999999777322
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhh-cCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV-EDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+.++-.+.+ .+.....+..++..+.+|+..||..||..||++.++++
T Consensus 238 ln---------------------pMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 238 LN---------------------PMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cc---------------------hHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 1222222222 22333445688899999999999999999999999986
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=231.46 Aligned_cols=194 Identities=22% Similarity=0.190 Sum_probs=154.8
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|+||+++++++..++..++|+||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||+|
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p 125 (260)
T cd05611 54 GESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKP 125 (260)
T ss_pred CCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCH
Confidence 58999999999999999999999999999999999765 46889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++|+|||++..... .....++..|+|||.+.+..++.++|+||||+++|++++|..||......
T Consensus 126 ~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~- 199 (260)
T cd05611 126 ENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD- 199 (260)
T ss_pred HHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-
Confidence 999999999999999998765422 22345778899999998877899999999999999999999998532210
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
.......... .........+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus 200 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 200 --------------------AVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred --------------------HHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0000000000 01111123567789999999999999999876555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=234.61 Aligned_cols=224 Identities=22% Similarity=0.320 Sum_probs=176.3
Q ss_pred CCCcccceeeEEEEeCC----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhC------CC
Q 044155 2 MSHNHILKLIGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFG------FP 71 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~------~~ 71 (239)
++|+||++++++-..+. .+|+|++|.+.|||.++++. ..++|....+++..++.||+|||+. +.
T Consensus 261 m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~K 334 (534)
T KOG3653|consen 261 MKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHK 334 (534)
T ss_pred ccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCC
Confidence 68999999999876555 78999999999999999987 4689999999999999999999942 35
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCC-cc-----cccchhhhhhHH
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGV-FN-----EKSNVFSFSVFL 144 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~Di~slG~~l 144 (239)
.+|+|||||+.|||+.+|+.+.|+|||++..+..... .....-.||.+|||||++.+.. +. .+.||||+|.++
T Consensus 335 p~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 335 PPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred CccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 5799999999999999999999999999988754432 2233467999999999998753 32 358999999999
Q ss_pred HHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHH-----HHHHHHHHHHhhhcCCCCCCC
Q 044155 145 FELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKE-----QQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 145 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~dp~~R 219 (239)
||++++....+. ....++..||...+.....-+...+.+ +.+..++..++ .....+.+.+..||..||+.|
T Consensus 415 WEi~SRC~~~~~-~~vp~Yqlpfe~evG~hPt~e~mq~~V---V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeAR 490 (534)
T KOG3653|consen 415 WEIASRCTDADP-GPVPEYQLPFEAEVGNHPTLEEMQELV---VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEAR 490 (534)
T ss_pred HHHHhhcccccC-CCCCcccCchhHHhcCCCCHHHHHHHH---HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhh
Confidence 999999877665 556666667665555444333333333 22222222222 345678899999999999999
Q ss_pred CCHHHHHHHHHHHHHh
Q 044155 220 PSMVDVAKKLRQIYRS 235 (239)
Q Consensus 220 ps~~ell~~L~~l~~~ 235 (239)
.||.-+.+++.++...
T Consensus 491 LTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 491 LTAGCVEERMAELMML 506 (534)
T ss_pred hhhHHHHHHHHHHhcc
Confidence 9999999999998654
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=231.64 Aligned_cols=199 Identities=23% Similarity=0.292 Sum_probs=152.6
Q ss_pred CCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 3 SHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+|+||+++++++.... ..++||||+++++|.+++..... ....++...+..++.|++.||.||| +.+++|
T Consensus 61 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H 136 (275)
T cd06608 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLH---ENKVIH 136 (275)
T ss_pred CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHh---cCCccc
Confidence 6999999999997654 37899999999999998875321 0156889999999999999999999 999999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-----CCcccccchhhhhhHHHHHhcCC
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-----GVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
+||+|+||+++.++.++|+|||.+....... .......++..|+|||++.. ..++.++||||||+++|++++|.
T Consensus 137 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~ 215 (275)
T cd06608 137 RDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215 (275)
T ss_pred CCCCHHHEEEccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCC
Confidence 9999999999999999999999876543222 22234457889999998754 23678899999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.||......... ........ ........+..+.+++.+||..||++|||+.++++
T Consensus 216 ~p~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 216 PPLCDMHPMRAL---------------------FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCccccchHHHH---------------------HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 998532211000 00000000 11112245678899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=230.08 Aligned_cols=205 Identities=21% Similarity=0.325 Sum_probs=158.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++.+......++++|++++++|.+++...... ..+++.....++.|++.||++|| +.+++|+||+
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~ 129 (267)
T cd06610 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPR--GGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIK 129 (267)
T ss_pred hcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 378999999999999999999999999999999999764221 45789999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc---eeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||++++++.++|+|||++......... ......++..|+|||++... .++.++|+||||+++++|++|..||..
T Consensus 130 p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 130 AGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred HHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 99999999999999999998765433221 22344578899999998776 688999999999999999999999854
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
....... ........ ..... .......+..+.+++.+||..||.+|||+.++++
T Consensus 210 ~~~~~~~--------~~~~~~~~------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 210 YPPMKVL--------MLTLQNDP------PSLET---GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cChhhhH--------HHHhcCCC------CCcCC---ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 3221100 00000000 00000 0001245577899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=228.84 Aligned_cols=197 Identities=24% Similarity=0.319 Sum_probs=156.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+..++..++||||+++++|.+++..... ..++...+..++.+++.|+.||| +++++|+||+
T Consensus 55 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~ 128 (256)
T cd08220 55 LLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVH---TKLILHRDLK 128 (256)
T ss_pred hCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 46899999999999988999999999999999999976532 45789999999999999999999 9999999999
Q ss_pred CcceeecCCC-ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++ .++++|||.+....... ......++..|+|||.+.+...+.++|+||||+++|++++|..||.....
T Consensus 129 ~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 206 (256)
T cd08220 129 TQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206 (256)
T ss_pred HHHEEEcCCCCEEEEccCCCceecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch
Confidence 9999998654 57999999987653322 12234578899999999888889999999999999999999888753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
............. ......+..+.+++.+||..+|.+|||++|+++
T Consensus 207 ---------------------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 207 ---------------------PALVLKIMSGTFA-PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---------------------HHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0111111111111 111234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=229.32 Aligned_cols=197 Identities=19% Similarity=0.241 Sum_probs=152.6
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.+. ...+++|||+++++|.+++.+. ..++......++.|++.||.||| +.+++|+|
T Consensus 60 ~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~d 131 (265)
T cd06652 60 NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH---SNMIVHRD 131 (265)
T ss_pred hcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCC
Confidence 47899999999988764 4567899999999999999765 45788889999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++|+||||+++|++++|+.||..
T Consensus 132 l~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 132 IKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred CCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 999999999999999999998865432111 112234578899999999888899999999999999999999999853
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ...............+...+..+.+++.+||. +|++|||++++++
T Consensus 212 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 212 FEAM---------------------AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred cchH---------------------HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 2110 00011111111111223455678899999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=232.24 Aligned_cols=199 Identities=23% Similarity=0.290 Sum_probs=153.1
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC-Ceeecccc
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFK 80 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-~i~H~dlk 80 (239)
++||||+++++++...+..+++|||++ ++|.+++....... ..+++..+..++.|++.||+||| ++ +++|+|||
T Consensus 57 ~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlk 131 (283)
T cd06617 57 VDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVK 131 (283)
T ss_pred cCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCC
Confidence 579999999999999999999999997 79988886532211 56899999999999999999999 76 99999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc----CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT----GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||+++.++.+||+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 132 p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 132 PSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred HHHEEECCCCCEEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 999999999999999999986543221 1223457888999998865 3468899999999999999999998753
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... +..................+..+.++|.+||..+|.+|||++++++
T Consensus 210 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 210 WKTPF--------------------QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred cccCH--------------------HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 21100 0001111111111111234577899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=233.92 Aligned_cols=192 Identities=21% Similarity=0.307 Sum_probs=156.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++.||||+++++++.+++..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||+
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~ 128 (290)
T cd05580 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLK 128 (290)
T ss_pred hCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCC
Confidence 468999999999999999999999999999999999775 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++...... .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||.....
T Consensus 129 p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 203 (290)
T cd05580 129 PENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP- 203 (290)
T ss_pred HHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 99999999999999999998765333 2344578899999999888888999999999999999999988753220
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
............ ..+...+..+.+++.+||..||.+|+ +++|+++
T Consensus 204 --------------------~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 204 --------------------IQIYEKILEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --------------------HHHHHHHhcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011111111111 11123356788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=247.27 Aligned_cols=212 Identities=13% Similarity=0.181 Sum_probs=149.9
Q ss_pred CCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeecccc
Q 044155 3 SHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFK 80 (239)
Q Consensus 3 ~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dlk 80 (239)
.|.+|+++++++... ...++|||++ +++|.+++... ..+++..+..++.||+.||.||| . .+|+|||||
T Consensus 189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlK 259 (467)
T PTZ00284 189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLK 259 (467)
T ss_pred cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCC
Confidence 466789999998765 4678999988 58998988765 56889999999999999999999 6 599999999
Q ss_pred CcceeecCCC----------------ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHH
Q 044155 81 TSCILFNEEN----------------VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFL 144 (239)
Q Consensus 81 ~~nil~~~~~----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 144 (239)
|+|||++.++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 335 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence 9999998765 489999998753221 12355789999999999999999999999999999
Q ss_pred HHHhcCCCCcccccccccc------cccchhhhhhhhhccchhhhhhhh-----------hhc--CCCcHHHHHHHHHHH
Q 044155 145 FELLTGWDVSDLVKDVHDL------VCPFSEYLKNCFEDNRFTEIVDHI-----------VVE--DVSSIEKEQQLHASA 205 (239)
Q Consensus 145 ~~~~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~--~~~~~~~~~~~~~~~ 205 (239)
|||++|+.||......... ...+...+..........+..... +.. .............+.
T Consensus 336 ~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (467)
T PTZ00284 336 YELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLC 415 (467)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHH
Confidence 9999999999754432111 011111110000000000000000 000 000000111245678
Q ss_pred HHHhhhcCCCCCCCCCHHHHHH
Q 044155 206 QVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 206 ~li~~cl~~dp~~Rps~~ell~ 227 (239)
+||..||.+||.+|||++|+++
T Consensus 416 dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 416 DLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHHhCCcChhhCCCHHHHhc
Confidence 9999999999999999999987
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=231.80 Aligned_cols=199 Identities=22% Similarity=0.244 Sum_probs=150.6
Q ss_pred CCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 3 SHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 3 ~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
+||||+++++++... ...++|+||+++++|.++++..... ...+++..+..++.|++.||.||| +.+++|+
T Consensus 77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~ 152 (291)
T cd06639 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLH---NNRIIHR 152 (291)
T ss_pred CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 799999999998754 3578999999999999988642111 156889999999999999999999 8999999
Q ss_pred cccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-----CcccccchhhhhhHHHHHhcCCC
Q 044155 78 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-----VFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 78 dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
||||+||+++.++.++|+|||.+........ ......++..|+|||.+... .++.++|+||||+++|+|++|+.
T Consensus 153 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 153 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred CCCHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCC
Confidence 9999999999999999999999876532221 12234578889999987543 26789999999999999999999
Q ss_pred CcccccccccccccchhhhhhhhhccchhhhhhhhhhcC-CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED-VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
||......... ....... .........+..+.++|.+||..+|.+|||+.++++
T Consensus 232 p~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 232 PLFDMHPVKTL---------------------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCcHHHHH---------------------HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 88543211000 0000000 000011234456899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=232.30 Aligned_cols=196 Identities=16% Similarity=0.252 Sum_probs=154.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..++..++++||+++++|.+++.. .+++...+..++.|++.||++|| +.+++|+||+
T Consensus 72 ~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~ 142 (285)
T cd06648 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIK 142 (285)
T ss_pred HcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 36899999999999999999999999999999998875 34778899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++|++++|..||.....
T Consensus 143 p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~- 220 (285)
T cd06648 143 SDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP- 220 (285)
T ss_pred hhhEEEcCCCcEEEcccccchhhccCC-cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-
Confidence 999999999999999999876543221 112234578899999999888899999999999999999999988743110
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
............ ........+..+.+++.+||..+|.+|||+.++++
T Consensus 221 --------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 221 --------------------LQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --------------------HHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000000000000 00001124567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=236.17 Aligned_cols=216 Identities=19% Similarity=0.174 Sum_probs=155.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.+.+..++||||+ +++|.+++.... ..+++..+..++.|++.||.||| +++++|+|||
T Consensus 58 ~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~ 129 (298)
T cd07841 58 ELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLK 129 (298)
T ss_pred hcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCC
Confidence 478999999999999988999999999 799999997642 26889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.++|+||||+++++|++|..+|....+
T Consensus 130 p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 130 PNNLLIASDGVLKLADFGLARSFGSPN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred hhhEEEcCCCCEEEccceeeeeccCCC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 999999999999999999987653322 11223345778999998855 4578899999999999999999777654332
Q ss_pred cccccccchhhhhhhhhccchh------hhhhhhhhcCCC-cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFT------EIVDHIVVEDVS-SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......+... ..+. ...+. ............ .......+..+.++|.+||+.||.+|||+.|+++
T Consensus 209 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 209 IDQLGKIFEAL-GTPT-EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred HHHHHHHHHHc-CCCc-hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 21111000000 0000 00000 000000000000 0011234577899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=238.92 Aligned_cols=198 Identities=18% Similarity=0.200 Sum_probs=152.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|+||+++++++.+.+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +++++||||||
T Consensus 58 ~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp 130 (331)
T cd05624 58 GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKP 130 (331)
T ss_pred CCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCch
Confidence 589999999999999999999999999999999997642 46788999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-----CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-----GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||+++.++.++|+|||++...............|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 131 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred HHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 99999999999999999987654332222334568999999999875 4578899999999999999999999853
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcC--C-CcHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--V-SSIEKEQQLHASAQVTFECIKDSPAD--RPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~ 227 (239)
.... +....+.... . .+......+..+.+++.+|+..++.+ |+++++++.
T Consensus 211 ~~~~---------------------~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 211 ESLV---------------------ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCHH---------------------HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 2210 0011111000 0 00011134567889999999865544 457887765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=233.44 Aligned_cols=193 Identities=25% Similarity=0.365 Sum_probs=152.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++|+||++ |++.+.+.... ..+++..+..++.|++.||.||| +.+++|+||+
T Consensus 71 ~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~ 142 (307)
T cd06607 71 QLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIK 142 (307)
T ss_pred hCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCC
Confidence 3789999999999999999999999997 78877776432 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++...... ....+++.|+|||++. ...++.++||||||+++|++++|..||...
T Consensus 143 p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 143 AGNILLTEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred cccEEECCCCCEEEeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999988654322 2345778899999874 345788999999999999999999887432
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ..................+..+.+++.+||..+|.+|||+.+++.
T Consensus 218 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 218 NAMS---------------------ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred cHHH---------------------HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 2110 000000001111112245667899999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=231.63 Aligned_cols=201 Identities=21% Similarity=0.268 Sum_probs=150.7
Q ss_pred CCcccceeeEEEE-----eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 3 SHNHILKLIGCCL-----ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 3 ~H~niv~l~~~~~-----~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
+||||+++++++. .++..++||||+++++|.+++...... ...++...+..++.|++.||.||| +.+++|+
T Consensus 73 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 148 (286)
T cd06638 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLH---VNKTIHR 148 (286)
T ss_pred cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 6999999999885 345679999999999999987643211 146788899999999999999999 8999999
Q ss_pred cccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-----CCcccccchhhhhhHHHHHhcCCC
Q 044155 78 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-----GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 78 dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
||||+||+++.++.++|+|||++........ ......+++.|+|||++.. ..++.++|+||||+++|+|++|..
T Consensus 149 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~ 227 (286)
T cd06638 149 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227 (286)
T ss_pred CCCHHhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999876533221 1223458899999998753 347889999999999999999999
Q ss_pred CcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
|+.......... . ..... ......+...+..+.+++.+||..||.+|||+.|+++.
T Consensus 228 p~~~~~~~~~~~-------~--~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 228 PLADLHPMRALF-------K--IPRNP-----------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCCCchhHHHh-------h--ccccC-----------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 875432111000 0 00000 00000011234568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=233.81 Aligned_cols=216 Identities=19% Similarity=0.223 Sum_probs=154.9
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++... ...++|+||++ ++|.+++.... ..++......++.|++.||+||| +.+++|+|
T Consensus 60 ~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~d 131 (293)
T cd07843 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRD 131 (293)
T ss_pred hcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecc
Confidence 47899999999999877 78999999997 69999887643 35889999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus 132 l~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 132 LKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred CCHHHEEECCCCcEEEeecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998876543221 12234467889999988754 4688999999999999999999998754
Q ss_pred cccccccccchhhhhhhhhccchhhhhh--hh----h----hcCCCcHHHHH-HHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVD--HI----V----VEDVSSIEKEQ-QLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~----~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
............ ...+. ...+..... .. . ........+.. .++.+.++|.+||+.||++|||+.|++
T Consensus 211 ~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 211 SEIDQLNKIFKL-LGTPT-EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred ChHHHHHHHHHH-hCCCc-hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 322111100000 00000 000000000 00 0 00000001111 366788999999999999999999998
Q ss_pred H
Q 044155 227 K 227 (239)
Q Consensus 227 ~ 227 (239)
+
T Consensus 289 ~ 289 (293)
T cd07843 289 K 289 (293)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=228.44 Aligned_cols=196 Identities=20% Similarity=0.287 Sum_probs=156.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++......++++||+++++|.+++... ..+++.....++.|++.||+||| +.+++|+||+
T Consensus 58 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 129 (258)
T cd06632 58 KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIK 129 (258)
T ss_pred hcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 368999999999999999999999999999999999765 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||.+....... ......++..|+|||.+.... ++.++|+||||+++|++++|..||.....
T Consensus 130 ~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~ 207 (258)
T cd06632 130 GANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207 (258)
T ss_pred HHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH
Confidence 999999999999999999876543222 223455788899999987666 88999999999999999999999864321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .............+...+..+.+++.+||..+|.+|||+.+++.
T Consensus 208 ~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 208 VAA---------------------VFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHH---------------------HHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000 00000000001111234567889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=240.56 Aligned_cols=211 Identities=18% Similarity=0.219 Sum_probs=149.6
Q ss_pred CCCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++... ...+++++++ +++|.+++.. ..++...+..++.|++.||.||| +.++
T Consensus 70 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~i 139 (343)
T cd07878 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGI 139 (343)
T ss_pred hcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 47899999999987643 3468899988 5899888754 45889999999999999999999 9999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+||||||+||+++.++.+||+|||++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 140 vHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 215 (343)
T cd07878 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215 (343)
T ss_pred ecccCChhhEEECCCCCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999999999999999999998765332 224467899999999876 4688999999999999999999999
Q ss_pred ccccccccccc-------ccchhhhhhhhhccchhhhhhhhhhcCCCc---HHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 154 SDLVKDVHDLV-------CPFSEYLKNCFEDNRFTEIVDHIVVEDVSS---IEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 154 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
|.......... .+..+..... ......... ..+...... ......++.+.+++.+||..||.+|||+.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ 293 (343)
T cd07878 216 FPGNDYIDQLKRIMEVVGTPSPEVLKKI-SSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS 293 (343)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhc-chhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 86432111000 0000000000 000000000 000000000 00012234578999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
|+++
T Consensus 294 ell~ 297 (343)
T cd07878 294 EALA 297 (343)
T ss_pred HHhc
Confidence 9985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=250.79 Aligned_cols=207 Identities=23% Similarity=0.356 Sum_probs=164.5
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCC---------CCCCC--cCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAP---------QPHFE--PLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~---------~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+|+||+.++|.|...+..++|+||+..|+|.++++..+ ..... .++......++.||+.|++||+ +
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~ 436 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---S 436 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---h
Confidence 69999999999999999999999999999999999876 11111 2888999999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcceeeccc--ccccccCccccccCCcccccchhhhhhHHHHHhc
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM--GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 149 (239)
.+++||||..+|||+..+..+||+|||+++.............. -+..|||||.+....++.+||+||||+++||++|
T Consensus 437 ~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs 516 (609)
T KOG0200|consen 437 VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT 516 (609)
T ss_pred CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhh
Confidence 99999999999999999999999999999865443332222222 4667999999999999999999999999999999
Q ss_pred -CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 150 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
|..||.... ...+++. .+..-.+...+..++.++.++|..||+.+|++||++.++.+.
T Consensus 517 LG~~PYp~~~--------------------~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 517 LGGTPYPGIP--------------------PTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred CCCCCCCCCC--------------------cHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 455664311 0112222 122222222233567889999999999999999999999999
Q ss_pred HHHHH
Q 044155 229 LRQIY 233 (239)
Q Consensus 229 L~~l~ 233 (239)
+...+
T Consensus 576 ~~~~l 580 (609)
T KOG0200|consen 576 FEKHL 580 (609)
T ss_pred HHHHH
Confidence 99854
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=229.06 Aligned_cols=195 Identities=21% Similarity=0.330 Sum_probs=156.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..+...++||||+++++|.+++.. ..++...+..++.|++.|+.+|| +.+++|+||+
T Consensus 58 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~ 128 (277)
T cd06641 58 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIK 128 (277)
T ss_pred hcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCC
Confidence 47899999999999999999999999999999998864 35788999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|++++|..|+......
T Consensus 129 p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 207 (277)
T cd06641 129 AANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM 207 (277)
T ss_pred HHhEEECCCCCEEEeecccceecccch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH
Confidence 999999999999999999886553221 1223345788899999998888899999999999999999999887532210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... ............+..+.+++.+||..+|.+||++.++++
T Consensus 208 ---------------------~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 208 ---------------------KVLFLI-PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ---------------------HHHHHH-hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000 000000111234567889999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=233.43 Aligned_cols=217 Identities=21% Similarity=0.248 Sum_probs=156.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++..++..++++||++++.+..+.... ..++...+..++.|++.||.||| ..+++|+||+
T Consensus 56 ~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~ 127 (288)
T cd07833 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIK 127 (288)
T ss_pred hcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 468999999999999999999999999976665555433 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............++..|+|||++.+. .++.++|+||||+++|++++|..||.....
T Consensus 128 ~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 128 PENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred HHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999876544332223345678889999999887 788999999999999999999998864332
Q ss_pred cccccc------cchhhhhhhhhccchhhhhhhhhhcCCCc-----HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVC------PFSEYLKNCFEDNRFTEIVDHIVVEDVSS-----IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... .+.......+......... ........ ..+...+..+.++|.+||..+|++|||+++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 208 IDQLYLIQKCLGPLPPSHQELFSSNPRFAGV--AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHHHHHhCCCCHHHhhhcccCcccccc--ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 111000 0000000000000000000 00000000 001123677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=232.28 Aligned_cols=198 Identities=18% Similarity=0.249 Sum_probs=156.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++|+||+++++|.+++.+ ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 72 ~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~ 142 (293)
T cd06647 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIK 142 (293)
T ss_pred hcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCC
Confidence 36899999999999999999999999999999999865 34678889999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++........ ......+++.|+|||.+....++.++|+||||+++|++++|..||......
T Consensus 143 p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~ 221 (293)
T cd06647 143 SDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221 (293)
T ss_pred HHHEEEcCCCCEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 9999999999999999998765433221 223345788899999998888899999999999999999999998643221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
..... ... ............+..+.+++.+||..+|.+||++++++..
T Consensus 222 ~~~~~--------~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 222 RALYL--------IAT------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred hheee--------hhc------------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11100 000 0000001112345678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=229.93 Aligned_cols=198 Identities=19% Similarity=0.293 Sum_probs=157.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++......++++||+++++|.+++.... ..++...+..++.|++.||.+|| ..+++|+||+
T Consensus 71 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~ 143 (286)
T cd06614 71 DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIK 143 (286)
T ss_pred HCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCC
Confidence 4789999999999999999999999999999999998752 36889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|++++|..||......
T Consensus 144 p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~ 222 (286)
T cd06614 144 SDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222 (286)
T ss_pred hhhEEEcCCCCEEECccchhhhhccch-hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999876543221 1122344678899999998888999999999999999999999887532210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcC-CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVED-VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. ......... .........+..+.++|.+||+.+|.+|||+.++++
T Consensus 223 ~---------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 223 R---------------------ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred H---------------------HHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 000000001 011111235677899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=241.24 Aligned_cols=188 Identities=25% Similarity=0.325 Sum_probs=155.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++.+.+.++...|+|||.+.|+-+.+.+... +....++..|+.+|+.++.||| ++|++||||||+
T Consensus 374 ~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~ 444 (612)
T KOG0603|consen 374 DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPG 444 (612)
T ss_pred CCCcceeecceecCCceeeeeehhccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChh
Confidence 7999999999999999999999999998888888764 3333777889999999999999 999999999999
Q ss_pred ceee-cCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 83 CILF-NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 83 nil~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
|||+ ++.+.++|+|||.++..... .....-|..|.|||++....+++++|+||||+++|+|++|+.||+...+.
T Consensus 445 NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~- 519 (612)
T KOG0603|consen 445 NILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG- 519 (612)
T ss_pred heeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-
Confidence 9999 68889999999998776443 11334577899999999899999999999999999999999998755532
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.++...+..... ....+...++|+.+||+.||.+||++.++..
T Consensus 520 -------------------~ei~~~i~~~~~----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 520 -------------------IEIHTRIQMPKF----SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -------------------HHHHHhhcCCcc----ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 122222221211 1467788999999999999999999999865
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=228.57 Aligned_cols=209 Identities=22% Similarity=0.238 Sum_probs=154.9
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.+. +..++||||+++++|.+++..... ....++......++.|++.||+||| +.+++|+|
T Consensus 55 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~d 130 (287)
T cd06621 55 SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRD 130 (287)
T ss_pred hCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCC
Confidence 47999999999998653 467899999999999988764211 1156788999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 131 l~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (287)
T cd06621 131 IKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207 (287)
T ss_pred CCHHHEEEecCCeEEEeeccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999976442221 123446788999999988889999999999999999999999986443
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... .+.... ......... ... .......++.+.+++.+||+.+|++|||+.|+++
T Consensus 208 ~~~~~~---~~~~~~-~~~~~~~~~-----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 208 EPPLGP---IELLSY-IVNMPNPEL-----KDE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCh---HHHHHH-HhcCCchhh-----ccC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 200000 000000 000000000 000 0000134567899999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=232.06 Aligned_cols=217 Identities=18% Similarity=0.245 Sum_probs=152.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+. ++|.+++.... ..++......++.|++.||.||| +.+++|+|||
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~ 130 (291)
T cd07844 59 DLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLK 130 (291)
T ss_pred hCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCC
Confidence 4789999999999999999999999998 69999887543 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+........ ......++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.....
T Consensus 131 p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 209 (291)
T cd07844 131 PQNLLISERGELKLADFGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209 (291)
T ss_pred HHHEEEcCCCCEEECccccccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999999999999999998764322111 1112345788999998875 4588999999999999999999999864331
Q ss_pred cccccccchhhhhhhhhccchhhhhhh-----hhhcCCC-cHHH---HHH--HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDH-----IVVEDVS-SIEK---EQQ--LHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-~~~~---~~~--~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..............+ ....+...... ....... .... ... ...+.+++.+||+.+|.+|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 210 VEDQLHKIFRVLGTP-TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHHHHhcCCC-ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 111000000000000 00000000000 0000000 0000 011 256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=227.14 Aligned_cols=207 Identities=23% Similarity=0.371 Sum_probs=155.5
Q ss_pred CCCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCC-CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 1 QMSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
+++||||+++++++.... ..+++++|+.+++|.+++..... .....++......++.|++.||+||| +.+
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~ 133 (273)
T cd05074 57 EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKN 133 (273)
T ss_pred cCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 478999999999886532 23688999999999888754321 11135788899999999999999999 899
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CC
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GW 151 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~ 151 (239)
++|+||||+||+++.++.++++|||.+......... ......+++.|++||.+....++.++||||||+++|++++ |.
T Consensus 134 i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~ 213 (273)
T cd05074 134 FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213 (273)
T ss_pred EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCC
Confidence 999999999999999999999999998765332211 1123345678999999988889999999999999999999 77
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||...... +........... ......+..+.+++.+||..+|++|||+.++++.|++
T Consensus 214 ~p~~~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 214 TPYAGVENS---------------------EIYNYLIKGNRL-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCCCCCCHH---------------------HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 776532210 000000000000 0001344678999999999999999999999999987
Q ss_pred H
Q 044155 232 I 232 (239)
Q Consensus 232 l 232 (239)
+
T Consensus 272 ~ 272 (273)
T cd05074 272 I 272 (273)
T ss_pred h
Confidence 6
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=229.35 Aligned_cols=200 Identities=21% Similarity=0.286 Sum_probs=156.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||+++++|.+++..... ..++...+..++.|++.||.||| ..+++|+||+
T Consensus 49 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~ 122 (277)
T cd05577 49 KVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLK 122 (277)
T ss_pred hCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 47899999999999999999999999999999999876532 36889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||||+++++|++|..||......
T Consensus 123 p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 200 (277)
T cd05577 123 PENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK 200 (277)
T ss_pred HHHEEECCCCCEEEccCcchhhhccC--CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc
Confidence 99999999999999999988654321 1222345678899999998888999999999999999999999998543210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.. ............. ..+...++.+.+++.+||+.||.+|| ++.+++.
T Consensus 201 ~~-----------------~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 201 VE-----------------KEELKRRTLEMAV--EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cc-----------------HHHHHhccccccc--cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 00 0001111110000 01123466789999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=230.40 Aligned_cols=223 Identities=18% Similarity=0.246 Sum_probs=155.4
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.+. ...++||||++ ++|.+.+..........++...+..++.|++.||.||| +.+++|+|
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~d 133 (316)
T cd07842 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRD 133 (316)
T ss_pred hcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCC
Confidence 47899999999999988 77899999997 67878776443222236889999999999999999999 89999999
Q ss_pred ccCcceeecC----CCceeEcccccccccCCCCc--ceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCC
Q 044155 79 FKTSCILFNE----ENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 79 lk~~nil~~~----~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|||+||+++. ++.+||+|||++........ .......+++.|+|||.+.+. .++.++|+||||+++++|++|.
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 213 (316)
T cd07842 134 LKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213 (316)
T ss_pred CCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcC
Confidence 9999999999 88999999999876533221 112234568889999988764 5789999999999999999999
Q ss_pred CCcccccccccccccchh-hhhhhhh---------------ccchhhhhhhhhhcCCC-cHHHH------HHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSE-YLKNCFE---------------DNRFTEIVDHIVVEDVS-SIEKE------QQLHASAQVT 208 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~-~~~~~~~---------------~~~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~li 208 (239)
.||...........++.. ....... ...+....+........ ..... ..+..+.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 293 (316)
T cd07842 214 PIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLL 293 (316)
T ss_pred CCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHH
Confidence 998754332211111000 0000000 00000000000000000 00010 2345688999
Q ss_pred hhhcCCCCCCCCCHHHHHH
Q 044155 209 FECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 209 ~~cl~~dp~~Rps~~ell~ 227 (239)
.+||+.||++|||+.|+++
T Consensus 294 ~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 294 RKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhcCCcccCcCHHHHhc
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=257.46 Aligned_cols=202 Identities=20% Similarity=0.299 Sum_probs=150.8
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCC----CCCe
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF----PRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~----~~~i 74 (239)
+|+|||||+++++|.+. ..+++||||+++++|.+++...... ...+++..++.++.||+.||.|||... ..+|
T Consensus 68 ~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~I 146 (1021)
T PTZ00266 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERV 146 (1021)
T ss_pred HcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCc
Confidence 47899999999998654 4678999999999999998753221 146899999999999999999999311 1459
Q ss_pred eeccccCcceeecCC-----------------CceeEcccccccccCCCCcceeecccccccccCcccccc--CCccccc
Q 044155 75 VFRNFKTSCILFNEE-----------------NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT--GVFNEKS 135 (239)
Q Consensus 75 ~H~dlk~~nil~~~~-----------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~ 135 (239)
+|+||||+|||++.. +.+||+|||++....... ......|++.|+|||++.+ ..++.++
T Consensus 147 VHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KS 224 (1021)
T PTZ00266 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKS 224 (1021)
T ss_pred eeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchh
Confidence 999999999999642 348999999987553221 1234468999999999864 3478999
Q ss_pred chhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCC
Q 044155 136 NVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDS 215 (239)
Q Consensus 136 Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 215 (239)
|||||||++|+|++|..||....... ............ + ....+..+.+||..||..+
T Consensus 225 DVWSLG~ILYELLTGk~PF~~~~~~~--------------------qli~~lk~~p~l-p-i~~~S~eL~dLI~~~L~~d 282 (1021)
T PTZ00266 225 DMWALGCIIYELCSGKTPFHKANNFS--------------------QLISELKRGPDL-P-IKGKSKELNILIKNLLNLS 282 (1021)
T ss_pred HHHHHHHHHHHHHHCCCCCCcCCcHH--------------------HHHHHHhcCCCC-C-cCCCCHHHHHHHHHHhcCC
Confidence 99999999999999999985322111 111111111100 0 1133567889999999999
Q ss_pred CCCCCCHHHHHH
Q 044155 216 PADRPSMVDVAK 227 (239)
Q Consensus 216 p~~Rps~~ell~ 227 (239)
|.+|||+.|++.
T Consensus 283 PeeRPSa~QlL~ 294 (1021)
T PTZ00266 283 AKERPSALQCLG 294 (1021)
T ss_pred hhHCcCHHHHhc
Confidence 999999999984
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=228.92 Aligned_cols=199 Identities=20% Similarity=0.296 Sum_probs=164.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
|...|++|++||.+.....+|||||||.-||+.|.++..+ +++.+.++..++...++||+||| ...-+|||||
T Consensus 84 QC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIK 156 (502)
T KOG0574|consen 84 QCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIK 156 (502)
T ss_pred HcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcc
Confidence 3467999999999988889999999999999999998765 78999999999999999999999 8889999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
..|||++-+|..||+|||.+-.+..-. ....+..||+.|||||++..-.|+.++||||||++..||..|++||...-.+
T Consensus 157 AGNILLNT~G~AKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM 235 (502)
T KOG0574|consen 157 AGNILLNTDGIAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM 235 (502)
T ss_pred cccEEEcccchhhhhhccccchhhhhH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc
Confidence 999999999999999999986653221 2345677999999999999999999999999999999999999998643322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... + ...+....-+..++.++-++|.+||..+|++|-||-++++
T Consensus 236 RAIFMI-------P-------------T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 236 RAIFMI-------P-------------TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ceeEec-------c-------------CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 222110 0 0000011123477888999999999999999999998876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=231.96 Aligned_cols=218 Identities=18% Similarity=0.202 Sum_probs=154.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++||||+. ++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||+
T Consensus 55 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~ 127 (284)
T cd07860 55 ELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLK 127 (284)
T ss_pred hcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 4789999999999999999999999996 789888876533 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.++|+||||+++|+++||+.||.....
T Consensus 128 p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~ 206 (284)
T cd07860 128 PQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 206 (284)
T ss_pred HHHEEECCCCCEEEeeccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999998865432211 122334678899999887644 58889999999999999999999864332
Q ss_pred cccccccchhhhhhhh----hc-cchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCF----ED-NRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... ....+. .. .................. .....+..+.++|.+||+.||++|||+++++.
T Consensus 207 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 207 IDQLFRIFR-TLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHHHH-HhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 111100000 000000 00 000000000000000000 01123466789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=226.15 Aligned_cols=203 Identities=19% Similarity=0.250 Sum_probs=157.7
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCC--CCCeee
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF--PRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~~~i~H 76 (239)
+++||||+++++++.. +...+++|||+++++|.+++..... ....+++..+..++.|++.||.+||..+ +.+++|
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h 133 (265)
T cd08217 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLH 133 (265)
T ss_pred hcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCccee
Confidence 4789999999998764 3457899999999999999876421 1156889999999999999999999433 578999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||+|+||+++.++.++++|||++........ ......++..|+|||++....++.++|+||||+++++|++|..||..
T Consensus 134 ~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 134 RDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred cCCCHHHEEEecCCCEEEecccccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 99999999999999999999999876543321 12334678899999999888889999999999999999999998853
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... ............ ...+...+..+.+++.+||..+|.+|||+.++++
T Consensus 213 ~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 213 RNQ---------------------LQLASKIKEGKF-RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cCH---------------------HHHHHHHhcCCC-CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 220 001111111111 1112245677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=228.79 Aligned_cols=195 Identities=19% Similarity=0.247 Sum_probs=154.7
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
..||||+++++++.+....++||||+.+++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||||
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p 125 (278)
T cd05606 54 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKP 125 (278)
T ss_pred CCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCH
Confidence 47999999999999999999999999999999988754 56899999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+||+++.++.++|+|||++....... .....|+..|+|||.+.+. .++.++||||+|+++|+|++|..||......
T Consensus 126 ~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~ 202 (278)
T cd05606 126 ANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202 (278)
T ss_pred HHEEECCCCCEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc
Confidence 99999999999999999986543221 2234688999999998754 5889999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
... ........... ..+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 203 ~~~------------------~~~~~~~~~~~--~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 203 DKH------------------EIDRMTLTMAV--ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred chH------------------HHHHHhhccCC--CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 100 00000000000 01112356789999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=229.91 Aligned_cols=204 Identities=14% Similarity=0.121 Sum_probs=151.6
Q ss_pred CCCcccceeeEEEEeCC----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 2 MSHNHILKLIGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
+.|+||+++++.+.... ..+++++++. .++.+.+... ...++..+..++.|++.||+||| +.+++||
T Consensus 80 ~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHr 150 (294)
T PHA02882 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHG 150 (294)
T ss_pred CCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 57999999998766543 2367788875 6777777543 33567888899999999999999 8999999
Q ss_pred cccCcceeecCCCceeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 78 NFKTSCILFNEENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 78 dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
||||+|||++.++.++|+|||+++....... .......||+.|+|||++.+..++.++||||||+++++|++|.
T Consensus 151 DiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~ 230 (294)
T PHA02882 151 DIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIK 230 (294)
T ss_pred CCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999876532211 1122346899999999999889999999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
.||........... . ...+.......... .....++.+.+++..||+.+|.+||+++++.+.+
T Consensus 231 ~P~~~~~~~~~~~~-------~-----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 231 LPWKGFGHNGNLIH-------A-----AKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCccccchHHHH-------H-----hHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99975532111100 0 00011111111111 1123457789999999999999999999998865
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=244.52 Aligned_cols=201 Identities=25% Similarity=0.426 Sum_probs=163.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||++++||+..+ ....+|||+++.|||.+.++.... ..+.......++.||+.|+.||. .+++|||||.
T Consensus 167 ~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLA 239 (1039)
T KOG0199|consen 167 KLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLA 239 (1039)
T ss_pred hccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhh
Confidence 5899999999999987 667899999999999999998433 67888999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC-CCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW-DVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~-~p~~~~ 157 (239)
.+|+++.....+||+|||+.+.+..+... .......++.|+|||.+....++.++|+|++||++|||+|+. .||-+.
T Consensus 240 ARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 240 ARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred hhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence 99999999999999999999888655433 234556788999999999999999999999999999999953 455332
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
. -..+...+. ......-+..+++++.+++..||..+|.+|||+..+.+.+-
T Consensus 320 ~---------------------g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 320 R---------------------GIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred C---------------------HHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 2 111111111 11112223467889999999999999999999999986543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=226.12 Aligned_cols=183 Identities=21% Similarity=0.221 Sum_probs=147.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
..||||+++++++.+....++||||+++++|.+++... ..+++.....++.|++.||.||| +.+++|+||||
T Consensus 42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp 113 (237)
T cd05576 42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNP 113 (237)
T ss_pred cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCH
Confidence 36899999999999999999999999999999998765 45889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++++|||.+....... ....++..|+|||......++.++|+||+|+++|++++|..|+.......
T Consensus 114 ~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~ 189 (237)
T cd05576 114 NNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI 189 (237)
T ss_pred HHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc
Confidence 99999999999999999875543221 12335677999999988888999999999999999999987754221100
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
. ... . ...+...+..+.+++.+||+.||++|||+.
T Consensus 190 ~-------------------~~~----~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 190 N-------------------THT----T----LNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred c-------------------ccc----c----cCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 0 000 0 000113456788999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=226.13 Aligned_cols=200 Identities=21% Similarity=0.336 Sum_probs=155.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++...+..++|+||+++++|.+++... ..++...+..++.|++.|+.||| +.+++|+||+
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~ 126 (264)
T cd06626 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIK 126 (264)
T ss_pred hCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 478999999999999999999999999999999999764 45778889999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce---eecccccccccCccccccCC---cccccchhhhhhHHHHHhcCCCCc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI---TDTVMGTLGYCAPEYMRTGV---FNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||+++.++.++|+|||.+.......... .....++..|+|||++.+.. .+.++|+||||++++++++|..||
T Consensus 127 ~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf 206 (264)
T cd06626 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206 (264)
T ss_pred HHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence 999999999999999999987654332211 11345778999999988765 889999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... .. .... ......+.....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 207 ~~~~~~~~~----------~~-------~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 207 SELDNEFQI----------MF-------HVGA--GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cCCcchHHH----------HH-------HHhc--CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 643210000 00 0000 000000011123566789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=227.64 Aligned_cols=213 Identities=20% Similarity=0.270 Sum_probs=151.6
Q ss_pred CCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 3 SHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 3 ~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+||+++++++.++ +..++|+||++ ++|.+.+.... ..+++..+..++.|++.||.||| +.+++|+||+
T Consensus 56 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~ 127 (282)
T cd07831 56 PHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIK 127 (282)
T ss_pred CCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccC
Confidence 499999999999987 78899999997 68888887542 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++. +.++|+|||.+........ .....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.....
T Consensus 128 p~ni~l~~-~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~ 204 (282)
T cd07831 128 PENILIKD-DILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204 (282)
T ss_pred HHHEEEcC-CCeEEEecccccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence 99999999 9999999999876533221 123457888999997754 4578899999999999999999999864322
Q ss_pred cccc------cccchhhhhhhhhccchhh-hhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDL------VCPFSEYLKNCFEDNRFTE-IVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ...........+....... ......... ........+..+.++|.+||..+|++|||++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTG-LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHHcCCCCHHHHHhhcccccccccCccccccc-HHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1100 0000000000000000000 000000000 00011245688999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=228.04 Aligned_cols=194 Identities=21% Similarity=0.357 Sum_probs=153.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.|||++++++++..+...++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||+|+
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ 130 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAA 130 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHH
Confidence 499999999999999999999999999999998864 35789999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
||+++.++.++|+|||.+....... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 131 ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 131 NILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred HEEEcCCCCEEEccCCceeecCCCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 9999999999999999887654332 12233457888999998865 347889999999999999999999986432111
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... ..... ..........+..+.+++.+||+.||.+||++.+++.
T Consensus 210 ~~~------------------~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 210 AMM------------------LIPKS---KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred hhh------------------ccccC---CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 000 00000 0000001124567889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=228.76 Aligned_cols=200 Identities=22% Similarity=0.227 Sum_probs=156.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+..+...++++||+++++|.+++.+. ..++...+..++.|++.||+||| +.+++|+||+
T Consensus 49 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~ 120 (265)
T cd05579 49 QAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV-----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLK 120 (265)
T ss_pred hCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCC
Confidence 368999999999999999999999999999999999865 46889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
|+||+++.++.++|+|||++........ .......++..|+|||.......+.++|+||||++++++++|..|
T Consensus 121 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 200 (265)
T cd05579 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200 (265)
T ss_pred HHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 9999999999999999998765432211 122334567889999999888889999999999999999999988
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..... .+..................+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus 201 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 201 FHGETP---------------------EEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCCCCH---------------------HHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 753221 1111111111111111112367789999999999999999995544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=229.99 Aligned_cols=200 Identities=22% Similarity=0.225 Sum_probs=149.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.||||+++++++...+..+++||++. +++.++...........++...+..++.|++.||+|||. ..+++|+||||+
T Consensus 61 ~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~ 137 (288)
T cd06616 61 DCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPS 137 (288)
T ss_pred CCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHH
Confidence 49999999999999889999999996 677664432100011568899999999999999999993 359999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC---CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG---VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+++.++.++|+|||++........ .....++..|+|||++.+. .++.++||||||+++|++++|..||.....
T Consensus 138 Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 215 (288)
T cd06616 138 NILLDRNGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215 (288)
T ss_pred HEEEccCCcEEEeecchhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch
Confidence 99999999999999999865433221 1233578889999998766 588999999999999999999999853320
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhc---CCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE---DVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. .+........ ..........+..+.+++.+||+.+|++|||+++++.
T Consensus 216 ~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 216 V--------------------FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred H--------------------HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000000000 0000001235667899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=221.36 Aligned_cols=195 Identities=21% Similarity=0.265 Sum_probs=154.2
Q ss_pred CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcc
Q 044155 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 83 (239)
Q Consensus 4 H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~n 83 (239)
-|+||+++|+|..+..++|.||.|. -.+..++++-. .++++..+=++...+..||.||-+ .++|+|||+||+|
T Consensus 150 cpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSN 222 (391)
T KOG0983|consen 150 CPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSN 222 (391)
T ss_pred CCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccc
Confidence 4899999999999999999999985 45555555443 568898888899999999999997 7899999999999
Q ss_pred eeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc---CCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 84 ILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 84 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
||++..|++|++|||++-.+-.+.. .+.-.|.+.|||||.+.. .+|..++|+||||+.++|+.||..||..-.
T Consensus 223 ILlDe~GniKlCDFGIsGrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-- 298 (391)
T KOG0983|consen 223 ILLDERGNIKLCDFGISGRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-- 298 (391)
T ss_pred eEEccCCCEEeecccccceeecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--
Confidence 9999999999999999866644432 223358899999999864 358899999999999999999999986422
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcC-CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVED-VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.-.+....++... .........++.+.+|+..||..|+.+||...++++
T Consensus 299 ------------------tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 299 ------------------TDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ------------------ccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1122233333221 111222347889999999999999999999999876
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=229.85 Aligned_cols=195 Identities=23% Similarity=0.363 Sum_probs=152.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||++++++++.+....++||||+. |+|.+.+.... ..+++..+..++.|++.|+.||| +.+++|+||+
T Consensus 81 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~ 152 (317)
T cd06635 81 RIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIK 152 (317)
T ss_pred hCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 4789999999999999999999999997 68878775432 46889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++..... .....+++.|+|||.+. ...++.++|+||||+++|+|++|..||...
T Consensus 153 p~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 153 AGNILLTEPGQVKLADFGSASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred cccEEECCCCCEEEecCCCccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999998754422 22345788899999874 345888999999999999999999887532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
... ...................+..+.+++.+||+.+|.+||++.++++.+
T Consensus 228 ~~~---------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 228 NAM---------------------SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred cHH---------------------HHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 100 000011111111111123456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=226.04 Aligned_cols=198 Identities=24% Similarity=0.303 Sum_probs=155.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++.+......++|+||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 55 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~ 128 (257)
T cd08225 55 KMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIK 128 (257)
T ss_pred hCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCC
Confidence 36899999999999999999999999999999999976533 45789999999999999999999 8999999999
Q ss_pred CcceeecCCC-ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++ .++++|||.+....... .......+++.|+|||...+..++.++|+||||++++++++|..||.....
T Consensus 129 ~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 207 (257)
T cd08225 129 SQNIFLSKNGMVAKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207 (257)
T ss_pred HHHEEEcCCCCeEEecccccchhccCCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 9999999886 46999999886653322 122234578899999999888899999999999999999999988753210
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+........... ......+..+.+++.+||..+|++|||+.+++.
T Consensus 208 ---------------------~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 208 ---------------------HQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---------------------HHHHHHHhcccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0001011111110 011134467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=227.29 Aligned_cols=218 Identities=18% Similarity=0.206 Sum_probs=151.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++..+...++|+||+. +++.+.+.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 59 ~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlk 130 (291)
T cd07870 59 GLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLK 130 (291)
T ss_pred hcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 4789999999999999889999999996 78877775432 34677888899999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||+...+
T Consensus 131 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 131 PQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred hHHEEEcCCCcEEEeccccccccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 9999999999999999998865322111 1123346888999999875 3578899999999999999999999875433
Q ss_pred cccccc--------cchhhhhhhhhccc-hhhhhhhhhhcCCCcH-HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVC--------PFSEYLKNCFEDNR-FTEIVDHIVVEDVSSI-EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~--------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+... +............. ................ .....+..+.+++.+|+..||++|||+.|++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 210 VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 211000 00000000000000 0000000000000000 00012456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=227.56 Aligned_cols=196 Identities=19% Similarity=0.237 Sum_probs=156.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+.++...++|+||+.+++|.+++... ..++......++.|++.||.||| +.+++|+||+
T Consensus 56 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~ 127 (258)
T cd05578 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIK 127 (258)
T ss_pred hCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCC
Confidence 478999999999999999999999999999999999764 46888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||++++++.++|+|||.+....... ......++..|+|||.+....++.++|+||||+++|++++|..||......
T Consensus 128 ~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 205 (258)
T cd05578 128 PDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205 (258)
T ss_pred HHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence 999999999999999999886653322 123445778899999998888999999999999999999999998644321
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH--HHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM--VDVA 226 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~--~ell 226 (239)
. ..... ..... .....+...+..+.++|.+||+.||.+||++ .|++
T Consensus 206 ~------------------~~~~~-~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 206 I------------------RDQIR-AKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred H------------------HHHHH-HHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 00000 00000 0011112345788899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=228.65 Aligned_cols=202 Identities=22% Similarity=0.268 Sum_probs=156.6
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++.+..+...++||||+.+++|.+.+... ..++......++.|++.||.||| ..+++|+||+|+
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~ 134 (288)
T cd05583 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLE 134 (288)
T ss_pred CCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 6999999999999999999999999999999998754 45788899999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC--cccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
||+++.++.++|+|||++...............++..|+|||...+.. .+.++|+||||+++|+|++|..||......
T Consensus 135 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 135 NILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred HeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 999999999999999998765433322233445788999999987655 788999999999999999999987532110
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
. ...+.......... ..+...+..+.+++.+||+.||++|||+.++.+.|.-
T Consensus 215 ~-----------------~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 215 N-----------------SQSEISRRILKSKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred c-----------------hHHHHHHHHHccCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 00011111111111 1112345678899999999999999998877765543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=227.69 Aligned_cols=197 Identities=16% Similarity=0.272 Sum_probs=154.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++..++..++||||+++++|.+++.. ..+++.....++.|++.|++||| +.+++|+||+
T Consensus 73 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~ 143 (292)
T cd06657 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIK 143 (292)
T ss_pred hcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 36899999999999999999999999999999988754 35788899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......++..|+|||...+..++.++|+||+|+++|++++|..||......
T Consensus 144 p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~ 222 (292)
T cd06657 144 SDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222 (292)
T ss_pred HHHEEECCCCCEEEcccccceeccccc-ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999876543221 1122345788899999998888899999999999999999999987532110
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. ............. .....+..+.+++.+||..+|.+||++.++++
T Consensus 223 ~~------------------~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 223 KA------------------MKMIRDNLPPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HH------------------HHHHHhhCCcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00 0000000000000 01134556789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=235.33 Aligned_cols=214 Identities=18% Similarity=0.247 Sum_probs=152.4
Q ss_pred CCCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++... ...++||||+. ++|.+.+.. .++...+..++.|++.||.||| ..++
T Consensus 71 ~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi 139 (353)
T cd07850 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGI 139 (353)
T ss_pred hcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 47899999999988643 24689999997 789888753 3778888999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
+|+||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus 140 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf 217 (353)
T cd07850 140 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLF 217 (353)
T ss_pred eeCCCCHHHEEECCCCCEEEccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCC
Confidence 999999999999999999999999987653321 122345788899999999888999999999999999999999998
Q ss_pred ccccccccc-------cccchhhhhhh-------hhc------cchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCC
Q 044155 155 DLVKDVHDL-------VCPFSEYLKNC-------FED------NRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKD 214 (239)
Q Consensus 155 ~~~~~~~~~-------~~~~~~~~~~~-------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 214 (239)
......... ..+..++.... ... ..+.+..................+..+.+++.+||+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 297 (353)
T cd07850 218 PGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297 (353)
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCC
Confidence 644321110 00000000000 000 0000000000000000000123456788999999999
Q ss_pred CCCCCCCHHHHHH
Q 044155 215 SPADRPSMVDVAK 227 (239)
Q Consensus 215 dp~~Rps~~ell~ 227 (239)
||++|||+.|+++
T Consensus 298 dP~~R~t~~eiL~ 310 (353)
T cd07850 298 DPEKRISVDDALQ 310 (353)
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=228.26 Aligned_cols=194 Identities=23% Similarity=0.343 Sum_probs=151.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+|++++++++......++|+||+. +++.+.+.... ..++...+..++.|++.|+.||| +.+++|+||+
T Consensus 71 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~ 142 (308)
T cd06634 71 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVK 142 (308)
T ss_pred hCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 3689999999999999999999999997 78888776432 45788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++...... ....+++.|+|||.+. ....+.++||||||+++|++++|..||...
T Consensus 143 p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 143 AGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred HHhEEECCCCcEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999987654322 2345788899999874 345788999999999999999999887532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
... ...................+..+.++|.+||..+|.+||++.+++..
T Consensus 218 ~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 218 NAM---------------------SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cHH---------------------HHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 210 00000011111111122455678899999999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=229.07 Aligned_cols=219 Identities=17% Similarity=0.199 Sum_probs=155.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++++||++ ++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+
T Consensus 54 ~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~ 126 (283)
T cd07835 54 ELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLK 126 (283)
T ss_pred hcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCC
Confidence 3689999999999999999999999996 799999876532 36889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+........ ......++..|+|||++.+. .++.++|+||||+++|+|++|..||....+
T Consensus 127 p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 127 PQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred HHHEEEcCCCcEEEeecccccccCCCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999865432211 11223457889999988764 468899999999999999999999864432
Q ss_pred cccccccchhh---hhhhhhc-cchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEY---LKNCFED-NRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........... ....+.. ....+........... .......+..+.+++.+||+.||.+|||++|+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 206 IDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 21111000000 0000000 0000000000000000 0011133467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=228.78 Aligned_cols=215 Identities=21% Similarity=0.295 Sum_probs=154.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++|+||+++++|..+.... ..+++..+..++.|++.||+||| +.+++|+|++
T Consensus 56 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~ 127 (286)
T cd07846 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIK 127 (286)
T ss_pred hcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 368999999999999999999999999988887766543 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 128 p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~ 206 (286)
T cd07846 128 PENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206 (286)
T ss_pred HHHEEECCCCcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence 999999999999999999987653322 22233457889999998875 3477899999999999999999988864322
Q ss_pred cccccc------cchhhhhhhhhccchhhhhhhhhhcCCCc-----HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVC------PFSEYLKNCFEDNRFTEIVDHIVVEDVSS-----IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... .+.......+..... ........... ......+..+.+++.+||..+|.+||++.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 207 IDQLYHIIKCLGNLIPRHQEIFQKNPL---FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHHHHHHHHhCCCchhhHHHhccchH---hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 110000 000000000000000 00000000000 001134677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=228.27 Aligned_cols=193 Identities=24% Similarity=0.373 Sum_probs=150.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||++++++++.+....++||||+. +++.+.+.... ..+++..+..++.|++.|+.||| +.+++|+||+
T Consensus 77 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~ 148 (313)
T cd06633 77 QLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIK 148 (313)
T ss_pred hCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 4789999999999999999999999997 68888776543 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++..... .....++..|+|||.+. ...++.++|+||||+++|+|++|..||...
T Consensus 149 p~nili~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 149 AGNILLTEPGQVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred hhhEEECCCCCEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999998754321 22446788899999984 355788999999999999999999887533
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... ................+..+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 224 NAMSAL---------------------YHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ChHHHH---------------------HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 211000 0000000000111233456889999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=220.64 Aligned_cols=198 Identities=22% Similarity=0.351 Sum_probs=157.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++.+......++++||+++++|.+++.... ..+++..+..++.|++.||.+|| ..+++|+||+
T Consensus 53 ~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~ 125 (253)
T cd05122 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIK 125 (253)
T ss_pred hCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCC
Confidence 4689999999999999999999999999999999987643 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+........ .....++..|+|||.+.+...+.++|+||||++++++++|..||......
T Consensus 126 p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 203 (253)
T cd05122 126 AANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM 203 (253)
T ss_pred HHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 9999999999999999998866543321 23456788999999998888899999999999999999999887533210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... ..... ............+..+.+++.+||..||++|||+.++++
T Consensus 204 ~~~------------------~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 204 KAL------------------FKIAT--NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHH------------------HHHHh--cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000 000000001112567899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=226.61 Aligned_cols=217 Identities=19% Similarity=0.208 Sum_probs=154.4
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++... +..++|+||++ ++|.+++.... ..++...+..++.|++.||+||| +.+++|+|
T Consensus 54 ~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~d 125 (287)
T cd07840 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRD 125 (287)
T ss_pred hccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecc
Confidence 36899999999999887 78999999997 68988886542 46889999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+|+||++++++.++|+|||.+...............++..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 126 l~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 126 IKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred CcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987654332212233456788999998765 45789999999999999999999998643
Q ss_pred cccccccccchhhhhhhhhccchhhhhh----hhh-h-cCCCc---HHHHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVD----HIV-V-EDVSS---IEKEQ-QLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~-~~~~~---~~~~~-~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......... .....+ ....+..... ... . ..... ..... .+..+.+++.+||..+|.+|||++++++
T Consensus 206 ~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 206 TELEQLEKIF-ELCGSP-TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ChHHHHHHHH-HHhCCC-chhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 3211100000 000000 0000000000 000 0 00000 00011 2677899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=224.32 Aligned_cols=210 Identities=17% Similarity=0.237 Sum_probs=158.7
Q ss_pred cceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceee
Q 044155 7 ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF 86 (239)
Q Consensus 7 iv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~ 86 (239)
+|.+.+||.-.++.|||+|.+ |.|+.|++..+.. .+++...++.++.|++.++++|| +.+++|.||||+|||+
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILf 225 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILF 225 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEE
Confidence 577888898899999999999 5899999998755 78999999999999999999999 9999999999999998
Q ss_pred cCC--------------------CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHH
Q 044155 87 NEE--------------------NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFE 146 (239)
Q Consensus 87 ~~~--------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 146 (239)
.+. -.++++|||.+...... .+....|..|+|||++.+.+++.++||||+|||++|
T Consensus 226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVE 301 (415)
T ss_pred eccceEEEeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEE
Confidence 532 24799999998664332 245667889999999999999999999999999999
Q ss_pred HhcCCCCcccccccc------cccccchhhhhhhh------hccc--hhhhhhh-----hhhcCCCc----HHHHHHHHH
Q 044155 147 LLTGWDVSDLVKDVH------DLVCPFSEYLKNCF------EDNR--FTEIVDH-----IVVEDVSS----IEKEQQLHA 203 (239)
Q Consensus 147 ~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~------~~~~--~~~~~~~-----~~~~~~~~----~~~~~~~~~ 203 (239)
+.+|...|+.+.+.+ ...+|++....... ..+. |.+...+ +....... ...+.....
T Consensus 302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 999999999887543 23334433322221 1110 1111100 00000000 011345566
Q ss_pred HHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 204 SAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 204 ~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+.+|++.||.+||++|+|+.|++.
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhc
Confidence 899999999999999999999885
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=223.92 Aligned_cols=212 Identities=18% Similarity=0.242 Sum_probs=154.8
Q ss_pred CCCcccceeeEEEEeCCC-----ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 2 MSHNHILKLIGCCLETPI-----PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~-----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++||||+++++++..... .+++||++. ++|.+++..... ..+++..+..++.|++.||.||| +.+++|
T Consensus 58 ~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH---~~~i~h 130 (287)
T cd07838 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH---SHRIVH 130 (287)
T ss_pred cCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeee
Confidence 579999999999987776 899999997 689888876432 35889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 131 ~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 131 RDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred ccCChhhEEEccCCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 99999999999999999999998866533221 1223467889999999988899999999999999999999888764
Q ss_pred ccccccccccchhhhhhhhh--ccchh-------hhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFE--DNRFT-------EIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~--~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........ ........ ...+. ........... .......+..+.+++.+||..||.+||++++++.
T Consensus 209 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 209 TSEADQLD----KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CChHHHHH----HHHHHcCCCChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 33211100 00000000 00000 00000000000 1111244677889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=220.26 Aligned_cols=199 Identities=23% Similarity=0.299 Sum_probs=158.8
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++.+... ...++++|++++++|.+++... ..+++..+..++.|++.||.||| +.+++|+|
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~d 126 (260)
T cd06606 55 SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRD 126 (260)
T ss_pred HcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccC
Confidence 47899999999999988 7889999999999999999865 46889999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
++|+||+++.++.++|+|||.+......... ......++..|+|||.......+.++|+||||++++++++|..||...
T Consensus 127 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 127 IKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred CCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998765433210 123455788999999998888999999999999999999999998643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+... ..............+...+..+.+++.+|+..+|.+|||+.+++.
T Consensus 207 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 207 GNPMA--------------------ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CchHH--------------------HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 31000 000000000011111234678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=221.72 Aligned_cols=197 Identities=20% Similarity=0.242 Sum_probs=154.1
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.+. +..++++||+++++|.+++... ..++......++.|++.||.||| +.+++|+|
T Consensus 60 ~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~d 131 (264)
T cd06653 60 NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH---SNMIVHRD 131 (264)
T ss_pred HcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCC
Confidence 47899999999998764 4578999999999999998764 45788889999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|+||||++++++++|+.||..
T Consensus 132 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 132 IKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred CCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999875432111 111234578899999999888889999999999999999999999853
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .+.+.+..........+...++.+.+++.+||. +|..|||+.+++.
T Consensus 212 ~~~---------------------~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 212 YEA---------------------MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cCH---------------------HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 211 011111111111112233566789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=227.40 Aligned_cols=216 Identities=18% Similarity=0.240 Sum_probs=152.4
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++|+||+++++++.+. +..++||||+. ++|.+++.... ..+++..+..++.|++.||.||| +.+++|+|
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~d 133 (309)
T cd07845 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRD 133 (309)
T ss_pred hCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 47899999999998765 45789999997 68988887543 46889999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|||+||+++.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 134 l~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 134 LKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CCHHHEEECCCCCEEECccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876543221 1122235778999998875 45789999999999999999999998643
Q ss_pred cccccccccchhhhhhhhhccchhhhhh-----h-hhh-cCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVD-----H-IVV-EDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-~~~-~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........ .......+ ....+..... . ... ...... .....++.+.++|.+||..||++|||+.++++
T Consensus 213 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 213 SEIEQLDL-IIQLLGTP-NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CHHHHHHH-HHHhcCCC-ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 32111000 00000000 0000000000 0 000 000000 00123567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=226.60 Aligned_cols=218 Identities=18% Similarity=0.233 Sum_probs=150.3
Q ss_pred CCCCcccceeeEEEEeCCC--------ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC
Q 044155 1 QMSHNHILKLIGCCLETPI--------PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR 72 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~--------~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 72 (239)
+++||||+++++++..... .++||||+. ++|.+.+.... ..+++..+..++.|++.||.||| ++
T Consensus 67 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~ 138 (310)
T cd07865 67 LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH---RN 138 (310)
T ss_pred hCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HC
Confidence 4789999999999876543 489999997 68888876542 36889999999999999999999 89
Q ss_pred CeeeccccCcceeecCCCceeEcccccccccCCCCc---ceeecccccccccCccccccCC-cccccchhhhhhHHHHHh
Q 044155 73 PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~ 148 (239)
+++|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+.. ++.++|+||||+++|+|+
T Consensus 139 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~ 218 (310)
T cd07865 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218 (310)
T ss_pred CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999875532221 1122345678899999886643 688999999999999999
Q ss_pred cCCCCcccccccccccccchhhh----hhhhhccchhhhhhhh-hhcCCCcHHH-----HHHHHHHHHHHhhhcCCCCCC
Q 044155 149 TGWDVSDLVKDVHDLVCPFSEYL----KNCFEDNRFTEIVDHI-VVEDVSSIEK-----EQQLHASAQVTFECIKDSPAD 218 (239)
Q Consensus 149 ~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~ 218 (239)
+|..||........... ..... ...+............ .......... ...+..+.++|.+||..||.+
T Consensus 219 t~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~ 297 (310)
T cd07865 219 TRSPIMQGNTEQHQLTL-ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAK 297 (310)
T ss_pred hCCCCCCCCCHHHHHHH-HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhh
Confidence 99988864332111000 00000 0000000000000000 0000000000 012345679999999999999
Q ss_pred CCCHHHHHH
Q 044155 219 RPSMVDVAK 227 (239)
Q Consensus 219 Rps~~ell~ 227 (239)
|||++++++
T Consensus 298 R~t~~e~l~ 306 (310)
T cd07865 298 RIDADTALN 306 (310)
T ss_pred ccCHHHHhc
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=235.92 Aligned_cols=194 Identities=23% Similarity=0.304 Sum_probs=164.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.|+|||||+++.+.+.....++||||+.+|.+.+++.+. .++....+..++.|+..|++||| ++.|+|||||
T Consensus 111 ~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk 182 (596)
T KOG0586|consen 111 SLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLK 182 (596)
T ss_pred hcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHh---hcceeccccc
Confidence 379999999999999999999999999999999999987 55666889999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
++|++++.+.++||+|||++..+..+ .....+.|++.|.|||.+.+..+ .+..|+||+|+++|.++.|..||++
T Consensus 183 ~eNilL~~~mnikIaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG--- 257 (596)
T KOG0586|consen 183 AENILLDENMNIKIADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG--- 257 (596)
T ss_pred hhhcccccccceeeeccccceeeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC---
Confidence 99999999999999999999887533 34568889999999999998774 5789999999999999999888753
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
....++....+.+.+.-+ -.++.+..+++.+++..+|.+|++.+++.+
T Consensus 258 ------------------~~lk~Lr~rvl~gk~rIp--~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 258 ------------------QNLKELRPRVLRGKYRIP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ------------------cccccccchheeeeeccc--ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 233344444444443322 245667889999999999999999999876
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=224.73 Aligned_cols=218 Identities=17% Similarity=0.206 Sum_probs=155.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||++ ++|.+++...... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 54 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~ 127 (284)
T cd07836 54 ELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLK 127 (284)
T ss_pred hhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCC--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCC
Confidence 4789999999999999999999999998 6898888754321 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||++++++.++++|||.+........ ......++..|++||.+.+. .++.++|+||||+++|++++|..||.....
T Consensus 128 p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 128 PQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred HHHEEECCCCcEEEeecchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999999865432211 11233467889999988654 478899999999999999999999864332
Q ss_pred cccccccchhhhhhhhhccchhhhhh-hhhhcCCC-------cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVD-HIVVEDVS-------SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........ .....+ ....+..... ........ .......+..+.+++.+||+.||.+||++.++++
T Consensus 207 ~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 207 EDQLLKIF-RIMGTP-TESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHHHH-HHhCCC-ChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11110000 000000 0000000000 00000000 0011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=227.61 Aligned_cols=217 Identities=19% Similarity=0.198 Sum_probs=151.9
Q ss_pred CCCCcccceeeEEEEeCC----------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCC
Q 044155 1 QMSHNHILKLIGCCLETP----------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF 70 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~----------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 70 (239)
+++||||+++++++.+.. ..++|+||++ +++.+.+.... ..+++..+..++.|++.||+|||
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH--- 133 (302)
T cd07864 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-HDLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCH--- 133 (302)
T ss_pred hCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccC-ccHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---
Confidence 478999999999987654 7889999998 57877776542 46889999999999999999999
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~ 149 (239)
+.+++|+||||+||++++++.++|+|||.+...............++..|+|||.+.+ ..++.++||||||++++++++
T Consensus 134 ~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~ 213 (302)
T cd07864 134 KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213 (302)
T ss_pred hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHh
Confidence 8999999999999999999999999999987654332211222345778999998865 347889999999999999999
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhh------hcCC---CcHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIV------VEDV---SSIEKEQQLHASAQVTFECIKDSPADRP 220 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rp 220 (239)
|+.||............ ......+. ...++....... .... ........+..+.+++.+||..||.+||
T Consensus 214 g~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 291 (302)
T cd07864 214 KKPIFQANQELAQLELI-SRLCGSPC-PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC 291 (302)
T ss_pred CCCCCCCCChHHHHHHH-HHHhCCCC-hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC
Confidence 99998643321111000 00000000 000000000000 0000 0001112356789999999999999999
Q ss_pred CHHHHHH
Q 044155 221 SMVDVAK 227 (239)
Q Consensus 221 s~~ell~ 227 (239)
|++++++
T Consensus 292 ~~~~il~ 298 (302)
T cd07864 292 TAEEALN 298 (302)
T ss_pred CHHHHhc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=219.91 Aligned_cols=200 Identities=24% Similarity=0.325 Sum_probs=158.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||++++++.+..+...++|+|++++++|.+++...... ...++...+..++.+++.||.+|| +.+++|+||+
T Consensus 55 ~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~ 130 (258)
T cd08215 55 KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIK 130 (258)
T ss_pred hcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCC
Confidence 368999999999999999999999999999999999864311 156889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.......+.++|+||+|++++++++|..||.....
T Consensus 131 ~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~- 208 (258)
T cd08215 131 PQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL- 208 (258)
T ss_pred hHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-
Confidence 999999999999999999886653322 223345678889999999888899999999999999999999988753220
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+........... ..+...+..+.+++.+||..+|.+|||+.++++
T Consensus 209 --------------------~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 209 --------------------LELALKILKGQYP-PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --------------------HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111111111110 111134567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=224.20 Aligned_cols=216 Identities=19% Similarity=0.208 Sum_probs=156.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++..+...++|+||++ ++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 54 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~ 125 (283)
T cd05118 54 ELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLK 125 (283)
T ss_pred HhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcC
Confidence 3689999999999999999999999997 68888887643 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|++++|+.||.....
T Consensus 126 p~nili~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 126 PENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred HHHEEECCCCcEEEeeeeeeEecCCCcc-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999998866543321 11223467789999998776 688999999999999999999988864332
Q ss_pred cccccccchhhhhhhhhccchhhhhh------hhhh-cCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVD------HIVV-EDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~-~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........... ..+ ....+..... .... ... ........+..+.++|.+||+.||.+||++.+++.
T Consensus 205 ~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 205 IDQLFKIFRTL-GTP-DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHHHHc-CCC-chHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11110000000 000 0000000000 0000 000 01112346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=224.82 Aligned_cols=218 Identities=15% Similarity=0.150 Sum_probs=151.3
Q ss_pred CCcccceeeEEEEeCCC-----ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 3 SHNHILKLIGCCLETPI-----PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~-----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
+||||+++++++..... .++||||++ ++|.+++..........+++..+..++.||+.||.||| +.+++|+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~ 134 (295)
T cd07837 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHR 134 (295)
T ss_pred CCCCccceeeeEeecCCCCCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 47999999999886655 789999998 58988887643321246789999999999999999999 8999999
Q ss_pred cccCcceeecC-CCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 78 NFKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 78 dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
||||+||+++. ++.++|+|||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 135 dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 135 DLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred CCChHHEEEecCCCeEEEeecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999998 88999999998865422211 1112345778999998865 457899999999999999999999886
Q ss_pred cccccccccccchhhhhhhhhccchhhhh---hhhhhcCCCcH----HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIV---DHIVVEDVSSI----EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...........+... ..+ ....+.... ........... .....+..+.++|.+||..||.+|||++|++.
T Consensus 214 ~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 214 GDSELQQLLHIFKLL-GTP-TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCHHHHHHHHHHHh-CCC-ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 533221111000000 000 000000000 00000000000 01134677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=225.73 Aligned_cols=219 Identities=16% Similarity=0.200 Sum_probs=151.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||++ ++|.+.+..... ..++......++.|++.||+||| +++++|+||+
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~ 129 (294)
T PLN00009 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLK 129 (294)
T ss_pred hccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCC
Confidence 4789999999999999999999999996 688888865432 34578888899999999999999 8999999999
Q ss_pred CcceeecC-CCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+||+++. ++.+||+|||++....... .......+++.|+|||.+.+. .++.++|+||||+++|++++|..||....
T Consensus 130 p~nill~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 130 PQNLLIDRRTNALKLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred cceEEEECCCCEEEEcccccccccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999985 4578999999986543221 111233567889999988664 57889999999999999999999986543
Q ss_pred ccccccccchhh---hhhhhhc-cchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEY---LKNCFED-NRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........+... ....+.. ....+............. .....+..+.+++.+||+.+|++|||+.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 209 EIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 221111000000 0000000 000000000000000000 01134566889999999999999999999986
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=225.23 Aligned_cols=196 Identities=21% Similarity=0.289 Sum_probs=149.7
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeeccccC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKT 81 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dlk~ 81 (239)
.||||+++++++.+....+++|||+. +++.+++.... ..+++..+..++.|++.|++||| + .+++|+||+|
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p 143 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKP 143 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcH
Confidence 59999999999999999999999996 68877776532 46888999999999999999999 6 5999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC----cccccchhhhhhHHHHHhcCCCCcccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV----FNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...
T Consensus 144 ~nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 144 SNILLDASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred HHEEEcCCCCEEECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999865432221 12234678899999987553 788999999999999999999998542
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCC-cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS-SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
....+ ........... .......+.++.+++.+||..||.+|||++++++.
T Consensus 222 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 222 KTEFE--------------------VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred hhHHH--------------------HHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 21100 00000000000 00001234678999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=230.84 Aligned_cols=217 Identities=18% Similarity=0.266 Sum_probs=153.9
Q ss_pred CCCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+++||||+++++++.. ....++||||+. ++|.+++... ..++...+..++.|++.||.||| +.+++|
T Consensus 60 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH 130 (334)
T cd07855 60 HFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH---SANVIH 130 (334)
T ss_pred hcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence 4789999999998763 345789999996 7999988754 45889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcc---eeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCC
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.
T Consensus 131 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~ 210 (334)
T cd07855 131 RDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210 (334)
T ss_pred CCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCC
Confidence 999999999999999999999998665332211 1123467889999998765 458899999999999999999999
Q ss_pred Ccccccccccc-------cccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 153 VSDLVKDVHDL-------VCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 153 p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
||......... ..+........ ............-..... .......+..+.++|.+||+.+|.+|||++
T Consensus 211 pf~~~~~~~~~~~~~~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 289 (334)
T cd07855 211 LFPGKNYVHQLKLILSVLGSPSEEVLNRI-GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVE 289 (334)
T ss_pred ccCCCChHHHHHHHHHHhCCChhHhhhhh-chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 98643321110 00000000000 000000000000000000 001123467899999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
+++.
T Consensus 290 ~~l~ 293 (334)
T cd07855 290 QALQ 293 (334)
T ss_pred HHHh
Confidence 9887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=221.77 Aligned_cols=199 Identities=20% Similarity=0.282 Sum_probs=155.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++|+||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||+
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~ 133 (260)
T cd08222 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLK 133 (260)
T ss_pred hCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCC
Confidence 468999999999999888999999999999999888653211 156889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||++++ +.++|+|||.+....... .......+++.|+|||...+..++.++|+||||+++|++++|..||....
T Consensus 134 ~~nili~~-~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-- 209 (260)
T cd08222 134 AKNIFLKN-NLLKIGDFGVSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-- 209 (260)
T ss_pred hhheEeec-CCEeecccCceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--
Confidence 99999975 569999999886653322 12234457888999999888888899999999999999999988874211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
............. +..+...+.++.++|.+||..+|.+||++.++++
T Consensus 210 -------------------~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 210 -------------------FLSVVLRIVEGPT-PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -------------------HHHHHHHHHcCCC-CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0011111111111 1112355678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=229.77 Aligned_cols=197 Identities=19% Similarity=0.237 Sum_probs=148.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.|.+||++++|-..++..+||||+=+ .+|...+++... ..+.-.++.+..||+.++.++| ..||||.||||.
T Consensus 418 g~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPA 489 (677)
T KOG0596|consen 418 GHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPA 489 (677)
T ss_pred CCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcc
Confidence 58899999999999999999999987 899999987653 3343477888999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcce-eecccccccccCccccccCC-----------cccccchhhhhhHHHHHhcC
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLGYCAPEYMRTGV-----------FNEKSNVFSFSVFLFELLTG 150 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l~~~~~g 150 (239)
|+|+-. |.+||+|||++.......+.. ...-.||+-||+||.+.... .+.++||||||||+|+|+.|
T Consensus 490 NFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYg 568 (677)
T KOG0596|consen 490 NFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYG 568 (677)
T ss_pred cEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhc
Confidence 999854 579999999998775443332 23456999999999885432 56789999999999999999
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+.||+.....-. +...+.+....-.+.. . ....++.+++..||.+||.+|||+.+||+
T Consensus 569 ktPf~~~~n~~a----------------Kl~aI~~P~~~Iefp~-~--~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 569 KTPFGQIINQIA----------------KLHAITDPNHEIEFPD-I--PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CCchHHHHHHHH----------------HHHhhcCCCccccccC-C--CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 999864331100 1111111100000000 0 11122889999999999999999999986
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=230.29 Aligned_cols=217 Identities=22% Similarity=0.271 Sum_probs=152.5
Q ss_pred CC-CCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 1 QM-SHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 1 ~l-~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
++ +||||+++++++... ...++||||+. ++|.+++... .+++..+..++.|++.||.||| +.+++|+
T Consensus 62 ~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~ 131 (337)
T cd07852 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH---SGNVIHR 131 (337)
T ss_pred HhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 35 899999999998653 35789999997 6999888653 4678888889999999999999 8999999
Q ss_pred cccCcceeecCCCceeEcccccccccCCCCc----ceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCC
Q 044155 78 NFKTSCILFNEENVAKLFDFSLSISIPEGET----HITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 78 dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.
T Consensus 132 dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~ 211 (337)
T cd07852 132 DLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211 (337)
T ss_pred CCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999876543221 12234467889999998765 457889999999999999999999
Q ss_pred Ccccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 153 VSDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSS--IEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 153 p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
||........... +..+.... .................... ......+..+.++|..||+.||.+|||+.
T Consensus 212 pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~ 290 (337)
T cd07852 212 LFPGTSTLNQLEKIIEVIGPPSAEDIES-IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAE 290 (337)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHH-HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHH
Confidence 9864322111000 00000000 00000000010000000000 00112467789999999999999999999
Q ss_pred HHHHH
Q 044155 224 DVAKK 228 (239)
Q Consensus 224 ell~~ 228 (239)
++++.
T Consensus 291 ~il~~ 295 (337)
T cd07852 291 EALEH 295 (337)
T ss_pred HHhhC
Confidence 99973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=219.66 Aligned_cols=198 Identities=18% Similarity=0.250 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++......++|+||+++++|.+++...... ...+++.....++.|++.||++|| +.+++|+||+
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~ 130 (256)
T cd08530 55 SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLK 130 (256)
T ss_pred hCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCC
Confidence 468999999999999999999999999999999988763211 145788899999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++++|||++....... .....++..|+|||.+.+..++.++|+||||++++++++|..||.....
T Consensus 131 ~~ni~~~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~- 206 (256)
T cd08530 131 SANILLVANDLVKIGDLGISKVLKKNM---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM- 206 (256)
T ss_pred cceEEEecCCcEEEeeccchhhhccCC---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 999999999999999999987654331 2234577889999999888889999999999999999999998753221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+............ .....+.++.+++.+||..+|.+|||+.++++
T Consensus 207 --------------------~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 207 --------------------QDLRYKVQRGKYPP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --------------------HHHHHHHhcCCCCC-CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111111111111 12255677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=222.60 Aligned_cols=198 Identities=22% Similarity=0.300 Sum_probs=152.6
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+|+||+++++.+..+...++|+||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||+|+
T Consensus 63 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~ 134 (290)
T cd05613 63 QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLE 134 (290)
T ss_pred cCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHH
Confidence 5999999999999888899999999999999999765 55788899999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC--CcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG--VFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
||+++.++.++|+|||++...............++..|+|||.+... .++.++|+||||+++|++++|..||......
T Consensus 135 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 135 NILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred HeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 99999999999999999866533222222344578899999998753 4678999999999999999999987532110
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
....+.......... ..+...+..+.+++.+||..||.+|| ++++++.
T Consensus 215 -----------------~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 215 -----------------NSQAEISRRILKSEP--PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----------------ccHHHHHHHhhccCC--CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 000111111111110 11123456788999999999999997 6777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=216.88 Aligned_cols=211 Identities=21% Similarity=0.271 Sum_probs=165.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.|+||++++++|++...+|+|||-+.||+|.+.+.+. ..+++.++.++..+|+.||.||| .+||.||||||+
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPE 205 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPE 205 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCcc
Confidence 5999999999999999999999999999999999887 67899999999999999999999 999999999999
Q ss_pred ceeecCCCc---eeEcccccccccCCCC------cceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHh
Q 044155 83 CILFNEENV---AKLFDFSLSISIPEGE------THITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 83 nil~~~~~~---~~l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~ 148 (239)
|||-...+. +||+||.+........ +....+..|+..|||||+.. ...|+.+.|.||||+++|-|+
T Consensus 206 NiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImL 285 (463)
T KOG0607|consen 206 NILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIML 285 (463)
T ss_pred ceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHH
Confidence 999876554 6999998765432111 12234567889999999763 245889999999999999999
Q ss_pred cCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHH--HHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 149 TGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEK--EQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 149 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
+|..||.++++..--.. +......--..+...+..+.+.-+.. ...+.+.+++|+..+..|+..|.++.+++
T Consensus 286 sGYpPFvG~Cg~dCGWd------rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 286 SGYPPFVGHCGADCGWD------RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred hCCCCccCccCCcCCcc------CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 99999998886321100 11111111233444555555554433 25677889999999999999999999887
Q ss_pred H
Q 044155 227 K 227 (239)
Q Consensus 227 ~ 227 (239)
.
T Consensus 360 n 360 (463)
T KOG0607|consen 360 N 360 (463)
T ss_pred C
Confidence 6
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=222.68 Aligned_cols=215 Identities=18% Similarity=0.231 Sum_probs=154.2
Q ss_pred CC-CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MS-HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~-H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++ ||||+++++++..++..++||||+ +++|.+.+..... ..+++..+..++.|++.+|.||| +.+++|+||+
T Consensus 54 ~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~ 126 (283)
T cd07830 54 LNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLK 126 (283)
T ss_pred ccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 45 999999999999999999999999 6899998877532 46789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+........ .....++..|+|||++.. ..++.++|+||||++++++++|..||.....
T Consensus 127 ~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 127 PENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred hhhEEEcCCCCEEEeecccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 9999999999999999999865533221 123457788999998754 4578999999999999999999988854322
Q ss_pred cccccccchhhhhhhhhccchhhh------hhhhhhcCCCc---HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEI------VDHIVVEDVSS---IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
....... ......+. ...+.+. ........... ......+..+.+++.+||..||.+|||++|++.
T Consensus 205 ~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 205 IDQLYKI-CSVLGTPT-KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HHHHHHH-HHhcCCCC-hhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1110000 00000000 0000000 00000000000 000122467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=216.64 Aligned_cols=196 Identities=24% Similarity=0.349 Sum_probs=157.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||++++++++.+.+..++++|++++++|.+++... ..+++..+..++.|++.||.+|| +.+++|+||+
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 126 (254)
T cd06627 55 NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIK 126 (254)
T ss_pred hCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCC
Confidence 468999999999999999999999999999999999765 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+........ ......++..|+|||...+...+.++|+||+|++++++++|..||......
T Consensus 127 p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~ 205 (254)
T cd06627 127 AANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM 205 (254)
T ss_pred HHHEEECCCCCEEEeccccceecCCCcc-cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 9999999999999999999876543322 123445788899999988777889999999999999999999887532210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... . ....... ...+...+..+.+++.+||..+|++|||+.+++.
T Consensus 206 ~~~--------------------~-~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 206 AAL--------------------F-RIVQDDH-PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHH--------------------H-HHhccCC-CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 000 0 0000000 0111234567889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=226.86 Aligned_cols=217 Identities=17% Similarity=0.217 Sum_probs=154.0
Q ss_pred CCCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++|+||+++++++... ...++|+||+. ++|.+++... ..++...+..++.|++.||.||| +.+++
T Consensus 60 ~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~ 130 (337)
T cd07858 60 HLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH---SANVL 130 (337)
T ss_pred hcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEe
Confidence 36899999999988644 34789999996 7998888764 56889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||||+||+++.++.++|+|||++....... .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||
T Consensus 131 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 209 (337)
T cd07858 131 HRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF 209 (337)
T ss_pred cCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999987653321 11223457888999998865 45889999999999999999999998
Q ss_pred ccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 155 DLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 155 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
........... +..+. ...................... .......+..+.++|.+||+.+|++|||++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el 288 (337)
T cd07858 210 PGKDYVHQLKLITELLGSPSEED-LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288 (337)
T ss_pred CCCChHHHHHHHHHHhCCCChHH-hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 64321110000 00000 0000000000000000000000 01112456778999999999999999999999
Q ss_pred HHH
Q 044155 226 AKK 228 (239)
Q Consensus 226 l~~ 228 (239)
++.
T Consensus 289 l~h 291 (337)
T cd07858 289 LAH 291 (337)
T ss_pred HcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=213.99 Aligned_cols=223 Identities=18% Similarity=0.253 Sum_probs=162.7
Q ss_pred CCCcccceeeEEEEe-CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MSHNHILKLIGCCLE-TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~H~niv~l~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
|+||||+.+..+|.. ....|+++||.+ -+|..+++-++......++...++.++-||+.|+.||| +.=|+|||||
T Consensus 84 l~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLK 159 (438)
T KOG0666|consen 84 LKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLK 159 (438)
T ss_pred hcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCC
Confidence 789999999999987 778999999998 69999998766544467889999999999999999999 8899999999
Q ss_pred CcceeecCC----CceeEcccccccccCCCCcc--eeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCC
Q 044155 81 TSCILFNEE----NVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 81 ~~nil~~~~----~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p 153 (239)
|.|||+..+ |.+||+|+|+++.+...... .......|++|+|||.+.+.. |+.+.|+|++|||+.||++-.+.
T Consensus 160 PaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~Pl 239 (438)
T KOG0666|consen 160 PANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPL 239 (438)
T ss_pred cceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcc
Confidence 999999988 89999999999887543221 123456799999999999876 88899999999999999998877
Q ss_pred cccccccccccccc-hhhhhhhh------hccchhh---------hhhhhhhcCCCcH-HH------HHHHHHHHHHHhh
Q 044155 154 SDLVKDVHDLVCPF-SEYLKNCF------EDNRFTE---------IVDHIVVEDVSSI-EK------EQQLHASAQVTFE 210 (239)
Q Consensus 154 ~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~---------~~~~~~~~~~~~~-~~------~~~~~~~~~li~~ 210 (239)
|.....--....|| ...+...+ .+.+|++ .+.......+... .. ..-++...+|+..
T Consensus 240 F~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~k 319 (438)
T KOG0666|consen 240 FKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQK 319 (438)
T ss_pred ccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHH
Confidence 76543322111121 11111111 1112221 1111111111110 00 0123446799999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 044155 211 CIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 211 cl~~dp~~Rps~~ell~~ 228 (239)
+|++||.+|.|+++.++.
T Consensus 320 lL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 320 LLTYDPIKRITAEQALEH 337 (438)
T ss_pred HhccCchhhccHHHHhcc
Confidence 999999999999998873
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=227.18 Aligned_cols=216 Identities=18% Similarity=0.215 Sum_probs=150.5
Q ss_pred CCCCcccceeeEEEEeCC-----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETP-----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~-----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++.... ..++++||+. ++|.+.+.. ..+++..+..++.|++.||.+|| +.+++
T Consensus 59 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~iv 128 (336)
T cd07849 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVL 128 (336)
T ss_pred hCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 478999999999876443 4689999997 688887754 46889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.
T Consensus 129 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~ 208 (336)
T cd07849 129 HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208 (336)
T ss_pred ccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999998654322111 1123457888999998754 458899999999999999999999
Q ss_pred Ccccccccccccccchhhhhhhhhccchhhhhhhh-------h-hcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHI-------V-VEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~-~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
||........... .......+ ............ . ....... .....+..+.+++.+||+.||++|||+
T Consensus 209 ~f~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 286 (336)
T cd07849 209 LFPGKDYLHQLNL-ILGVLGTP-SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV 286 (336)
T ss_pred CCCCCCHHHHHHH-HHHHcCCC-CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH
Confidence 9854221100000 00000000 000000000000 0 0000000 011335678999999999999999999
Q ss_pred HHHHHH
Q 044155 223 VDVAKK 228 (239)
Q Consensus 223 ~ell~~ 228 (239)
.|+++.
T Consensus 287 ~e~l~h 292 (336)
T cd07849 287 EEALAH 292 (336)
T ss_pred HHHhcC
Confidence 999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=225.36 Aligned_cols=218 Identities=19% Similarity=0.204 Sum_probs=157.5
Q ss_pred CCCCcccceeeEEEEeCC-----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETP-----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~-----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++.... ..+++|||+. ++|.+++... ..+++..+..++.|++.||++|| +.+++
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~ 125 (330)
T cd07834 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH---SANVI 125 (330)
T ss_pred hcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 468999999999988765 6799999997 6899988765 46889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|+||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.++|+||||+++|+|++|..
T Consensus 126 H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~ 205 (330)
T cd07834 126 HRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205 (330)
T ss_pred cCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999876543321 122344578889999999887 78999999999999999999999
Q ss_pred Ccccccccccccc------cchhhhhhhhhccchhhhhhhhhhcCCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 153 VSDLVKDVHDLVC------PFSEYLKNCFEDNRFTEIVDHIVVEDVSS--IEKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 153 p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
||........... ................+.+.......... ......+..+.+++.+||+.+|.+|||+++
T Consensus 206 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 285 (330)
T cd07834 206 LFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285 (330)
T ss_pred CcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9865442111000 00000000000000011111000000000 011134677899999999999999999999
Q ss_pred HHH
Q 044155 225 VAK 227 (239)
Q Consensus 225 ll~ 227 (239)
++.
T Consensus 286 ll~ 288 (330)
T cd07834 286 ALA 288 (330)
T ss_pred HHh
Confidence 997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=223.94 Aligned_cols=219 Identities=15% Similarity=0.180 Sum_probs=149.9
Q ss_pred CCCCcccceeeEEEEeCC--------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC
Q 044155 1 QMSHNHILKLIGCCLETP--------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR 72 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~--------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 72 (239)
+++||||+++++++.+.. ..++|+||+. +++...+.... ..++...+..++.|++.||.||| ..
T Consensus 63 ~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~ 134 (311)
T cd07866 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEGINYLH---EN 134 (311)
T ss_pred hcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 478999999999876543 3589999997 67877776532 46899999999999999999999 89
Q ss_pred CeeeccccCcceeecCCCceeEcccccccccCCCCcc----------eeecccccccccCccccccC-Ccccccchhhhh
Q 044155 73 PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH----------ITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFS 141 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG 141 (239)
+++|+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+. .++.++|+||||
T Consensus 135 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 214 (311)
T cd07866 135 HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG 214 (311)
T ss_pred CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHH
Confidence 9999999999999999999999999988654322110 11223467789999987654 478899999999
Q ss_pred hHHHHHhcCCCCcccccccccccccchhhhhhhhhccc----hhhhhhhhhhcCCCcHH---HHHHHHHHHHHHhhhcCC
Q 044155 142 VFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR----FTEIVDHIVVEDVSSIE---KEQQLHASAQVTFECIKD 214 (239)
Q Consensus 142 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~ 214 (239)
+++|+|++|+.||............+............ ................. .......+.+++.+||..
T Consensus 215 ~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 294 (311)
T cd07866 215 CVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL 294 (311)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHccc
Confidence 99999999999986433321111100000000000000 00000000000000000 012336688999999999
Q ss_pred CCCCCCCHHHHHH
Q 044155 215 SPADRPSMVDVAK 227 (239)
Q Consensus 215 dp~~Rps~~ell~ 227 (239)
||.+|||+.|++.
T Consensus 295 ~p~~R~t~~ell~ 307 (311)
T cd07866 295 DPYKRLTASDALE 307 (311)
T ss_pred CcccCcCHHHHhc
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=222.93 Aligned_cols=195 Identities=20% Similarity=0.261 Sum_probs=155.8
Q ss_pred CC-CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MS-HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~-H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++ ||||+++++++......++|||++++++|.+++.+. ..+++..+..++.|++.||.+|| +.+++|+|++
T Consensus 58 l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~ 129 (280)
T cd05581 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLK 129 (280)
T ss_pred cccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCC
Confidence 55 999999999999999999999999999999999865 46899999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-------------------ceeecccccccccCccccccCCcccccchhhhh
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-------------------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFS 141 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 141 (239)
|+||+++.++.++++|||++........ .......++..|+|||.......+.++|+||||
T Consensus 130 ~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG 209 (280)
T cd05581 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG 209 (280)
T ss_pred HHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHH
Confidence 9999999999999999998865532211 122344577889999999888889999999999
Q ss_pred hHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 142 VFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 142 ~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
++++++++|..||...... ........... ..+...+..+.+++.+||+.+|.+|||
T Consensus 210 ~~l~~l~~g~~p~~~~~~~---------------------~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~ 266 (280)
T cd05581 210 CIIYQMLTGKPPFRGSNEY---------------------LTFQKILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLG 266 (280)
T ss_pred HHHHHHHhCCCCCCCccHH---------------------HHHHHHHhcCC--CCCCccCHHHHHHHHHHhcCCHhhCCC
Confidence 9999999999988643210 00001111000 011133567889999999999999999
Q ss_pred H----HHHHH
Q 044155 222 M----VDVAK 227 (239)
Q Consensus 222 ~----~ell~ 227 (239)
+ ++++.
T Consensus 267 ~~~~~~~ll~ 276 (280)
T cd05581 267 VNEGYDELKA 276 (280)
T ss_pred cccCHHHHhc
Confidence 9 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=217.39 Aligned_cols=192 Identities=25% Similarity=0.318 Sum_probs=153.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++.+..+...++|||++++++|.+++... ..+++.....++.|++.|+.||| +.+++|+||+
T Consensus 49 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~ 120 (250)
T cd05123 49 RINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-----GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLK 120 (250)
T ss_pred HcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCC
Confidence 468999999999999999999999999999999999765 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......++..|+|||...+...+.++|+||||+++|++++|..||.....
T Consensus 121 p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~- 198 (250)
T cd05123 121 PENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR- 198 (250)
T ss_pred cceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-
Confidence 999999999999999999886653321 122344578889999999888889999999999999999999988753221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
............ ..+...+..+.+++.+||..||.+|||+.+
T Consensus 199 --------------------~~~~~~~~~~~~--~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 199 --------------------KEIYEKILKDPL--RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --------------------HHHHHHHhcCCC--CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 011111111110 111123567889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=223.45 Aligned_cols=216 Identities=19% Similarity=0.203 Sum_probs=154.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..+...++||||+. ++|.+++... ..++......++.|++.||.||| +.+++|+||+
T Consensus 76 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~ 146 (335)
T PTZ00024 76 EIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLS 146 (335)
T ss_pred hCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccc
Confidence 4789999999999999999999999997 7999998764 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-------------cceeecccccccccCccccccC-CcccccchhhhhhHHHH
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-------------THITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFE 146 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ 146 (239)
|+||+++.++.++|+|||.+....... ........++..|+|||.+.+. .++.++|+||||+++|+
T Consensus 147 ~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~e 226 (335)
T PTZ00024 147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226 (335)
T ss_pred HHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999999886543110 1111223457789999988764 46889999999999999
Q ss_pred HhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhh----hhcCCCc---HHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 147 LLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHI----VVEDVSS---IEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 147 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
|++|..||....+....... ......+. ...+....... ....... ......+..+.+++.+||+.+|++|
T Consensus 227 l~tg~~p~~~~~~~~~~~~i-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 227 LLTGKPLFPGENEIDQLGRI-FELLGTPN-EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred HHhCCCCCCCCCHHHHHHHH-HHHhCCCc-hhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence 99999998654322111000 00000000 00000000000 0000000 0011235678899999999999999
Q ss_pred CCHHHHHH
Q 044155 220 PSMVDVAK 227 (239)
Q Consensus 220 ps~~ell~ 227 (239)
||++|++.
T Consensus 305 ~s~~~~l~ 312 (335)
T PTZ00024 305 ISAKEALK 312 (335)
T ss_pred cCHHHHhc
Confidence 99999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=234.13 Aligned_cols=197 Identities=20% Similarity=0.244 Sum_probs=161.5
Q ss_pred CCcccceeeEEEEe-----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 3 SHNHILKLIGCCLE-----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 3 ~H~niv~l~~~~~~-----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
.|||++.+||++.- ++.+|+|||||.+||..|+++...+ .++.+..+..|+..++.|+.+|| ...++||
T Consensus 74 ~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH---~nkviHR 147 (953)
T KOG0587|consen 74 HHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLH---NNKVIHR 147 (953)
T ss_pred CCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHh---hcceeee
Confidence 79999999999873 4578999999999999999998764 78999999999999999999999 9999999
Q ss_pred cccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-----cccccchhhhhhHHHHHhcCCC
Q 044155 78 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-----FNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 78 dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|+|-.|||++.++.+|++|||.+.... +......+..||+.|||||++.... |+..+|+||||++..||..|.+
T Consensus 148 DikG~NiLLT~e~~VKLvDFGvSaQld-sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 148 DIKGQNVLLTENAEVKLVDFGVSAQLD-STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred cccCceEEEeccCcEEEeeeeeeeeee-cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 999999999999999999999987763 3334566788999999999986533 7788999999999999999988
Q ss_pred Ccccccccccccccchhhhhhhhhccchhhhhhhhhh-cCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV-EDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
|+--+- .....-.+.. .+.....+..++.++-++|+.||..|-.+||+..++++
T Consensus 227 Pl~DmH---------------------PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 227 PLCDMH---------------------PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CccCcc---------------------hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 853211 1111111111 11122234588899999999999999999999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=219.62 Aligned_cols=193 Identities=22% Similarity=0.322 Sum_probs=158.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++.+.||.+--.|++....|+|+..|.||+|.=.|.+.+. ..+++..+.-++.+|+.||.+|| ..+||.||+||
T Consensus 242 V~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKP 315 (591)
T KOG0986|consen 242 VSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKP 315 (591)
T ss_pred hccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCCh
Confidence 5678899998788899999999999999999887766543 56899999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+|||+|+.|.++|+|.|++...+.+.. .....||.+|||||++....|+...|-|||||++|||+.|+.||..
T Consensus 316 eNILLDd~GhvRISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~----- 388 (591)
T KOG0986|consen 316 ENILLDDHGHVRISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ----- 388 (591)
T ss_pred hheeeccCCCeEeeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh-----
Confidence 999999999999999999988766543 3455899999999999999999999999999999999999888732
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
.....++.++-+..+.... ..++..+++.+++.+..|..||++|.-
T Consensus 389 ------------~KeKvk~eEvdrr~~~~~~--ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 389 ------------RKEKVKREEVDRRTLEDPE--EYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ------------hhhhhhHHHHHHHHhcchh--hcccccCHHHHHHHHHHHccCHHHhcc
Confidence 1222222233222222222 223578889999999999999999973
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=220.57 Aligned_cols=212 Identities=19% Similarity=0.243 Sum_probs=150.3
Q ss_pred CCCCcccceeeEEEEe-CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLE-TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||+++++++.. +...++++||+. ++|.++++. ..++......++.|++.||.||| ..+++|+||
T Consensus 65 ~l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl 134 (328)
T cd07856 65 HLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDL 134 (328)
T ss_pred hcCCCCeeeEeeeEecCCCcEEEEeehhc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 4789999999999875 457789999995 799888864 35778888889999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||....
T Consensus 135 ~p~Nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 135 KPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred CHHHEeECCCCCEEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999988654221 123456788999998866 568899999999999999999999885432
Q ss_pred ccccc------c-ccchhhhhhhhhccchhhhhhhhhhcCCCcHH--HHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDL------V-CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE--KEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... . .+..++... .......+...........+.. ....+..+.++|.+||+.+|++|||+++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 211 HVNQFSIITDLLGTPPDDVINT-ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHHHHHHHHHHhCCCCHHHHHh-ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11000 0 000000000 0000001111110000000000 0124577899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=218.78 Aligned_cols=216 Identities=22% Similarity=0.257 Sum_probs=155.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++.+....++|+|+++ ++|.+++.... ..++...+..++.|++.||.+|| +.+++|+||+
T Consensus 54 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~ 125 (282)
T cd07829 54 ELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLK 125 (282)
T ss_pred hcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 3689999999999999999999999997 69999998653 36889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||++++++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||++++++++|..||.....
T Consensus 126 ~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 204 (282)
T cd07829 126 PQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204 (282)
T ss_pred hheEEEcCCCCEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 9999999999999999998866533221 12223456789999998766 788999999999999999999988865432
Q ss_pred cccccccchhhhhhhhhccchhhhh-----hhhhhcCCCc---HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIV-----DHIVVEDVSS---IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... ....+. ...+.... .......... ......+..+.+++.+||..||++||++++++.
T Consensus 205 ~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 205 IDQLFKIFQ-ILGTPT-EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHH-HhCCCc-HHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 111100000 000000 00000000 0000000000 000123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=219.63 Aligned_cols=215 Identities=20% Similarity=0.208 Sum_probs=149.9
Q ss_pred CCcccceeeEEEEeC----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 3 SHNHILKLIGCCLET----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 3 ~H~niv~l~~~~~~~----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+||||+++++.+... ...+++++++. ++|.+.+... ..++...++.++.|++.||.||| +.+++|+|
T Consensus 60 ~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~d 130 (332)
T cd07857 60 GHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIH---SANVLHRD 130 (332)
T ss_pred CCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence 599999999876532 34678888886 7999988754 56889999999999999999999 99999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcc---eeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|||+||+++.++.++|+|||.+......... ......|+..|+|||...+ ..++.++||||||+++|++++|..||
T Consensus 131 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf 210 (332)
T cd07857 131 LKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210 (332)
T ss_pred CCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC
Confidence 9999999999999999999998765332211 1223467889999998765 46889999999999999999999988
Q ss_pred cccccccccc-------ccchhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 155 DLVKDVHDLV-------CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 155 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
.......... .+..+...... ................... .....+..+.+++.+||+.||.+|||+.++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l 289 (332)
T cd07857 211 KGKDYVDQLNQILQVLGTPDEETLSRIG-SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289 (332)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhh-hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 6433211000 00000000000 0000000000000000000 001235678899999999999999999998
Q ss_pred HH
Q 044155 226 AK 227 (239)
Q Consensus 226 l~ 227 (239)
+.
T Consensus 290 l~ 291 (332)
T cd07857 290 LE 291 (332)
T ss_pred hc
Confidence 76
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=221.78 Aligned_cols=211 Identities=17% Similarity=0.204 Sum_probs=150.3
Q ss_pred CCCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++.... ..++|||++ +++|.+++.. ..+++..+..++.|++.||.||| +.++
T Consensus 70 ~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi 139 (343)
T cd07880 70 HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGI 139 (343)
T ss_pred hcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 478999999999987553 348999999 6899888864 45889999999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+|+||||+||+++.++.++++|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|..|
T Consensus 140 ~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p 215 (343)
T cd07880 140 IHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL 215 (343)
T ss_pred ecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998654322 223456788999998876 4578899999999999999999999
Q ss_pred cccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCc---HHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 154 SDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSS---IEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 154 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
|........... ....+.... ............ ...... ......+..+.+++.+|+..||++|||+.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~ 293 (343)
T cd07880 216 FKGHDHLDQLMEIMKVTGTPSKEFVQKL-QSEDAKNYVKKL-PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA 293 (343)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHhh-cchhHHHHHHhc-cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHH
Confidence 864332111000 000000000 000000000000 000000 00113456688999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
+++.
T Consensus 294 ~~l~ 297 (343)
T cd07880 294 EALA 297 (343)
T ss_pred HHhc
Confidence 9984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=216.95 Aligned_cols=225 Identities=20% Similarity=0.305 Sum_probs=166.1
Q ss_pred CCCCcccceeeEEEEeCC----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHh-----hCCC
Q 044155 1 QMSHNHILKLIGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLH-----FGFP 71 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-----~~~~ 71 (239)
.|+|+||+.+++.-..++ ..|+|++|-+.|||.|++.+ ..++....++++..++.||++|| ....
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgK 334 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGK 334 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCC
Confidence 379999999988755333 46899999999999999987 56889999999999999999999 2236
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCC---cceeecccccccccCccccccCC------cccccchhhhhh
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE---THITDTVMGTLGYCAPEYMRTGV------FNEKSNVFSFSV 142 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~ 142 (239)
..|.|||||+.|||+.+++.+-|+|+|++....... .-......||.+|||||++.... .-..+||||||+
T Consensus 335 PaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgL 414 (513)
T KOG2052|consen 335 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGL 414 (513)
T ss_pred chhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHH
Confidence 679999999999999999999999999987654321 23456778999999999996543 124699999999
Q ss_pred HHHHHhcCCCCcccccccccccccchhhhhhhhhccchhh--hhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 044155 143 FLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTE--IVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP 220 (239)
Q Consensus 143 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 220 (239)
++||+..+...- .-..+...|+..+......-+.+.+ .+++......+.....+....+.++|..||..+|..|.
T Consensus 415 VlWEiarRc~~g---gi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl 491 (513)
T KOG2052|consen 415 VLWEIARRCESG---GIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL 491 (513)
T ss_pred HHHHHHHHhhcC---CEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh
Confidence 999997753221 1122334444444433222211111 22222222222333456778899999999999999999
Q ss_pred CHHHHHHHHHHHHH
Q 044155 221 SMVDVAKKLRQIYR 234 (239)
Q Consensus 221 s~~ell~~L~~l~~ 234 (239)
||-.+...|.++.+
T Consensus 492 tALriKKtl~~l~~ 505 (513)
T KOG2052|consen 492 TALRIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHHHHHhc
Confidence 99999999998874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=211.13 Aligned_cols=211 Identities=18% Similarity=0.272 Sum_probs=173.1
Q ss_pred CCCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcCCC---CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 2 MSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQ---PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 2 l~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
+.|||+.++.+++.+. ...++++.+..-|+|..++...++ .+.+.++..+...++.|++.|++||| .++++|.
T Consensus 344 ~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHk 420 (563)
T KOG1024|consen 344 ASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHK 420 (563)
T ss_pred CcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccc
Confidence 5799999999998754 467888999988999999983322 12255667778889999999999999 9999999
Q ss_pred cccCcceeecCCCceeEcccccccccCCCCcceee-cccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcc
Q 044155 78 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITD-TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSD 155 (239)
Q Consensus 78 dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~ 155 (239)
||..+|++|++.-++||+|=.+++.+.+...++.+ ..-.+..||+||.+....++..+|+||||+++||++| |+.|+.
T Consensus 421 DiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 421 DIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred hhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 99999999999999999999999877666655433 3446889999999999999999999999999999988 667765
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
..+ +.-+...++..++...+-++++++..+|--||..+|++|||++|+..-|.++..+
T Consensus 501 eID----------------------PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 501 EID----------------------PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ccC----------------------HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 433 1222233444455555568889999999999999999999999999999999887
Q ss_pred hc
Q 044155 236 LS 237 (239)
Q Consensus 236 ~~ 237 (239)
++
T Consensus 559 lt 560 (563)
T KOG1024|consen 559 LT 560 (563)
T ss_pred Hh
Confidence 65
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=220.95 Aligned_cols=211 Identities=19% Similarity=0.217 Sum_probs=148.1
Q ss_pred CCCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++... ...+++++++ +++|.+.+.. ..+++..+..++.|++.||+||| +.++
T Consensus 72 ~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~i 141 (345)
T cd07877 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADI 141 (345)
T ss_pred HcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 47899999999988643 3357788877 6899887764 35788999999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+|+||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..|
T Consensus 142 vH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p 217 (345)
T cd07877 142 IHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217 (345)
T ss_pred eecCCChHHEEEcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998654322 223457888999998866 4678899999999999999999999
Q ss_pred cccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcHHH---HHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 154 SDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEK---EQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 154 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
|........... +....... ...... ................ ...+..+.++|.+|++.||.+|||+.
T Consensus 218 f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 295 (345)
T cd07877 218 FPGTDHIDQLKLILRLVGTPGAELLKK-ISSESA-RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295 (345)
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHhh-cccHhH-HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH
Confidence 854322111000 00000000 000000 0000000000000000 12356788999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
++++
T Consensus 296 e~l~ 299 (345)
T cd07877 296 QALA 299 (345)
T ss_pred HHhc
Confidence 9886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=222.34 Aligned_cols=212 Identities=20% Similarity=0.250 Sum_probs=151.5
Q ss_pred CCCCcccceeeEEEEeCCC------ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETPI------PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~------~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++..... .++|+||+ +++|.+++.. ..+++..+..++.|++.||.||| +.++
T Consensus 70 ~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi 139 (343)
T cd07851 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGI 139 (343)
T ss_pred hccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 4689999999988765544 78999999 5899998865 45889999999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+|+||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..|
T Consensus 140 ~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p 215 (343)
T cd07851 140 IHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL 215 (343)
T ss_pred ecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998665332 223456788999998865 3678899999999999999999999
Q ss_pred cccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 154 SDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 154 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
|........... +...+... ..................... .....+..+.+++.+||..||.+|||+.+
T Consensus 216 f~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 216 FPGSDHIDQLKRIMNLVGTPDEELLQK-ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred CCCCChHHHHHHHHHhcCCCCHHHHhh-ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 864322111000 00000000 000000000000000000000 11123678899999999999999999999
Q ss_pred HHH
Q 044155 225 VAK 227 (239)
Q Consensus 225 ll~ 227 (239)
|++
T Consensus 295 ll~ 297 (343)
T cd07851 295 ALA 297 (343)
T ss_pred Hhc
Confidence 976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=220.91 Aligned_cols=210 Identities=18% Similarity=0.241 Sum_probs=147.2
Q ss_pred CCCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++.... ..++|+||+. .+|.+... ..++...+..++.|++.||+||| ..++
T Consensus 70 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i 138 (342)
T cd07879 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGI 138 (342)
T ss_pred hcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence 478999999999987543 3589999996 57766552 35788999999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+|+||||+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.|
T Consensus 139 ~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~p 214 (342)
T cd07879 139 IHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTL 214 (342)
T ss_pred ccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998654322 123456788999999876 4588899999999999999999999
Q ss_pred ccccccccccc-------ccchhhhhhhhhccchhhhhhhhhhcCCCc---HHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 154 SDLVKDVHDLV-------CPFSEYLKNCFEDNRFTEIVDHIVVEDVSS---IEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 154 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
|.......... .+...+.... ........... ....... ......+..+.++|.+||+.||.+|||++
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~ 292 (342)
T cd07879 215 FKGKDYLDQLTQILKVTGVPGPEFVQKL-EDKAAKSYIKS-LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT 292 (342)
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHHh-cccchHHHHhh-cCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 87432111000 0000000000 00000000000 0000000 00112346688999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
+++.
T Consensus 293 e~l~ 296 (342)
T cd07879 293 EALE 296 (342)
T ss_pred HHhc
Confidence 9984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-34 Score=215.11 Aligned_cols=200 Identities=22% Similarity=0.248 Sum_probs=154.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+-||||++||.+..++..||-||+|+ .||..+.+.-......++++...-.+.-....||.||-. +..|+|||+||+
T Consensus 121 ~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPS 197 (361)
T KOG1006|consen 121 NCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPS 197 (361)
T ss_pred CCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChh
Confidence 45899999999999999999999997 888655443221122678888888888888999999997 789999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC--CcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG--VFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|||++..|.+||+|||++-.+..+.. .+.-.|..+|+|||.+... .+..+||+||||++++|+.||..|+..-.+
T Consensus 198 NILldr~G~vKLCDFGIcGqLv~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s- 274 (361)
T KOG1006|consen 198 NILLDRHGDVKLCDFGICGQLVDSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS- 274 (361)
T ss_pred heEEecCCCEeeecccchHhHHHHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-
Confidence 99999999999999999866543321 2344588899999998653 489999999999999999999999753221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcH----HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSI----EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+.+..+..++.... ..-..+..+..+|..|+..|.++||+..+++.
T Consensus 275 -------------------vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 275 -------------------VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -------------------HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1222223333332211 11246788999999999999999999999876
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=223.33 Aligned_cols=216 Identities=16% Similarity=0.205 Sum_probs=147.7
Q ss_pred CCCCcccceeeEEEEeC--------------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHH
Q 044155 1 QMSHNHILKLIGCCLET--------------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYL 66 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--------------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 66 (239)
+++||||+++++++... ...++|+||++ ++|.+++.. ..++...+..++.|++.||.||
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~L 130 (342)
T cd07854 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYI 130 (342)
T ss_pred hcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHH
Confidence 47899999999876643 24689999997 699888854 4578899999999999999999
Q ss_pred hhCCCCCeeeccccCcceeecC-CCceeEcccccccccCCCCcc--eeecccccccccCcccccc-CCcccccchhhhhh
Q 044155 67 HFGFPRPIVFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSV 142 (239)
Q Consensus 67 H~~~~~~i~H~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ 142 (239)
| +.+++|+||||+||+++. ++.++++|||.+......... ......++..|+|||.+.. ..++.++||||||+
T Consensus 131 H---~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGv 207 (342)
T cd07854 131 H---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 207 (342)
T ss_pred H---hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHH
Confidence 9 899999999999999975 457899999998654322111 1122346788999998754 45788999999999
Q ss_pred HHHHHhcCCCCcccccccccccccchhh------hhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCC
Q 044155 143 FLFELLTGWDVSDLVKDVHDLVCPFSEY------LKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKD 214 (239)
Q Consensus 143 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~ 214 (239)
++|+|++|..||................ ....+. ................+. .....+.++.+++.+||..
T Consensus 208 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 286 (342)
T cd07854 208 IFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL-NVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTF 286 (342)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh-hhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCC
Confidence 9999999999986443211110000000 000000 000000000000000000 0113456788999999999
Q ss_pred CCCCCCCHHHHHH
Q 044155 215 SPADRPSMVDVAK 227 (239)
Q Consensus 215 dp~~Rps~~ell~ 227 (239)
||.+|||+.+++.
T Consensus 287 dP~~R~t~~ell~ 299 (342)
T cd07854 287 NPMDRLTAEEALM 299 (342)
T ss_pred CchhccCHHHHhC
Confidence 9999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-33 Score=233.09 Aligned_cols=205 Identities=21% Similarity=0.338 Sum_probs=168.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|.|||+++++|+|.... ..+|++|++.|+|.|+++.++ .++..+..+.|+.||++|+.||| ++++|||||.
T Consensus 754 sldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLa 825 (1177)
T KOG1025|consen 754 SLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLA 825 (1177)
T ss_pred cCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhh
Confidence 479999999999998776 788999999999999999865 67889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
.+|||+..-..+||.|||+++.+..-. ........-++.|+|=|.+....++.++|||||||++||++| |..|++.+.
T Consensus 826 aRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 826 ARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred hhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 999999999999999999998764332 222334445788999999999999999999999999999988 777775433
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.+-+...+....+...+...+-++.-++.+||..|+..||+++++...+.+..+.
T Consensus 906 ----------------------~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 906 ----------------------AEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ----------------------HHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1111122222222333446677889999999999999999999999988876653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=231.27 Aligned_cols=197 Identities=22% Similarity=0.272 Sum_probs=148.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.|||||++|+.-.+..+.||..|.|. .+|.|++..... .......-.......|++.||++|| ..+||||||||.
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQ 635 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQ 635 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCc
Confidence 69999999988888889999999997 999999987411 0011111344667899999999999 899999999999
Q ss_pred ceeecC---CC--ceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcC-CCCc
Q 044155 83 CILFNE---EN--VAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG-WDVS 154 (239)
Q Consensus 83 nil~~~---~~--~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g-~~p~ 154 (239)
||||+. ++ .++|+|||+++.+..+.. .......||-+|+|||++.....+.++||+||||++|+.++| ..||
T Consensus 636 NILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF 715 (903)
T KOG1027|consen 636 NILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF 715 (903)
T ss_pred eEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC
Confidence 999987 33 679999999998865432 234566799999999999988888899999999999999987 6787
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHH-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEK-EQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+... +.-..++.+.+....- ........+||.+|++.||..||||.+|+.
T Consensus 716 Gd~~-----------------------~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 716 GDSL-----------------------ERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred CchH-----------------------HhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 5221 1111111111111000 011116789999999999999999999974
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=241.67 Aligned_cols=194 Identities=18% Similarity=0.208 Sum_probs=138.8
Q ss_pred CCC-cccceeeEEEE-------eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 2 MSH-NHILKLIGCCL-------ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 2 l~H-~niv~l~~~~~-------~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
++| +||++++++|. +...++.++|++. ++|.+++.... ..++...++.++.||+.||.||| +++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~g 100 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAH---SQG 100 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence 467 79999999882 3345677899885 79999997532 46899999999999999999999 999
Q ss_pred eeeccccCcceeecC-------------------CCceeEcccccccccCCCC--------c-------ceeeccccccc
Q 044155 74 IVFRNFKTSCILFNE-------------------ENVAKLFDFSLSISIPEGE--------T-------HITDTVMGTLG 119 (239)
Q Consensus 74 i~H~dlk~~nil~~~-------------------~~~~~l~dfg~~~~~~~~~--------~-------~~~~~~~~~~~ 119 (239)
|+||||||+|||++. ++.+|++|||+++...... . .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999964 3456667777664321100 0 00112357888
Q ss_pred ccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHH
Q 044155 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQ 199 (239)
Q Consensus 120 y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (239)
|+|||++.+..++.++|||||||++|||++|..|+..... ......... . +.....
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-------------------~~~~~~~~~----~-~~~~~~ 236 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-------------------TMSSLRHRV----L-PPQILL 236 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-------------------HHHHHHHhh----c-Chhhhh
Confidence 9999999988999999999999999999998776532110 000000000 0 010111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 200 QLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 200 ~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......++..||..+|.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 2234568889999999999999999976
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=205.45 Aligned_cols=197 Identities=25% Similarity=0.340 Sum_probs=156.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|+||+++++++......++++|++.+++|.+++... ..++...+..++.+++.++.+|| ..+++|+|++
T Consensus 43 ~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~ 114 (244)
T smart00220 43 KLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR-----GRLSEDEARFYARQILSALEYLH---SNGIIHRDLK 114 (244)
T ss_pred hCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcC
Confidence 368999999999999988999999999988999998764 33788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++++|||.+....... ......++..|++||......++.++|+||||++++++++|..||....+
T Consensus 115 ~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~- 191 (244)
T smart00220 115 PENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ- 191 (244)
T ss_pred HHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-
Confidence 999999999999999999987654321 22344577889999999888889999999999999999999888753211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHH-HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKE-QQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
................... ..+..+.+++.+||..+|++||++.++++
T Consensus 192 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 192 -------------------LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -------------------HHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0111111111111111110 15567899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=212.21 Aligned_cols=202 Identities=23% Similarity=0.266 Sum_probs=154.3
Q ss_pred CCCcccceeeEEEE-eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~H~niv~l~~~~~-~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
|.||.||++|++|. +...+|.|+|||+|.+|.-+++.+ ..+.+++++.|+.||+.||.||.+- ..+|+|.|||
T Consensus 524 LDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLK 597 (775)
T KOG1151|consen 524 LDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLK 597 (775)
T ss_pred cCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccC
Confidence 78999999999986 667899999999999997788776 6688999999999999999999954 6689999999
Q ss_pred CcceeecC---CCceeEcccccccccCCCCc------ceeecccccccccCcccccc----CCcccccchhhhhhHHHHH
Q 044155 81 TSCILFNE---ENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRT----GVFNEKSNVFSFSVFLFEL 147 (239)
Q Consensus 81 ~~nil~~~---~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~~ 147 (239)
|.|||+-+ .|.+||+|||+++.+..... ..++...||.+|++||.+.- .+.+.+.|+||+|+++|.+
T Consensus 598 PgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQC 677 (775)
T KOG1151|consen 598 PGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQC 677 (775)
T ss_pred CccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhh
Confidence 99999854 46789999999988754221 24567789999999998753 3478899999999999999
Q ss_pred hcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 148 LTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 148 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
+.|+.||+.....-+ ....+...... .+..+...-.+.+.++||++||.+.-.+|....++.
T Consensus 678 lYGrKPFGhnqsQQd-----------ILqeNTIlkAt------EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 678 LYGRKPFGHNQSQQD-----------ILQENTILKAT------EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hccCCCCCCchhHHH-----------HHhhhchhcce------eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 999999964321111 11111111111 011111123456778999999999999998776654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=219.92 Aligned_cols=227 Identities=19% Similarity=0.187 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
||+|+|||+++++=++.. ...+|||||.+|||+..+.+-... ..+++.+.+.++.+++.||.||| +++|
T Consensus 67 KLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~Lr---En~I 141 (732)
T KOG4250|consen 67 KLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLR---ENGI 141 (732)
T ss_pred HcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCc
Confidence 589999999998865443 457999999999999999864332 56999999999999999999999 9999
Q ss_pred eeccccCcceeecC--CC--ceeEcccccccccCCCCcceeecccccccccCccccc-cCCcccccchhhhhhHHHHHhc
Q 044155 75 VFRNFKTSCILFNE--EN--VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-TGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 75 ~H~dlk~~nil~~~--~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~~ 149 (239)
+||||||.||++.. +| .-||+|||.|+..+.+. ......||..|.+||... ...++...|.|||||++|+++|
T Consensus 142 vHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT 219 (732)
T KOG4250|consen 142 VHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT 219 (732)
T ss_pred eeccCCCCcEEEeecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc
Confidence 99999999999743 33 35999999999876554 456778999999999998 5789999999999999999999
Q ss_pred CCCCcccccccccccc-cchhhhhhhhhcc---chhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCC--C
Q 044155 150 GWDVSDLVKDVHDLVC-PFSEYLKNCFEDN---RFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRP--S 221 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rp--s 221 (239)
|..||.++........ ......+.+-.-. ...+...-...... ...........+...+..+|..+|.+|- .
T Consensus 220 G~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~ 299 (732)
T KOG4250|consen 220 GELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEG 299 (732)
T ss_pred cCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCC
Confidence 9999987665432110 0000000000000 00000000000000 1111123334455677778888998888 6
Q ss_pred HHHHHHHHHHHHH
Q 044155 222 MVDVAKKLRQIYR 234 (239)
Q Consensus 222 ~~ell~~L~~l~~ 234 (239)
..+....+..++.
T Consensus 300 ~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 300 FDRFFAEVDDILN 312 (732)
T ss_pred cchHHHHHHHHHh
Confidence 6666666665554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=218.58 Aligned_cols=189 Identities=20% Similarity=0.304 Sum_probs=157.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.+.|.||++|--|.+....|++||-|-||.|+..++.. ..++....+-++..+.+|+.||| .++|+.|||||
T Consensus 477 ~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKP 548 (732)
T KOG0614|consen 477 CRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKP 548 (732)
T ss_pred cCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHH---hcCceeccCCh
Confidence 35789999999999999999999999999999999876 56888889999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+|.+++.+|-+||.|||+++....+. .+-+++||+.|.|||++.....+.++|.||||+++||+++|.+||.....+
T Consensus 549 ENllLd~~Gy~KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm- 625 (732)
T KOG0614|consen 549 ENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM- 625 (732)
T ss_pred hheeeccCCceEEeehhhHHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-
Confidence 99999999999999999998875554 356789999999999999999999999999999999999999998754422
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
..+..++.+.-.-..+........++|.+..+.+|.+|.-
T Consensus 626 --------------------ktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 626 --------------------KTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --------------------HHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 2222222222111122345566778999999999999975
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=205.60 Aligned_cols=213 Identities=20% Similarity=0.258 Sum_probs=154.2
Q ss_pred CCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 2 MSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 2 l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
++|+||++++.+|.-. ...++|||++. .+|...+. .+++=.....++.|++.|++||| +.+|+
T Consensus 72 v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lh---s~~Ii 140 (369)
T KOG0665|consen 72 VNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL-------MELDHETISYILYQMLCGIKHLH---SAGII 140 (369)
T ss_pred hcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHH---hccee
Confidence 6899999999998632 35789999997 89999887 34666788899999999999999 99999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
||||||+||++..+..+||.|||+++..... -..+....+..|.|||++.+..+.+.+||||+||++.||++|+..|.
T Consensus 141 hRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 141 HRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred ecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 9999999999999999999999998764332 23445667889999999999889999999999999999999998876
Q ss_pred ccccccc-------ccccchhhhhhhhhccc-hhhhhh--------hhhhcCCCcH---HHHHHHHHHHHHHhhhcCCCC
Q 044155 156 LVKDVHD-------LVCPFSEYLKNCFEDNR-FTEIVD--------HIVVEDVSSI---EKEQQLHASAQVTFECIKDSP 216 (239)
Q Consensus 156 ~~~~~~~-------~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp 216 (239)
+...... +..+...+......... +..... ........+. .....+....+++.+||..+|
T Consensus 219 g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~p 298 (369)
T KOG0665|consen 219 GKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDP 298 (369)
T ss_pred CchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccCh
Confidence 4333221 12222222221111100 000000 0000000000 001234456799999999999
Q ss_pred CCCCCHHHHHH
Q 044155 217 ADRPSMVDVAK 227 (239)
Q Consensus 217 ~~Rps~~ell~ 227 (239)
++|.|++++|+
T Consensus 299 e~Risv~daL~ 309 (369)
T KOG0665|consen 299 EKRISVDDALR 309 (369)
T ss_pred hhcccHHHHhc
Confidence 99999999985
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=231.21 Aligned_cols=190 Identities=21% Similarity=0.268 Sum_probs=152.4
Q ss_pred cceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceee
Q 044155 7 ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF 86 (239)
Q Consensus 7 iv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~ 86 (239)
|+.+.-.|.++.+.|+||||++||+|-.++.+. .+++++.++-++..|..||.-+| ..|+|||||||+|||+
T Consensus 137 iv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 137 IVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLL 208 (1317)
T ss_pred HHHHHHHhcCccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEe
Confidence 566666788999999999999999999999876 57999999999999999999999 9999999999999999
Q ss_pred cCCCceeEcccccccccCCCCcceeecccccccccCcccccc-----CCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 87 NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-----GVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 87 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+..|.+||+|||.+..+...+.-......|||.|.+||++.. +.|++..|-||+||++|||+.|..||...
T Consensus 209 d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad---- 284 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD---- 284 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----
Confidence 999999999999887776555555667789999999999863 45889999999999999999998887532
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhc--CCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC---HHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVE--DVSSIEKEQQLHASAQVTFECIKDSPADRPS---MVDVA 226 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ell 226 (239)
...+.+.+++.- ....+.....+...++||.+.+. +|..|.. ++++.
T Consensus 285 -----------------slveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 285 -----------------SLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred -----------------HHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 222222222211 12222223467788899988777 7888877 66553
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=204.55 Aligned_cols=194 Identities=21% Similarity=0.279 Sum_probs=158.8
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
-+||.+..+.-.|......|+||||..||.|.-.+.+. ..+++...+-+...|..||.||| +++||.||+|.
T Consensus 225 ~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKL 296 (516)
T KOG0690|consen 225 CRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKL 296 (516)
T ss_pred ccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechh
Confidence 37999999988899999999999999999998888765 56778888889999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+|.|++.+|.+||+|||+++.... .......++|||.|+|||++....|....|-|.+|+++|||+.|+.||..
T Consensus 297 ENLlLDkDGHIKitDFGLCKE~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn----- 370 (516)
T KOG0690|consen 297 ENLLLDKDGHIKITDFGLCKEEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN----- 370 (516)
T ss_pred hhheeccCCceEeeecccchhccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-----
Confidence 999999999999999999876432 22346788999999999999999999999999999999999999888753
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC--HHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS--MVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps--~~ell~ 227 (239)
.+...+..-++.+...- +...+++.+.++...|..||.+|.- .+++.+
T Consensus 371 ----------------~dh~kLFeLIl~ed~kF--Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakE 420 (516)
T KOG0690|consen 371 ----------------KDHEKLFELILMEDLKF--PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKE 420 (516)
T ss_pred ----------------cchhHHHHHHHhhhccC--CccCCHHHHHHHHHHhhcChHhhcCCCchhHHH
Confidence 22223333333333221 2355677889999999999999973 444444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=189.37 Aligned_cols=169 Identities=17% Similarity=0.195 Sum_probs=126.0
Q ss_pred CChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcc
Q 044155 30 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 109 (239)
Q Consensus 30 ~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 109 (239)
|||.++++... ..+++..+..++.|++.||.||| +.+ ||+||+++.++.+++ ||.+......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc---
Confidence 68999997642 56899999999999999999999 665 999999999999998 9988665332
Q ss_pred eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhh
Q 044155 110 ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV 189 (239)
Q Consensus 110 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (239)
...|++.|+|||++.+..++.++||||||+++|||++|..||......... .. ........
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-------~~---------~~~~~~~~ 123 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-------LE---------ILLNGMPA 123 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-------HH---------HHHHHhcc
Confidence 125789999999999999999999999999999999999998532211100 00 00000000
Q ss_pred c-CCCcHHHHHHHH--HHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 190 E-DVSSIEKEQQLH--ASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 190 ~-~~~~~~~~~~~~--~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
. ............ .+.+++.+||..+|.+|||+.|+++.+..+..+
T Consensus 124 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 124 DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0 000011122333 689999999999999999999999988776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=198.93 Aligned_cols=218 Identities=17% Similarity=0.243 Sum_probs=156.9
Q ss_pred CCCcccceeeEEEEe--------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 2 MSHNHILKLIGCCLE--------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 2 l~H~niv~l~~~~~~--------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
|+|+|++.+++.|.. ...+++||.+|+ -+|.-++.... .++...++.+++.++..||.|+| ...
T Consensus 73 lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH---r~k 144 (376)
T KOG0669|consen 73 LKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH---RNK 144 (376)
T ss_pred hcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH---Hhh
Confidence 689999999998863 234789999998 68888886543 57899999999999999999999 899
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCc---ceeecccccccccCccccccC-CcccccchhhhhhHHHHHhc
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~ 149 (239)
|+|||+|+.|+||+.++.++|+|||+++.+..+.. ..-+.+..|.+|++||.+.+. .++++.|||.-||++.||++
T Consensus 145 ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt 224 (376)
T KOG0669|consen 145 ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT 224 (376)
T ss_pred HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc
Confidence 99999999999999999999999999976643221 112345679999999999885 48999999999999999999
Q ss_pred CCCCccccccccccccc---chhhhhhhhhccchhhhhhhhhhcCCCcHHHH---------HHHHHHHHHHhhhcCCCCC
Q 044155 150 GWDVSDLVKDVHDLVCP---FSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKE---------QQLHASAQVTFECIKDSPA 217 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~dp~ 217 (239)
|.+.+++-......... -.......|.+.....+..++-.++....... ...+...+++..++..||.
T Consensus 225 rspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~ 304 (376)
T KOG0669|consen 225 RSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPT 304 (376)
T ss_pred cCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcc
Confidence 99988764432221110 00111111222222222222211111110000 1124567999999999999
Q ss_pred CCCCHHHHHH
Q 044155 218 DRPSMVDVAK 227 (239)
Q Consensus 218 ~Rps~~ell~ 227 (239)
+|+.+++++.
T Consensus 305 kR~~ad~aln 314 (376)
T KOG0669|consen 305 KRIDADQALN 314 (376)
T ss_pred cCcchHhhhc
Confidence 9999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=226.07 Aligned_cols=92 Identities=25% Similarity=0.245 Sum_probs=85.8
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++......++||||+.+++|.+++... ..++...++.++.||+.||.||| ..+|+|+||||
T Consensus 61 l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP 132 (669)
T cd05610 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKP 132 (669)
T ss_pred cCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccH
Confidence 68999999999999999999999999999999999764 45788889999999999999999 89999999999
Q ss_pred cceeecCCCceeEccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~ 101 (239)
+|||++.++.++|+|||+++
T Consensus 133 ~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 133 DNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=216.53 Aligned_cols=200 Identities=20% Similarity=0.145 Sum_probs=130.8
Q ss_pred eCCCceEEEEEccCCChhhhhhcCCCCCC---------------CcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 16 ETPIPILVFESVQYGTLWDRILGAPQPHF---------------EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 16 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.....++|+||+.+++|.+++........ .......+..++.|++.||.||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 45578999999999999999875431100 01123345678999999999999 8999999999
Q ss_pred CcceeecC-CCceeEcccccccccCCCCcceeecccccccccCccccccC----------------------Ccccccch
Q 044155 81 TSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG----------------------VFNEKSNV 137 (239)
Q Consensus 81 ~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di 137 (239)
|+|||++. ++.+||+|||++...............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57899999999976544433344566789999999966422 23345699
Q ss_pred hhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcH------HHHHHHHHHHHHHhhh
Q 044155 138 FSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSI------EKEQQLHASAQVTFEC 211 (239)
Q Consensus 138 ~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~c 211 (239)
|||||++|||+++..++.... ..+....... ........ .......... ..+.......+|+.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~~------~~~~~~l~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL------IQFNRQLKRN--DYDLVAWR-KLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH------HHHHHHHHhc--CCcHHHHH-HhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 999999999998765533110 0000000000 00000000 0000000000 0011223456899999
Q ss_pred cCCCCCCCCCHHHHHH
Q 044155 212 IKDSPADRPSMVDVAK 227 (239)
Q Consensus 212 l~~dp~~Rps~~ell~ 227 (239)
|+.||.+|||++++++
T Consensus 434 L~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 434 MRFKGRQRISAKAALA 449 (566)
T ss_pred ccCCcccCCCHHHHhC
Confidence 9999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=187.66 Aligned_cols=148 Identities=22% Similarity=0.241 Sum_probs=123.1
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.-|.+|++||...+....||.||.|+ .||..+.+.--. ....+++...=+|+..+..||.|||+ ...++|||+||.
T Consensus 103 ~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPs 178 (282)
T KOG0984|consen 103 DCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPS 178 (282)
T ss_pred CCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcc
Confidence 35889999999999999999999997 788665443211 11678999999999999999999997 679999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc----CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT----GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||++.+|++|++|||++-.+..+.. .+.-.|...|+|||.+.. ..|+.++||||||+.+.||.+++.||+.
T Consensus 179 NiLIn~~GqVKiCDFGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 179 NILINYDGQVKICDFGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eEEEccCCcEEEcccccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 99999999999999999866644421 122457889999998864 3589999999999999999999999753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=209.96 Aligned_cols=196 Identities=22% Similarity=0.295 Sum_probs=156.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++.||-||.+.-.|++....++|||-+. |+....+-+... .++++...+.++.||+.||.||| .++|+|.|||
T Consensus 619 ~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLK 691 (888)
T KOG4236|consen 619 NLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSSEK---GRLPERITKFLVTQILVALRYLH---FKNIVHCDLK 691 (888)
T ss_pred hcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCC
Confidence 4789999999999999999999999996 677676655443 68999999999999999999999 8999999999
Q ss_pred CcceeecCCC---ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+|||+.+.. ++||+|||+++...+.. ......||++|+|||++....|+..-|+||.|+++|.-++|.+||.+.
T Consensus 692 PENVLLas~~~FPQvKlCDFGfARiIgEks--FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 692 PENVLLASASPFPQVKLCDFGFARIIGEKS--FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred chheeeccCCCCCceeeccccceeecchhh--hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 9999997654 68999999998875433 244678999999999999999999999999999999999999999877
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
.++.+..+- ....+..+.| .+.+....++|...|+.+=.+|-|.++-+
T Consensus 770 EdIndQIQN----AaFMyPp~PW-----------------~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 770 EDINDQIQN----AAFMYPPNPW-----------------SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cchhHHhhc----cccccCCCch-----------------hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 765543320 0001111111 24445567788888888888888876654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=221.63 Aligned_cols=179 Identities=21% Similarity=0.325 Sum_probs=131.5
Q ss_pred CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccc
Q 044155 19 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS 98 (239)
Q Consensus 19 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg 98 (239)
..||-||||+..++.++++.+... . ......+++.+|++||+|+| ++|++||||||.||+++.++.+||+|||
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~---~-~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFG 742 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFN---S-QRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFG 742 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccc---h-hhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccc
Confidence 457889999988888888765321 1 46778899999999999999 9999999999999999999999999999
Q ss_pred cccccC----------------CCC-cceeecccccccccCccccccCC---cccccchhhhhhHHHHHhcCCCCccccc
Q 044155 99 LSISIP----------------EGE-THITDTVMGTLGYCAPEYMRTGV---FNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 99 ~~~~~~----------------~~~-~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
++.... .+. ....+...||.-|+|||.+.+.. |+.|+|+||||++++||+.- |+.--
T Consensus 743 LAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM 819 (1351)
T KOG1035|consen 743 LATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSM 819 (1351)
T ss_pred cchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchH
Confidence 987621 011 11345677999999999997644 99999999999999999874 22100
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.-...+.....+..+.. ...+..+.-+++|+.|++.||++||||.|||.
T Consensus 820 --------------------ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 --------------------ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --------------------HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 00011111111111111 12234455678999999999999999999985
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=182.58 Aligned_cols=215 Identities=18% Similarity=0.176 Sum_probs=157.6
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
|+|+|||+++++.-..+...+|+|+|. .+|..+..+-+ ..++....+.++.|++.||.|+| ++++.|||+||
T Consensus 58 lkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkp 129 (292)
T KOG0662|consen 58 LKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKP 129 (292)
T ss_pred hhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCc
Confidence 689999999999988889999999997 79998888765 56889999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
.|.+++.+|++|++|||+++.+.-. ..+-+....|.+|++|.++.+.+ |++.-|+||-||++.|+.....|.-+..+.
T Consensus 130 qnllin~ngelkladfglarafgip-vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv 208 (292)
T KOG0662|consen 130 QNLLINRNGELKLADFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_pred ceEEeccCCcEEecccchhhhcCCc-eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH
Confidence 9999999999999999999877432 23445566799999999999876 888999999999999998865554333332
Q ss_pred cc-ccccchhhhhhhhhccchhhhhhhhhhcCCC--------cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HD-LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--------SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+ ....|... . ......|+....-.....+. ..........-.++++..+.-+|..|.|+++.++
T Consensus 209 ddqlkrif~~l-g-~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 209 DDQLKRIFRLL-G-TPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HHHHHHHHHHh-C-CCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22 11111110 0 01111222211111111111 0111233344568889999999999999998875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=192.43 Aligned_cols=194 Identities=22% Similarity=0.317 Sum_probs=155.7
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||.+|-+...|.++...++|.||..||+|--.+++. ..+++..++.+...|+.||.||| ++||+.||||.+
T Consensus 309 n~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh---~rgiiyrdlkld 380 (593)
T KOG0695|consen 309 NNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLD 380 (593)
T ss_pred CCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeecccc
Confidence 7999999999999999999999999999997777665 67999999999999999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
|+|++..|.+|++|+|+.+..... ...++++.||+-|.|||++.+..|....|-|+||++++||+.|+.||+.......
T Consensus 381 nvlldaeghikltdygmcke~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~ 459 (593)
T KOG0695|consen 381 NVLLDAEGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP 459 (593)
T ss_pred ceEEccCCceeecccchhhcCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc
Confidence 999999999999999998754322 2236788999999999999999999999999999999999999999986542111
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP 220 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 220 (239)
..+....+.+-++.+..+- +...+-....++..-|+.||.+|.
T Consensus 460 -------------d~ntedylfqvilekqiri--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 460 -------------DMNTEDYLFQVILEKQIRI--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -------------ccchhHHHHHHHhhhcccc--cceeehhhHHHHHHhhcCCcHHhc
Confidence 1122222333333332221 123444456777788899999886
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=197.32 Aligned_cols=186 Identities=22% Similarity=0.309 Sum_probs=153.2
Q ss_pred CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcc
Q 044155 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 83 (239)
Q Consensus 4 H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~n 83 (239)
-|.++++...|.+-+.+++||||+.||+|-=.+++- ..+.+..+.-++..|+.||-+|| ++||+.||||.+|
T Consensus 409 ppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDN 480 (683)
T KOG0696|consen 409 PPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDN 480 (683)
T ss_pred CchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccc
Confidence 467788888888889999999999999997667654 56778888899999999999999 9999999999999
Q ss_pred eeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccc
Q 044155 84 ILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDL 163 (239)
Q Consensus 84 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~ 163 (239)
|+++.+|.+||+|||+++.-... ..-+.++.||+.|+|||++...+|+..+|-||+|+++|||+.|+.||++
T Consensus 481 vmLd~eGHiKi~DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG------- 552 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG------- 552 (683)
T ss_pred eEeccCCceEeeecccccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-------
Confidence 99999999999999998653222 2235688999999999999999999999999999999999999888863
Q ss_pred cccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 164 VCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
++..++.+++...+.. .+...+.+..++....+...|++|.-
T Consensus 553 --------------eDE~elF~aI~ehnvs--yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 553 --------------EDEDELFQAIMEHNVS--YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --------------CCHHHHHHHHHHccCc--CcccccHHHHHHHHHHhhcCCccccC
Confidence 2333444444444432 23456677788888999999999963
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=202.19 Aligned_cols=209 Identities=16% Similarity=0.125 Sum_probs=139.0
Q ss_pred ccceeeEEEEe--------CCCceEEEEEccCCChhhhhhcCCCCC-------------------CCcCCHHHHHHHHHH
Q 044155 6 HILKLIGCCLE--------TPIPILVFESVQYGTLWDRILGAPQPH-------------------FEPLLLKHRLKIAMD 58 (239)
Q Consensus 6 niv~l~~~~~~--------~~~~~iv~e~~~~~sL~~~l~~~~~~~-------------------~~~~~~~~~~~~~~~ 58 (239)
++++++++|.. .+..++|+||+++++|.++++...+.. ...+++..++.++.|
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 34677777753 346799999999999999987532110 023456778899999
Q ss_pred HHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-------
Q 044155 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF------- 131 (239)
Q Consensus 59 i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~------- 131 (239)
++.||.||| ..+++||||||+||+++.++.++|+|||++...............+++.|+|||.+.....
T Consensus 318 l~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~ 394 (507)
T PLN03224 318 VLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAP 394 (507)
T ss_pred HHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchh
Confidence 999999999 8999999999999999999999999999986543322211222334789999998754321
Q ss_pred ---------------ccccchhhhhhHHHHHhcCCC-CcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcH
Q 044155 132 ---------------NEKSNVFSFSVFLFELLTGWD-VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSI 195 (239)
Q Consensus 132 ---------------~~~~Di~slG~~l~~~~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (239)
..+.|+||+||++++|+++.. |+......... ... ..... ..............
T Consensus 395 ~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-------~~~--~~~~~-~~~r~~~~~~~~~~ 464 (507)
T PLN03224 395 AMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-------LRQ--YDNDL-NRWRMYKGQKYDFS 464 (507)
T ss_pred hhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-------Hhh--ccchH-HHHHhhcccCCCcc
Confidence 134699999999999999864 55322111000 000 00000 00000111111111
Q ss_pred HHHHHHHHHHHHHhhhcCCCC---CCCCCHHHHHH
Q 044155 196 EKEQQLHASAQVTFECIKDSP---ADRPSMVDVAK 227 (239)
Q Consensus 196 ~~~~~~~~~~~li~~cl~~dp---~~Rps~~ell~ 227 (239)
..+..+...++++.+||..+| .+|+|++|+++
T Consensus 465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 123456778999999999866 68999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-29 Score=205.10 Aligned_cols=198 Identities=21% Similarity=0.257 Sum_probs=157.1
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
-+||||+.++|.+......|+.||||.+|+|.|..+.. ..+.+.++...+...++|++||| +.+-+|||+|-
T Consensus 69 c~h~nivay~gsylr~dklwicMEycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylh---s~gk~hRdiKG 140 (829)
T KOG0576|consen 69 CRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKG 140 (829)
T ss_pred CCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhh---cCCcccccccc
Confidence 37999999999999999999999999999999988776 67899999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCC-cccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDV-SDLV 157 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p-~~~~ 157 (239)
.||++++.|.+|+.|||.+..... ...+...+.||+.|||||+.. .+.|...+|||++|+...|+-.-..| |..+
T Consensus 141 anilltd~gDvklaDfgvsaqita-ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 141 ANILLTDEGDVKLADFGVSAQITA-TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred cceeecccCceeecccCchhhhhh-hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 999999999999999998755432 223456788999999999874 35589999999999999998776554 2211
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. .....+..+....+........+.+.+.+|+..|+..+|++|||++.+++
T Consensus 220 p-------------------mr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 220 P-------------------MRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred h-------------------HHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 11111111111111112222366778899999999999999999998875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=199.16 Aligned_cols=213 Identities=20% Similarity=0.217 Sum_probs=157.9
Q ss_pred ccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCccee
Q 044155 6 HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCIL 85 (239)
Q Consensus 6 niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil 85 (239)
|+++++..|...+++|+|||.+. .+|.++++..+.. ..+..+.+..++.|+..||.+|- ..+++|.||||+|||
T Consensus 495 Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNIL 568 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceE
Confidence 56778888889999999999995 9999999987543 45778888999999999999999 999999999999999
Q ss_pred ecCCC-ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc---
Q 044155 86 FNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH--- 161 (239)
Q Consensus 86 ~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~--- 161 (239)
++... .+||||||.|.....+. .+.+..+..|.|||++.+-+|+..-|+||.||.+||+.||+..|.+-.+..
T Consensus 569 VNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred eccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 98765 57999999986654433 234566788999999999999999999999999999999998887654422
Q ss_pred ---cccccch-------hhhhhhhhccc------------------------hhhhhhhhhhcCCCcHHHHHHHHHHHHH
Q 044155 162 ---DLVCPFS-------EYLKNCFEDNR------------------------FTEIVDHIVVEDVSSIEKEQQLHASAQV 207 (239)
Q Consensus 162 ---~~~~~~~-------~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l 207 (239)
+..++|+ +|....|..+- ..++....+.....+.........+.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 1122221 11112221110 0111111111111122223566788999
Q ss_pred HhhhcCCCCCCCCCHHHHHH
Q 044155 208 TFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 208 i~~cl~~dp~~Rps~~ell~ 227 (239)
+..|+..||++|.|..++|.
T Consensus 726 Ldkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHhccChhhcCCHHHHhc
Confidence 99999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=192.22 Aligned_cols=77 Identities=21% Similarity=0.263 Sum_probs=68.7
Q ss_pred CcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 4 HNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 4 H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
-.+||+|++.|.. +.++|||+|++ |.+|..+|..... +.++...+++|+.||+.||.|||. ..+|+|.||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDl 214 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDL 214 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCC
Confidence 3579999999984 44789999999 5899898887765 679999999999999999999998 789999999
Q ss_pred cCcceee
Q 044155 80 KTSCILF 86 (239)
Q Consensus 80 k~~nil~ 86 (239)
||+|||+
T Consensus 215 KPENvLl 221 (590)
T KOG1290|consen 215 KPENVLL 221 (590)
T ss_pred Ccceeee
Confidence 9999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=190.47 Aligned_cols=213 Identities=20% Similarity=0.293 Sum_probs=153.3
Q ss_pred CCCcccceeeEEEEeCC-----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 2 MSHNHILKLIGCCLETP-----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~-----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++|.|++..+++..-.. ..++++|+++ .+|..++-+- +.++.+.++.+.+||+.||.||| +.+|.|
T Consensus 109 FkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILH 179 (449)
T KOG0664|consen 109 FRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLH---TANILH 179 (449)
T ss_pred hccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHh---hcchhh
Confidence 57999999888765332 3578899997 8998888654 78899999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCcc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|||||.|.|+++|-.+||+|||+++..........+....|..|+|||.+.+.+ |+...||||.||++.|++.++..|+
T Consensus 180 RDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 180 RDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred ccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 999999999999999999999999876544333445666788999999998865 8999999999999999999887776
Q ss_pred ccccccc------ccc-cchhhhhhhhhccchhhhhhhhhhcCCCcH---------HHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 156 LVKDVHD------LVC-PFSEYLKNCFEDNRFTEIVDHIVVEDVSSI---------EKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 156 ~~~~~~~------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
....... +.+ |-.+-.+..-+. . ..+++......+ .++....+-..+...++..||.+|
T Consensus 260 Aq~PiqQL~lItdLLGTPs~EaMr~ACEG-A----k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkr 334 (449)
T KOG0664|consen 260 AAGPIEQLQMIIDLLGTPSQEAMKYACEG-A----KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKR 334 (449)
T ss_pred ccChHHHHHHHHHHhCCCcHHHHHHHhhh-h----HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccc
Confidence 5433221 111 111111111110 0 011111111111 112333445678888999999999
Q ss_pred CCHHHHHHH
Q 044155 220 PSMVDVAKK 228 (239)
Q Consensus 220 ps~~ell~~ 228 (239)
.+.++.+.-
T Consensus 335 is~~~A~~~ 343 (449)
T KOG0664|consen 335 ISVEEALQH 343 (449)
T ss_pred ccHhhhccc
Confidence 998887653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=174.48 Aligned_cols=166 Identities=30% Similarity=0.490 Sum_probs=143.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|++|+++++++......++++|++.+++|.+++.... ..++...+..++.+++.++.+|| ..+++|+||+
T Consensus 47 ~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~ 119 (215)
T cd00180 47 KLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLK 119 (215)
T ss_pred hcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCC
Confidence 3689999999999999889999999999899999987642 35788999999999999999999 8999999999
Q ss_pred CcceeecC-CCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|.||+++. ++.++|+|||.+........ ......+...|++||..... ..+.++|+|++|++++++
T Consensus 120 ~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------- 187 (215)
T cd00180 120 PENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------- 187 (215)
T ss_pred HhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------
Confidence 99999999 88999999998876543321 12234467889999998876 788999999999999998
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
..+.+++.+|+..+|.+||++.+++..
T Consensus 188 -------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 457789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=193.98 Aligned_cols=145 Identities=19% Similarity=0.307 Sum_probs=125.6
Q ss_pred CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcc
Q 044155 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 83 (239)
Q Consensus 4 H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~n 83 (239)
.+-||+||-.|.+...+|+||+|++||++-.+|-+- .-+++..++.++..+..|+.+.| ..|++||||||+|
T Consensus 688 n~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDN 759 (1034)
T KOG0608|consen 688 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDN 759 (1034)
T ss_pred CcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccc
Confidence 456899999999999999999999999999888765 56888899999999999999999 9999999999999
Q ss_pred eeecCCCceeEcccccccccC---------CCC--------------------------------cceeecccccccccC
Q 044155 84 ILFNEENVAKLFDFSLSISIP---------EGE--------------------------------THITDTVMGTLGYCA 122 (239)
Q Consensus 84 il~~~~~~~~l~dfg~~~~~~---------~~~--------------------------------~~~~~~~~~~~~y~a 122 (239)
|||+.+|.+||+|||++..+. .+. ........||+-|+|
T Consensus 760 ILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 760 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred eEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence 999999999999999865320 000 001123569999999
Q ss_pred ccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 123 PEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 123 PE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
||++....++...|-||.|+++|||+.|+.||-.
T Consensus 840 pevl~r~g~~q~cdwws~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 840 PEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred hHHhcccCccccchhhHhhHHHHHHhhCCCCccC
Confidence 9999999999999999999999999999999853
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=193.60 Aligned_cols=142 Identities=23% Similarity=0.310 Sum_probs=127.5
Q ss_pred CCcccceeeEEEEeCCCceEEEEEc-cCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESV-QYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~-~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.|+||++++++|++++.++++||-- ++.+|.+++... .++++.++..|+.|++.|+++|| +.+|+|||||-
T Consensus 627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikd 698 (772)
T KOG1152|consen 627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKD 698 (772)
T ss_pred CccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhcccccc---ccCceeccccc
Confidence 4999999999999999999999974 567889999876 67999999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcc-cccchhhhhhHHHHHhcCCCCcc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFN-EKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
+|+.++.+|.+||+|||.+.....+. -..+.||..|.|||++.+.+|- ..-|||++|+++|.++...+||.
T Consensus 699 envivd~~g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 699 ENVIVDSNGFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccEEEecCCeEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999999999886654332 4578899999999999988754 56899999999999999988875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=168.92 Aligned_cols=212 Identities=15% Similarity=0.171 Sum_probs=148.8
Q ss_pred CCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 3 SHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 3 ~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.||||++++++..+. ....+|+|+..+.+...+. ..++...+..++.+++.||.|+| ++||.|||+|
T Consensus 91 gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVK 159 (338)
T KOG0668|consen 91 GGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVK 159 (338)
T ss_pred CCCCeeehhhhhcCccccCchhHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCC
Confidence 499999999998764 4677999999988887666 56788889999999999999999 9999999999
Q ss_pred CcceeecCCC-ceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|.|++++... .++|+|||++.....+.... .+..+..|-.||.+... .+.-.-|+|||||++..|+..+.||-...
T Consensus 160 PhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 160 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred cceeeechhhceeeeeecchHhhcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 9999999754 68999999997765544322 34456678899988764 47888999999999999999999875333
Q ss_pred cc-ccccccchhh----hhhhh--hccchhhhhhhhhhcC--------CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 159 DV-HDLVCPFSEY----LKNCF--EDNRFTEIVDHIVVED--------VSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 159 ~~-~~~~~~~~~~----~~~~~--~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
+. ..+....... +.... ...........++... ..+....-.+++..+++...|.+|..+|+||.
T Consensus 238 dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTak 317 (338)
T KOG0668|consen 238 DNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAK 317 (338)
T ss_pred CCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchH
Confidence 22 2111110000 00000 0000001111111111 11111123347788999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
|.+.
T Consensus 318 Eam~ 321 (338)
T KOG0668|consen 318 EAMA 321 (338)
T ss_pred HHhc
Confidence 9875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=171.52 Aligned_cols=202 Identities=18% Similarity=0.226 Sum_probs=139.8
Q ss_pred CCcccceeeEE-EEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 3 SHNHILKLIGC-CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 3 ~H~niv~l~~~-~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.|.||+.-|++ |++.+.+++++||++.|+|.+-+... .+-+....+++.|++.||.||| +.++||||||.
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~ 149 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKA 149 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhh---ccchhhccccc
Confidence 48888888775 56667788999999999999888653 3567778899999999999999 99999999999
Q ss_pred cceeecCCC--ceeEcccccccccCCCCcceeecccccccccCccccccC-----CcccccchhhhhhHHHHHhcCCCCc
Q 044155 82 SCILFNEEN--VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-----VFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 82 ~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
+||||...+ .+|++|||.......- .........|.+||..... ...+.+|+|.||+++|.++||+.||
T Consensus 150 eNiLif~~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 150 ENILIFDADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred ceEEEecCCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 999986543 7899999987543211 1122235668899976432 2567899999999999999999999
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
+.........- + ...+.....+ .+ +......++....+..+-+..+|++|=-..++......+
T Consensus 226 Qka~~~d~~Y~---~--~~~w~~rk~~-----~~-----P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 226 QKASIMDKPYW---E--WEQWLKRKNP-----AL-----PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred hhhhccCchHH---H--HHHHhcccCc-----cC-----chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 84332221111 1 1111111111 01 111124455667788888889999885555555544443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-26 Score=194.86 Aligned_cols=204 Identities=16% Similarity=0.255 Sum_probs=155.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.|+|||++.....+.+.....-.||||++ +|..++.+. ..+....+..++.|++.|++|+| ..|+.|||+|
T Consensus 377 ~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK 447 (601)
T KOG0590|consen 377 SLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLK 447 (601)
T ss_pred cccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCc
Confidence 47899998887777666555445999997 999999875 46788889999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc---ceeecccccccccCccccccCCccc-ccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTLGYCAPEYMRTGVFNE-KSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
++|+++..++.+||+|||.+..+..... .......|+-+|+|||++.+..|.+ ..||||.|+++..|.+|+.||..
T Consensus 448 ~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 448 LENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred cccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 9999999999999999999876643222 3455678999999999999888765 58999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
-....... ..... .................+...+.+|.+||+.||.+|.|++++++
T Consensus 528 a~~~~~~~-----------~~~~~---~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 528 AKKSDNSF-----------KTNNY---SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccch-----------hhhcc---ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 33221111 00000 00000001111122356677889999999999999999999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=166.32 Aligned_cols=148 Identities=31% Similarity=0.388 Sum_probs=126.7
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|+|++++++++......++++|++++++|.+++..... .++......++.+++.++.+|| ..+++|+|++|
T Consensus 54 ~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~ 126 (225)
T smart00221 54 LKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKP 126 (225)
T ss_pred CCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 6899999999999988899999999998899999986521 1788999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCcccc-ccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYM-RTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
.||+++.++.++|+|||.+...............++..|++||.+ ....++.++|+|+||++++++++|+.||..
T Consensus 127 ~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 127 ENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred HHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999999999999999998876643321112344567789999998 666788899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=174.75 Aligned_cols=211 Identities=28% Similarity=0.422 Sum_probs=159.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe-eeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI-VFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i-~H~dl 79 (239)
++.|.|+.+++|.+.+++..++|.+||..|+|.|.+.... ..+++.....++.+++.|+.|+| ..++ .|+.+
T Consensus 3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l 75 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLH---NSPIGYHGAL 75 (484)
T ss_pred ccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHh---cCcceeeeee
Confidence 4789999999999999999999999999999999998743 56888889999999999999999 5554 99999
Q ss_pred cCcceeecCCCceeEcccccccccCCC-CcceeecccccccccCccccccCC-------cccccchhhhhhHHHHHhcCC
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEG-ETHITDTVMGTLGYCAPEYMRTGV-------FNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~~~~g~ 151 (239)
++.|++++....+|++|||+....... .........-..-|.|||.+.... .+.+.||||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999997655321 111111222345699999987642 356799999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhh---cCCCc-HH-HHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV---EDVSS-IE-KEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~-~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
.||......... .+++..+.. ....+ .. .....+.+..++.+||..+|.+||+++++-
T Consensus 156 ~~~~~~~~~~~~-----------------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 156 GPFDLRNLVEDP-----------------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CccccccccCCh-----------------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 998653322211 111111111 00111 11 113445788999999999999999999999
Q ss_pred HHHHHHHHh
Q 044155 227 KKLRQIYRS 235 (239)
Q Consensus 227 ~~L~~l~~~ 235 (239)
..+..+...
T Consensus 219 ~~~~~~~~~ 227 (484)
T KOG1023|consen 219 SKLLTINKG 227 (484)
T ss_pred hhhhhhccc
Confidence 988877654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=169.23 Aligned_cols=197 Identities=16% Similarity=0.202 Sum_probs=143.4
Q ss_pred CCcccceeeEEEEe---------------------------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHH
Q 044155 3 SHNHILKLIGCCLE---------------------------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 55 (239)
Q Consensus 3 ~H~niv~l~~~~~~---------------------------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~ 55 (239)
+|||||++.+.|.+ +...++||..++ .+|+.++-.. .........+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC------CCchHHHHHH
Confidence 79999999998753 235689999997 7999999764 3456677789
Q ss_pred HHHHHHHHhHHhhCCCCCeeeccccCcceeec--CCC--ceeEcccccccccCCCC-----cceeecccccccccCcccc
Q 044155 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFN--EEN--VAKLFDFSLSISIPEGE-----THITDTVMGTLGYCAPEYM 126 (239)
Q Consensus 56 ~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~--~~~--~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~ 126 (239)
+.|+++|+.||| .+|+.|||+|++|||+- +|+ .+.++|||++....... ....-...|.-..||||+.
T Consensus 347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999 99999999999999974 343 46789999875433211 1122344577788999988
Q ss_pred ccCC------cccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHH
Q 044155 127 RTGV------FNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQ 200 (239)
Q Consensus 127 ~~~~------~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (239)
...+ .-.++|.|+.|.+.||+++..+||..-.... ..... -.+..-+..++..
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-------------L~~r~--------Yqe~qLPalp~~v 482 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-------------LDTRT--------YQESQLPALPSRV 482 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-------------echhh--------hhhhhCCCCcccC
Confidence 6533 3468999999999999999999987532111 11101 1111122233466
Q ss_pred HHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 201 LHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 201 ~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
++.+.+++...|+.||++|+|++-....|.
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 678899999999999999999775555443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=162.59 Aligned_cols=198 Identities=18% Similarity=0.287 Sum_probs=152.7
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
+.||||+.++|.|....+..++..|++.|||+..++.... .-.+..++.+++.+++.|++|||+. +.-|....|.+
T Consensus 244 fshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~---vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns 319 (448)
T KOG0195|consen 244 FSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNS 319 (448)
T ss_pred ecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhccc
Confidence 4799999999999999999999999999999999998754 4567788889999999999999953 33455557889
Q ss_pred cceeecCCCceeEc--ccccccccCCCCcceeecccccccccCccccccCC---cccccchhhhhhHHHHHhcCCCCccc
Q 044155 82 SCILFNEENVAKLF--DFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV---FNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 82 ~nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
..++++++.+.+|+ |--++.. ......+++|++||.+...+ .-..+|+|||++++||+.|...||..
T Consensus 320 ~hvmidedltarismad~kfsfq--------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 320 KHVMIDEDLTARISMADTKFSFQ--------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred ceEEecchhhhheecccceeeee--------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 99999999877764 4333211 11334578999999987544 34679999999999999999888754
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
... ++...++..+..+...+...+..+..++.-|++.||.+||.++.++-.|++.
T Consensus 392 lsp---------------------mecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 392 LSP---------------------MECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCc---------------------hhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 332 2333333333333334456677888999999999999999999998888764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=165.53 Aligned_cols=142 Identities=26% Similarity=0.304 Sum_probs=117.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.+.||+++.+.+..++...+|+||+++....++.. .+....+..++..++.||+++| ..||+|||+||.
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKps 161 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPS 161 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCcc
Confidence 46799999999999999999999999999988884 4668899999999999999999 999999999999
Q ss_pred ceeecCC-CceeEcccccccccC-----------------C------------------CCcc--------eeecccccc
Q 044155 83 CILFNEE-NVAKLFDFSLSISIP-----------------E------------------GETH--------ITDTVMGTL 118 (239)
Q Consensus 83 nil~~~~-~~~~l~dfg~~~~~~-----------------~------------------~~~~--------~~~~~~~~~ 118 (239)
|+|.+.. +.-.|.|||++.... . +... ..-...||+
T Consensus 162 NFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~ 241 (418)
T KOG1167|consen 162 NFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTP 241 (418)
T ss_pred ccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCC
Confidence 9999865 345889999987110 0 0000 012346899
Q ss_pred cccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 119 GYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 119 ~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
+|+|||++.. ...+++.||||-|+++.-++++..||-
T Consensus 242 GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 242 GFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred CCCchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence 9999999875 568899999999999999999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.4e-20 Score=146.77 Aligned_cols=212 Identities=28% Similarity=0.379 Sum_probs=152.2
Q ss_pred CCCc-ccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MSHN-HILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~H~-niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+.|+ +|+++++.+......+++++++.++++.+++...... ..+.......++.|++.++.++| ..+++|||+|
T Consensus 54 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~k 128 (384)
T COG0515 54 LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIK 128 (384)
T ss_pred ccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCC
Confidence 5666 7999999997777789999999999999777654211 16888999999999999999999 8999999999
Q ss_pred CcceeecCCC-ceeEcccccccccCCCCcc-----eeecccccccccCcccccc---CCcccccchhhhhhHHHHHhcCC
Q 044155 81 TSCILFNEEN-VAKLFDFSLSISIPEGETH-----ITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 81 ~~nil~~~~~-~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|+||+++..+ .++++|||.+......... ......++..|+|||.+.+ ...+...|+||+|++++++++|.
T Consensus 129 p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~ 208 (384)
T COG0515 129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208 (384)
T ss_pred HHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 9999999988 7999999998755433221 2356678999999999987 57889999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
.|+...... ............. ... .................+.+++..|+..+|..|.+..+....
T Consensus 209 ~p~~~~~~~----~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 209 PPFEGEKNS----SATSQTLKIILEL-PTP-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCCCCCCcc----ccHHHHHHHHHhc-CCc-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 885433321 0000000000000 000 000000000001223567899999999999999998776653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.3e-20 Score=147.44 Aligned_cols=206 Identities=19% Similarity=0.200 Sum_probs=152.0
Q ss_pred cccceeeEEE-EeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcc
Q 044155 5 NHILKLIGCC-LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 83 (239)
Q Consensus 5 ~niv~l~~~~-~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~n 83 (239)
+++..+++.. ..+...++||+.+ |.+|.++...... ..++..+..+++.|++.+|.++| +.|++||||||+|
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~---~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPP---GRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPEN 152 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCC---CCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHH
Confidence 4778888887 4666789999999 6999998866542 67999999999999999999999 9999999999999
Q ss_pred eeecCC-----CceeEcccccccccC---CCC---cc--e-eecccccccccCccccccCCcccccchhhhhhHHHHHhc
Q 044155 84 ILFNEE-----NVAKLFDFSLSISIP---EGE---TH--I-TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 84 il~~~~-----~~~~l~dfg~~~~~~---~~~---~~--~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 149 (239)
++++.. ..+.+.|||+++... ... .. . ...+.||..|+++....+...+.+.|+||++-++.++..
T Consensus 153 ~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~ 232 (322)
T KOG1164|consen 153 FVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK 232 (322)
T ss_pred eeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc
Confidence 999875 358999999998321 111 11 1 234569999999999999999999999999999999999
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||........... +.. ......... .....+..+.++...+-+.+..++|....+...+
T Consensus 233 g~LPW~~~~~~~~~~~---------~~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 233 GSLPWEALEMTDLKSK---------FEK-----DPRKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred CCCCCccccccchHHH---------HHH-----Hhhhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 9998855443222100 000 000000000 1112334556666666668999999999999988
Q ss_pred HHHHHh
Q 044155 230 RQIYRS 235 (239)
Q Consensus 230 ~~l~~~ 235 (239)
.++...
T Consensus 295 ~~~~~~ 300 (322)
T KOG1164|consen 295 KDVFDS 300 (322)
T ss_pred HHHHHh
Confidence 877654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-21 Score=155.08 Aligned_cols=123 Identities=28% Similarity=0.395 Sum_probs=105.4
Q ss_pred CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccc
Q 044155 19 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS 98 (239)
Q Consensus 19 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg 98 (239)
..+|.|++|...+|.+.+.+.... ..-+....+.++.|++.|+.| ++.+|+|+||.||.+..+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 467899999999999999755433 567788899999999999997 688999999999999999999999999
Q ss_pred cccccCCCC-----cceeecccccccccCccccccCCcccccchhhhhhHHHHHhc
Q 044155 99 LSISIPEGE-----THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 99 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 149 (239)
+........ ....+.-.||..||+||.+.+..++.++||||||++++|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 976554332 123345579999999999999999999999999999999988
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-19 Score=137.48 Aligned_cols=209 Identities=15% Similarity=0.150 Sum_probs=158.9
Q ss_pred cccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcce
Q 044155 5 NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 84 (239)
Q Consensus 5 ~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ni 84 (239)
+.|-..|-+..++....+|+|++ |.||+|++.=.+ .+++.++++.+|.|++.-+.++| ++.++.|||||+|+
T Consensus 84 ~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNF 155 (449)
T KOG1165|consen 84 EGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNF 155 (449)
T ss_pred CCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccce
Confidence 55666666666777889999999 699999988654 67999999999999999999999 99999999999999
Q ss_pred eecCCC-----ceeEcccccccccCCCCcc------eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 85 LFNEEN-----VAKLFDFSLSISIPEGETH------ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 85 l~~~~~-----~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
||+..+ .+.++|||+++...+..+. -.....||..||+--...+...+.+-|+=|||=++++.+.|..|
T Consensus 156 LIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLP 235 (449)
T KOG1165|consen 156 LIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 235 (449)
T ss_pred eecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCc
Confidence 998654 5789999999876443321 22456799999999999999999999999999999999999999
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
|+++...... .+++++.+.-...+.. ....+.+.++..-+...-+.+-.+-|..+-+..-+..++
T Consensus 236 WQGLKA~tnK--------------~kYeKIGe~Kr~T~i~-~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 236 WQGLKADTNK--------------EKYEKIGETKRSTPIE-VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred cccccCcchH--------------HHHHHhccccccCCHH-HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 9876532211 1122222211111111 122356777888888888888888899888777777776
Q ss_pred Hhh
Q 044155 234 RSL 236 (239)
Q Consensus 234 ~~~ 236 (239)
..+
T Consensus 301 dr~ 303 (449)
T KOG1165|consen 301 DRL 303 (449)
T ss_pred Hhc
Confidence 544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=162.58 Aligned_cols=197 Identities=22% Similarity=0.260 Sum_probs=137.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.+|||.+++.-+.+...-.++|=+|.. -+|+|++... .-+...+++-|+.|++.||.-+| ..||+|+|||.
T Consensus 78 ~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKs 148 (1431)
T KOG1240|consen 78 MKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKS 148 (1431)
T ss_pred hcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHH---HcCcccccccc
Confidence 378888887766666666677777886 7999999765 33567788899999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccc--cCC-CC---cceeecccccccccCccccccCC-----------cccccchhhhhhHH
Q 044155 82 SCILFNEENVAKLFDFSLSIS--IPE-GE---THITDTVMGTLGYCAPEYMRTGV-----------FNEKSNVFSFSVFL 144 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~--~~~-~~---~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l 144 (239)
+|||++.=+.+.|+||..=+- ++. +. ...-.+...-..|.|||.+.... .+++.||||+||++
T Consensus 149 ENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 149 ENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred ceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 999999999999999974221 111 10 01111222345799999885411 56789999999999
Q ss_pred HHHhcC-CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 145 FELLTG-WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 145 ~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
.|+++- +++|.. ++.+...-.. .......+.+. .+..++.+|..|++.||++|.||+
T Consensus 229 aELf~Eg~PlF~L-----------SQL~aYr~~~---~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAe 286 (1431)
T KOG1240|consen 229 AELFLEGRPLFTL-----------SQLLAYRSGN---ADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAE 286 (1431)
T ss_pred HHHHhcCCCcccH-----------HHHHhHhccC---ccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHH
Confidence 999885 566542 1221111111 11111112111 123577899999999999999999
Q ss_pred HHHHHH
Q 044155 224 DVAKKL 229 (239)
Q Consensus 224 ell~~L 229 (239)
+.++.-
T Consensus 287 dyL~~y 292 (1431)
T KOG1240|consen 287 DYLQKY 292 (1431)
T ss_pred HHHHhh
Confidence 999863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=129.96 Aligned_cols=206 Identities=17% Similarity=0.173 Sum_probs=153.0
Q ss_pred eeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecC
Q 044155 9 KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE 88 (239)
Q Consensus 9 ~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~ 88 (239)
.+..+..+.....+||+.. |.||++++.-.. ..++.++.+.++-|++..+.|+| .++.+||||||+|+|.+-
T Consensus 75 ~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGl 146 (341)
T KOG1163|consen 75 HIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGL 146 (341)
T ss_pred hhhhhccccccceeeeecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeecc
Confidence 3344555677788999999 699999887654 57899999999999999999999 999999999999999875
Q ss_pred C---CceeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 89 E---NVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 89 ~---~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
+ ..+.++|||+++......+ .-.....||..|.+--...+...+..-|+=|+|-++.++-.|..||+++..
T Consensus 147 grh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 147 GRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 4 4678999999987643322 122455689999998888888889999999999999999999999987653
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~~ 237 (239)
....+ +.+.+...-..-.. .......|.++.-.+..|-...-.+-|...-+-+.+.-|...++
T Consensus 227 ~tk~Q--------------KyEkI~EkK~s~~i-e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 227 ATKKQ--------------KYEKISEKKMSTPI-EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred hhHHH--------------HHHHHHHhhcCCCH-HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 21111 11111111111111 11223567788888899999999999998877777776665543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-19 Score=150.22 Aligned_cols=178 Identities=22% Similarity=0.245 Sum_probs=144.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||.+|++...+...+..++++++..+|.|...+... ..++......+...++.+++++| ..+++++|+|++
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~e 126 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLE 126 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhccccc
Confidence 4899999999999999999999999998998777655 55677778888899999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
||+++.+|.+++.|||+++..-+.. ..+|+..|||||+.. .....+|.||||++.++|++|..||.+
T Consensus 127 nilld~~Ghi~~tdfglske~v~~~-----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------ 193 (612)
T KOG0603|consen 127 NVLLLLEGHIKLTDFGLSKEAVKEK-----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------ 193 (612)
T ss_pred ceeecccCccccCCchhhhHhHhhh-----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------
Confidence 9999999999999999987654332 227899999999998 566789999999999999999888753
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
+....+.... ...+...+....+++..+...+|..|.-.
T Consensus 194 -------------------~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 -------------------DTMKRILKAE--LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -------------------HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2222222211 12234566677788888888898888744
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-19 Score=137.19 Aligned_cols=164 Identities=19% Similarity=0.246 Sum_probs=105.0
Q ss_pred ceEEEEEccCCChhhhhhc---CCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcc
Q 044155 20 PILVFESVQYGTLWDRILG---APQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD 96 (239)
Q Consensus 20 ~~iv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~d 96 (239)
.+++|+-+. ++|.+++.. .... ...+....++.+..|+++.+++|| ..|++|+||+|+|++++.+|.+.|+|
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~ 188 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGD 188 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--
T ss_pred hhhccchhh-hcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcC
Confidence 467888886 899887552 2110 022334445666689999999999 89999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCccccccC--------CcccccchhhhhhHHHHHhcCCCCcccccccccccccch
Q 044155 97 FSLSISIPEGETHITDTVMGTLGYCAPEYMRTG--------VFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFS 168 (239)
Q Consensus 97 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~ 168 (239)
|+......... .....+..|.+||..... .++.+.|.|+||+++|.++++..||+..........
T Consensus 189 F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--- 261 (288)
T PF14531_consen 189 FSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--- 261 (288)
T ss_dssp GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---
T ss_pred hHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---
Confidence 98664432211 113345778999976442 478899999999999999999999875432111100
Q ss_pred hhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 169 EYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
.. ..+. +.++.++.+|..+|+.+|.+|
T Consensus 262 ------------------~f-----~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ------------------DF-----SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ------------------GG-----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ------------------cc-----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 00 1122 667889999999999999988
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-18 Score=138.26 Aligned_cols=110 Identities=16% Similarity=0.081 Sum_probs=83.4
Q ss_pred CCCCcccce-eeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILK-LIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~-l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++|+||+. +++ .+..++||||++|++|.. .... . ...++.|++.+|.||| +++|+||||
T Consensus 77 ~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~-~~~~-----~------~~~~~~~i~~aL~~lH---~~gIiHrDL 137 (365)
T PRK09188 77 TVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHL-ARPH-----G------DPAWFRSAHRALRDLH---RAGITHNDL 137 (365)
T ss_pred hccCCCCCcEEEE----cCCcEEEEEccCCCCHHH-hCcc-----c------hHHHHHHHHHHHHHHH---HCCCeeCCC
Confidence 478999985 443 245799999999999962 2110 1 1357889999999999 899999999
Q ss_pred -cCcceeecCCCceeEcccccccccCCCCc-------ceeecccccccccCccccccC
Q 044155 80 -KTSCILFNEENVAKLFDFSLSISIPEGET-------HITDTVMGTLGYCAPEYMRTG 129 (239)
Q Consensus 80 -k~~nil~~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~ 129 (239)
||+|||++.++.++|+|||+++....... .......+++.|+|||.+...
T Consensus 138 ~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 138 AKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999999999999999886643221 111345677889999998643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=118.79 Aligned_cols=135 Identities=13% Similarity=0.047 Sum_probs=96.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc-cC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF-KT 81 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl-k~ 81 (239)
+|++|.+++++ +..+++|||+.|.+|.+.... ....++.|++.+|.++| +.|++|+|| ||
T Consensus 60 ~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp 120 (218)
T PRK12274 60 GLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKE 120 (218)
T ss_pred CCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCc
Confidence 45788888876 345899999998888654311 11246789999999999 999999999 79
Q ss_pred cceeecCCCceeEcccccccccCCCCcc----e--------eecccccccccCccccccC-Ccc-cccchhhhhhHHHHH
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETH----I--------TDTVMGTLGYCAPEYMRTG-VFN-EKSNVFSFSVFLFEL 147 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~----~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~Di~slG~~l~~~ 147 (239)
.||+++.++.++|+|||++......... . ......++.+++|+..... ..+ ...+-++.|.-+|.+
T Consensus 121 ~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~ 200 (218)
T PRK12274 121 ANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRF 200 (218)
T ss_pred ceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHH
Confidence 9999999999999999999755432210 0 1122345666666644322 233 345556899999999
Q ss_pred hcCCCCccc
Q 044155 148 LTGWDVSDL 156 (239)
Q Consensus 148 ~~g~~p~~~ 156 (239)
+|++.+...
T Consensus 201 ~~~~~~~~~ 209 (218)
T PRK12274 201 VTRRVLHWE 209 (218)
T ss_pred HhccCCccc
Confidence 999877544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.5e-17 Score=123.64 Aligned_cols=118 Identities=12% Similarity=0.124 Sum_probs=87.6
Q ss_pred CCCcccceeeEEEEeC--------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 2 MSHNHILKLIGCCLET--------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 2 l~H~niv~l~~~~~~~--------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
+.|++|.....++... +..+++|||++|.+|.+... ++. ....+++.++..+| ..|
T Consensus 92 L~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~g 155 (232)
T PRK10359 92 VRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHG 155 (232)
T ss_pred HHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcC
Confidence 6799999998886633 35789999999999977632 222 23569999999999 999
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 149 (239)
++|+|++|.||+++.++ ++++|||........... ........+..++|+||||+++.....
T Consensus 156 i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 156 MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999999999999988 999999987544221110 002223345678999999998775543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=114.44 Aligned_cols=87 Identities=15% Similarity=0.026 Sum_probs=68.9
Q ss_pred CCcccceeeEEEEeCC---C-ceEEEEE--ccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHH-hHHhhCCCCCee
Q 044155 3 SHNHILKLIGCCLETP---I-PILVFES--VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL-AYLHFGFPRPIV 75 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~---~-~~iv~e~--~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~LH~~~~~~i~ 75 (239)
.||||++++|+++++. . +.+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +||| +++|+
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh---~~~Iv 127 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL---DNRIV 127 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH---HCCEe
Confidence 6899999999999863 3 3478999 5579999999653 24444 35577888777 9999 99999
Q ss_pred eccccCcceeecCC----CceeEcccccc
Q 044155 76 FRNFKTSCILFNEE----NVAKLFDFSLS 100 (239)
Q Consensus 76 H~dlk~~nil~~~~----~~~~l~dfg~~ 100 (239)
||||||+|||++.. ..++|+|++.+
T Consensus 128 hrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 128 TMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99999999999743 37999995543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.6e-16 Score=114.83 Aligned_cols=74 Identities=16% Similarity=0.255 Sum_probs=62.5
Q ss_pred ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHH-hhCCCCCeeeccccCcceeecCCCceeEcccc
Q 044155 20 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYL-HFGFPRPIVFRNFKTSCILFNEENVAKLFDFS 98 (239)
Q Consensus 20 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-H~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg 98 (239)
.++||||++++++....... ..++......++.|++.+|.++ | ..+++|+|+||+||+++ ++.++|+|||
T Consensus 92 ~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~v~LiDFG 162 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGKLYIIDVS 162 (190)
T ss_pred CEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCcEEEEEcc
Confidence 48999999977665443322 4578889999999999999999 8 88999999999999998 4789999999
Q ss_pred cccc
Q 044155 99 LSIS 102 (239)
Q Consensus 99 ~~~~ 102 (239)
++..
T Consensus 163 ~a~~ 166 (190)
T cd05147 163 QSVE 166 (190)
T ss_pred cccc
Confidence 9864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-16 Score=138.16 Aligned_cols=139 Identities=24% Similarity=0.306 Sum_probs=105.8
Q ss_pred HHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcc--------------eeecccccccccCcc
Q 044155 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--------------ITDTVMGTLGYCAPE 124 (239)
Q Consensus 59 i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~y~aPE 124 (239)
++.++.||| ..+|+|||+||+|.+|..-|.+|++|||+++...+.... ......||+.|.|||
T Consensus 152 mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 378899999 999999999999999999999999999998764322110 123447899999999
Q ss_pred ccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHH-HHHHHHH
Q 044155 125 YMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE-KEQQLHA 203 (239)
Q Consensus 125 ~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 203 (239)
++....|...+|-|++|+++|+.+.|+.||.+. ...+++...+......++ ....+++
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGd---------------------tpeelfg~visd~i~wpE~dea~p~E 287 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---------------------TPEELFGQVISDDIEWPEEDEALPPE 287 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCC---------------------CHHHHHhhhhhhhccccccCcCCCHH
Confidence 999999999999999999999999998887532 222333333322221111 1244577
Q ss_pred HHHHHhhhcCCCCCCCCC
Q 044155 204 SAQVTFECIKDSPADRPS 221 (239)
Q Consensus 204 ~~~li~~cl~~dp~~Rps 221 (239)
.++++.+.|+.+|..|.-
T Consensus 288 a~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 288 AQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred HHHHHHHHHHhChHhhcc
Confidence 889999999999999973
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.7e-15 Score=113.54 Aligned_cols=91 Identities=15% Similarity=0.149 Sum_probs=68.7
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeecccc
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFK 80 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dlk 80 (239)
+.|++|.....+... ..++||||++++++....... ..++......++.|++.++.++| . .|++|+|+|
T Consensus 76 l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlk 145 (190)
T cd05145 76 LYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLS 145 (190)
T ss_pred HHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCC
Confidence 345555333333222 248999999877554332222 34677888999999999999999 7 999999999
Q ss_pred CcceeecCCCceeEccccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISI 103 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~ 103 (239)
|+||+++ ++.++|+|||++...
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceec
Confidence 9999998 788999999998655
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-16 Score=137.37 Aligned_cols=199 Identities=18% Similarity=0.253 Sum_probs=150.3
Q ss_pred CcccceeeEEEEeCCCceEEEEEccCCChhhhh-hcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRI-LGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 4 H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
|+|++++++...+....++++++..++++.+.+ .... ...+......++.|+..++.|+|. ..++.|+|+||+
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~ 153 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPS 153 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCc----cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCc
Confidence 999999999999999999999999999998888 4331 245566777889999999999996 678999999999
Q ss_pred ceeecCCC-ceeEcccccccccCC--CCcceeecccc-cccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 83 CILFNEEN-VAKLFDFSLSISIPE--GETHITDTVMG-TLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 83 nil~~~~~-~~~l~dfg~~~~~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|.+++..+ ..+++|||++..... +.........| ++.|+|||...+. -.....|+||.|+++.-+++|..|++..
T Consensus 154 n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 154 NSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred cchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 99999999 999999999987654 33334455667 9999999998874 4677899999999999999999887654
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
.........+.+ .. ................+++..++..+|+.|.+.+++.
T Consensus 234 ~~~~~~~~~~~~----------------~~--~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 234 SRKDGRYSSWKS----------------NK--GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccccceeecc----------------cc--cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 433221111000 00 0000000113344566788888989999999988764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.5e-16 Score=120.40 Aligned_cols=200 Identities=19% Similarity=0.258 Sum_probs=136.0
Q ss_pred CCCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
|+-|.|||++..|+.+. ....+++||+..|++.+++++..... ..+..+.-.+|+.||+.||.|||+ ++..++
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs-~~Ppii 200 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHS-CDPPII 200 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhc-cCCccc
Confidence 35699999999988654 35789999999999999998754322 567788888999999999999995 378899
Q ss_pred eccccCcceeecCCCceeEcccccccccC--CCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIP--EGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~--~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|+++..+.|.+..++-+|+.--.-..... ... ..-.....+-++|.|||.=...+.+.++|||+||....+|.-+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 99999999999988877765321110000 000 001122335678999998777778889999999999999877632
Q ss_pred CcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
-..... ..-...+.+...+....+ ..-..++..|++-.|..||+|++++.
T Consensus 281 q~tnse-----------------S~~~~ee~ia~~i~~len--------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 281 QSTNSE-----------------SKVEVEENIANVIIGLEN--------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred ccCCCc-----------------ceeehhhhhhhheeeccC--------ccccCcCcccccCCCCCCcchhhhhc
Confidence 100000 000011122221111111 11246788999999999999998874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=129.06 Aligned_cols=128 Identities=20% Similarity=0.192 Sum_probs=106.5
Q ss_pred CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCC-------
Q 044155 17 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE------- 89 (239)
Q Consensus 17 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~------- 89 (239)
.+.-++|+||.+.|||.+++... +.+++-....++.|++.-+.+|| ..+|+|+||||+|+++...
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred CCcceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcc
Confidence 45568899999999999999744 66888899999999999999999 9999999999999998643
Q ss_pred CceeEcccccccccCC-CCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCC
Q 044155 90 NVAKLFDFSLSISIPE-GETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 90 ~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
..++|+|||.+.-+.- .....-....++-.+-.+|+..+.+|+...|-|.|+.+++.|+.|+.
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 3589999998865421 11123345557778889999999999999999999999999999954
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-13 Score=104.61 Aligned_cols=88 Identities=19% Similarity=0.223 Sum_probs=74.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
+.|++|.....++.+....+++|||++|++|.+.+... . . ....++.+++.+|.++| ..+++|+|++|
T Consensus 56 l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~-----~---~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p 123 (211)
T PRK14879 56 ARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN-----G---M-EELELSREIGRLVGKLH---SAGIIHGDLTT 123 (211)
T ss_pred HHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc-----c---H-HHHHHHHHHHHHHHHHH---hCCcccCCCCc
Confidence 45777776666777777889999999999999988643 1 1 77889999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~ 102 (239)
.||+++ ++.++++|||.+..
T Consensus 124 ~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 124 SNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred ccEEEE-CCCEEEEECCcccC
Confidence 999999 77899999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.5e-13 Score=117.20 Aligned_cols=85 Identities=18% Similarity=0.183 Sum_probs=74.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|++++..+.++.+....++||||+++++|.+++. ....++.+++.+|.+|| +.+++|+|+|
T Consensus 392 ~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlk 455 (535)
T PRK09605 392 EARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLT 455 (535)
T ss_pred hhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCC
Confidence 3678999888777777778899999999999988874 23568899999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~ 102 (239)
|+||++ .++.++|+|||++..
T Consensus 456 p~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 456 TSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred hHHEEE-ECCcEEEEeCccccc
Confidence 999999 577899999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.6e-13 Score=100.17 Aligned_cols=85 Identities=20% Similarity=0.217 Sum_probs=68.6
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
+.|+++.....++......++||||++|++|.+.+... .. .++.+++.+|.++| +.+++|+|++|
T Consensus 54 l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~ 118 (199)
T TIGR03724 54 ARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEG-----ND-------ELLREIGRLVGKLH---KAGIVHGDLTT 118 (199)
T ss_pred HHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhc-----HH-------HHHHHHHHHHHHHH---HCCeecCCCCc
Confidence 34555544444555666779999999999998887542 11 67899999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~ 102 (239)
.||+++ ++.++++|||.+..
T Consensus 119 ~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 119 SNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ceEEEE-CCcEEEEECCCCcC
Confidence 999999 78899999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=8.7e-13 Score=102.11 Aligned_cols=88 Identities=16% Similarity=0.152 Sum_probs=67.4
Q ss_pred CCCccc--ceeeEEEEeCC----CceEEEEEccC-CChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 2 MSHNHI--LKLIGCCLETP----IPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 2 l~H~ni--v~l~~~~~~~~----~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
|.|++| ...+++..... ..++|||++++ .+|.+++... .++.. .+.+++.++.+|| +.||
T Consensus 97 L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH---~~GI 163 (239)
T PRK01723 97 LYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH---DAGV 163 (239)
T ss_pred HHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH---HCCC
Confidence 455554 56666644322 23599999996 6898887542 34443 3578999999999 9999
Q ss_pred eeccccCcceeecCCCceeEcccccccc
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~ 102 (239)
+|+||||.|||++.++.++|+|||.+..
T Consensus 164 ~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 164 YHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 9999999999999988999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-12 Score=101.20 Aligned_cols=75 Identities=19% Similarity=0.169 Sum_probs=62.1
Q ss_pred CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC-eeeccccCcceeecCCCceeEccc
Q 044155 19 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP-IVFRNFKTSCILFNEENVAKLFDF 97 (239)
Q Consensus 19 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~-i~H~dlk~~nil~~~~~~~~l~df 97 (239)
..++||||+++.+|....... ..........++.|++.++.+|| ..+ ++|+|+||+||+++ ++.++++||
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~-~~~i~LiDF 192 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH-DGKVVIIDV 192 (237)
T ss_pred CceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE-CCCEEEEEC
Confidence 358999999987876654322 23455667889999999999999 899 99999999999999 788999999
Q ss_pred ccccc
Q 044155 98 SLSIS 102 (239)
Q Consensus 98 g~~~~ 102 (239)
|.+..
T Consensus 193 g~a~~ 197 (237)
T smart00090 193 SQSVE 197 (237)
T ss_pred hhhhc
Confidence 98754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3e-12 Score=108.20 Aligned_cols=135 Identities=19% Similarity=0.175 Sum_probs=102.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.|+||||++++..++..+..|+|+|.+. .|..+++. +.......-+.||+.||.|||. +.+++|+++.
T Consensus 65 tlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~ 132 (690)
T KOG1243|consen 65 TLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGKEEVCLGLFQILAALSFLND--DCNLVHGNVC 132 (690)
T ss_pred hccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEe
Confidence 3799999999999999999999999985 78788854 4467777889999999999985 7899999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcC
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g 150 (239)
-+.|+++..|..||++|.++........ .......--.|..|+.+.... -..|.|.||+++++++.|
T Consensus 133 ~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 133 KDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 9999999999999999987644321110 011111111244555433222 235999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.4e-12 Score=105.36 Aligned_cols=193 Identities=20% Similarity=0.202 Sum_probs=138.3
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHH----HHhHHhhCCCCCeeecc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH----ALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~LH~~~~~~i~H~d 78 (239)
.|+|.++.+..++.++..++-+|++. .+|.++.+... .-++.........+... |+.++| ..+++|.|
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~ 247 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDD 247 (524)
T ss_pred ccccccccCcccccCCcceeeecccc-chhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccC---CCcccccc
Confidence 58888998888999999999999996 88888887653 23667777777888888 999999 99999999
Q ss_pred ccCcceeecCC-CceeEcccccccccCCCCc---ceeecc-cccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 79 FKTSCILFNEE-NVAKLFDFSLSISIPEGET---HITDTV-MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 79 lk~~nil~~~~-~~~~l~dfg~~~~~~~~~~---~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+||+||....+ ...+++|||+......+.. ...... .+...|++||..+ ..++...|||++|.++.+...+...
T Consensus 248 ~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 248 LKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred cchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccc
Confidence 99999999999 7889999998776544321 111122 5677899999876 5567899999999999999888544
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
..... ...|....... .........+.++...+.+|++.+|-.|++++.+.
T Consensus 327 ~~~g~------------------~~~W~~~r~~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 327 PSVGK------------------NSSWSQLRQGY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ccCCC------------------CCCcccccccc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 22110 01111111100 01111123334455588899999999999987654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.2e-11 Score=91.89 Aligned_cols=72 Identities=13% Similarity=0.165 Sum_probs=60.4
Q ss_pred CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEccc
Q 044155 18 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF 97 (239)
Q Consensus 18 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~df 97 (239)
...++||||+++++|...... .....++.+++.++.++| ..+++|+|+||.||+++.++.++|+||
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDf 169 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDW 169 (198)
T ss_pred CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEEC
Confidence 456899999999888654321 234567899999999999 899999999999999999999999999
Q ss_pred cccccc
Q 044155 98 SLSISI 103 (239)
Q Consensus 98 g~~~~~ 103 (239)
|.+...
T Consensus 170 g~~~~~ 175 (198)
T cd05144 170 PQMVST 175 (198)
T ss_pred CccccC
Confidence 988544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.1e-11 Score=85.37 Aligned_cols=86 Identities=16% Similarity=0.135 Sum_probs=70.0
Q ss_pred cccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcce
Q 044155 5 NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 84 (239)
Q Consensus 5 ~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ni 84 (239)
.++.+++++....+..++++||+++.++..+ +......++.+++.+++.+|.....+++|+|++|.||
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Ni 120 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNI 120 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceE
Confidence 4778888888777789999999987666433 3455667789999999999942225799999999999
Q ss_pred eecCCCceeEcccccccc
Q 044155 85 LFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 85 l~~~~~~~~l~dfg~~~~ 102 (239)
+++..+.++++|||.+..
T Consensus 121 l~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 121 LVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEECCcEEEEEecccccC
Confidence 999988999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.9e-10 Score=91.24 Aligned_cols=210 Identities=15% Similarity=0.162 Sum_probs=138.0
Q ss_pred EEEEEccC-CChhhhhhcC-CCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEccccc
Q 044155 22 LVFESVQY-GTLWDRILGA-PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 99 (239)
Q Consensus 22 iv~e~~~~-~sL~~~l~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~ 99 (239)
+.|..+.+ ..+.+++... +..+.....|...++.+..++.+.+.|| +.|.+-+|+.++|+|+++++.+.+.|=..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccc
Confidence 44555433 2333333322 2233467789999999999999999999 99999999999999999999999987443
Q ss_pred ccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcC-CCCcccccccccccccch-hhhh
Q 044155 100 SISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTG-WDVSDLVKDVHDLVCPFS-EYLK 172 (239)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g-~~p~~~~~~~~~~~~~~~-~~~~ 172 (239)
-+.-..+ .......|...|++||.-. +...+...|.|.||+++++++.| +.||.+.........+.. ....
T Consensus 164 fqi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 164 FQINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eeeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 2221122 1233556788999999654 33466789999999999998776 899988766544433332 1111
Q ss_pred hhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCC--CCCCCCHHHHHHHHHHHHHhhcCC
Q 044155 173 NCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDS--PADRPSMVDVAKKLRQIYRSLSCN 239 (239)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d--p~~Rps~~ell~~L~~l~~~~~~~ 239 (239)
..|...+ +. ..-.........-.-.++++..+..+|+... +.-|||++..+..|.++-.++..|
T Consensus 242 g~f~ya~--~~-~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 242 GRFAYAS--DQ-RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred ceeeech--hc-cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 1111100 00 0001111111122345677889999998654 568999999999999998887654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-10 Score=86.49 Aligned_cols=74 Identities=16% Similarity=0.198 Sum_probs=58.0
Q ss_pred CceEEEEEccCCChhhh-hhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeeccccCcceeecCCCceeEcc
Q 044155 19 IPILVFESVQYGTLWDR-ILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFD 96 (239)
Q Consensus 19 ~~~iv~e~~~~~sL~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dlk~~nil~~~~~~~~l~d 96 (239)
..++||||++++++... +... .. ......++.+++.++.++| . .+++|+|+||+||+++ ++.++++|
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~------~~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liD 157 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDV------RL-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIID 157 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhh------hh-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEE
Confidence 45899999997544221 1111 01 1566788999999999999 7 9999999999999999 88999999
Q ss_pred ccccccc
Q 044155 97 FSLSISI 103 (239)
Q Consensus 97 fg~~~~~ 103 (239)
||.+...
T Consensus 158 fg~a~~~ 164 (187)
T cd05119 158 VPQAVEI 164 (187)
T ss_pred Ccccccc
Confidence 9998544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=8.3e-11 Score=100.02 Aligned_cols=150 Identities=17% Similarity=0.228 Sum_probs=99.8
Q ss_pred HHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcc--------eeecccccccccCccccc
Q 044155 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--------ITDTVMGTLGYCAPEYMR 127 (239)
Q Consensus 56 ~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~ 127 (239)
+.+++.|+.|+|. +.++||+++.|++|.++..+.+||+.|+++......... ......-..-|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4556689999996 778999999999999999999999999876544321100 011122345799999999
Q ss_pred cCCcccccchhhhhhHHHHHhcC-CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHH
Q 044155 128 TGVFNEKSNVFSFSVFLFELLTG-WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQ 206 (239)
Q Consensus 128 ~~~~~~~~Di~slG~~l~~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (239)
+.-.+.++|+||+|+++|.+..| +..+.......... ......+..........+.++.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------------~~~~~~~~~~~~~s~~~p~el~~ 243 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------------FSRNLLNAGAFGYSNNLPSELRE 243 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------------hhhcccccccccccccCcHHHHH
Confidence 88888999999999999999954 33332211100000 00000000001111356677888
Q ss_pred HHhhhcCCCCCCCCCHHHHH
Q 044155 207 VTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 207 li~~cl~~dp~~Rps~~ell 226 (239)
-+..++..++..||++.++.
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHhcCCcccCcchhhhh
Confidence 88899999999999776654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=7.7e-11 Score=98.54 Aligned_cols=189 Identities=19% Similarity=0.124 Sum_probs=130.7
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.|.+++..+..+......++=-|||.++++.....-. ..+.....+++..|++.++.++| ...++|+|+||.
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~ps 395 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPS 395 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhccccccc
Confidence 4667777777776666677889999999987766322 55778888899999999999999 999999999999
Q ss_pred ceeecCC-CceeEcccccccccCCCCcceeeccccccccc--CccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 83 CILFNEE-NVAKLFDFSLSISIPEGETHITDTVMGTLGYC--APEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 83 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||++..+ +..++.|||.+..+.... ....+.-++. ++.......+..++|++|||.-+.+..++.........
T Consensus 396 ni~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~ 471 (524)
T KOG0601|consen 396 NILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ 471 (524)
T ss_pred ceeeccchhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc
Confidence 9999987 677899999875432211 1112222333 45555567788999999999999999998543221110
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
+..+. .+... ..+ .....+..+...++..++..||++.++....
T Consensus 472 --------------------~~~i~----~~~~p-~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 472 --------------------SLTIR----SGDTP-NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred --------------------ceeee----ccccc-CCC-chHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 00000 01000 001 2225566777788999999999988876544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.1e-10 Score=103.37 Aligned_cols=179 Identities=21% Similarity=0.231 Sum_probs=127.2
Q ss_pred eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEc
Q 044155 16 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF 95 (239)
Q Consensus 16 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~ 95 (239)
......++++|..+++|...++... .....-.+..+..+.+++.+|| ...++|+|++|.|.+...++..+++
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~ 946 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLT 946 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccC
Confidence 4556789999999999999988753 2333344455677888999999 7779999999999999999999999
Q ss_pred cccccccc---------------------CCCC---------cceeecccccccccCccccccCCcccccchhhhhhHHH
Q 044155 96 DFSLSISI---------------------PEGE---------THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLF 145 (239)
Q Consensus 96 dfg~~~~~---------------------~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 145 (239)
||+..... ..+. ........+++.|.+||...+......+|.|+.|+.++
T Consensus 947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen 947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhh
Confidence 98732110 0000 01123456889999999999999999999999999999
Q ss_pred HHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCC-cHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 146 ELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS-SIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 146 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
+.++|..||..-. ..+.++.+...... +.-+...+...++++...+..+|.+|..+.
T Consensus 1027 e~l~g~pp~na~t---------------------pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAET---------------------PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhcCCCCCCCcc---------------------hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999998875322 11122222222111 111234556677888889999999988765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.9e-09 Score=76.12 Aligned_cols=74 Identities=22% Similarity=0.263 Sum_probs=60.5
Q ss_pred EEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCce
Q 044155 13 CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA 92 (239)
Q Consensus 13 ~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~ 92 (239)
+..+.+...|+|||++|..|.+.+... ...++..+-.-+.-|| ..+|+|+||+++||+++..+ +
T Consensus 67 ~dvD~~~~~I~me~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i 130 (204)
T COG3642 67 YDVDPDNGLIVMEYIEGELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-I 130 (204)
T ss_pred EEEcCCCCEEEEEEeCChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-E
Confidence 344677778999999998998888653 1245666777788899 99999999999999998776 9
Q ss_pred eEcccccccc
Q 044155 93 KLFDFSLSIS 102 (239)
Q Consensus 93 ~l~dfg~~~~ 102 (239)
.++|||++..
T Consensus 131 ~~IDfGLg~~ 140 (204)
T COG3642 131 YFIDFGLGEF 140 (204)
T ss_pred EEEECCcccc
Confidence 9999999854
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.8e-09 Score=77.79 Aligned_cols=76 Identities=12% Similarity=0.132 Sum_probs=57.0
Q ss_pred CCceEEEEEccCCChh-hhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHH-hhCCCCCeeeccccCcceeecCCCceeEc
Q 044155 18 PIPILVFESVQYGTLW-DRILGAPQPHFEPLLLKHRLKIAMDIVHALAYL-HFGFPRPIVFRNFKTSCILFNEENVAKLF 95 (239)
Q Consensus 18 ~~~~iv~e~~~~~sL~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-H~~~~~~i~H~dlk~~nil~~~~~~~~l~ 95 (239)
...++||||+.+..+. ..++. ..++......+..+++.++..+ | ..+++|+||++.||++.. +.+.++
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL~~~-~~v~iI 166 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYNMLWHD-GKVWFI 166 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEC-CcEEEE
Confidence 4568999999754332 12221 2344455667789999999988 8 889999999999999974 679999
Q ss_pred cccccccc
Q 044155 96 DFSLSISI 103 (239)
Q Consensus 96 dfg~~~~~ 103 (239)
|||.+...
T Consensus 167 DF~qav~~ 174 (197)
T cd05146 167 DVSQSVEP 174 (197)
T ss_pred ECCCceeC
Confidence 99977544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.7e-09 Score=75.00 Aligned_cols=84 Identities=24% Similarity=0.230 Sum_probs=65.7
Q ss_pred EEEeCCCceEEEEEccC-CChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCc
Q 044155 13 CCLETPIPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV 91 (239)
Q Consensus 13 ~~~~~~~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~ 91 (239)
++.+.+...++|||++| .++.+++..... ..........++..+-+.+.-|| ..+++|+||+.+||++..++.
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~ 151 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGN 151 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCC
Confidence 45677788999999984 388898877543 22233333678888999999999 999999999999999877663
Q ss_pred ---eeEcccccccc
Q 044155 92 ---AKLFDFSLSIS 102 (239)
Q Consensus 92 ---~~l~dfg~~~~ 102 (239)
+.++|||++..
T Consensus 152 ~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 152 QITPILIDFGLSSV 165 (229)
T ss_pred cCceEEEeecchhc
Confidence 47899999754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.7e-09 Score=87.74 Aligned_cols=78 Identities=15% Similarity=0.113 Sum_probs=59.7
Q ss_pred CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHH-HHhHHhhCCCCCeeeccccCcceeecCCCceeEc
Q 044155 17 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH-ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF 95 (239)
Q Consensus 17 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~ 95 (239)
....++||||++|++|.+...... ...+ ...++..++. .+..+| ..|++|+|++|.||+++.++.++++
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~li 299 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIAL 299 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHh----cCCC---HHHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEE
Confidence 345689999999999988765321 1121 2345555555 467889 8999999999999999999999999
Q ss_pred ccccccccC
Q 044155 96 DFSLSISIP 104 (239)
Q Consensus 96 dfg~~~~~~ 104 (239)
|||++....
T Consensus 300 DfG~~~~l~ 308 (437)
T TIGR01982 300 DFGIVGRLS 308 (437)
T ss_pred eCCCeeECC
Confidence 999986653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.1e-08 Score=78.71 Aligned_cols=77 Identities=12% Similarity=0.109 Sum_probs=62.7
Q ss_pred CceEEEEEccCC-ChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecC-------CC
Q 044155 19 IPILVFESVQYG-TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE-------EN 90 (239)
Q Consensus 19 ~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~-------~~ 90 (239)
..++|||++++. +|.+++..... .......+..++.+++..+.-|| ..|++|+|+++.|||++. +.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence 467999999865 79888853211 33456677789999999999999 999999999999999975 35
Q ss_pred ceeEccccccc
Q 044155 91 VAKLFDFSLSI 101 (239)
Q Consensus 91 ~~~l~dfg~~~ 101 (239)
.+.++||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 78999999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.7e-08 Score=72.95 Aligned_cols=87 Identities=18% Similarity=0.143 Sum_probs=68.9
Q ss_pred ceeeEEEEeCC----CceEEEEEccC-CChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 8 LKLIGCCLETP----IPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 8 v~l~~~~~~~~----~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.+.+++.+... ..++|+|++++ .+|.+++... ...+......++.+++..++-|| ..|++|+|+++.
T Consensus 76 P~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~ 147 (206)
T PF06293_consen 76 PEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALARLIAKLH---DAGIYHGDLNPS 147 (206)
T ss_pred CcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcc
Confidence 34455555422 34799999986 3798888764 22556677889999999999999 999999999999
Q ss_pred ceeecCCC---ceeEcccccccc
Q 044155 83 CILFNEEN---VAKLFDFSLSIS 102 (239)
Q Consensus 83 nil~~~~~---~~~l~dfg~~~~ 102 (239)
|||++.++ .+.++||+.++.
T Consensus 148 NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 148 NILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cEEEeCCCCceeEEEEcchhcee
Confidence 99999987 788999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.4e-08 Score=71.78 Aligned_cols=68 Identities=16% Similarity=0.193 Sum_probs=52.4
Q ss_pred CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC-----eeeccccCcceeecCCCc
Q 044155 17 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP-----IVFRNFKTSCILFNEENV 91 (239)
Q Consensus 17 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~-----i~H~dlk~~nil~~~~~~ 91 (239)
....++|||+++|.++.+.. . .....+.+++.+|+.|| ..+ ++|+|++|.||+++ ++.
T Consensus 63 ~~~~~lv~e~i~G~~l~~~~----------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~ 125 (170)
T cd05151 63 PETGVLITEFIEGSELLTED----------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGR 125 (170)
T ss_pred CCCCeEEEEecCCCcccccc----------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCe
Confidence 33458999999987775420 0 01234678999999999 666 59999999999998 567
Q ss_pred eeEccccccc
Q 044155 92 AKLFDFSLSI 101 (239)
Q Consensus 92 ~~l~dfg~~~ 101 (239)
++++||+.+.
T Consensus 126 ~~liDf~~a~ 135 (170)
T cd05151 126 LWLIDWEYAG 135 (170)
T ss_pred EEEEeccccc
Confidence 9999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.4e-07 Score=77.10 Aligned_cols=130 Identities=15% Similarity=0.204 Sum_probs=96.1
Q ss_pred CCCCcccceeeEEEEeC----CCceEEEEEccC-CChhhhhhcCCCC----------CCCcCCHHHHHHHHHHHHHHHhH
Q 044155 1 QMSHNHILKLIGCCLET----PIPILVFESVQY-GTLWDRILGAPQP----------HFEPLLLKHRLKIAMDIVHALAY 65 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~----~~~~iv~e~~~~-~sL~~~l~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~ 65 (239)
++.|+|||++.++|... ...++|++|.++ ++|.++....... .....++...+.++.|+..||.+
T Consensus 329 kl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~s 408 (655)
T KOG3741|consen 329 KLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYS 408 (655)
T ss_pred HhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHH
Confidence 47899999999998732 356899999864 5676654432211 11346788999999999999999
Q ss_pred HhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHH
Q 044155 66 LHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLF 145 (239)
Q Consensus 66 LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 145 (239)
+| ..|+.-+-|.+.+|++..+.+++|+..|......... .+| + .-..+-|.=.||.+++
T Consensus 409 IH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------------~~~--l---e~~Qq~D~~~lG~ll~ 467 (655)
T KOG3741|consen 409 IH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------------TEP--L---ESQQQNDLRDLGLLLL 467 (655)
T ss_pred HH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCC-------------Ccc--h---hHHhhhhHHHHHHHHH
Confidence 99 8999999999999999999889988777654432221 001 1 1123458889999999
Q ss_pred HHhcCC
Q 044155 146 ELLTGW 151 (239)
Q Consensus 146 ~~~~g~ 151 (239)
.+.+|.
T Consensus 468 aLAt~~ 473 (655)
T KOG3741|consen 468 ALATGT 473 (655)
T ss_pred HHhhcc
Confidence 999993
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.7e-06 Score=74.27 Aligned_cols=87 Identities=11% Similarity=0.090 Sum_probs=55.7
Q ss_pred ccceeeEEEEe-CCCceEEEEEccCCChhhh--hhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 6 HILKLIGCCLE-TPIPILVFESVQYGTLWDR--ILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 6 niv~l~~~~~~-~~~~~iv~e~~~~~sL~~~--l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+.+.+..++.+ ....++||||++|+++.++ +...+. ....+.......++.| +. ..|++|+|++|.
T Consensus 221 ~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Q-------if---~~GffHaDpHPG 289 (537)
T PRK04750 221 DMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQ-------VF---RDGFFHADMHPG 289 (537)
T ss_pred CCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHH-------HH---hCCeeeCCCChH
Confidence 33444444432 4556899999999999774 222110 0011222222223333 34 679999999999
Q ss_pred ceeecCCC----ceeEccccccccc
Q 044155 83 CILFNEEN----VAKLFDFSLSISI 103 (239)
Q Consensus 83 nil~~~~~----~~~l~dfg~~~~~ 103 (239)
||+++.++ .++++|||+....
T Consensus 290 NIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 290 NIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HeEEecCCCCCCeEEEEecceEEEC
Confidence 99999988 8999999987554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.9e-07 Score=69.33 Aligned_cols=73 Identities=18% Similarity=0.241 Sum_probs=48.2
Q ss_pred CceEEEEEcc--CCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhH-HhhCCCCCeeeccccCcceeecCCCceeEc
Q 044155 19 IPILVFESVQ--YGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAY-LHFGFPRPIVFRNFKTSCILFNEENVAKLF 95 (239)
Q Consensus 19 ~~~iv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-LH~~~~~~i~H~dlk~~nil~~~~~~~~l~ 95 (239)
..++||||++ |..+.. +... .+.......++.+++..+.. +| ..|++|+||.+.||+++.+ .+.++
T Consensus 80 ~~~ivME~I~~~G~~~~~-l~~~------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPR-LKDV------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp TTEEEEE--EETTEEGGC-HHHC------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred CCEEEEEecCCCccchhh-HHhc------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence 3479999998 655544 3322 12234445667777775444 68 8999999999999999987 79999
Q ss_pred ccccccc
Q 044155 96 DFSLSIS 102 (239)
Q Consensus 96 dfg~~~~ 102 (239)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.3e-06 Score=64.44 Aligned_cols=91 Identities=25% Similarity=0.389 Sum_probs=64.6
Q ss_pred ccceeeEEEEeC---CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhC-------------
Q 044155 6 HILKLIGCCLET---PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFG------------- 69 (239)
Q Consensus 6 niv~l~~~~~~~---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~------------- 69 (239)
++.+++.+.... +..++|||+++|.++.+.+.. ..++......++.+++..|..||+.
T Consensus 58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~ 131 (223)
T cd05154 58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRP 131 (223)
T ss_pred CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCC
Confidence 345666665543 256899999998888765531 1245566666777777777777721
Q ss_pred ----------------------------------------CCCCeeeccccCcceeecC--CCceeEcccccccc
Q 044155 70 ----------------------------------------FPRPIVFRNFKTSCILFNE--ENVAKLFDFSLSIS 102 (239)
Q Consensus 70 ----------------------------------------~~~~i~H~dlk~~nil~~~--~~~~~l~dfg~~~~ 102 (239)
....++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 132 GGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred CchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356899999999999998 56688999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.6e-06 Score=64.25 Aligned_cols=66 Identities=18% Similarity=0.136 Sum_probs=51.9
Q ss_pred CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccc
Q 044155 19 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFS 98 (239)
Q Consensus 19 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg 98 (239)
..+++|||++|..|.+... ++. .++..+.+++.-+| ..|++|+|..|.|++++.++ ++++|++
T Consensus 117 ~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred EEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 3468999999988866542 222 24466778899999 99999999999999998665 9999998
Q ss_pred ccc
Q 044155 99 LSI 101 (239)
Q Consensus 99 ~~~ 101 (239)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=1e-05 Score=60.86 Aligned_cols=77 Identities=17% Similarity=0.090 Sum_probs=62.6
Q ss_pred CceEEEEEccC-CChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCc--eeEc
Q 044155 19 IPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENV--AKLF 95 (239)
Q Consensus 19 ~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~--~~l~ 95 (239)
...+|+|-+.+ .||.+.+..... .+.+...+..++.+++..++-|| ..|+.|+|+-+.||+++.++. +.++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEE
Confidence 35789997743 578777755422 45677888899999999999999 999999999999999987776 8999
Q ss_pred cccccc
Q 044155 96 DFSLSI 101 (239)
Q Consensus 96 dfg~~~ 101 (239)
||.-++
T Consensus 173 DlEk~r 178 (216)
T PRK09902 173 DLEKSR 178 (216)
T ss_pred Ehhccc
Confidence 998654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.08 E-value=3e-05 Score=57.82 Aligned_cols=92 Identities=23% Similarity=0.273 Sum_probs=70.7
Q ss_pred cccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcce
Q 044155 5 NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 84 (239)
Q Consensus 5 ~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ni 84 (239)
+++.+++|+|- ..+++|+...+++...... .......+|..+.+++.++++.+.+++.+....+.-.|++++|+
T Consensus 20 ~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nf 93 (188)
T PF12260_consen 20 EPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNF 93 (188)
T ss_pred CCCCCeeeECC----CEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHe
Confidence 48899999982 2669999986666432100 00013457999999999999999999965556788899999999
Q ss_pred eecCCCceeEcccccccc
Q 044155 85 LFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 85 l~~~~~~~~l~dfg~~~~ 102 (239)
.+++++.+|++|......
T Consensus 94 gv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 94 GVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeCCCcEEEEechhcch
Confidence 999999999999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.6e-06 Score=72.86 Aligned_cols=140 Identities=17% Similarity=0.134 Sum_probs=99.9
Q ss_pred CCCCcc-cceeeEEEEeCCCceEEEEEccCC-ChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNH-ILKLIGCCLETPIPILVFESVQYG-TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~n-iv~l~~~~~~~~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
|.+||| .+..++-+..+...+++++++.++ +..+...... ..+..-+...+...-..+++++| +..-+|+|
T Consensus 289 K~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se----~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d 361 (829)
T KOG0576|consen 289 KVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSE----IALEQYQFAYPLRKETRPLAELH---SSYKVHRD 361 (829)
T ss_pred HccCCCCcccccccCCcccccchhhhhhcCCccccccCChhh----Hhhhhhhhhhhhhhhcccccccc---cccccCcc
Confidence 468999 666666666667789999999766 2322222111 22334444556666778999999 55557888
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
||+.++ +..+..||+....+.... ......+++.|+|||+.....+....|.|++|.-..++--|-.|.
T Consensus 362 ----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 362 ----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 777655 568999999876654432 345677899999999999999999999999998777777776654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.5e-05 Score=71.20 Aligned_cols=186 Identities=16% Similarity=0.204 Sum_probs=119.2
Q ss_pred CCCCcccceeeEEEEeCCCc----eEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLETPIP----ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~----~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++.|+|++.+++|-...... .+..+++.+-++.+.+..- ..++..+.+.+..++.+|++++| +....|
T Consensus 238 k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~h---~~~l~~ 309 (1351)
T KOG1035|consen 238 KIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYLH---SLSLEH 309 (1351)
T ss_pred hhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHHH---Hhccce
Confidence 36899999999887644321 2446778878887777654 56888999999999999999999 555555
Q ss_pred ccccCc---ceeecCCCceeEc--ccccccccCCCCcceeecccccccccCccccccCC--cccccchhhhhhHHHHHhc
Q 044155 77 RNFKTS---CILFNEENVAKLF--DFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 77 ~dlk~~---nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~ 149 (239)
.-+... +--.+.++...++ ||+.++....... ......+..+-++|...... .+..+|+|.+|.....+..
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~ 387 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ 387 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence 544444 3333444455555 7877655433221 11222345577777766544 4445899999999999888
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
|..+-... ......+.. .......+....|+..++++|+++.+++..
T Consensus 388 ~~~i~~~~------------------------~~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 388 GEDISEKS------------------------AVPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred cCcccccc------------------------cchhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 85432110 000000000 000145667789999999999999998863
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=1.8e-05 Score=61.36 Aligned_cols=70 Identities=19% Similarity=0.171 Sum_probs=51.1
Q ss_pred CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEccc
Q 044155 18 PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF 97 (239)
Q Consensus 18 ~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~df 97 (239)
+...+|||+++|-.|...- +.......++..|+.-+...- ..|++|+|+.+-||+++.+|.+.++||
T Consensus 180 nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~~~vIDw 246 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGDIVVIDW 246 (304)
T ss_pred ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCCEEEEeC
Confidence 4568999999975553221 123334445666666666666 689999999999999999999999999
Q ss_pred ccc
Q 044155 98 SLS 100 (239)
Q Consensus 98 g~~ 100 (239)
=-+
T Consensus 247 PQ~ 249 (304)
T COG0478 247 PQA 249 (304)
T ss_pred ccc
Confidence 644
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.002 Score=48.35 Aligned_cols=85 Identities=21% Similarity=0.189 Sum_probs=60.5
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccC------CChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQY------GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~------~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
.+.+|.+++|+.+++.-.-+|+|.+.. .+|.+++... .++. ...+.+.++ ..+|- +.+|+.
T Consensus 75 ~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~~L~~f---~~~l~---~~~Iv~ 141 (199)
T PF10707_consen 75 DWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQALDEF---KRYLL---DHHIVI 141 (199)
T ss_pred cccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHHHHHHH---HHHHH---HcCCee
Confidence 477899999999998888889987532 5688888543 3444 333444444 44555 788999
Q ss_pred ccccCcceeecCCC----ceeEcc-cccc
Q 044155 77 RNFKTSCILFNEEN----VAKLFD-FSLS 100 (239)
Q Consensus 77 ~dlk~~nil~~~~~----~~~l~d-fg~~ 100 (239)
+|++|.||++..+. .+.|+| ||..
T Consensus 142 ~dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 142 RDLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 99999999997643 467777 5643
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0028 Score=48.73 Aligned_cols=30 Identities=7% Similarity=0.091 Sum_probs=26.1
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
...++|+|+.|.||+++.++ +.++||+.+.
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 44678999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0012 Score=50.77 Aligned_cols=76 Identities=21% Similarity=0.228 Sum_probs=54.4
Q ss_pred CceEEEEEccCC-ChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEccc
Q 044155 19 IPILVFESVQYG-TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF 97 (239)
Q Consensus 19 ~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~df 97 (239)
...+||||+... .-.-.|+. ..+...+...+..++++++.-|-. ..++||+||..-|||+. ++.+.|+|+
T Consensus 140 ~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~ 210 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDV 210 (268)
T ss_pred CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEEC
Confidence 457899999532 11112211 223333677778889999888873 48999999999999999 778999999
Q ss_pred cccccc
Q 044155 98 SLSISI 103 (239)
Q Consensus 98 g~~~~~ 103 (239)
+-+...
T Consensus 211 ~QaV~~ 216 (268)
T COG1718 211 SQAVTI 216 (268)
T ss_pred cccccc
Confidence 976543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0028 Score=49.28 Aligned_cols=31 Identities=6% Similarity=0.021 Sum_probs=26.8
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
...++|+|+.|.||+++.++...|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 4569999999999999998777899998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.002 Score=55.41 Aligned_cols=79 Identities=15% Similarity=0.093 Sum_probs=53.8
Q ss_pred CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcc
Q 044155 17 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD 96 (239)
Q Consensus 17 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~d 96 (239)
.+.-.++|||++|-.+.+...-.. ...+.+.....+.++. +..+- ..|+.|.|..|.||++..++.+.+.|
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~ia~~~~~~f--~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lD 308 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKS----AGIDRKELAELLVRAF--LRQLL---RDGFFHADPHPGNILVRSDGRIVLLD 308 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHh----cCCCHHHHHHHHHHHH--HHHHH---hcCccccCCCccceEEecCCcEEEEc
Confidence 456689999999988888742211 2233333322222221 23333 57999999999999999999999999
Q ss_pred cccccccC
Q 044155 97 FSLSISIP 104 (239)
Q Consensus 97 fg~~~~~~ 104 (239)
||+.....
T Consensus 309 fGi~g~l~ 316 (517)
T COG0661 309 FGIVGRLD 316 (517)
T ss_pred CcceecCC
Confidence 99876543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0015 Score=55.44 Aligned_cols=37 Identities=16% Similarity=0.209 Sum_probs=28.7
Q ss_pred CCCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcC
Q 044155 2 MSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGA 39 (239)
Q Consensus 2 l~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~ 39 (239)
+.|+|+..++++.... ...++|+|++. -||+|.+..+
T Consensus 39 l~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~ 76 (725)
T KOG1093|consen 39 LQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTG 76 (725)
T ss_pred hcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhc
Confidence 5789988888776533 34778999995 8999998765
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.00012 Score=69.04 Aligned_cols=150 Identities=13% Similarity=-0.042 Sum_probs=101.5
Q ss_pred CCcccceeeEEEE--eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHh--hCCCCCeeecc
Q 044155 3 SHNHILKLIGCCL--ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLH--FGFPRPIVFRN 78 (239)
Q Consensus 3 ~H~niv~l~~~~~--~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~~~i~H~d 78 (239)
.|+++...+.=.. +....+..++++.+|.+.+.+.++.... ..+...-....-.+...+..-.| .....--+|++
T Consensus 1287 ~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~ 1365 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-PDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKS 1365 (2724)
T ss_pred hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-CcchhchHHHHHHHHHhccchhhhcccCCccchhhh
Confidence 4555554433322 2335578899999999999887764321 22222222222223245555544 22234478999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
+|+.|.+|..+-.++++++|+.+.. .......+...+|+.|++|+..+.-.++.++|+|..|+.+|..-.|..+|
T Consensus 1366 Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1366 LKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999999999999999998732 22233345666788899999998888888899999999999887776554
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.007 Score=46.79 Aligned_cols=32 Identities=13% Similarity=0.238 Sum_probs=26.5
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~ 102 (239)
...++|+|+.+.|++++.++..-|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 45699999999999998776567999997643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.024 Score=52.12 Aligned_cols=32 Identities=25% Similarity=0.446 Sum_probs=25.1
Q ss_pred CCeeeccccCcceeecCC-C-ceeEccccccccc
Q 044155 72 RPIVFRNFKTSCILFNEE-N-VAKLFDFSLSISI 103 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~-~-~~~l~dfg~~~~~ 103 (239)
..++|+|+++.|++++.+ + ..-|.||+++...
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 359999999999999853 3 3578999987654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.015 Score=50.22 Aligned_cols=75 Identities=16% Similarity=0.098 Sum_probs=50.1
Q ss_pred CCceEEEEEccCCChhhh--hhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecC----CCc
Q 044155 18 PIPILVFESVQYGTLWDR--ILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNE----ENV 91 (239)
Q Consensus 18 ~~~~iv~e~~~~~sL~~~--l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~----~~~ 91 (239)
..-.++|||++|..+.|. +.+. .+....+..-+.+...-.-+ ..|.+|.|=-|.||++.. +..
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~------gi~~~~i~~~l~~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ 343 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKR------GISPHDILNKLVEAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEE 343 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHc------CCCHHHHHHHHHHHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCcc
Confidence 356899999999877664 4443 24344333333333222222 568999999999999994 567
Q ss_pred eeEccccccccc
Q 044155 92 AKLFDFSLSISI 103 (239)
Q Consensus 92 ~~l~dfg~~~~~ 103 (239)
+.+.|||+....
T Consensus 344 ivllDhGl~~~i 355 (538)
T KOG1235|consen 344 IVLLDHGLYAVI 355 (538)
T ss_pred EEEEcccccccc
Confidence 899999987654
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.0076 Score=48.53 Aligned_cols=69 Identities=14% Similarity=0.120 Sum_probs=49.5
Q ss_pred eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEc
Q 044155 16 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLF 95 (239)
Q Consensus 16 ~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~ 95 (239)
+.+..++|||++.+..|...-+- .+...+..-+..+ +.-|- .+|++|+|..-=||++.+++.++++
T Consensus 179 D~~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~---Iv~la---~~GlIHgDFNEFNimv~dd~~i~vI 244 (465)
T KOG2268|consen 179 DHNRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGL---IVRLA---NHGLIHGDFNEFNIMVKDDDKIVVI 244 (465)
T ss_pred cccceeeHHHhhcccceeeeeec--------CChHHHHHHHHHH---HHHHH---HcCceecccchheeEEecCCCEEEe
Confidence 34567899999998888654422 2233333333333 33344 8899999999999999999999999
Q ss_pred ccc
Q 044155 96 DFS 98 (239)
Q Consensus 96 dfg 98 (239)
||=
T Consensus 245 DFP 247 (465)
T KOG2268|consen 245 DFP 247 (465)
T ss_pred ech
Confidence 995
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.045 Score=44.23 Aligned_cols=34 Identities=12% Similarity=0.332 Sum_probs=29.5
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccccC
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 104 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~ 104 (239)
...++|+|+.+.|++++..+-+-+.||+++....
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 4569999999999999999888999999986543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.035 Score=42.74 Aligned_cols=31 Identities=23% Similarity=0.463 Sum_probs=26.8
Q ss_pred CCCeeeccccCcceeecC-CCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNE-ENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~-~~~~~l~dfg~~~ 101 (239)
...++|+|+.+.||+++. ++.+.++||..+.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 457999999999999998 5779999998763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.033 Score=45.19 Aligned_cols=55 Identities=16% Similarity=0.063 Sum_probs=35.1
Q ss_pred HHHHHHHHHHHHHHHhHHhhC-CCCCeeeccccCcceeecCCC------------------ceeEccccccccc
Q 044155 49 LKHRLKIAMDIVHALAYLHFG-FPRPIVFRNFKTSCILFNEEN------------------VAKLFDFSLSISI 103 (239)
Q Consensus 49 ~~~~~~~~~~i~~~l~~LH~~-~~~~i~H~dlk~~nil~~~~~------------------~~~l~dfg~~~~~ 103 (239)
....+-+..||+.-.--.-+. +-...+|.||||+|||+.+.. .+++.||.+++..
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 345556677775433223221 245799999999999997654 2567777776653
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.072 Score=42.79 Aligned_cols=31 Identities=19% Similarity=0.313 Sum_probs=27.1
Q ss_pred CCCeeeccccCcceeecCC----CceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEE----NVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~----~~~~l~dfg~~~ 101 (239)
...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 5679999999999999885 789999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.1 Score=42.86 Aligned_cols=52 Identities=27% Similarity=0.307 Sum_probs=40.5
Q ss_pred CHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccc
Q 044155 48 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 48 ~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~ 102 (239)
...+...++-+.+.-+.-+.. .-+.-|||+.-+||+|+ +|++.|+||-+++.
T Consensus 319 ~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 319 RSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred cHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence 456666666666555555553 55788999999999999 89999999999874
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.026 Score=45.77 Aligned_cols=31 Identities=19% Similarity=0.532 Sum_probs=26.5
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
..+++|+|+.|.||+++.+...-++||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 5689999999999999876656899999763
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.048 Score=41.68 Aligned_cols=39 Identities=15% Similarity=0.153 Sum_probs=33.6
Q ss_pred HHHHhHHhhCCCCCeeeccccCcceeecCCCceeEccccc
Q 044155 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 99 (239)
Q Consensus 60 ~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~ 99 (239)
+.+|.-.|++ ..+.+|+|..|+||+-++.|-+||.|-+.
T Consensus 151 i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 3567778854 67899999999999999999999999774
|
The function of this family is unknown. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.066 Score=43.18 Aligned_cols=31 Identities=23% Similarity=0.554 Sum_probs=27.4
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
..+++|+|+.+.|++++.++.+.++||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5789999999999999988767899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.041 Score=40.88 Aligned_cols=30 Identities=7% Similarity=0.161 Sum_probs=25.7
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
..-.+|+|+.|.|++++.++ ++++||+.+.
T Consensus 76 ~~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 76 RLAPLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred CeeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 34569999999999998877 8899999874
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.04 Score=42.08 Aligned_cols=31 Identities=16% Similarity=0.337 Sum_probs=21.6
Q ss_pred CCCeeeccccCcceeec-CCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFN-EENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~-~~~~~~l~dfg~~~ 101 (239)
...++|+|+.|.||+++ .++.+.|+||+.+.
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred CcEEEEeccccccceeeeccceeEEEecccce
Confidence 56799999999999999 55656799998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.045 Score=41.54 Aligned_cols=31 Identities=26% Similarity=0.436 Sum_probs=21.5
Q ss_pred CCCeeeccccCcceee-cCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILF-NEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~-~~~~~~~l~dfg~~~ 101 (239)
..-+.|+|+.+.||++ +.++.++++||..+.
T Consensus 142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp GEEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred CceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 3468999999999999 788899999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.16 Score=41.19 Aligned_cols=42 Identities=12% Similarity=0.037 Sum_probs=29.2
Q ss_pred HHHHHHHHHHHHHHHhHHhh-CCCCCeeeccccCcceeecCCC
Q 044155 49 LKHRLKIAMDIVHALAYLHF-GFPRPIVFRNFKTSCILFNEEN 90 (239)
Q Consensus 49 ~~~~~~~~~~i~~~l~~LH~-~~~~~i~H~dlk~~nil~~~~~ 90 (239)
....+-+..||+.-.-.+.+ .+-...+|.||||+|||+.+..
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 45566777888665434432 2245799999999999997665
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.13 Score=40.80 Aligned_cols=45 Identities=11% Similarity=0.098 Sum_probs=34.1
Q ss_pred HHHHHHHHHhHHhhCCC-CCeeeccccCcceeecCCCceeEccccccc
Q 044155 55 IAMDIVHALAYLHFGFP-RPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 55 ~~~~i~~~l~~LH~~~~-~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
.+..+-.++.-.+. + .-++|+|+.|.|++.++.+.+.|+||..|.
T Consensus 137 ~~~~l~~~l~~~~~--~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPK--DDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCC--CceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 44444555555552 2 359999999999999998999999998763
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.51 E-value=0.05 Score=42.61 Aligned_cols=29 Identities=10% Similarity=0.196 Sum_probs=25.4
Q ss_pred CCeeeccccCcceeecCCCceeEccccccc
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
..++|+|+.|.||+++.++ +.++||+.+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 3589999999999999877 7899999764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.43 E-value=0.048 Score=43.63 Aligned_cols=31 Identities=19% Similarity=0.550 Sum_probs=27.0
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
..+++|+|+.|.|++++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3579999999999999988777899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.18 Score=40.54 Aligned_cols=29 Identities=21% Similarity=0.397 Sum_probs=25.1
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLS 100 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~ 100 (239)
..+++|+|+.+.|++++. +.+.++||+.+
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 368999999999999987 56889999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria | Back alignment and domain information |
|---|
Probab=93.03 E-value=0.57 Score=38.56 Aligned_cols=118 Identities=12% Similarity=0.202 Sum_probs=57.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEcc-CCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQ-YGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~-~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.||+.++. .+-.+.+.+.+.++.-+ .-++ ..+ ..++...+++++.+| ..|... ...-+|--+.|
T Consensus 21 ~~~~f~~~-~i~~~ed~~~~~y~~~~~~~~f-~~i--------~~~~~~eklr~~~ni-~~l~~~----~~~~~~f~l~P 85 (359)
T PF10140_consen 21 HDPYFLPQ-EIEEDEDELTFTYQIPESYQSF-EEI--------KKLDKSEKLRLLINI-AALKEH----LNSRYTFILHP 85 (359)
T ss_dssp --TTB--E-EEEE-SSEEEEEE---TTSEEG-GGG--------GGS-HHHHHHHHHHG-GGGGGG----GGSSEE---SG
T ss_pred cCcccCCc-eEEEeCCEEEEEEEcCcccCcH-HHH--------HhcCHHHHHHHHHHH-HHHHHH----hcCceeEEEec
Confidence 57777774 44445555444444332 1222 223 456778898988884 344432 22357889999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchh-hhhhHHHHHhcCCCCcccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVF-SFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~-slG~~l~~~~~g~~p~~~~~~ 159 (239)
+|++++.++.+++.-.|+-..++ |. .. ...|.| ..=+++..+++++..|+..-.
T Consensus 86 ~Nl~fd~~~~p~i~hrGi~~~l~------------------P~-----~~-~ee~fl~qyKali~~ll~~k~~Fe~ly~ 140 (359)
T PF10140_consen 86 ENLVFDKNLMPKILHRGIKEILP------------------PY-----EL-DEEDFLKQYKALIIALLDPKYSFEDLYN 140 (359)
T ss_dssp GGEEE-TTS-EEES--EETTTBS-----------------------------HHHHHHHHHHHHHHHH-TT--HHHHHH
T ss_pred hheEEcCCCCEEEEEcCCcCCCC------------------CC-----CC-CHHHHHHHHHHHHHHHHcCCCCHHHHHh
Confidence 99999999999999888743321 11 00 122322 466677788888888876433
|
This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.54 E-value=0.21 Score=41.12 Aligned_cols=31 Identities=10% Similarity=0.275 Sum_probs=26.4
Q ss_pred CCCeeeccccCcceeecC-CCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNE-ENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~-~~~~~l~dfg~~~ 101 (239)
...++|+|+++.||++++ ++.+.++||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 457899999999999986 4679999998864
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.21 E-value=0.35 Score=39.49 Aligned_cols=28 Identities=18% Similarity=0.438 Sum_probs=25.0
Q ss_pred eeeccccCcceeecCCCc-eeEccccccc
Q 044155 74 IVFRNFKTSCILFNEENV-AKLFDFSLSI 101 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~-~~l~dfg~~~ 101 (239)
++|+|+-|+||+++.+.. ..++||+.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999874 8899999753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.08 E-value=0.12 Score=41.05 Aligned_cols=32 Identities=19% Similarity=0.321 Sum_probs=25.8
Q ss_pred CCCeeeccccCcceeecCCCc-eeEcccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENV-AKLFDFSLSIS 102 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~-~~l~dfg~~~~ 102 (239)
...++|+|+.|.||+++.++. .-|+||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 345899999999999997554 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.60 E-value=0.16 Score=38.13 Aligned_cols=31 Identities=23% Similarity=0.314 Sum_probs=25.6
Q ss_pred CCCeeeccccCcceeecCCC-----ceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEEN-----VAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~-----~~~l~dfg~~~ 101 (239)
...++|+|+.+.|+++..++ .+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 45799999999999998654 57899998764
|
subfamily of choline kinases |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.56 E-value=0.58 Score=44.29 Aligned_cols=31 Identities=19% Similarity=0.418 Sum_probs=25.9
Q ss_pred CCCeeeccccCcceeecCCC--ce-eEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEEN--VA-KLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~--~~-~l~dfg~~~ 101 (239)
..+++|+|+.+.||+++.++ .+ -|+|||.+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 56899999999999999875 44 599999764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=89.50 E-value=0.2 Score=40.46 Aligned_cols=32 Identities=16% Similarity=0.238 Sum_probs=28.0
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~ 102 (239)
..+++|+|+.+.|++++.++.+-++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999988899999987643
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=89.41 E-value=0.29 Score=39.99 Aligned_cols=29 Identities=17% Similarity=0.337 Sum_probs=24.9
Q ss_pred CeeeccccCcceeecC-CCceeEccccccc
Q 044155 73 PIVFRNFKTSCILFNE-ENVAKLFDFSLSI 101 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~-~~~~~l~dfg~~~ 101 (239)
-..|+|+.+.||+++. ++.++++||..+-
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 3799999999999975 4679999999873
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=88.00 E-value=0.83 Score=43.09 Aligned_cols=31 Identities=13% Similarity=0.210 Sum_probs=25.4
Q ss_pred CCCeeeccccCcceeecCCC--c---eeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEEN--V---AKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~--~---~~l~dfg~~~ 101 (239)
..+++|+|+.+.||+++.+. . ..|+|||.+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 67899999999999998653 2 3789999753
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=87.80 E-value=0.89 Score=38.19 Aligned_cols=32 Identities=19% Similarity=0.310 Sum_probs=27.1
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~ 103 (239)
...++|+|+.+.||++..+ .++++||.++...
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~G 253 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFYG 253 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccccC
Confidence 5679999999999999776 5899999877543
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=87.50 E-value=4.4 Score=33.45 Aligned_cols=87 Identities=14% Similarity=0.106 Sum_probs=60.3
Q ss_pred cCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccc
Q 044155 46 PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEY 125 (239)
Q Consensus 46 ~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 125 (239)
.+....+++++.+.+..|.-+- +.-.|-=+.|+||+++.+..+.+..+|+-...+ |.=+.||
T Consensus 81 ~~~k~~Klr~a~~~I~~l~e~~----~tr~~~~laPeNilf~~~l~p~~vH~Glk~~lp-------------Pye~tee- 142 (434)
T COG4499 81 RKEKTRKLRLALQNIATLSELN----NTRYTFFLAPENILFDGGLTPFFVHRGLKNSLP-------------PYEMTEE- 142 (434)
T ss_pred HHHHHHHHHHHHHHHHHHHHhh----ccceeEEecchheEEcCCCceEEEecchhccCC-------------CCCCCHH-
Confidence 4556667777888887777644 345667788999999999999999999753332 2123444
Q ss_pred cccCCcccccchh-hhhhHHHHHhcCCCCccccccc
Q 044155 126 MRTGVFNEKSNVF-SFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 126 ~~~~~~~~~~Di~-slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+.| ++-+++..++.|+.+|+.....
T Consensus 143 ----------~f~~~ykA~~~~~fn~k~~Fe~l~~g 168 (434)
T COG4499 143 ----------RFLKEYKALAIYAFNGKFSFESLVNG 168 (434)
T ss_pred ----------HHHHHHHHHHHHHHcCCccHHHHhcc
Confidence 333 4667778889999998765443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.02 E-value=1.3 Score=36.15 Aligned_cols=29 Identities=10% Similarity=0.115 Sum_probs=24.4
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
..+++|+|+-+.||+++ + .+.++||+.+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 55789999999999995 4 57899999764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=85.77 E-value=2.6 Score=35.67 Aligned_cols=63 Identities=14% Similarity=-0.022 Sum_probs=45.1
Q ss_pred ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCC
Q 044155 20 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN 90 (239)
Q Consensus 20 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~ 90 (239)
..++=+|..|.++..+++.. ..++....+++.-...|+--+-. ..+.+|.|+.|.||++..+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~------~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK------SQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhcc------cChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEecC
Confidence 35666688888998888753 34455666666666666554443 67899999999999986654
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=85.76 E-value=0.49 Score=37.83 Aligned_cols=30 Identities=30% Similarity=0.452 Sum_probs=24.7
Q ss_pred CCeeeccccCcceeecCCC-----ceeEccccccc
Q 044155 72 RPIVFRNFKTSCILFNEEN-----VAKLFDFSLSI 101 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~-----~~~l~dfg~~~ 101 (239)
.-++|+|+.+.||++..++ .+.+.||..+.
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 4599999999999997653 57899998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=83.24 E-value=0.95 Score=37.43 Aligned_cols=32 Identities=13% Similarity=0.297 Sum_probs=26.8
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~ 103 (239)
...++|+|+-+.||+++.++ ++++|+.++...
T Consensus 191 ~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~G 222 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEHE-TKVIDPEFAFYG 222 (370)
T ss_pred cceeeeccCCcccEEEcCCC-CEEEcCcccccC
Confidence 66899999999999997765 789999876544
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 239 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-04 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 239 | |||
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 9e-59 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-54 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 9e-53 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-39 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-32 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 8e-32 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-31 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 9e-31 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-30 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-30 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-30 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-29 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-29 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 8e-27 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-26 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-26 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-25 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-25 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-19 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-17 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-17 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-17 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-17 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 8e-17 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-17 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-17 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-16 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-16 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-16 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-16 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-16 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-16 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-16 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-16 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-16 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 7e-16 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 8e-16 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-15 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-15 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-15 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-15 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-15 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-15 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-15 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-15 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-15 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-15 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-15 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-15 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-15 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-14 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-14 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-14 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-14 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-14 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-14 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-14 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-14 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-14 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-14 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-14 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 9e-14 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-13 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-13 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-13 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-13 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-13 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-13 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-13 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-13 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-13 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-13 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-13 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-13 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 9e-13 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-12 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-12 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-12 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-12 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-12 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-12 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-12 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-12 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-12 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-12 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 7e-12 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 8e-12 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 9e-12 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-11 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-11 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-11 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-11 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-11 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-11 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-11 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-11 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-11 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-11 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-11 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 6e-11 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 8e-11 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 9e-11 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 9e-11 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-10 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-10 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-10 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-10 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 4e-10 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-10 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-10 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-10 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 8e-10 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-10 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-10 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 9e-10 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-09 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-09 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-09 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-09 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-09 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-09 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-09 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-09 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-09 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-09 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-08 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-08 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-08 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-08 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-08 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-08 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-08 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-08 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-08 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-08 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 6e-08 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-07 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-07 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-06 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-06 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-06 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-06 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-06 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-06 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-06 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 7e-06 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-06 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-06 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-05 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-05 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-05 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 1e-05 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-05 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-05 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-05 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-05 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-05 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-05 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-05 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-05 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 4e-05 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-05 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-05 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-05 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 9e-05 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 9e-05 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-04 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-04 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-04 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-04 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-04 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-04 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-04 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-04 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-04 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-04 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 8e-04 |
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 9e-59
Identities = 73/232 (31%), Positives = 111/232 (47%), Gaps = 15/232 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
H H++ LIG C E IL+++ ++ G L + G+ P + + RL+I +
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT-MSMSWEQRLEICIGAA 149
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG-ETHITDTVMGTLG 119
L YLH I+ R+ K+ IL +E V K+ DF +S E +TH++ V GTLG
Sbjct: 150 RGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSD--LVKDVHDLVCPFSEYLKNCFED 177
Y PEY G EKS+V+SF V LFE+L L +++ +L E+ +
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA----EWAVESHNN 262
Query: 178 NRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229
+ +IVD + + + L +C+ S DRPSM DV KL
Sbjct: 263 GQLEQIVDPNLADKIRPES----LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-54
Identities = 72/226 (31%), Positives = 118/226 (52%), Gaps = 5/226 (2%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
H ++L+L G C+ +LV+ + G++ + P+ PL R +IA+ L
Sbjct: 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQRIALGSARGL 144
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123
AYLH I+ R+ K + IL +EE A + DF L+ + +TH+T V GT+G+ AP
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 204
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEI 183
EY+ TG +EK++VF + V L EL+TG DL + +D +++K ++ + +
Sbjct: 205 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264
Query: 184 VDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229
VD + + E EQ + QV C + SP +RP M +V + L
Sbjct: 265 VDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 9e-53
Identities = 56/239 (23%), Positives = 108/239 (45%), Gaps = 21/239 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H ++++L+G + LV+ + G+L DR+ PL R KIA
Sbjct: 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAA 143
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLG 119
+ + +LH + R+ K++ IL +E AK+ DF L+ + + T +T ++GT
Sbjct: 144 NGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y APE + G KS+++SF V L E++TG D ++ L+ + + ++ +
Sbjct: 201 YMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL----DIKEEIEDEEK 255
Query: 180 -FTEIVDHIVVEDVSSIEK--EQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
+ +D + + A V +C+ + RP + V + L+++ S
Sbjct: 256 TIEDYID-------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-39
Identities = 52/257 (20%), Positives = 96/257 (37%), Gaps = 33/257 (12%)
Query: 1 QMSHNHILKLIGCCLETPIP----ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
M H +IL+ IG L+ + G+L D + + IA
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELCHIA 127
Query: 57 MDIVHALAYLH------FGFPRP-IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 109
+ LAYLH +P I R+ K+ +L A + DF L++ G++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 110 I-TDTVMGTLGYCAPEYMRTGV-----FNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDL 163
T +GT Y APE + + + ++++ + L+EL + +D D + L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 164 VCPFSEYLKNCFEDNRFTEIVDHIVVEDV-----SSIEKEQQLHASAQVTFECIKDSPAD 218
PF E + + ++ + +V + +K + + EC
Sbjct: 248 --PFEEEIG---QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 219 RPSMVDVAKKLRQIYRS 235
R S V +++ Q+ R
Sbjct: 303 RLSAGCVGERITQMQRL 319
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-32
Identities = 47/261 (18%), Positives = 96/261 (36%), Gaps = 35/261 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPI----LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
M H +IL I ++ L+ + + G+L+D + L K LK+A
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLA 140
Query: 57 MDIVHALAYLHFGFPR-----PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
V L +LH I R+ K+ IL + + D L++ +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 112 DTVM---GTLGYCAPE------YMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162
GT Y PE ++++SF + L+E+ +V+ +
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE---E 257
Query: 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-----SSIEKEQQLHASAQVTFECIKDSPA 217
P+ + + D + ++ + + ++ + + ++ L ++ EC +PA
Sbjct: 258 YQLPYHDLV---PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314
Query: 218 DRPSMVDVAKKLRQIYRSLSC 238
R + + V K L ++ S
Sbjct: 315 SRLTALRVKKTLAKMSESQDI 335
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 8e-32
Identities = 43/270 (15%), Positives = 88/270 (32%), Gaps = 40/270 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPI-----LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 55
M H++I + I LV E G+L + ++
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCRL 116
Query: 56 AMDIVHALAYLHFGFPR------PIVFRNFKTSCILFNEENVAKLFDFSLS-------IS 102
A + LAYLH PR I R+ + +L + + DF LS +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 103 IPEGETHITDTVMGTLGYCAPEYMRTGV-------FNEKSNVFSFSVFLFELLTGWDVSD 155
P E + + +GT+ Y APE + V ++ ++++ + +E+
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV------SSIEKEQQLHASAQVTF 209
+ V + F + N F ++ + E + E + + +
Sbjct: 237 PGESVPEYQMAFQTEVGN---HPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 210 ECIKDSPADRPSMVDVAKKLRQIYRSLSCN 239
+C R + +++ ++ N
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-31
Identities = 56/241 (23%), Positives = 103/241 (42%), Gaps = 35/241 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+++H +I+KL G CL LV E + G+L++ + GA H + +
Sbjct: 57 RVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCS 112
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLG 119
+AYLH P+ ++ R+ K +L V K+ DF + I +TH+T+ G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAA 168
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTG---WDVSDLVKDVHDLVCPFSEYLKNCFE 176
+ APE ++EK +VFS+ + L+E++T +D ++ P +
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD---------EIGGPAFRIMWAVHN 219
Query: 177 DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236
R I + + + + S+ C P+ RPSM ++ K + + R
Sbjct: 220 GTRPPLIKN--LPKPIESLMT------------RCWSKDPSQRPSMEEIVKIMTHLMRYF 265
Query: 237 S 237
Sbjct: 266 P 266
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-31
Identities = 43/240 (17%), Positives = 91/240 (37%), Gaps = 46/240 (19%)
Query: 3 SHNHILKLIGCCLETPIPIL--VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
SH ++L ++G C P P + + YG+L++ + + + +K A+D+
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMA 121
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+A+LH I + ++ +E+ A++ + S M +
Sbjct: 122 RGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP------GRMYAPAW 174
Query: 121 CAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFED 177
APE ++ ++++SF+V L+EL+T PF++
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTR-------------EVPFADL------- 214
Query: 178 NRFTEIVDHIVVEDV-----SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
EI + +E + I +++ C+ + PA RP + L ++
Sbjct: 215 -SNMEIGMKVALEGLRPTIPPGISPHV-----SKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-30
Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 29/235 (12%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
H +I+ +G + P +V E + G+L+ +L L + RL +A D+ +
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR-LLHKSGARE-QLDERRRLSMAYDVAKGM 150
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123
YLH PIV RN K+ +L +++ K+ DF LS + GT + AP
Sbjct: 151 NYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK-SAAGTPEWMAP 208
Query: 124 EYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEI 183
E +R NEKS+V+SF V L+EL T P+ ++
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATL-------------QQPWGNL--------NPAQV 247
Query: 184 VDHIVVEDVS-SIEKEQQLHAS-AQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236
V + + I + L+ A + C + P RPS + LR + +S
Sbjct: 248 VAAVGFKCKRLEIPRN--LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-30
Identities = 43/258 (16%), Positives = 100/258 (38%), Gaps = 35/258 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPI----LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
+ H +IL I + LV + ++G+L+D + + + ++ +K+A
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLA 145
Query: 57 MDIVHALAYLHFGFPR-----PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
+ LA+LH I R+ K+ IL + + D L++ I
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 112 D---TVMGTLGYCAPEYMRTGV------FNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162
+GT Y APE + + +++++++ + +E+ + + +D
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ- 264
Query: 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-----SSIEKEQQLHASAQVTFECIKDSPA 217
P+ + + D E+ + + + + + + L A++ EC + A
Sbjct: 265 --LPYYDLVP---SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319
Query: 218 DRPSMVDVAKKLRQIYRS 235
R + + + K L Q+ +
Sbjct: 320 ARLTALRIKKTLSQLSQQ 337
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-29
Identities = 54/240 (22%), Positives = 94/240 (39%), Gaps = 38/240 (15%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H +I+ L G CL+ P LV E + G L + + + + A+ I
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWAVQIA 115
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEE--------NVAKLFDFSLSISIPEGETHITD 112
+ YLH PI+ R+ K+S IL ++ + K+ DF L+
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---M 172
Query: 113 TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLK 172
+ G + APE +R +F++ S+V+S+ V L+ELLTG PF
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG-------------EVPFRGI-- 217
Query: 173 NCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
+ + + ++ A++ +C P RPS ++ +L I
Sbjct: 218 ------DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-29
Identities = 49/255 (19%), Positives = 99/255 (38%), Gaps = 35/255 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPI----LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
+ H +IL I + + L+ + G+L+D + L L+I
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIV 111
Query: 57 MDIVHALAYLH-----FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
+ I LA+LH I R+ K+ IL + + D L++ + +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 112 DTVM---GTLGYCAPE------YMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162
GT Y APE + ++ ++++F + L+E+ + +V+ D
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE---D 228
Query: 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-----SSIEKEQQLHASAQVTFECIKDSPA 217
PF + + N D F ++ + V+ + + L + A++ EC +P+
Sbjct: 229 YKPPFYDVVPN---DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 218 DRPSMVDVAKKLRQI 232
R + + + K L +I
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-27
Identities = 54/251 (21%), Positives = 88/251 (35%), Gaps = 42/251 (16%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H ++LK IG + + E ++ GTL I + R+ A DI
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIA 118
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD-------- 112
+AYLH I+ R+ + L E + DF L+ + + +T
Sbjct: 119 SGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 113 -----TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPF 167
TV+G + APE + ++EK +VFSF + L E++ V
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR-------------VNAD 222
Query: 168 SEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHAS-AQVTFECIKDSPADRPSMVDVA 226
+YL + + V S +T C P RPS V +
Sbjct: 223 PDYLPR--------TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274
Query: 227 KKLRQIYRSLS 237
L + L+
Sbjct: 275 HWLETLRMHLA 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-26
Identities = 53/238 (22%), Positives = 108/238 (45%), Gaps = 35/238 (14%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
H +IL +G + I V + + +L+ L A + FE +K + IA +
Sbjct: 79 HVNILLFMGYSTAPQLAI-VTQWCEGSSLYH-HLHASETKFE---MKKLIDIARQTARGM 133
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGTLGYCA 122
YLH + I+ R+ K++ I +E+N K+ DF L+ +H + + G++ + A
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 123 PEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
PE +R + ++ +S+V++F + L+EL+TG P+S N
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTG-------------QLPYSNI-------NN 230
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTF---ECIKDSPADRPSMVDVAKKLRQIYR 234
+I++ + +S + + + ++ EC+K +RPS + ++ ++ R
Sbjct: 231 RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 56/241 (23%), Positives = 98/241 (40%), Gaps = 41/241 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++H +I+KL G P +V E V G L+ R+L P+ +L++ +DI
Sbjct: 79 NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIA 132
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEEN-----VAKLFDFSLSISIPEGETHITDTVM 115
+ Y+ PIV R+ ++ I + AK+ DF LS + H ++
Sbjct: 133 LGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLL 187
Query: 116 GTLGYCAPE--YMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKN 173
G + APE + EK++ +SF++ L+ +LTG PF EY
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG-------------EGPFDEY--- 231
Query: 174 CFEDNRFTEIVDHIVVEDVS-SIEKEQQLHAS-AQVTFECIKDSPADRPSMVDVAKKLRQ 231
+ ++ I E + +I ++ V C P RP + K+L +
Sbjct: 232 ---SYGKIKFINMIREEGLRPTIPED--CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
Query: 232 I 232
+
Sbjct: 287 L 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 44/253 (17%), Positives = 90/253 (35%), Gaps = 45/253 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H +++ +G C+ P ++ + TL+ + A L + +IA +IV
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIV 140
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM----G 116
+ YLH + I+ ++ K+ + ++ V + DF L + + + G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 117 TLGYCAPEYMRTGV---------FNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPF 167
L + APE +R F++ S+VF+ +EL P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR-------------EWP- 242
Query: 168 SEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227
F+ I+ + ++ + + + C +RP+ +
Sbjct: 243 -------FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295
Query: 228 KLRQI---YRSLS 237
L ++ R LS
Sbjct: 296 MLEKLPKRNRRLS 308
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 59/257 (22%), Positives = 94/257 (36%), Gaps = 71/257 (27%)
Query: 1 QMSHNHILKLIG-CCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
Q SH +I++LIG C + PI I V E VQ G + + L +K L++ D
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYI-VMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDA 222
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+ YL H R + RN L E+NV K+ DF +S +G
Sbjct: 223 AAGMEYLESKCCIH----RDLAARN-----CLVTEKNVLKISDFGMSREEADGVY----A 269
Query: 114 VMGTLGYC-----APEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVH 161
G L APE + G ++ +S+V+SF + L+E + + V
Sbjct: 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
Query: 162 D---LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPAD 218
L CP + C + ++ +C P
Sbjct: 330 KGGRLPCP-----ELC-----------------------PDAVF---RLMEQCWAYEPGQ 358
Query: 219 RPSMVDVAKKLRQIYRS 235
RPS + ++L+ I +
Sbjct: 359 RPSFSTIYQELQSIRKR 375
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 59/251 (23%), Positives = 91/251 (36%), Gaps = 60/251 (23%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +++L E PI I V E + G+L D L + L L + +A I
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDF-LKGETGKY--LRLPQLVDMAAQIA 373
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+AY+ H R + N IL E V K+ DF L+ I + E
Sbjct: 374 SGMAYVERMNYVH----RDLRAAN-----ILVGENLVCKVADFGLARLIEDNEYTARQGA 424
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD---LV 164
+ + APE G F KS+V+SF + L EL T G +++ V +
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 484
Query: 165 CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224
CP C E LH + +C + P +RP+
Sbjct: 485 CP-----PECPES-----------------------LH---DLMCQCWRKEPEERPTFEY 513
Query: 225 VAKKLRQIYRS 235
+ L + S
Sbjct: 514 LQAFLEDYFTS 524
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 51/255 (20%), Positives = 97/255 (38%), Gaps = 63/255 (24%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ + +I++LIG C + + V E G L + L + + ++ +
Sbjct: 66 QLDNPYIVRLIGVCQAEALML-VMEMAGGGPL-HKFLVGKREEIPVSNV---AELLHQVS 120
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ YL H R + RN +L + AK+ DF LS ++ +++ T
Sbjct: 121 MGMKYLEEKNFVH----RDLAARN-----VLLVNRHYAKISDFGLSKALGADDSYYTARS 171
Query: 115 MGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDVHD 162
G + APE + F+ +S+V+S+ V ++E L+ G +V ++
Sbjct: 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 231
Query: 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222
+ CP C + L+ + +C DRP
Sbjct: 232 MECP-----PECPPE-----------------------LY---ALMSDCWIYKWEDRPDF 260
Query: 223 VDVAKKLRQIYRSLS 237
+ V +++R Y SL+
Sbjct: 261 LTVEQRMRACYYSLA 275
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-17
Identities = 59/251 (23%), Positives = 91/251 (36%), Gaps = 60/251 (23%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +++L E PI I V E + G+L D L + L L + +A I
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDF-LKGETGKY--LRLPQLVDMAAQIA 290
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+AY+ H R + N IL E V K+ DF L+ I + E
Sbjct: 291 SGMAYVERMNYVH----RDLRAAN-----ILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD---LV 164
+ + APE G F KS+V+SF + L EL T G +++ V +
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 401
Query: 165 CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224
CP C E LH + +C + P +RP+
Sbjct: 402 CP-----PECPES-----------------------LH---DLMCQCWRKEPEERPTFEY 430
Query: 225 VAKKLRQIYRS 235
+ L + S
Sbjct: 431 LQAFLEDYFTS 441
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-17
Identities = 42/256 (16%), Positives = 89/256 (34%), Gaps = 70/256 (27%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ + H+ +L+G CL + + + + + + +G L D + + + L L + I
Sbjct: 73 SVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDY-VREHKDNIGSQYL---LNWCVQIA 127
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ YL H R + RN +L K+ DF L+ + E
Sbjct: 128 KGMNYLEDRRLVH----RDLAARN-----VLVKTPQHVKITDFGLAKLLGAEE----KEY 174
Query: 115 MGTLG-----YCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKD 159
G + A E + ++ +S+V+S+ V ++EL+T ++S +++
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
Query: 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219
L P C D ++ + +C R
Sbjct: 235 GERLPQP-----PICTID-----------------------VY---MIMRKCWMIDADSR 263
Query: 220 PSMVDVAKKLRQIYRS 235
P ++ + ++ R
Sbjct: 264 PKFRELIIEFSKMARD 279
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 8e-17
Identities = 48/255 (18%), Positives = 93/255 (36%), Gaps = 64/255 (25%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ + +I+++IG C + V E + G L + + K+ +++ +
Sbjct: 74 QLDNPYIVRMIGICEAESWML-VMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVS 127
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ YL H R + RN +L ++ AK+ DF LS ++ E +
Sbjct: 128 MGMKYLEESNFVH----RDLAARN-----VLLVTQHYAKISDFGLSKALRADENYYKAQT 178
Query: 115 MGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDVHD 162
G + APE + F+ KS+V+SF V ++E + G +V+ +++
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 238
Query: 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222
+ CP C + ++ + C +RP
Sbjct: 239 MGCP-----AGCPRE-----------------------MY---DLMNLCWTYDVENRPGF 267
Query: 223 VDVAKKLRQIYRSLS 237
V +LR Y +
Sbjct: 268 AAVELRLRNYYYDVV 282
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 8e-17
Identities = 57/251 (22%), Positives = 88/251 (35%), Gaps = 61/251 (24%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H HI+KLIG E P+ I + E G L L + + L + A +
Sbjct: 447 QFDHPHIVKLIGVITENPVWI-IMELCTLGEL-RSFLQVRKFSLDLASL---ILYAYQLS 501
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
ALAYL H R I RN +L + + KL DF LS + + +
Sbjct: 502 TALAYLESKRFVH----RDIAARN-----VLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDVHDLV 164
+ + APE + F S+V+ F V ++E+L DV +++ L
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612
Query: 165 CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224
P NC L+ + +C P+ RP +
Sbjct: 613 MP-----PNC-----------------------PPTLY---SLMTKCWAYDPSRRPRFTE 641
Query: 225 VAKKLRQIYRS 235
+ +L I
Sbjct: 642 LKAQLSTILEE 652
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 9e-17
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 44/232 (18%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
++ H ++++L+G C P P ++ E + YG L D L + L +A I
Sbjct: 272 EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLD-YLRECNRQ--EVSAVVLLYMATQI 327
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
A+ YL H R + RN L E ++ K+ DF LS +
Sbjct: 328 SSAMEYLEKKNFIH----RNLAARN-----CLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDV---HDL 163
+ + APE + F+ KS+V++F V L+E+ T G D+S + + + + +
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438
Query: 164 VCP------FSEYLKNCFEDNR-----FTEIV---DHIVVEDVSSIEKEQQL 201
P E ++ C++ N F EI + + E S E E++L
Sbjct: 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-16
Identities = 49/257 (19%), Positives = 93/257 (36%), Gaps = 64/257 (24%)
Query: 1 QMSHNHILKLIGCCLETPIPIL-VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
SH ++L L+G CL + L V +++G L + + L + + +
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDL---IGFGLQV 201
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+ +L H R + RN + +E+ K+ DF L+ + + E
Sbjct: 202 AKGMKFLASKKFVH----RDLAARN-----CMLDEKFTVKVADFGLARDMYDKEFDSVHN 252
Query: 114 VMGTL---GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDV 160
G + A E ++T F KS+V+SF V L+EL+T +D++ +
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
Query: 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP 220
L+ P + C L+ +V +C RP
Sbjct: 313 RRLLQP-----EYC-----------------------PDPLY---EVMLKCWHPKAEMRP 341
Query: 221 SMVDVAKKLRQIYRSLS 237
S ++ ++ I+ +
Sbjct: 342 SFSELVSRISAIFSTFI 358
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-16
Identities = 50/257 (19%), Positives = 95/257 (36%), Gaps = 64/257 (24%)
Query: 1 QMSHNHILKLIGCCLETPIPIL-VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
SH ++L L+G CL + L V +++G L + + +K + + +
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHN---PTVKDLIGFGLQV 137
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+ YL H R + RN + +E+ K+ DF L+ + + E +
Sbjct: 138 AKGMKYLASKKFVH----RDLAARN-----CMLDEKFTVKVADFGLARDMYDKEYYSVHN 188
Query: 114 VMGTL---GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDV 160
G + A E ++T F KS+V+SF V L+EL+T +D++ +
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
Query: 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP 220
L+ P + C L+ +V +C RP
Sbjct: 249 RRLLQP-----EYC-----------------------PDPLY---EVMLKCWHPKAEMRP 277
Query: 221 SMVDVAKKLRQIYRSLS 237
S ++ ++ I+ +
Sbjct: 278 SFSELVSRISAIFSTFI 294
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-16
Identities = 58/254 (22%), Positives = 98/254 (38%), Gaps = 43/254 (16%)
Query: 1 QMSHNHILKLIGCCLETPI-PI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
+ H++I+K G C + L+ E + YG+L D + Q H E + L+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 122
Query: 59 IVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
I + YL H R + RN IL EN K+ DF L+ +P+ +
Sbjct: 123 ICKGMEYLGTKRYIH----RDLATRN-----ILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 113 TVMGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEY 170
G + APE + F+ S+V+SF V L+EL T + S + +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 171 LKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASA-------QVTFECIKDSPADRPSMV 223
IV + ++ +L + EC ++ RPS
Sbjct: 234 -------------GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR 280
Query: 224 DVAKKLRQIYRSLS 237
D+A ++ QI +++
Sbjct: 281 DLALRVDQIRDNMA 294
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 49/267 (18%), Positives = 97/267 (36%), Gaps = 76/267 (28%)
Query: 1 QMSHNHILKLIGCCLE------TPIPILVFESVQYGTLWDRILGA-PQPHFEPLLLKHRL 53
+ H H+ KL+G L PIP+++ +++G L +L + + L L+ +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 54 KIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 107
+ +DI + YL H R + RN + E+ + DF LS I G+
Sbjct: 141 RFMVDIACGMEYLSSRNFIH----RDLAARN-----CMLAEDMTVCVADFGLSRKIYSGD 191
Query: 108 THITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------G 150
+ + A E + ++ S+V++F V ++E++T
Sbjct: 192 YYRQGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245
Query: 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFE 210
++ + + + L P C ++++ + ++
Sbjct: 246 AEIYNYLIGGNRLKQP-----PEC-----------------------MEEVY---DLMYQ 274
Query: 211 CIKDSPADRPSMVDVAKKLRQIYRSLS 237
C P RPS + +L I LS
Sbjct: 275 CWSADPKQRPSFTCLRMELENILGHLS 301
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-16
Identities = 53/266 (19%), Positives = 105/266 (39%), Gaps = 75/266 (28%)
Query: 1 QMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGA-PQPHFEPLLLKHRLK 54
SH ++++L+G C+E P P+++ ++YG L +L + + + + L+ LK
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 55 IAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 108
+DI + YL H R + RN + ++ + DF LS I G+
Sbjct: 152 FMVDIALGMEYLSNRNFLH----RDLAARN-----CMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 109 HITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GW 151
+ + + A E + V+ KS+V++F V ++E+ T
Sbjct: 203 YRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256
Query: 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFEC 211
++ D + H L P ++C +L+ ++ + C
Sbjct: 257 EMYDYLLHGHRLKQP-----EDC-----------------------LDELY---EIMYSC 285
Query: 212 IKDSPADRPSMVDVAKKLRQIYRSLS 237
+ P DRP+ + +L ++ SL
Sbjct: 286 WRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 51/255 (20%), Positives = 96/255 (37%), Gaps = 63/255 (24%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ + +I++LIG C + + V E G L + L + + ++ +
Sbjct: 392 QLDNPYIVRLIGVCQAEALML-VMEMAGGGPL-HKFLVGKREEIPVSNV---AELLHQVS 446
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ YL H R + RN +L + AK+ DF LS ++ +++ T
Sbjct: 447 MGMKYLEEKNFVH----RNLAARN-----VLLVNRHYAKISDFGLSKALGADDSYYTARS 497
Query: 115 MGTLGY--CAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDVHD 162
G APE + F+ +S+V+S+ V ++E L+ G +V ++
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR 557
Query: 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222
+ CP C + L+ + +C DRP
Sbjct: 558 MECP-----PECPPE-----------------------LY---ALMSDCWIYKWEDRPDF 586
Query: 223 VDVAKKLRQIYRSLS 237
+ V +++R Y SL+
Sbjct: 587 LTVEQRMRACYYSLA 601
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-16
Identities = 54/257 (21%), Positives = 95/257 (36%), Gaps = 64/257 (24%)
Query: 1 QMSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
++H ++L LIG L +P ++ + +G L I + +K + + +
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQV 133
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+ YL H R + RN + +E K+ DF L+ I + E +
Sbjct: 134 ARGMEYLAEQKFVH----RDLAARN-----CMLDESFTVKVADFGLARDILDREYYSVQQ 184
Query: 114 VMGTL---GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDV 160
+ A E ++T F KS+V+SF V L+ELLT +D++ +
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244
Query: 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP 220
L P + C L+ QV +C + PA RP
Sbjct: 245 RRLPQP-----EYC-----------------------PDSLY---QVMQQCWEADPAVRP 273
Query: 221 SMVDVAKKLRQIYRSLS 237
+ + ++ QI +L
Sbjct: 274 TFRVLVGEVEQIVSALL 290
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-16
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 22/157 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H ++++L G L P+ + V E G+L DR L Q HF L + A+ +
Sbjct: 77 SLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR-LRKHQGHFLLGTL---SRYAVQVA 131
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ YL H R + RN +L ++ K+ DF L ++P+ + H
Sbjct: 132 EGMGYLESKRFIH----RDLAARN-----LLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 115 MGTLGY--CAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+ + CAPE ++T F+ S+ + F V L+E+ T
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-16
Identities = 57/251 (22%), Positives = 88/251 (35%), Gaps = 61/251 (24%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H HI+KLIG E P+ I + E G L L + + L + A +
Sbjct: 72 QFDHPHIVKLIGVITENPVWI-IMELCTLGEL-RSFLQVRKYSLDLASL---ILYAYQLS 126
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
ALAYL H R I RN +L + + KL DF LS + + +
Sbjct: 127 TALAYLESKRFVH----RDIAARN-----VLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDVHDLV 164
+ + APE + F S+V+ F V ++E+L DV +++ L
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 237
Query: 165 CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224
P NC L+ + +C P+ RP +
Sbjct: 238 MP-----PNCPPT-----------------------LY---SLMTKCWAYDPSRRPRFTE 266
Query: 225 VAKKLRQIYRS 235
+ +L I
Sbjct: 267 LKAQLSTILEE 277
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-16
Identities = 58/254 (22%), Positives = 98/254 (38%), Gaps = 43/254 (16%)
Query: 1 QMSHNHILKLIGCCLETPI-PI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
+ H++I+K G C + L+ E + YG+L D + Q H E + L+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 153
Query: 59 IVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
I + YL H R + RN IL EN K+ DF L+ +P+ + +
Sbjct: 154 ICKGMEYLGTKRYIH----RDLATRN-----ILVENENRVKIGDFGLTKVLPQDKEYYKV 204
Query: 113 TVMGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEY 170
G + APE + F+ S+V+SF V L+EL T + S + +
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264
Query: 171 LKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASA-------QVTFECIKDSPADRPSMV 223
IV + ++ +L + EC ++ RPS
Sbjct: 265 -------------GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR 311
Query: 224 DVAKKLRQIYRSLS 237
D+A ++ QI ++
Sbjct: 312 DLALRVDQIRDQMA 325
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-16
Identities = 53/261 (20%), Positives = 95/261 (36%), Gaps = 70/261 (26%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWD-----RILGAPQPHFEPLLLKHRLKI 55
+ + +H+++L+G + +++ E + G L R A P P L +++
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 56 AMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 109
A +I +AYL H R + RN + E+ K+ DF ++ I E +
Sbjct: 144 AGEIADGMAYLNANKFVH----RDLAARN-----CMVAEDFTVKIGDFGMTRDIYETDY- 193
Query: 110 ITDTVMGTLGYC-----APEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVS 154
G G +PE ++ GVF S+V+SF V L+E+ T V
Sbjct: 194 ---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250
Query: 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKD 214
V + L P NC L ++ C +
Sbjct: 251 RFVMEGGLLDKP-----DNC-----------------------PDMLF---ELMRMCWQY 279
Query: 215 SPADRPSMVDVAKKLRQIYRS 235
+P RPS +++ +++
Sbjct: 280 NPKMRPSFLEIISSIKEEMEP 300
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 1e-15
Identities = 32/216 (14%), Positives = 67/216 (31%), Gaps = 23/216 (10%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ +K L +LV E YGTL + I + + + AM ++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVA-----------KLFDFSLSI---SIPEG 106
+ + +H I+ + K + + L D SI P+G
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 107 ETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCP 166
T G+ E + +N + + F + ++ +L G + + C
Sbjct: 240 TIFTAKC--ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG---TYMKVKNEGGECK 294
Query: 167 FSEYLKNCFEDNRFTEIVDHIV-VEDVSSIEKEQQL 201
+ + + E ++ + D + L
Sbjct: 295 PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 51/251 (20%), Positives = 95/251 (37%), Gaps = 60/251 (23%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H+ ++KL + PI I + E + G+L L + + L + + I
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSL-LDFLKSDEG--SKQPLPKLIDFSAQIA 294
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+A++ H R + N IL + V K+ DF L+ I + E +
Sbjct: 295 EGMAFIEQRNYIH----RDLRAAN-----ILVSASLVCKIADFGLARVIEDNEYTAREGA 345
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD---LV 164
+ + APE + G F KS+V+SF + L E++T G ++++ + +
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 405
Query: 165 CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224
P +NC E+ L+ + C K+ P +RP+
Sbjct: 406 RP-----ENCPEE-----------------------LY---NIMMRCWKNRPEERPTFEY 434
Query: 225 VAKKLRQIYRS 235
+ L Y +
Sbjct: 435 IQSVLDDFYTA 445
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-15
Identities = 48/254 (18%), Positives = 97/254 (38%), Gaps = 66/254 (25%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H HI++L+G C + + + V + + G+L D + + P LL L + I
Sbjct: 71 SLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDH-VRQHRGALGPQLL---LNWGVQIA 125
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ YL H R + RN +L + ++ DF ++ +P + + +
Sbjct: 126 KGMYYLEEHGMVH----RNLAARN-----VLLKSPSQVQVADFGVADLLPPDDKQLLYS- 175
Query: 115 MGT---LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKDVH 161
+ + A E + G + +S+V+S+ V ++EL+T +V DL++
Sbjct: 176 -EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234
Query: 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221
L P + C D ++ V +C RP+
Sbjct: 235 RLAQP-----QICTID-----------------------VY---MVMVKCWMIDENIRPT 263
Query: 222 MVDVAKKLRQIYRS 235
++A + ++ R
Sbjct: 264 FKELANEFTRMARD 277
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-15
Identities = 54/252 (21%), Positives = 100/252 (39%), Gaps = 46/252 (18%)
Query: 1 QMSHNHILKLIGCCLETPI-PI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
+ H +I+K G C E I L+ E + G+L + + + + LK +LK A+
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQ 134
Query: 59 IVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
I + YL H R + RN +L E+ K+ DF L+ +I + + T
Sbjct: 135 ICKGMDYLGSRQYVH----RDLAARN-----VLVESEHQVKIGDFGLTKAIETDKEYYTV 185
Query: 113 TVMGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKDVHDLVCPFSE 169
+ APE + F S+V+SF V L ELLT S + ++ P
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245
Query: 170 YLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASA-------QVTFECIKDSPADRPSM 222
+ V+++++ ++L Q+ +C + P++R S
Sbjct: 246 QMTVT---------------RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF 290
Query: 223 VDVAKKLRQIYR 234
++ + + +
Sbjct: 291 QNLIEGFEALLK 302
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 40/225 (17%), Positives = 75/225 (33%), Gaps = 55/225 (24%)
Query: 17 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76
P+ +V E V +L L + + ++I+ AL+YLH +V+
Sbjct: 156 DPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH---SIGLVY 205
Query: 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT--VMGTLGYCAPEYMRTGVFNEK 134
+ K I+ EE + KL D + I + GT G+ APE +RTG
Sbjct: 206 NDLKPENIMLTEEQL-KLIDLGAV-------SRINSFGYLYGTPGFQAPEIVRTGP-TVA 256
Query: 135 SNVFSFSVFLFELLTG--WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV 192
+++++ L L V + + Y + ++
Sbjct: 257 TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTY-----------DSYGRLL---- 301
Query: 193 SSIEKEQQLHASAQVTFECIKDSPADRP-SMVDVAKKLRQIYRSL 236
A D P R + +++ +L + R +
Sbjct: 302 --------RRAID-------PD-PRQRFTTAEEMSAQLTGVLREV 330
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-15
Identities = 57/251 (22%), Positives = 91/251 (36%), Gaps = 61/251 (24%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H HI+KLIG E P I + E YG L L + + L L + ++ I
Sbjct: 69 NLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHY-LERNKNSLKVLTL---VLYSLQIC 123
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
A+AYL H R I RN IL KL DF LS I + + +
Sbjct: 124 KAMAYLESINCVH----RDIAVRN-----ILVASPECVKLGDFGLSRYIEDEDYYKASVT 174
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD---LV 164
+ + +PE + F S+V+ F+V ++E+L+ + D++ + L
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 234
Query: 165 CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224
P C L+ + C P+DRP +
Sbjct: 235 KP-----DLCPPV-----------------------LY---TLMTRCWDYDPSDRPRFTE 263
Query: 225 VAKKLRQIYRS 235
+ L +Y+
Sbjct: 264 LVCSLSDVYQM 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-15
Identities = 42/256 (16%), Positives = 89/256 (34%), Gaps = 70/256 (27%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ + H+ +L+G CL + + + + + + +G L D + + + L L + I
Sbjct: 73 SVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDY-VREHKDNIGSQYL---LNWCVQIA 127
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ YL H R + RN +L K+ DF L+ + E
Sbjct: 128 KGMNYLEDRRLVH----RDLAARN-----VLVKTPQHVKITDFGLAKLLGAEE----KEY 174
Query: 115 MGTLG-----YCAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSDLVKD 159
G + A E + ++ +S+V+S+ V ++EL+T ++S +++
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
Query: 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219
L P C D ++ + +C R
Sbjct: 235 GERLPQP-----PICTID-----------------------VY---MIMVKCWMIDADSR 263
Query: 220 PSMVDVAKKLRQIYRS 235
P ++ + ++ R
Sbjct: 264 PKFRELIIEFSKMARD 279
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-15
Identities = 49/223 (21%), Positives = 80/223 (35%), Gaps = 48/223 (21%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMD 58
+ +H +I++ IG L++ ++ E + G L R L + L +A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 59 IVHALAYL------HFGFPRPIVFRNFKTSCIL--FNEENVAKLFDFSLSISIPEGETHI 110
I YL H R I RN C+L VAK+ DF ++ I
Sbjct: 190 IACGCQYLEENHFIH----RDIAARN----CLLTCPGPGRVAKIGDFGMARDIYRAGY-- 239
Query: 111 TDTVMGTLGY-----CAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSD 155
G PE G+F K++ +SF V L+E+ + +V +
Sbjct: 240 --YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297
Query: 156 LVKDVHDL----VCPFSEY--LKNCFEDNR-----FTEIVDHI 187
V + CP Y + C++ F I++ I
Sbjct: 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-15
Identities = 41/150 (27%), Positives = 74/150 (49%), Gaps = 8/150 (5%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+SH +I+ +I E LV E ++ TL + I + H PL + + I+
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHG-PLSVDTAINFTNQIL 121
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+ + H IV R+ K IL + K+FDF ++ ++ E T+ V+GT+ Y
Sbjct: 122 DGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+PE + +E ++++S + L+E+L G
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVG 208
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-15
Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 10/137 (7%)
Query: 16 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75
P+P +V E V TL D + P+ K +++ D AL + H I+
Sbjct: 87 AGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSH---QNGII 138
Query: 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT--VMGTLGYCAPEYMRTGVFNE 133
R+ K + I+ + N K+ DF ++ +I + +T T V+GT Y +PE R +
Sbjct: 139 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 198
Query: 134 KSNVFSFSVFLFELLTG 150
+S+V+S L+E+LTG
Sbjct: 199 RSDVYSLGCVLYEVLTG 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-15
Identities = 53/266 (19%), Positives = 93/266 (34%), Gaps = 75/266 (28%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTL----------WDRILGAPQPHFEPLLLK 50
+ H HI++ G C E ++VFE +++G L + G PL L
Sbjct: 99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 51 HRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 104
L +A + + YL H R + RN L + V K+ DF +S I
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVH----RDLATRN-----CLVGQGLVVKIGDFGMSRDIY 209
Query: 105 EGETHITDTVMGTLG-----YCAPEYMRTGVFNEKSNVFSFSVFLFELLT---------- 149
+ +G + PE + F +S+V+SF V L+E+ T
Sbjct: 210 STDY----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTF 209
+ D + +L P + C +++ +
Sbjct: 266 NTEAIDCITQGRELERP-----RAC-----------------------PPEVY---AIMR 294
Query: 210 ECIKDSPADRPSMVDVAKKLRQIYRS 235
C + P R S+ DV +L+ + ++
Sbjct: 295 GCWQREPQQRHSIKDVHARLQALAQA 320
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-15
Identities = 50/226 (22%), Positives = 94/226 (41%), Gaps = 42/226 (18%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ H +++L + PI I + E ++ G+L D L P L + L +A I
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVD-FLKTPSGI--KLTINKLLDMAAQIA 119
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+A++ H R + N IL ++ K+ DF L+ I + E +
Sbjct: 120 EGMAFIEERNYIH----RDLRAAN-----ILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD----- 162
+ + APE + G F KS+V+SF + L E++T G ++++++
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 163 --LVCPFSEY--LKNCFEDNR-----FTEIVDHIVVEDVSSIEKEQ 199
CP Y ++ C+++ F + + ED + + Q
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL--EDFFTATEGQ 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-15
Identities = 49/223 (21%), Positives = 80/223 (35%), Gaps = 48/223 (21%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMD 58
+ +H +I++ IG L++ ++ E + G L R L + L +A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 59 IVHALAYL------HFGFPRPIVFRNFKTSCIL--FNEENVAKLFDFSLSISIPEGETHI 110
I YL H R I RN C+L VAK+ DF ++ I
Sbjct: 149 IACGCQYLEENHFIH----RDIAARN----CLLTCPGPGRVAKIGDFGMARDIYRASY-- 198
Query: 111 TDTVMGTLGY-----CAPEYMRTGVFNEKSNVFSFSVFLFELLT----------GWDVSD 155
G PE G+F K++ +SF V L+E+ + +V +
Sbjct: 199 --YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256
Query: 156 LVKDVHDL----VCPFSEY--LKNCFEDNR-----FTEIVDHI 187
V + CP Y + C++ F I++ I
Sbjct: 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-14
Identities = 53/252 (21%), Positives = 102/252 (40%), Gaps = 62/252 (24%)
Query: 1 QMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
++SH +++L G CL + PI + V E +++G L L + F L L + +D+
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICL-VTEFMEHGCL-SDYLRTQRGLFAAETL---LGMCLDV 113
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+AYL H R + RN L E V K+ DF ++ + + + +
Sbjct: 114 CEGMAYLEEACVIH----RDLAARN-----CLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD---L 163
+ + +PE ++ KS+V+SF V ++E+ + S++V+D+ L
Sbjct: 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 224
Query: 164 VCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223
P + ++ Q+ C ++ P DRP+
Sbjct: 225 YKP-----RLASTH-----------------------VY---QIMNHCWRERPEDRPAFS 253
Query: 224 DVAKKLRQIYRS 235
+ ++L +I S
Sbjct: 254 RLLRQLAEIAES 265
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 56/253 (22%), Positives = 91/253 (35%), Gaps = 46/253 (18%)
Query: 1 QMSHNHILKLIGCCLETPI-PI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
+ + I+K G + LV E + G L D L + + L L +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF-LQRHRARLDASRL---LLYSSQ 135
Query: 59 IVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
I + YL H R + RN IL E K+ DF L+ +P + +
Sbjct: 136 ICKGMEYLGSRRCVH----RDLAARN-----ILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 113 TVMGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEY 170
G + APE + +F+ +S+V+SF V L+EL T D S
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---------------C 231
Query: 171 LKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASA-------QVTFECIKDSPADRPSM 222
+ D + + +E+ Q+L A ++ C SP DRPS
Sbjct: 232 SPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSF 291
Query: 223 VDVAKKLRQIYRS 235
+ +L ++
Sbjct: 292 SALGPQLDMLWSG 304
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 51/265 (19%), Positives = 91/265 (34%), Gaps = 80/265 (30%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLLKH 51
H +I+ L+G C + ++ E G L + + E + K
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 52 RLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 105
+ + + YL H R + RN +L E NV K+ DF L+ I
Sbjct: 205 LVSCTYQLARGMEYLASQKCIH----RDLAARN-----VLVTENNVMKIADFGLARDINN 255
Query: 106 GETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--------- 149
+ + T M APE + V+ +S+V+SF V ++E+ T
Sbjct: 256 IDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309
Query: 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVT 208
++ L+K+ H + P NC +L+ +
Sbjct: 310 PVEELFKLLKEGHRMDKP-----ANC-----------------------TNELY---MMM 338
Query: 209 FECIKDSPADRPSMVDVAKKLRQIY 233
+C P+ RP+ + + L +I
Sbjct: 339 RDCWHAVPSQRPTFKQLVEDLDRIL 363
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 58/236 (24%), Positives = 99/236 (41%), Gaps = 44/236 (18%)
Query: 1 QMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
++ H ++++L+G C E P I + E + YG L D + + ++L L +A I
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYI-ITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQI 120
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
A+ YL H R + RN L E ++ K+ DF LS +
Sbjct: 121 SSAMEYLEKKNFIH----RDLAARN-----CLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD---- 162
+ + APE + F+ KS+V++F V L+E+ T G D+S + + +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
Query: 163 ---LVCPFSEY--LKNCFEDNR-----FTEIV---DHIVVEDVSSIEKEQQLHASA 205
CP Y ++ C++ N F EI + + E S E E++L
Sbjct: 232 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRG 287
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 51/265 (19%), Positives = 91/265 (34%), Gaps = 80/265 (30%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLLKH 51
H +I+ L+G C + ++ E G L + + E + K
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 52 RLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 105
+ + + YL H R + RN +L E NV K+ DF L+ I
Sbjct: 159 LVSCTYQLARGMEYLASQKCIH----RDLAARN-----VLVTENNVMKIADFGLARDINN 209
Query: 106 GETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--------- 149
+ + T M APE + V+ +S+V+SF V ++E+ T
Sbjct: 210 IDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVT 208
++ L+K+ H + P NC +L+ +
Sbjct: 264 PVEELFKLLKEGHRMDKP-----ANC-----------------------TNELY---MMM 292
Query: 209 FECIKDSPADRPSMVDVAKKLRQIY 233
+C P+ RP+ + + L +I
Sbjct: 293 RDCWHAVPSQRPTFKQLVEDLDRIL 317
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-14
Identities = 45/231 (19%), Positives = 85/231 (36%), Gaps = 32/231 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPIL--VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
++ H +I++ ++ L V E + G L I + + L + L++
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQ 119
Query: 59 IVHALAYLH--FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 116
+ AL H ++ R+ K + + + + KL DF L+ + +T T +G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFVG 178
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFE 176
T Y +PE M +NEKS+++S L+EL L F
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA---------------------LMPPFT 217
Query: 177 DNRFTEIVDHIVVEDVSSIEKE--QQLHASAQVTFECIKDSPADRPSMVDV 225
E+ I I +L+ ++ + RPS+ ++
Sbjct: 218 AFSQKELAGKIREGKFRRIPYRYSDELN---EIITRMLNLKDYHRPSVEEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-14
Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 35/228 (15%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDI 59
M H +I++ E +V + + G L+ RI F E +L + I
Sbjct: 79 NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD----WFVQI 134
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
AL ++H R I+ R+ K+ I ++ +L DF ++ + + +GT
Sbjct: 135 CLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPY 190
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y +PE +N KS++++ L+EL T LK+ FE
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCT---------------------LKHAFEAGS 229
Query: 180 FTEIVDHIVVEDVSSIEKE--QQLHASAQVTFECIKDSPADRPSMVDV 225
+V I+ + L + + K +P DRPS+ +
Sbjct: 230 MKNLVLKIISGSFPPVSLHYSYDLR---SLVSQLFKRNPRDRPSVNSI 274
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-14
Identities = 57/263 (21%), Positives = 99/263 (37%), Gaps = 64/263 (24%)
Query: 1 QMSHNHILKLIGCCLET-PIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK---- 54
+ H HI+K GCC + + LV E V G+L D L +H +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD------------YLPRHSIGLAQL 136
Query: 55 --IAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 106
A I +AYL H R + RN +L + + + K+ DF L+ ++PEG
Sbjct: 137 LLFAQQICEGMAYLHAQHYIH----RDLAARN-----VLLDNDRLVKIGDFGLAKAVPEG 187
Query: 107 ETHITDTVMGTL--GYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--GWDVSDLVKDVHD 162
+ G + APE ++ F S+V+SF V L+ELLT S K +
Sbjct: 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
Query: 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASA-------QVTFECIKD 214
+ + + V + +E+ ++L + C +
Sbjct: 248 IGIAQGQ-----------------MTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWET 290
Query: 215 SPADRPSMVDVAKKLRQIYRSLS 237
+ RP+ ++ L+ ++
Sbjct: 291 EASFRPTFENLIPILKTVHEKYQ 313
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-14
Identities = 48/254 (18%), Positives = 94/254 (37%), Gaps = 62/254 (24%)
Query: 1 QMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
+SH +++L G C + PI I + E + G L L + F+ L L++ D+
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFI-ITEYMANGCL-LNYLREMRHRFQTQQL---LEMCKDV 129
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
A+ YL H R + RN L N++ V K+ DF LS + + E +
Sbjct: 130 CEAMEYLESKQFLH----RDLAARN-----CLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD---L 163
+ + PE + F+ KS++++F V ++E+ + + S+ + + L
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240
Query: 164 VCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223
P E ++ + + C + +RP+
Sbjct: 241 YRP-----HLASEK-----------------------VY---TIMYSCWHEKADERPTFK 269
Query: 224 DVAKKLRQIYRSLS 237
+ + + S
Sbjct: 270 ILLSNILDVMDEES 283
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-14
Identities = 44/215 (20%), Positives = 89/215 (41%), Gaps = 42/215 (19%)
Query: 1 QMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
++SH ++K G C E PI I V E + G L L + EP L L++ D+
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYI-VTEYISNGCL-LNYLRSHGKGLEPSQL---LEMCYDV 113
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+A+L H R + RN L + + K+ DF ++ + + + +
Sbjct: 114 CEGMAFLESHQFIH----RDLAARN-----CLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD---- 162
+ + APE ++ KS+V++F + ++E+ + + S++V V
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL 224
Query: 163 ---LVCPFSEY--LKNCFEDNR-----FTEIVDHI 187
+ + Y + +C+ + F +++ I
Sbjct: 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-14
Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 12/137 (8%)
Query: 16 ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75
+ + L + PL + I I AL H
Sbjct: 105 IDGQLYVDMRLINGVDLAAMLR-----RQGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156
Query: 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT--VMGTLGYCAPEYMRTGVFNE 133
R+ K IL + ++ A L DF ++ + + +T +GTL Y APE
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 134 KSNVFSFSVFLFELLTG 150
++++++ + L+E LTG
Sbjct: 215 RADIYALTCVLYECLTG 231
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 9e-14
Identities = 45/155 (29%), Positives = 68/155 (43%), Gaps = 18/155 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
+ H +I+KL E LV E + G L+D I+ + F E I
Sbjct: 92 LLDHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIH--RMKFNE----VDAAVIIKQ 144
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 115
++ + YLH IV R+ K +L ++ + K+ DF LS + +
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERL 199
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE +R ++EK +V+S V LF LL G
Sbjct: 200 GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 47/269 (17%), Positives = 97/269 (36%), Gaps = 82/269 (30%)
Query: 3 SHNHILKLIGCCLETPIPILV-FESVQYGTL-----------WDRILGAPQPHFEPLLLK 50
H +++ L+G C + P++V E ++G L + + + L L+
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 51 HRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 104
H + + + + +L H R + RN IL +E+NV K+ DF L+ I
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIH----RDLAARN-----ILLSEKNVVKICDFGLARDIY 199
Query: 105 EGETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------- 149
+ ++ M APE + V+ +S+V+SF V L+E+ +
Sbjct: 200 KDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 150 ---GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQ 206
+ +K+ + P +++ Q
Sbjct: 254 VKIDEEFCRRLKEGTRMRAP-----DYT-----------------------TPEMY---Q 282
Query: 207 VTFECIKDSPADRPSMVDVAKKLRQIYRS 235
+C P+ RP+ ++ + L + ++
Sbjct: 283 TMLDCWHGEPSQRPTFSELVEHLGNLLQA 311
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 18/155 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
Q+ H +I+KL E LV E G L+D I+ + F E +I
Sbjct: 82 QLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIIS--RKRFSE----VDAARIIRQ 134
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 115
++ + Y+H IV R+ K +L +++ ++ DF LS + +
Sbjct: 135 VLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKI 189
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE + G ++EK +V+S V L+ LL+G
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 54/269 (20%), Positives = 93/269 (34%), Gaps = 80/269 (29%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLLKH 51
H +I+ L+G C + ++ E G L + E L K
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 52 RLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPE 105
+ A + + YL H R + RN +L E+NV K+ DF L+ I
Sbjct: 193 LVSCAYQVARGMEYLASKKCIH----RDLAARN-----VLVTEDNVMKIADFGLARDIHH 243
Query: 106 GETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--------- 149
+ + T M APE + ++ +S+V+SF V L+E+ T
Sbjct: 244 IDYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
Query: 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVT 208
++ L+K+ H + P NC +L+ +
Sbjct: 298 PVEELFKLLKEGHRMDKP-----SNC-----------------------TNELY---MMM 326
Query: 209 FECIKDSPADRPSMVDVAKKLRQIYRSLS 237
+C P+ RP+ + + L +I S
Sbjct: 327 RDCWHAVPSQRPTFKQLVEDLDRIVALTS 355
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 57/254 (22%), Positives = 99/254 (38%), Gaps = 68/254 (26%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
Q+ H+++++L+G +E + +V E + G+L D L + L LK ++D+
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRS--VLGGDCLLKFSLDV 298
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
A+ YL H R + RN +L +E+NVAK+ DF L+ +
Sbjct: 299 CEAMEYLEGNNFVH----RDLAARN-----VLVSEDNVAKVSDFGLTKEA------SSTQ 343
Query: 114 VMGTLGY--CAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD-- 162
G L APE +R F+ KS+V+SF + L+E+ + + D+V V
Sbjct: 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 403
Query: 163 -LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221
+ P C ++ V C A RP+
Sbjct: 404 KMDAP-----DGCPPA-----------------------VY---DVMKNCWHLDAATRPT 432
Query: 222 MVDVAKKLRQIYRS 235
+ + ++L I
Sbjct: 433 FLQLREQLEHIRTH 446
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-13
Identities = 58/254 (22%), Positives = 100/254 (39%), Gaps = 68/254 (26%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
Q+ H+++++L+G +E + +V E + G+L D L + L LK ++D+
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRS--VLGGDCLLKFSLDV 126
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
A+ YL H R + RN +L +E+NVAK+ DF L+ +
Sbjct: 127 CEAMEYLEGNNFVH----RDLAARN-----VLVSEDNVAKVSDFGLTKEA------SSTQ 171
Query: 114 VMGTLGY--CAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDVHD-- 162
G L APE +R F+ KS+V+SF + L+E+ + + D+V V
Sbjct: 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 231
Query: 163 -LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS 221
+ P C ++ +V C A RPS
Sbjct: 232 KMDAP-----DGCPPA-----------------------VY---EVMKNCWHLDAAMRPS 260
Query: 222 MVDVAKKLRQIYRS 235
+ + ++L I
Sbjct: 261 FLQLREQLEHIKTH 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-13
Identities = 37/165 (22%), Positives = 63/165 (38%), Gaps = 19/165 (11%)
Query: 1 QMSHNHILKLIGCCLETPIP----ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
+H +IL+L+ CL L+ + GTLW+ I L L +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG-NFLTEDQILWLL 140
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF-SLSISIPEGETHIT---- 111
+ I L +H + R+ K + IL +E L D S++ + E
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 112 ---DTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLTG 150
T+ Y APE V +E+++V+S L+ ++ G
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 55/258 (21%), Positives = 88/258 (34%), Gaps = 72/258 (27%)
Query: 1 QMSHNHILKLIGCCLETPIPIL-VFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
Q H +I++L G + V E ++ G+L D L F + L + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGR-LAMIVTEYMENGSL-DTFLRTHDGQFTIMQL---VGMLRGV 160
Query: 60 VHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
+ YL H R + RN +L + V K+ DF LS + + D
Sbjct: 161 GAGMRYLSDLGYVH----RDLAARN-----VLVDSNLVCKVSDFGLSRVLEDDP----DA 207
Query: 114 VMGTLG------YCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWDVSDLVKDV 160
T G + APE + F+ S+V+SF V ++E+L D++ V
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
Query: 161 HD---LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPA 217
+ L P C LH Q+ +C A
Sbjct: 268 EEGYRLPAP-----MGCPHA-----------------------LH---QLMLDCWHKDRA 296
Query: 218 DRPSMVDVAKKLRQIYRS 235
RP + L + RS
Sbjct: 297 QRPRFSQIVSVLDALIRS 314
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-13
Identities = 57/277 (20%), Positives = 94/277 (33%), Gaps = 84/277 (30%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTL-------------------WDRILGAPQ 41
+ + +I+KL+G C L+FE + YG L
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 42 PHFEPLLLKHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLF 95
P PL +L IA + +AYL H R + RN L E V K+
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVH----RDLATRN-----CLVGENMVVKIA 216
Query: 96 DFSLSISIPEGETHITDTVMGTLGYC-----APEYMRTGVFNEKSNVFSFSVFLFELLT- 149
DF LS +I + + PE + + +S+V+++ V L+E+ +
Sbjct: 217 DFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 150 ---------GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQ 200
+V V+D + L CP +NC +
Sbjct: 273 GLQPYYGMAHEEVIYYVRDGNILACP-----ENC-----------------------PLE 304
Query: 201 LHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237
L+ + C PADRPS + + L+++
Sbjct: 305 LY---NLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 53/267 (19%), Positives = 94/267 (35%), Gaps = 76/267 (28%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLL 49
+ H HI+K G C + I+VFE +++G L + G P+ L L
Sbjct: 73 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 50 KHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103
L IA I + YL H R + RN L + K+ DF +S +
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVH----RDLATRN-----CLVGANLLVKIGDFGMSRDV 183
Query: 104 PEGETHITDTVMGTLG-----YCAPEYMRTGVFNEKSNVFSFSVFLFELLT--------- 149
+ + +G + PE + F +S+V+SF V L+E+ T
Sbjct: 184 YSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVT 208
+V + + L P + C ++++ V
Sbjct: 240 SNTEVIECITQGRVLERP-----RVC-----------------------PKEVY---DVM 268
Query: 209 FECIKDSPADRPSMVDVAKKLRQIYRS 235
C + P R ++ ++ K L + ++
Sbjct: 269 LGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 6e-13
Identities = 35/160 (21%), Positives = 65/160 (40%), Gaps = 18/160 (11%)
Query: 1 QMSHNHILKLIGCCLETP-------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL 53
+++H +++ + +P+L E + G L + + + L
Sbjct: 68 KLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFE-NCCGLKEGPIR 124
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHI 110
+ DI AL YLH I+ R+ K I+ + + K+ D + + +GE +
Sbjct: 125 TLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--L 179
Query: 111 TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GTL Y APE + + + +SF FE +TG
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-13
Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
++ H +I+KL E +V E G L+D I+ + F E +I
Sbjct: 77 KLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIK--RKRFSE----HDAARIIKQ 129
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 115
+ + Y+H IV R+ K IL ++ K+ DF LS + + D +
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI- 184
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE +R G ++EK +V+S V L+ LL+G
Sbjct: 185 GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-13
Identities = 37/196 (18%), Positives = 68/196 (34%), Gaps = 32/196 (16%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQY----------------GTLWDRILGAPQPHF 44
++ H +I+ GC GTL I
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 45 -EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103
+ L L+ + I + Y+H + ++ R+ K S I + K+ DF L S+
Sbjct: 120 DKVLALE----LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 104 PEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW----DVSDLVKD 159
GTL Y +PE + + + ++ ++++ + L ELL + S D
Sbjct: 173 KNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD 230
Query: 160 VHDLVCP--FSEYLKN 173
+ D + F + K
Sbjct: 231 LRDGIISDIFDKKEKT 246
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 9e-13
Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
+ H +I+KL E LV E + G L+++I+ + F E I
Sbjct: 102 SLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIIN--RHKFDE----CDAANIMKQ 154
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 115
I+ + YLH IV R+ K IL N K+ DF LS + +
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRL 209
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
GT Y APE ++ +NEK +V+S V ++ LL G+
Sbjct: 210 GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY 244
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 24/155 (15%), Positives = 62/155 (40%), Gaps = 12/155 (7%)
Query: 2 MSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRIL---GAPQPHFEPLLLKHRLKIAM 57
+ + + L G + + +++E ++ ++ + + + ++ I
Sbjct: 100 IKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
++++ +Y+H + I R+ K S IL ++ KL DF S + + + GT
Sbjct: 159 SVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK---GSRGT 213
Query: 118 LGYCAPE--YMRTGVFNEKSNVFSFSVFLFELLTG 150
+ PE + K +++S + L+ +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 47/240 (19%), Positives = 87/240 (36%), Gaps = 30/240 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI--LGAPQPHF-EPLLLKHRLKIAM 57
Q++H +++K +E +V E G L I + E + K +
Sbjct: 88 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFV 143
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
+ AL ++H R ++ R+ K + + V KL D L +T +++GT
Sbjct: 144 QLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGT 199
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFED 177
Y +PE + +N KS+++S L+E+ L PF N
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-------------LQSPFYGDKMN---- 242
Query: 178 NRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237
+ I D + + Q+ CI P RP + V ++++ +
Sbjct: 243 --LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 31/149 (20%), Positives = 52/149 (34%), Gaps = 11/149 (7%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
H ++L E I L E +L E + D + A
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWG----YLRDTLLA 169
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCA 122
LA+LH + +V + K + I KL DF L + + + G Y A
Sbjct: 170 LAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMA 224
Query: 123 PEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
PE ++ + ++VFS + + E+
Sbjct: 225 PELLQGS-YGTAADVFSLGLTILEVACNM 252
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 21/157 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H +I++L G ++ ++V E ++ G+L D L F + L + + I
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQL---VGMLRGIA 157
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ YL H R + RN IL N V K+ DF L + + T
Sbjct: 158 SGMKYLSDMGYVH----RDLAARN-----ILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 115 MGTLGY--CAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
G + +PE + F S+V+S+ + L+E+++
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-12
Identities = 56/274 (20%), Positives = 100/274 (36%), Gaps = 88/274 (32%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTL-------------------WDRILGAPQ 41
Q++H H++KL G C + +L+ E +YG+L
Sbjct: 82 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 42 PHFEPLLLKHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLF 95
P L + + A I + YL H R + RN IL E K+
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVH----RDLAARN-----ILVAEGRKMKIS 192
Query: 96 DFSLSISIPEGETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148
DF LS + E ++++ + M A E + ++ +S+V+SF V L+E++
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 149 T----------GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKE 198
T + +L+K H + P NC
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTGHRMERP-----DNC-----------------------S 278
Query: 199 QQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
++++ ++ +C K P RP D++K L ++
Sbjct: 279 EEMY---RLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-12
Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 16/157 (10%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRIL--GAPQPHF-EPLLLKHRLKIA 56
+ H HI++L+ + + +VFE + L I+ + E
Sbjct: 82 MLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE----AVASHYM 136
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILF-NEENVA--KLFDFSLSISIPEGETHITDT 113
I+ AL Y H I+ R+ K C+L ++EN A KL F ++I + E
Sbjct: 137 RQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
V GT + APE ++ + + +V+ V LF LL+G
Sbjct: 194 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-12
Identities = 35/151 (23%), Positives = 60/151 (39%), Gaps = 13/151 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
+ H +IL++ I L+ E G L+ + F+ + ++
Sbjct: 70 HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--QKHGRFDE---QRSATFMEEL 123
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
AL Y H R ++ R+ K +L + K+ DF S+ P T+ GTL
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---TMCGTLD 177
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
Y PE + +EK +++ V +E L G
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-12
Identities = 55/253 (21%), Positives = 94/253 (37%), Gaps = 62/253 (24%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q SH++I++L G + +++ E ++ G L D+ L F L L + + I
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQL---VGMLRGIA 157
Query: 61 HALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ YL H R + RN IL N V K+ DF LS + + T
Sbjct: 158 AGMKYLANMNYVH----RDLAARN-----ILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208
Query: 115 MGTLGY--CAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GW---DVSDLVKDVHD 162
G + APE + F S+V+SF + ++E++T +V + D
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 268
Query: 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222
L P +C ++ Q+ +C + A RP
Sbjct: 269 LPTP-----MDCPSA-----------------------IY---QLMMQCWQQERARRPKF 297
Query: 223 VDVAKKLRQIYRS 235
D+ L ++ R+
Sbjct: 298 ADIVSILDKLIRA 310
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-12
Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 13/151 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
+ H +IL+L G + L+ E GT++ + F+ + ++
Sbjct: 65 HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL--QKLSKFDE---QRTATYITEL 118
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
+AL+Y H + ++ R+ K +L K+ DF S+ P + + GTL
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLD 172
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
Y PE + + +EK +++S V +E L G
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-12
Identities = 35/155 (22%), Positives = 60/155 (38%), Gaps = 15/155 (9%)
Query: 1 QMSHNHILKLIGCCLETPIP----ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
+ H +I++ T +LV E + GTL + F+ + +K
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWC 135
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVM 115
I+ L +LH P PI+ R+ K I K+ D L+ V+
Sbjct: 136 RQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVI 191
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT + APE +E +V++F + + E+ T
Sbjct: 192 GTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATS 225
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 7e-12
Identities = 16/146 (10%), Positives = 45/146 (30%), Gaps = 25/146 (17%)
Query: 45 EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 104
+ L+ RL++ + ++ LA LH +V + I+ ++ L F +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEH--LVR 255
Query: 105 EGETHITDTVMGTLGYCAPEYM-----------RTGVFNEKSNVFSFSVFLFELLTGW-- 151
+G + G+ PE R + + ++ + ++ +
Sbjct: 256 DGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
Query: 152 ----DVSDLVKDVHDLVCPFSEYLKN 173
+ + + ++
Sbjct: 313 ITKDAALGGSEWIFRSCKNIPQPVRA 338
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 8e-12
Identities = 15/133 (11%), Positives = 35/133 (26%), Gaps = 12/133 (9%)
Query: 22 LVFESVQYGTLWDRI--LGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79
L+ + L L + + ++ A L + +V +F
Sbjct: 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHF 220
Query: 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYM--RTGVFNEKSNV 137
+ + L D S + + Y E++ T F N
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNA 276
Query: 138 FSFSVFLFELLTG 150
+ + ++ +
Sbjct: 277 WQLGLSIYRVWCL 289
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 9e-12
Identities = 13/141 (9%), Positives = 41/141 (29%), Gaps = 16/141 (11%)
Query: 45 EPLLLKHRLKIAMDIVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103
+ L+ RL++ + ++ LA LH +G +V + I+ ++ L F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 104 PEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGW------D 152
A + + + ++ + ++ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 153 VSDLVKDVHDLVCPFSEYLKN 173
+ + + ++
Sbjct: 322 ALGGSEWIFRSCKNIPQPVRA 342
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 45/199 (22%), Positives = 75/199 (37%), Gaps = 34/199 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESV---------QY---GTLWDRILGAPQPHFEPLL 48
++ H I++ LE + S Q L D + G
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER- 117
Query: 49 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-------- 100
L I + I A+ +LH + ++ R+ K S I F ++V K+ DF L
Sbjct: 118 -SVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 101 ---ISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL----TGWDV 153
+ P +GT Y +PE + ++ K ++FS + LFELL T +
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMER 233
Query: 154 SDLVKDVHDLVCP--FSEY 170
+ DV +L P F++
Sbjct: 234 VRTLTDVRNLKFPPLFTQK 252
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 41/191 (21%), Positives = 74/191 (38%), Gaps = 24/191 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
S + + + + + + L D + + E L I + I
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIA 174
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS------------ISIPEGET 108
A+ +LH + ++ R+ K S I F ++V K+ DF L ++
Sbjct: 175 EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 109 HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL----TGWDVSDLVKDVHDLV 164
T V GT Y +PE + ++ K ++FS + LFELL T + ++ DV +L
Sbjct: 232 THTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK 290
Query: 165 CP--FSEYLKN 173
P F++
Sbjct: 291 FPLLFTQKYPQ 301
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 37/173 (21%), Positives = 65/173 (37%), Gaps = 41/173 (23%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTL-------------WDRILGAPQPHFEPLLL 49
+H +I+ L+G C +++ E YG L + L L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 50 KHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103
+ L + + +A+L H R + RN IL + K+ DF L+ I
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIH----RDLAARN-----ILLTHGRITKICDFGLARDI 195
Query: 104 PEGETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
++ M APE + V+ +S+V+S+ +FL+EL +
Sbjct: 196 KNDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 16/155 (10%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
+ H +I++L L+F+ V G L++ I+ + ++ E
Sbjct: 66 LLKHPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVA--REYYSE----ADASHCIQQ 118
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVA-KLFDFSLSISIPEGETHITDTVM 115
I+ A+ + H +V RN K +L + A KL DF L+I + +
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 174
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT GY +PE +R + + ++++ V L+ LL G
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-11
Identities = 54/266 (20%), Positives = 91/266 (34%), Gaps = 83/266 (31%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLLKHR 52
H +I+ L+G C L E +G L D L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 53 LKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG 106
L A D+ + YL H R + RN IL E VAK+ DF LS
Sbjct: 145 LHFAADVARGMDYLSQKQFIH----RDLAARN-----ILVGENYVAKIADFGLS---RGQ 192
Query: 107 ETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-------GWD 152
E ++ T+ M A E + V+ S+V+S+ V L+E+++ G
Sbjct: 193 EVYVKKTMGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
Query: 153 VSDLVKDVHD---LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTF 209
++L + + L P NC ++ ++ +
Sbjct: 247 CAELYEKLPQGYRLEKP-----LNCDDE-----------------------VY---DLMR 275
Query: 210 ECIKDSPADRPSMVDVAKKLRQIYRS 235
+C ++ P +RPS + L ++
Sbjct: 276 QCWREKPYERPSFAQILVSLNRMLEE 301
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-11
Identities = 31/158 (19%), Positives = 54/158 (34%), Gaps = 20/158 (12%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
H ++++ C + + E TL + + H + +
Sbjct: 77 HPNVIRYF-CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG----LEPITLLQQTTSG 130
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEEN-----VAKLFDFSLSISIPEGE--THITDTVM 115
LA+LH IV R+ K IL + N A + DF L + G V
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 116 GTLGYCAPEYMRTGVF---NEKSNVFSFSVFLFELLTG 150
GT G+ APE + ++FS + +++
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-11
Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
++SH +I+KL ETP I LV E V G L+DRI+ + ++ E +
Sbjct: 104 RLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVE--KGYYSE----RDAADAVKQ 156
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 115
I+ A+AYLH IV R+ K +L+ + K+ DF LS + + TV
Sbjct: 157 ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVC 211
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT GYCAPE +R + + +++S + + LL G
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-11
Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 16/152 (10%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDIVH 61
H +I+KL + LV E + G L++RI + HF E I +V
Sbjct: 65 HPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKK--KKHFSE----TEASYIMRKLVS 117
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
A++++H +V R+ K +LF N+ K+ DF + P + TL
Sbjct: 118 AVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
Y APE + ++E +++S V L+ +L+G
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-11
Identities = 42/264 (15%), Positives = 87/264 (32%), Gaps = 80/264 (30%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTL-----------WDRILGAPQPHFEPLLL 49
++ H +++ L+G + ++F +G L + L
Sbjct: 68 RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 50 KHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103
+ + I + YL H + + RN +L ++ K+ D L +
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHVVH----KDLATRN-----VLVYDKLNVKISDLGLFREV 178
Query: 104 PEGETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT------- 149
+ + M APE + G F+ S+++S+ V L+E+ +
Sbjct: 179 YAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 150 ---GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQ 206
DV +++++ L CP +C ++
Sbjct: 233 GYSNQDVVEMIRNRQVLPCP-----DDC-----------------------PAWVY---A 261
Query: 207 VTFECIKDSPADRPSMVDVAKKLR 230
+ EC + P+ RP D+ +LR
Sbjct: 262 LMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-11
Identities = 36/169 (21%), Positives = 64/169 (37%), Gaps = 37/169 (21%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWD---------RILGAPQPHFEPLLLKHRL 53
H +I+ L+G C +++ E YG L + A + L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 54 KIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE 107
+ + +A+L H R + RN +L +VAK+ DF L+ I
Sbjct: 168 HFSSQVAQGMAFLASKNCIH----RDVAARN-----VLLTNGHVAKIGDFGLARDIMNDS 218
Query: 108 THITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
+I M APE + V+ +S+V+S+ + L+E+ +
Sbjct: 219 NYIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-11
Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
++ H +I++L + LVF+ V G L++ I+ + + E
Sbjct: 84 KLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVA--REFYSE----ADASHCIQQ 136
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVA-KLFDFSLSISIPEGETHITDTVM 115
I+ ++AY H IV RN K +L + A KL DF L+I + + E
Sbjct: 137 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFA 191
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG----WDVSD 155
GT GY +PE ++ +++ ++++ V L+ LL G WD
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 5e-11
Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
+ H +I++L E I LV E G L++R++ + F E +I D
Sbjct: 62 SLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVH--KRVFRE----SDAARIMKD 114
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 115
++ A+AY H + R+ K LF + ++ KL DF L+ G+ T +
Sbjct: 115 VLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKV 169
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y +P+ + G++ + + +S V ++ LL G
Sbjct: 170 GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-11
Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 34/177 (19%)
Query: 1 QMSHNHILKLIGCCLETPIPI-------------LVFESVQYGTLWDRILGAPQPHFEPL 47
++H ++++ LE + + E + GTL+D I
Sbjct: 58 SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR-- 115
Query: 48 LLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS------- 100
++ I+ AL+Y+H + I+ R+ K I +E K+ DF L+
Sbjct: 116 --DEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 101 ------ISIPEGETHITDTVMGTLGYCAPEYMR-TGVFNEKSNVFSFSVFLFELLTG 150
G + + +GT Y A E + TG +NEK +++S + FE++
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-11
Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 18/155 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
++ H +I+KL E +V E G L+D I+ + F E +I
Sbjct: 77 KLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIK--RKRFSE----HDAARIIKQ 129
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 115
+ + Y+H IV R+ K IL ++ K+ DF LS + +
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRI 184
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT Y APE +R G ++EK +V+S V L+ LL+G
Sbjct: 185 GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-11
Identities = 41/193 (21%), Positives = 73/193 (37%), Gaps = 45/193 (23%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQP--HF-EPLLLKHRLKIA 56
+ H +I+K+ E + +V E+ + G L +RI+ A E + ++
Sbjct: 76 SLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSE----GYVAELM 130
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDT 113
+++ALAY H + +V ++ K ILF + + K+ DF L+ E
Sbjct: 131 KQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TN 185
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG----------------------- 150
GT Y APE + K +++S V ++ LLTG
Sbjct: 186 AAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244
Query: 151 ----WDVSDLVKD 159
++ D
Sbjct: 245 AVECRPLTPQAVD 257
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 9e-11
Identities = 45/261 (17%), Positives = 81/261 (31%), Gaps = 78/261 (29%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++SH H++ G C+ ILV E V++G+L D L + L L++A +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSL-DTYLKKNKNCINILWK---LEVAKQLA 123
Query: 61 HALAYL------HFGFPRPIVFRN---FKTSCILFNEENVAKLFDFSLSISIPEGETHIT 111
A+ +L H + +N + KL D +SI++ +
Sbjct: 124 AAMHFLEENTLIH----GNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175
Query: 112 DTVMGTLGY------CAPEYMRTG-VFNEKSNVFSFSVFLFELLT----------GWDVS 154
PE + N ++ +SF L+E+ +
Sbjct: 176 -------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKD 214
+D H L P K +L + C+
Sbjct: 229 QFYEDRHQLPAP-----KAA-------------------------ELA---NLINNCMDY 255
Query: 215 SPADRPSMVDVAKKLRQIYRS 235
P RPS + + L ++
Sbjct: 256 EPDHRPSFRAIIRDLNSLFTP 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 9e-11
Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 27/160 (16%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 53
++ H +I++L + LVF+ V G L++ I+ +
Sbjct: 61 KLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVA-----------REFYSEADAS 108
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVA-KLFDFSLSISIPEGETHI 110
I+ ++AY H IV RN K +L + A KL DF L+I + + E
Sbjct: 109 HCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-- 163
Query: 111 TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT GY +PE ++ +++ ++++ V L+ LL G
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 29/162 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------K 54
+++H I+K+ + +V E ++ G L+D+++G RL
Sbjct: 196 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-----------NKRLKEATCKL 243
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHIT 111
++ A+ YLH I+ R+ K +L E+ + K+ DF S + E +
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LM 298
Query: 112 DTVMGTLGYCAPE---YMRTGVFNEKSNVFSFSVFLFELLTG 150
T+ GT Y APE + T +N + +S V LF L+G
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-10
Identities = 36/158 (22%), Positives = 64/158 (40%), Gaps = 20/158 (12%)
Query: 2 MSHNHILKLIGCCLETPIPI-----LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKI 55
HI+ ++ E ++ E ++ G L+ RI F E + +I
Sbjct: 79 SGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE----REAAEI 133
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITD 112
DI A+ +LH I R+ K +L+ ++ V KL DF + +
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ--- 187
Query: 113 TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T T Y APE + +++ +++S V ++ LL G
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 30/117 (25%), Positives = 58/117 (49%), Gaps = 9/117 (7%)
Query: 34 DRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAK 93
D++L E +L K +++ ++ L YL I+ R+ K S IL N K
Sbjct: 119 DQVLKKAGRIPEQILGK----VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 172
Query: 94 LFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
L DF +S + + + ++ +GT Y +PE ++ ++ +S+++S + L E+ G
Sbjct: 173 LCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 40/162 (24%), Positives = 65/162 (40%), Gaps = 35/162 (21%)
Query: 2 MSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------K 54
++H +I+KL +ET + L+ E G ++D ++ R+
Sbjct: 71 LNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVA-----------HGRMKEKEARS 118
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
IV A+ Y H + IV R+ K +L + + K+ DF S G D
Sbjct: 119 KFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAF 173
Query: 115 MGTLGYCAPEYMRTGVFNEK------SNVFSFSVFLFELLTG 150
G Y APE +F K +V+S V L+ L++G
Sbjct: 174 CGAPPYAAPE-----LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-10
Identities = 38/178 (21%), Positives = 66/178 (37%), Gaps = 46/178 (25%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTL------------------WDRILGAPQPHF 44
SH +I+ L+G C + L+FE YG L ++ +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 45 EPLLLKHRLKIAMDIVHALAYL------HFGFPRPIVFRNFKTSCILFNEENVAKLFDFS 98
L + L A + + +L H R + RN +L V K+ DF
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVH----RDLAARN-----VLVTHGKVVKICDFG 217
Query: 99 LSISIPEGETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149
L+ I ++ M APE + G++ KS+V+S+ + L+E+ +
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-10
Identities = 33/157 (21%), Positives = 60/157 (38%), Gaps = 23/157 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 53
++H H++ G E + +V E + +L + + L
Sbjct: 71 SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEAR 118
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
IV YLH ++ R+ K + NE+ K+ DF L+ + E +
Sbjct: 119 YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV 174
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ GT Y APE + + + +V+S ++ LL G
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-10
Identities = 36/150 (24%), Positives = 58/150 (38%), Gaps = 10/150 (6%)
Query: 2 MSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H IL+L E + LV E G + + +P E + R I+
Sbjct: 68 LKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN---EAR-HFMHQII 122
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+ YLH I+ R+ S +L K+ DF L+ + + T+ GT Y
Sbjct: 123 TGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNY 178
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+PE +S+V+S + LL G
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-10
Identities = 42/160 (26%), Positives = 65/160 (40%), Gaps = 30/160 (18%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------KIA 56
H +I++L ET LVF+ ++ G L+D + K L KI
Sbjct: 83 HPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTE-----------KVTLSEKETRKIM 130
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 116
++ + LH IV R+ K IL +++ KL DF S + GE V G
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCG 185
Query: 117 TLGYCAPEYMRTGVFNEKSN------VFSFSVFLFELLTG 150
T Y APE + + + ++S V ++ LL G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-10
Identities = 48/202 (23%), Positives = 65/202 (32%), Gaps = 51/202 (25%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 53
++ H +I +L E I LV E G L D++ +
Sbjct: 84 KLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 54 -----------------------------KIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 84
I I AL YLH + I R+ K
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENF 199
Query: 85 LF--NEENVAKLFDFSLSISIP---EGETHITDTVMGTLGYCAPEYMRTGV--FNEKSNV 137
LF N+ KL DF LS GE + T GT + APE + T + K +
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 138 FSFSVFLFELLTG----WDVSD 155
+S V L LL G V+D
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVND 281
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 8e-10
Identities = 35/164 (21%), Positives = 65/164 (39%), Gaps = 21/164 (12%)
Query: 1 QMSHNHILKLIGC--CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
+++H +I+KL T +L+ E G+L+ + + L L + D
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRD 120
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLFDFSLSISIPEGETHITDTV 114
+V + +L IV RN K I+ + ++V KL DF + + + E ++
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSL 175
Query: 115 MGTLGYCAPEYMRTGV--------FNEKSNVFSFSVFLFELLTG 150
GT Y P+ V + +++S V + TG
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 8e-10
Identities = 28/173 (16%), Positives = 57/173 (32%), Gaps = 31/173 (17%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRIL--GAPQPHFEPLLLKHRLKIAMDIV 60
H ++++ C T + + E L D + + + + + + I
Sbjct: 68 HPNVIRYY-CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENV-------------AKLFDFSLSISIPEGE 107
+A+LH I+ R+ K IL + + + DF L + G+
Sbjct: 126 SGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 108 ---THITDTVMGTLGYCAPEYMRTGVF-------NEKSNVFSFSVFLFELLTG 150
+ GT G+ APE + ++FS + +L+
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-10
Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 19/156 (12%)
Query: 4 HNHILKLIGCCLETPIPI-----LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAM 57
HI++++ E +V E + G L+ RI F E + +I
Sbjct: 114 CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE----REASEIMK 168
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTV 114
I A+ YLH I R+ K +L+ + KL DF + + T
Sbjct: 169 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTP 223
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
T Y APE + +++ +++S V ++ LL G
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-09
Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 18/155 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
++ H +I+ L E+ LV + V G L+DRIL + + E K +
Sbjct: 62 KIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILE--RGVYTE----KDASLVIQQ 114
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTVM 115
++ A+ YLH IV R+ K +L+ E + + DF LS G T
Sbjct: 115 VLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS---TAC 168
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT GY APE + +++ + +S V + LL G
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 33/157 (21%), Positives = 60/157 (38%), Gaps = 23/157 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------ 53
++H H++ G E + +V E + +L + + L
Sbjct: 97 SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEAR 144
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
IV YLH ++ R+ K + NE+ K+ DF L+ + E +
Sbjct: 145 YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV 200
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ GT Y APE + + + +V+S ++ LL G
Sbjct: 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-09
Identities = 35/164 (21%), Positives = 65/164 (39%), Gaps = 21/164 (12%)
Query: 1 QMSHNHILKLIGC--CLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
+++H +I+KL T +L+ E G+L+ + + L L + D
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRD 120
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLFDFSLSISIPEGETHITDTV 114
+V + +L IV RN K I+ + ++V KL DF + + + E ++
Sbjct: 121 VVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSL 175
Query: 115 MGTLGYCAPEYMRTGV--------FNEKSNVFSFSVFLFELLTG 150
GT Y P+ V + +++S V + TG
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-09
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 24/164 (14%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDIVH 61
H HI+ LI E+ + LVF+ ++ G L+D + + E K I ++
Sbjct: 159 HPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTE--KVALSE----KETRSIMRSLLE 211
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYC 121
A+++LH IV R+ K IL ++ +L DF S + GE + GT GY
Sbjct: 212 AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYL 266
Query: 122 APEYMRTGVFNEKSN------VFSFSVFLFELLTG----WDVSD 155
APE ++ + +++ V LF LL G W
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 29/153 (18%), Positives = 59/153 (38%), Gaps = 13/153 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
+ H ++ L E + +++E + G L++++ E ++ +
Sbjct: 210 VLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKMSE----DEAVEYMRQV 264
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGT 117
L ++H V + K I+F N KL DF L+ + ++ GT
Sbjct: 265 CKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGT 319
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE ++++S V + LL+G
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 32/170 (18%), Positives = 54/170 (31%), Gaps = 24/170 (14%)
Query: 2 MSHNHILKLIGCCLETPIP-------ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 54
H +I++ L+ + G L + + PL LK
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLK 140
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF---SLSISIPEGETHIT 111
I A+ ++H P PI+ R+ K +L + + KL DF + P+
Sbjct: 141 IFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 112 D--------TVMGTLGYCAPE---YMRTGVFNEKSNVFSFSVFLFELLTG 150
T T Y PE EK ++++ L+ L
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-09
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
Q+ H++++ L E + L+ E V G L+D + A + E +
Sbjct: 71 QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL--AQKESLSE----EEATSFIKQ 123
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA----KLFDFSLSISIPEGETHITDTV 114
I+ + YLH + I + K I+ ++N+ KL DF L+ I +G +
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI 178
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT + APE + +++++S V + LL+G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 17/153 (11%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDIVH 61
H +I+ L + + +V E ++ G L D+IL Q F E + + I
Sbjct: 75 HPNIITLKDVY-DDGKYVYVVTELMKGGELLDKILR--QKFFSE----REASAVLFTITK 127
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILF--NEENVA--KLFDFSLSISIPEGETHITDTVMGT 117
+ YLH + +V R+ K S IL+ N ++ DF + + E + T T
Sbjct: 128 TVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCYT 183
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE + ++ +++S V L+ +LTG
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-09
Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 29/162 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------K 54
+++H I+K+ + +V E ++ G L+D+++G RL
Sbjct: 71 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-----------NKRLKEATCKL 118
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHIT 111
++ A+ YLH I+ R+ K +L E+ + K+ DF S + E +
Sbjct: 119 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LM 173
Query: 112 DTVMGTLGYCAPE---YMRTGVFNEKSNVFSFSVFLFELLTG 150
T+ GT Y APE + T +N + +S V LF L+G
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-09
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 2 MSHNHILKL---IGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
+ H +++KL + E + +VFE V G + + +PL D
Sbjct: 93 LDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVP------TLKPLSEDQARFYFQD 145
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
++ + YLH+ + I+ R+ K S +L E+ K+ DF +S + +G + +GT
Sbjct: 146 LIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGSDALLSNTVGTP 201
Query: 119 GYCAPE---YMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE R + +V++ V L+ + G
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 18/101 (17%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
+V AL YL + I+ R+ K IL +E + DF+++ +P T+ GT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTK 178
Query: 119 GYCAPEYMRTGVFNEKSNV--------FSFSVFLFELLTGW 151
Y APE +F+ + +S V +ELL G
Sbjct: 179 PYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 31/153 (20%), Positives = 57/153 (37%), Gaps = 13/153 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
Q+ H ++ L E + L+ E + G L+DRI E +
Sbjct: 104 QLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSE----AEVINYMRQA 158
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGT 117
L ++H IV + K I+ + + K+ DF L+ + E T
Sbjct: 159 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTAT 213
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE + +++++ V + LL+G
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 18/156 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
Q+ H +I+ L E + L+ E V G L+D + A + E +
Sbjct: 71 QVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFL--AQKESLSE----EEATSFIKQ 123
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA----KLFDFSLSISIPEGETHITDTV 114
I+ + YLH + I + K I+ ++N+ KL DF L+ I +G +
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNI 178
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT + APE + +++++S V + LL+G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
I+ L ++H R +V+R+ K + IL +E ++ D L+ + + H +GT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTH 354
Query: 119 GYCAPEYMRTGVFNEKSNV--FSFSVFLFELLTGW 151
GY APE ++ GV + S FS LF+LL G
Sbjct: 355 GYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGH 388
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 36/156 (23%), Positives = 66/156 (42%), Gaps = 18/156 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
++ H +++ L E + L+ E V G L+D + A + E + +
Sbjct: 70 EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFL--AEKESLTE----EEATEFLKQ 122
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA----KLFDFSLSISIPEGETHITDTV 114
I++ + YLH I + K I+ + NV K+ DF L+ I G +
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 177
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT + APE + +++++S V + LL+G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 31/160 (19%), Positives = 59/160 (36%), Gaps = 24/160 (15%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
+ I++L T I +V E L + + + R +++ A
Sbjct: 87 SDKIIRLYDY-EITDQYIYMVMECGN-IDLNSWLK-----KKKSIDPWERKSYWKNMLEA 139
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTLGYC 121
+ +H IV + K + L + + KL DF ++ + T + D+ +GT+ Y
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 122 APE-----------YMRTGVFNEKSNVFSFSVFLFELLTG 150
PE + KS+V+S L+ + G
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 26/93 (27%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
I L LH IV+R+ K IL ++ ++ D L++ +PEG+T +GT+
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTV 349
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
GY APE ++ + + ++ L+E++ G
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-08
Identities = 30/160 (18%), Positives = 58/160 (36%), Gaps = 24/160 (15%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
+ I++L T I +V E L + + + R +++ A
Sbjct: 115 SDKIIRLYDY-EITDQYIYMVMECGN-IDLNSWLK-----KKKSIDPWERKSYWKNMLEA 167
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTLGYC 121
+ +H IV + K + L + + KL DF ++ + T + D+ +G + Y
Sbjct: 168 VHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 122 APE-----------YMRTGVFNEKSNVFSFSVFLFELLTG 150
PE + KS+V+S L+ + G
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-08
Identities = 36/132 (27%), Positives = 53/132 (40%), Gaps = 21/132 (15%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMDIVH 61
H ++L+LI E LVFE ++ G++ I + HF E + D+
Sbjct: 70 HRNVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHK--RRHFNE----LEASVVVQDVAS 122
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILF-NEENVA--KLFDFSLSISIPEGETHITD------ 112
AL +LH + I R+ K IL + V+ K+ DF L I
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 113 TVMGTLGYCAPE 124
T G+ Y APE
Sbjct: 180 TPCGSAEYMAPE 191
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 36/153 (23%), Positives = 62/153 (40%), Gaps = 13/153 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
Q+ H ++++L E+ I LV E V G L+DRI+ E + I
Sbjct: 142 QLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTE----LDTILFMKQI 196
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGT 117
+ ++H I+ + K IL + K+ DF L+ E GT
Sbjct: 197 CEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGT 251
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE + + ++++S V + LL+G
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-08
Identities = 35/156 (22%), Positives = 55/156 (35%), Gaps = 21/156 (13%)
Query: 3 SHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EP---LLLKHRLKIAM 57
S ++ L E I L+ E G ++ L E L+K
Sbjct: 87 SCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ------ 139
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILF---NEENVAKLFDFSLSISIPEGETHITDTV 114
I+ + YLH IV + K IL K+ DF +S I +
Sbjct: 140 -ILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREI 193
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
MGT Y APE + +++++ + + LLT
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-08
Identities = 31/160 (19%), Positives = 59/160 (36%), Gaps = 24/160 (15%)
Query: 4 HNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
+ I++L T I +V E L + + + R +++ A
Sbjct: 68 SDKIIRLYDY-EITDQYIYMVMECGN-IDLNSWLK-----KKKSIDPWERKSYWKNMLEA 120
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT-DTVMGTLGYC 121
+ +H IV + K + L + + KL DF ++ + T + D+ +GT+ Y
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 122 APE-----------YMRTGVFNEKSNVFSFSVFLFELLTG 150
PE + KS+V+S L+ + G
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-07
Identities = 35/156 (22%), Positives = 62/156 (39%), Gaps = 18/156 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
++ H +I+ L E + L+ E V G L+D + A + E +
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFL--AEKESLTE----DEATQFLKQ 116
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF----NEENVAKLFDFSLSISIPEGETHITDTV 114
I+ + YLH + I + K I+ KL DF ++ I G +
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNI 171
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT + APE + +++++S V + LL+G
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 28/154 (18%), Positives = 61/154 (39%), Gaps = 15/154 (9%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHF-EPLLLKHRLKIAMD 58
H +IL L E+ + ++FE + +++RI E + +
Sbjct: 57 IARHRNILHLHESF-ESMEELVMIFEFISGLDIFERIN-TSAFELNE----REIVSYVHQ 110
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMG 116
+ AL +LH I + + I++ + K+ +F + + G+ +
Sbjct: 111 VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFT 165
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
Y APE + V + ++++S ++ LL+G
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-07
Identities = 40/196 (20%), Positives = 78/196 (39%), Gaps = 48/196 (24%)
Query: 40 PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 99
+ + L L+H + + + + +L R + R+ IL +E+NV K+ DF L
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 100 SISIPEGETHITDTV-------MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT--- 149
+ I + ++ M APE + V+ +S+V+SF V L+E+ +
Sbjct: 240 ARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293
Query: 150 --------GWDVSDLVKDVHDLVCPFS------EYLKNCFEDN---R--FTEIVDHIVVE 190
+ +K+ + P + + +C+ R F+E+V+H+
Sbjct: 294 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL--- 350
Query: 191 DVSSIEKEQQLHASAQ 206
L A+AQ
Sbjct: 351 -------GNLLQANAQ 359
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
IV L +LH R I++R+ K +L +++ ++ D L++ + G+T T GT
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTP 353
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
G+ APE + ++ + F+ V L+E++
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 39/163 (23%), Positives = 61/163 (37%), Gaps = 36/163 (22%)
Query: 2 MSHNHILKLIGCCLETPIPI-LVFES-VQYGTLWDRILGAPQPHFEPLLLKHRL------ 53
+ H +I+K++ E LV E L+ I RL
Sbjct: 86 VEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFID-----------RHPRLDEPLAS 133
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
I +V A+ YL + I+ R+ K I+ E+ KL DF + + G+ + T
Sbjct: 134 YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYT 188
Query: 114 VMGTLGYCAPEYMRTGVFNEKS------NVFSFSVFLFELLTG 150
GT+ YCAPE V ++S V L+ L+
Sbjct: 189 FCGTIEYCAPE-----VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 5/94 (5%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 117
IV AL YLH + +V+R+ K ++ +++ K+ DF L I +G T T GT
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGT 312
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
Y APE + + + + V ++E++ G
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 26/94 (27%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 117
IV AL YLH + I+ R+ K IL NE+ ++ DF + + PE + ++ +GT
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
Y +PE + + S++++ +++L+ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 31/107 (28%), Positives = 46/107 (42%), Gaps = 19/107 (17%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
K+ + IV AL YL ++ R+ K S IL +E KL DF +S + D
Sbjct: 128 KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS-------GRLVDD 178
Query: 114 V-----MGTLGYCAPE-----YMRTGVFNEKSNVFSFSVFLFELLTG 150
G Y APE ++ +++V+S + L EL TG
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-06
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 14/104 (13%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE---THI 110
KIA+ IV AL +LH ++ R+ K S +L N K+ DF +S G
Sbjct: 113 KIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVA 165
Query: 111 TDTVMGTLGYCAPE----YMRTGVFNEKSNVFSFSVFLFELLTG 150
D G Y APE + ++ KS+++S + + EL
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-06
Identities = 36/158 (22%), Positives = 60/158 (37%), Gaps = 24/158 (15%)
Query: 2 MSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA---- 56
++H +++K G L E G L+DRI +
Sbjct: 62 LNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQR 109
Query: 57 --MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDT 113
++ + YLH I R+ K +L +E + K+ DF L+ + + +
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 114 VMGTLGYCAPE-YMRTGVFNEKSNVFSFSVFLFELLTG 150
+ GTL Y APE R E +V+S + L +L G
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-06
Identities = 35/158 (22%), Positives = 60/158 (37%), Gaps = 28/158 (17%)
Query: 3 SHNHILKLIGCCLETPIPI-LVFE-SVQYGTLWDRILGAPQPHFEPLLLKHRL------K 54
H +++L+ ET LV E + L+D I K L
Sbjct: 96 GHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYIT-----------EKGPLGEGPSRC 143
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDFSLSISIPEGETHITDT 113
+V A+ + H R +V R+ K IL + AKL DF + +
Sbjct: 144 FFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT---D 197
Query: 114 VMGTLGYCAPEYMRTGVFN-EKSNVFSFSVFLFELLTG 150
GT Y PE++ ++ + V+S + L++++ G
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-06
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 13/155 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWD--RILGAPQPHFEPLLLKHRLKIAMD 58
+ H +I++ +G E + E V G+L R P E +
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF----YTKQ 130
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGT 117
I+ L YLH IV R+ K +L N + V K+ DF S + T+T GT
Sbjct: 131 ILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-TETFTGT 186
Query: 118 LGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLTG 150
L Y APE + G + + ++++S + E+ TG
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 25/100 (25%), Positives = 45/100 (45%), Gaps = 7/100 (7%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVM 115
++V AL +H + R+ K +L ++ KL DF + + + DT +
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 116 GTLGYCAPEYMRTGVFNEKSNV----FSFSVFLFELLTGW 151
GT Y +PE +++ + +S VFL+E+L G
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 18/106 (16%)
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT 113
KI + V AL +L I+ R+ K S IL + KL DF +S + D+
Sbjct: 129 KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS-------GQLVDS 179
Query: 114 V-----MGTLGYCAPE----YMRTGVFNEKSNVFSFSVFLFELLTG 150
+ G Y APE ++ +S+V+S + L+EL TG
Sbjct: 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 36/158 (22%), Positives = 61/158 (38%), Gaps = 24/158 (15%)
Query: 2 MSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRL------K 54
++H +++K G L E G L+DRI + +
Sbjct: 62 LNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPEPDAQR 109
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDT 113
++ + YLH I R+ K +L +E + K+ DF L+ + + +
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 114 VMGTLGYCAPE-YMRTGVFNEKSNVFSFSVFLFELLTG 150
+ GTL Y APE R E +V+S + L +L G
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 34/155 (21%), Positives = 60/155 (38%), Gaps = 13/155 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+S I+ L G E P + E ++ G+L I L L +
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK-----QMGCLPEDRALYYLGQAL 160
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEE-NVAKLFDFSLSISIPEGETHIT----DTVM 115
L YLH R I+ + K +L + + + A L DF ++ + + D +
Sbjct: 161 EGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
GT + APE + + K +++S + +L G
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 18/103 (17%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
+V A+ +H V R+ K IL + +L DF + + E T + +GT
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240
Query: 119 GYCAPEYMRTGVFNEKSNVF----------SFSVFLFELLTGW 151
Y +PE + S V ++E+L G
Sbjct: 241 DYISPE-----ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 10/100 (10%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
IV A+ +H V R+ K IL + +L DF + + T + +GT
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 119 GYCAPEYMRTGVFNEKSNVF-------SFSVFLFELLTGW 151
Y +PE ++ + + + VF +E+ G
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-05
Identities = 29/156 (18%), Positives = 59/156 (37%), Gaps = 30/156 (19%)
Query: 6 HILKLIGCCLETPIPI-LVFESVQ-YGTLWDRILGAPQPHFEPLLLKHRL------KIAM 57
+++L+ E P L+ E + L+D I + L
Sbjct: 109 GVIRLLDW-FERPDSFVLILERPEPVQDLFDFIT-----------ERGALQEELARSFFW 156
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEE--NVAKLFDFSLSISIPEGETHITDTVM 115
++ A+ + H ++ R+ K IL + + KL DF + +
Sbjct: 157 QVLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL-KLIDFGSGALLKDTVYT---DFD 209
Query: 116 GTLGYCAPEYMRTGVFN-EKSNVFSFSVFLFELLTG 150
GT Y PE++R ++ + V+S + L++++ G
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 33/95 (34%), Positives = 44/95 (46%), Gaps = 5/95 (5%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
IV AL +LH I++R+ K IL + L DF LS ET GT+
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 119 GYCAPEYMRTGVFNEKSNV--FSFSVFLFELLTGW 151
Y AP+ +R G V +S V ++ELLTG
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 3e-05
Identities = 31/100 (31%), Positives = 45/100 (45%), Gaps = 18/100 (18%)
Query: 59 IVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 116
I AL +LH G I++R+ K I+ N + KL DF L SI +G T T G
Sbjct: 130 ISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCG 183
Query: 117 TLGYCAPEYMRTGVFNEKSNVF-----SFSVFLFELLTGW 151
T+ Y APE + + S ++++LTG
Sbjct: 184 TIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-05
Identities = 31/162 (19%), Positives = 59/162 (36%), Gaps = 22/162 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI-LGAPQPHFEPLLLKHRLKIAM-- 57
+H +I+ + +V + YG+ D I E IA
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IAYIL 134
Query: 58 -DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEG------ETHI 110
++ AL Y+H V R+ K S IL + + L ++S+
Sbjct: 135 QGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 111 TDTVMGTLGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLTG 150
+ L + +PE ++ + ++ KS+++S + EL G
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 4e-05
Identities = 36/100 (36%), Positives = 49/100 (49%), Gaps = 18/100 (18%)
Query: 59 IVHALAYLH-FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMG 116
+ AL +LH G I++R+ K IL +EE KL DF LS SI + + G
Sbjct: 135 LALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 188
Query: 117 TLGYCAPEYMRTGVFNEKSNVF-----SFSVFLFELLTGW 151
T+ Y APE V N + + SF V +FE+LTG
Sbjct: 189 TVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-05
Identities = 25/96 (26%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
I +I+ L YLH + R+ K + +L +E KL DF ++ + + + +T
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTF 179
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+GT + APE ++ ++ K++++S + EL G
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 4e-05
Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTV 114
A +I L +L + I++R+ K ++ + E K+ DF + +I +G T T T
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTF 502
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
GT Y APE + + + + ++F V L+E+L G
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-05
Identities = 34/142 (23%), Positives = 55/142 (38%), Gaps = 30/142 (21%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 117
I AL YLH R I++R+ K +L + E KL D+ + + G+T T T GT
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGT 216
Query: 118 LGYCAPEYMRTGVFNEKSNVF-----SFSVFLFELLTGWDVSDLVKDVHDLVCPF-SEYL 171
Y APE + + F + V +FE++ G PF
Sbjct: 217 PNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGR-------------SPFDIVGS 258
Query: 172 KNCFEDNRFTEIVDHIVVEDVS 193
+ + N + I+ + +
Sbjct: 259 SDNPDQNTEDYLFQVILEKQIR 280
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 27/99 (27%), Positives = 44/99 (44%), Gaps = 16/99 (16%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 117
I L +L + I++R+ K ++ + E K+ DF + +I +G T T T GT
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGT 184
Query: 118 LGYCAPEYMRTGVFNEKSNVF-----SFSVFLFELLTGW 151
Y APE + + +F V L+E+L G
Sbjct: 185 PDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 6e-05
Identities = 34/137 (24%), Positives = 57/137 (41%), Gaps = 20/137 (14%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 117
I AL YLH R I++R+ K +L + E KL D+ + + G+T T T GT
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGT 173
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPF-SEYLKNCFE 176
Y APE +R + + ++ V +FE++ G PF + +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR-------------SPFDIVGSSDNPD 220
Query: 177 DNRFTEIVDHIVVEDVS 193
N + I+ + +
Sbjct: 221 QNTEDYLFQVILEKQIR 237
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 9e-05
Identities = 33/138 (23%), Positives = 56/138 (40%), Gaps = 25/138 (18%)
Query: 1 QMSHNHILKLIGCCLETPIPI--------LVFESVQYGTLWD--RILGAPQPHFEPLLLK 50
+ H +++ LI C P LVF+ ++ D +L F +K
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIK 127
Query: 51 HRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL----SISIPEG 106
+ +++ L Y+H I+ R+ K + +L + V KL DF L S++
Sbjct: 128 R---VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 107 ETHITDTVMGTLGYCAPE 124
T+ V+ TL Y PE
Sbjct: 182 PNRYTNRVV-TLWYRPPE 198
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 9e-05
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 117
I+ L +LH + IV+R+ K IL +++ K+ DF + ++ T+T GT
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGT 181
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
Y APE + +N + +SF V L+E+L G
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 1e-04
Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 16/99 (16%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 117
IV AL YLH R +V+R+ K ++ +++ K+ DF L I +G T T GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGT 168
Query: 118 LGYCAPEYMRTGVFNEKSNVF-----SFSVFLFELLTGW 151
Y APE V + V ++E++ G
Sbjct: 169 PEYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 31/99 (31%), Positives = 44/99 (44%), Gaps = 16/99 (16%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 117
I+ AL +LH + I++R+ K +L + E KL DF + I G T T T GT
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGT 187
Query: 118 LGYCAPEYMRTGVFNEKSNVF-----SFSVFLFELLTGW 151
Y APE + E + V L+E+L G
Sbjct: 188 PDYIAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 26/170 (15%), Positives = 54/170 (31%), Gaps = 35/170 (20%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRIL--GAPQPHF-EPLLLKHRLKIAMDIV 60
H+H+++ E ++ E G+L D I +F E L + + +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----LLLQVG 125
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENV-------------------AKLFDFSLSI 101
L Y+H +V + K S I + ++ K+ D
Sbjct: 126 RGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 102 SIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTG 150
I G + A E ++ K+++F+ ++ +
Sbjct: 183 RISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 8/101 (7%)
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDF----SLSISIPEGETHI 110
I +++ L YLH + R+ K IL E+ ++ DF L+ +
Sbjct: 126 ILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 111 TDTVMGTLGYCAPEYM-RTGVFNEKSNVFSFSVFLFELLTG 150
T +GT + APE M + ++ K++++SF + EL TG
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 14/150 (9%), Positives = 38/150 (25%), Gaps = 38/150 (25%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ + +++ ++V E ++ G+L + +P P ++ +
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV-------GAIRAMQSLA 139
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
A H + S + + + L
Sbjct: 140 AAADAAH---RAGVALSIDHPSRVRVSIDGDVVL---------------------AYPAT 175
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
N + ++ L+ LL
Sbjct: 176 MPDA-------NPQDDIRGIGASLYALLVN 198
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 31/99 (31%), Positives = 41/99 (41%), Gaps = 16/99 (16%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGT 117
I AL YLH IV+R+ K IL + + L DF L +I T T T GT
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGT 202
Query: 118 LGYCAPEYMRTGVFNEKSNVF-----SFSVFLFELLTGW 151
Y APE V +++ L+E+L G
Sbjct: 203 PEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 3e-04
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 14/153 (9%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM--- 57
Q H++K G + +V E G++ D I + E +IA
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-------EIATILQ 132
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGT 117
+ L YLHF + R+ K IL N E AKL DF ++ + + +TV+GT
Sbjct: 133 STLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK-RNTVIGT 188
Query: 118 LGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE ++ +N ++++S + E+ G
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 30/150 (20%), Positives = 62/150 (41%), Gaps = 10/150 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ + +I+ + L +V E + G+L D + + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECL 126
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL +LH ++ R+ K+ IL + KL DF I ++ T++GT +
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYW 182
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE + + K +++S + E++ G
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 21/93 (22%), Positives = 45/93 (48%), Gaps = 7/93 (7%)
Query: 59 IVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
IV YLH +++R+ K +L +++ ++ DF + + T T+ GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTP 202
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151
APE + + +N+ + ++ V ++E+ G+
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 7e-04
Identities = 36/133 (27%), Positives = 50/133 (37%), Gaps = 22/133 (16%)
Query: 1 QMSHNHILKLIGCCLETPIPI-----LVFESVQY--GTLWDRILGAPQPHFEPLLLKHRL 53
H ++++L+ C + LVFE V T D+ P P +K
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAETIK--- 123
Query: 54 KIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL--SISIPEGETHIT 111
+ + L +LH IV R+ K IL KL DF L S T +
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV- 179
Query: 112 DTVMGTLGYCAPE 124
V+ TL Y APE
Sbjct: 180 --VV-TLWYRAPE 189
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 8e-04
Identities = 31/150 (20%), Positives = 66/150 (44%), Gaps = 10/150 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
H +++++ L ++ E +Q G L D + L + + ++
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV------SQVRLNEEQIATVCEAVL 151
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
ALAYLH + ++ R+ K+ IL + KL DF I + +++GT +
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYW 207
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE + ++ + +++S + + E++ G
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 239 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.67 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.4 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.17 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.76 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.63 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.6 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.47 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.91 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.81 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.8 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 95.6 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.33 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.5 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.77 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 91.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 90.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.15 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.13 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 86.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 84.42 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=334.44 Aligned_cols=210 Identities=20% Similarity=0.316 Sum_probs=161.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||+++|++.+ +..++|||||++|+|.+++.... ..+++..+..++.|++.||+||| +++|+|||||
T Consensus 88 ~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlK 159 (307)
T 3omv_A 88 KTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMK 159 (307)
T ss_dssp TCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCC
T ss_pred hCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccC
Confidence 5899999999998854 56899999999999999997653 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-cceeecccccccccCcccccc---CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+|||++.++.+||+|||+|+...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 160 SNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp SSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999997654322 223445679999999999864 3589999999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
....... . ..+......+.........++.+.++|.+||+.||++|||+.||++.|+.+-..
T Consensus 240 ~~~~~~~--------~---------~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 240 INNRDQI--------I---------FMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCHHHH--------H---------HHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CChHHHH--------H---------HHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 3321100 0 000000000000111124567789999999999999999999999999877544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=335.33 Aligned_cols=210 Identities=23% Similarity=0.355 Sum_probs=171.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCC--------CCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAP--------QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR 72 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 72 (239)
+|+|||||+++|+|.+++..++|||||++|+|.++++... ......+++..++.++.|++.||.||| ++
T Consensus 71 ~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~ 147 (299)
T 4asz_A 71 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQ 147 (299)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 5899999999999999999999999999999999997642 112257899999999999999999999 89
Q ss_pred CeeeccccCcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-C
Q 044155 73 PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-G 150 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g 150 (239)
+|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |
T Consensus 148 ~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G 227 (299)
T 4asz_A 148 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 227 (299)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999999865433222 2234568999999999999999999999999999999999 8
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
+.||..... .++...+..+... ..+...++++.++|.+||+.||++|||++||.+.|+
T Consensus 228 ~~Pf~~~~~---------------------~~~~~~i~~~~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 228 KQPWYQLSN---------------------NEVIECITQGRVL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp CCTTTTSCH---------------------HHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCH---------------------HHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 888864321 1222222222111 112345678999999999999999999999999999
Q ss_pred HHHHh
Q 044155 231 QIYRS 235 (239)
Q Consensus 231 ~l~~~ 235 (239)
++.+.
T Consensus 286 ~~~~~ 290 (299)
T 4asz_A 286 NLAKA 290 (299)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 88654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=334.58 Aligned_cols=208 Identities=21% Similarity=0.250 Sum_probs=168.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||++++++.+++..++|||||+||+|.++++.. ..+++..++.++.||+.||+||| +++|+|||||
T Consensus 106 ~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlK 177 (336)
T 4g3f_A 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVK 177 (336)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCC
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccC
Confidence 479999999999999999999999999999999999875 57999999999999999999999 9999999999
Q ss_pred CcceeecCCC-ceeEcccccccccCCCCc----ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 81 TSCILFNEEN-VAKLFDFSLSISIPEGET----HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~-~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+|||++.++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 178 p~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~ 257 (336)
T 4g3f_A 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257 (336)
T ss_dssp GGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred HHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 9999999987 599999999987643221 11234579999999999999999999999999999999999999996
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCC-cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS-SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
...... ....+...... ...+...++.+.++|.+||+.||.+|||+.|+++.|...+.
T Consensus 258 ~~~~~~---------------------~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 258 QYFRGP---------------------LCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp TTCCSC---------------------CHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHH---------------------HHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 432111 00111111100 00112456778999999999999999999999999998877
Q ss_pred hhc
Q 044155 235 SLS 237 (239)
Q Consensus 235 ~~~ 237 (239)
++.
T Consensus 317 ~~~ 319 (336)
T 4g3f_A 317 EVG 319 (336)
T ss_dssp HTT
T ss_pred hhh
Confidence 654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=332.87 Aligned_cols=210 Identities=25% Similarity=0.356 Sum_probs=164.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC----------CCCcCCHHHHHHHHHHHHHHHhHHhhCC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP----------HFEPLLLKHRLKIAMDIVHALAYLHFGF 70 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 70 (239)
+|+|||||+++|+|.+.+..++|||||++|+|.++++..... ...++++..++.++.|++.||+|||
T Consensus 99 ~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--- 175 (329)
T 4aoj_A 99 MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--- 175 (329)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---
Confidence 589999999999999999999999999999999999865321 1146899999999999999999999
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHhc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 149 (239)
+++|+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 176 ~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt 255 (329)
T 4aoj_A 176 GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255 (329)
T ss_dssp HTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHc
Confidence 8999999999999999999999999999998654332 222345678999999999999999999999999999999999
Q ss_pred -CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 150 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
|+.||..... .+.+..+..+. ....+...++++.+++.+||+.||++|||++||++.
T Consensus 256 ~G~~Pf~~~~~---------------------~~~~~~i~~g~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 256 YGKQPWYQLSN---------------------TEAIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TSCCTTCSSCH---------------------HHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCCCCCH---------------------HHHHHHHHcCC-CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 8889864331 11122221111 111122456789999999999999999999999999
Q ss_pred HHHHHHh
Q 044155 229 LRQIYRS 235 (239)
Q Consensus 229 L~~l~~~ 235 (239)
|+.+.+.
T Consensus 314 L~~l~~~ 320 (329)
T 4aoj_A 314 LQALAQA 320 (329)
T ss_dssp HHHHHHS
T ss_pred HHHHhhC
Confidence 9988653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=332.17 Aligned_cols=207 Identities=18% Similarity=0.312 Sum_probs=168.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFG 69 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~ 69 (239)
+|+|||||+++|+|.+.+..++|||||++|+|.+++...... ....+++..+..++.||+.||.|||
T Consensus 85 ~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-- 162 (308)
T 4gt4_A 85 RLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS-- 162 (308)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred hCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--
Confidence 479999999999999999999999999999999999754211 1145889999999999999999999
Q ss_pred CCCCeeeccccCcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 70 FPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 70 ~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
+++|+||||||+|||+++++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 163 -~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~ 241 (308)
T 4gt4_A 163 -SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241 (308)
T ss_dssp -HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -hCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHH
Confidence 8999999999999999999999999999997653322 12234567899999999999999999999999999999999
Q ss_pred c-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 149 T-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 149 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
| |..||..... .++...+..+.. .+.+...++.+.+++.+||+.||++|||+.||++
T Consensus 242 t~g~~Pf~~~~~---------------------~~~~~~i~~~~~-~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 242 SYGLQPYCGYSN---------------------QDVVEMIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp TTTCCTTTTCCH---------------------HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCH---------------------HHHHHHHHcCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8 8888864321 112222222111 1122356678999999999999999999999999
Q ss_pred HHHHH
Q 044155 228 KLRQI 232 (239)
Q Consensus 228 ~L~~l 232 (239)
.|+..
T Consensus 300 ~L~a~ 304 (308)
T 4gt4_A 300 RLRAW 304 (308)
T ss_dssp HHHTS
T ss_pred HHHhc
Confidence 99753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=324.00 Aligned_cols=195 Identities=19% Similarity=0.308 Sum_probs=156.1
Q ss_pred CCCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC--e
Q 044155 1 QMSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--I 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--i 74 (239)
+|+|||||+++++|.+ ....++|||||++|+|.+++.+. ..+++..++.++.||+.||+||| +++ |
T Consensus 81 ~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~I 152 (290)
T 3fpq_A 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPI 152 (290)
T ss_dssp TCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCC
T ss_pred hCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCE
Confidence 5899999999999975 24578999999999999999875 67899999999999999999999 777 9
Q ss_pred eeccccCcceeecC-CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 75 VFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 75 ~H~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+||||||+|||++. ++.+||+|||+|+..... ......||+.|+|||++.+ .++.++|||||||++|||+||..|
T Consensus 153 iHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~P 228 (290)
T 3fpq_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 228 (290)
T ss_dssp CCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EecccChhheeEECCCCCEEEEeCcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999975 789999999999754332 2345679999999998864 699999999999999999999999
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
|...... ..+...+.........+...++++.+||.+||+.||++|||++|+++
T Consensus 229 f~~~~~~--------------------~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 229 YSECQNA--------------------AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTCSSH--------------------HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCcH--------------------HHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8543211 11111111111111112233457899999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=334.44 Aligned_cols=198 Identities=21% Similarity=0.308 Sum_probs=164.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||++++++.+++..++|||||+||+|.+++..... ..+++..++.++.||+.||.||| +++|+|||||
T Consensus 79 ~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlK 152 (350)
T 4b9d_A 79 NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH---DRKILHRDIK 152 (350)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCC
T ss_pred HCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCC
Confidence 47999999999999999999999999999999999976543 45789999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 153 p~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-- 229 (350)
T 4b9d_A 153 SQNIFLTKDGTVQLGDFGIARVLNST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-- 229 (350)
T ss_dssp GGGEEECTTCCEEECSTTEESCCCHH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred HHHEEECCCCCEEEcccccceeecCC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--
Confidence 99999999999999999999765321 122345679999999999999999999999999999999999999985322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+....+....... .....++++.+||.+||+.||.+|||++|+++
T Consensus 230 -------------------~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 230 -------------------MKNLVLKIISGSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -------------------HHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------------HHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112222222222211 11245677899999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=325.10 Aligned_cols=220 Identities=19% Similarity=0.323 Sum_probs=164.3
Q ss_pred CCCCcccceeeEEEEeCC----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC----
Q 044155 1 QMSHNHILKLIGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR---- 72 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~---- 72 (239)
+++|||||+++|++.+.+ ..++||||+++|+|.++++. ..+++..+.+++.|++.||+||| ++
T Consensus 53 ~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH---~~~~~~ 123 (303)
T 3hmm_A 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLH---MEIVGT 123 (303)
T ss_dssp TCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHH---CCBCST
T ss_pred cCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---Hhhhhc
Confidence 479999999999998654 46899999999999999986 45889999999999999999999 55
Q ss_pred ----CeeeccccCcceeecCCCceeEcccccccccCCCCcc---eeecccccccccCccccccC------Ccccccchhh
Q 044155 73 ----PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRTG------VFNEKSNVFS 139 (239)
Q Consensus 73 ----~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~s 139 (239)
+|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+. .++.++||||
T Consensus 124 ~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS 203 (303)
T 3hmm_A 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203 (303)
T ss_dssp TCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred cCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhh
Confidence 9999999999999999999999999999766433221 22345799999999998754 3678999999
Q ss_pred hhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCc-----HHHHHHHHHHHHHHhhhcCC
Q 044155 140 FSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSS-----IEKEQQLHASAQVTFECIKD 214 (239)
Q Consensus 140 lG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~ 214 (239)
|||++|||+||..|+........ ++.... ..................++ ......+..+.+++.+||+.
T Consensus 204 ~Gvvl~El~tg~~~~~~~~~~~~---p~~~~~---~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T 3hmm_A 204 MGLVFWEIARRCSIGGIHEDYQL---PYYDLV---PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHTBCBTTBCCCCCC---TTTTTS---CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCS
T ss_pred HHHHHHHHHHCCCCCCccccccc---cchhcc---cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHccc
Confidence 99999999999888754432211 111100 00111111221122211111 11124567889999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHh
Q 044155 215 SPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 215 dp~~Rps~~ell~~L~~l~~~ 235 (239)
||++|||+.||++.|+++.++
T Consensus 278 dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 278 NGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SGGGSCCHHHHHHHHHHHHHC
T ss_pred CHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=328.40 Aligned_cols=196 Identities=16% Similarity=0.244 Sum_probs=162.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||+++++|.+++..|+|||||++|+|.+++.. ..+++..++.++.||+.||+||| +++|+|||||
T Consensus 127 ~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlK 197 (346)
T 4fih_A 127 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIK 197 (346)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCC
Confidence 37999999999999999999999999999999999976 45899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 198 p~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~- 275 (346)
T 4fih_A 198 SDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP- 275 (346)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred HHHEEECCCCCEEEecCcCceecCCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-
Confidence 999999999999999999998764322 234467899999999999999999999999999999999999999853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+....+..... ........++++++||.+||+.||++|||++|+++
T Consensus 276 --------------------~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 276 --------------------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --------------------HHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------------------HHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111110 01111245678899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=324.35 Aligned_cols=195 Identities=17% Similarity=0.242 Sum_probs=164.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||++++++.+.+..++|||||+||+|.+++.+. ..+++..++.++.||+.||.||| +++|+|||||
T Consensus 88 ~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlK 159 (311)
T 4aw0_A 88 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLK 159 (311)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCC
Confidence 579999999999999999999999999999999999875 57999999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCC-CcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEG-ETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+|||++.++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 160 PeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~- 238 (311)
T 4aw0_A 160 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN- 238 (311)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred HHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999999999999999999876432 2233456789999999999999999999999999999999999999985321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
..+....+....... +...++++++||.+||+.||++|||++|++
T Consensus 239 --------------------~~~~~~~i~~~~~~~--p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 239 --------------------EGLIFAKIIKLEYDF--PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --------------------HHHHHHHHHHTCCCC--CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --------------------HHHHHHHHHcCCCCC--CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 112222222222221 123456789999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=328.08 Aligned_cols=210 Identities=21% Similarity=0.358 Sum_probs=167.7
Q ss_pred CCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCC
Q 044155 3 SHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGF 70 (239)
Q Consensus 3 ~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 70 (239)
+|||||+++|+|.+. +..++|||||++|+|.++++..... ....+++..+..++.||+.||.|||
T Consensus 126 hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--- 202 (353)
T 4ase_A 126 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 202 (353)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---
T ss_pred CCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---
Confidence 459999999999764 5689999999999999999864220 1145889999999999999999999
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 149 (239)
+++|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 203 ~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t 282 (353)
T 4ase_A 203 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282 (353)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred hCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh
Confidence 89999999999999999999999999999986644332 23445678999999999999999999999999999999998
Q ss_pred -CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 150 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
|..||....... .+...+........+...++++.++|.+||+.||++|||+.||++.
T Consensus 283 ~G~~Pf~~~~~~~---------------------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 283 LGASPYPGVKIDE---------------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TSCCSSTTCCCSH---------------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHH---------------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 889986432111 0111111111111123456788999999999999999999999999
Q ss_pred HHHHHHhh
Q 044155 229 LRQIYRSL 236 (239)
Q Consensus 229 L~~l~~~~ 236 (239)
|.++++.-
T Consensus 342 L~~llq~~ 349 (353)
T 4ase_A 342 LGNLLQAN 349 (353)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHHh
Confidence 99987653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=319.55 Aligned_cols=195 Identities=24% Similarity=0.296 Sum_probs=160.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||++++++.+++..++|||||+||+|.+++.+. ..+++..++.++.|++.||+||| +++|+|||||
T Consensus 82 ~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlK 153 (304)
T 3ubd_A 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLK 153 (304)
T ss_dssp CCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCC
T ss_pred HCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCC
Confidence 579999999999999999999999999999999999875 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 154 p~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-- 230 (304)
T 3ubd_A 154 PENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD-- 230 (304)
T ss_dssp GGGEEECTTSCEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred HHHeEEcCCCCEEecccccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--
Confidence 999999999999999999997653322 22345679999999999999999999999999999999999999986322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM-----VDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~ell~ 227 (239)
..+....+....... +...++++.+||.+||+.||++|||+ +|+++
T Consensus 231 -------------------~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 231 -------------------RKETMTMILKAKLGM--PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -------------------HHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -------------------HHHHHHHHHcCCCCC--CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112222222222211 12456778999999999999999985 56664
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=329.34 Aligned_cols=196 Identities=16% Similarity=0.244 Sum_probs=162.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||+++++|.+++..|+|||||+||+|.++++. ..+++..++.++.||+.||+||| +++|+|||||
T Consensus 204 ~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiK 274 (423)
T 4fie_A 204 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIK 274 (423)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCC
Confidence 37999999999999999999999999999999999975 45899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 275 p~NILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~- 352 (423)
T 4fie_A 275 SDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP- 352 (423)
T ss_dssp TTTEEECTTCCEEECCCTTCEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-
T ss_pred HHHEEEcCCCCEEEecCccceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-
Confidence 999999999999999999998764322 234567899999999999999999999999999999999999999853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+....+..... ........++.+++||.+||..||.+|||++|+++
T Consensus 353 --------------------~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 353 --------------------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --------------------HHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------------------HHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111100 00111245677899999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=312.14 Aligned_cols=193 Identities=23% Similarity=0.320 Sum_probs=151.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+.+..++||||+ +|+|.+++.+. ..+++..++.++.||+.||+||| +++|+|||||
T Consensus 69 ~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiK 139 (275)
T 3hyh_A 69 LLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLK 139 (275)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred HCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCC
Confidence 378999999999999999999999999 58999999876 57999999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+|||++.++.+||+|||+++...... ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||....
T Consensus 140 P~NILl~~~~~vkl~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~- 216 (275)
T 3hyh_A 140 PENLLLDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES- 216 (275)
T ss_dssp TTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred hHHeEECCCCCEEEeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-
Confidence 999999999999999999997653322 2345679999999999998775 579999999999999999999985321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......+....... +...+++++++|.+||+.||++|||++|+++
T Consensus 217 --------------------~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 217 --------------------IPVLFKNISNGVYTL--PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --------------------HHHHHHHHHHTCCCC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------------------HHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111122222222111 1234577899999999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=305.07 Aligned_cols=198 Identities=22% Similarity=0.326 Sum_probs=148.6
Q ss_pred CCCCcccceeeEEEEeCCC------------ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhh
Q 044155 1 QMSHNHILKLIGCCLETPI------------PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHF 68 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~------------~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~ 68 (239)
+|+|||||++++++.+.+. .++|||||++|+|.+++...... ...+...++.++.||+.||+|||
T Consensus 59 ~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH- 135 (299)
T 4g31_A 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLH- 135 (299)
T ss_dssp TCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHH-
T ss_pred hCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHH-
Confidence 5899999999999976543 58999999999999999865321 34567778899999999999999
Q ss_pred CCCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-----------ceeecccccccccCccccccCCcccccch
Q 044155 69 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-----------HITDTVMGTLGYCAPEYMRTGVFNEKSNV 137 (239)
Q Consensus 69 ~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 137 (239)
+++|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||
T Consensus 136 --~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di 213 (299)
T 4g31_A 136 --SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213 (299)
T ss_dssp --HTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHH
T ss_pred --HCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHH
Confidence 89999999999999999999999999999986643211 11234579999999999999999999999
Q ss_pred hhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCC
Q 044155 138 FSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPA 217 (239)
Q Consensus 138 ~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~ 217 (239)
|||||++|||++ ||.... .............. +......++...++|.+||+.||.
T Consensus 214 wSlGvilyell~---Pf~~~~--------------------~~~~~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~ 269 (299)
T 4g31_A 214 FSLGLILFELLY---PFSTQM--------------------ERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPM 269 (299)
T ss_dssp HHHHHHHHHHHS---CCSSHH--------------------HHHHHHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHcc---CCCCcc--------------------HHHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChh
Confidence 999999999996 553110 00011111111222 233345556778999999999999
Q ss_pred CCCCHHHHHH
Q 044155 218 DRPSMVDVAK 227 (239)
Q Consensus 218 ~Rps~~ell~ 227 (239)
+|||+.|+++
T Consensus 270 ~Rps~~eil~ 279 (299)
T 4g31_A 270 ERPEAINIIE 279 (299)
T ss_dssp GSCCHHHHHT
T ss_pred HCcCHHHHhc
Confidence 9999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=299.47 Aligned_cols=144 Identities=19% Similarity=0.305 Sum_probs=124.8
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+|||||++++++.+.+..++||||+++|+|.+++ ..+++.+++.++.|++.||+||| +++|+||||||+
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPe 146 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPS 146 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHH
Confidence 6999999999999999999999999999999998 34789999999999999999999 899999999999
Q ss_pred ceeecCC-CceeEcccccccccCCCCc---------------------------ceeecccccccccCccccccC-Cccc
Q 044155 83 CILFNEE-NVAKLFDFSLSISIPEGET---------------------------HITDTVMGTLGYCAPEYMRTG-VFNE 133 (239)
Q Consensus 83 nil~~~~-~~~~l~dfg~~~~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~ 133 (239)
|||++.+ +.+||+|||+|+....... .......||+.|+|||++.+. .++.
T Consensus 147 NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~ 226 (361)
T 4f9c_A 147 NFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTT 226 (361)
T ss_dssp GEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCT
T ss_pred HeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCC
Confidence 9999877 7999999999975432211 112345699999999999875 4889
Q ss_pred ccchhhhhhHHHHHhcCCCCcccc
Q 044155 134 KSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 134 ~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
++||||+||++|+|++|+.||...
T Consensus 227 ~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 227 AIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp HHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccchhhhHHHHHHHHHCCCCCCCC
Confidence 999999999999999999998543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=312.61 Aligned_cols=195 Identities=18% Similarity=0.232 Sum_probs=160.7
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|||||+++++|.+....++||||++||+|.+++... ..+++..++.++.||+.||.||| +++|+||||||
T Consensus 249 ~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKP 320 (689)
T 3v5w_A 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKP 320 (689)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSG
T ss_pred CCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCch
Confidence 68999999999999999999999999999999999875 56999999999999999999999 99999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+|||++.+|.+||+|||++....... .....||+.|+|||++.. ..++.++|+|||||++|||++|..||......
T Consensus 321 eNILld~~G~vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 321 ANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred HHeEEeCCCCEEecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999998764332 345689999999999974 57999999999999999999999998642210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
...++........... +...++++++||.+||..||.+|++ ++|+++
T Consensus 398 ------------------~~~~i~~~i~~~~~~~--p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 398 ------------------DKHEIDRMTLTMAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------------------CHHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------------------HHHHHHHhhcCCCCCC--CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0111122222222111 1245677899999999999999998 677764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=299.92 Aligned_cols=217 Identities=18% Similarity=0.227 Sum_probs=156.9
Q ss_pred CCCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+|+|||||++++++... +..++|||||+ |+|.+++... ..+++..++.++.||+.||.||| +++|
T Consensus 109 ~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH---~~~i 179 (398)
T 4b99_A 109 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMH---SAQV 179 (398)
T ss_dssp HCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred hcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcC
Confidence 37899999999998643 56799999996 7899999765 67999999999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCC---cceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGE---THITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTG 150 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g 150 (239)
+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus 180 iHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G 259 (398)
T 4b99_A 180 IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 259 (398)
T ss_dssp BCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred cCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHC
Confidence 999999999999999999999999997653321 1233467899999999998875 468999999999999999999
Q ss_pred CCCcccccccccccccch------hhhhhhhhccchhhhhhhhhhcCCCcHH---HHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 151 WDVSDLVKDVHDLVCPFS------EYLKNCFEDNRFTEIVDHIVVEDVSSIE---KEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
..||.............. .................. ......... ....++++.+||.+||..||.+|||
T Consensus 260 ~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 338 (398)
T 4b99_A 260 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS-LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS 338 (398)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHS-SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc-CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC
Confidence 999975432211110000 000000000000000000 000000000 0134567899999999999999999
Q ss_pred HHHHHH
Q 044155 222 MVDVAK 227 (239)
Q Consensus 222 ~~ell~ 227 (239)
++|+++
T Consensus 339 a~e~L~ 344 (398)
T 4b99_A 339 AAAALR 344 (398)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=307.84 Aligned_cols=197 Identities=16% Similarity=0.259 Sum_probs=162.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||+++++|.+.+..++|||||+||+|.+++.... ..+++..+..++.||+.||.||| +++|+|||||
T Consensus 210 ~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlK 282 (573)
T 3uto_A 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLK 282 (573)
T ss_dssp HTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCC
Confidence 3799999999999999999999999999999999996543 46899999999999999999999 8999999999
Q ss_pred CcceeecCC--CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEE--NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 283 p~Nill~~~~~~~vKl~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 283 PENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp GGGEEESSSSCCCEEECCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred hhhccccCCCCCCEEEeeccceeEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999865 789999999998764433 2345679999999999999999999999999999999999999986432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. .+....+..... ........++.+++||.+||..||.+|||+.|+++
T Consensus 361 ~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 361 D---------------------DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp H---------------------HHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred H---------------------HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111111111111 11112245677899999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=284.39 Aligned_cols=223 Identities=31% Similarity=0.526 Sum_probs=176.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC---Ceeec
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR---PIVFR 77 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~---~i~H~ 77 (239)
+++||||+++++++.+....++||||+++++|.+++...... ...+++..+..++.|++.||.||| +. +++|+
T Consensus 83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~ 158 (326)
T 3uim_A 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHR 158 (326)
T ss_dssp TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECC
T ss_pred hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeC
Confidence 478999999999999999999999999999999999875432 145899999999999999999999 67 99999
Q ss_pred cccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 78 NFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 78 dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
||||+||+++.++.++|+|||++...............||+.|+|||++.+..++.++||||||+++|+|++|..||+..
T Consensus 159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (326)
T 3uim_A 159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHH
T ss_pred CCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccc
Confidence 99999999999999999999999876544444445556899999999998888999999999999999999999999744
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
............+..............+...... .....+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTS----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccccchhHHHHHHHHhhchhhhhhcChhhccc----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 3322222222333333333323222222222222 224667889999999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=283.97 Aligned_cols=222 Identities=23% Similarity=0.309 Sum_probs=168.2
Q ss_pred CCCCcccceeeEEEEeCCC----ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC----
Q 044155 1 QMSHNHILKLIGCCLETPI----PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR---- 72 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~---- 72 (239)
+++||||+++++++.+... .++||||+++|+|.++++. ..+++..+..++.|++.||+||| +.
T Consensus 74 ~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH---~~~~~l 144 (322)
T 3soc_A 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLH---EDIPGL 144 (322)
T ss_dssp TCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHT---CCEEEE
T ss_pred cCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---hhcccc
Confidence 4789999999999987654 5899999999999999976 35889999999999999999999 88
Q ss_pred ------CeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccC-----Ccccccchhhh
Q 044155 73 ------PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTG-----VFNEKSNVFSF 140 (239)
Q Consensus 73 ------~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~sl 140 (239)
+++|+||||+||+++.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||
T Consensus 145 ~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl 224 (322)
T 3soc_A 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224 (322)
T ss_dssp TTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHH
T ss_pred ccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHH
Confidence 999999999999999999999999999976643322 122345689999999999863 46678999999
Q ss_pred hhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCc-----HHHHHHHHHHHHHHhhhcCCC
Q 044155 141 SVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSS-----IEKEQQLHASAQVTFECIKDS 215 (239)
Q Consensus 141 G~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~d 215 (239)
|+++|+|++|..||....+... .++...... .................+ ......++.+.++|.+||+.|
T Consensus 225 G~il~el~tg~~pf~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (322)
T 3soc_A 225 GLVLWELASRCTAADGPVDEYM--LPFEEEIGQ---HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299 (322)
T ss_dssp HHHHHHHHTTBTTSSSCCCCCC--CTTHHHHCS---SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSS
T ss_pred HHHHHHHHhCCCCCCCCcchhc--cchhhhhcc---CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCC
Confidence 9999999999999875433221 111111111 111111111111111111 011245677999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHhh
Q 044155 216 PADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 216 p~~Rps~~ell~~L~~l~~~~ 236 (239)
|.+|||+.|+++.|+++.+..
T Consensus 300 P~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 300 AEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp GGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999987654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=278.84 Aligned_cols=225 Identities=32% Similarity=0.517 Sum_probs=173.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++...... ...+++..+..++.|++.||.||| +++++|+|||
T Consensus 91 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlk 166 (321)
T 2qkw_B 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVK 166 (321)
T ss_dssp SCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred hCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCC
Confidence 478999999999999999999999999999999999765321 135889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++....... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 167 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 167 SINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp STTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred HHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 999999999999999999987643221 1223345689999999999888999999999999999999999999865332
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
..... ...+..............+ ...........+..+.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 247 ~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 247 REMVN--LAEWAVESHNNGQLEQIVD----PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSCCC--HHHHTHHHHTTTCCCSSSS----SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHH--HHHHhhhccccccHHHhcC----hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 21111 1111111111111111111 1111122346778899999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=280.01 Aligned_cols=209 Identities=27% Similarity=0.385 Sum_probs=158.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC--eeecc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--i~H~d 78 (239)
+++||||+++++++.+....++||||+++++|.+++...... ..++...+..++.|++.||+||| +.+ ++|+|
T Consensus 90 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~D 164 (309)
T 3p86_A 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRN 164 (309)
T ss_dssp HCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHH--HHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTT
T ss_pred hCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCC
Confidence 378999999999999999999999999999999999865211 24889999999999999999999 889 99999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|||+||+++.++.+||+|||++...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 165 ikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 165 LKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp CCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CChhhEEEeCCCcEEECCCCCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998654322 122335568999999999999999999999999999999999999986432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
.. +..............+...++.+.++|.+||+.||.+|||+.++++.|+.+.++.
T Consensus 244 ~~---------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 244 PA---------------------QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HH---------------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HH---------------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 10 1111110011111111244567899999999999999999999999999988654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=277.55 Aligned_cols=209 Identities=24% Similarity=0.326 Sum_probs=166.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+|||
T Consensus 63 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlk 135 (310)
T 3s95_A 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLN 135 (310)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCC
Confidence 4799999999999999999999999999999999998743 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce-------------eecccccccccCccccccCCcccccchhhhhhHHHHH
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI-------------TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFEL 147 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~ 147 (239)
|+||+++.++.+||+|||++.......... .....||+.|+|||++.+..++.++||||||+++|+|
T Consensus 136 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 215 (310)
T 3s95_A 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215 (310)
T ss_dssp TTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999987653322111 1145689999999999999999999999999999999
Q ss_pred hcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 148 LTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 148 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
++|..|+............ ........... ...++.+.+++.+||+.||.+|||+.++++
T Consensus 216 ~~g~~~~~~~~~~~~~~~~------------~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 216 IGRVNADPDYLPRTMDFGL------------NVRGFLDRYCP--------PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCCSSTTTSCBCTTSSB------------CHHHHHHHTCC--------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCcchhhhHHHHhh------------hhhccccccCC--------CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999887543221111100 00001110000 123456889999999999999999999999
Q ss_pred HHHHHHHhh
Q 044155 228 KLRQIYRSL 236 (239)
Q Consensus 228 ~L~~l~~~~ 236 (239)
.|+++...+
T Consensus 276 ~L~~l~~~~ 284 (310)
T 3s95_A 276 WLETLRMHL 284 (310)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhc
Confidence 999987664
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=286.98 Aligned_cols=206 Identities=24% Similarity=0.347 Sum_probs=165.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++|+|.++++... ..++...+..++.|++.||+||| +++++|||||
T Consensus 168 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlk 240 (377)
T 3cbl_A 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLA 240 (377)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccC
Confidence 4789999999999999999999999999999999997642 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcce-eecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHI-TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.+||+|||++.......... .....+++.|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 241 p~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 241 ARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred HHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987643322111 122345778999999998889999999999999999998 888876432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.. +....... ......+...++.+.++|.+||+.||.+|||++++++.|+++.+.
T Consensus 321 ~~---------------------~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 321 NQ---------------------QTREFVEK-GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HH---------------------HHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---------------------HHHHHHHc-CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 10 01101101 111111123456789999999999999999999999999998765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=275.72 Aligned_cols=196 Identities=18% Similarity=0.235 Sum_probs=159.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++..++..++||||+++++|.+++.. ..++...+..++.|++.||.||| +++++|+||||
T Consensus 74 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp 144 (297)
T 3fxz_A 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKS 144 (297)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred CCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCH
Confidence 6899999999999999999999999999999999976 35889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 145 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 223 (297)
T 3fxz_A 145 DNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (297)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred HHEEECCCCCEEEeeCCCceecCCcc-cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999987654322 22345578999999999999999999999999999999999999985432110
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .............+...+..+.+++.+||+.||.+|||++|+++
T Consensus 224 ~~--------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 224 AL--------------------YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HH--------------------HHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HH--------------------HHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 00000000011111245567899999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=273.53 Aligned_cols=206 Identities=23% Similarity=0.405 Sum_probs=166.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dik 133 (269)
T 4hcu_A 61 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133 (269)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcc
Confidence 5789999999999999999999999999999999997643 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 134 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 134 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp GGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred hheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 999999999999999999987654332222334456778999999998899999999999999999999 8888753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.+........ .....+...+..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 214 ---------------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 214 ---------------------SEVVEDISTG-FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---------------------HHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------------------HHHHHHHhcC-ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1111111111 00111123356789999999999999999999999999998763
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=282.69 Aligned_cols=210 Identities=20% Similarity=0.349 Sum_probs=167.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++.+.+..++||||+++|+|.+++...... ....++...+..++.|++.||.||| +
T Consensus 145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~ 221 (370)
T 2psq_A 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---S 221 (370)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---h
Confidence 7999999999999999999999999999999999875321 1135789999999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
++++||||||+||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||++
T Consensus 222 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~ 301 (370)
T 2psq_A 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 301 (370)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999999876543221 12233456788999999998899999999999999999999
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||..... .+......... ....+...+..+.++|.+||+.||.+|||+.|+++.|
T Consensus 302 g~~p~~~~~~---------------------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 302 GGSPYPGIPV---------------------EELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp SCCSSTTCCG---------------------GGHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCH---------------------HHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 8888854321 01111111110 0011123456789999999999999999999999999
Q ss_pred HHHHHhhc
Q 044155 230 RQIYRSLS 237 (239)
Q Consensus 230 ~~l~~~~~ 237 (239)
+++.....
T Consensus 360 ~~il~~~~ 367 (370)
T 2psq_A 360 DRILTLTT 367 (370)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHhc
Confidence 99886543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=278.95 Aligned_cols=207 Identities=21% Similarity=0.302 Sum_probs=165.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 106 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlk 178 (325)
T 3kul_A 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLA 178 (325)
T ss_dssp TCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCC
Confidence 4789999999999999999999999999999999997643 46899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 179 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp GGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999976643321 12223345778999999998889999999999999999999 98887543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
.. .+........ .....+...+..+.+++.+||..||.+|||+.++++.|+.+....
T Consensus 259 ~~---------------------~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 259 TN---------------------RDVISSVEEG-YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CH---------------------HHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CH---------------------HHHHHHHHcC-CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 21 1111111111 111111245567899999999999999999999999999987653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=282.38 Aligned_cols=229 Identities=16% Similarity=0.232 Sum_probs=165.1
Q ss_pred CCCcccceeeEEEEe-----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC----
Q 044155 2 MSHNHILKLIGCCLE-----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR---- 72 (239)
Q Consensus 2 l~H~niv~l~~~~~~-----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~---- 72 (239)
++||||+++++.+.. ....++||||+++|+|.+++... ..++..+..++.|++.||.||| +.
T Consensus 64 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~ 134 (336)
T 3g2f_A 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH---TELPRG 134 (336)
T ss_dssp CCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCCG
T ss_pred ccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHH---hhhccc
Confidence 689999999986653 22468999999999999999764 4578889999999999999999 88
Q ss_pred -----CeeeccccCcceeecCCCceeEcccccccccCCCC-------cceeecccccccccCcccccc-------CCccc
Q 044155 73 -----PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-------THITDTVMGTLGYCAPEYMRT-------GVFNE 133 (239)
Q Consensus 73 -----~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~~~ 133 (239)
+++|+||||+||+++.++.+||+|||++....... ........||+.|+|||++.+ ..++.
T Consensus 135 ~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (336)
T 3g2f_A 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214 (336)
T ss_dssp GGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred cccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc
Confidence 99999999999999999999999999997654321 112234568999999999986 34667
Q ss_pred ccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhh-cCCCc--HHHHHHHHHHHHHHhh
Q 044155 134 KSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV-EDVSS--IEKEQQLHASAQVTFE 210 (239)
Q Consensus 134 ~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~li~~ 210 (239)
++||||||+++|+|++|..|+............+...................... ..... ......++.+.++|.+
T Consensus 215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (336)
T 3g2f_A 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294 (336)
T ss_dssp HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHH
Confidence 89999999999999999887755443333222111111100000000000000000 00000 0012456789999999
Q ss_pred hcCCCCCCCCCHHHHHHHHHHHHHhhcCC
Q 044155 211 CIKDSPADRPSMVDVAKKLRQIYRSLSCN 239 (239)
Q Consensus 211 cl~~dp~~Rps~~ell~~L~~l~~~~~~~ 239 (239)
||+.||++|||+.|+++.|+++...+..|
T Consensus 295 cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 295 CWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp HSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999888765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=280.20 Aligned_cols=217 Identities=14% Similarity=0.131 Sum_probs=166.8
Q ss_pred CCCCcccceeeEEEEeC----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLET----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+++||||+++++++... ...++||||+ +++|.+++.... ..+++..+..++.|++.||.||| +.+|+|
T Consensus 104 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~iiH 175 (364)
T 3op5_A 104 KLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIH---EHEYVH 175 (364)
T ss_dssp TCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred hccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEE
Confidence 46899999999999865 3478999999 899999998753 56899999999999999999999 899999
Q ss_pred ccccCcceeec--CCCceeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 77 RNFKTSCILFN--EENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 77 ~dlk~~nil~~--~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
|||||+|||++ .++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 255 (364)
T 3op5_A 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255 (364)
T ss_dssp CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999 889999999999976532211 1123445899999999999988999999999999999999
Q ss_pred cCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 149 TGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 149 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
+|..||........... ..... .........+..+.. ...+..+.+++..||..||.+|||+.++++.
T Consensus 256 ~g~~Pf~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 256 TGHLPWEDNLKDPKYVR----DSKIR-YRENIASLMDKCFPA-------ANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HSCCTTGGGTTCHHHHH----HHHHH-HHHCHHHHHHHHSCT-------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred hCCCCccccccCHHHHH----HHHHH-hhhhHHHHHHHhccc-------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 99999974322111100 00000 000111111111100 1235678999999999999999999999999
Q ss_pred HHHHHHhhc
Q 044155 229 LRQIYRSLS 237 (239)
Q Consensus 229 L~~l~~~~~ 237 (239)
|++++....
T Consensus 324 l~~~~~~~~ 332 (364)
T 3op5_A 324 LLQGLKAIG 332 (364)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHcC
Confidence 999988754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=273.33 Aligned_cols=220 Identities=22% Similarity=0.399 Sum_probs=163.1
Q ss_pred CCCcccceeeEEEEeC----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC-----
Q 044155 2 MSHNHILKLIGCCLET----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR----- 72 (239)
Q Consensus 2 l~H~niv~l~~~~~~~----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~----- 72 (239)
++||||+++++++... ...++||||+++++|.++++. ..++...+..++.|++.||.||| ..
T Consensus 88 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~ 158 (337)
T 3mdy_A 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQ 158 (337)
T ss_dssp CCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTT
T ss_pred hcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---Hhhhhhc
Confidence 5899999999999887 678999999999999999976 45889999999999999999999 77
Q ss_pred ---CeeeccccCcceeecCCCceeEcccccccccCCCCcc---eeecccccccccCccccccCCcccc------cchhhh
Q 044155 73 ---PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRTGVFNEK------SNVFSF 140 (239)
Q Consensus 73 ---~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~------~Di~sl 140 (239)
+++|+||||+||+++.++.+||+|||++......... ......||+.|+|||++.+...... +|||||
T Consensus 159 ~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp CBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred cCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 9999999999999999999999999998765332211 1234568999999999987765554 999999
Q ss_pred hhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhc----CCC-cHHHHHHHHHHHHHHhhhcCCC
Q 044155 141 SVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE----DVS-SIEKEQQLHASAQVTFECIKDS 215 (239)
Q Consensus 141 G~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~li~~cl~~d 215 (239)
|+++|+|++|..|+....... .++..... ............... ... .......++.+.+++.+||+.|
T Consensus 239 G~il~el~tg~~~~~~~~~~~---~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 312 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQ---LPYHDLVP---SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCC---CTTTTTSC---SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHhccCccccccccc---ccHhhhcC---CCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhC
Confidence 999999999965553222111 11110000 000111111111111 111 1112367788999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHhh
Q 044155 216 PADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 216 p~~Rps~~ell~~L~~l~~~~ 236 (239)
|.+|||+.++++.|+++.++.
T Consensus 313 P~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 313 PASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp GGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhCCCHHHHHHHHHHHHhhc
Confidence 999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=273.14 Aligned_cols=207 Identities=23% Similarity=0.371 Sum_probs=162.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 67 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlk 138 (294)
T 4eqm_A 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIK 138 (294)
T ss_dssp TCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred cCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 478999999999999999999999999999999999875 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++...............||+.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 139 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~ 218 (294)
T 4eqm_A 139 PQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218 (294)
T ss_dssp GGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH
T ss_pred HHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999998765443333344566899999999999988999999999999999999999998643210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHH---HHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHHHHhh
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE---KEQQLHASAQVTFECIKDSPADRP-SMVDVAKKLRQIYRSL 236 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~l~~~~ 236 (239)
............... ....++.+.+++.+||+.||.+|| +++++.+.|..+..+-
T Consensus 219 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 219 ---------------------SIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp ---------------------HHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred ---------------------HHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 000011111111110 113457789999999999999999 8999999998766543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=277.19 Aligned_cols=223 Identities=23% Similarity=0.350 Sum_probs=163.9
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.. ....++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|
T Consensus 67 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 139 (295)
T 3ugc_A 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRD 139 (295)
T ss_dssp TCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred hCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHh---cCCcccCC
Confidence 4789999999999864 356899999999999999998753 45899999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++|..|+..
T Consensus 140 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 140 LATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp CSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred CCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 999999999999999999999876543221 122334567789999999989999999999999999999999888754
Q ss_pred ccccccccccchhhhhhh-hhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 157 VKDVHDLVCPFSEYLKNC-FEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
....... ..... ........... ..........+...++.+.+++.+||+.||.+|||+.|+++.|+++.++
T Consensus 220 ~~~~~~~------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 220 PPAEFMR------MIGNDKQGQMIVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHH------HHCTTCCTHHHHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ChHHHHh------hhcCccccchhHHHHHH-HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 3211000 00000 00000001111 1111111112235567899999999999999999999999999999877
Q ss_pred hc
Q 044155 236 LS 237 (239)
Q Consensus 236 ~~ 237 (239)
+.
T Consensus 293 l~ 294 (295)
T 3ugc_A 293 MA 294 (295)
T ss_dssp --
T ss_pred cc
Confidence 53
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=271.02 Aligned_cols=206 Identities=23% Similarity=0.313 Sum_probs=154.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++ ..+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 72 ~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 143 (281)
T 1mp8_A 72 QFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIA 143 (281)
T ss_dssp TCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccc
Confidence 47899999999998 4566889999999999999998653 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 144 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 144 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp GGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred HHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 999999999999999999987664433223334456788999999998889999999999999999996 8888864321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
. +.......... ...+...++.+.+++.+||+.||.+|||+.++++.|+++.++.
T Consensus 224 ~---------------------~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 224 N---------------------DVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp G---------------------GHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H---------------------HHHHHHHcCCC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 01111111100 0011244567899999999999999999999999999988764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=270.09 Aligned_cols=205 Identities=18% Similarity=0.338 Sum_probs=165.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dik 131 (268)
T 3sxs_A 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131 (268)
T ss_dssp HCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCS
T ss_pred hCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcC
Confidence 3789999999999999999999999999999999997642 45899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 132 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp GGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 999999999999999999987664443333334456778999999998889999999999999999999 8888754321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
. +.......... ...+...++.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 212 ~---------------------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 212 S---------------------EVVLKVSQGHR-LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp H---------------------HHHHHHHTTCC-CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred H---------------------HHHHHHHcCCC-CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1 11111111100 00011234578899999999999999999999999988754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=293.26 Aligned_cols=206 Identities=22% Similarity=0.384 Sum_probs=166.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++|+|.++++.... ..++...+..++.|++.||.||| +++++|||||
T Consensus 272 ~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlk 345 (495)
T 1opk_A 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLA 345 (495)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 37899999999999999999999999999999999987543 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+|||++.++.+||+|||+++..............+++.|+|||++....++.++||||||+++|||++ |..||.....
T Consensus 346 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 346 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp GGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654333222233446788999999998889999999999999999999 8888864321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
. +.... +........+...+..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 426 ~---------------------~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 426 S---------------------QVYEL-LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp G---------------------GHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred H---------------------HHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0 00100 01111111112445778999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=271.39 Aligned_cols=207 Identities=18% Similarity=0.358 Sum_probs=166.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+|||
T Consensus 75 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dik 147 (283)
T 3gen_A 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147 (283)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCS
T ss_pred cCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCc
Confidence 4789999999999999999999999999999999997642 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 148 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp GGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999999987654332222233446778999999998889999999999999999998 9888754321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
. +........ .....+...++.+.+++.+||+.||.+|||+.++++.|.++..+-
T Consensus 228 ~---------------------~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 228 S---------------------ETAEHIAQG-LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp H---------------------HHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred h---------------------HHHHHHhcc-cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 0 111111110 000011123467889999999999999999999999999988753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=269.34 Aligned_cols=209 Identities=21% Similarity=0.328 Sum_probs=158.1
Q ss_pred CCCcccceeeEEEEeC----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCC-----CC
Q 044155 2 MSHNHILKLIGCCLET----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF-----PR 72 (239)
Q Consensus 2 l~H~niv~l~~~~~~~----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----~~ 72 (239)
++||||+++++++... ...++||||+++++|.++++. ..+++..+..++.|++.||+|||... +.
T Consensus 59 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 132 (301)
T 3q4u_A 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132 (301)
T ss_dssp CCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred ccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 7899999999997653 357899999999999999954 46889999999999999999999311 46
Q ss_pred CeeeccccCcceeecCCCceeEcccccccccCCCCcc---eeecccccccccCccccccC------CcccccchhhhhhH
Q 044155 73 PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRTG------VFNEKSNVFSFSVF 143 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~ 143 (239)
+++|+||||+||+++.++.+||+|||++......... ......||+.|+|||++.+. .++.++||||||++
T Consensus 133 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~i 212 (301)
T 3q4u_A 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212 (301)
T ss_dssp EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHH
T ss_pred CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHH
Confidence 8999999999999999999999999998765433221 12334689999999999876 45679999999999
Q ss_pred HHHHhcC----------CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhc----CC-CcHHHHHHHHHHHHHH
Q 044155 144 LFELLTG----------WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE----DV-SSIEKEQQLHASAQVT 208 (239)
Q Consensus 144 l~~~~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~li 208 (239)
+|+|++| ..||........ ............ .. ........+..+.+++
T Consensus 213 l~el~tg~~~~~~~~~~~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 276 (301)
T 3q4u_A 213 LWEVARRMVSNGIVEDYKPPFYDVVPNDP----------------SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276 (301)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSC----------------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHH
T ss_pred HHHHHhhhcCccccccccccccccCCCCc----------------chhhhhHHHhccCCCCCCChhhccCccHHHHHHHH
Confidence 9999999 444432211110 000000000000 00 0111235678899999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 209 FECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 209 ~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
.+||+.||.+|||+.++++.|+++
T Consensus 277 ~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 277 KECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcChhhCCCHHHHHHHHhcc
Confidence 999999999999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=272.99 Aligned_cols=210 Identities=22% Similarity=0.374 Sum_probs=167.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-------------------CCCcCCHHHHHHHHHHHHH
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-------------------HFEPLLLKHRLKIAMDIVH 61 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~~~~~~~~~i~~ 61 (239)
+++||||+++++++.+.+..++||||+++++|.+++...... ....++...+..++.|++.
T Consensus 82 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 161 (314)
T 2ivs_A 82 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQ 161 (314)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHH
T ss_pred hCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHH
Confidence 478999999999999999999999999999999999875321 0134889999999999999
Q ss_pred HHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhh
Q 044155 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSF 140 (239)
Q Consensus 62 ~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 140 (239)
||.||| +++++|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||
T Consensus 162 ~l~~lH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 162 GMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp HHHHHH---HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHH---HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 999999 89999999999999999999999999999876543322 12234456788999999998889999999999
Q ss_pred hhHHHHHhc-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 141 SVFLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 141 G~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
|+++|+|++ |..||...... .......... ....+...++.+.+++.+||+.||.+|
T Consensus 239 G~il~el~t~g~~p~~~~~~~---------------------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R 296 (314)
T 2ivs_A 239 GVLLWEIVTLGGNPYPGIPPE---------------------RLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKR 296 (314)
T ss_dssp HHHHHHHHTTSCCSSTTCCGG---------------------GHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHhCCCCCCCCCCHH---------------------HHHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhC
Confidence 999999999 98888543210 0000000000 001112445678999999999999999
Q ss_pred CCHHHHHHHHHHHHHh
Q 044155 220 PSMVDVAKKLRQIYRS 235 (239)
Q Consensus 220 ps~~ell~~L~~l~~~ 235 (239)
||+.++++.|+++...
T Consensus 297 ps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 297 PVFADISKDLEKMMVK 312 (314)
T ss_dssp CCHHHHHHHHHHHHHT
T ss_pred cCHHHHHHHHHHHHhh
Confidence 9999999999998765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=266.97 Aligned_cols=213 Identities=12% Similarity=0.055 Sum_probs=168.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+|+||+++++++.+....++||||+ +++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+
T Consensus 64 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~ 135 (298)
T 1csn_A 64 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPD 135 (298)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGG
T ss_pred cCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHH
Confidence 7999999999999999999999999 899999998653 46899999999999999999999 999999999999
Q ss_pred ceeecCCCc-----eeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 83 CILFNEENV-----AKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 83 nil~~~~~~-----~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
||+++.++. ++|+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 136 NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 215 (298)
T 1csn_A 136 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215 (298)
T ss_dssp GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC
Confidence 999987765 99999999876543221 1234556899999999999888999999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||.......... ... ...... ............++.+.+++.+||+.||.+|||+++|++.|++
T Consensus 216 ~pf~~~~~~~~~~-----~~~---------~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 216 LPWQGLKAATNKQ-----KYE---------RIGEKK-QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp CTTSSCCSCCHHH-----HHH---------HHHHHH-HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CCcchhhccccHH-----HHH---------HHHhhc-cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 9987543211100 000 000000 0000000111345778999999999999999999999999999
Q ss_pred HHHhhcC
Q 044155 232 IYRSLSC 238 (239)
Q Consensus 232 l~~~~~~ 238 (239)
+.+++..
T Consensus 281 ~~~~~~~ 287 (298)
T 1csn_A 281 VLERLNT 287 (298)
T ss_dssp HHHHTTC
T ss_pred HHHhcCC
Confidence 9987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=285.13 Aligned_cols=203 Identities=26% Similarity=0.370 Sum_probs=162.9
Q ss_pred CCCCcccceeeEEEEeCC-CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~-~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||+++++++.+.. ..++||||+++|+|.+++..... ..++...+..++.|++.||+||| +++++||||
T Consensus 242 ~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDl 315 (450)
T 1k9a_A 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDL 315 (450)
T ss_dssp TCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred hccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCC
Confidence 579999999999987765 78999999999999999987532 34789999999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
||+|||++.++.+||+|||+++..... .....+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 316 kp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 316 AARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred CHhhEEECCCCCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998754222 123356889999999999999999999999999999998 988886432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.. +.......+ .....+...++.+.++|.+||+.||.+|||+.++++.|+++...
T Consensus 392 ~~---------------------~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 392 LK---------------------DVVPRVEKG-YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TT---------------------THHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH---------------------HHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11 111111111 11111124567889999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=270.85 Aligned_cols=208 Identities=22% Similarity=0.384 Sum_probs=169.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 65 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dik 138 (288)
T 3kfa_A 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLA 138 (288)
T ss_dssp HCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCS
T ss_pred hCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCC
Confidence 37899999999999999999999999999999999987543 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 139 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 139 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp GGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred cceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987665443333444557788999999998899999999999999999999 8888754321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
. ...+.+.. ......+...++.+.+++.+||..||.+|||+.++++.|+++..+.
T Consensus 219 ~------------------~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 219 S------------------QVYELLEK----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp G------------------GHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H------------------HHHHHHhc----cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 00011111 1111111234567899999999999999999999999999987754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=273.14 Aligned_cols=220 Identities=24% Similarity=0.322 Sum_probs=166.4
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.+. ...++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|
T Consensus 79 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~d 151 (302)
T 4e5w_A 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRD 151 (302)
T ss_dssp TCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred hCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCC
Confidence 47899999999999876 56789999999999999996543 46889999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++|..|+..
T Consensus 152 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 152 LAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 999999999999999999999876644322 223345678889999999988899999999999999999999888643
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
....... ................ ..........+...++.+.+++.+||+.||.+|||+.++++.|+++++
T Consensus 232 ~~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 232 PMALFLK------MIGPTHGQMTVTRLVN-TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHH------HHCSCCGGGHHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred hhhHHhh------ccCCcccccCHHHHHH-HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 2110000 0000000111111111 111111111122456789999999999999999999999999998863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=279.28 Aligned_cols=209 Identities=22% Similarity=0.350 Sum_probs=167.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++.+.+..++||||+++++|.+++...... ....+++..+..++.|++.||.||| +
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 209 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---S 209 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---h
Confidence 8999999999999999999999999999999999875421 1135899999999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
.+++|+||||+||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 210 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876543221 22334456889999999999899999999999999999999
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||..... .+......... ....+...+..+.+++.+||+.||.+|||+.|+++.|
T Consensus 290 g~~p~~~~~~---------------------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 290 GGSPYPGVPV---------------------EELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp SCCSSTTCCH---------------------HHHHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCH---------------------HHHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 8888753221 11111111110 0001123456789999999999999999999999999
Q ss_pred HHHHHhh
Q 044155 230 RQIYRSL 236 (239)
Q Consensus 230 ~~l~~~~ 236 (239)
+++....
T Consensus 348 ~~~~~~~ 354 (382)
T 3tt0_A 348 DRIVALT 354 (382)
T ss_dssp HHHHHHS
T ss_pred HHHHHHH
Confidence 9988654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=274.60 Aligned_cols=196 Identities=21% Similarity=0.284 Sum_probs=161.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+++|+|||
T Consensus 71 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlk 142 (361)
T 2yab_A 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142 (361)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCC
Confidence 478999999999999999999999999999999999764 56899999999999999999999 8999999999
Q ss_pred CcceeecCCC----ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEEN----VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 143 p~NIll~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp GGGEEESCTTSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred HHHEEEeCCCCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999998877 79999999997654332 22345689999999999988899999999999999999999999854
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .+....+..... ........+..++++|.+||..||.+|||+.|+++
T Consensus 221 ~~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 221 DTK---------------------QETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp SSH---------------------HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCH---------------------HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 221 111112211111 11122345677899999999999999999999985
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=275.06 Aligned_cols=193 Identities=21% Similarity=0.313 Sum_probs=159.8
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++||||||
T Consensus 71 l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp 142 (328)
T 3fe3_A 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKA 142 (328)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred CCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCH
Confidence 68999999999999999999999999999999999775 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcc-cccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFN-EKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+||+++.++.+||+|||++....... ......||+.|+|||++.+..+. .++||||||+++|+|++|..||....
T Consensus 143 ~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-- 218 (328)
T 3fe3_A 143 ENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-- 218 (328)
T ss_dssp GGEEECTTSCEEECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred HHEEEcCCCCEEEeeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--
Confidence 99999999999999999987654332 23456789999999999887764 78999999999999999999985422
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+............+ ...++.+.+++.+||..||.+|||++|+++
T Consensus 219 -------------------~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 219 -------------------LKELRERVLRGKYRIP--FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -------------------HHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -------------------HHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1122222222222111 134567889999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=271.78 Aligned_cols=196 Identities=15% Similarity=0.252 Sum_probs=161.7
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||
T Consensus 58 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp 130 (321)
T 1tki_A 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRP 130 (321)
T ss_dssp SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred CCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCH
Confidence 689999999999999999999999999999999997642 46899999999999999999999 89999999999
Q ss_pred cceeecC--CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 82 SCILFNE--ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 82 ~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
+||+++. ++.+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 131 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 131 ENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp GGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HHEEEccCCCCCEEEEECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 9999987 7899999999997764432 23455689999999999988889999999999999999999999853221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSS--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+....+....... ......+..+.+++.+||..||.+|||+.|+++
T Consensus 209 ---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 209 ---------------------QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---------------------HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------------------HHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11222222222211 112245678899999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=265.27 Aligned_cols=201 Identities=20% Similarity=0.353 Sum_probs=160.8
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC--eee
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--i~H 76 (239)
+++||||+++++++.+. ...++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+ ++|
T Consensus 63 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H 136 (271)
T 3kmu_A 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLH---TLEPLIPR 136 (271)
T ss_dssp CCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTT
T ss_pred hcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCceec
Confidence 47899999999999877 678999999999999999987532 35899999999999999999999 888 999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCccc---ccchhhhhhHHHHHhcCCCC
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNE---KSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~l~~~~~g~~p 153 (239)
+||||+||+++.++.++++|||++..... ....+|+.|+|||.+.+...+. ++||||||+++|+|++|..|
T Consensus 137 ~dikp~Nil~~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 210 (271)
T 3kmu_A 137 HALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210 (271)
T ss_dssp CCCSGGGEEECTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred CCCccceEEEcCCcceeEEeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999998887654322 2345789999999998765544 79999999999999999999
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
|..... .+..............+...++.+.+++.+||+.||.+|||++++++.|+++.
T Consensus 211 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 211 FADLSN---------------------MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TTTSCH---------------------HHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccccCh---------------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 853321 11111111111111112245567899999999999999999999999999875
Q ss_pred H
Q 044155 234 R 234 (239)
Q Consensus 234 ~ 234 (239)
+
T Consensus 270 ~ 270 (271)
T 3kmu_A 270 D 270 (271)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=278.39 Aligned_cols=206 Identities=19% Similarity=0.289 Sum_probs=155.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 102 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk 174 (373)
T 2qol_A 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLA 174 (373)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCC
Confidence 5799999999999999999999999999999999998653 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++||+++ |..||...
T Consensus 175 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 175 ARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp GGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred cceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998765432211 1122235678999999998899999999999999999998 98887543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.. .+......... ....+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 255 ~~---------------------~~~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 255 SN---------------------QDVIKAVDEGY-RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CH---------------------HHHHHHHHTTE-ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CH---------------------HHHHHHHHcCC-CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 21 01111111110 0000113456789999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=267.25 Aligned_cols=206 Identities=23% Similarity=0.383 Sum_probs=165.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 59 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 131 (267)
T 3t9t_A 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131 (267)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCC
T ss_pred hCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCc
Confidence 4789999999999999999999999999999999998653 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 132 p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (267)
T 3t9t_A 132 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211 (267)
T ss_dssp GGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred hheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH
Confidence 999999999999999999987654322222234456788999999998889999999999999999999 8888753221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.+......... ....+...+..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 212 ---------------------~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 212 ---------------------SEVVEDISTGF-RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ---------------------HHHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------------------HHHHHHHhcCC-cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 01111111110 0001113356788999999999999999999999999998763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=289.91 Aligned_cols=206 Identities=21% Similarity=0.361 Sum_probs=164.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++. ....++||||+++|+|.++++.... ..++...+..++.|++.||.||| +++++|||||
T Consensus 239 ~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlk 311 (454)
T 1qcf_A 239 TLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLR 311 (454)
T ss_dssp TCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCS
T ss_pred hCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCC
Confidence 479999999999986 5678999999999999999975422 35788899999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+|||++.++.+||+|||+++..............+++.|+|||++....++.++||||||+++|||++ |..||.....
T Consensus 312 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp GGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred HHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997654322222223346788999999998899999999999999999999 9888854321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.+........ .....+...++.+.++|.+||+.||.+|||+++|++.|+++...
T Consensus 392 ---------------------~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 392 ---------------------PEVIRALERG-YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ---------------------HHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ---------------------HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111111 11111124567789999999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=270.36 Aligned_cols=208 Identities=16% Similarity=0.136 Sum_probs=166.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++..+...++||||+ +++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+
T Consensus 63 ~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~ 134 (330)
T 2izr_A 63 SGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPE 134 (330)
T ss_dssp SCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred CCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHH
Confidence 8999999999999999999999999 899999998652 56899999999999999999999 899999999999
Q ss_pred ceeecCCCc-----eeEcccccccccCCCCcc------eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 83 CILFNEENV-----AKLFDFSLSISIPEGETH------ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 83 nil~~~~~~-----~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
||+++.++. ++|+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 135 Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 214 (330)
T 2izr_A 135 NFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214 (330)
T ss_dssp GEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCC
Confidence 999999887 999999999765332211 124567899999999999999999999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhc--CCCcH-HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE--DVSSI-EKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
.||....... ..+....+... ..... .....+ .+.+++..||+.||.+||+++++.+.
T Consensus 215 ~Pf~~~~~~~------------------~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~ 275 (330)
T 2izr_A 215 LPWQGLKADT------------------LKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKL 275 (330)
T ss_dssp CTTTTCCCSS------------------HHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CCcccccccc------------------HHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHH
Confidence 9986542110 00111111000 00000 001133 79999999999999999999999999
Q ss_pred HHHHHHhhc
Q 044155 229 LRQIYRSLS 237 (239)
Q Consensus 229 L~~l~~~~~ 237 (239)
|+++.....
T Consensus 276 l~~~~~~~~ 284 (330)
T 2izr_A 276 FTDLFDRKG 284 (330)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHcC
Confidence 999987653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=274.01 Aligned_cols=205 Identities=19% Similarity=0.316 Sum_probs=162.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++. .++|+|++.+|+|.+++.... ..++...+..++.|++.||.||| +++++|||||
T Consensus 73 ~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dik 144 (327)
T 3poz_A 73 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLA 144 (327)
T ss_dssp HCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCC
Confidence 378999999999998755 778999999999999998753 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 145 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 145 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp GGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred hheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 9999999999999999999876643322 12234456789999999999999999999999999999999 988886432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.. .....+... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 225 ~~------------------~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 225 AS------------------EISSILEKG----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GG------------------GHHHHHHTT----CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HH------------------HHHHHHHcC----CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 10 001111111 00111123456788999999999999999999999999988653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=275.14 Aligned_cols=210 Identities=20% Similarity=0.335 Sum_probs=164.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCC------------------CCcCCHHHHHHHHHHHHHHHh
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPH------------------FEPLLLKHRLKIAMDIVHALA 64 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~------------------~~~~~~~~~~~~~~~i~~~l~ 64 (239)
+||||+++++++...+..++||||+++++|.+++....... ...+++..+..++.|++.||.
T Consensus 107 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 186 (344)
T 1rjb_A 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 186 (344)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999999998753210 123789999999999999999
Q ss_pred HHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhH
Q 044155 65 YLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVF 143 (239)
Q Consensus 65 ~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 143 (239)
||| +.+++|+||||+||+++.++.++|+|||++....... ........+|+.|+|||.+.+..++.++||||||++
T Consensus 187 ~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 263 (344)
T 1rjb_A 187 FLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263 (344)
T ss_dssp HHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHH---hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHH
Confidence 999 8999999999999999999999999999987553322 222344557889999999988889999999999999
Q ss_pred HHHHhc-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 144 LFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 144 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
+|+|++ |..||........ ..... ........+...++.+.+++.+||+.||.+|||+
T Consensus 264 l~el~t~g~~p~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 264 LWEIFSLGVNPYPGIPVDAN-----------------FYKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp HHHHTTTSCCSSTTCCCSHH-----------------HHHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHcCCCCCcccCCcHHH-----------------HHHHH----hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 999998 9888864331110 00111 1111111112345678999999999999999999
Q ss_pred HHHHHHHHHHHHhh
Q 044155 223 VDVAKKLRQIYRSL 236 (239)
Q Consensus 223 ~ell~~L~~l~~~~ 236 (239)
.++++.|+.+....
T Consensus 323 ~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 323 PNLTSFLGCQLADA 336 (344)
T ss_dssp HHHHHHHHHHC---
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=265.59 Aligned_cols=219 Identities=24% Similarity=0.415 Sum_probs=168.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++...... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlk 160 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIK 160 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCC
Confidence 368999999999999999999999999999999998754221 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++........ .......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.....
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 9999999999999999999876543222 22334568999999998864 578999999999999999999999875443
Q ss_pred cccccccchhhhhhhhh-ccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFE-DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
..... ........ .......+ ..... ......+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 240 ~~~~~----~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 240 PQLLL----DIKEEIEDEEKTIEDYI----DKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSBTT----HHHHHHHTTSCCHHHHS----CSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHH----HHHHHhhhhhhhhhhhc----ccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 21111 11111110 11111111 11111 1123567789999999999999999999999999998864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=275.08 Aligned_cols=207 Identities=15% Similarity=0.127 Sum_probs=161.7
Q ss_pred CCCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+++||||+++++++.. ....++||||+ +++|.+++... ..+++..+..++.|++.||+||| +.+++|
T Consensus 104 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH 174 (345)
T 2v62_A 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIH---ENEYVH 174 (345)
T ss_dssp TCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred cccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeC
Confidence 3689999999999987 67789999999 89999999765 47899999999999999999999 899999
Q ss_pred ccccCcceeecCCC--ceeEcccccccccCCCC------cceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 77 RNFKTSCILFNEEN--VAKLFDFSLSISIPEGE------THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 77 ~dlk~~nil~~~~~--~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
+||||+||+++.++ .+||+|||+++...... ........|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 175 ~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 254 (345)
T 2v62_A 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254 (345)
T ss_dssp SCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999887 99999999997653221 11123456899999999999888999999999999999999
Q ss_pred cCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHH-----HHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 149 TGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEK-----EQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 149 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
+|..||.......... ................ ...+..+.+++.+||+.||.+|||++
T Consensus 255 ~g~~pf~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 317 (345)
T 2v62_A 255 CGKLPWEQNLKDPVAV-----------------QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQ 317 (345)
T ss_dssp HSSCTTGGGTTCHHHH-----------------HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred hCCCCccccccccHHH-----------------HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHH
Confidence 9999985321110000 0000000001110000 03456789999999999999999999
Q ss_pred HHHHHHHHHH
Q 044155 224 DVAKKLRQIY 233 (239)
Q Consensus 224 ell~~L~~l~ 233 (239)
++++.|+++.
T Consensus 318 ~l~~~L~~~~ 327 (345)
T 2v62_A 318 ALKKILNPHG 327 (345)
T ss_dssp HHHHHHCTTC
T ss_pred HHHHHHhccC
Confidence 9999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=270.15 Aligned_cols=195 Identities=19% Similarity=0.274 Sum_probs=160.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++|+|.+++... ..+++..++.++.||+.||.||| +++|+|||||
T Consensus 61 ~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlk 132 (337)
T 1o6l_A 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIK 132 (337)
T ss_dssp SCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCC
T ss_pred hCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCC
Confidence 478999999999999999999999999999999999765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 133 p~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-- 209 (337)
T 1o6l_A 133 LENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-- 209 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCBCSCCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred HHHEEECCCCCEEEeeccchhhcccC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--
Confidence 99999999999999999998753222 122345679999999999999899999999999999999999999985322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.......+....... +...++.+.++|.+||+.||.+|| +++|+++
T Consensus 210 -------------------~~~~~~~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 210 -------------------HERLFELILMEEIRF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------------------HHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------------------HHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111111111111111 123456789999999999999999 8999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=271.67 Aligned_cols=211 Identities=19% Similarity=0.356 Sum_probs=167.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-------------CCCcCCHHHHHHHHHHHHHHHhHHhhC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-------------HFEPLLLKHRLKIAMDIVHALAYLHFG 69 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~LH~~ 69 (239)
+||||+++++++.+.+..++||||+++++|.+++...... ....+++..+..++.|++.||.|||
T Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-- 162 (313)
T 1t46_A 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-- 162 (313)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred cCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--
Confidence 8999999999999999999999999999999999875421 0124889999999999999999999
Q ss_pred CCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 70 FPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 70 ~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
+.+++|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 163 -~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 241 (313)
T 1t46_A 163 -SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (313)
T ss_dssp -HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999876543322 1233455778899999998889999999999999999999
Q ss_pred c-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 149 T-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 149 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+ |..||........ ....... ......+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 242 t~g~~p~~~~~~~~~-----------------~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 242 SLGSSPYPGMPVDSK-----------------FYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp TTTCCSSTTCCSSHH-----------------HHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCcccchhH-----------------HHHHhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9 8888864321100 0011111 0111111234567899999999999999999999999
Q ss_pred HHHHHHHhhc
Q 044155 228 KLRQIYRSLS 237 (239)
Q Consensus 228 ~L~~l~~~~~ 237 (239)
.|+++..+..
T Consensus 301 ~L~~~~~~~~ 310 (313)
T 1t46_A 301 LIEKQISEST 310 (313)
T ss_dssp HHHHHHHHTC
T ss_pred HHHHHHHHhh
Confidence 9999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=266.54 Aligned_cols=205 Identities=22% Similarity=0.325 Sum_probs=163.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++ ..+..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 74 ~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dik 144 (291)
T 1xbb_A 74 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLA 144 (291)
T ss_dssp TCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCC
Confidence 47899999999999 666789999999999999999875 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 145 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 145 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999998765433221 1223345688999999988889999999999999999999 98888643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
... +......... ....+...+..+.+++.+||+.||.+|||+.++++.|++++.+.
T Consensus 225 ~~~---------------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 225 KGS---------------------EVTAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CHH---------------------HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHH---------------------HHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 210 0111111110 01111244567899999999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=274.02 Aligned_cols=205 Identities=20% Similarity=0.331 Sum_probs=160.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++. ....++||||+.+++|.+++.... ..+++..+..++.|++.||.||| +.+++|||||
T Consensus 71 ~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dik 142 (325)
T 3kex_A 71 SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLA 142 (325)
T ss_dssp TCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred cCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccc
Confidence 478999999999986 456889999999999999997653 46888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 143 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 143 ARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp STTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred hheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 9999999999999999999987643322 22344567789999999998899999999999999999999 999986432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.. .....+....... .+...+..+.+++.+||..||.+|||+.++++.|+++...
T Consensus 223 ~~------------------~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 223 LA------------------EVPDLLEKGERLA----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TT------------------HHHHHHHTTCBCC----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HH------------------HHHHHHHcCCCCC----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 10 0001111000000 0112344578899999999999999999999999988653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=278.81 Aligned_cols=209 Identities=20% Similarity=0.344 Sum_probs=164.7
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC--CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP--HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
++||||+++++++.+....++||||+++|+|.+++...... ....++...++.++.|++.||.||| +++|+||||
T Consensus 131 l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDl 207 (367)
T 3l9p_A 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDI 207 (367)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred CCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCC
Confidence 68999999999999999999999999999999999865321 1145889999999999999999999 899999999
Q ss_pred cCcceeecCCC---ceeEcccccccccCC-CCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCc
Q 044155 80 KTSCILFNEEN---VAKLFDFSLSISIPE-GETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVS 154 (239)
Q Consensus 80 k~~nil~~~~~---~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~ 154 (239)
||+|||++.++ .+||+|||+++.... ..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 208 kp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf 287 (367)
T 3l9p_A 208 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287 (367)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999555 599999999875421 11122335567889999999998899999999999999999998 88887
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
..... .+.......... ...+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 288 ~~~~~---------------------~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 288 PSKSN---------------------QEVLEFVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TTCCH---------------------HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCH---------------------HHHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 53221 111111111110 00112345678899999999999999999999999998765
Q ss_pred h
Q 044155 235 S 235 (239)
Q Consensus 235 ~ 235 (239)
.
T Consensus 346 ~ 346 (367)
T 3l9p_A 346 D 346 (367)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=276.49 Aligned_cols=210 Identities=21% Similarity=0.367 Sum_probs=164.0
Q ss_pred CCcccceeeEEEEeCC-CceEEEEEccCCChhhhhhcCCCCC--------------------------------------
Q 044155 3 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPH-------------------------------------- 43 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~-~~~iv~e~~~~~sL~~~l~~~~~~~-------------------------------------- 43 (239)
+||||+++++++.+.+ ..++||||+++|+|.+++.......
T Consensus 84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (359)
T 3vhe_A 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163 (359)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence 7999999999998765 4899999999999999998753210
Q ss_pred -----------------------CCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccc
Q 044155 44 -----------------------FEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS 100 (239)
Q Consensus 44 -----------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~ 100 (239)
...+++..+..++.|++.||+||| +++++|+||||+||+++.++.++|+|||++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 240 (359)
T 3vhe_A 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLA 240 (359)
T ss_dssp --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccce
Confidence 012889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccccccccccchhhhhhhhhcc
Q 044155 101 ISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDN 178 (239)
Q Consensus 101 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (239)
....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 241 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------- 304 (359)
T 3vhe_A 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------------- 304 (359)
T ss_dssp SCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----------------
T ss_pred eeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----------------
Confidence 7653322 223345567889999999998899999999999999999998 9888854321100
Q ss_pred chhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
.............+...++.+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 305 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 305 -----FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -----HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 00000110001111234567899999999999999999999999999988753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=274.60 Aligned_cols=212 Identities=24% Similarity=0.354 Sum_probs=165.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-------------------CCCcCCHHHHHHHHHHHHH
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-------------------HFEPLLLKHRLKIAMDIVH 61 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~~~~~~~~~i~~ 61 (239)
+++||||+++++++.+....++||||+++++|.+++...... ....+++..++.++.|++.
T Consensus 106 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 185 (343)
T 1luf_A 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185 (343)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHH
T ss_pred hCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHH
Confidence 478999999999999999999999999999999999874311 0146889999999999999
Q ss_pred HHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhh
Q 044155 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSF 140 (239)
Q Consensus 62 ~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 140 (239)
||.||| +++++|+||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||
T Consensus 186 ~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 186 GMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp HHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHH---hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence 999999 89999999999999999999999999999876532211 12234557889999999998889999999999
Q ss_pred hhHHHHHhc-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 141 SVFLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 141 G~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
|+++|+|++ |..||..... .+........... ..+...+..+.+++.+||+.||.+|
T Consensus 263 G~il~el~t~g~~p~~~~~~---------------------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~R 320 (343)
T 1luf_A 263 GVVLWEIFSYGLQPYYGMAH---------------------EEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADR 320 (343)
T ss_dssp HHHHHHHHTTTCCTTTTSCH---------------------HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHhcCCCcCCCCCh---------------------HHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccC
Confidence 999999999 8888753221 1111111111110 0112345678999999999999999
Q ss_pred CCHHHHHHHHHHHHHhhc
Q 044155 220 PSMVDVAKKLRQIYRSLS 237 (239)
Q Consensus 220 ps~~ell~~L~~l~~~~~ 237 (239)
||+.++++.|+++.....
T Consensus 321 ps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 321 PSFCSIHRILQRMCERAE 338 (343)
T ss_dssp CCHHHHHHHHHHTTC---
T ss_pred CCHHHHHHHHHHHHhhhh
Confidence 999999999999876653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=280.61 Aligned_cols=197 Identities=22% Similarity=0.307 Sum_probs=160.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+|||||
T Consensus 66 ~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlK 137 (444)
T 3soa_A 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLK 137 (444)
T ss_dssp HCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCS
T ss_pred hCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 378999999999999999999999999999999999876 56899999999999999999999 8999999999
Q ss_pred Ccceeec---CCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++ .++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 138 p~NIll~~~~~~~~vkL~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp STTEEESBSSTTCCEEECCCSSCBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HHHEEEeccCCCCcEEEccCceeEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 9999998 45789999999997654322 1223457899999999999889999999999999999999999998532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+....+..+... .......++.+.++|.+||+.||.+|||+.|+++
T Consensus 217 ~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 217 DQ---------------------HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp SH---------------------HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cH---------------------HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 21 1111111111111 1111244577899999999999999999999987
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=287.79 Aligned_cols=206 Identities=24% Similarity=0.346 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+ ...++||||+++|+|.+++..... ..++...+..++.|++.||+||| +++++|||||
T Consensus 235 ~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlk 307 (452)
T 1fmk_A 235 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 307 (452)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCC
Confidence 3789999999999866 678999999999999999975322 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+|||++.++.+||+|||++...............+++.|+|||.+....++.++||||||+++|+|++ |..||.....
T Consensus 308 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp GGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654332222334456788999999998899999999999999999999 8888854321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.+.......+ .....+...+..+.++|.+||+.||.+|||++++++.|+++..+
T Consensus 388 ---------------------~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 388 ---------------------REVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---------------------HHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---------------------HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1111111111 11111124567789999999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=272.04 Aligned_cols=200 Identities=21% Similarity=0.292 Sum_probs=159.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+.+...... ...+++..+..++.|++.||.||| +++++|||||
T Consensus 82 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlk 157 (351)
T 3c0i_A 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVK 157 (351)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCC
Confidence 368999999999999999999999999999998877643210 035789999999999999999999 8999999999
Q ss_pred CcceeecCCCc---eeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENV---AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++. +||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 158 p~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 158 PHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp GGGEEECSSSTTCCEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred hHHeEEecCCCCCcEEEecCcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 99999987654 9999999987664332 1233456899999999999888999999999999999999999998542
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. +........... .......+..+.++|.+||+.||.+|||+.|+++
T Consensus 237 ~~----------------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 237 KE----------------------RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HH----------------------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH----------------------HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 111111111111 1111234677899999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=267.50 Aligned_cols=196 Identities=17% Similarity=0.267 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++......++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlk 168 (321)
T 2c30_A 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIK 168 (321)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 47899999999999999999999999999999999864 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 169 p~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 169 SDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred HHHEEECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999987654322 1233556899999999999888999999999999999999999998543210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........... ........++.+.+++.+||+.||.+|||+.|+++
T Consensus 248 ---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 248 ---------------------QAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---------------------HHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---------------------HHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001111100 00011234567889999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=266.33 Aligned_cols=208 Identities=23% Similarity=0.372 Sum_probs=166.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++ ..+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 66 ~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 137 (287)
T 1u59_A 66 QLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLA 137 (287)
T ss_dssp HCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCc
Confidence 36899999999999 5566899999999999999997543 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 138 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 138 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999876643322 11233446788999999988889999999999999999998 98888543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~~ 237 (239)
... +......... ....+...++.+.+++.+||+.||.+|||+.++++.|.+++.+..
T Consensus 218 ~~~---------------------~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 218 KGP---------------------EVMAFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CTH---------------------HHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CHH---------------------HHHHHHhcCC-cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 210 1111111110 001112455778999999999999999999999999999988764
Q ss_pred C
Q 044155 238 C 238 (239)
Q Consensus 238 ~ 238 (239)
.
T Consensus 276 ~ 276 (287)
T 1u59_A 276 S 276 (287)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=275.97 Aligned_cols=208 Identities=23% Similarity=0.388 Sum_probs=155.1
Q ss_pred CCCCcccceeeEEEEe-CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLE-TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||+++++++.+ .+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++||||
T Consensus 146 ~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDl 218 (373)
T 3c1x_A 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDL 218 (373)
T ss_dssp TCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred hCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCcc
Confidence 4789999999998764 457899999999999999997653 45788999999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCc---ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSD 155 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~ 155 (239)
||+||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 219 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~ 298 (373)
T 3c1x_A 219 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298 (373)
T ss_dssp CGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred chheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence 99999999999999999999875532211 11233456788999999998999999999999999999999 556664
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
...... ......... ....+...+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 299 ~~~~~~---------------------~~~~~~~~~-~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 299 DVNTFD---------------------ITVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp TSCSSC---------------------HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHH---------------------HHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 322110 000000000 0000123456789999999999999999999999999999887
Q ss_pred hc
Q 044155 236 LS 237 (239)
Q Consensus 236 ~~ 237 (239)
+.
T Consensus 357 ~~ 358 (373)
T 3c1x_A 357 FI 358 (373)
T ss_dssp CC
T ss_pred cc
Confidence 64
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=266.59 Aligned_cols=209 Identities=23% Similarity=0.303 Sum_probs=164.4
Q ss_pred CCCCcccceeeEEEEeCCCc-eEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIP-ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~-~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||+++++++.+.... ++||||+.+++|.+++.... ..++...+..++.|++.||.||| +.+++|+||
T Consensus 78 ~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~di 150 (298)
T 3pls_A 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDL 150 (298)
T ss_dssp TCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred hCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 47899999999999876655 89999999999999998643 56789999999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCC---cceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGE---THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
||+||+++.++.++|+|||++....... ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+..
T Consensus 151 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~ 230 (298)
T 3pls_A 151 AARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230 (298)
T ss_dssp SGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred CcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc
Confidence 9999999999999999999987543221 1122344578899999999998999999999999999999997665432
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
..+.. +......... ....+...++.+.+++.+||+.||.+|||+.++++.|+++.+++
T Consensus 231 ~~~~~--------------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 231 HIDPF--------------------DLTHFLAQGR-RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp TSCGG--------------------GHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCHH--------------------HHHHHhhcCC-CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 21110 0111110100 00111234567899999999999999999999999999998876
Q ss_pred c
Q 044155 237 S 237 (239)
Q Consensus 237 ~ 237 (239)
.
T Consensus 290 ~ 290 (298)
T 3pls_A 290 L 290 (298)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=270.97 Aligned_cols=198 Identities=23% Similarity=0.317 Sum_probs=158.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+++..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||||
T Consensus 62 l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp 133 (323)
T 3tki_A 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKP 133 (323)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred CCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccch
Confidence 68999999999999999999999999999999999765 56899999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
+||+++.++.+||+|||++....... ........|++.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 134 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp GGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred HHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 99999999999999999987553222 122335678999999999987765 7789999999999999999999864332
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... . ...............+..+.+++.+||+.||.+|||+.|+++
T Consensus 214 ~~~~~-------~-------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 214 SCQEY-------S-------------DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TSHHH-------H-------------HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHH-------H-------------HHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11100 0 000000000011234566789999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=268.67 Aligned_cols=196 Identities=20% Similarity=0.279 Sum_probs=160.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 70 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlk 141 (326)
T 2y0a_A 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141 (326)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCC
Confidence 368999999999999999999999999999999999764 56899999999999999999999 8999999999
Q ss_pred CcceeecCCC----ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEEN----VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 142 p~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp GGGEEESCSSSSSCCEEECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred HHHEEEecCCCCCCCEEEEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 9999999887 79999999987654322 12345689999999999988899999999999999999999999853
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .+......... .........+..+.++|.+||..||.+|||+.|+++
T Consensus 220 ~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 220 DTK---------------------QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp SSH---------------------HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCH---------------------HHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 221 01111111111 111122244577899999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=266.50 Aligned_cols=192 Identities=21% Similarity=0.355 Sum_probs=159.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +++++|||||
T Consensus 62 ~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlk 133 (318)
T 1fot_A 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLK 133 (318)
T ss_dssp SCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCC
T ss_pred hCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 478999999999999999999999999999999999875 56899999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||++...... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 134 p~NIll~~~g~~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~- 208 (318)
T 1fot_A 134 PENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT- 208 (318)
T ss_dssp GGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-
T ss_pred hheEEEcCCCCEEEeecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-
Confidence 99999999999999999998765332 2355789999999999998999999999999999999999999853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.+....+....... +...+..+.+++.+||..||++|| +++++++
T Consensus 209 --------------------~~~~~~i~~~~~~~--p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 209 --------------------MKTYEKILNAELRF--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --------------------HHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------------------HHHHHHHHhCCCCC--CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11111222211111 123456789999999999999999 8888874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=275.21 Aligned_cols=199 Identities=20% Similarity=0.283 Sum_probs=149.6
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +++++||||||
T Consensus 73 l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp 144 (361)
T 3uc3_A 73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKL 144 (361)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCG
T ss_pred CCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCH
Confidence 78999999999999999999999999999999999765 56899999999999999999999 89999999999
Q ss_pred cceeecCCCc--eeEcccccccccCCCCcceeecccccccccCccccccCCcccc-cchhhhhhHHHHHhcCCCCccccc
Q 044155 82 SCILFNEENV--AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEK-SNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 82 ~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
+||+++.++. +||+|||++...... .......||+.|+|||++.+..++.+ +||||||+++|+|++|..||....
T Consensus 145 ~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 145 ENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp GGEEECSSSSCCEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred HHEEEcCCCCceEEEeecCcccccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 9999987765 999999998643222 12234568999999999988777655 899999999999999999986543
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... ..............+.....++.+.++|.+||..||.+|||+.|+++
T Consensus 223 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 223 EPRDY-----------------RKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -CCCH-----------------HHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cHHHH-----------------HHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 21111 11111111111111111134567889999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=266.36 Aligned_cols=204 Identities=23% Similarity=0.341 Sum_probs=159.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+ +..++||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||
T Consensus 70 l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp 141 (281)
T 3cc6_A 70 LDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAV 141 (281)
T ss_dssp HCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSG
T ss_pred CCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCcc
Confidence 689999999999865 45689999999999999997643 45889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~~ 160 (239)
+||+++.++.++|+|||++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 142 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~ 221 (281)
T 3cc6_A 142 RNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221 (281)
T ss_dssp GGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG
T ss_pred ceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH
Confidence 99999999999999999987654333222334456788999999988889999999999999999998 98888532211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
. ....+. .... ...+...++.+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 222 ~------------------~~~~~~---~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 222 D------------------VIGVLE---KGDR-LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp G------------------HHHHHH---HTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H------------------HHHHHh---cCCC-CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0 000010 0000 001113456788999999999999999999999999988753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=273.64 Aligned_cols=197 Identities=23% Similarity=0.331 Sum_probs=157.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++||||+++|+|.+++... ..+++..++.++.||+.||.||| +++|+||||||+
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~ 182 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLD 182 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGG
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHH
Confidence 7999999999999999999999999999999999875 56899999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|+||||+++|+|++|..||........
T Consensus 183 NILl~~~g~ikL~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~ 261 (396)
T 4dc2_A 183 NVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261 (396)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---
T ss_pred HEEECCCCCEEEeecceeeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccc
Confidence 999999999999999998753221 1234466799999999999999999999999999999999999999964332111
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
.. ..........+....... +...+..+.++|.+||+.||.+||++
T Consensus 262 ~~------------~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 262 PD------------QNTEDYLFQVILEKQIRI--PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---------------CCHHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cc------------hhhHHHHHHHHhccccCC--CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 10 001111222222222111 12355678999999999999999996
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=265.55 Aligned_cols=198 Identities=26% Similarity=0.440 Sum_probs=152.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC---eeecc
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP---IVFRN 78 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~---i~H~d 78 (239)
++||||+++++++.+.+..++||||+++++|.+++.. ..++...+..++.|++.||.||| +.+ ++|+|
T Consensus 63 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~d 133 (271)
T 3dtc_A 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRD 133 (271)
T ss_dssp CCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSC
T ss_pred cCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecC
Confidence 6899999999999999999999999999999998854 56889999999999999999999 777 99999
Q ss_pred ccCcceeecC--------CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcC
Q 044155 79 FKTSCILFNE--------ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150 (239)
Q Consensus 79 lk~~nil~~~--------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g 150 (239)
|||+||+++. ++.++|+|||.+....... .....|++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 134 ikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp CSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred CchHHEEEecccccccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999986 6779999999987553322 2244689999999999988899999999999999999999
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 230 (239)
..||...... ...............+...++.+.+++.+||+.||.+|||+.|+++.|+
T Consensus 211 ~~p~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 211 EVPFRGIDGL---------------------AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp CCTTTTSCHH---------------------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCHH---------------------HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 9998643211 0011111111111111244567899999999999999999999999997
Q ss_pred HH
Q 044155 231 QI 232 (239)
Q Consensus 231 ~l 232 (239)
++
T Consensus 270 ~l 271 (271)
T 3dtc_A 270 TI 271 (271)
T ss_dssp C-
T ss_pred cC
Confidence 64
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=263.49 Aligned_cols=200 Identities=26% Similarity=0.444 Sum_probs=157.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC--eeecc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--IVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--i~H~d 78 (239)
+++||||+++++++.+.. ++||||+++++|.+.+.... ..+++..+..++.|++.||.||| +.+ ++|+|
T Consensus 79 ~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~d 149 (287)
T 4f0f_A 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRD 149 (287)
T ss_dssp TCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSC
T ss_pred hCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCC
Confidence 478999999999986554 79999999999999887653 56899999999999999999999 888 99999
Q ss_pred ccCcceeecCCCc-----eeEcccccccccCCCCcceeecccccccccCccccc--cCCcccccchhhhhhHHHHHhcCC
Q 044155 79 FKTSCILFNEENV-----AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR--TGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 79 lk~~nil~~~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|||+||+++.++. ++|+|||++..... ......|++.|+|||++. ...++.++||||||+++|+|++|.
T Consensus 150 ikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 150 LRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp CSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CCcceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 9999999988776 99999999864432 234566899999999984 445788999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||........ ...............+...++.+.+++.+||+.||.+|||++++++.|++
T Consensus 226 ~pf~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 226 GPFDEYSYGKI-------------------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CTTTTCCCCHH-------------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCccccccHH-------------------HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 99864321100 00111111111111122445778999999999999999999999999976
Q ss_pred H
Q 044155 232 I 232 (239)
Q Consensus 232 l 232 (239)
+
T Consensus 287 l 287 (287)
T 4f0f_A 287 L 287 (287)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=266.35 Aligned_cols=224 Identities=18% Similarity=0.178 Sum_probs=164.8
Q ss_pred CCCCcccceeeEEEEeCC--CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLETP--IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~--~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.... ..++||||+++++|.+++...... ..+++..+..++.|++.||.||| +.+++|+|
T Consensus 63 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~D 137 (319)
T 4euu_A 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRN 137 (319)
T ss_dssp HCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred hcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCC
Confidence 368999999999998765 678999999999999999865321 33899999999999999999999 89999999
Q ss_pred ccCcceee----cCCCceeEcccccccccCCCCcceeecccccccccCccccc--------cCCcccccchhhhhhHHHH
Q 044155 79 FKTSCILF----NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR--------TGVFNEKSNVFSFSVFLFE 146 (239)
Q Consensus 79 lk~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~ 146 (239)
|||+||++ +.++.+||+|||++........ .....|++.|+|||++. +..++.++||||||+++|+
T Consensus 138 lkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~e 215 (319)
T 4euu_A 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215 (319)
T ss_dssp CSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHH
T ss_pred CCHHHEEEeccCCCCceEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHH
Confidence 99999999 7777899999999976543322 23456899999999886 4678899999999999999
Q ss_pred HhcCCCCcccccccccccccchhhhhhhhhccchhh---h----hhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 147 LLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTE---I----VDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 147 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
|++|..||....................... .+.. . ......-..........+..+.+++.+||+.||++|
T Consensus 216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R 294 (319)
T 4euu_A 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSG-AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294 (319)
T ss_dssp HHHSSCSEECTTCGGGCHHHHHHHHHHCCTT-CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTS
T ss_pred HHhCCCCCCCCCccchhHHHHHHHhcCCCcc-cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhh
Confidence 9999999975443222111111111110000 0000 0 000000001111224677889999999999999999
Q ss_pred CCHHHHHHHHHHH
Q 044155 220 PSMVDVAKKLRQI 232 (239)
Q Consensus 220 ps~~ell~~L~~l 232 (239)
||++|+++...+-
T Consensus 295 ~s~~ell~h~~d~ 307 (319)
T 4euu_A 295 WGFDQFFAETSDI 307 (319)
T ss_dssp CCHHHHHHHHHHH
T ss_pred ccHHHhhhccHHH
Confidence 9999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=270.33 Aligned_cols=220 Identities=23% Similarity=0.369 Sum_probs=166.7
Q ss_pred CCCCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.+. ...++||||+++++|.+++.. ..++...+..++.|++.||.||| +.+++|+|
T Consensus 89 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~D 159 (318)
T 3lxp_A 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRD 159 (318)
T ss_dssp HCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred hCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCC
Confidence 37899999999999874 467899999999999999976 34889999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 160 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 160 LAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 999999999999999999999987644322 123344578889999999988899999999999999999999998864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
......... ............. ...........+...+..+.++|.+||+.||.+|||+.|+++.|+++.+.+
T Consensus 240 ~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 240 PPTKFLELI------GIAQGQMTVLRLT-ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHH------CSCCHHHHHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhhhhhh------cccccchhHHHHH-HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 321100000 0000000001111 111111111112345678999999999999999999999999999998765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=274.20 Aligned_cols=221 Identities=16% Similarity=0.195 Sum_probs=158.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+|+|||||
T Consensus 82 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlk 155 (389)
T 3gni_B 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVK 155 (389)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 36899999999999999999999999999999999987643 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC------cceeecccccccccCcccccc--CCcccccchhhhhhHHHHHhcCCC
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE------THITDTVMGTLGYCAPEYMRT--GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|+|||++.++.+||+|||.+....... ........|++.|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 156 p~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~ 235 (389)
T 3gni_B 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235 (389)
T ss_dssp GGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 999999999999999999875432111 111223468899999999987 578999999999999999999999
Q ss_pred Ccccccccccccccchhhhhhhhhc------------------cchhhhhhhhh-----hcCCCcHHHHHHHHHHHHHHh
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFED------------------NRFTEIVDHIV-----VEDVSSIEKEQQLHASAQVTF 209 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~ 209 (239)
||....................... ....+...... ............++.+.+||.
T Consensus 236 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 315 (389)
T 3gni_B 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE 315 (389)
T ss_dssp TTTTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHH
T ss_pred CCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHH
Confidence 9975433221111000000000000 00000000000 000001122345677999999
Q ss_pred hhcCCCCCCCCCHHHHHH
Q 044155 210 ECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 210 ~cl~~dp~~Rps~~ell~ 227 (239)
+||+.||.+|||+.|+++
T Consensus 316 ~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 316 QCLQRNPDARPSASTLLN 333 (389)
T ss_dssp HHTCSCTTTSCCHHHHTT
T ss_pred HHhhcCcccCCCHHHHhc
Confidence 999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.12 Aligned_cols=207 Identities=24% Similarity=0.370 Sum_probs=162.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.. ...++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +++|+|||||
T Consensus 392 ~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlk 463 (613)
T 2ozo_A 392 QLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLA 463 (613)
T ss_dssp TCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCC
Confidence 4799999999999976 56899999999999999997543 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+|||++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 464 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 464 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp GGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred HHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999976533221 11223345688999999998999999999999999999998 98888643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~~ 237 (239)
... +....+..+. ....+...+..+.++|.+||+.||.+|||+.++++.|+.++.++.
T Consensus 544 ~~~---------------------~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 544 KGP---------------------EVMAFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CSH---------------------HHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CHH---------------------HHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 311 1111111111 111112456788999999999999999999999999999887653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=264.31 Aligned_cols=179 Identities=22% Similarity=0.332 Sum_probs=140.2
Q ss_pred ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEccccc
Q 044155 20 PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSL 99 (239)
Q Consensus 20 ~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~ 99 (239)
.++||||+++++|.+++...... ...+...+..++.|++.||+||| +++++|+||||+||+++.++.+||+|||+
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 210 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSL--EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL 210 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEecCCCCHHHHHhcccCc--cchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCc
Confidence 68999999999999999875432 44567778999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCc-----------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccccccccch
Q 044155 100 SISIPEGET-----------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFS 168 (239)
Q Consensus 100 ~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~ 168 (239)
+........ .......||+.|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus 211 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------- 279 (332)
T 3qd2_B 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------- 279 (332)
T ss_dssp CEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----------
T ss_pred ccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----------
Confidence 876643321 1123456899999999999989999999999999999999986653210
Q ss_pred hhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 169 EYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......... ..+......++.+.+++.+||+.||.+|||++|+++
T Consensus 280 ------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 280 ------------VRIITDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ------------HHHHHHHHTT-CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ------------HHHHHHhhcc-CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 0111111111 222333456677899999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=268.47 Aligned_cols=216 Identities=19% Similarity=0.193 Sum_probs=158.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||++ ++|.+.+.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 75 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dik 146 (311)
T 3niz_A 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLK 146 (311)
T ss_dssp HCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred HcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCc
Confidence 3789999999999999999999999998 68988887653 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++....... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 147 p~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 147 PQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp GGGEEECTTCCEEECCCTTCEETTSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred hHhEEECCCCCEEEccCcCceecCCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999987653222 12334567999999999876 5689999999999999999999999975443
Q ss_pred cccccccchhhhhhhhhccchhhhhh------hh---hhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVD------HI---VVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........... ..+ ....+..... .. .............++++.+++.+||+.||.+|||++|+++
T Consensus 226 ~~~~~~i~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 226 DDQLPKIFSIL-GTP-NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTHHHHHHHHH-CCC-CTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHHH-CCC-ChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22211100000 000 0000000000 00 0000000011134567889999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=266.25 Aligned_cols=208 Identities=23% Similarity=0.381 Sum_probs=161.1
Q ss_pred CCCCcccceeeEEEE-eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCL-ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~-~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||+++++++. .++..++||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||
T Consensus 82 ~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~di 154 (298)
T 3f66_A 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDL 154 (298)
T ss_dssp TCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred hCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCC
Confidence 478999999999965 4557889999999999999997643 56789999999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCc---ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCC-Ccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWD-VSD 155 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~-p~~ 155 (239)
||+||+++.++.++|+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|++++|.. ||.
T Consensus 155 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 234 (298)
T 3f66_A 155 AARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234 (298)
T ss_dssp SGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred chheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999876533221 12234457788999999998899999999999999999999554 443
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
..... +.......... ...+...+..+.+++.+||+.||.+|||+.|+++.|+++..+
T Consensus 235 ~~~~~---------------------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 235 DVNTF---------------------DITVYLLQGRR-LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp TSCTT---------------------THHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCHH---------------------HHHHHHhcCCC-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 22110 00000111000 000113346789999999999999999999999999999886
Q ss_pred hc
Q 044155 236 LS 237 (239)
Q Consensus 236 ~~ 237 (239)
+.
T Consensus 293 ~~ 294 (298)
T 3f66_A 293 FI 294 (298)
T ss_dssp SC
T ss_pred hc
Confidence 53
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=291.56 Aligned_cols=206 Identities=21% Similarity=0.319 Sum_probs=163.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.. ...++||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+|||||
T Consensus 426 ~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLk 496 (635)
T 4fl3_A 426 QLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLA 496 (635)
T ss_dssp HCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCC
Confidence 3789999999999964 5578999999999999999865 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 497 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 497 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp GGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred hHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999876643321 12233446788999999998899999999999999999998 99998543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~~ 237 (239)
.. .+....+.... ....+...+..+.++|..||+.||.+|||+.+|++.|++++.++.
T Consensus 577 ~~---------------------~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 577 KG---------------------SEVTAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CH---------------------HHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CH---------------------HHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 31 11111111111 111112456788999999999999999999999999999988764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=270.53 Aligned_cols=205 Identities=19% Similarity=0.318 Sum_probs=157.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..+. .++|++++.+++|.+++.... ..++...+..++.|++.||.||| +++++|+|||
T Consensus 73 ~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 144 (327)
T 3lzb_A 73 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLA 144 (327)
T ss_dssp TCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCC
Confidence 478999999999998765 788999999999999998753 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 145 p~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 145 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp GGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred HHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 9999999999999999999876533221 12233446788999999999999999999999999999999 988886432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
... ....+.. ......+...+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 225 ~~~------------------~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 225 ASE------------------ISSILEK----GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GGG------------------HHHHHHT----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHH------------------HHHHHHc----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 110 0111111 111111123456788999999999999999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=267.03 Aligned_cols=208 Identities=24% Similarity=0.393 Sum_probs=155.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++. +..++||||+++++|.+++...... ..++...+..++.|++.||.|||....++++|+|||
T Consensus 57 ~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlk 132 (307)
T 2eva_A 57 RVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132 (307)
T ss_dssp HCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSE--ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCS
T ss_pred cCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCC--CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCC
Confidence 368999999999876 4579999999999999999865321 347888999999999999999992111899999999
Q ss_pred CcceeecCCCc-eeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENV-AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++. +||+|||++...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 133 p~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 208 (307)
T 2eva_A 133 PPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208 (307)
T ss_dssp GGGEEEETTTTEEEECCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred hhHEEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence 99999998886 799999998654322 2234589999999999988999999999999999999999999864321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
... .......... ........+..+.+++.+||+.||.+|||++++++.|+++....
T Consensus 209 ~~~-------------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 209 PAF-------------------RIMWAVHNGT-RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp SHH-------------------HHHHHHHTTC-CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cHH-------------------HHHHHHhcCC-CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 100 0000000000 00011234567889999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=267.24 Aligned_cols=209 Identities=22% Similarity=0.413 Sum_probs=152.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++ .....++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 76 ~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlk 147 (289)
T 3og7_A 76 KTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147 (289)
T ss_dssp TCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCc
Confidence 47899999999965 5566899999999999999996543 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCC-CcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEG-ETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||+++.++.++|+|||++...... .........|++.|+|||.+. +..++.++||||||+++|+|++|..||..
T Consensus 148 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp GGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 99999999999999999998654321 112233456899999999986 55688899999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
....... . ...................++.+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 228 ~~~~~~~--------~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 228 INNRDQI--------I---------EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCHHHH--------H---------HHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchHHHH--------H---------HHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 3321110 0 00000000000000112345678999999999999999999999999998764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=265.59 Aligned_cols=196 Identities=18% Similarity=0.266 Sum_probs=154.1
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 4789999999999986 4578999999999999876543 56899999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC---cccccchhhhhhHHHHHhcCCCCcc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV---FNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|||+||+++.++.+||+|||++....... .......||+.|+|||.+.+.. .+.++||||||+++|+|++|..||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654332 2233457899999999998655 4778999999999999999999985
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ....................++.+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERI---------------------MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSH---------------------HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccH---------------------HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 3211 01111111111111111134567899999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=269.03 Aligned_cols=211 Identities=20% Similarity=0.359 Sum_probs=156.7
Q ss_pred CCCCcccceeeEEEEeCCCc------eEEEEEccCCChhhhhhcCCC-CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 1 QMSHNHILKLIGCCLETPIP------ILVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~------~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
+++||||+++++++...... ++||||+++++|.+++..... .....++...+..++.|++.||.||| +.+
T Consensus 81 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ 157 (323)
T 3qup_A 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRN 157 (323)
T ss_dssp TCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred HCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCC
Confidence 47899999999999877654 899999999999999875422 11135889999999999999999999 899
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CC
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GW 151 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~ 151 (239)
++|+||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 158 ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 237 (323)
T 3qup_A 158 FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237 (323)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCC
Confidence 99999999999999999999999999876533221 12233446788999999998899999999999999999999 88
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||...... +.......... ...+...+..+.+++.+||+.||.+|||+.++++.|++
T Consensus 238 ~p~~~~~~~---------------------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 238 TPYAGIENA---------------------EIYNYLIGGNR-LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295 (323)
T ss_dssp CTTTTCCGG---------------------GHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCccccChH---------------------HHHHHHhcCCC-CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 887643211 11111111110 00112345678999999999999999999999999999
Q ss_pred HHHhh
Q 044155 232 IYRSL 236 (239)
Q Consensus 232 l~~~~ 236 (239)
+....
T Consensus 296 ~l~~~ 300 (323)
T 3qup_A 296 ILGHL 300 (323)
T ss_dssp HHHC-
T ss_pred HHHHh
Confidence 88754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=275.66 Aligned_cols=201 Identities=19% Similarity=0.286 Sum_probs=152.2
Q ss_pred CCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 2 MSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 2 l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
.+||||+++++++.. ....++||||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||
T Consensus 112 ~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHr 185 (400)
T 1nxk_A 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHR 185 (400)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 479999999999875 5568999999999999999987532 46899999999999999999999 8999999
Q ss_pred cccCcceeecC---CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 78 NFKTSCILFNE---ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 78 dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
||||+|||++. ++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 186 Dlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 263 (400)
T 1nxk_A 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSC
T ss_pred CcCcceEEEecCCCCccEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 99999999998 7889999999987653221 233556899999999999889999999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........... ....+...... .......+..+.++|.+||+.||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~~-----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 264 YSNHGLAISPG-----------------MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCCTTCSSCCS-----------------HHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCccccccHH-----------------HHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 65332111000 00000111110 0001234567899999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=264.18 Aligned_cols=207 Identities=22% Similarity=0.361 Sum_probs=164.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++. .+..++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 64 ~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dik 136 (279)
T 1qpc_A 64 QLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136 (279)
T ss_dssp HCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 368999999999986 4558899999999999999975321 25889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 137 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred HhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 999999999999999999987764433222334456788999999988889999999999999999999 8888754321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
. +........ .....+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 217 ~---------------------~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 217 P---------------------EVIQNLERG-YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp H---------------------HHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred H---------------------HHHHHHhcc-cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 0 111111110 000111234567899999999999999999999999999988764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=268.72 Aligned_cols=210 Identities=21% Similarity=0.312 Sum_probs=164.6
Q ss_pred CC-CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----------CCCCcCCHHHHHHHHHHHHHHHhHHhh
Q 044155 1 QM-SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHF 68 (239)
Q Consensus 1 ~l-~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~ 68 (239)
++ +||||+++++++.+.+..++||||+++++|.+++..... .....++...+..++.|++.||.|||
T Consensus 81 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH- 159 (327)
T 1fvr_A 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS- 159 (327)
T ss_dssp TCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-
T ss_pred hccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-
Confidence 35 899999999999999999999999999999999986530 11146899999999999999999999
Q ss_pred CCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 69 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 69 ~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
+++++|+||||+||+++.++.++|+|||++..... ........+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 160 --~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 235 (327)
T 1fvr_A 160 --QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235 (327)
T ss_dssp --HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred --hCCccCCCCccceEEEcCCCeEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHH
Confidence 89999999999999999999999999999864321 11122344678899999998888999999999999999999
Q ss_pred c-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 149 T-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 149 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+ |..||..... .+......... ....+...+..+.+++.+||+.||.+|||++++++
T Consensus 236 t~g~~pf~~~~~---------------------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 293 (327)
T 1fvr_A 236 SLGGTPYCGMTC---------------------AELYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293 (327)
T ss_dssp TTSCCTTTTCCH---------------------HHHHHHGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCCcH---------------------HHHHHHhhcCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8 9888854321 01111111110 00011134567899999999999999999999999
Q ss_pred HHHHHHHhhc
Q 044155 228 KLRQIYRSLS 237 (239)
Q Consensus 228 ~L~~l~~~~~ 237 (239)
.|.++..+..
T Consensus 294 ~L~~~~~~~~ 303 (327)
T 1fvr_A 294 SLNRMLEERK 303 (327)
T ss_dssp HHHHHHHSSS
T ss_pred HHHHHHHhhc
Confidence 9999887654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=264.69 Aligned_cols=211 Identities=24% Similarity=0.426 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEeCC-----CceEEEEEccCCChhhhhhcCCC-CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETP-----IPILVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~-----~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++.+.. ..++||||+++++|.+++..... .....++...+..++.|++.||.||| +.++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i 168 (313)
T 3brb_A 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNF 168 (313)
T ss_dssp TCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTC
T ss_pred cCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 478999999999998654 34899999999999999854321 11156899999999999999999999 9999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWD 152 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~ 152 (239)
+|+||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 169 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 248 (313)
T 3brb_A 169 LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248 (313)
T ss_dssp CCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999876533221 12234456788999999998889999999999999999999 777
Q ss_pred CcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
||...... ........... ...+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 249 p~~~~~~~---------------------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 249 PYPGVQNH---------------------EMYDYLLHGHR-LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp SSTTCCGG---------------------GHHHHHHTTCC-CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCHH---------------------HHHHHHHcCCC-CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 87543211 11111111100 001123456789999999999999999999999999999
Q ss_pred HHhh
Q 044155 233 YRSL 236 (239)
Q Consensus 233 ~~~~ 236 (239)
..++
T Consensus 307 ~~~l 310 (313)
T 3brb_A 307 LESL 310 (313)
T ss_dssp HHHC
T ss_pred HHhc
Confidence 8875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=272.40 Aligned_cols=196 Identities=23% Similarity=0.353 Sum_probs=158.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+.+... ..+++..+..++.|++.||.||| +.+|+|+|||
T Consensus 84 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlk 155 (362)
T 2bdw_A 84 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLK 155 (362)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCS
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCc
Confidence 378999999999999999999999999999999999765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCC---ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 p~NIll~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 156 PENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hHHEEEecCCCCCCEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9999998654 59999999987654322 123456899999999999888999999999999999999999998542
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+....+...... .......++.+.++|.+||+.||.+|||+.++++
T Consensus 234 ~~---------------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 234 DQ---------------------HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp SH---------------------HHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CH---------------------HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 21 1111111111111 1111234567899999999999999999999886
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=271.66 Aligned_cols=210 Identities=18% Similarity=0.320 Sum_probs=164.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC---------CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP---------HFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
+||||+++++++.+.+..++||||+++++|.+++...... ....++...+..++.|++.||.||| +.+
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ 184 (333)
T 2i1m_A 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKN 184 (333)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCC
Confidence 7999999999999999999999999999999998753210 0145789999999999999999999 899
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CC
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GW 151 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~ 151 (239)
++|+||||+||+++.++.++|+|||++....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 185 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 264 (333)
T 2i1m_A 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264 (333)
T ss_dssp EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999987543222 122334456788999999998889999999999999999998 88
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||........ ....... ......+...+..+.+++.+||+.||.+|||+.++++.|++
T Consensus 265 ~p~~~~~~~~~-----------------~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 265 NPYPGILVNSK-----------------FYKLVKD----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp CSSTTCCSSHH-----------------HHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcccchhHH-----------------HHHHHhc----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 88754321100 0011111 00000111234678899999999999999999999999999
Q ss_pred HHHhh
Q 044155 232 IYRSL 236 (239)
Q Consensus 232 l~~~~ 236 (239)
+..+.
T Consensus 324 ~~~~~ 328 (333)
T 2i1m_A 324 QAQED 328 (333)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 87653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=267.14 Aligned_cols=207 Identities=22% Similarity=0.289 Sum_probs=160.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 102 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 174 (333)
T 1mqb_A 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLA 174 (333)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCC
Confidence 4789999999999999999999999999999999997653 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 175 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 175 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999876533221 11223345778999999998889999999999999999999 98887533
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
.. .+......... ....+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 255 ~~---------------------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 255 SN---------------------HEVMKAINDGF-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CH---------------------HHHHHHHHTTC-CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CH---------------------HHHHHHHHCCC-cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 21 11111111110 00111234567899999999999999999999999999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=268.19 Aligned_cols=209 Identities=21% Similarity=0.345 Sum_probs=165.3
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+||||+++++++.+.+..++||||+++++|.+++...... ....++...+..++.|++.||.||| +
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~ 175 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---S 175 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---h
Confidence 7999999999999999999999999999999999865321 0134889999999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
.+++|+||||+||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 176 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 255 (334)
T 2pvf_A 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255 (334)
T ss_dssp TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876543321 12233456788999999988889999999999999999999
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||..... .+.......... ...+...+..+.+++.+||+.||.+|||+.|+++.|
T Consensus 256 g~~p~~~~~~---------------------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 256 GGSPYPGIPV---------------------EELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp SCCSSTTCCH---------------------HHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcCcCCH---------------------HHHHHHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 8888753221 011111111100 001123456789999999999999999999999999
Q ss_pred HHHHHhh
Q 044155 230 RQIYRSL 236 (239)
Q Consensus 230 ~~l~~~~ 236 (239)
+++....
T Consensus 314 ~~l~~~~ 320 (334)
T 2pvf_A 314 DRILTLT 320 (334)
T ss_dssp HHHHHHH
T ss_pred HHHHhcc
Confidence 9987653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=263.23 Aligned_cols=191 Identities=18% Similarity=0.172 Sum_probs=153.3
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.+||||+++++++.+++..++||||+ +++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp 185 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKP 185 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCH
Confidence 38999999999999999999999999 589999887653 46899999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..|+.....
T Consensus 186 ~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-- 260 (311)
T 3p1a_A 186 ANIFLGPRGRCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-- 260 (311)
T ss_dssp GGEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--
T ss_pred HHEEECCCCCEEEccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--
Confidence 99999999999999999987653322 2334558999999998875 789999999999999999999766532110
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+ ................+..+.+++.+||+.||.+|||++|+++
T Consensus 261 ------------------~----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 261 ------------------W----QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------------------H----HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------------------H----HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 0111111112222345678899999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=269.31 Aligned_cols=197 Identities=21% Similarity=0.282 Sum_probs=158.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+.+|+|.+++... ..++...+..++.|++.||.||| +.+|+|||||
T Consensus 71 ~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlk 142 (384)
T 4fr4_A 71 GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMK 142 (384)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCc
Confidence 478999999999999999999999999999999999865 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc---CCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++....... ......||+.|+|||++.. ..++.++||||||+++|+|++|..||...
T Consensus 143 p~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 143 PDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred HHHeEECCCCCEEEeccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 999999999999999999997654332 2345679999999999874 45889999999999999999999998643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-MVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~ell~ 227 (239)
... ...+........... .+...+..+.++|.+||+.||.+||+ +++++.
T Consensus 221 ~~~------------------~~~~~~~~~~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 221 SST------------------SSKEIVHTFETTVVT--YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTS------------------CHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCc------------------cHHHHHHHHhhcccC--CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 211 011111111111111 01234567899999999999999998 666654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=266.94 Aligned_cols=201 Identities=21% Similarity=0.349 Sum_probs=157.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+|||
T Consensus 68 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlk 140 (289)
T 4fvq_A 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVC 140 (289)
T ss_dssp TSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred hCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcC
Confidence 4789999999999999999999999999999999998752 34889999999999999999999 8999999999
Q ss_pred CcceeecCCCc--------eeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCC
Q 044155 81 TSCILFNEENV--------AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 81 ~~nil~~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|+||+++.++. ++|+|||.+..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 141 p~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 215 (289)
T 4fvq_A 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGG 215 (289)
T ss_dssp GGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTT
T ss_pred cceEEEecCCcccccccceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCC
Confidence 99999998886 99999999865422 224457889999999987 66899999999999999999965
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.|+....+... ....... ..... ...+..+.+++.+||+.||.+|||+.++++.|++
T Consensus 216 ~~~~~~~~~~~-----------------~~~~~~~--~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 272 (289)
T 4fvq_A 216 DKPLSALDSQR-----------------KLQFYED--RHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272 (289)
T ss_dssp CCTTTTSCHHH-----------------HHHHHHT--TCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHT
T ss_pred CCCccccchHH-----------------HHHHhhc--cCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 54321110000 0000000 00000 0123457899999999999999999999999998
Q ss_pred HHHhh
Q 044155 232 IYRSL 236 (239)
Q Consensus 232 l~~~~ 236 (239)
+...-
T Consensus 273 l~~p~ 277 (289)
T 4fvq_A 273 LFTPD 277 (289)
T ss_dssp CC---
T ss_pred hcCCC
Confidence 87653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=267.92 Aligned_cols=215 Identities=20% Similarity=0.271 Sum_probs=158.4
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++......++||||+ +++|.+++..... ..++...+..++.|++.||+||| +.+|+||||||
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp 165 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKP 165 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCc
Confidence 46999999999999999999999999 7999999987643 45889999999999999999999 89999999999
Q ss_pred cceeecC-------------------------CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccc
Q 044155 82 SCILFNE-------------------------ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSN 136 (239)
Q Consensus 82 ~nil~~~-------------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 136 (239)
+|||++. ++.+||+|||++...... .....||+.|+|||++.+..++.++|
T Consensus 166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~D 241 (360)
T 3llt_A 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSD 241 (360)
T ss_dssp GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccc
Confidence 9999975 778999999998764332 23456899999999999999999999
Q ss_pred hhhhhhHHHHHhcCCCCcccccccccc------cccchhhhhhhhhccchhhhhhh-----hhh------------cCCC
Q 044155 137 VFSFSVFLFELLTGWDVSDLVKDVHDL------VCPFSEYLKNCFEDNRFTEIVDH-----IVV------------EDVS 193 (239)
Q Consensus 137 i~slG~~l~~~~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~-----~~~------------~~~~ 193 (239)
|||||+++|+|++|..||......... ..+.................... ... ....
T Consensus 242 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 321 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCC
T ss_pred hHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcc
Confidence 999999999999999999754322111 00000000000000000000000 000 0000
Q ss_pred cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 194 SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 194 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+......++.+.+++.+||+.||.+|||++|+++
T Consensus 322 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1111122367889999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=264.96 Aligned_cols=188 Identities=21% Similarity=0.283 Sum_probs=156.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCC-ChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYG-TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||+++++++.+.+..++|||++.+| +|.+++... ..+++..+..++.|++.||.||| ..+++|+||
T Consensus 85 ~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dl 156 (335)
T 3dls_A 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDI 156 (335)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred hCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEecc
Confidence 478999999999999999999999998766 999999875 56899999999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
||+||+++.++.+||+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....
T Consensus 157 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 157 KDENIVIAEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred CHHHEEEcCCCcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 99999999999999999999876543322 234568999999999988776 789999999999999999999986432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... ..... ...++.+.+++.+||+.||.+|||++++++
T Consensus 235 ~~~~~-----------------------~~~~~------~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 235 ETVEA-----------------------AIHPP------YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp GGTTT-----------------------CCCCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhh-----------------------ccCCC------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11100 00000 013456889999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=269.56 Aligned_cols=221 Identities=24% Similarity=0.367 Sum_probs=166.8
Q ss_pred CCCCcccceeeEEEEeCC--CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLETP--IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~--~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++...+ ..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|
T Consensus 98 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~d 170 (326)
T 2w1i_A 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRD 170 (326)
T ss_dssp TCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred hCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccC
Confidence 478999999999987654 7899999999999999998753 45889999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+..
T Consensus 171 ikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 171 LATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred CCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999998766433221 12234467789999999988899999999999999999999888753
Q ss_pred ccccccccccchhhhhhhhhccc---hhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNR---FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
... .+......... ........+........+...+..+.++|.+||+.||.+|||+.|+++.|+++.
T Consensus 251 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 251 PPA---------EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHH---------HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHH---------HHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 210 00000000000 000111111111111112245678999999999999999999999999999998
Q ss_pred Hhhc
Q 044155 234 RSLS 237 (239)
Q Consensus 234 ~~~~ 237 (239)
.++.
T Consensus 322 ~~l~ 325 (326)
T 2w1i_A 322 DQMA 325 (326)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 8764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=267.92 Aligned_cols=192 Identities=18% Similarity=0.261 Sum_probs=159.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...++.++.|++.||.||| +++|+|||||
T Consensus 97 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlk 168 (350)
T 1rdq_E 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLK 168 (350)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCc
Confidence 478999999999999999999999999999999999875 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.+||+|||++...... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 169 p~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~- 243 (350)
T 1rdq_E 169 PENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP- 243 (350)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred cceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-
Confidence 99999999999999999998765332 2345789999999999998999999999999999999999999853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
.+....+....... +...+..+.++|.+||+.||.+||+ ++|+++
T Consensus 244 --------------------~~~~~~i~~~~~~~--p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 244 --------------------IQIYEKIVSGKVRF--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------------------HHHHHHHHHCCCCC--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------------------HHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11111222221111 1234567899999999999999998 788765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=271.46 Aligned_cols=193 Identities=21% Similarity=0.312 Sum_probs=155.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++||||+++|+|.+++... ..+++..++.++.|++.||.||| +++|+||||||+
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~ 153 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLD 153 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGG
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHH
Confidence 7999999999999999999999999999999999875 56899999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 154 NILl~~~g~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---- 228 (353)
T 3txo_A 154 NVLLDHEGHCKLADFGMCKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---- 228 (353)
T ss_dssp GEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred HEEECCCCCEEEccccceeecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC----
Confidence 999999999999999998753222 123345679999999999998889999999999999999999999985322
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM------VDVAK 227 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~------~ell~ 227 (239)
..+....+....... +...+..+.+++.+||+.||.+||++ +|+++
T Consensus 229 -----------------~~~~~~~i~~~~~~~--p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 229 -----------------EDDLFEAILNDEVVY--PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----------------HHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----------------HHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 112222222222111 11345678899999999999999998 67664
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=268.70 Aligned_cols=197 Identities=25% Similarity=0.349 Sum_probs=150.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 104 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dik 175 (349)
T 2w4o_A 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLK 175 (349)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred hCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCC
Confidence 368999999999999999999999999999999999765 56889999999999999999999 8999999999
Q ss_pred CcceeecC---CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNE---ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++. ++.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 176 p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 176 PENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp GGGEEESSSSTTCCEEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred cccEEEecCCCCCCEEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 99999976 7889999999987653221 223456899999999999888999999999999999999999998533
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ........... ........+..+.+++.+||+.||.+|||+.|+++
T Consensus 254 ~~~~--------------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 254 RGDQ--------------------FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TCHH--------------------HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccH--------------------HHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2110 00111111110 00111234567889999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=269.59 Aligned_cols=222 Identities=22% Similarity=0.290 Sum_probs=165.2
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.. ....++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|
T Consensus 80 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~D 152 (327)
T 3lxl_A 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRD 152 (327)
T ss_dssp TCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred hcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCC
Confidence 4789999999999874 456789999999999999997642 45899999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||+||+++.++.++|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 153 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 153 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999766433221 22344578889999999988899999999999999999999998764
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
......... .............. ..........+...++.+.+++.+||+.||.+|||+.|+++.|+.+..+.
T Consensus 233 ~~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 233 PSAEFLRMM------GCERDVPALSRLLE-LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHC------C----CCHHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccchhhhhc------ccccccccHHHHHH-HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 321100000 00000000111111 11111111112345677999999999999999999999999999877653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=264.33 Aligned_cols=213 Identities=18% Similarity=0.277 Sum_probs=162.2
Q ss_pred CCCcccceeeEEEEeCC----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCC-----CC
Q 044155 2 MSHNHILKLIGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF-----PR 72 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~-----~~ 72 (239)
++||||+++++++.... ..++||||+++++|.+++.. ..+++..+..++.|++.||.|||... +.
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 166 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC
Confidence 78999999999998775 78999999999999999976 35889999999999999999999211 36
Q ss_pred CeeeccccCcceeecCCCceeEcccccccccCCCCcc---eeecccccccccCccccccC------CcccccchhhhhhH
Q 044155 73 PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRTG------VFNEKSNVFSFSVF 143 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~ 143 (239)
+++|+||||+||+++.++.+||+|||++......... ......|++.|+|||.+.+. .++.++||||||++
T Consensus 167 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 246 (342)
T 1b6c_B 167 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246 (342)
T ss_dssp EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHH
T ss_pred CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHH
Confidence 8999999999999999999999999998765433221 12345689999999998765 23478999999999
Q ss_pred HHHHhcCC----------CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcC----CCc-HHHHHHHHHHHHHH
Q 044155 144 LFELLTGW----------DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED----VSS-IEKEQQLHASAQVT 208 (239)
Q Consensus 144 l~~~~~g~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~li 208 (239)
+|+|++|. .||....... .............. ... ......+..+.+++
T Consensus 247 l~el~tg~~~~~~~~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 310 (342)
T 1b6c_B 247 FWEIARRCSIGGIHEDYQLPYYDLVPSD----------------PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 310 (342)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSS----------------CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHH
T ss_pred HHHHHhccCcCCcccccccCccccCcCc----------------ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHH
Confidence 99999994 4443221100 01111111111111 110 11235677899999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 209 FECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 209 ~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
.+||+.||.+|||+.++++.|+++.++.
T Consensus 311 ~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 311 RECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=262.00 Aligned_cols=212 Identities=20% Similarity=0.262 Sum_probs=157.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||+++++|.+++...... ...++...+..++.|++.||.||| +.+++|+|||
T Consensus 88 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~ 163 (310)
T 2wqm_A 88 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIK 163 (310)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred hCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCc
Confidence 478999999999999999999999999999999988742110 156889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 164 p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 242 (310)
T 2wqm_A 164 PANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 242 (310)
T ss_dssp GGGEEECTTSCEEECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC
T ss_pred HHHEEEcCCCCEEEEeccceeeecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh
Confidence 999999999999999999986553221 1223456889999999999888999999999999999999999988532210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
.....................+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 243 -------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 243 -------------------LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp -------------------HHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------------HHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 001111111111111111234567899999999999999999999999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=270.83 Aligned_cols=191 Identities=22% Similarity=0.293 Sum_probs=157.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||+++|+|.+++... ..++...++.++.||+.||.||| +++|+||||||
T Consensus 96 ~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp 167 (373)
T 2r5t_A 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKP 167 (373)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred CCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCH
Confidence 68999999999999999999999999999999999875 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|+||||+++|||++|..||....
T Consensus 168 ~NIll~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--- 243 (373)
T 2r5t_A 168 ENILLDSQGHIVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--- 243 (373)
T ss_dssp GGEEECTTSCEEECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---
T ss_pred HHEEECCCCCEEEeeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---
Confidence 99999999999999999987542221 22345679999999999999899999999999999999999999985322
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
..+....+....... +...+..+.++|.+||+.||.+||++.+
T Consensus 244 ------------------~~~~~~~i~~~~~~~--~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 244 ------------------TAEMYDNILNKPLQL--KPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ------------------HHHHHHHHHHSCCCC--CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ------------------HHHHHHHHHhcccCC--CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 112222222222111 1134567899999999999999999853
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=260.38 Aligned_cols=217 Identities=16% Similarity=0.166 Sum_probs=156.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++||||++ +++.+.+.... ..++...+..++.|++.||+||| +.+++|+|||
T Consensus 57 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dik 128 (292)
T 3o0g_A 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLK 128 (292)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred cCCCCCEeeEEeEEEeCCEEEEEEecCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 4789999999999999999999999998 57777776543 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++...... ........+|+.|+|||++.+.. ++.++||||||+++|+|++|..|+....+
T Consensus 129 p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~ 207 (292)
T 3o0g_A 129 PQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCSC-CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred HHHEEEcCCCCEEEeecccceecCCc-cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC
Confidence 99999999999999999999765322 12234456899999999998765 79999999999999999999888643222
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhh--------cCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVV--------EDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.............. .....+......... ...........+..+.+++.+||+.||++|||++|+++
T Consensus 208 ~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 208 VDDQLKRIFRLLGT-PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHHHCC-CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHHhCC-CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 11110000000000 000000000000000 00000001134567889999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=264.53 Aligned_cols=205 Identities=18% Similarity=0.202 Sum_probs=155.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 90 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlk 161 (309)
T 2h34_A 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVK 161 (309)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCC
Confidence 478999999999999999999999999999999999865 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++...............+++.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (309)
T 2h34_A 162 PENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS 241 (309)
T ss_dssp GGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH
T ss_pred hHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH
Confidence 99999999999999999998765433322334556899999999999888999999999999999999999998643210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHHHHh
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRP-SMVDVAKKLRQIYRS 235 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~l~~~ 235 (239)
.....+..... .......+..+.+++.+||+.||.+|| |++++++.|+++...
T Consensus 242 ----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 242 ----------------------VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ----------------------HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ----------------------HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 00000000000 001123456788999999999999999 999999999987544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=266.05 Aligned_cols=202 Identities=23% Similarity=0.310 Sum_probs=142.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+
T Consensus 64 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~ 135 (325)
T 3kn6_A 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPE 135 (325)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred CCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHH
Confidence 4999999999999999999999999999999999876 56899999999999999999999 899999999999
Q ss_pred ceeecCCC---ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 83 CILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 83 nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+++.++ .+||+|||++....... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 136 NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 136 NLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp GEEEEC----CEEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred HEEEecCCCcccEEEeccccceecCCCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 99998766 79999999987653322 223345679999999999988999999999999999999999999865432
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ....+....+..... ........++.+.++|.+||+.||.+|||++|+++
T Consensus 215 ~~~~--------------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 215 SLTC--------------TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ---C--------------CCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccc--------------ccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1110 111122222222222 12222345678999999999999999999998873
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=267.48 Aligned_cols=197 Identities=23% Similarity=0.326 Sum_probs=156.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++||||+++|+|.+++... ..+++..++.++.|++.||.||| +++|+||||||+
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~ 139 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLD 139 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGG
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHH
Confidence 8999999999999999999999999999999999865 56899999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|+||||+++|+|++|..||........
T Consensus 140 NIll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 218 (345)
T 3a8x_A 140 NVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218 (345)
T ss_dssp GEEECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---
T ss_pred HEEECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccc
Confidence 9999999999999999987532221 223456789999999999998999999999999999999999999964332111
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
... .........+....... +...+..+.++|.+||+.||.+||++
T Consensus 219 ~~~------------~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 219 PDQ------------NTEDYLFQVILEKQIRI--PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----------------CHHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ccc------------ccHHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 100 01111111112221111 12345678999999999999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=263.59 Aligned_cols=212 Identities=21% Similarity=0.237 Sum_probs=156.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||+||| +.+++|+||||
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp 139 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKP 139 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCH
Confidence 47999999999999999999999999999999999875 56889999999999999999999 89999999999
Q ss_pred cceeecCCCc---eeEcccccccccCCCCc------ceeecccccccccCcccccc-----CCcccccchhhhhhHHHHH
Q 044155 82 SCILFNEENV---AKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRT-----GVFNEKSNVFSFSVFLFEL 147 (239)
Q Consensus 82 ~nil~~~~~~---~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~ 147 (239)
+||+++.++. +||+|||++........ .......|++.|+|||++.. ..++.++||||||+++|+|
T Consensus 140 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l 219 (316)
T 2ac3_A 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL 219 (316)
T ss_dssp GGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHH
T ss_pred HHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHH
Confidence 9999998776 89999999865432111 11223458999999999875 4578999999999999999
Q ss_pred hcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHH--HHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 148 LTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE--KEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 148 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
++|..||........... .......................+. ....+..+.+++.+||+.||.+|||+.|+
T Consensus 220 ~~g~~pf~~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 293 (316)
T 2ac3_A 220 LSGYPPFVGRCGSDCGWD------RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293 (316)
T ss_dssp HHSSCSCCCCCCSCSCC----------CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHCCCCCccccccccccc------ccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence 999999975443221100 0000000001112222222222111 12356778999999999999999999999
Q ss_pred HH
Q 044155 226 AK 227 (239)
Q Consensus 226 l~ 227 (239)
++
T Consensus 294 l~ 295 (316)
T 2ac3_A 294 LQ 295 (316)
T ss_dssp HH
T ss_pred hc
Confidence 87
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=269.31 Aligned_cols=193 Identities=22% Similarity=0.329 Sum_probs=158.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||+++|+|.+++... ..+++..+..++.|++.||.||| +++++||||||
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp 146 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKL 146 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCG
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCh
Confidence 38999999999999999999999999999999999875 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 147 ~NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-- 223 (345)
T 1xjd_A 147 DNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-- 223 (345)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred hhEEECCCCCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999987542221 223456789999999999998999999999999999999999999864221
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV-DVA 226 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell 226 (239)
.+....+....... +...+..+.++|.+||..||.+||++. +++
T Consensus 224 -------------------~~~~~~i~~~~~~~--p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 224 -------------------EELFHSIRMDNPFY--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------------------HHHHHHHHHCCCCC--CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------------------HHHHHHHHhCCCCC--CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111111111110 113456789999999999999999987 654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=257.40 Aligned_cols=213 Identities=16% Similarity=0.185 Sum_probs=163.8
Q ss_pred CCCcccceeeEEE-EeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MSHNHILKLIGCC-LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~H~niv~l~~~~-~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++|++++..++.+ ..+...++||||+ +++|.+++.... ..++...+..++.|++.||.||| +++++|+|||
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk 132 (296)
T 4hgt_A 61 MQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVK 132 (296)
T ss_dssp HTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 4677777666655 5667789999999 799999998543 56899999999999999999999 8999999999
Q ss_pred Ccceee---cCCCceeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 81 TSCILF---NEENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 81 ~~nil~---~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|+||++ +.++.+||+|||++........ .......|++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 133 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 212 (296)
T 4hgt_A 133 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212 (296)
T ss_dssp GGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCC
Confidence 999999 7888999999999876543321 1223557899999999999989999999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||........... ............ ........++.+.+++.+||+.||.+|||+.++++.|++
T Consensus 213 ~pf~~~~~~~~~~~--------------~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 213 LPWQGLKAATKRQK--------------YERISEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp CTTSSCCCSSSSSH--------------HHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CCCcccchhhhhhh--------------hhhhhcccccch-hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 99975432211110 000000000000 000011335678999999999999999999999999999
Q ss_pred HHHhhc
Q 044155 232 IYRSLS 237 (239)
Q Consensus 232 l~~~~~ 237 (239)
+..+..
T Consensus 278 ~~~~~~ 283 (296)
T 4hgt_A 278 LFHRQG 283 (296)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 988764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=269.22 Aligned_cols=193 Identities=21% Similarity=0.314 Sum_probs=156.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+ +|+|.+++... ..+++..+..++.|++.||.||| +.+++|||||
T Consensus 65 ~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlk 135 (336)
T 3h4j_B 65 LLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLK 135 (336)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCS
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCc
Confidence 478999999999999999999999999 58999988765 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 136 p~NIll~~~~~~kl~DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 136 PENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp TTTEEECTTCCEEECCSSCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred hhhEEEcCCCCEEEEEeccceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 999999999999999999987654332 2234568999999999988775 6899999999999999999999864221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ......... .+...++.+.+++.+||+.||.+|||++|+++
T Consensus 214 ~~~~---------------------~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 214 PNLF---------------------KKVNSCVYV--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp TTCB---------------------CCCCSSCCC--CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHH---------------------HHHHcCCCC--CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1100 000000000 01124566889999999999999999999976
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=275.84 Aligned_cols=195 Identities=18% Similarity=0.266 Sum_probs=159.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dl 79 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.||| + .+|+||||
T Consensus 204 ~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDl 275 (446)
T 4ejn_A 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDL 275 (446)
T ss_dssp CCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCC
T ss_pred hCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCC
Confidence 478999999999999999999999999999999999765 56899999999999999999999 7 89999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 276 kp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 276 KLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp CGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CHHHEEECCCCCEEEccCCCceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 9999999999999999999987542221 223456789999999999999999999999999999999999999853221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
......+....... +...++.+.++|.+||+.||.+|| |++|+++
T Consensus 355 ---------------------~~~~~~i~~~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 355 ---------------------EKLFELILMEEIRF--PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---------------------HHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---------------------HHHHHHHHhCCCCC--CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11111111111111 113456789999999999999999 9999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=274.98 Aligned_cols=194 Identities=24% Similarity=0.325 Sum_probs=159.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|||||
T Consensus 72 ~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLk 143 (476)
T 2y94_A 72 LFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLK 143 (476)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCS
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCccccc
Confidence 478999999999999999999999999999999999764 56899999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 144 p~NIll~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 144 PENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred HHHEEEecCCCeEEEeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 999999999999999999987654332 2335568999999999988765 6899999999999999999999853221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......+....... +...++.+.++|.+||+.||.+|||++|+++
T Consensus 222 ---------------------~~~~~~i~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 222 ---------------------PTLFKKICDGIFYT--PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---------------------HHHHHHHHTTCCCC--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------------------HHHHHHHhcCCcCC--CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11111111111111 1123467889999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=289.20 Aligned_cols=206 Identities=24% Similarity=0.346 Sum_probs=163.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+||||+++++++.+ ...++||||+++|+|.+++..... ..++...+..++.||+.||.||| +++++|||||
T Consensus 318 ~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlk 390 (535)
T 2h8h_A 318 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 390 (535)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCC
Confidence 3789999999999866 678999999999999999975322 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+|||++.++.+||+|||++...............++..|+|||++....++.++||||||+++|||++ |..||.....
T Consensus 391 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp GGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred HhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654322112223446788999999998899999999999999999999 8888754321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.+....+... .....+...+..+.++|.+||+.||.+|||+++|++.|+++..+
T Consensus 471 ---------------------~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 471 ---------------------REVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---------------------HHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---------------------HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1111111111 11111124456789999999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=269.92 Aligned_cols=197 Identities=18% Similarity=0.268 Sum_probs=159.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 104 ~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlk 176 (387)
T 1kob_A 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIK 176 (387)
T ss_dssp TCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccc
Confidence 4789999999999999999999999999999999997643 46899999999999999999999 8999999999
Q ss_pred CcceeecC--CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNE--ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+||+++. ++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 177 p~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 177 PENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp GGGEEESSTTCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred hHHeEEecCCCCceEEEecccceecCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 99999974 4679999999997664332 2334568999999999998889999999999999999999999986432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. +......... .........++.+.++|.+||..||.+|||+.|+++
T Consensus 255 ~~---------------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 255 DL---------------------ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HH---------------------HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HH---------------------HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11 0011111100 001111234567899999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=268.13 Aligned_cols=198 Identities=21% Similarity=0.304 Sum_probs=157.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.++...++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~ 145 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPS 145 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHH
Confidence 7999999999999999999999999999999999865 56899999999999999999999 899999999999
Q ss_pred ceeecCC----CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 83 CILFNEE----NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 83 nil~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
||++..+ +.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 146 NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 146 NILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp GEEESSSSCSGGGEEECCCTTCEECBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred HEEEecCCCCcCeEEEEECCCcccCcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 9998543 259999999987653322 12335568999999999988889999999999999999999999986422
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. ...+....+...... .......+..+.++|.+||..||.+|||+.++++
T Consensus 225 ~~------------------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 225 DD------------------TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TS------------------CHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cC------------------CHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 111111111111111 0011245567899999999999999999999886
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=269.62 Aligned_cols=197 Identities=21% Similarity=0.266 Sum_probs=159.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 142 ~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk 214 (373)
T 2x4f_A 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES----YNLTELDTILFMKQICEGIRHMH---QMYILHLDLK 214 (373)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCC
Confidence 4799999999999999999999999999999999887642 46889999999999999999999 8999999999
Q ss_pred Ccceee--cCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+||++ +.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 215 p~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 215 PENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp GGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred HHHEEEecCCCCcEEEEeCCCceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999 5667899999999876543321 234468999999999998889999999999999999999999986432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. +....+.... .........++.+.++|.+||+.||.+|||+.|+++
T Consensus 293 ~~---------------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 293 DA---------------------ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HH---------------------HHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HH---------------------HHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 1111111111 011111234567899999999999999999999997
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=274.45 Aligned_cols=196 Identities=17% Similarity=0.252 Sum_probs=158.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +++|+||||||
T Consensus 126 l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp 196 (410)
T 3v8s_A 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKP 196 (410)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCH
Confidence 6899999999999999999999999999999999975 35889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC----cccccchhhhhhHHHHHhcCCCCcccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV----FNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
+|||++.++.+||+|||++...............||+.|+|||++.+.. ++.++|+||||+++|+|++|..||...
T Consensus 197 ~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred HHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 9999999999999999999776544333344667999999999998655 789999999999999999999998532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhc--CCCcHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE--DVSSIEKEQQLHASAQVTFECIKDSPAD--RPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~ 227 (239)
.. .+....+... ....+.....+..++++|.+||..+|.+ ||+++|+++
T Consensus 277 ~~---------------------~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 277 SL---------------------VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp SH---------------------HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred Ch---------------------hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 21 1111111110 0000001134567899999999999988 999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=256.16 Aligned_cols=200 Identities=21% Similarity=0.328 Sum_probs=161.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlk 133 (277)
T 3f3z_A 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLK 133 (277)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCC
Confidence 478999999999999999999999999999999988765 56889999999999999999999 8999999999
Q ss_pred Ccceee---cCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||++ +.++.++|+|||++....... ......+++.|+|||.+.+. ++.++||||||+++|+|++|..||...
T Consensus 134 p~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp GGGEEESSSSTTCCEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEEecCCCCCcEEEEecccceeccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 999999 778899999999987654332 23345689999999988754 899999999999999999999998543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHH--HHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE--KEQQLHASAQVTFECIKDSPADRPSMVDVAK--KLRQI 232 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rps~~ell~--~L~~l 232 (239)
.. .+.............. ....++.+.+++.+||+.||.+|||+.++++ ++++.
T Consensus 211 ~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 211 TD---------------------SEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp SH---------------------HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred CH---------------------HHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 21 1111122222211111 1144678899999999999999999999986 45443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=261.98 Aligned_cols=203 Identities=26% Similarity=0.368 Sum_probs=155.9
Q ss_pred CCCCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||+++++++.+. +..++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+||
T Consensus 70 ~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl 143 (278)
T 1byg_A 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDL 143 (278)
T ss_dssp TCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred hCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCC
Confidence 47899999999997654 478999999998999999976421 23788999999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
||+||+++.++.++|+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 144 kp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 144 AARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp SGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred CcceEEEeCCCcEEEeecccccccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998654322 123356888999999988889999999999999999998 988875322
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
. .+........ .....+...++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 220 ~---------------------~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 220 L---------------------KDVVPRVEKG-YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp G---------------------GGHHHHHTTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---------------------HHHHHHHhcC-CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1 0111111010 00011123456789999999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=269.83 Aligned_cols=216 Identities=19% Similarity=0.282 Sum_probs=160.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC-Ceeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-~i~H~dl 79 (239)
+++||||+++++++.+++..++||||+++++|.+++... ..++...+..++.|++.||.||| +. +++|+||
T Consensus 87 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dl 158 (360)
T 3eqc_A 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDV 158 (360)
T ss_dssp GCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCC
T ss_pred HCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCc
Confidence 478999999999999999999999999999999999875 56889999999999999999999 65 8999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+||+++.++.++|+|||++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 159 kp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 159 KPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp SGGGEEECTTCCEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred cHHHEEECCCCCEEEEECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999998654211 12345689999999999998999999999999999999999999865332
Q ss_pred ccccc---------------------ccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCC
Q 044155 160 VHDLV---------------------CPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPAD 218 (239)
Q Consensus 160 ~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~ 218 (239)
..... ..+..+...........+..+...............+..+.++|.+||+.||.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 315 (360)
T 3eqc_A 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315 (360)
T ss_dssp HHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTT
T ss_pred HHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhh
Confidence 11000 000000000001111122222222222221112234667899999999999999
Q ss_pred CCCHHHHHH
Q 044155 219 RPSMVDVAK 227 (239)
Q Consensus 219 Rps~~ell~ 227 (239)
|||++|+++
T Consensus 316 Rpt~~ell~ 324 (360)
T 3eqc_A 316 RADLKQLMV 324 (360)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhh
Confidence 999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=264.59 Aligned_cols=210 Identities=21% Similarity=0.370 Sum_probs=164.2
Q ss_pred CCcccceeeEEEEeCC-CceEEEEEccCCChhhhhhcCCCCC-----------CCcCCHHHHHHHHHHHHHHHhHHhhCC
Q 044155 3 SHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPH-----------FEPLLLKHRLKIAMDIVHALAYLHFGF 70 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~-~~~iv~e~~~~~sL~~~l~~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~LH~~~ 70 (239)
+||||+++++++...+ ..++||||+++++|.+++....... ...++...+..++.|++.||.|||
T Consensus 89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--- 165 (316)
T 2xir_A 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 165 (316)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---
T ss_pred cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---
Confidence 6999999999988755 5899999999999999998753210 022789999999999999999999
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 149 (239)
+.+++|+||||+||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 166 ~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 166 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 89999999999999999999999999999876543322 22344567889999999998889999999999999999998
Q ss_pred -CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 150 -GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 150 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
|..||......... ..... .. .....+...++.+.+++.+||+.||.+|||+.++++.
T Consensus 246 ~g~~p~~~~~~~~~~-----------------~~~~~---~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 246 LGASPYPGVKIDEEF-----------------CRRLK---EG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TSCCSSTTCCCSHHH-----------------HHHHH---HT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccchhHHH-----------------HHHhc---cC-ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88888543211000 00000 00 0000011345678899999999999999999999999
Q ss_pred HHHHHHhh
Q 044155 229 LRQIYRSL 236 (239)
Q Consensus 229 L~~l~~~~ 236 (239)
|+++...-
T Consensus 305 L~~~~~~~ 312 (316)
T 2xir_A 305 LGNLLQAN 312 (316)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhhh
Confidence 99988754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=258.64 Aligned_cols=203 Identities=21% Similarity=0.307 Sum_probs=161.0
Q ss_pred CCCCcccceeeEEEEe----------------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHh
Q 044155 1 QMSHNHILKLIGCCLE----------------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALA 64 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~----------------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 64 (239)
+++||||+++++++.. ....++||||+++++|.+++..... ..+++..+..++.|++.||.
T Consensus 60 ~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~ 136 (284)
T 2a19_B 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVD 136 (284)
T ss_dssp HCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHH
T ss_pred hCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHH
Confidence 3689999999998864 3457899999999999999976432 56889999999999999999
Q ss_pred HHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHH
Q 044155 65 YLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFL 144 (239)
Q Consensus 65 ~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 144 (239)
||| +.+++|+||||+||+++.++.++|+|||++........ .....+++.|+|||.+.+..++.++||||||+++
T Consensus 137 ~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (284)
T 2a19_B 137 YIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211 (284)
T ss_dssp HHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHH
T ss_pred HHH---hCCeeeccCCHHHEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHH
Confidence 999 89999999999999999999999999999876543321 2344689999999999988899999999999999
Q ss_pred HHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 145 FELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 145 ~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
|+|++|..|+.... ............ ...+..+.+++.+||+.||.+|||+.|
T Consensus 212 ~~l~~~~~~~~~~~-----------------------~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e 264 (284)
T 2a19_B 212 AELLHVCDTAFETS-----------------------KFFTDLRDGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSE 264 (284)
T ss_dssp HHHHSCCSSHHHHH-----------------------HHHHHHHTTCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHhcCCcchhHH-----------------------HHHHHhhccccc----ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999987753211 000001111111 123456789999999999999999999
Q ss_pred HHHHHHHHHHhhcC
Q 044155 225 VAKKLRQIYRSLSC 238 (239)
Q Consensus 225 ll~~L~~l~~~~~~ 238 (239)
+++.|..+.++...
T Consensus 265 ~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 265 ILRTLTVWKKSPEK 278 (284)
T ss_dssp HHHHHHHHTC----
T ss_pred HHHHHHHHhhCCCc
Confidence 99999988766543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=272.22 Aligned_cols=197 Identities=20% Similarity=0.206 Sum_probs=157.4
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+.+..++||||+++|+|.+++.+.. ..+++..++.++.|++.||.||| +.+|+||||||
T Consensus 118 ~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp 190 (412)
T 2vd5_A 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKP 190 (412)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCH
Confidence 689999999999999999999999999999999997642 46889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-------cCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-------TGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
+|||++.++.+||+|||++...............||+.|+|||++. ...++.++|+||||+++|||++|..||
T Consensus 191 ~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred HHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 9999999999999999999776443332334567999999999987 356899999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhh---cCCCcHHHHHHHHHHHHHHhhhcCCCCCCC---CCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVV---EDVSSIEKEQQLHASAQVTFECIKDSPADR---PSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~ell~ 227 (239)
..... .+....+.. ....+......+..+.++|.+||. +|.+| |+++|+++
T Consensus 271 ~~~~~---------------------~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 271 YADST---------------------AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCSSH---------------------HHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCCH---------------------HHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 54221 111111110 000111123456788999999999 99998 58888864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=269.17 Aligned_cols=214 Identities=13% Similarity=0.149 Sum_probs=163.9
Q ss_pred CCCcccce---------------eeEEEEe-CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhH
Q 044155 2 MSHNHILK---------------LIGCCLE-TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAY 65 (239)
Q Consensus 2 l~H~niv~---------------l~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 65 (239)
++||||++ +++++.. +...++||||+ +++|.+++..... ..+++..+..++.|++.||.|
T Consensus 99 l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~ 174 (352)
T 2jii_A 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEF 174 (352)
T ss_dssp HCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHH
T ss_pred hcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHH
Confidence 46777776 7788876 66789999999 8999999987532 568999999999999999999
Q ss_pred HhhCCCCCeeeccccCcceeecCCC--ceeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccch
Q 044155 66 LHFGFPRPIVFRNFKTSCILFNEEN--VAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNV 137 (239)
Q Consensus 66 LH~~~~~~i~H~dlk~~nil~~~~~--~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 137 (239)
|| +++++|+||||+||+++.++ .++|+|||++........ .......|++.|+|||++.+..++.++||
T Consensus 175 LH---~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 251 (352)
T 2jii_A 175 LH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251 (352)
T ss_dssp HH---HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred HH---hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhH
Confidence 99 89999999999999999998 899999999876532211 11234478999999999998899999999
Q ss_pred hhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcH----HHHHHHHHHHHHHhhhcC
Q 044155 138 FSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSI----EKEQQLHASAQVTFECIK 213 (239)
Q Consensus 138 ~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~ 213 (239)
||||+++|+|++|..||......... ................ .....+..+.+++.+||+
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 315 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNTED----------------IMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMA 315 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCHHH----------------HHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCCcccCCcCHHH----------------HHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHh
Confidence 99999999999999998654311100 0000000000000000 000234678999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcC
Q 044155 214 DSPADRPSMVDVAKKLRQIYRSLSC 238 (239)
Q Consensus 214 ~dp~~Rps~~ell~~L~~l~~~~~~ 238 (239)
.||.+|||++++++.|+++......
T Consensus 316 ~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 316 LTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CChhhCCCHHHHHHHHHHHHHhcCC
Confidence 9999999999999999999887653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=261.98 Aligned_cols=216 Identities=17% Similarity=0.224 Sum_probs=154.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||++ ++|.+++.... ..++...+..++.|++.||.||| +++++|+|||
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 127 (288)
T 1ob3_A 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLK 127 (288)
T ss_dssp GCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 4789999999999999999999999998 69999887643 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++....... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||.....
T Consensus 128 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 128 PQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp GGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHHEEEcCCCCEEEeECccccccCccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999987653221 122344679999999998764 589999999999999999999999975432
Q ss_pred cccccccchhhhhhhhhccchhhhhh-----hhhhc--CC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVD-----HIVVE--DV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........... .. .....++.... ..... .. ........++.+.+++.+||+.||++|||++|+++
T Consensus 207 ~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 207 ADQLMRIFRIL-GT-PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHHHHHHHHH-CC-CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHH-CC-CChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 21111000000 00 00000000000 00000 00 00001134567889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=263.47 Aligned_cols=204 Identities=23% Similarity=0.333 Sum_probs=153.2
Q ss_pred CCCCcccceeeEEEEeCCCc----eEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLETPIP----ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~----~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+++||||+++++++...... ++||||+++++|.+++... ..++...+..++.|++.||.||| +++++|
T Consensus 68 ~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH 139 (311)
T 3ork_A 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIH 139 (311)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCc
Confidence 47899999999999876554 8999999999999999865 56889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
+||||+||+++.++.+||+|||++........ .......|++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 140 ~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf 219 (311)
T 3ork_A 140 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219 (311)
T ss_dssp CCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999876543221 1233456899999999999889999999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHH--HHHHHHHHHHHHhhhcCCCCCCCCCHHH-HHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE--KEQQLHASAQVTFECIKDSPADRPSMVD-VAKKLRQ 231 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rps~~e-ll~~L~~ 231 (239)
..... ................ ....+..+.++|.+||+.||.+||++.+ +...|.+
T Consensus 220 ~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 220 TGDSP---------------------VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCSSH---------------------HHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCh---------------------HHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 54321 1111111111111111 1235677899999999999999996554 5556655
Q ss_pred HH
Q 044155 232 IY 233 (239)
Q Consensus 232 l~ 233 (239)
+.
T Consensus 279 ~~ 280 (311)
T 3ork_A 279 VH 280 (311)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=256.91 Aligned_cols=195 Identities=19% Similarity=0.295 Sum_probs=153.7
Q ss_pred CCCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC--e
Q 044155 1 QMSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--I 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--i 74 (239)
+++||||+++++++.. ....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+ +
T Consensus 81 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i 152 (290)
T 1t4h_A 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPI 152 (290)
T ss_dssp TCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCC
T ss_pred hCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCE
Confidence 4789999999999875 34578999999999999999875 56889999999999999999999 888 9
Q ss_pred eeccccCcceeec-CCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 75 VFRNFKTSCILFN-EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 75 ~H~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+|+||||+||+++ .++.++|+|||++....... .....|++.|+|||.+. ..++.++||||||+++|+|++|..|
T Consensus 153 ~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~p 228 (290)
T 1t4h_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP 228 (290)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EECCCCHHHEEEECCCCCEEEeeCCCcccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCC
Confidence 9999999999997 78899999999986543322 23456899999999886 4589999999999999999999999
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
|........ ..................++.+.+++.+||+.||.+|||+.|+++
T Consensus 229 f~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 229 YSECQNAAQ--------------------IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTCSSHHH--------------------HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcCcHHH--------------------HHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 854321111 111111111111111223456899999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=264.41 Aligned_cols=194 Identities=22% Similarity=0.292 Sum_probs=154.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.||| +++++||||||
T Consensus 78 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp 149 (327)
T 3a62_A 78 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKP 149 (327)
T ss_dssp CCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCT
T ss_pred CCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCH
Confidence 68999999999999999999999999999999999865 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 150 ~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-- 226 (327)
T 3a62_A 150 ENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-- 226 (327)
T ss_dssp TTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred HHeEECCCCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--
Confidence 99999999999999999986542221 123355689999999999988899999999999999999999999864221
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.+....+....... +...+..+.+++.+||+.||.+|| ++.|+++
T Consensus 227 -------------------~~~~~~i~~~~~~~--p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 227 -------------------KKTIDKILKCKLNL--PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------------------HHHHHHHHHTCCCC--CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------------------HHHHHHHHhCCCCC--CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11111111111111 113456789999999999999999 7778765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=265.59 Aligned_cols=216 Identities=18% Similarity=0.223 Sum_probs=154.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||++ ++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dik 127 (324)
T 3mtl_A 56 DLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLK 127 (324)
T ss_dssp CCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCC
T ss_pred hcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcC
Confidence 4789999999999999999999999997 79999988753 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 128 p~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 128 PQNLLINERGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp GGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHHEEECCCCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999987543221 12234567999999999876 5689999999999999999999999975432
Q ss_pred cccccccchhhhhhhhhccchhhhhhhh-----hhcC--CCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHI-----VVED--VSS--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... ... ......+....... .... ... ......+..+.+++.+||+.||.+|||++|+++
T Consensus 207 ~~~~~~i~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 207 EEQLHFIFR-ILG-TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHHHHH-HHC-CCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHH-HhC-CCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 111100000 000 00000011110000 0000 000 011134567889999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=261.33 Aligned_cols=215 Identities=20% Similarity=0.239 Sum_probs=158.1
Q ss_pred CCCcccceeeEEEEeCC-----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 2 MSHNHILKLIGCCLETP-----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~-----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++||||+++++++.... ..++|||++. ++|.+++..... ..+++..+..++.|++.||+||| +.+++|
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH 143 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVH 143 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 36999999999998765 4789999997 799999987643 45899999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||||+||+++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 144 RDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp SCCCTTTEEECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred CCCCHHHEEEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987653322 23456789999999999989999999999999999999999999865
Q ss_pred ccccccccccchhhhhhhhhccchhhhh---hhhhhcCCCcH---HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIV---DHIVVEDVSSI---EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
............. ... .....+.... ........... .....++.+.++|.+||+.||.+|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 222 NSEADQLGKIFDL-IGL-PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SSHHHHHHHHHHH-HCC-CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHH-hCC-CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 4322111000000 000 0000000000 00000000000 01134567889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=255.57 Aligned_cols=199 Identities=23% Similarity=0.318 Sum_probs=157.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 132 (276)
T 2yex_A 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIK 132 (276)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCC
Confidence 478999999999999999999999999999999998754 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+||+++.++.++|+|||.+....... ........|++.|+|||.+.+..+ +.++||||||+++|+|++|..||....
T Consensus 133 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (276)
T ss_dssp GGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSC
T ss_pred hHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999999987543221 122334568999999999987665 778999999999999999999986533
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... . .. .............+..+.+++.+||+.||.+|||++|+++
T Consensus 213 ~~~~~~-------~---------~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 213 DSCQEY-------S---------DW----KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTSHHH-------H---------HH----HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHHHH-------H---------Hh----hhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 211100 0 00 0000000001234567889999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=261.34 Aligned_cols=196 Identities=20% Similarity=0.283 Sum_probs=160.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 71 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dik 142 (321)
T 2a2a_A 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142 (321)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 368999999999999999999999999999999999765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCC----ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEEN----VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||+++.++ .++|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 143 p~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp GGGEEESCTTSSSCCEEECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred hHHEEEecCCCCcCCEEEccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 9999999888 79999999987654332 12345689999999999988899999999999999999999999854
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .+......... .........+..+.++|.+||+.||.+|||+.|+++
T Consensus 221 ~~~---------------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 221 DTK---------------------QETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp SSH---------------------HHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCH---------------------HHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 221 01111111111 111112244567899999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=276.18 Aligned_cols=201 Identities=18% Similarity=0.208 Sum_probs=159.6
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||++++++|.+....++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||
T Consensus 131 ~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp 203 (437)
T 4aw2_A 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKP 203 (437)
T ss_dssp SCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred CCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCH
Confidence 689999999999999999999999999999999998642 56899999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+|||++.++.+||+|||+++..............||+.|+|||++. ...++.++||||||+++|||++|..||..
T Consensus 204 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred HHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999766444433344567999999999987 45689999999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPAD--RPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~ 227 (239)
...... ...+........... .....++.++++|.+||..+|.+ ||+++|+++
T Consensus 284 ~~~~~~-----------------~~~i~~~~~~~~~p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 284 ESLVET-----------------YGKIMNHKERFQFPT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp SSHHHH-----------------HHHHHTHHHHCCCCS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CChhHH-----------------HHhhhhccccccCCc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 221000 001110000000000 00124567899999999998888 999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=264.87 Aligned_cols=193 Identities=21% Similarity=0.301 Sum_probs=158.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++||||+++|+|.+++... ..+++..+..++.|++.||.||| +++|+||||||+
T Consensus 79 ~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~ 150 (353)
T 2i0e_A 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLD 150 (353)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGG
T ss_pred CCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHH
Confidence 7999999999999999999999999999999999865 56899999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
||+++.++.+||+|||++....... .......||+.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 151 NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---- 225 (353)
T 2i0e_A 151 NVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---- 225 (353)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred HEEEcCCCcEEEEeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC----
Confidence 9999999999999999987532221 22345679999999999998899999999999999999999999985322
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
..+....+....... +...+..+.++|.+||..||.+||+ ++++++
T Consensus 226 -----------------~~~~~~~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 226 -----------------EDELFQSIMEHNVAY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----------------HHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----------------HHHHHHHHHhCCCCC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111222222222111 1245677899999999999999995 466654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=265.32 Aligned_cols=218 Identities=19% Similarity=0.217 Sum_probs=157.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||+++++++.+.+..++||||++ ++|.+++..... .....++...+..++.|++.||.||| +.+++|+||
T Consensus 59 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dl 134 (317)
T 2pmi_A 59 ELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDL 134 (317)
T ss_dssp TCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred hcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCC
Confidence 4789999999999999999999999998 799998875421 11135889999999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
||+||+++.++.+||+|||++....... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||....
T Consensus 135 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 135 KPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ChHHeEEcCCCCEEECcCccceecCCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987653221 122345689999999998764 58999999999999999999999997543
Q ss_pred ccccccccc-------hhhhhhhhhccch--------hhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 159 DVHDLVCPF-------SEYLKNCFEDNRF--------TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 159 ~~~~~~~~~-------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
......... ...+........+ ............ ....+..+.+++.+||+.||.+|||++
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ 289 (317)
T 2pmi_A 214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAK 289 (317)
T ss_dssp HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHH
Confidence 221110000 0000000000000 000000000000 012346789999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
|+++
T Consensus 290 e~l~ 293 (317)
T 2pmi_A 290 QALH 293 (317)
T ss_dssp HHTT
T ss_pred HHhC
Confidence 9985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=267.68 Aligned_cols=193 Identities=23% Similarity=0.352 Sum_probs=154.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+++..++||||+. |+|.+++.... ..+++..+..++.|++.||.||| +.+++|+|||
T Consensus 110 ~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk 181 (348)
T 1u5q_A 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVK 181 (348)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCS
T ss_pred hCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCC
Confidence 3789999999999999999999999997 78888886532 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++.+||+|||++..... .....|++.|+|||++. ...++.++||||||+++|+|++|..||...
T Consensus 182 p~NIll~~~~~~kL~DfG~a~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 182 AGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp GGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HHHEEECCCCCEEEeeccCceecCC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999866532 22456899999999985 456889999999999999999999998543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ..................+..+.++|.+||+.||.+|||++++++
T Consensus 257 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 257 NAMS---------------------ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CHHH---------------------HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ChHH---------------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 2110 000111111100111234567889999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=260.83 Aligned_cols=206 Identities=24% Similarity=0.443 Sum_probs=160.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.. .++|+||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 77 ~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dik 148 (291)
T 1u46_A 77 SLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLA 148 (291)
T ss_dssp HCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred hCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCc
Confidence 368999999999997765 789999999999999997642 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 149 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 99999999999999999998766433221 2234456778999999988889999999999999999999 98887543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.. .+..................+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 229 ~~---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 229 NG---------------------SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CH---------------------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CH---------------------HHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 21 1111111111111111124456789999999999999999999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=259.85 Aligned_cols=218 Identities=19% Similarity=0.236 Sum_probs=155.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlk 129 (311)
T 4agu_A 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVK 129 (311)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCC
Confidence 378999999999999999999999999999998888755 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.....
T Consensus 130 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 130 PENILITKHSVIKLCDFGFARLLTGPS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhhEEEcCCCCEEEeeCCCchhccCcc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999987654222 12234568899999999876 5689999999999999999999999975443
Q ss_pred cccccc------cchhhhhhhhhccchhhhhhhhhhcCCCcHH--HHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVC------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE--KEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... .........+....+................ ....+..+.+++.+||+.||.+|||++|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 209 VDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 211110 0000000001110000000000000000000 0134567889999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=256.10 Aligned_cols=193 Identities=21% Similarity=0.383 Sum_probs=155.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 65 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlk 136 (279)
T 3fdn_A 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIK 136 (279)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCC
T ss_pred cCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCC
Confidence 478999999999999999999999999999999999765 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++...... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 137 p~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 212 (279)
T 3fdn_A 137 PENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY- 212 (279)
T ss_dssp GGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-
T ss_pred hHhEEEcCCCCEEEEeccccccCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-
Confidence 99999999999999999987544322 22345689999999999988899999999999999999999998853221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+........... .+...+..+.+++.+||+.||.+|||++|+++
T Consensus 213 --------------------~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 213 --------------------QETYKRISRVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --------------------HHHHHHHHHTCCC--CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --------------------HHHHHHHHhCCCC--CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111111110 01134567889999999999999999999997
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=271.59 Aligned_cols=227 Identities=18% Similarity=0.179 Sum_probs=166.7
Q ss_pred CCCCcccceeeEEEEeCC--CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLETP--IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~--~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.... ..++||||+++++|.+++...... ..++...+..++.|++.||+||| +.+++|+|
T Consensus 63 ~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D 137 (396)
T 4eut_A 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRN 137 (396)
T ss_dssp HCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred hcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECC
Confidence 368999999999998765 678999999999999999764321 33899999999999999999999 89999999
Q ss_pred ccCcceee----cCCCceeEcccccccccCCCCcceeecccccccccCcccccc--------CCcccccchhhhhhHHHH
Q 044155 79 FKTSCILF----NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT--------GVFNEKSNVFSFSVFLFE 146 (239)
Q Consensus 79 lk~~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ 146 (239)
|||+||++ +.++.+||+|||++....... ......|++.|+|||++.. ..++.++||||||+++|+
T Consensus 138 lkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~e 215 (396)
T 4eut_A 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215 (396)
T ss_dssp CCGGGEEEEECTTSCEEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHH
T ss_pred cCHHHEEEeecCCCceeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHH
Confidence 99999999 777789999999997654322 2234568999999999865 457889999999999999
Q ss_pred HhcCCCCcccccccccccccchhhhhhhhhccchhhh-------hhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 147 LLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEI-------VDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 147 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
|++|..||....................... .+... +.....-..........+..+.+++.+||+.||.+|
T Consensus 216 l~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R 294 (396)
T 4eut_A 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSG-AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294 (396)
T ss_dssp HHHSSCSEECTTCTTTCHHHHHHHHHSCCTT-CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTS
T ss_pred HHHCCCCCCCCCcccchHHHHHHHhcCCCcc-cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhh
Confidence 9999999975443221111111111100000 00000 000000001111224677889999999999999999
Q ss_pred CCHHHHHHHHHHHHHh
Q 044155 220 PSMVDVAKKLRQIYRS 235 (239)
Q Consensus 220 ps~~ell~~L~~l~~~ 235 (239)
||++++++.+.+++..
T Consensus 295 ~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 295 WGFDQFFAETSDILHR 310 (396)
T ss_dssp CCHHHHHHHHHHHHTC
T ss_pred ccHHHHHHHHHHHhhc
Confidence 9999999999988764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.37 Aligned_cols=206 Identities=23% Similarity=0.309 Sum_probs=161.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++. .+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +++++|||||
T Consensus 447 ~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDik 518 (656)
T 2j0j_A 447 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIA 518 (656)
T ss_dssp HCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccc
Confidence 368999999999984 456899999999999999998653 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||++...............+++.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 519 p~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp GGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred hHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999999999999997664433323334456789999999998899999999999999999997 8888754321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
. +.......... ...+...++.+.+++.+||+.||.+|||+.++++.|+++..+.
T Consensus 599 ~---------------------~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 599 N---------------------DVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp H---------------------HHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H---------------------HHHHHHHcCCC-CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1 11111111110 0111244567899999999999999999999999999987653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=254.86 Aligned_cols=213 Identities=16% Similarity=0.184 Sum_probs=162.9
Q ss_pred CCCcccceeeEEE-EeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MSHNHILKLIGCC-LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~H~niv~l~~~~-~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++|++++..+.++ ..+...++||||+ +++|.+++.... ..++...+..++.|++.||.||| +++++|+|||
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlk 132 (296)
T 3uzp_A 61 MQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVK 132 (296)
T ss_dssp HTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred hhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCC
Confidence 5677766666655 5666779999999 799999997543 56899999999999999999999 8999999999
Q ss_pred Ccceeec---CCCceeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 81 TSCILFN---EENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 81 ~~nil~~---~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|+||+++ .++.+||+|||++........ .......|++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 133 p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 212 (296)
T 3uzp_A 133 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212 (296)
T ss_dssp GGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence 9999994 788999999999876543322 1124557899999999999989999999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||........... ............ ........++.+.+++.+||+.||.+|||+.++++.|++
T Consensus 213 ~pf~~~~~~~~~~~--------------~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 213 LPWQGLKAATKRQK--------------YERISEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp CTTSSCCCSSSSSH--------------HHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CCCCCcCchhhhhh--------------hhhhcccccCCc-hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 99875432211100 000000000000 000112345678999999999999999999999999999
Q ss_pred HHHhhc
Q 044155 232 IYRSLS 237 (239)
Q Consensus 232 l~~~~~ 237 (239)
+.....
T Consensus 278 ~~~~~~ 283 (296)
T 3uzp_A 278 LFHRQG 283 (296)
T ss_dssp HHHHTT
T ss_pred HHHhcC
Confidence 987754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=262.83 Aligned_cols=209 Identities=19% Similarity=0.356 Sum_probs=163.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++.++...++||||+++++|.+++..... .....++...+..++.|++.||.||| +++++
T Consensus 84 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~ 160 (322)
T 1p4o_A 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFV 160 (322)
T ss_dssp GCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCB
T ss_pred hcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCc
Confidence 47899999999999999999999999999999999875311 01135688999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDV 153 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p 153 (239)
|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 161 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 240 (322)
T 1p4o_A 161 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240 (322)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred cCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999875432221 11223456788999999998889999999999999999999 7778
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
|..... .+........... ..+...+..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 241 ~~~~~~---------------------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 241 YQGLSN---------------------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp TTTSCH---------------------HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred cccCCH---------------------HHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 754321 1111111111110 001244567899999999999999999999999998764
Q ss_pred H
Q 044155 234 R 234 (239)
Q Consensus 234 ~ 234 (239)
.
T Consensus 299 ~ 299 (322)
T 1p4o_A 299 E 299 (322)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=266.00 Aligned_cols=217 Identities=14% Similarity=0.174 Sum_probs=151.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.++...++||||++ ++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 89 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlk 159 (329)
T 3gbz_A 89 ELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLK 159 (329)
T ss_dssp GCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred HcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCC
Confidence 4789999999999999999999999998 6999999876 56889999999999999999999 8999999999
Q ss_pred Ccceeec-----CCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCc
Q 044155 81 TSCILFN-----EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 81 ~~nil~~-----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||+++ .++.+||+|||++....... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||
T Consensus 160 p~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 238 (329)
T 3gbz_A 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238 (329)
T ss_dssp GGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHHEEEecCCCCccceEEECcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 9999995 44569999999987653221 123345679999999999875 4899999999999999999999998
Q ss_pred ccccccccccccch-------hhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFS-------EYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.............. ...........+....................+..+.++|.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 239 PGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 65432211110000 00000000000000000000000000011124567899999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=263.76 Aligned_cols=208 Identities=23% Similarity=0.243 Sum_probs=155.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------------------------------CCC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------------------------------HFE 45 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------------------------------~~~ 45 (239)
+++||||+++++++.+.+..++||||+++++|.+++...... ...
T Consensus 84 ~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (345)
T 3hko_A 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDF 163 (345)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCH
T ss_pred hCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 368999999999999999999999999999999988521000 002
Q ss_pred cCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCC--ceeEcccccccccCC---CCcceeecccccccc
Q 044155 46 PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN--VAKLFDFSLSISIPE---GETHITDTVMGTLGY 120 (239)
Q Consensus 46 ~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~--~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~y 120 (239)
.+++..+..++.|++.||.||| +.+++|+||||+||+++.++ .+||+|||++..... ..........|++.|
T Consensus 164 ~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 240 (345)
T 3hko_A 164 VQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred cccHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence 3457778889999999999999 89999999999999998776 899999999875432 111223456689999
Q ss_pred cCcccccc--CCcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHH
Q 044155 121 CAPEYMRT--GVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIE 196 (239)
Q Consensus 121 ~aPE~~~~--~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 196 (239)
+|||++.+ ..++.++||||||+++|+|++|..||...... +.......... ....
T Consensus 241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------~~~~~~~~~~~~~~~~~ 299 (345)
T 3hko_A 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA---------------------DTISQVLNKKLCFENPN 299 (345)
T ss_dssp CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------------HHHHHHHHCCCCTTSGG
T ss_pred cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH---------------------HHHHHHHhcccccCCcc
Confidence 99999875 56889999999999999999999998643311 11111111111 1111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHHH
Q 044155 197 KEQQLHASAQVTFECIKDSPADRPSMVDVAK--KLRQI 232 (239)
Q Consensus 197 ~~~~~~~~~~li~~cl~~dp~~Rps~~ell~--~L~~l 232 (239)
....++.+.++|.+||+.||.+|||+.++++ ++.++
T Consensus 300 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 1234567899999999999999999999987 44443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=256.19 Aligned_cols=196 Identities=23% Similarity=0.347 Sum_probs=158.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+.+... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dik 132 (284)
T 3kk8_A 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLK 132 (284)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred HcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCC
Confidence 368999999999999999999999999999999988765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCc---eeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENV---AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++. ++|+|||.+....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 133 p~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 133 PENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp GGGEEESSSSTTCCEEECCCTTCEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEEecCCCCCcEEEeeceeeEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 99999987665 9999999987654332 123456899999999999989999999999999999999999998532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... ........... ........++.+.+++.+||+.||.+|||+.|+++
T Consensus 211 ~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 211 DQH---------------------RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp SHH---------------------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chh---------------------HHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 210 11111111111 01111234567889999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=276.59 Aligned_cols=199 Identities=21% Similarity=0.293 Sum_probs=161.0
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||+++|+|.+++..... ..+++..+..++.||+.||.||| +++|+||||||
T Consensus 241 l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKP 314 (576)
T 2acx_A 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKP 314 (576)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred cCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCch
Confidence 6899999999999999999999999999999999976532 45899999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+|||++.++.+||+|||++....... ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 315 eNILld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~ 392 (576)
T 2acx_A 315 ENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI 392 (576)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC
T ss_pred heEEEeCCCCeEEEecccceecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch
Confidence 99999999999999999997764332 2334579999999999998889999999999999999999999986432110
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
. .......+...... .+...+..+.++|.+||+.||.+|| +++|+++
T Consensus 393 ~-----------------~~~i~~~i~~~~~~--~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 393 K-----------------REEVERLVKEVPEE--YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp C-----------------HHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred h-----------------HHHHHHHhhccccc--CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 01111111111111 0124457789999999999999999 7888875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=255.80 Aligned_cols=196 Identities=22% Similarity=0.327 Sum_probs=138.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 67 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~ 139 (278)
T 3cok_A 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLT 139 (278)
T ss_dssp TBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCC
T ss_pred hCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence 4789999999999999999999999999999999998643 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 140 p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 218 (278)
T 3cok_A 140 LSNLLLTRNMNIKIADFGLATQLKMPH-EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK 218 (278)
T ss_dssp GGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC
T ss_pred HHHEEEcCCCCEEEEeecceeeccCCC-CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH
Confidence 999999999999999999987653222 1223456889999999999888999999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ......... +...+..+.+++.+||+.||.+|||++++++
T Consensus 219 ~~~~---------------------~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 219 NTLN---------------------KVVLADYEM--PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --------------------------CCSSCCCC--CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHH---------------------HHhhcccCC--ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1100 000000000 0123456889999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=260.84 Aligned_cols=204 Identities=15% Similarity=0.160 Sum_probs=162.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.|+||+++++++...+..++||||+++|+|.+++..........+++..+..++.|++.||+||| +++|+||||||+
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~ 201 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPD 201 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGG
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHH
Confidence 49999999999999999999999999999999997532211256899999999999999999999 999999999999
Q ss_pred ceeecC-----------CCceeEcccccccccCC-CCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcC
Q 044155 83 CILFNE-----------ENVAKLFDFSLSISIPE-GETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150 (239)
Q Consensus 83 nil~~~-----------~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g 150 (239)
|||++. ++.+||+|||++..... ..........||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus 202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 999998 88999999999965431 122234456799999999999998999999999999999999999
Q ss_pred CCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHH
Q 044155 151 WDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-SMVDVAKKL 229 (239)
Q Consensus 151 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L 229 (239)
+.||.......... ...... . ..++.+.+++..|++.+|.+|+ ++.++.+.|
T Consensus 282 ~~pf~~~~~~~~~~--------------------~~~~~~-~------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 282 TYMKVKNEGGECKP--------------------EGLFRR-L------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp SCCCEEEETTEEEE--------------------CSCCTT-C------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred CCccccCCCCceee--------------------chhccc-c------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 99985433211100 000000 0 1134567899999999999984 788888888
Q ss_pred HHHHHhh
Q 044155 230 RQIYRSL 236 (239)
Q Consensus 230 ~~l~~~~ 236 (239)
+++..+.
T Consensus 335 ~~~l~~~ 341 (365)
T 3e7e_A 335 KKVFQQH 341 (365)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 8877653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=261.26 Aligned_cols=210 Identities=20% Similarity=0.339 Sum_probs=162.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC--CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP--HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++.+....++||||+++++|.+++...... ....++...+..++.|++.||.||| +.+++|+|
T Consensus 89 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~d 165 (327)
T 2yfx_A 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRD 165 (327)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred hCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCc
Confidence 368999999999999999999999999999999999875421 1135889999999999999999999 89999999
Q ss_pred ccCcceeecCC---CceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCC
Q 044155 79 FKTSCILFNEE---NVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDV 153 (239)
Q Consensus 79 lk~~nil~~~~---~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p 153 (239)
|||+||+++.+ ..++|+|||++....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 166 lkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 245 (327)
T 2yfx_A 166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245 (327)
T ss_dssp CCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999844 469999999986543222 122335567889999999988889999999999999999998 8888
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
|..... .+........... ......+..+.+++.+||+.||.+|||+.++++.|..+.
T Consensus 246 ~~~~~~---------------------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 246 YPSKSN---------------------QEVLEFVTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp STTCCH---------------------HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcCH---------------------HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 753221 0111111111000 001234567889999999999999999999999999876
Q ss_pred Hh
Q 044155 234 RS 235 (239)
Q Consensus 234 ~~ 235 (239)
..
T Consensus 304 ~~ 305 (327)
T 2yfx_A 304 QD 305 (327)
T ss_dssp HC
T ss_pred cC
Confidence 53
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=254.16 Aligned_cols=193 Identities=22% Similarity=0.330 Sum_probs=158.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 70 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~ 141 (284)
T 2vgo_A 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCH---ERKVIHRDIK 141 (284)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCS
T ss_pred cCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCC
Confidence 478999999999999999999999999999999999865 56889999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 142 p~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 218 (284)
T 2vgo_A 142 PENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218 (284)
T ss_dssp GGGEEECTTCCEEECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred HHHEEEcCCCCEEEecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence 999999999999999999986543221 23456899999999999888999999999999999999999998643210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+........... .+...+..+.+++.+||+.||.+|||++++++
T Consensus 219 ---------------------~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 219 ---------------------ETHRRIVNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---------------------HHHHHHHTTCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---------------------HHHHHHhccccC--CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 001111111110 01134567889999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=267.26 Aligned_cols=196 Identities=21% Similarity=0.308 Sum_probs=148.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.. ...++||||+++++|.+++... ..+++..+..++.|++.||+||| +++++|||||
T Consensus 196 ~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlk 266 (419)
T 3i6u_A 196 KLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLK 266 (419)
T ss_dssp HCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 3789999999999854 4578999999999999998765 56899999999999999999999 8999999999
Q ss_pred CcceeecCCC---ceeEcccccccccCCCCcceeecccccccccCcccccc---CCcccccchhhhhhHHHHHhcCCCCc
Q 044155 81 TSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 81 ~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||+++.++ .+||+|||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 267 p~NIll~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf 344 (419)
T 3i6u_A 267 PENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344 (419)
T ss_dssp GGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred hHhEEEecCCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999997654 4999999999765332 22345678999999999864 56788999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... ......... .+......++.+.++|.+||+.||.+|||++|+++
T Consensus 345 ~~~~~~~~~--------------------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 345 SEHRTQVSL--------------------KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCSSSCCH--------------------HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcchHHH--------------------HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 643221111 000111111 11111234677899999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=263.58 Aligned_cols=198 Identities=21% Similarity=0.279 Sum_probs=157.1
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++......++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||||+
T Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~ 188 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLE 188 (355)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGG
T ss_pred CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHH
Confidence 6999999999999999999999999999999999865 56889999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc--CCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT--GVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
||+++.++.+||+|||+++..............||+.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 189 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 268 (355)
T 1vzo_A 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268 (355)
T ss_dssp GEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred HEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc
Confidence 9999999999999999987654333333445678999999999985 34788999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.. .............. .+...+..+.++|.+||..||.+|| |++|+++
T Consensus 269 ~~-----------------~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 269 NS-----------------QAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp CC-----------------HHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ch-----------------HHHHHHHHhccCCC--CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 11 01111111111110 1123456788999999999999999 9999886
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=256.99 Aligned_cols=199 Identities=21% Similarity=0.272 Sum_probs=159.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++.... ..++...+..++.|++.||.||| ..+++|+|||
T Consensus 80 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~ 152 (314)
T 3com_A 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIK 152 (314)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcC
Confidence 4789999999999999999999999999999999987432 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 153 p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 231 (314)
T 3com_A 153 AGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM 231 (314)
T ss_dssp GGGEEECTTCCEEECCCTTCEECBTTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred HHHEEECCCCCEEEeecccchhhhhhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999999987653322 1233456889999999999888999999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... . .......... ..+...+..+.+++.+||..||.+|||+.++++
T Consensus 232 ~~~--------~----------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 232 RAI--------F----------MIPTNPPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHH--------H----------HHHHSCCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHH--------H----------HHhcCCCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 0 0000000000 011234567889999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=269.58 Aligned_cols=212 Identities=18% Similarity=0.234 Sum_probs=151.8
Q ss_pred CCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 2 MSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
++||||+++++++.... ..++||||++ ++|.+.+. ..++...+..++.|++.||+||| +.+|+
T Consensus 118 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~-~~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH---~~~ii 186 (464)
T 3ttj_A 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGII 186 (464)
T ss_dssp CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred CCCCCCCcEEEEEccCCccccCCeEEEEEeCCC-CCHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 68999999999997554 4599999997 57777774 34889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 187 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp CCCCCGGGEEECTTSCEEECCCCCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCChHhEEEeCCCCEEEEEEEeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987653321 2345678999999999999999999999999999999999999997
Q ss_pred ccccccccc-------ccchhhhhhh-------hh------ccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCC
Q 044155 156 LVKDVHDLV-------CPFSEYLKNC-------FE------DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDS 215 (239)
Q Consensus 156 ~~~~~~~~~-------~~~~~~~~~~-------~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 215 (239)
......... .+..++.... .. ...+......... ..........++.+.+|+.+||..|
T Consensus 265 g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dLl~~mL~~d 343 (464)
T 3ttj_A 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDLLSKMLVID 343 (464)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccc-ccccccccccCHHHHHHHHHHcCCC
Confidence 543221110 0001110000 00 0000111100000 1111222344778999999999999
Q ss_pred CCCCCCHHHHHH
Q 044155 216 PADRPSMVDVAK 227 (239)
Q Consensus 216 p~~Rps~~ell~ 227 (239)
|.+|||++|+++
T Consensus 344 P~~R~ta~e~L~ 355 (464)
T 3ttj_A 344 PAKRISVDDALQ 355 (464)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=263.05 Aligned_cols=206 Identities=18% Similarity=0.276 Sum_probs=155.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 85 ~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlk 157 (319)
T 2y4i_B 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLK 157 (319)
T ss_dssp TCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred cCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCC
Confidence 4789999999999999999999999999999999997643 46889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC----cceeecccccccccCcccccc---------CCcccccchhhhhhHHHHH
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE----THITDTVMGTLGYCAPEYMRT---------GVFNEKSNVFSFSVFLFEL 147 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~~ 147 (239)
|+||+++ ++.++|+|||++....... ........|++.|+|||++.. ..++.++||||||+++|+|
T Consensus 158 p~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 236 (319)
T 2y4i_B 158 SKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236 (319)
T ss_dssp STTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHH
T ss_pred hhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHH
Confidence 9999998 6789999999876542111 112234458899999999874 3478899999999999999
Q ss_pred hcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 148 LTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 148 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
++|..||...... ...................+..+.+++.+||..||.+|||+.++++
T Consensus 237 ~~g~~p~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 237 HAREWPFKTQPAE---------------------AIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHSSCSSSSCCHH---------------------HHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HhCCCCCCCCCHH---------------------HHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999998643210 0000000000000000123456889999999999999999999999
Q ss_pred HHHHHHHh
Q 044155 228 KLRQIYRS 235 (239)
Q Consensus 228 ~L~~l~~~ 235 (239)
.|+++...
T Consensus 296 ~l~~l~~~ 303 (319)
T 2y4i_B 296 MLEKLPKR 303 (319)
T ss_dssp HHTTC---
T ss_pred HHHHHHHh
Confidence 99887654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=269.53 Aligned_cols=199 Identities=10% Similarity=0.091 Sum_probs=151.1
Q ss_pred CCCCcccceee-------EEEEeCC-----------------CceEEEEEccCCChhhhhhcCCCCC--CCcCCHHHHHH
Q 044155 1 QMSHNHILKLI-------GCCLETP-----------------IPILVFESVQYGTLWDRILGAPQPH--FEPLLLKHRLK 54 (239)
Q Consensus 1 ~l~H~niv~l~-------~~~~~~~-----------------~~~iv~e~~~~~sL~~~l~~~~~~~--~~~~~~~~~~~ 54 (239)
+++||||++++ +++.+.+ ..++||||+ +|+|.+++....... ...+++..+..
T Consensus 132 ~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~ 210 (377)
T 3byv_A 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQ 210 (377)
T ss_dssp TCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHH
T ss_pred ccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHH
Confidence 46899999998 6766553 278999999 589999998642100 02334578888
Q ss_pred HHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-----
Q 044155 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG----- 129 (239)
Q Consensus 55 ~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----- 129 (239)
++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+.
T Consensus 211 i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~ 282 (377)
T 3byv_A 211 LTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISY 282 (377)
T ss_dssp HHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHH
T ss_pred HHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccc
Confidence 9999999999999 89999999999999999999999999999875322 2334557 899999999887
Q ss_pred ------CcccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHH
Q 044155 130 ------VFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHA 203 (239)
Q Consensus 130 ------~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (239)
.++.++||||||+++|+|++|..||.......... ...... ...++.
T Consensus 283 ~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~---------------------~~~~~~------~~~~~~ 335 (377)
T 3byv_A 283 HRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE---------------------WIFRSC------KNIPQP 335 (377)
T ss_dssp HHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG---------------------GGGSSC------CCCCHH
T ss_pred cccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh---------------------hhhhhc------cCCCHH
Confidence 79999999999999999999999986433211110 000000 123456
Q ss_pred HHHHHhhhcCCCCCCCCCHHHHHH--HHHHHHHh
Q 044155 204 SAQVTFECIKDSPADRPSMVDVAK--KLRQIYRS 235 (239)
Q Consensus 204 ~~~li~~cl~~dp~~Rps~~ell~--~L~~l~~~ 235 (239)
+.++|.+||+.||.+|||+.|+++ +++++...
T Consensus 336 ~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 336 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 889999999999999999999996 56555443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=255.94 Aligned_cols=201 Identities=22% Similarity=0.306 Sum_probs=155.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++...+..++||||+++++|.+++...... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 75 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~ 149 (295)
T 2clq_A 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIK 149 (295)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCC--CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccC--CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCC
Confidence 478999999999999999999999999999999999875332 35678889999999999999999 8999999999
Q ss_pred CcceeecC-CCceeEcccccccccCCCCcceeecccccccccCccccccCC--cccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++. ++.++|+|||.+....... .......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...
T Consensus 150 p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 150 GDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp GGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred hhhEEEECCCCCEEEeecccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 99999987 8899999999987653321 1233456899999999987643 788999999999999999999998543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... ........ .....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~-------------------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 229 GEPQAA-------------------MFKVGMFK-VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp SSHHHH-------------------HHHHHHHC-CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CchhHH-------------------HHhhcccc-ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 211000 00000000 000011234567889999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=266.23 Aligned_cols=194 Identities=18% Similarity=0.265 Sum_probs=147.9
Q ss_pred CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcc
Q 044155 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 83 (239)
Q Consensus 4 H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~n 83 (239)
||||+++++++......++||| +.+++|.+++... ..++...+..++.||+.||.||| +.+|+||||||+|
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~N 185 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPAN 185 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGG
T ss_pred CCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHH
Confidence 6999999999999999999999 5579999999876 56888899999999999999999 9999999999999
Q ss_pred eeecCCCceeEcccccccccCCCCcc-eeecccccccccCcccccc-----------CCcccccchhhhhhHHHHHhcCC
Q 044155 84 ILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRT-----------GVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 84 il~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
||++ ++.+||+|||++......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 186 Ill~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 186 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp EEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 9995 578999999999765433211 2335568999999999865 35888999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.||....... ...............+...+..+.++|.+||+.||.+|||+.|+++
T Consensus 265 ~Pf~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 265 TPFQQIINQI--------------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CTTTTCCCHH--------------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcchhhhHHH--------------------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 9985432100 0001111111000000112456889999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=271.91 Aligned_cols=195 Identities=23% Similarity=0.318 Sum_probs=159.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+.+... ..+++..+..++.|++.||.||| +.+++|||||
T Consensus 102 ~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlk 173 (504)
T 3q5i_A 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIK 173 (504)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCc
Confidence 478999999999999999999999999999999998765 56899999999999999999999 8999999999
Q ss_pred CcceeecCCC---ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++ .+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 174 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 174 PENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp GGGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999876 68999999997654332 233556899999999987 46899999999999999999999998642
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSS--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+....+....... ......++.+.++|.+||..||.+|||++|+++
T Consensus 251 ~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 251 ND---------------------QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp SH---------------------HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CH---------------------HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 21 12222222222211 111245678999999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=265.96 Aligned_cols=214 Identities=21% Similarity=0.268 Sum_probs=152.0
Q ss_pred CCcccceeeEEEEeCC--CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 3 SHNHILKLIGCCLETP--IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~--~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+||||+++++++...+ ..++||||++ ++|.+++.. ..++...+..++.|++.||+||| +.+|+|||||
T Consensus 67 ~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlk 136 (388)
T 3oz6_A 67 GHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMK 136 (388)
T ss_dssp TCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred CCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCC
Confidence 3999999999997544 6799999997 799999976 45888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC--------------------cceeecccccccccCcccccc-CCcccccchhh
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE--------------------THITDTVMGTLGYCAPEYMRT-GVFNEKSNVFS 139 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s 139 (239)
|+|||++.++.+||+|||+++...... ........||+.|+|||++.+ ..++.++||||
T Consensus 137 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 216 (388)
T 3oz6_A 137 PSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS 216 (388)
T ss_dssp GGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHH
T ss_pred HHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHH
Confidence 999999999999999999987643210 112234578999999999986 56899999999
Q ss_pred hhhHHHHHhcCCCCcccccccccccc-------cchhhhhhhhhccchhhhhhhhh------hcCCCcHHH---------
Q 044155 140 FSVFLFELLTGWDVSDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIV------VEDVSSIEK--------- 197 (239)
Q Consensus 140 lG~~l~~~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~--------- 197 (239)
|||++|+|++|..||........... +..+..... ............. ........+
T Consensus 217 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (388)
T 3oz6_A 217 LGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESI-QSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295 (388)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTS-CCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhc-cCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccc
Confidence 99999999999999975433211110 000000000 0000000000000 000000000
Q ss_pred ---HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 198 ---EQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 198 ---~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...++.+.+|+.+||+.||.+|||++|+++
T Consensus 296 ~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp CTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 023567899999999999999999999976
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=255.77 Aligned_cols=199 Identities=23% Similarity=0.324 Sum_probs=150.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+.+...... ...++...+..++.|++.||.||| +.+++|+|||
T Consensus 76 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dik 151 (285)
T 3is5_A 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLK 151 (285)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCS
T ss_pred hCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCC
Confidence 478999999999999999999999999999999988643110 046889999999999999999999 8999999999
Q ss_pred Ccceee---cCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||++ +.++.++|+|||++....... ......+++.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 152 p~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 152 PENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp GGGEEESSSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEEecCCCCCCEEEEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 999999 455789999999987553322 233456899999999886 56789999999999999999999998643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhc-CCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE-DVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+........ ..........++.+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 229 SL---------------------EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp SH---------------------HHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CH---------------------HHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 21 0111111000 0001111123567889999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=272.09 Aligned_cols=200 Identities=25% Similarity=0.355 Sum_probs=159.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+|||||
T Consensus 92 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlk 163 (494)
T 3lij_A 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLK 163 (494)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCC
Confidence 478999999999999999999999999999999988765 56889999999999999999999 8999999999
Q ss_pred CcceeecCC---CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEE---NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.. +.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 164 p~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 164 PENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhEEEeCCCCCCcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999764 459999999987654332 233456899999999886 56899999999999999999999998643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK--KLRQI 232 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~--~L~~l 232 (239)
.. .+....+...... .......++.+.++|.+||+.||.+|||+.|+++ ++.+.
T Consensus 241 ~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 241 TD---------------------QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp SH---------------------HHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CH---------------------HHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 21 1111111111111 1111234567899999999999999999999986 45443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=256.15 Aligned_cols=204 Identities=20% Similarity=0.244 Sum_probs=148.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC-Ceeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-~i~H~dl 79 (239)
+++||||+++++++.+++..++||||++ ++|.+++...... ...+++..+..++.|++.||.||| ++ +++|+||
T Consensus 62 ~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl 136 (290)
T 3fme_A 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDV 136 (290)
T ss_dssp TCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCC
T ss_pred hCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCC
Confidence 3689999999999999999999999997 6988877642110 056899999999999999999999 77 9999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccc----ccCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYM----RTGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
||+||+++.++.++|+|||++....... ......|++.|+|||.+ ....++.++||||||+++|+|++|..||.
T Consensus 137 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (290)
T 3fme_A 137 KPSNVLINALGQVKMCDFGISGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214 (290)
T ss_dssp SGGGCEECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CHHHEEECCCCCEEEeecCCcccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 9999999999999999999987653322 12334689999999996 45568899999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK--KLRQ 231 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~--~L~~ 231 (239)
...... ...................+..+.+++.+||+.||.+|||+.|+++ ++..
T Consensus 215 ~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 215 SWGTPF--------------------QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CCSCHH--------------------HHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ccCchH--------------------HHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 322100 0011111111111111234567899999999999999999999987 4443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=252.47 Aligned_cols=202 Identities=20% Similarity=0.290 Sum_probs=159.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 64 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~ 135 (283)
T 3bhy_A 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLK 135 (283)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCC
Confidence 368999999999999999999999999999999999764 56899999999999999999999 8999999999
Q ss_pred CcceeecCCC----ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEEN----VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||+++.++ .++|+|||.+....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 136 p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp GGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hHHEEEecCCCCCCceEEEecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 9999998877 79999999987653322 12344688999999999988899999999999999999999999854
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK--KLRQI 232 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~--~L~~l 232 (239)
.... +......... .........+..+.+++.+||..||.+|||+.++++ +++++
T Consensus 214 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 214 ETKQ---------------------ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp SSHH---------------------HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cchH---------------------HHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 3210 1111111111 111122244567899999999999999999999997 55554
Q ss_pred H
Q 044155 233 Y 233 (239)
Q Consensus 233 ~ 233 (239)
.
T Consensus 273 ~ 273 (283)
T 3bhy_A 273 R 273 (283)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=259.94 Aligned_cols=209 Identities=21% Similarity=0.294 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+++||||+++++++.. ....++||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|
T Consensus 82 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH 157 (317)
T 2buj_A 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIH---AKGYAH 157 (317)
T ss_dssp TCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred hcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 4789999999999873 34678999999999999988763110 156899999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCc--------ceeecccccccccCccccccCC---cccccchhhhhhHHH
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGET--------HITDTVMGTLGYCAPEYMRTGV---FNEKSNVFSFSVFLF 145 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~ 145 (239)
+||||+||+++.++.++|+|||.+........ .......|++.|+|||.+.+.. ++.++||||||+++|
T Consensus 158 ~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 237 (317)
T 2buj_A 158 RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237 (317)
T ss_dssp CCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999998765421110 0012345689999999987554 688999999999999
Q ss_pred HHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 146 ELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 146 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
+|++|..||........ ............. .....+..+.+++.+||+.||.+|||+.++
T Consensus 238 el~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 297 (317)
T 2buj_A 238 AMMFGEGPYDMVFQKGD----------------SVALAVQNQLSIP----QSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297 (317)
T ss_dssp HHHHSSCTTHHHHHTTS----------------CHHHHHHCC--CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHhCCCChhhhhcccc----------------hhhHHhhccCCCC----ccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 99999999853221100 0001111000000 012345678999999999999999999999
Q ss_pred HHHHHHHH
Q 044155 226 AKKLRQIY 233 (239)
Q Consensus 226 l~~L~~l~ 233 (239)
++.|+++.
T Consensus 298 l~~L~~~~ 305 (317)
T 2buj_A 298 LSQLEALQ 305 (317)
T ss_dssp HHHHHHTC
T ss_pred HHHhhhcC
Confidence 99998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=273.67 Aligned_cols=195 Identities=23% Similarity=0.346 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+.+++|.+.+... ..+++..+..++.|++.||.||| +++++|||||
T Consensus 82 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlk 153 (484)
T 3nyv_A 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLK 153 (484)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCC
Confidence 479999999999999999999999999999999999865 56899999999999999999999 8999999999
Q ss_pred Ccceee---cCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||++ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...
T Consensus 154 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 154 PENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp GGGEEESSSSTTCCEEECCTTHHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEEecCCCCCcEEEEeeeeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 999999 567789999999987664432 2234568999999999875 6899999999999999999999998643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+....+...... .+.....++.+.++|.+||+.||.+|||+.|+++
T Consensus 231 ~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 231 NE---------------------YDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SH---------------------HHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CH---------------------HHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 21 1111111111111 1111245677899999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=272.39 Aligned_cols=202 Identities=18% Similarity=0.280 Sum_probs=160.6
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||++||+|.+++...... ...+++..+..++.||+.||.||| +++|+||||||
T Consensus 242 l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP 317 (543)
T 3c4z_A 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKP 317 (543)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred cCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCCh
Confidence 68999999999999999999999999999999998764321 146899999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 318 ~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~ 396 (543)
T 3c4z_A 318 ENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 396 (543)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC
T ss_pred HHEEEeCCCCEEEeecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch
Confidence 999999999999999999976543321 2334579999999999999899999999999999999999999986432110
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM-----VDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~ell~ 227 (239)
...+....+....... +...+..+.++|.+||+.||.+||++ +++++
T Consensus 397 -----------------~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 397 -----------------ENKELKQRVLEQAVTY--PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -----------------CHHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -----------------hHHHHHHHHhhcccCC--CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0111111222211111 12456778999999999999999964 66653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=254.86 Aligned_cols=195 Identities=19% Similarity=0.278 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 71 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~ 142 (294)
T 2rku_A 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLK 142 (294)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 478999999999999999999999999999999988765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 143 p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 221 (294)
T 2rku_A 143 LGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221 (294)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred hHhEEEcCCCCEEEEeccCceecccCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999987653222 1233456899999999999888999999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+........... .+...+..+.+++.+||+.||.+|||++|+++
T Consensus 222 ---------------------~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 222 ---------------------ETYLRIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---------------------HHHHHHHTTCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---------------------HHHHHHhhccCC--CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 001111111110 01133466889999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=271.21 Aligned_cols=195 Identities=22% Similarity=0.323 Sum_probs=156.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+.+++|.+.+... ..++...+..++.|++.||.||| +.+|+|||||
T Consensus 77 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlk 148 (486)
T 3mwu_A 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLK 148 (486)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCc
Confidence 378999999999999999999999999999999988765 56899999999999999999999 8999999999
Q ss_pred Ccceeec---CCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++ .++.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...
T Consensus 149 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 149 PENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp GGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hHHEEEecCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999995 45579999999987654332 2334568999999999875 5899999999999999999999998543
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+....+..... ..+.....++.+.++|.+||..||.+|||+.++++
T Consensus 226 ~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 226 NE---------------------YDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SH---------------------HHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CH---------------------HHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 21 111111111111 11111244677899999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=256.37 Aligned_cols=195 Identities=24% Similarity=0.345 Sum_probs=157.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dik 133 (304)
T 2jam_A 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLK 133 (304)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCC
T ss_pred hCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 368999999999999999999999999999999998765 56889999999999999999999 8999999999
Q ss_pred Ccceee---cCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILF---NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||++ +.++.++|+|||++...... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 134 p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 134 PENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp GGGCEESSSSTTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HHHEEEecCCCCCCEEEccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999999 77889999999998654322 123456899999999999888999999999999999999999998542
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+.......... ........+..+.+++.+||+.||.+|||+.|+++
T Consensus 211 ~~---------------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 211 TE---------------------SKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CH---------------------HHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CH---------------------HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 21 011111111110 11111234567899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=256.66 Aligned_cols=194 Identities=20% Similarity=0.322 Sum_probs=157.8
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||+++++|.+++.. ..++...+..++.|++.||.||| +.+++|+||||
T Consensus 77 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p 147 (303)
T 3a7i_A 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKA 147 (303)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred CCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCh
Confidence 6899999999999999999999999999999999864 46889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 148 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 226 (303)
T 3a7i_A 148 ANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 226 (303)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred heEEECCCCCEEEeecccceecCccc-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH
Confidence 99999999999999999987654322 12334568999999999998889999999999999999999999885432110
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......... .......+..+.+++.+||+.||.+|||+.++++
T Consensus 227 ---------------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 227 ---------------------VLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp ---------------------HHHHHHHSCC-CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---------------------HHHHhhcCCC-CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000 0001133466889999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=260.18 Aligned_cols=195 Identities=19% Similarity=0.280 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 97 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlk 168 (335)
T 2owb_A 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLK 168 (335)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred hCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCC
Confidence 478999999999999999999999999999999998765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 169 p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 247 (335)
T 2owb_A 169 LGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247 (335)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred chhEEEcCCCCEEEeeccCceecccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 999999999999999999987653222 1233456899999999999888999999999999999999999998643210
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+............ +...+..+.++|.+||+.||.+|||++|+++
T Consensus 248 ---------------------~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 248 ---------------------ETYLRIKKNEYSI--PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---------------------HHHHHHHHTCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---------------------HHHHHHhcCCCCC--CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011111111100 1133456889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=263.21 Aligned_cols=193 Identities=19% Similarity=0.270 Sum_probs=146.0
Q ss_pred cccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcce
Q 044155 5 NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCI 84 (239)
Q Consensus 5 ~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ni 84 (239)
|||+++++++.+....++|||+ .+++|.+++... ..++...+..++.|++.||.||| +.+|+||||||+||
T Consensus 69 ~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NI 139 (343)
T 3dbq_A 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANF 139 (343)
T ss_dssp TTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred CceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceE
Confidence 9999999999999999999995 568999999875 56889999999999999999999 89999999999999
Q ss_pred eecCCCceeEcccccccccCCCCcc-eeecccccccccCcccccc-----------CCcccccchhhhhhHHHHHhcCCC
Q 044155 85 LFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRT-----------GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 85 l~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|++ ++.+||+|||++......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 140 ll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 218 (343)
T 3dbq_A 140 LIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218 (343)
T ss_dssp EEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 997 578999999998765433221 2335568999999999865 568889999999999999999999
Q ss_pred CcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
||....... ...............+...+..+.+++..||+.||.+|||+.|+++
T Consensus 219 pf~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 219 PFQQIINQI--------------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp TTTTCCSHH--------------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchhhhhHH--------------------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 985422110 0000111100000001122356889999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=263.57 Aligned_cols=215 Identities=20% Similarity=0.210 Sum_probs=157.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++.+....++||||++ ++|.+++.... ..++...+..++.|++.||.||| +.+++|+||||
T Consensus 69 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp 140 (346)
T 1ua2_A 69 LSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKP 140 (346)
T ss_dssp CCCTTBCCEEEEECCTTCCEEEEECCS-EEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred CCCCCCCeEEEEEeeCCceEEEEEcCC-CCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCH
Confidence 689999999999999999999999998 59988887643 46788899999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+||+++.++.+||+|||++....... .......+|+.|+|||++.+. .++.++||||||+++|+|++|..||......
T Consensus 141 ~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~ 219 (346)
T 1ua2_A 141 NNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 219 (346)
T ss_dssp GGEEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHEEEcCCCCEEEEecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 99999999999999999987653222 123345689999999998764 4889999999999999999999988654322
Q ss_pred ccccccchhhhhhhhhccchhhhhh---hhhhcCCC--c--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVD---HIVVEDVS--S--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......+... . ......+..... ........ + ......+..+.++|.+||..||.+|||+.|+++
T Consensus 220 ~~~~~i~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 220 DQLTRIFETL-G-TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHHHHHHHH-C-CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHc-C-CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1111000000 0 000000100000 00000000 0 001234577899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=260.77 Aligned_cols=212 Identities=17% Similarity=0.233 Sum_probs=149.8
Q ss_pred CCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 2 MSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
++||||+++++++.... ..++||||++ ++|.+.+. ..++...+..++.|++.||.||| +.+++
T Consensus 81 l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH---~~~iv 149 (371)
T 2xrw_A 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGII 149 (371)
T ss_dssp CCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred cCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence 68999999999997654 5799999997 68988885 34788999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+||||+||+++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 150 H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp CSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccCCHHHEEEcCCCCEEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987653221 2334568999999999999889999999999999999999999997
Q ss_pred cccccccc-------cccchhhhhhh-------h------hccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCC
Q 044155 156 LVKDVHDL-------VCPFSEYLKNC-------F------EDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDS 215 (239)
Q Consensus 156 ~~~~~~~~-------~~~~~~~~~~~-------~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 215 (239)
........ ..+..++.... . ....+........ .+.........+..+.+|+.+||..|
T Consensus 228 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~mL~~d 306 (371)
T 2xrw_A 228 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL-FPADSEHNKLKASQARDLLSKMLVID 306 (371)
T ss_dssp CSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGG-SCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccccc-CcccccccccccHHHHHHHHHHCcCC
Confidence 54331110 01111110000 0 0000000110000 11112223355778999999999999
Q ss_pred CCCCCCHHHHHH
Q 044155 216 PADRPSMVDVAK 227 (239)
Q Consensus 216 p~~Rps~~ell~ 227 (239)
|.+|||++|+++
T Consensus 307 P~~R~t~~e~l~ 318 (371)
T 2xrw_A 307 ASKRISVDEALQ 318 (371)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHhC
Confidence 999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=263.49 Aligned_cols=146 Identities=19% Similarity=0.256 Sum_probs=122.4
Q ss_pred CCCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++... ...++||||++ ++|.+++... ..++...++.++.||+.||.||| +.+|+
T Consensus 81 ~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH---~~giv 151 (432)
T 3n9x_A 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH---ESGII 151 (432)
T ss_dssp HCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred HcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCC
Confidence 36899999999999866 56899999997 7999999865 56899999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCc---------------------ceeecccccccccCcccc-ccCCccc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGET---------------------HITDTVMGTLGYCAPEYM-RTGVFNE 133 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---------------------~~~~~~~~~~~y~aPE~~-~~~~~~~ 133 (239)
||||||+|||++.++.+||+|||+++....... .......||+.|+|||++ ....++.
T Consensus 152 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~ 231 (432)
T 3n9x_A 152 HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231 (432)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCT
T ss_pred CCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCc
Confidence 999999999999999999999999976533211 112456789999999986 4566999
Q ss_pred ccchhhhhhHHHHHhcCCCCcc
Q 044155 134 KSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 134 ~~Di~slG~~l~~~~~g~~p~~ 155 (239)
++|||||||++|||++|..|+.
T Consensus 232 ~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 232 SIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp HHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccchHHHHHHHHHhcccccc
Confidence 9999999999999999766654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=257.64 Aligned_cols=196 Identities=20% Similarity=0.238 Sum_probs=154.7
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~ 160 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQ 160 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChH
Confidence 579999999999999999999999999999999865433 56899999999999999999999 899999999999
Q ss_pred ceeecC---CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 83 CILFNE---ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 83 nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+++. ++.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 161 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 161 NILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp GEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEEecCCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999998 7899999999987653322 12345689999999999988999999999999999999999999854321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhh--cCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVV--EDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. +....... ...........+..+.++|.+||+.||.+|||++++++
T Consensus 239 ~---------------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 239 Q---------------------ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp H---------------------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred h---------------------HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1 00000000 01111111244567889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=256.87 Aligned_cols=216 Identities=17% Similarity=0.235 Sum_probs=155.2
Q ss_pred CCCcccceeeEEEEeC--------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC
Q 044155 2 MSHNHILKLIGCCLET--------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP 73 (239)
Q Consensus 2 l~H~niv~l~~~~~~~--------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~ 73 (239)
++||||+++++++... +..++||||++ ++|.+.+.... ..++...+..++.|++.||.||| +.+
T Consensus 73 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ 144 (351)
T 3mi9_A 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNK 144 (351)
T ss_dssp CCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred ccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 6899999999999873 45789999998 68888887653 46899999999999999999999 899
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCC---cceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhc
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE---THITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~ 149 (239)
++|+||||+||+++.++.+||+|||++....... ........||+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 145 ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 224 (351)
T 3mi9_A 145 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224 (351)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHh
Confidence 9999999999999999999999999987653221 112234568999999999876 458999999999999999999
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhh-----hhhh--hhcCCCcHHH----HHHHHHHHHHHhhhcCCCCCC
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEI-----VDHI--VVEDVSSIEK----EQQLHASAQVTFECIKDSPAD 218 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~----~~~~~~~~~li~~cl~~dp~~ 218 (239)
|..||............. .. ........+... .... .......... ...++.+.++|.+||+.||.+
T Consensus 225 g~~pf~~~~~~~~~~~i~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 302 (351)
T 3mi9_A 225 RSPIMQGNTEQHQLALIS-QL-CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302 (351)
T ss_dssp SSCSCCCSSHHHHHHHHH-HH-HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGG
T ss_pred CCCCCCCCChHHHHHHHH-HH-hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhh
Confidence 999987543211110000 00 000000000000 0000 0000001100 112466889999999999999
Q ss_pred CCCHHHHHH
Q 044155 219 RPSMVDVAK 227 (239)
Q Consensus 219 Rps~~ell~ 227 (239)
|||++|+++
T Consensus 303 R~t~~e~l~ 311 (351)
T 3mi9_A 303 RIDSDDALN 311 (351)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhC
Confidence 999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=257.05 Aligned_cols=194 Identities=24% Similarity=0.370 Sum_probs=157.3
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++......++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||||+
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~ 229 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPE 229 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHH
Confidence 7999999999999999999999999999999999764 56899999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc------CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT------GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
||+++.++.++|+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..
T Consensus 230 NIl~~~~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 230 NILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HEEECCCCCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999987654332 2334568999999998863 3578899999999999999999999854
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSS--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... ......+....... ......+..+.+++.+||+.||.+|||+.++++
T Consensus 308 ~~~---------------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 308 RRQ---------------------ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SSH---------------------HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCH---------------------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221 01111111111111 111234567899999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=256.81 Aligned_cols=211 Identities=20% Similarity=0.305 Sum_probs=154.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcC---CCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGA---PQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
+++||||+++++++...+..++||||+++++|.+++... .......++...+..++.|++.||.||| +.+++|+
T Consensus 69 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 145 (303)
T 2vwi_A 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHR 145 (303)
T ss_dssp CCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred hcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCC
Confidence 478999999999999999999999999999999998741 0001156899999999999999999999 8999999
Q ss_pred cccCcceeecCCCceeEcccccccccCCCC----cceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCC
Q 044155 78 NFKTSCILFNEENVAKLFDFSLSISIPEGE----THITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 78 dlk~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
||||+||+++.++.++|+|||++....... ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..
T Consensus 146 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp CCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999986553321 112234568999999999876 568899999999999999999999
Q ss_pred CcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
||......... ........ ............ ....+..+.+++.+||+.||.+|||+.++++
T Consensus 226 pf~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 226 PYHKYPPMKVL--------MLTLQNDP-PSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTTTSCGGGHH--------HHHHTSSC-CCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccCchhhHH--------HHHhccCC-Cccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 98654321110 00000000 000000000000 0123456889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=258.63 Aligned_cols=211 Identities=16% Similarity=0.219 Sum_probs=158.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhh------hhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CC
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDR------ILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RP 73 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~ 73 (239)
+++||||+++++++.+.+..++||||+++++|.++ +..... ..++...+..++.|++.||.||| + .+
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~ 172 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT---CFIPIQVIKCIIKSVLNSFSYIH---NEKN 172 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSC---CCCCHHHHHHHHHHHHHHHHHHH---HTSC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccc---cCCCHHHHHHHHHHHHHHHHHHh---ccCC
Confidence 47899999999999999999999999999999998 554222 67899999999999999999999 7 99
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-Cccc-ccchhhhhhHHHHHhcCC
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNE-KSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~~~~~g~ 151 (239)
++|+||||+||+++.++.++|+|||.+...... ......+++.|+|||.+.+. .++. ++||||||+++|+|++|.
T Consensus 173 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 249 (348)
T 2pml_X 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249 (348)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred EeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998765332 23455689999999999877 5666 999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhc-cchhhhhh---hhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFED-NRFTEIVD---HIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.||.......... ...... ...+.... ...............+..+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~pf~~~~~~~~~~-------~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 250 VPFSLKISLVELF-------NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSSCCSSCSHHHH-------HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcHHHHH-------HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9987543211100 000000 00000000 000000000111245677899999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=254.97 Aligned_cols=196 Identities=21% Similarity=0.304 Sum_probs=154.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++..+. .++||||+++++|.+++... ..++...+..++.|++.||.||| +++++|+|||
T Consensus 71 ~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlk 141 (322)
T 2ycf_A 71 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLK 141 (322)
T ss_dssp HCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 368999999999987655 89999999999999998765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCc---eeEcccccccccCCCCcceeecccccccccCccccc---cCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 81 TSCILFNEENV---AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR---TGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 81 ~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||+++.++. +||+|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||
T Consensus 142 p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (322)
T 2ycf_A 142 PENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219 (322)
T ss_dssp GGGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999987664 9999999987653321 223456899999999874 456889999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... ... ...... .+......+..+.+++.+||+.||.+|||+.++++
T Consensus 220 ~~~~~~~~~-----------------~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 220 SEHRTQVSL-----------------KDQ---ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CSTTCSSCH-----------------HHH---HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchHHHH-----------------HHH---HHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 643321111 000 001111 11111234677899999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=249.86 Aligned_cols=194 Identities=24% Similarity=0.331 Sum_probs=149.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 67 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~ 138 (276)
T 2h6d_A 67 LFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLK 138 (276)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCC
T ss_pred cCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCC
Confidence 478999999999999999999999999999999999765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.....
T Consensus 139 p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 216 (276)
T 2h6d_A 139 PENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216 (276)
T ss_dssp GGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhEEECCCCCEEEeecccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 999999999999999999987653322 1234568899999999987665 6899999999999999999999853210
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.............. +...+..+.+++.+||+.||.+|||++++++
T Consensus 217 ---------------------~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 217 ---------------------PTLFKKIRGGVFYI--PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---------------------HHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------HHHHHHhhcCcccC--chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11111111111100 1123466889999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=262.49 Aligned_cols=146 Identities=21% Similarity=0.248 Sum_probs=129.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.+|+||+++++++......++|||++. ++|.+++..... ..+++..+..++.|++.||+||| +.+|+||||||
T Consensus 156 ~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp 228 (429)
T 3kvw_A 156 DNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKP 228 (429)
T ss_dssp TSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSG
T ss_pred cCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCH
Confidence 478999999999999999999999996 799999987643 45899999999999999999999 89999999999
Q ss_pred cceeecCCCc--eeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 82 SCILFNEENV--AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 82 ~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
+|||++.++. +||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 229 ~NILl~~~~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 229 ENILLKQQGRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp GGEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHeEEccCCCcceEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999987 999999998654322 234568999999999999999999999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=265.39 Aligned_cols=141 Identities=21% Similarity=0.305 Sum_probs=117.6
Q ss_pred CCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 2 MSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 2 l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++||||+++++++... ...++|||++. ++|.+++... ..+++..++.++.||+.||.||| +.+|+|
T Consensus 109 l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiH 179 (458)
T 3rp9_A 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVH---SAGILH 179 (458)
T ss_dssp CCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBC
T ss_pred CCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCC
Confidence 6899999999999543 46799999985 8999999765 56899999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCc--------------------------ceeecccccccccCccccc-cC
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGET--------------------------HITDTVMGTLGYCAPEYMR-TG 129 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~-~~ 129 (239)
|||||+|||++.++.+||+|||+++....... .......||+.|+|||++. ..
T Consensus 180 rDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 259 (458)
T 3rp9_A 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE 259 (458)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC
T ss_pred CCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC
Confidence 99999999999999999999999976532110 1123456799999999864 56
Q ss_pred CcccccchhhhhhHHHHHhcCC
Q 044155 130 VFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 130 ~~~~~~Di~slG~~l~~~~~g~ 151 (239)
.++.++|||||||++|||++|.
T Consensus 260 ~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 260 NYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CCCTHHHHHHHHHHHHHHHTTS
T ss_pred CCCcHhHHHHHHHHHHHHHHhc
Confidence 6999999999999999999953
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=256.11 Aligned_cols=197 Identities=19% Similarity=0.268 Sum_probs=152.4
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++||||+++++++...+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+||||
T Consensus 73 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp 145 (302)
T 2j7t_A 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKA 145 (302)
T ss_dssp CCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSG
T ss_pred CCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCH
Confidence 689999999999999999999999999999999887632 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||+++.++.++|+|||++...... ........|++.|+|||.+. ...++.++||||||+++|+|++|..||..
T Consensus 146 ~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 146 GNVLMTLEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp GGEEECTTSCEEECCCHHHHHHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHEEECCCCCEEEEECCCCcccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 9999999999999999986532111 11123456889999999883 56688999999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ........... ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 225 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 225 LNPM---------------------RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SCHH---------------------HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCHH---------------------HHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 3211 00001111100 00111234567899999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=258.00 Aligned_cols=204 Identities=19% Similarity=0.221 Sum_probs=142.3
Q ss_pred CCcccceeeEEEEe--------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC-
Q 044155 3 SHNHILKLIGCCLE--------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP- 73 (239)
Q Consensus 3 ~H~niv~l~~~~~~--------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~- 73 (239)
+||||+++++++.. ....++||||+. |+|.+++...... ..+++..+..++.|++.||.||| ..+
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~~ 157 (337)
T 3ll6_A 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMH---RQKP 157 (337)
T ss_dssp TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHH---TSSS
T ss_pred cCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCC
Confidence 49999999999953 234689999996 8999988752211 46899999999999999999999 888
Q ss_pred -eeeccccCcceeecCCCceeEcccccccccCCCCcc-----------eeecccccccccCcccc---ccCCcccccchh
Q 044155 74 -IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH-----------ITDTVMGTLGYCAPEYM---RTGVFNEKSNVF 138 (239)
Q Consensus 74 -i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~ 138 (239)
++|+||||+||+++.++.+||+|||++......... ......+++.|+|||++ .+..++.++|||
T Consensus 158 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~ 237 (337)
T 3ll6_A 158 PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237 (337)
T ss_dssp CCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHH
T ss_pred CEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHH
Confidence 999999999999999999999999998765432211 11244588999999998 456688999999
Q ss_pred hhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCC
Q 044155 139 SFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPAD 218 (239)
Q Consensus 139 slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~ 218 (239)
|||+++|+|++|..||......... ...... ......+..+.+++.+||+.||.+
T Consensus 238 slG~il~el~~g~~p~~~~~~~~~~---------------------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~ 292 (337)
T 3ll6_A 238 ALGCILYLLCFRQHPFEDGAKLRIV---------------------NGKYSI----PPHDTQYTVFHSLIRAMLQVNPEE 292 (337)
T ss_dssp HHHHHHHHHHHSSCCC---------------------------------CCC----CTTCCSSGGGHHHHHHHSCSSGGG
T ss_pred HHHHHHHHHHhCCCCCcchhHHHhh---------------------cCcccC----CcccccchHHHHHHHHHccCChhh
Confidence 9999999999999998543211100 000000 000122234778999999999999
Q ss_pred CCCHHHHHHHHHHHHHhhc
Q 044155 219 RPSMVDVAKKLRQIYRSLS 237 (239)
Q Consensus 219 Rps~~ell~~L~~l~~~~~ 237 (239)
|||+.|+++.|.++.....
T Consensus 293 Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 293 RLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp SCCHHHHHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHHHHhccC
Confidence 9999999999999877543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=276.95 Aligned_cols=193 Identities=21% Similarity=0.303 Sum_probs=160.1
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++||||+++|+|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~ 471 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLD 471 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCST
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChh
Confidence 7999999999999999999999999999999999875 56899999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~ 162 (239)
|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|+||||+++|||++|..||....
T Consensus 472 NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---- 546 (674)
T 3pfq_A 472 NVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---- 546 (674)
T ss_dssp TEEECSSSCEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred hEEEcCCCcEEEeecceeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC----
Confidence 9999999999999999987542221 22446679999999999999999999999999999999999999986422
Q ss_pred ccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 044155 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM-----VDVAK 227 (239)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~ell~ 227 (239)
..+....+....... +...+.++.+||.+||+.||.+||++ +|+++
T Consensus 547 -----------------~~~~~~~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 547 -----------------EDELFQSIMEHNVAY--PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----------------HHHHHHHHHSSCCCC--CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----------------HHHHHHHHHhCCCCC--CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 112222222222211 12456778999999999999999997 66653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=251.77 Aligned_cols=191 Identities=16% Similarity=0.199 Sum_probs=150.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+.+..++||||+++++|.+++...... ...+++..+..++.|++.||.||| +++++|+||||+
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~ 144 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPS 144 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHH
Confidence 8999999999999999999999999999999999764210 035789999999999999999999 899999999999
Q ss_pred ceeecCC-------------------CceeEcccccccccCCCCcceeecccccccccCccccccC-Ccccccchhhhhh
Q 044155 83 CILFNEE-------------------NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSV 142 (239)
Q Consensus 83 nil~~~~-------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ 142 (239)
||+++.+ ..++|+|||.+....... ...+++.|+|||.+.+. .++.++||||||+
T Consensus 145 NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (289)
T 1x8b_A 145 NIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALAL 219 (289)
T ss_dssp GEEEC--------------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred HEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence 9999844 478999999987654322 33488999999999865 5678999999999
Q ss_pred HHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 143 FLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 143 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
++|+|++|..++..... ..... ..... ..+...+..+.+++.+||+.||.+|||+
T Consensus 220 il~~l~~~~~~~~~~~~--------------------~~~~~----~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~ 274 (289)
T 1x8b_A 220 TVVCAAGAEPLPRNGDQ--------------------WHEIR----QGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSA 274 (289)
T ss_dssp HHHHHTTCCCCCSSSHH--------------------HHHHH----TTCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHhcCCCCCcchhH--------------------HHHHH----cCCCC-CCCcccCHHHHHHHHHHhCCCcccCCCH
Confidence 99999999876532110 00000 00000 0011345678999999999999999999
Q ss_pred HHHHH
Q 044155 223 VDVAK 227 (239)
Q Consensus 223 ~ell~ 227 (239)
.|+++
T Consensus 275 ~~ll~ 279 (289)
T 1x8b_A 275 MALVK 279 (289)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=256.69 Aligned_cols=218 Identities=20% Similarity=0.290 Sum_probs=154.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.++.... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 80 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlk 151 (331)
T 4aaa_A 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIK 151 (331)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred hCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcC
Confidence 378999999999999999999999999988888776654 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.++|+|||++....... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.....
T Consensus 152 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 152 PENILVSQSGVVKLCDFGFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp GGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hheEEEcCCCcEEEEeCCCceeecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999987553221 122345689999999999875 688999999999999999999999875443
Q ss_pred ccccccc------chhhhhhhhhccchhh-hhhhhhhcCCC-cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCP------FSEYLKNCFEDNRFTE-IVDHIVVEDVS-SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
....... ........+....... ........... .......++.+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 231 IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 2111100 0000000000000000 00000000000 0011134677999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=263.55 Aligned_cols=212 Identities=17% Similarity=0.177 Sum_probs=163.3
Q ss_pred CCC-cccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MSH-NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~H-~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
|+| ++|..+..++......++||||+ +++|.+++.... ..+++..++.++.||+.||.||| .++|+|+|||
T Consensus 59 L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIK 130 (483)
T 3sv0_A 59 LQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIK 130 (483)
T ss_dssp TTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccC
Confidence 444 56666666677788889999999 799999998543 56899999999999999999999 8999999999
Q ss_pred Ccceee---cCCCceeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 81 TSCILF---NEENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 81 ~~nil~---~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|+|||+ +.++.+||+|||+++....... .......|++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 131 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~ 210 (483)
T 3sv0_A 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210 (483)
T ss_dssp GGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 999999 5788999999999976543321 1123567899999999999999999999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||.......... ............. ........+.++.+++..||+.||.+||++.+|++.|++
T Consensus 211 ~Pf~~~~~~~~~~--------------~~~~i~~~~~~~~-~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 211 LPWQGLKAGTKKQ--------------KYEKISEKKVATS-IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp CTTSSCCCSSHHH--------------HHHHHHHHHHHSC-HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CCCccccchhHHH--------------HHHHHhhcccccc-HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 9997543211110 0001111111000 011112345788999999999999999999999999999
Q ss_pred HHHhh
Q 044155 232 IYRSL 236 (239)
Q Consensus 232 l~~~~ 236 (239)
+....
T Consensus 276 l~~~~ 280 (483)
T 3sv0_A 276 LFIRE 280 (483)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 87754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=256.21 Aligned_cols=197 Identities=20% Similarity=0.283 Sum_probs=148.5
Q ss_pred CCcccceeeEEEEe------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 3 SHNHILKLIGCCLE------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 3 ~H~niv~l~~~~~~------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+||||+++++++.. ....++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH 152 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIH 152 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 79999999999987 4578999999998999999987532 46889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCC
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
+||||+||+++.++.++|+|||++....... .......|++.|+|||++. ...++.++||||||+++|+|++|.
T Consensus 153 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 231 (326)
T 2x7f_A 153 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231 (326)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSS
T ss_pred cCCcHHHEEEcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCC
Confidence 9999999999999999999999987653221 1223456899999999987 456889999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.||........ .................+..+.++|.+||..||.+|||+.++++
T Consensus 232 ~p~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 232 PPLCDMHPMRA---------------------LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CTTTTSCHHHH---------------------HHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCcHHHH---------------------HHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 99854321100 00000000000001133567889999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=255.90 Aligned_cols=211 Identities=16% Similarity=0.196 Sum_probs=155.0
Q ss_pred CCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 2 MSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
++||||+++++++.... ..++||||+ +++|.+++.. ..++...+..++.|++.||.||| +.+++
T Consensus 81 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH---~~~iv 150 (367)
T 1cm8_A 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGII 150 (367)
T ss_dssp CCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred CCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 68999999999998653 459999999 6999999976 35889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
||||||+||+++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 151 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 226 (367)
T 1cm8_A 151 HRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCcCHHHEEEcCCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998765332 234568999999999887 67899999999999999999999999
Q ss_pred ccccccccccc-------cchhhhhhhhhccchhhhhhhhhh--cCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 155 DLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVV--EDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 155 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
........... +..++... ............... ...........++.+.+++.+||..||.+|||++|+
T Consensus 227 ~~~~~~~~l~~i~~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~ 305 (367)
T 1cm8_A 227 KGSDHLDQLKEIMKVTGTPPAEFVQR-LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 305 (367)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHT-CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHH-hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH
Confidence 75432211100 00000000 000000000000000 000000011345678999999999999999999999
Q ss_pred HH
Q 044155 226 AK 227 (239)
Q Consensus 226 l~ 227 (239)
++
T Consensus 306 l~ 307 (367)
T 1cm8_A 306 LA 307 (367)
T ss_dssp HH
T ss_pred hc
Confidence 87
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=254.24 Aligned_cols=202 Identities=20% Similarity=0.275 Sum_probs=155.1
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC-----
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP----- 73 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~----- 73 (239)
+++||||+++++++.. +...++||||+++++|.+++...... ...+++..+..++.|++.||.||| ..+
T Consensus 61 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ 136 (279)
T 2w5a_A 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECH---RRSDGGHT 136 (279)
T ss_dssp HCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHC-----
T ss_pred hcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCe
Confidence 3689999999998864 56789999999989999999764211 145889999999999999999999 777
Q ss_pred eeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 74 IVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 74 i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
++|+||||+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 137 ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 215 (279)
T 2w5a_A 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215 (279)
T ss_dssp -CCCCCSGGGEEECSSSCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEeccchhhEEEcCCCCEEEecCchheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999987653322 112345688999999999988899999999999999999999999
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..... .+........... ..+...+..+.+++.+||+.||.+|||+.|+++.+
T Consensus 216 ~~~~~~---------------------~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 216 FTAFSQ---------------------KELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp SCCSSH---------------------HHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CcccCH---------------------HHHHHHHhhcccc-cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 864321 0111111111110 00113456789999999999999999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=257.29 Aligned_cols=202 Identities=19% Similarity=0.267 Sum_probs=136.5
Q ss_pred CCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 2 MSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 2 l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
++||||+++++++.. +...++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+
T Consensus 79 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~ 152 (336)
T 3fhr_A 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLH---SHNIAHR 152 (336)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 589999999999986 3457899999999999999987543 46899999999999999999999 8999999
Q ss_pred cccCcceeecCC---CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 78 NFKTSCILFNEE---NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 78 dlk~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
||||+||+++.+ +.++|+|||++...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred CCCHHHEEEEecCCCceEEEeccccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 999999999864 45999999998755322 123456799999999998888999999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........... ....+... ............+..+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~--------------~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 230 YSNTGQAISPG--------------MKRRIRLG-QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCccchhhhhh--------------HHHhhhcc-ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 64332111000 00000000 000000011134567889999999999999999999997
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=258.43 Aligned_cols=212 Identities=17% Similarity=0.228 Sum_probs=154.3
Q ss_pred CCcccceeeEEEE----eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC-Ceeec
Q 044155 3 SHNHILKLIGCCL----ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFR 77 (239)
Q Consensus 3 ~H~niv~l~~~~~----~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-~i~H~ 77 (239)
+|+||+++++++. ++...++||||+. ++|.+.+..... ..++...++.++.||+.||.||| ++ +|+||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~givHr 171 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHT 171 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECC
T ss_pred CcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecC
Confidence 4899999999988 4557899999995 777777765432 56899999999999999999999 77 99999
Q ss_pred cccCcceeecCCC-------------------------------------------------ceeEcccccccccCCCCc
Q 044155 78 NFKTSCILFNEEN-------------------------------------------------VAKLFDFSLSISIPEGET 108 (239)
Q Consensus 78 dlk~~nil~~~~~-------------------------------------------------~~~l~dfg~~~~~~~~~~ 108 (239)
||||+|||++.++ .++|+|||.+......
T Consensus 172 Dikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-- 249 (397)
T 1wak_A 172 DIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-- 249 (397)
T ss_dssp CCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--
T ss_pred CCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--
Confidence 9999999999775 7999999998765332
Q ss_pred ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccccccccc-chhhhhhhhhc--------cc
Q 044155 109 HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCP-FSEYLKNCFED--------NR 179 (239)
Q Consensus 109 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~--------~~ 179 (239)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||............ ........... ..
T Consensus 250 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 250 --FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp --SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred --CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 22446899999999999988999999999999999999999999754432111000 00000000000 00
Q ss_pred hh-hh-----------------hhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 180 FT-EI-----------------VDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 180 ~~-~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .. ....+..... .....+..+.+||.+||+.||.+|||++|+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYE--WSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSC--CCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcc--cchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 00 0000000000 12356778999999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=261.45 Aligned_cols=206 Identities=8% Similarity=0.024 Sum_probs=142.0
Q ss_pred CCcccceee-------EEEEeCC-----------------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHH------
Q 044155 3 SHNHILKLI-------GCCLETP-----------------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHR------ 52 (239)
Q Consensus 3 ~H~niv~l~-------~~~~~~~-----------------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~------ 52 (239)
+||||++++ +++...+ ..++||||++ ++|.+++.... ..++...+
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk 196 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILAL 196 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhH
Confidence 599988755 4554333 2699999998 89999998642 22344444
Q ss_pred HHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc--CC
Q 044155 53 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT--GV 130 (239)
Q Consensus 53 ~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~ 130 (239)
..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++..... ......+++.|+|||++.+ ..
T Consensus 197 ~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 197 HILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp HHHHHHHHHHHHHHH---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEE
T ss_pred HHHHHHHHHHHHHHH---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCC
Confidence 677899999999999 89999999999999999999999999999876532 1224556799999999987 67
Q ss_pred cccccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhh
Q 044155 131 FNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFE 210 (239)
Q Consensus 131 ~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 210 (239)
++.++||||||+++|+|++|..||........... ....... ..............++.+.++|.+
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----------~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW----------KRPSLRV----PGTDSLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCC----------CBCCTTS----CCCCSCCCTTSSCCCHHHHHHHHH
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCcccccch----------hhhhhhh----ccccccchhhccCCCHHHHHHHHH
Confidence 89999999999999999999999975532211100 0000000 000000000011345678999999
Q ss_pred hcCCCCCCCCCHHHHHH--HHHHHHH
Q 044155 211 CIKDSPADRPSMVDVAK--KLRQIYR 234 (239)
Q Consensus 211 cl~~dp~~Rps~~ell~--~L~~l~~ 234 (239)
||+.||++|||+.++++ +++++..
T Consensus 336 ~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 336 FLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp HTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred HcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 99999999999999986 5555443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=261.95 Aligned_cols=154 Identities=20% Similarity=0.273 Sum_probs=119.9
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCC----CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQ----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+|+||||+++++++.. ....++||||+. ++|.+++..... .....+++..++.++.||+.||.||| +.+|
T Consensus 74 ~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~i 149 (405)
T 3rgf_A 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWV 149 (405)
T ss_dssp HCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred hcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence 3789999999999965 567899999997 788888763211 01135889999999999999999999 8999
Q ss_pred eeccccCcceee----cCCCceeEcccccccccCCCCc--ceeecccccccccCccccccC-CcccccchhhhhhHHHHH
Q 044155 75 VFRNFKTSCILF----NEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFEL 147 (239)
Q Consensus 75 ~H~dlk~~nil~----~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~ 147 (239)
+||||||+|||+ +.++.+||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 150 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 229 (405)
T 3rgf_A 150 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 229 (405)
T ss_dssp CCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHH
T ss_pred eCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHH
Confidence 999999999999 6778999999999976543211 223456789999999999874 489999999999999999
Q ss_pred hcCCCCccccc
Q 044155 148 LTGWDVSDLVK 158 (239)
Q Consensus 148 ~~g~~p~~~~~ 158 (239)
++|..||....
T Consensus 230 l~g~~pf~~~~ 240 (405)
T 3rgf_A 230 LTSEPIFHCRQ 240 (405)
T ss_dssp HHSSCTTCCCC
T ss_pred HhCCCCCCCcc
Confidence 99999996543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=249.55 Aligned_cols=194 Identities=24% Similarity=0.324 Sum_probs=156.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++||||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||||+
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~ 153 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPE 153 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcc
Confidence 4999999999999999999999999999999999865 56889999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc------cCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR------TGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
||+++.++.++|+|||.+....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||..
T Consensus 154 Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 154 NILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eEEEcCCCcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 9999999999999999987654332 223456889999999885 34578899999999999999999999854
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... ............ .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 232 RKQM---------------------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SSHH---------------------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccHH---------------------HHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 2210 011111111110 1111244567899999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=250.24 Aligned_cols=208 Identities=16% Similarity=0.205 Sum_probs=153.2
Q ss_pred CCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 3 SHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 3 ~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.||||+++++++.+ ....++||||+.+++|.+++. .++...+..++.|++.||.||| +.+++|+|||
T Consensus 89 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dik 157 (330)
T 3nsz_A 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVK 157 (330)
T ss_dssp TSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred CCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCC
Confidence 39999999999987 567899999999999998883 4788999999999999999999 8999999999
Q ss_pred CcceeecCCC-ceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 158 p~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 158 PHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred HHHEEEcCCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9999999777 899999999976543322 234568899999999877 668999999999999999999999985332
Q ss_pred ccccccccchhhhhhhhhccchhhhhhh-----------hh--------hcCCCcHHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDH-----------IV--------VEDVSSIEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~--------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
.......... .........+.... .. ............++.+.++|.+||+.||.+|
T Consensus 236 ~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 311 (330)
T 3nsz_A 236 DNYDQLVRIA----KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311 (330)
T ss_dssp SHHHHHHHHH----HHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGS
T ss_pred chHHHHHHHH----HhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccC
Confidence 2111100000 00000000000000 00 0000001111246788999999999999999
Q ss_pred CCHHHHHH
Q 044155 220 PSMVDVAK 227 (239)
Q Consensus 220 ps~~ell~ 227 (239)
||++|+++
T Consensus 312 pta~e~l~ 319 (330)
T 3nsz_A 312 LTAREAME 319 (330)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=257.49 Aligned_cols=215 Identities=18% Similarity=0.234 Sum_probs=152.2
Q ss_pred CCCCcccceeeEEEEeCCC------ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETPI------PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~------~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++...+. .++||||++ +++.+.+..... ....++...+..++.|++.||.||| +.+|
T Consensus 88 ~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i 162 (394)
T 4e7w_A 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIH---SIGI 162 (394)
T ss_dssp TCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS-EEHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hCCCCCcceEEEEEEecCCCCCceEEEEEeeccC-ccHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence 4789999999999976543 679999998 455554432110 0156889999999999999999999 8999
Q ss_pred eeccccCcceeec-CCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCC
Q 044155 75 VFRNFKTSCILFN-EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 75 ~H~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
+||||||+||+++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||||+++|+|++|..
T Consensus 163 vHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 240 (394)
T 4e7w_A 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240 (394)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999 78999999999997653332 12345689999999998765 58999999999999999999999
Q ss_pred Ccccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcHH----HHHHHHHHHHHHhhhcCCCCCCCCC
Q 044155 153 VSDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE----KEQQLHASAQVTFECIKDSPADRPS 221 (239)
Q Consensus 153 p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dp~~Rps 221 (239)
||........... +..+..... ...+ ............. ....++.+.+++.+||+.||.+|||
T Consensus 241 pf~~~~~~~~l~~i~~~~g~p~~~~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 241 LFPGESGIDQLVEIIKVLGTPSREQIKTM--NPNY---MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHH--CGGG---SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhh--Chhh---hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 9975432211110 000000000 0000 0000000000000 0124567899999999999999999
Q ss_pred HHHHHH
Q 044155 222 MVDVAK 227 (239)
Q Consensus 222 ~~ell~ 227 (239)
+.|+++
T Consensus 316 ~~e~l~ 321 (394)
T 4e7w_A 316 AIEALC 321 (394)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=248.45 Aligned_cols=199 Identities=19% Similarity=0.326 Sum_probs=145.2
Q ss_pred CCCCcccceeeEEEEe-------------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHh
Q 044155 1 QMSHNHILKLIGCCLE-------------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLH 67 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~-------------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH 67 (239)
+++||||+++++++.+ ....++||||+++++|.+++.... ..++...+..++.|++.||.|||
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH 133 (303)
T 1zy4_A 58 SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIH 133 (303)
T ss_dssp TCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHH
T ss_pred hcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHH
Confidence 4789999999999865 345789999999999999998643 46788899999999999999999
Q ss_pred hCCCCCeeeccccCcceeecCCCceeEcccccccccCCCC-------------cceeecccccccccCccccccC-Cccc
Q 044155 68 FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-------------THITDTVMGTLGYCAPEYMRTG-VFNE 133 (239)
Q Consensus 68 ~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~ 133 (239)
+.+++|+||||+||+++.++.++|+|||.+....... ........|++.|+|||++.+. .++.
T Consensus 134 ---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 210 (303)
T 1zy4_A 134 ---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE 210 (303)
T ss_dssp ---HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCT
T ss_pred ---hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcc
Confidence 8999999999999999999999999999987553211 1122345688999999999864 6899
Q ss_pred ccchhhhhhHHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcC
Q 044155 134 KSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIK 213 (239)
Q Consensus 134 ~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 213 (239)
++||||||+++|+|+++ |....+.. .....+... ............+..+.+++.+||+
T Consensus 211 ~~Di~slG~il~~l~~p---~~~~~~~~-----------------~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 269 (303)
T 1zy4_A 211 KIDMYSLGIIFFEMIYP---FSTGMERV-----------------NILKKLRSV-SIEFPPDFDDNKMKVEKKIIRLLID 269 (303)
T ss_dssp HHHHHHHHHHHHHHHSC---CSSHHHHH-----------------HHHHHHHST-TCCCCTTCCTTTSHHHHHHHHHHTC
T ss_pred hhhHHHHHHHHHHHHhc---cCCchhHH-----------------HHHHhcccc-ccccCccccccchHHHHHHHHHHHh
Confidence 99999999999999983 32111000 000000000 0001111112344668899999999
Q ss_pred CCCCCCCCHHHHHH
Q 044155 214 DSPADRPSMVDVAK 227 (239)
Q Consensus 214 ~dp~~Rps~~ell~ 227 (239)
.||.+|||+.++++
T Consensus 270 ~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 270 HDPNKRPGARTLLN 283 (303)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred cCcccCcCHHHHhC
Confidence 99999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=246.96 Aligned_cols=212 Identities=20% Similarity=0.270 Sum_probs=156.9
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.|++|+++++++.+.+..++||||+ +++|.+++..... ..++...+..++.|++.||+||| +++++|+||||+
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 147 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPE 147 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHH
Confidence 4667999999999999999999999 6999999987643 46889999999999999999999 899999999999
Q ss_pred ceeecC-------------------CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhH
Q 044155 83 CILFNE-------------------ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVF 143 (239)
Q Consensus 83 nil~~~-------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 143 (239)
||+++. ++.++|+|||++...... .....||+.|+|||++.+..++.++||||||++
T Consensus 148 Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 223 (339)
T 1z57_A 148 NILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223 (339)
T ss_dssp GEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHH
T ss_pred HEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHH
Confidence 999987 567999999998764332 234568999999999998899999999999999
Q ss_pred HHHHhcCCCCcccccccccc------cccchhhhhhhhhcc--------chhh------hhhhh---hhcCCCcHHHHHH
Q 044155 144 LFELLTGWDVSDLVKDVHDL------VCPFSEYLKNCFEDN--------RFTE------IVDHI---VVEDVSSIEKEQQ 200 (239)
Q Consensus 144 l~~~~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~--------~~~~------~~~~~---~~~~~~~~~~~~~ 200 (239)
+|+|++|..||......... ..+.+.......... .+.. ..... ..... ......
T Consensus 224 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 301 (339)
T 1z57_A 224 LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM--LSQDVE 301 (339)
T ss_dssp HHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGC--SCCSHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhc--ccchhh
Confidence 99999999999754321110 000000000000000 0000 00000 00000 001245
Q ss_pred HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 201 LHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 201 ~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
++.+.+++.+||+.||.+|||+.|+++
T Consensus 302 ~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 302 HERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 678999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=256.35 Aligned_cols=211 Identities=19% Similarity=0.235 Sum_probs=142.0
Q ss_pred CCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 2 MSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 2 l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
++||||+++++++... ...++|+|++ +++|.+++.. ..++...+..++.|++.||.||| +.+++
T Consensus 85 l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~giv 154 (367)
T 2fst_X 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADII 154 (367)
T ss_dssp CCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred CCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence 6899999999998754 5678999999 5899998865 45889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
||||||+||+++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 155 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 230 (367)
T 2fst_X 155 HRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230 (367)
T ss_dssp CCCCCGGGEEECTTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred eCCCCHhhEEECCCCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998764322 234568999999999887 67899999999999999999999999
Q ss_pred ccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 155 DLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 155 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
........... +..+..... .................... .....++.+.+|+.+||..||.+|||+.|+
T Consensus 231 ~~~~~~~~l~~i~~~~g~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~ 309 (367)
T 2fst_X 231 PGTDHIDQLKLILRLVGTPGAELLKKI-SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309 (367)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHTTC-CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHHh-hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH
Confidence 75432211100 000000000 00000000000000000000 011335678999999999999999999999
Q ss_pred HH
Q 044155 226 AK 227 (239)
Q Consensus 226 l~ 227 (239)
++
T Consensus 310 L~ 311 (367)
T 2fst_X 310 LA 311 (367)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=254.67 Aligned_cols=216 Identities=16% Similarity=0.182 Sum_probs=155.0
Q ss_pred CCCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++... ...++|||++. ++|.+++.. ..++...+..++.|++.||.||| +.+++
T Consensus 81 ~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~iv 150 (364)
T 3qyz_A 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVL 150 (364)
T ss_dssp HCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred hcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence 37899999999999755 35789999997 799999976 45889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|+||||+||+++.++.++|+|||++......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 151 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 230 (364)
T 3qyz_A 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230 (364)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999998765322211 1234578999999998765 458999999999999999999999
Q ss_pred Cccccccccccccc-------chhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 153 VSDLVKDVHDLVCP-------FSEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 153 p~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
||............ ..+.... ..................... .....+..+.+++.+||+.||.+|||+.
T Consensus 231 pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 309 (364)
T 3qyz_A 231 IFPGKHYLDQLNHILGILGSPSQEDLNC-IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309 (364)
T ss_dssp SSCCSSGGGHHHHHHHHHCSCCHHHHHT-CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHH-hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 99654322211100 0000000 000000000000000000000 0113456789999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
|+++
T Consensus 310 e~l~ 313 (364)
T 3qyz_A 310 QALA 313 (364)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=246.37 Aligned_cols=195 Identities=22% Similarity=0.325 Sum_probs=155.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....++|||++++++|.+.+... ..++...+..++.|++.||.||| +.+++|+|||
T Consensus 77 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~ 148 (287)
T 2wei_A 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLK 148 (287)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence 478999999999999999999999999999999988765 56889999999999999999999 8999999999
Q ss_pred CcceeecCCC---ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEEN---VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||+++.++ .++|+|||++....... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...
T Consensus 149 p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 149 PENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp GGGEEESCSSTTCCEEECSTTGGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhEEEecCCCcccEEEeccCcceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 9999997644 69999999987654332 1234458899999998875 4889999999999999999999998643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... +.......... ........+..+.+++.+||+.||.+|||+.|+++
T Consensus 226 ~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 226 NEY---------------------DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SHH---------------------HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHH---------------------HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 211 11111111111 01111234567899999999999999999999997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=245.34 Aligned_cols=197 Identities=15% Similarity=0.205 Sum_probs=152.1
Q ss_pred CCCCcccceeeEEEE--eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecc
Q 044155 1 QMSHNHILKLIGCCL--ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRN 78 (239)
Q Consensus 1 ~l~H~niv~l~~~~~--~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~d 78 (239)
+++||||+++++++. +....++||||+++ +|.+++..... ..++...+..++.|++.||.||| +++++|+|
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~d 134 (305)
T 2wtk_C 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVC-GMQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKD 134 (305)
T ss_dssp TCCCTTBCCEEEEEECC---CEEEEEECCSE-EHHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred hcCCCCeeEEEEEEEcCCCCeEEEEehhccC-CHHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHH---HCCeeecC
Confidence 478999999999985 45578999999985 57787776533 57899999999999999999999 89999999
Q ss_pred ccCcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCC--cccccchhhhhhHHHHHhcCCCCcc
Q 044155 79 FKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGV--FNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 79 lk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|||+||+++.++.++|+|||.+....... ........+++.|+|||++.+.. .+.++||||||+++|+|++|..||.
T Consensus 135 lkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 135 IKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999987654321 22234556899999999987644 4779999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.... .+............ +...+..+.+++.+||+.||.+|||+.|+++
T Consensus 215 ~~~~---------------------~~~~~~i~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 215 GDNI---------------------YKLFENIGKGSYAI--PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CSSH---------------------HHHHHHHHHCCCCC--CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CchH---------------------HHHHHHHhcCCCCC--CCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3221 11111111111110 1134567889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=249.76 Aligned_cols=147 Identities=20% Similarity=0.224 Sum_probs=126.8
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.|++|+++++++...+..++||||+. ++|.+++..... ..+++..+..++.|++.||.|||.. ..+|+||||||+
T Consensus 114 ~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~ 188 (382)
T 2vx3_A 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPE 188 (382)
T ss_dssp GGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGG
T ss_pred cceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcc
Confidence 35579999999999999999999996 699999987643 4588999999999999999999932 368999999999
Q ss_pred ceeec--CCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 83 CILFN--EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 83 nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|||++ .++.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 189 NIll~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 189 NILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp GEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEecCCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99995 4678999999998765332 234568999999999999899999999999999999999999997543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=260.02 Aligned_cols=203 Identities=17% Similarity=0.277 Sum_probs=144.3
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCC--CcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHF--EPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+||||+++++++.+....++||||+. |+|.+++........ .......+..++.|++.||+||| +.+|+|||||
T Consensus 67 ~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLk 142 (434)
T 2rio_A 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLK 142 (434)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred CCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence 79999999999999999999999996 799999987532110 00122345679999999999999 8999999999
Q ss_pred CcceeecCC-------------CceeEcccccccccCCCCcc---eeecccccccccCcccccc-------CCcccccch
Q 044155 81 TSCILFNEE-------------NVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRT-------GVFNEKSNV 137 (239)
Q Consensus 81 ~~nil~~~~-------------~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di 137 (239)
|+||+++.+ +.+||+|||++......... ......||+.|+|||++.+ ..++.++||
T Consensus 143 p~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 222 (434)
T 2rio_A 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI 222 (434)
T ss_dssp GGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred hHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence 999999754 47999999999876433211 1234568999999999975 568899999
Q ss_pred hhhhhHHHHHhc-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCC
Q 044155 138 FSFSVFLFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSP 216 (239)
Q Consensus 138 ~slG~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 216 (239)
||||+++|+|++ |..||....... ......... ............+..+.++|.+||+.||
T Consensus 223 wSlG~il~ellt~g~~Pf~~~~~~~------~~i~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dP 284 (434)
T 2rio_A 223 FSMGCVFYYILSKGKHPFGDKYSRE------SNIIRGIFS------------LDEMKCLHDRSLIAEATDLISQMIDHDP 284 (434)
T ss_dssp HHHHHHHHHHHTTSCCTTCSTTTHH------HHHHHTCCC------------CCCCTTCCCHHHHHHHHHHHHHHTCSSG
T ss_pred HhHHHHHHHHHhCCCCCCCCchhhH------HHHhcCCCC------------cccccccccccchHHHHHHHHHHhhCCh
Confidence 999999999999 888885322100 000000000 0000011113566789999999999999
Q ss_pred CCCCCHHHHHH
Q 044155 217 ADRPSMVDVAK 227 (239)
Q Consensus 217 ~~Rps~~ell~ 227 (239)
.+|||+.++++
T Consensus 285 ~~Rps~~eil~ 295 (434)
T 2rio_A 285 LKRPTAMKVLR 295 (434)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHHh
Confidence 99999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=249.07 Aligned_cols=215 Identities=19% Similarity=0.257 Sum_probs=156.9
Q ss_pred CCCcccceeeEEEE-----eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 2 MSHNHILKLIGCCL-----ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 2 l~H~niv~l~~~~~-----~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++||||+++++++. .....++||||+. ++|.+++..... ..++...+..++.|++.||.||| +.+++|
T Consensus 71 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H 143 (326)
T 1blx_A 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVH 143 (326)
T ss_dssp TCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcee
Confidence 48999999999987 4557889999998 799999987543 45889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
+||||+||+++.++.++|+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 144 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 144 RDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCHHHeEEcCCCCEEEecCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999998654322 123345688999999999988899999999999999999999999875
Q ss_pred ccccccccccchhhhhhhhhccchhhhhh---hhhhc-CCC--cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVD---HIVVE-DVS--SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
............ ....+ ....+..... ..... ... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~~~~~~~~i~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 222 SSDVDQLGKILD-VIGLP-GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SSHHHHHHHHHH-HHCCC-CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHH-HcCCC-CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 432211100000 00000 0000000000 00000 000 0001134567889999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=251.51 Aligned_cols=212 Identities=17% Similarity=0.233 Sum_probs=152.2
Q ss_pred CCcccceeeEEEEeCC----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC-Ceeec
Q 044155 3 SHNHILKLIGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFR 77 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-~i~H~ 77 (239)
.||||+++++++...+ ..++|||++ +++|.+++..... ..++...+..++.|++.||.||| ++ +++|+
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~ 156 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHT 156 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECS
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEec
Confidence 4899999999998654 678999999 7999999987543 45889999999999999999999 77 99999
Q ss_pred cccCcceeec------CCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 78 NFKTSCILFN------EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 78 dlk~~nil~~------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
||||+||+++ ..+.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 157 Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 157 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp CCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 9999999994 3447999999998765332 22446899999999999988999999999999999999999
Q ss_pred CCcccccccccccc--cchhhhhhh-------hhccchh----------hh--------hhhhhhcCCCcHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVC--PFSEYLKNC-------FEDNRFT----------EI--------VDHIVVEDVSSIEKEQQLHAS 204 (239)
Q Consensus 152 ~p~~~~~~~~~~~~--~~~~~~~~~-------~~~~~~~----------~~--------~~~~~~~~~~~~~~~~~~~~~ 204 (239)
.||........... ......... ....... .. .......... .+...+..+
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 310 (373)
T 1q8y_A 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK--FSKDEAKEI 310 (373)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC--CCHHHHHHH
T ss_pred CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhccc--CCcchHHHH
Confidence 99975432110000 000000000 0000000 00 0000011110 113667889
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHH
Q 044155 205 AQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 205 ~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.+||.+||+.||.+|||++|+++
T Consensus 311 ~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 311 SDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHhccCccccCCHHHHhh
Confidence 99999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=255.68 Aligned_cols=223 Identities=19% Similarity=0.242 Sum_probs=155.3
Q ss_pred CCCCcccceeeEEEEeCC--------------------------------------CceEEEEEccCCChhhhhhcCCCC
Q 044155 1 QMSHNHILKLIGCCLETP--------------------------------------IPILVFESVQYGTLWDRILGAPQP 42 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~--------------------------------------~~~iv~e~~~~~sL~~~l~~~~~~ 42 (239)
+++||||+++++++.... ..++||||++ ++|.+.+......
T Consensus 56 ~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~ 134 (383)
T 3eb0_A 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS 134 (383)
T ss_dssp TCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT
T ss_pred HcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc
Confidence 478999999999985432 3789999998 6887777641110
Q ss_pred CCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeec-CCCceeEcccccccccCCCCcceeeccccccccc
Q 044155 43 HFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN-EENVAKLFDFSLSISIPEGETHITDTVMGTLGYC 121 (239)
Q Consensus 43 ~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~ 121 (239)
...++...+..++.|++.||.||| +.+++||||||+||+++ .++.+||+|||++....... ......+++.|+
T Consensus 135 -~~~l~~~~~~~i~~qi~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~ 208 (383)
T 3eb0_A 135 -GRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYR 208 (383)
T ss_dssp -TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCC
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCcc
Confidence 156899999999999999999999 99999999999999997 67899999999997654332 223456789999
Q ss_pred CccccccC-CcccccchhhhhhHHHHHhcCCCCcccccccccccc-------cchhhhhhhhhccchhhh-hhhhhhcCC
Q 044155 122 APEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEI-VDHIVVEDV 192 (239)
Q Consensus 122 aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 192 (239)
|||.+.+. .++.++||||+|+++|+|++|..||........... +..+..... .....+. .........
T Consensus 209 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 286 (383)
T 3eb0_A 209 APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRM--NPHYTEVRFPTLKAKDW 286 (383)
T ss_dssp CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH--CTTC--CCCCCCCCCCH
T ss_pred CHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh--CcccccccCCccCcccH
Confidence 99998875 489999999999999999999999975432211110 000000000 0000000 000000000
Q ss_pred CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHHHH
Q 044155 193 SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK--KLRQI 232 (239)
Q Consensus 193 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~--~L~~l 232 (239)
....+...+..+.+++.+||+.||.+|||+.|+++ +++++
T Consensus 287 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 287 RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred HhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 00001134567899999999999999999999985 44444
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=252.50 Aligned_cols=216 Identities=16% Similarity=0.123 Sum_probs=148.5
Q ss_pred CCCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++... ...++||||+. ++|.+.+.... ..++...+..++.|++.||.||| +.+++
T Consensus 85 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iv 156 (362)
T 3pg1_A 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLH---EAGVV 156 (362)
T ss_dssp HCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred hCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCcCE
Confidence 37899999999998643 24689999998 79989887643 46899999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||||+||+++.++.++|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 234 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986543221 2334568899999999877 67899999999999999999999998
Q ss_pred cccccccccccc-------chhhhhhhhhccchhhhhhhhhhcCCC---cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 155 DLVKDVHDLVCP-------FSEYLKNCFEDNRFTEIVDHIVVEDVS---SIEKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 155 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
............ .... ...+......+........... .......++.+.+++.+||+.||.+|||+.|
T Consensus 235 ~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 235 RGSTFYNQLNKIVEVVGTPKIED-VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHH-HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCHHHHHHHHHHHcCCCChHH-hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 653321110000 0000 0000000000000000000000 0011233567899999999999999999999
Q ss_pred HHH
Q 044155 225 VAK 227 (239)
Q Consensus 225 ll~ 227 (239)
+++
T Consensus 314 ll~ 316 (362)
T 3pg1_A 314 ALR 316 (362)
T ss_dssp HHT
T ss_pred HHc
Confidence 986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=249.27 Aligned_cols=216 Identities=15% Similarity=0.148 Sum_probs=151.6
Q ss_pred CCCcccceeeEEEEeCCC-------ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 2 MSHNHILKLIGCCLETPI-------PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~-------~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
++||||+++++++..... .++||||++ ++|.+.+..... ....++...+..++.|++.||.|||.. +.++
T Consensus 76 l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~i 152 (360)
T 3e3p_A 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNV 152 (360)
T ss_dssp HCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCS-CBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCC
T ss_pred cCCCCcccHHHhhhccccccccceeEEEEeeccc-ccHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCe
Confidence 589999999999976443 789999998 566655443111 015688999999999999999999943 5789
Q ss_pred eeccccCcceeecC-CCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCC
Q 044155 75 VFRNFKTSCILFNE-ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 75 ~H~dlk~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~ 152 (239)
+|+||||+||+++. ++.+||+|||++....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..
T Consensus 153 vH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~ 230 (360)
T 3e3p_A 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230 (360)
T ss_dssp BCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999997 8899999999987654332 223456899999999987654 8999999999999999999999
Q ss_pred Ccccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcHHH-------HHHHHHHHHHHhhhcCCCCCC
Q 044155 153 VSDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEK-------EQQLHASAQVTFECIKDSPAD 218 (239)
Q Consensus 153 p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dp~~ 218 (239)
||........... +..+............. .......... ...+..+.+++.+||+.||.+
T Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 305 (360)
T 3e3p_A 231 IFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVD-----LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305 (360)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGG-----GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGG
T ss_pred CcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcc-----ccccccCCcccccchhhccccHHHHHHHHHHhccCccc
Confidence 9975432211100 00000000000000000 0000000000 124577999999999999999
Q ss_pred CCCHHHHHH
Q 044155 219 RPSMVDVAK 227 (239)
Q Consensus 219 Rps~~ell~ 227 (239)
|||+.|+++
T Consensus 306 Rpt~~e~l~ 314 (360)
T 3e3p_A 306 RMKPYEALC 314 (360)
T ss_dssp SCCHHHHTT
T ss_pred cCCHHHHhc
Confidence 999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=256.64 Aligned_cols=197 Identities=19% Similarity=0.217 Sum_probs=143.6
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+||||+++++++.+....++|||++. ++|.+++..... ......+..++.|++.||.||| +.+|+||||||+
T Consensus 76 ~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~ 147 (432)
T 3p23_A 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPH 147 (432)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTT
T ss_pred CCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHH
Confidence 79999999999999999999999997 799999987542 2344456689999999999999 899999999999
Q ss_pred ceeecCC-----CceeEcccccccccCCCCc--ceeecccccccccCcccccc---CCcccccchhhhhhHHHHHhc-CC
Q 044155 83 CILFNEE-----NVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLT-GW 151 (239)
Q Consensus 83 nil~~~~-----~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~-g~ 151 (239)
||+++.+ ..++|+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |.
T Consensus 148 NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~ 227 (432)
T 3p23_A 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227 (432)
T ss_dssp SEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred HEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence 9999532 2578999999876543221 22344568999999999973 557789999999999999999 88
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.||...... .......... ..... .....+..+.++|.+||+.||.+|||+.++++
T Consensus 228 ~pf~~~~~~---------~~~~~~~~~~---------~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 228 HPFGKSLQR---------QANILLGACS---------LDCLH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp BTTBSTTTH---------HHHHHTTCCC---------CTTSC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcchhhHH---------HHHHHhccCC---------ccccC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 887432110 0000000000 00000 01134556789999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=254.73 Aligned_cols=203 Identities=20% Similarity=0.221 Sum_probs=136.5
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC-Ceeecccc
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFK 80 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-~i~H~dlk 80 (239)
++||||+++++++.+.+..++||||++ ++|.+++..........++...+..++.|++.||.||| +. +++|+|||
T Consensus 78 ~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlk 153 (327)
T 3aln_A 78 SDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIK 153 (327)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCC
T ss_pred CCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCC
Confidence 689999999999999999999999998 68888776311101156889999999999999999999 77 99999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccc----ccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYM----RTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||+++.++.+||+|||++....... ......|++.|+|||++ .+..++.++||||||+++|+|++|..||..
T Consensus 154 p~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 154 PSNILLDRSGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp GGGEEEETTTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred HHHEEEcCCCCEEEccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999987653322 12234689999999998 455688999999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... ..... .. ...........+..+.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~-------~~~~~-~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 232 WNSVFDQLT-------QVVKG-DP---------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-------C-------CCCCS-CC---------CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cchHHHHHH-------HHhcC-CC---------CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 322111100 00000 00 00000000123467889999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=252.04 Aligned_cols=210 Identities=17% Similarity=0.211 Sum_probs=151.1
Q ss_pred CCCcccceeeEEEEeCCCc------eEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 2 MSHNHILKLIGCCLETPIP------ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~------~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
++||||+++++++...... ++||||+. ++|.+.+. ..++...+..++.|++.||.||| +.+++
T Consensus 98 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~iv 166 (371)
T 4exu_A 98 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH---SAGVV 166 (371)
T ss_dssp CCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred cCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCc
Confidence 6899999999999876654 99999997 79988774 45889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||||+||+++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 167 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 242 (371)
T 4exu_A 167 HRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242 (371)
T ss_dssp CSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCcCHHHeEECCCCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998654322 234568999999999887 67899999999999999999999999
Q ss_pred cccccccccccc-------chhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 155 DLVKDVHDLVCP-------FSEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 155 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
............ ..++.. ...................... .....++.+.++|.+||+.||.+|||++|+
T Consensus 243 ~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 321 (371)
T 4exu_A 243 KGKDYLDQLTQILKVTGVPGTEFVQ-KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 321 (371)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHT-TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCChHHHHHHHHHHhCCCcHHHHH-HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence 754321111000 000000 0000000000000000010100 111346788999999999999999999999
Q ss_pred HH
Q 044155 226 AK 227 (239)
Q Consensus 226 l~ 227 (239)
++
T Consensus 322 l~ 323 (371)
T 4exu_A 322 LT 323 (371)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=254.93 Aligned_cols=214 Identities=19% Similarity=0.215 Sum_probs=151.4
Q ss_pred CCCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+|+||||+++++++.... ..++||||++ ++|.+.+..... ....++...+..++.||+.||.||| +.+|
T Consensus 103 ~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~i 177 (420)
T 1j1b_A 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGI 177 (420)
T ss_dssp TCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTE
T ss_pred HcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCc
Confidence 478999999999986432 2568999998 577776653110 0156899999999999999999999 9999
Q ss_pred eeccccCcceeecCC-CceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCC
Q 044155 75 VFRNFKTSCILFNEE-NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 75 ~H~dlk~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
+||||||+|||++.+ +.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 178 vHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCChhhEEEeCCCCeEEeccchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999965 568999999997654332 12345689999999998765 68999999999999999999999
Q ss_pred Ccccccccccccccchhhhhhhhhccchhhhhhhhh--------hcCC-CcH---HHHHHHHHHHHHHhhhcCCCCCCCC
Q 044155 153 VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIV--------VEDV-SSI---EKEQQLHASAQVTFECIKDSPADRP 220 (239)
Q Consensus 153 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~---~~~~~~~~~~~li~~cl~~dp~~Rp 220 (239)
||........... ..+.. .... .+.+.... .... ... .....+..+.+||.+||..||.+||
T Consensus 256 pf~~~~~~~~l~~----i~~~l-g~p~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~ 329 (420)
T 1j1b_A 256 IFPGDSGVDQLVE----IIKVL-GTPT-REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329 (420)
T ss_dssp SSCCSSHHHHHHH----HHHHH-CSCC-HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCCCCHHHHHHH----HHHHh-CCCC-HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCC
Confidence 9975432211110 00000 0000 00000000 0000 000 0012356789999999999999999
Q ss_pred CHHHHHH
Q 044155 221 SMVDVAK 227 (239)
Q Consensus 221 s~~ell~ 227 (239)
|+.|+++
T Consensus 330 t~~e~l~ 336 (420)
T 1j1b_A 330 TPLEACA 336 (420)
T ss_dssp CHHHHHT
T ss_pred CHHHHhC
Confidence 9999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=251.36 Aligned_cols=217 Identities=20% Similarity=0.222 Sum_probs=153.9
Q ss_pred CCCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++... ...++||||+. ++|.+++.. ..++...+..++.|++.||.||| +.+++
T Consensus 65 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~iv 134 (353)
T 2b9h_A 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLH---GSNVI 134 (353)
T ss_dssp HCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred hCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence 36899999999998754 56799999997 799999876 45889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcc---------eeecccccccccCcccccc-CCcccccchhhhhhHHH
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETH---------ITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLF 145 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ 145 (239)
|+||||+||+++.++.++|+|||++......... ......|++.|+|||++.. ..++.++||||||+++|
T Consensus 135 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 214 (353)
T 2b9h_A 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214 (353)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHH
T ss_pred cCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHH
Confidence 9999999999999999999999998765422111 1223467999999998765 67899999999999999
Q ss_pred HHhcCCCCcccccccccccccch-------hhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCC
Q 044155 146 ELLTGWDVSDLVKDVHDLVCPFS-------EYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSP 216 (239)
Q Consensus 146 ~~~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp 216 (239)
+|++|..||.............. .............+............. .....++.+.+++.+||+.||
T Consensus 215 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (353)
T 2b9h_A 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294 (353)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSG
T ss_pred HHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCc
Confidence 99999999875432111000000 000000000000000000000000000 112346778999999999999
Q ss_pred CCCCCHHHHHH
Q 044155 217 ADRPSMVDVAK 227 (239)
Q Consensus 217 ~~Rps~~ell~ 227 (239)
.+|||+.|+++
T Consensus 295 ~~Rpt~~ell~ 305 (353)
T 2b9h_A 295 AKRITAKEALE 305 (353)
T ss_dssp GGSCCHHHHHT
T ss_pred ccCCCHHHHhc
Confidence 99999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=246.94 Aligned_cols=194 Identities=19% Similarity=0.265 Sum_probs=145.6
Q ss_pred CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcc
Q 044155 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 83 (239)
Q Consensus 4 H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~n 83 (239)
||||+++++++.+....++||| +.+++|.+++... ..++...+..++.|++.||.||| +.+++|+||||+|
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~N 157 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPAN 157 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCccc
Confidence 6999999999999999999999 4569999999875 56889999999999999999999 8999999999999
Q ss_pred eeecCCCceeEcccccccccCCCCc-ceeecccccccccCcccccc-----------CCcccccchhhhhhHHHHHhcCC
Q 044155 84 ILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRT-----------GVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 84 il~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|++++ +.+||+|||++........ .......|++.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 158 Il~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 158 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp EEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 99964 7899999999876533221 12234568999999999875 46788999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.||....... ...............+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~pf~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 237 TPFQQIINQI--------------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CTTTTCCSHH--------------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhhHHHHH--------------------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 9985432110 0000011100000000122456889999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=244.53 Aligned_cols=213 Identities=17% Similarity=0.230 Sum_probs=154.1
Q ss_pred CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcc
Q 044155 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSC 83 (239)
Q Consensus 4 H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~n 83 (239)
|.+++.+++++...+..++||||+ ++++.+.+..... ..++...+..++.|++.||.||| +++++|+||||+|
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~N 153 (355)
T 2eu9_A 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPEN 153 (355)
T ss_dssp CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGG
T ss_pred ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHH
Confidence 445999999999999999999999 4788888876533 46899999999999999999999 9999999999999
Q ss_pred eee-------------------cCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHH
Q 044155 84 ILF-------------------NEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFL 144 (239)
Q Consensus 84 il~-------------------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 144 (239)
|++ +.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++
T Consensus 154 Ill~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 154 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229 (355)
T ss_dssp EEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEEecccccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHH
Confidence 999 56788999999998764322 2345689999999999988999999999999999
Q ss_pred HHHhcCCCCcccccccccc------cccchhhhhhhhhccc--------hhh------hhhhhhhc-CCCcHHHHHHHHH
Q 044155 145 FELLTGWDVSDLVKDVHDL------VCPFSEYLKNCFEDNR--------FTE------IVDHIVVE-DVSSIEKEQQLHA 203 (239)
Q Consensus 145 ~~~~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~--------~~~------~~~~~~~~-~~~~~~~~~~~~~ 203 (239)
|+|++|..||......... ..+.+........... +.. ........ ..........+..
T Consensus 230 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 9999999999754332111 0000000000000000 000 00000000 0000001234568
Q ss_pred HHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 204 SAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 204 ~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+.+++.+||+.||.+|||+.|+++
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCcCHHHHhc
Confidence 899999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=247.27 Aligned_cols=185 Identities=18% Similarity=0.314 Sum_probs=152.4
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccC-CChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.||||+++++++.+.+..++|+|++.+ ++|.+++... ..++...+..++.|++.||.||| +.+++|+||||
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp 177 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKD 177 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCH
Confidence 479999999999999999999999976 8999999865 56889999999999999999999 89999999999
Q ss_pred cceeec-CCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 82 SCILFN-EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 82 ~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
+||+++ .++.+||+|||++....... .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 178 ~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 254 (320)
T 3a99_A 178 ENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254 (320)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred HHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh
Confidence 999999 77899999999987654322 234568999999999887665 6889999999999999999999853221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. ...... . ....+..+.++|.+||+.||.+|||++|+++
T Consensus 255 ~-----------------------~~~~~~--~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 I-----------------------IRGQVF--F----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp H-----------------------HHCCCC--C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h-----------------------hccccc--c----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000 0 0123456889999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=245.71 Aligned_cols=185 Identities=21% Similarity=0.331 Sum_probs=148.7
Q ss_pred CCcccceeeEEEEeCCCceEEEEE-ccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 3 SHNHILKLIGCCLETPIPILVFES-VQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
+||||+++++++...+..++|+|+ +.+++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp 167 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKD 167 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSG
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCh
Confidence 899999999999999999999999 7889999999875 56899999999999999999999 89999999999
Q ss_pred cceeec-CCCceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 82 SCILFN-EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 82 ~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
+||+++ .++.++|+|||++....... .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||.....
T Consensus 168 ~Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 244 (312)
T 2iwi_A 168 ENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244 (312)
T ss_dssp GGEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred hhEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH
Confidence 999999 78899999999987654322 234568999999999887665 4589999999999999999999853211
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. ..... .. ....+..+.++|.+||+.||.+|||++|+++
T Consensus 245 ~-----------------------~~~~~--~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 I-----------------------LEAEL--HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H-----------------------HHTCC--CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H-----------------------hhhcc--CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 00 0133456889999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=243.59 Aligned_cols=215 Identities=17% Similarity=0.224 Sum_probs=152.2
Q ss_pred CCCCcccceeeEEEE--------------eCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHH
Q 044155 1 QMSHNHILKLIGCCL--------------ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYL 66 (239)
Q Consensus 1 ~l~H~niv~l~~~~~--------------~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 66 (239)
+++||||+++++++. +....++||||++ ++|.+++.. ..++...+..++.|++.||+||
T Consensus 64 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~l 136 (320)
T 2i6l_A 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYI 136 (320)
T ss_dssp TCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred hcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHH
Confidence 478999999999874 3356789999998 799999864 4588999999999999999999
Q ss_pred hhCCCCCeeeccccCcceeec-CCCceeEcccccccccCCCC--cceeecccccccccCcccccc-CCcccccchhhhhh
Q 044155 67 HFGFPRPIVFRNFKTSCILFN-EENVAKLFDFSLSISIPEGE--THITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSV 142 (239)
Q Consensus 67 H~~~~~~i~H~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ 142 (239)
| +.+++|+||||+||+++ .++.+||+|||++....... ........++..|+|||.+.. ..++.++||||||+
T Consensus 137 H---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 213 (320)
T 2i6l_A 137 H---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 213 (320)
T ss_dssp H---HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHH
T ss_pred H---hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHH
Confidence 9 89999999999999997 56689999999987653221 112234557889999998865 67899999999999
Q ss_pred HHHHHhcCCCCcccccccccccccc-------hhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcC
Q 044155 143 FLFELLTGWDVSDLVKDVHDLVCPF-------SEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIK 213 (239)
Q Consensus 143 ~l~~~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~ 213 (239)
++|+|++|..||............. ......... ................. .....+..+.++|.+||+
T Consensus 214 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 291 (320)
T 2i6l_A 214 IFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS--VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILT 291 (320)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHT--TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSC
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhh--cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcC
Confidence 9999999999997543211110000 000000000 00000000111111111 111346789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 044155 214 DSPADRPSMVDVAK 227 (239)
Q Consensus 214 ~dp~~Rps~~ell~ 227 (239)
.||.+|||++|+++
T Consensus 292 ~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 292 FSPMDRLTAEEALS 305 (320)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CCccccCCHHHHhC
Confidence 99999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=248.26 Aligned_cols=210 Identities=17% Similarity=0.222 Sum_probs=149.8
Q ss_pred CCCcccceeeEEEEeCCC------ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 2 MSHNHILKLIGCCLETPI------PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~------~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
++||||+++++++..... .++||||+. ++|.+++. ..++...+..++.|++.||.||| +++++
T Consensus 80 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~iv 148 (353)
T 3coi_A 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH---SAGVV 148 (353)
T ss_dssp CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred cCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 689999999999987654 499999997 79988774 34889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|+||||+||+++.++.+||+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus 149 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 224 (353)
T 3coi_A 149 HRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224 (353)
T ss_dssp CSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCCHHHEeECCCCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998654322 234567999999999887 67899999999999999999999999
Q ss_pred ccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 155 DLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 155 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
........... +..++... .................. ........+..+.+++.+||+.||.+|||++++
T Consensus 225 ~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 303 (353)
T 3coi_A 225 KGKDYLDQLTQILKVTGVPGTEFVQK-LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 303 (353)
T ss_dssp BSSCHHHHHHHHHHHHCBCCHHHHTT-CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHH-HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 75432111000 00000000 000000000000000000 000012346778999999999999999999999
Q ss_pred HH
Q 044155 226 AK 227 (239)
Q Consensus 226 l~ 227 (239)
++
T Consensus 304 l~ 305 (353)
T 3coi_A 304 LT 305 (353)
T ss_dssp HT
T ss_pred hc
Confidence 85
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=245.77 Aligned_cols=196 Identities=21% Similarity=0.269 Sum_probs=143.8
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC-Ceeecccc
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR-PIVFRNFK 80 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~-~i~H~dlk 80 (239)
++||||+++++++.+....++||||+ ++.+..+..... ..++...+..++.|++.||.||| .. +++|+|||
T Consensus 81 ~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlk 152 (318)
T 2dyl_A 81 HDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVK 152 (318)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCC
T ss_pred cCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCC
Confidence 68999999999999999999999999 466666554322 56889999999999999999999 75 99999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+||+++.++.++|+|||++....... ......+++.|+|||.+. ...++.++||||||+++|+|++|..||.
T Consensus 153 p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 153 PSNILLDERGQIKLCDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp GGGEEECTTSCEEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHHEEECCCCCEEEEECCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 999999999999999999986553322 123446899999999985 4567889999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCC-cHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS-SIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... .+........... .......+..+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 231 NCKTD--------------------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp TCCSH--------------------HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCcc--------------------HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 42211 0111111111100 0000124567889999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=260.91 Aligned_cols=219 Identities=18% Similarity=0.183 Sum_probs=154.1
Q ss_pred CCCCcccceeeEEEEe------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLE------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||+++++++.. ++..++||||+++++|.+++...... ..+++..+..++.|++.||.||| +.++
T Consensus 68 ~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLH---s~gI 142 (676)
T 3qa8_A 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLH---ENRI 142 (676)
T ss_dssp HCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHH---HTTB
T ss_pred hCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCC
Confidence 3689999999998765 66779999999999999999875321 35888899999999999999999 8999
Q ss_pred eeccccCcceeecCCCc---eeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 75 VFRNFKTSCILFNEENV---AKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
+|+||||+||+++.++. ++|+|||.+....... ......|++.|+|||.+.+..++.++||||||+++|++++|.
T Consensus 143 VHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~ 220 (676)
T 3qa8_A 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220 (676)
T ss_dssp CCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSC
T ss_pred ccCCCCHHHeEeecCCCceeEEEccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCC
Confidence 99999999999997764 8999999987654332 223456899999999999999999999999999999999999
Q ss_pred CCcccccccccccccchhhhhhh-hhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNC-FEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
.||.................... ..........................+..+.+++.+||..||.+|||+.+++
T Consensus 221 ~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 221 RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred CCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 99865322111100000000000 0000000000000000000011124667899999999999999999998844
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=260.04 Aligned_cols=189 Identities=21% Similarity=0.275 Sum_probs=149.7
Q ss_pred CCCCcccceeeEEEEeCCC-----ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETPI-----PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~-----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++||||+++++++...+. .++||||+++++|.+++. ..+++..+..++.||+.||.||| +++|+
T Consensus 135 ~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH---~~gii 204 (681)
T 2pzi_A 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLH---SIGLV 204 (681)
T ss_dssp GCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred hcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCe
Confidence 4789999999999987765 699999999999988764 35889999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
||||||+||+++.+ .+||+|||++...... ....||+.|+|||++.+.. +.++||||||+++|+|++|..|+.
T Consensus 205 HrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 205 YNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp CCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEET
T ss_pred ecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCc
Confidence 99999999999886 8999999998765432 3456899999999987654 889999999999999999987764
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-SMVDVAKKLRQIYR 234 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~l~~ 234 (239)
..... ... ........++.+.++|.+||+.||.+|| +++++...|..+..
T Consensus 278 ~~~~~------------------~~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 278 GRYVD------------------GLP-----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp TEECS------------------SCC-----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccccc------------------ccc-----------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 31100 000 0001113446788999999999999999 57777777777654
Q ss_pred h
Q 044155 235 S 235 (239)
Q Consensus 235 ~ 235 (239)
.
T Consensus 329 ~ 329 (681)
T 2pzi_A 329 E 329 (681)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=234.66 Aligned_cols=180 Identities=18% Similarity=0.303 Sum_probs=139.8
Q ss_pred CCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 2 MSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 2 l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
++||||+++++++.. ....++||||+++++|.+++..... ..++...+..++.|++.||.||| +.+++|+
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 141 (299)
T 3m2w_A 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHR 141 (299)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred ccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 489999999999987 6678999999999999999987543 46899999999999999999999 8999999
Q ss_pred cccCcceeecC---CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 78 NFKTSCILFNE---ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 78 dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
||||+||+++. ++.++|+|||++.... +..++.++||||||+++|+|++|..||
T Consensus 142 dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf 198 (299)
T 3m2w_A 142 DVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPF 198 (299)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCHHHEEEecCCCCCcEEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999998 7889999999875432 134678999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhc--CCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVE--DVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
........... ........ ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 199 ~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 199 YSNHGLAISPG-----------------MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CC-------CC-----------------SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCcchhhhHH-----------------HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 64332111000 00000000 0111111245677899999999999999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=229.80 Aligned_cols=178 Identities=10% Similarity=-0.003 Sum_probs=138.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++++|.++++.. ........++.|++.||.||| +++++|+|||
T Consensus 87 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dik 156 (286)
T 3uqc_A 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDH 156 (286)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCS
T ss_pred cCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCC
Confidence 479999999999999999999999999999999999542 245567889999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+||+++.++.++|++++. ++ .++.++||||||+++|+|++|..||......
T Consensus 157 p~NIll~~~g~~kl~~~~~---------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 157 PSRVRVSIDGDVVLAYPAT---------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp GGGEEEETTSCEEECSCCC---------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred cccEEEcCCCCEEEEeccc---------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 9999999999999885432 22 3678999999999999999999998754432
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCc--HHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSS--IEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
......... ....... ......++.+.+++.+||+.||.+| |+.|+++.|+++...
T Consensus 209 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 209 SGLAPAERD------------------TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CCSEECCBC------------------TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hhhHHHHHH------------------hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 211100000 0000000 0112345678999999999999999 999999999987654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=228.28 Aligned_cols=174 Identities=11% Similarity=0.051 Sum_probs=131.7
Q ss_pred CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCC------
Q 044155 17 TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN------ 90 (239)
Q Consensus 17 ~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~------ 90 (239)
....++||||+++|++.+.+.+ ..+++..++.++.|++.||.|||. +++|+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~ 205 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHY 205 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEE
T ss_pred cCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceee
Confidence 6788999999999977776643 457899999999999999999993 37999999999999999887
Q ss_pred --------------ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhH-HHHHhcCCCCcc
Q 044155 91 --------------VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVF-LFELLTGWDVSD 155 (239)
Q Consensus 91 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~-l~~~~~g~~p~~ 155 (239)
.+||+|||+++..... ...||+.|+|||++.+.. +.++||||++++ .+++++|..||.
T Consensus 206 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 206 TLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred eccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 8999999999765432 346899999999998766 889999998776 778899988763
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhh-hhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHI-VVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVA 226 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 226 (239)
... +............ .............++++.+||.+||++| |++|++
T Consensus 279 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 279 NVL----------------WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHH----------------HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred chh----------------hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 210 0000000111110 1112223345578899999999999977 999887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=236.00 Aligned_cols=173 Identities=11% Similarity=0.120 Sum_probs=131.8
Q ss_pred CceEEEEEccCCChhhhhhcCC--CCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcc
Q 044155 19 IPILVFESVQYGTLWDRILGAP--QPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFD 96 (239)
Q Consensus 19 ~~~iv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~d 96 (239)
..+++|+.+ +++|.+++.... ......+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecCCeEEEEe
Confidence 456777777 489999885210 001156778899999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccc----------ccCCcccccchhhhhhHHHHHhcCCCCccccccccccccc
Q 044155 97 FSLSISIPEGETHITDTVMGTLGYCAPEYM----------RTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCP 166 (239)
Q Consensus 97 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~~~~~~ 166 (239)
||++...... .....| +.|+|||++ ....++.++||||||+++|+|++|+.||........
T Consensus 255 FG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---- 325 (413)
T 3dzo_A 255 FEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG---- 325 (413)
T ss_dssp GGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC----
T ss_pred ccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh----
Confidence 9998654322 334557 899999999 555688899999999999999999999864332111
Q ss_pred chhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 167 FSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
......... ..++.+.++|.+||+.||.+|||+.++++
T Consensus 326 -----------------~~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 326 -----------------SEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp -----------------SGGGGSSCC------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----------------HHHHHhhcc------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111111111 22356899999999999999999888865
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=229.00 Aligned_cols=138 Identities=16% Similarity=0.150 Sum_probs=104.2
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.|+||+++++++++++..||||||++|++|.+++... .+++.. +++.||+.||+|+| ++||+||||||+
T Consensus 300 ~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPe 368 (569)
T 4azs_A 300 AGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPW 368 (569)
T ss_dssp TTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGG
T ss_pred CCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchH
Confidence 7999999999999999999999999999999999875 456554 47899999999999 999999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
|||++.++.+||+|||+++...... .......||+.|+|||++.+ ....++|+||+|++.+++.++..+
T Consensus 369 NILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 369 NVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp GEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred hEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9999999999999999997654322 23445679999999999875 456789999999999988776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-24 Score=185.88 Aligned_cols=136 Identities=15% Similarity=0.101 Sum_probs=113.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++..++......++||||+++++|.+++.. +..++.|++.||.||| +++|+|||||
T Consensus 395 ~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiK 458 (540)
T 3en9_A 395 LVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLT 458 (540)
T ss_dssp HGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCC
T ss_pred hcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCC
Confidence 36899999776677788888999999999999999864 4478999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc------eeecccccccccCcccccc--CCcccccchhhhhhHHHHHhcCCC
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH------ITDTVMGTLGYCAPEYMRT--GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
|+|||++. .+||+|||+++........ ......||+.|+|||++.. ..|+...|+||..+-..+-+.++.
T Consensus 459 p~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~ 536 (540)
T 3en9_A 459 TSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRA 536 (540)
T ss_dssp TTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCS
T ss_pred HHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcc
Confidence 99999998 8999999999876443211 1235679999999999987 568888999999888887777655
Q ss_pred Cc
Q 044155 153 VS 154 (239)
Q Consensus 153 p~ 154 (239)
+|
T Consensus 537 rY 538 (540)
T 3en9_A 537 RY 538 (540)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-17 Score=131.84 Aligned_cols=78 Identities=17% Similarity=0.165 Sum_probs=64.8
Q ss_pred ceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeec
Q 044155 8 LKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFN 87 (239)
Q Consensus 8 v~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~ 87 (239)
+++++++.. +..++||||+++++|.+ +.. .....++.|++.||.||| +.+++|+||||+|||++
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS 227 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence 566665543 55699999999999988 421 123368999999999999 89999999999999999
Q ss_pred CCCceeEcccccccc
Q 044155 88 EENVAKLFDFSLSIS 102 (239)
Q Consensus 88 ~~~~~~l~dfg~~~~ 102 (239)
++.++|+|||++..
T Consensus 228 -~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE 241 (282)
T ss_dssp -TTEEEECCCTTCEE
T ss_pred -CCcEEEEECCCCeE
Confidence 99999999999853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.8e-13 Score=106.44 Aligned_cols=74 Identities=16% Similarity=0.144 Sum_probs=59.0
Q ss_pred CCceEEEEEccC-C----ChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCce
Q 044155 18 PIPILVFESVQY-G----TLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVA 92 (239)
Q Consensus 18 ~~~~iv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~ 92 (239)
...++||||+.+ | +|.+.... .+......++.|++.||.+||. ..+++|+||||+|||++. .+
T Consensus 141 ~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl~~--~~ 208 (258)
T 1zth_A 141 MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMYID--KV 208 (258)
T ss_dssp ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEESS--SE
T ss_pred CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEEcC--cE
Confidence 356899999942 3 66665432 2234567889999999999995 579999999999999988 89
Q ss_pred eEccccccccc
Q 044155 93 KLFDFSLSISI 103 (239)
Q Consensus 93 ~l~dfg~~~~~ 103 (239)
+|+|||++...
T Consensus 209 ~liDFG~a~~~ 219 (258)
T 1zth_A 209 YFIDMGQAVTL 219 (258)
T ss_dssp EECCCTTCEET
T ss_pred EEEECcccccC
Confidence 99999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.17 E-value=2.2e-12 Score=105.02 Aligned_cols=70 Identities=16% Similarity=0.191 Sum_probs=56.5
Q ss_pred CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCC--------
Q 044155 19 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-------- 90 (239)
Q Consensus 19 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~-------- 90 (239)
..++||||++|++|.++... .....++.|++.+|.+|| ..|++||||||.|||++.++
T Consensus 185 ~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~~~ 250 (397)
T 4gyi_A 185 RHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPSSI 250 (397)
T ss_dssp TTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTTSE
T ss_pred CceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCccccccc
Confidence 34799999998888654321 123467899999999999 89999999999999998876
Q ss_pred --ceeEcccccccc
Q 044155 91 --VAKLFDFSLSIS 102 (239)
Q Consensus 91 --~~~l~dfg~~~~ 102 (239)
.+.|+||+-+..
T Consensus 251 ~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 251 TLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECCCTTCEE
T ss_pred ccceEEEEeCCccc
Confidence 378999997644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=8.7e-09 Score=79.84 Aligned_cols=88 Identities=11% Similarity=-0.006 Sum_probs=67.3
Q ss_pred CcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCC-------------
Q 044155 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF------------- 70 (239)
Q Consensus 4 H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~------------- 70 (239)
+..+.++++++.+.+..++|||+++|.+|.+.+.. ......++.+++.+++.||...
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~ 138 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSR 138 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHH
Confidence 45677888888888888999999999998776421 1122367888999999999510
Q ss_pred -------------------------------------------CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 -------------------------------------------PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 -------------------------------------------~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
...++|+|++|.||+++.+..+.|+||+.+.
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 139 LAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876556799998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.63 E-value=4.2e-08 Score=75.66 Aligned_cols=82 Identities=12% Similarity=-0.004 Sum_probs=59.5
Q ss_pred cceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCC----------------
Q 044155 7 ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF---------------- 70 (239)
Q Consensus 7 iv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---------------- 70 (239)
+.+++++...++..++|||+++|.+|. ... ... ..++.+++..|..||...
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~--------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~ 143 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIER 143 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc--------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Confidence 456788877777789999999988873 211 111 245677777788888321
Q ss_pred ---------------------------------------CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 ---------------------------------------PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ---------------------------------------~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
...++|+|++|.||+++.++.+.|+||+.+.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 144 ARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.60 E-value=1.2e-07 Score=76.80 Aligned_cols=92 Identities=20% Similarity=0.307 Sum_probs=70.6
Q ss_pred CcccceeeEEEEeC---CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCC----------
Q 044155 4 HNHILKLIGCCLET---PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF---------- 70 (239)
Q Consensus 4 H~niv~l~~~~~~~---~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---------- 70 (239)
+..+.+++.++.+. +..++|||+++|.++.+... ..++......++.+++..|+.||...
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~ 169 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYG 169 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSS
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccC
Confidence 34577888888766 44789999999877744211 34677888889999999999999410
Q ss_pred ---------------------------------------------CCCeeeccccCcceeecCCCc--eeEcccccccc
Q 044155 71 ---------------------------------------------PRPIVFRNFKTSCILFNEENV--AKLFDFSLSIS 102 (239)
Q Consensus 71 ---------------------------------------------~~~i~H~dlk~~nil~~~~~~--~~l~dfg~~~~ 102 (239)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 170 KPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.47 E-value=5.7e-08 Score=76.96 Aligned_cols=127 Identities=17% Similarity=0.251 Sum_probs=79.0
Q ss_pred CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhC-----------------------------
Q 044155 19 IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFG----------------------------- 69 (239)
Q Consensus 19 ~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----------------------------- 69 (239)
..++||++++|.++.+... ..++..++..++.+++..++.||..
T Consensus 90 ~~~~vm~~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS 162 (304)
T ss_dssp CSCEEEECCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred cceEEEcccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence 3478999999988865332 2356666777777777777777731
Q ss_pred --------------------------CCCCeeeccccCcceeecC--CCceeEcccccccccCCCCcce-e---------
Q 044155 70 --------------------------FPRPIVFRNFKTSCILFNE--ENVAKLFDFSLSISIPEGETHI-T--------- 111 (239)
Q Consensus 70 --------------------------~~~~i~H~dlk~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~-~--------- 111 (239)
....++|+|++|.||+++. ...+.++||+.+........-. .
T Consensus 163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~ 242 (304)
T 3sg8_A 163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGM 242 (304)
T ss_dssp TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCH
T ss_pred ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCH
Confidence 0135899999999999998 4567899999876543211000 0
Q ss_pred ---ecccccccccC-ccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 112 ---DTVMGTLGYCA-PEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 112 ---~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
.......+... |+... ......+.|++|.++|.+.+|..++
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00000001111 12111 1122357899999999999996654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=4.5e-05 Score=58.99 Aligned_cols=86 Identities=12% Similarity=0.038 Sum_probs=60.3
Q ss_pred cceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhC-----------------
Q 044155 7 ILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFG----------------- 69 (239)
Q Consensus 7 iv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~----------------- 69 (239)
+-++++++.+.+..++|||+++|.++.+..... ......+..++...|+.||..
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~ 152 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQ 152 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhh
Confidence 456778888888889999999988877655332 112223455555666666610
Q ss_pred --------------------------------------CCCCeeeccccCcceeecCCCceeEccccccc
Q 044155 70 --------------------------------------FPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 70 --------------------------------------~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
....++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 153 AQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 02238999999999999987767799999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00019 Score=56.69 Aligned_cols=32 Identities=13% Similarity=0.218 Sum_probs=25.5
Q ss_pred CCCeeeccccCcceeecC---CCc-eeEcccccccc
Q 044155 71 PRPIVFRNFKTSCILFNE---ENV-AKLFDFSLSIS 102 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~---~~~-~~l~dfg~~~~ 102 (239)
...++|+|+.|.||+++. ++. +.|+||+.+..
T Consensus 189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 346799999999999987 344 48999997644
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0011 Score=49.34 Aligned_cols=103 Identities=12% Similarity=-0.021 Sum_probs=65.6
Q ss_pred CChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcc
Q 044155 30 GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 109 (239)
Q Consensus 30 ~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 109 (239)
-||.++++..+ .++.+.++..++.|.+.+|.-+-. ...-..+=..|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc--------
Confidence 58999998765 789999999999999999887621 11111223346788888888776553 1110
Q ss_pred eeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 110 ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 110 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
.....+.|||... ...+.+.-|||||+++|.-+.-..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122356777653 3456788899999999998875443
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00081 Score=54.08 Aligned_cols=32 Identities=6% Similarity=0.276 Sum_probs=26.4
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~ 102 (239)
...++|+|+.+.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 45799999999999999644578999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.012 Score=46.75 Aligned_cols=31 Identities=13% Similarity=0.232 Sum_probs=27.6
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
...++|+|+.+.||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999877889999999763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.034 Score=43.44 Aligned_cols=31 Identities=13% Similarity=0.062 Sum_probs=25.4
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~ 102 (239)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 445899999999999 5566789999987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.11 Score=38.38 Aligned_cols=142 Identities=5% Similarity=-0.065 Sum_probs=86.1
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.||+.+.. .+-.+.+.+ ++.|-...+..++-.- ...+...+++++.+|+.-..+++ .-+|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v--~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSF--QIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEE--EEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGG
T ss_pred cCCcccce-EEEEcccEE--EEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecc
Confidence 56777765 444455544 4444332323222221 45778999999999988776655 3478889999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccch-hhhhhHHHHHhcCCCCcccccccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNV-FSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
|++++.++.+++.-.|+...++ |. ..+ ..|. -..=+++..+++++..|+..-.+.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~------------------P~-----~~~-ee~fL~qyKAliiall~~K~~Fe~l~~G~ 164 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVD------------------PL-----PVS-EAEFLTRYKALVICAFNEKQSFDALVEGN 164 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBS------------------CC-----CCC-HHHHHHHHHHHHHHHHCTTCCHHHHHHSC
T ss_pred eEEEcCCCCEEEEEccCccCCC------------------CC-----CCC-HHHHHHHHHHHHHHHHcCCCCHHHHHcCh
Confidence 9999999999999888642221 11 111 1122 246677888999988887655444
Q ss_pred cccccchhhhhhhhhccchhh
Q 044155 162 DLVCPFSEYLKNCFEDNRFTE 182 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~ 182 (239)
........+........+..+
T Consensus 165 lel~k~~~f~~~I~~a~tlee 185 (215)
T 4ann_A 165 LELHKGTPFETKVIEAATLDL 185 (215)
T ss_dssp GGGCCCCHHHHHHHHCCSHHH
T ss_pred HhhccCCHHHHHHHccCCHHH
Confidence 433323444444444444433
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.33 E-value=0.02 Score=47.08 Aligned_cols=77 Identities=14% Similarity=0.237 Sum_probs=45.8
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccc--cccccCccccccC---CcccccchhhhhhHHH
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG--TLGYCAPEYMRTG---VFNEKSNVFSFSVFLF 145 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~---~~~~~~Di~slG~~l~ 145 (239)
...++|+|+.|.||+++.++ +.++||+.+........ ...... ...|++|+..... .......+.+....+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 78899999999999998876 99999998765432111 011111 1235555544311 1112234446666677
Q ss_pred HHhcC
Q 044155 146 ELLTG 150 (239)
Q Consensus 146 ~~~~g 150 (239)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76664
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.68 E-value=0.78 Score=33.99 Aligned_cols=86 Identities=13% Similarity=0.159 Sum_probs=59.4
Q ss_pred CcCCHHHHHHHHHHHHHHHh-HHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCc
Q 044155 45 EPLLLKHRLKIAMDIVHALA-YLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123 (239)
Q Consensus 45 ~~~~~~~~~~~~~~i~~~l~-~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aP 123 (239)
...+...+++++.+|+.-.. +++ .-+|--+.|+|++++.++.+++.-.|+-..+ +|
T Consensus 80 ~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~l------------------pP 136 (219)
T 4ano_A 80 RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKESL------------------PP 136 (219)
T ss_dssp HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTTB------------------SS
T ss_pred HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCcccC------------------CC
Confidence 34678899999999988666 544 4578889999999999999999988864222 11
Q ss_pred cccccCCcccccchh-hhhhHHHHHhcCCCCcccccc
Q 044155 124 EYMRTGVFNEKSNVF-SFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 124 E~~~~~~~~~~~Di~-slG~~l~~~~~g~~p~~~~~~ 159 (239)
.. . ...|.| ..=+++..++.++..|+..-.
T Consensus 137 ~e-----~-~ee~fl~qyKali~all~~K~~Fe~l~~ 167 (219)
T 4ano_A 137 DE-----W-DDERLLREVKATVLALTEGEYRFDEYLK 167 (219)
T ss_dssp CS-----C-CHHHHHHHHHHHHHHHTTCSSCHHHHHH
T ss_pred CC-----C-CHHHHHHHHHHHHHHHHcCCCCHHHHHh
Confidence 11 1 112222 456677788888777765443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.50 E-value=0.13 Score=40.67 Aligned_cols=33 Identities=21% Similarity=0.243 Sum_probs=28.0
Q ss_pred CCCeeeccccCcceeecCC----CceeEccccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEE----NVAKLFDFSLSISI 103 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~----~~~~l~dfg~~~~~ 103 (239)
...++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999874 67899999987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.45 E-value=0.026 Score=44.41 Aligned_cols=31 Identities=16% Similarity=0.442 Sum_probs=26.2
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
...++|+|+.+.||+++.++.+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4579999999999999887656899998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.90 E-value=0.14 Score=40.33 Aligned_cols=30 Identities=10% Similarity=0.118 Sum_probs=25.6
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~ 102 (239)
...++|+|+.+.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 56789999999999998 4 789999987644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.02 E-value=0.18 Score=42.01 Aligned_cols=17 Identities=18% Similarity=0.239 Sum_probs=15.2
Q ss_pred CCCeeeccccCcceeec
Q 044155 71 PRPIVFRNFKTSCILFN 87 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~ 87 (239)
...++|+|+.+.|||++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 34699999999999998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.77 E-value=0.11 Score=41.27 Aligned_cols=32 Identities=9% Similarity=0.221 Sum_probs=27.6
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~ 102 (239)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999998877899999987643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=91.18 E-value=0.15 Score=42.09 Aligned_cols=19 Identities=16% Similarity=0.377 Sum_probs=16.0
Q ss_pred CCCeeeccccCcceeecCC
Q 044155 71 PRPIVFRNFKTSCILFNEE 89 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~ 89 (239)
...++|+|+.+.||+++.+
T Consensus 248 ~~v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 248 PVTFCHNDLQEGNILLPKA 266 (429)
T ss_dssp CEEEECSCCCGGGEEEEC-
T ss_pred CeEEEeCCCCCCeEEeeCC
Confidence 3469999999999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.15 E-value=0.11 Score=41.87 Aligned_cols=30 Identities=17% Similarity=0.251 Sum_probs=24.7
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
...++|+|+.+.||+++.++ +.++||..+.
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 45699999999999997655 8999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=90.28 E-value=0.16 Score=41.26 Aligned_cols=32 Identities=16% Similarity=0.296 Sum_probs=26.9
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~ 103 (239)
...++|+|+.+.||+++.++ +.++||..+...
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~G 257 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 257 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCceeeCCCCcCcEEEeCCC-eEEEeCcccccC
Confidence 56899999999999998764 899999876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.52 E-value=0.18 Score=40.92 Aligned_cols=31 Identities=26% Similarity=0.367 Sum_probs=26.7
Q ss_pred CCCeeeccccCcceeecCC----CceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEE----NVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~----~~~~l~dfg~~~ 101 (239)
...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 4579999999999999876 678999998763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.13 E-value=0.26 Score=40.18 Aligned_cols=28 Identities=25% Similarity=0.382 Sum_probs=23.4
Q ss_pred eeeccccCcceee------cCCCceeEccccccc
Q 044155 74 IVFRNFKTSCILF------NEENVAKLFDFSLSI 101 (239)
Q Consensus 74 i~H~dlk~~nil~------~~~~~~~l~dfg~~~ 101 (239)
++|+|+.+.||++ +.+..+.++||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 345678999998864
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=84.42 E-value=0.47 Score=39.08 Aligned_cols=30 Identities=13% Similarity=0.337 Sum_probs=25.9
Q ss_pred CCCeeeccccCcceeecCCCceeEccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
...++|+|+.+.||+ +.++.+.++||..+.
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 356899999999999 777889999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 239 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-35 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-32 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-32 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-31 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-29 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-28 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-28 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-28 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-27 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-26 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-26 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-26 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-25 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-23 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-23 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-22 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-22 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-22 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-19 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-19 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-19 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-18 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-18 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-18 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-18 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-17 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-17 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-17 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-17 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-16 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-16 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-14 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-13 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-38
Identities = 43/243 (17%), Positives = 96/243 (39%), Gaps = 35/243 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H +IL +G P +V + + +L+ + + + IA
Sbjct: 60 KTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTA 114
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLG 119
+ YLH + I+ R+ K++ I +E+ K+ DF L+ +H + + G++
Sbjct: 115 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 120 YCAPEYMRT---GVFNEKSNVFSFSVFLFELLTG---WDVSDLVKDVHDLVCPFSEYLKN 173
+ APE +R ++ +S+V++F + L+EL+TG + + + +V
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV-------GR 224
Query: 174 CFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233
+ +++ + + + C+K +RP + + +
Sbjct: 225 GYLSPDLSKVRSNCPKAMKRLMAE-------------CLKKKRDERPLFPQILASIELLA 271
Query: 234 RSL 236
RSL
Sbjct: 272 RSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-35
Identities = 47/235 (20%), Positives = 95/235 (40%), Gaps = 28/235 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ H +++L + PI ++ E ++ G+L D + P L + L +A I
Sbjct: 64 QLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQIA 119
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+A++ R + R+ + + IL ++ K+ DF L+ I + E + + +
Sbjct: 120 EGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
APE + G F KS+V+SF + L E++T + +
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHG--------------------RIPYPGMTN 216
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
E++ ++ + + Q+ C K+ P DRP+ + L + +
Sbjct: 217 PEVIQNL-ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-34
Identities = 51/235 (21%), Positives = 99/235 (42%), Gaps = 28/235 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++SH +++L G CLE LVFE +++G L D + + L + +D+
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVC 111
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+AYL ++ R+ L E V K+ DF ++ + + + + + +
Sbjct: 112 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 168
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
+PE ++ KS+V+SF V ++E+ + K +E+
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG--------------------KIPYENRSN 208
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
+E+V+ I + H Q+ C K+ P DRP+ + ++L +I S
Sbjct: 209 SEVVEDISTGFRLYKPRLASTHV-YQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-33
Identities = 39/232 (16%), Positives = 89/232 (38%), Gaps = 28/232 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+SH +++L G C + ++ E + G L + + + + L++ D+
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVC 110
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
A+ YL + + R+ L N++ V K+ DF LS + + E + + +
Sbjct: 111 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PE + F+ KS++++F V ++E+ + K +E
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG--------------------KMPYERFTN 207
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
+E +HI + + + + C + +RP+ + + +
Sbjct: 208 SETAEHI-AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-33
Identities = 42/255 (16%), Positives = 96/255 (37%), Gaps = 29/255 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPI----LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
+ H +IL I + LV + ++G+L+D + + + ++ +K+A
Sbjct: 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLA 106
Query: 57 MDIVHALAYLH-----FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI- 110
+ LA+LH I R+ K+ IL + + D L++ I
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166
Query: 111 --TDTVMGTLGYCAPEYMRTGV------FNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162
+ +GT Y APE + + +++++++ + +E+ + + +D
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226
Query: 163 LVCPFSEYLKNCFE--DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP 220
+ E + + + S E + + A++ EC + A R
Sbjct: 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM---AKIMRECWYANGAARL 283
Query: 221 SMVDVAKKLRQIYRS 235
+ + + K L Q+ +
Sbjct: 284 TALRIKKTLSQLSQQ 298
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-32
Identities = 49/241 (20%), Positives = 98/241 (40%), Gaps = 31/241 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ + +I++LIG C + +LV E G L ++G E + + + ++ +
Sbjct: 65 QLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVS 119
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTL 118
+ YL + V R+ +L + AK+ DF LS ++ +++ T L
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDN 178
+ APE + F+ +S+V+S+ V ++E L+ Y + ++
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALS--------------------YGQKPYKKM 216
Query: 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLSC 238
+ E++ I E + +C DRP + V +++R Y SL+
Sbjct: 217 KGPEVMAFIEQGKRMECPPECPPEL-YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
Query: 239 N 239
Sbjct: 276 K 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-32
Identities = 50/233 (21%), Positives = 96/233 (41%), Gaps = 32/233 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
Q+ H+++++L+G +E + +V E + G+L D + + LK ++D+
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG---DCLLKFSLDV 112
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
A+ YL V R+ +L +E+NVAK+ DF L+ + T +
Sbjct: 113 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVK 165
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
+ APE +R F+ KS+V+SF + L+E+ + + +
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFG--------------------RVPYPRIP 205
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
++V + + A +V C A RPS + + ++L I
Sbjct: 206 LKDVVPRVEKGYKMDAP-DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-32
Identities = 44/246 (17%), Positives = 91/246 (36%), Gaps = 31/246 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ + +I+ G + E + G+L + + + K+++ ++
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVI 114
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
L YL I+ R+ K S IL N KL DF +S + + + + +GT Y
Sbjct: 115 KGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSY 169
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG---------------------WDVSDLVKD 159
+PE ++ ++ +S+++S + L E+ G D ++
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219
P S Y + E++D+IV E + +C+ +PA+R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289
Query: 220 PSMVDV 225
+ +
Sbjct: 290 ADLKQL 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-32
Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 28/236 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +++L E PI I V E + G+L D + G + L + +A I
Sbjct: 68 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQIA 123
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+AY+ V R+ + + IL E V K+ DF L+ I + E + +
Sbjct: 124 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
APE G F KS+V+SF + L EL T + +
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKG--------------------RVPYPGMVN 220
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236
E++D + E + +C + P +RP+ + L + S
Sbjct: 221 REVLDQVERGYRMPCPPECPESL-HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-31
Identities = 43/247 (17%), Positives = 81/247 (32%), Gaps = 42/247 (17%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFE---------------- 45
SH +I+ L+G C + L+FE YG L + + + E
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 46 --PLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103
L + L A + + +L F + V R+ +L V K+ DF L+ I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 104 PEGETHITD-TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHD 162
++ + + APE + G++ KS+V+S+ + L+E+ +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG----------- 263
Query: 163 LVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222
N + ++ + + C RPS
Sbjct: 264 ---------VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314
Query: 223 VDVAKKL 229
++ L
Sbjct: 315 PNLTSFL 321
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 2e-31
Identities = 50/252 (19%), Positives = 93/252 (36%), Gaps = 44/252 (17%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI-------------------LGAPQ 41
+ + +I+KL+G C L+FE + YG L + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 42 PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSI 101
P PL +L IA + +AYL R V R+ T L E V K+ DF LS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 102 SIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160
+I + + + PE + + +S+V+++ V L+E+ +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG--------- 239
Query: 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP 220
+ E++ ++ ++ + + L + C PADRP
Sbjct: 240 -----------LQPYYGMAHEEVIYYVRDGNILACPENCPLEL-YNLMRLCWSKLPADRP 287
Query: 221 SMVDVAKKLRQI 232
S + + L+++
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-31
Identities = 44/238 (18%), Positives = 88/238 (36%), Gaps = 32/238 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ + +I+++IG C E +LV E + G L + + K+ +++ +
Sbjct: 64 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-----QQNRHVKDKNIIELVHQVS 117
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT--DTVMGTL 118
+ YL V R+ +L ++ AK+ DF LS ++ E + +
Sbjct: 118 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDN 178
+ APE + F+ KS+V+SF V ++E + Y + +
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS--------------------YGQKPYRGM 214
Query: 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236
+ +E+ + + + C +RP V +LR Y +
Sbjct: 215 KGSEVTAMLEKGERMGCPAGCPREM-YDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 3e-31
Identities = 46/225 (20%), Positives = 86/225 (38%), Gaps = 34/225 (15%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H +IL+L G + L+ E GT++ + + ++
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELA 116
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+AL+Y H + ++ R+ K +L K+ DF S+ P T+ GTL Y
Sbjct: 117 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDY 170
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
PE + + +EK +++S V +E L G K FE N +
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVG---------------------KPPFEANTY 209
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
E I + + + + + + +K +P+ RP + +V
Sbjct: 210 QETYKRISRVEFTFPDFVTE--GARDLISRLLKHNPSQRPMLREV 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 6e-31
Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 30/234 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H ++++L G L P+ +V E G+L DR + H LL + A+ +
Sbjct: 67 SLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDR----LRKHQGHFLLGTLSRYAVQVA 121
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTL 118
+ YL + + R+ +L ++ K+ DF L ++P+ + H + +
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDN 178
+CAPE ++T F+ S+ + F V L+E+ T Y + +
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFT--------------------YGQEPWIGL 218
Query: 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
++I+ I E E V +C P DRP+ V + L +
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 2e-30
Identities = 46/237 (19%), Positives = 90/237 (37%), Gaps = 27/237 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H ++++L+G C P ++ E + YG L D + + L +A I
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA---VVLLYMATQIS 125
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
A+ YL + + R+ L E ++ K+ DF LS + + +
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
APE + F+ KS+V++F V L+E+ T
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATY---------------------GMSPYPGID 221
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237
V ++ +D E ++ C + +P+DRPS ++ + +++ S
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 9e-30
Identities = 39/244 (15%), Positives = 84/244 (34%), Gaps = 37/244 (15%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRI-------------LGAPQPHFEPLLL 49
+H +I+ L+G C +++ E YG L + + + L L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 50 KHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH 109
+ L + + +A+L + + R+ IL + K+ DF L+ I +
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 110 ITDT-VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFS 168
+ + + APE + V+ +S+V+S+ +FL+EL +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG----------------- 244
Query: 169 EYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228
+ + ++ E + E + C P RP+ + +
Sbjct: 245 ---SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 229 LRQI 232
+ +
Sbjct: 302 IEKQ 305
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-29
Identities = 44/248 (17%), Positives = 96/248 (38%), Gaps = 36/248 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPI-LVFESVQYGTLWDRI-----------LGAPQPHFEPLL 48
H +++ L+G C + P+ ++ E ++G L + + + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 49 LKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET 108
L+H + + + + +L R + R+ IL +E+NV K+ DF L+ I +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 109 HI-TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPF 167
++ L + APE + V+ +S+V+SF V L+E+ +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG---------------- 233
Query: 168 SEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227
+ + + E + E + Q +C P+ RP+ ++ +
Sbjct: 234 ----ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
Query: 228 KLRQIYRS 235
L + ++
Sbjct: 290 HLGNLLQA 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (272), Expect = 4e-29
Identities = 42/239 (17%), Positives = 89/239 (37%), Gaps = 32/239 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H +++ L G ++ +++ E ++ G+L + + + I
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV----IQLVGMLRGIA 138
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDT----VMG 116
+ YL V R+ IL N V K+ DF LS + + + T T
Sbjct: 139 AGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFE 176
+ + APE ++ F S+V+S+ + ++E+++ Y + +
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS--------------------YGERPYW 235
Query: 177 DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
D ++++ I +D A Q+ +C + RP + L ++ R+
Sbjct: 236 DMTNQDVINAI-EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-29
Identities = 36/226 (15%), Positives = 80/226 (35%), Gaps = 32/226 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ + +I+ + L +V E + G+L D + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------EGQIAAVCRECL 126
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL +LH ++ R+ K+ IL + KL DF I ++ + T++GT +
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYW 182
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
APE + + K +++S + E++ G + + +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG---------------------EPPYLNENP 221
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQ-VTFECIKDSPADRPSMVDV 225
+ I ++ ++L A + C+ R S ++
Sbjct: 222 LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-28
Identities = 36/235 (15%), Positives = 87/235 (37%), Gaps = 30/235 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ + H+ +L+G CL + + ++ + + +G L D + ++ L + I
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGS----QYLLNWCVQIA 121
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLG 119
+ YL R +V R+ +L K+ DF L+ + E + + +
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
+ A E + ++ +S+V+S+ V ++EL+T + ++
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMT--------------------FGSKPYDGIP 218
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234
+EI + + + + +C RP ++ + ++ R
Sbjct: 219 ASEISSILEKGERLPQPPICTIDV-YMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-28
Identities = 40/229 (17%), Positives = 79/229 (34%), Gaps = 28/229 (12%)
Query: 1 QMSHNHILKLIGCCLETP--IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMD 58
++ H +I++ ++ +V E + G L I + + L + L++
Sbjct: 59 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQ 117
Query: 59 IVHALAYLH--FGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMG 116
+ AL H ++ R+ K + + + + KL DF L+ + + +G
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVG 176
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFE 176
T Y +PE M +NEKS+++S L+EL F
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL---------------------MPPFT 215
Query: 177 DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
E+ I I ++ + RPS+ ++
Sbjct: 216 AFSQKELAGKIREGKFRRIPYRYSDEL-NEIITRMLNLKDYHRPSVEEI 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-28
Identities = 45/240 (18%), Positives = 95/240 (39%), Gaps = 32/240 (13%)
Query: 1 QMSHNHILKLIGCCLETP-IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDI 59
SH ++L L+G CL + P++V +++G L + + +K + + +
Sbjct: 84 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGFGLQV 139
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE---THITDTVMG 116
+ +L + V R+ + +E+ K+ DF L+ + + E H
Sbjct: 140 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFE 176
+ + A E ++T F KS+V+SF V L+EL+T +
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG--------------------APPYP 236
Query: 177 DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236
D +I ++ ++ ++ E +V +C RPS ++ ++ I+ +
Sbjct: 237 DVNTFDITVYL-LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (266), Expect = 3e-28
Identities = 44/228 (19%), Positives = 79/228 (34%), Gaps = 37/228 (16%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H + ++ GC L LV E + H +PL + +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGAL 125
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
LAYLH ++ R+ K IL +E + KL DF + + ++ +GT +
Sbjct: 126 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYW 177
Query: 121 CAPEY---MRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFED 177
APE M G ++ K +V+S + EL K +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAER---------------------KPPLFN 216
Query: 178 NRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
+ HI + +++ C++ P DRP+ +
Sbjct: 217 MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 5e-28
Identities = 39/231 (16%), Positives = 81/231 (35%), Gaps = 35/231 (15%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
H +I+KL+ ++ E G + +L PL + +
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE----LERPLTESQIQVVCKQTL 120
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL YLH I+ R+ K ILF + KL DF +S D+ +GT +
Sbjct: 121 DALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYW 176
Query: 121 CAPEYMRT-----GVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCF 175
APE + ++ K++V+S + L E+ +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI---------------------EPPH 215
Query: 176 EDNRFTEIVDHIVVEDVSSIEKEQQLHASAQ-VTFECIKDSPADRPSMVDV 225
+ ++ I + ++ + + ++ + +C++ + R + +
Sbjct: 216 HELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 6e-28
Identities = 52/232 (22%), Positives = 84/232 (36%), Gaps = 29/232 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q H HI+KLIG E P+ I + E G L Q L L + A +
Sbjct: 64 QFDHPHIVKLIGVITENPVWI-IMELCTLGELRSF----LQVRKYSLDLASLILYAYQLS 118
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
ALAYL + V R+ +L + + KL DF LS + + + + +
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRF 180
APE + F S+V+ F V ++E+L +D++ E+
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--------GRIENGER 227
Query: 181 TEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
+ + S + K C P+ RP ++ +L I
Sbjct: 228 LPMPPNCPPTLYSLMTK-------------CWAYDPSRRPRFTELKAQLSTI 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-27
Identities = 47/240 (19%), Positives = 84/240 (35%), Gaps = 37/240 (15%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEP-----------LLLKHR 52
H +I+ L+G C L E +G L D + + +P L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 53 LKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITD 112
L A D+ + YL + + R+ IL E VAK+ DF LS
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 113 TVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLK 172
+ + A E + V+ S+V+S+ V L+E+++ +L E L
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLP 240
Query: 173 NCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
+ + D + + +C ++ P +RPS + L ++
Sbjct: 241 QGYRLEKPLNCDDEV-----------------YDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-27
Identities = 46/229 (20%), Positives = 87/229 (37%), Gaps = 30/229 (13%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++H +++K G E I L E G L+DRI + + ++
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLM 113
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI-PEGETHITDTVMGTLG 119
+ YLH I R+ K +L +E + K+ DF L+ + + + GTL
Sbjct: 114 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 120 YCAPEYMRTGVFN-EKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDN 178
Y APE ++ F+ E +V+S + L +L G + D + + E
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG-------ELPWDQPSDSCQEYSDWKEKK 223
Query: 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227
+ I ++ + K + ++P+ R ++ D+ K
Sbjct: 224 TYLNPWKKIDSAPLALLHK-------------ILVENPSARITIPDIKK 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-26
Identities = 46/237 (19%), Positives = 91/237 (38%), Gaps = 30/237 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q SH++I++L G + +++ E ++ G L + + + + I
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIA 120
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGTL 118
+ YL V R+ IL N V K+ DF LS + + T+ T +
Sbjct: 121 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDN 178
+ APE + F S+V+SF + ++E++T + H+++ + + + F
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM----KAINDGFRLP 233
Query: 179 RFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235
+ I Q+ +C + A RP D+ L ++ R+
Sbjct: 234 TPMDCPSAI-----------------YQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 2e-26
Identities = 44/230 (19%), Positives = 83/230 (36%), Gaps = 35/230 (15%)
Query: 1 QMSHNHILKLIGCCLET----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
+ H +I++ T +LV E + GTL + F+ + +K
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWC 118
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVM 115
I+ L +LH P PI+ R+ K I K+ D L+ V+
Sbjct: 119 RQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVI 174
Query: 116 GTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCF 175
GT + APE ++E +V++F + + E+ T P+S
Sbjct: 175 GTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATS-------------EYPYS------- 213
Query: 176 EDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
E +I + + + + ++ CI+ + +R S+ D+
Sbjct: 214 ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-26
Identities = 43/242 (17%), Positives = 84/242 (34%), Gaps = 36/242 (14%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRI-----------LGAPQPHFEPLLLKH 51
H +I+ L+G C + ++ E G L + + E L K
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 52 RLKIAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI- 110
+ A + + YL + + R+ +L E+NV K+ DF L+ I + +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 111 TDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEY 170
T + + APE + ++ +S+V+SF V L+E+ T
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------------------- 234
Query: 171 LKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLR 230
+ + E+ + + +C P+ RP+ + + L
Sbjct: 235 -GSPYPGVPVEELFKLLKEGHRMDKPSNCTNEL-YMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 231 QI 232
+I
Sbjct: 293 RI 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 7e-26
Identities = 41/238 (17%), Positives = 96/238 (40%), Gaps = 30/238 (12%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRI-----LGAPQPHFEPLLLKHRLKI 55
+ + +H+++L+G + +++ E + G L + A P P L +++
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTV 114
A +I +AYL+ V R+ + E+ K+ DF ++ I E +
Sbjct: 139 AGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNC 174
+ + + +PE ++ GVF S+V+SF V L+E+ T +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA--------------------EQP 235
Query: 175 FEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232
++ +++ ++ + ++ C + +P RPS +++ +++
Sbjct: 236 YQGLSNEQVLRFVMEGGLLDKPDNCPDML-FELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.3 bits (247), Expect = 1e-25
Identities = 32/151 (21%), Positives = 61/151 (40%), Gaps = 9/151 (5%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +KL + + G L I +IV
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIV 118
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLS-ISIPEGETHITDTVMGTLG 119
AL YLH + I+ R+ K IL NE+ ++ DF + + PE + ++ +GT
Sbjct: 119 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
Y +PE + + S++++ +++L+ G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 95.1 bits (236), Expect = 1e-23
Identities = 27/152 (17%), Positives = 59/152 (38%), Gaps = 11/152 (7%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ H ++ L + ++++E + G L++++ + ++ +
Sbjct: 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVC 134
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFN--EENVAKLFDFSLSISIPEGETHITDTVMGTL 118
L ++H V + K I+F N KL DF L+ + ++ GT
Sbjct: 135 KGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTA 189
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE ++++S V + LL+G
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 94.4 bits (234), Expect = 3e-23
Identities = 29/152 (19%), Positives = 57/152 (37%), Gaps = 11/152 (7%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
Q+ H ++ L + +L+ E + G L+DRI + +
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQAC 137
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
L ++H IV + K I+ + + K+ DF L+ + E T
Sbjct: 138 EGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATA 192
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
+ APE + +++++ V + LL+G
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 92.5 bits (229), Expect = 4e-23
Identities = 51/243 (20%), Positives = 98/243 (40%), Gaps = 38/243 (15%)
Query: 1 QMSHNHILKLIGCCLET----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIA 56
++H I+ + P+P +V E V TL D + P+ K +++
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVI 117
Query: 57 MDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHI--TDTV 114
D AL + H I+ R+ K + I+ + N K+ DF ++ +I + + T V
Sbjct: 118 ADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNC 174
+GT Y +PE R + +S+V+S L+E+LTG +
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG---------------------EPP 213
Query: 175 FEDNRFTEIVDHIVVED-VSSIEKEQQLHASAQ-VTFECIKDSPADRP-SMVDVAKKLRQ 231
F + + V ED + + + L A V + + +P +R + ++ L +
Sbjct: 214 FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
Query: 232 IYR 234
++
Sbjct: 274 VHN 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 5e-22
Identities = 41/183 (22%), Positives = 68/183 (37%), Gaps = 15/183 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
H + + V E + G L I L A +I+
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEII 113
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
L +LH + IV+R+ K IL +++ K+ DF + G+ T GT Y
Sbjct: 114 LGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTPDY 169
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG------WDVSDLVKDVHDLVCPFSEYLKNC 174
APE + +N + +SF V L+E+L G D +L + + +L+
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 229
Query: 175 FED 177
+D
Sbjct: 230 AKD 232
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 89.7 bits (222), Expect = 6e-22
Identities = 33/150 (22%), Positives = 59/150 (39%), Gaps = 7/150 (4%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +I+ L L+ + V G L+DRI+ + ++ ++
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVL 117
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
A+ YLH + +E++ + DF LS G T GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGY 175
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE + +++ + +S V + LL G
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.7 bits (222), Expect = 9e-22
Identities = 34/229 (14%), Positives = 80/229 (34%), Gaps = 34/229 (14%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
H +IL L +++FE + +++RI L + + +
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVC 112
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILF--NEENVAKLFDFSLSISIPEGETHITDTVMGTL 118
AL +LH I + + I++ + K+ +F + + G+ +
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAP 167
Query: 119 GYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDN 178
Y APE + V + ++++S ++ LL+G N F
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG---------------------INPFLAE 206
Query: 179 RFTEIVDHIVVEDVSSIEKE-QQLHASAQ-VTFECIKDSPADRPSMVDV 225
+I+++I+ + + E+ +++ A + R + +
Sbjct: 207 TNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.6 bits (211), Expect = 4e-20
Identities = 33/151 (21%), Positives = 62/151 (41%), Gaps = 12/151 (7%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
I+ + + + + G L + A +I+
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEII 117
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
L ++H R +V+R+ K + IL +E ++ D L+ + + H + +GT GY
Sbjct: 118 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 171
Query: 121 CAPEYMRTGV-FNEKSNVFSFSVFLFELLTG 150
APE ++ GV ++ ++ FS LF+LL G
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 83.0 bits (204), Expect = 2e-19
Identities = 38/232 (16%), Positives = 79/232 (34%), Gaps = 16/232 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H++I+KL +LVFE + + L + ++
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV-----CEGGLESVTAKSFLLQLL 110
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
+ +AY H R ++ R+ K +L N E K+ DF L+ + T ++
Sbjct: 111 NGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGW-------DVSDLVKDVHDLVCPFSEYLKN 173
M + ++ +++S E++ G + L++ L P S+ N
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 174 CFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
E ++ S K ++ + +K P R +
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS-KMLKLDPNQRITAKQA 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 82.4 bits (203), Expect = 2e-19
Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 16/154 (10%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
H +I++L LVF+ ++ G L+D + L K KI ++
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMRALLEV 122
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCA 122
+ LH IV R+ K IL +++ KL DF S + GE V GT Y A
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 123 PEYMRTGV------FNEKSNVFSFSVFLFELLTG 150
PE + + + ++ +++S V ++ LL G
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 3e-19
Identities = 39/230 (16%), Positives = 76/230 (33%), Gaps = 10/230 (4%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLL-LKHRLKIAMDI 59
H ++++L C + ++ + + + EP + + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 60 VHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLG 119
+ L +LH +V R+ K IL KL DF L+ +V+ TL
Sbjct: 126 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLW 180
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNR 179
Y APE + + +++S E+ + DV L ED
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 180 FTEIVDHIVVEDVSSIEKEQQLHASAQVTFE----CIKDSPADRPSMVDV 225
+ S+ E+ + ++ + C+ +PA R S
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 3e-19
Identities = 42/231 (18%), Positives = 82/231 (35%), Gaps = 37/231 (16%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +++ L IL+ E V G L+D E L + + I+
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFD-----FLAEKESLTEEEATEFLKQIL 123
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVA----KLFDFSLSISIPEGETHITDTVMG 116
+ + YLH I + K I+ + NV K+ DF L+ I G + G
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFG 178
Query: 117 TLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFE 176
T + APE + +++++S V + LL+G + F
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---------------------ASPFL 217
Query: 177 DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTF--ECIKDSPADRPSMVDV 225
+ E + ++ + ++ ++ F + P R ++ D
Sbjct: 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 9e-19
Identities = 42/231 (18%), Positives = 79/231 (34%), Gaps = 30/231 (12%)
Query: 2 MSHNHILKLIGCC----LETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAM 57
HI++++ ++V E + G L+ RI + + +I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMK 118
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN---VAKLFDFSLSISIPEGETHITDTV 114
I A+ YLH I R+ K +L+ + + KL DF + + T
Sbjct: 119 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTP 173
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKNC 174
T Y APE + +++ +++S V ++ LL G+ H L +
Sbjct: 174 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRIR 230
Query: 175 FEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
F V E+V + + +K P R ++ +
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIR------------NLLKTEPTQRMTITEF 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 2e-18
Identities = 41/232 (17%), Positives = 74/232 (31%), Gaps = 17/232 (7%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++SH +I+ L+ LVF+ ++ + + L H + +
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTL 110
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
L YLH I+ R+ K + +L +E V KL DF L+ S T V T Y
Sbjct: 111 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWY 166
Query: 121 CAPE-YMRTGVFNEKSNVFSFSVFLFELLTGW------DVSDLVKDVHDLVCPFSEYLKN 173
APE ++ ++++ L ELL D + + + + +E
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226
Query: 174 CFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
+ I + +P R +
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDL-LDLIQGLFLFNPCARITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 2e-18
Identities = 35/232 (15%), Positives = 72/232 (31%), Gaps = 15/232 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+++H +I+KL+ LVFE + + L ++
Sbjct: 57 ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS----ALTGIPLPLIKSYLFQLL 112
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
LA+ H ++ R+ K +L N E KL DF L+ + T V+
Sbjct: 113 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTGW-------DVSDLVKDVHDLVCPFSEYLKN 173
+ ++ +++S E++T ++ L + L P
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 174 CFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
+ +D S + + ++ + + P R S
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS-QMLHYDPNKRISAKAA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 79.9 bits (196), Expect = 2e-18
Identities = 33/243 (13%), Positives = 65/243 (26%), Gaps = 32/243 (13%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
I + C E ++V E + LK L +A ++
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF-----CSRKFSLKTVLLLADQMISR 115
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNEENVAKL---FDFSLSISIPEGETHI------TDT 113
+ Y+H + + R+ K L L DF L+ + TH
Sbjct: 116 IEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYLKN 173
+ GT Y + + + ++ S L G + ++ K
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG-------SLPWQGLKAATKRQKY 225
Query: 174 CFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233
+ ++ + S A C D+P + + R ++
Sbjct: 226 ERISEKKMSTPIEVLCKGYPS--------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
Query: 234 RSL 236
Sbjct: 278 HRQ 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.2 bits (192), Expect = 9e-18
Identities = 34/150 (22%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++H I+++ G + ++ + ++ G L+ + A ++
Sbjct: 60 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-----LRKSQRFPNPVAKFYAAEVC 114
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL YLH + I++R+ K IL ++ K+ DF + +P+ T+ GT Y
Sbjct: 115 LALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TLCGTPDY 167
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE + T +N+ + +SF + ++E+L G
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 77.9 bits (191), Expect = 1e-17
Identities = 29/248 (11%), Positives = 65/248 (26%), Gaps = 34/248 (13%)
Query: 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHA 62
I + E +LV + + G + +L F K A ++
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV---KTVAMAAKQMLAR 113
Query: 63 LAYLHFGFPRPIVFRNFKTSCILFNE-----ENVAKLFDFSLSISIPEGETHI------T 111
+ +H + +V+R+ K L N+ + DF + + T
Sbjct: 114 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 112 DTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVHDLVCPFSEYL 171
+ GT Y + + + ++ + L G +K + E +
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY--ERI 228
Query: 172 KNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231
+ E+ E + + P + +
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHY-------------ARNLAFDATPDYDYLQGLFSK 275
Query: 232 IYRSLSCN 239
+ L+
Sbjct: 276 VLERLNTT 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.8 bits (191), Expect = 1e-17
Identities = 34/214 (15%), Positives = 76/214 (35%), Gaps = 25/214 (11%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
+ +++L+ +L+ E + + L + ++ A+
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAV 123
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCA 122
+ H ++ R+ K IL + KL DF + + GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSP 177
Query: 123 PEYMRTG-VFNEKSNVFSFSVFLFELLTG----WDVSDLVKDVHDLVCPFSEYLKN---- 173
PE++R + V+S + L++++ G ++++ S ++
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237
Query: 174 CFEDN---RFT--EIVDHIVVEDVSSIEKEQQLH 202
C R T EI +H ++DV ++ ++H
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 2e-17
Identities = 35/238 (14%), Positives = 80/238 (33%), Gaps = 19/238 (7%)
Query: 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 54
++ H +I++L + LV + V R+ + L + +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET--VYRVARHYSRAKQTLPVIYVKL 126
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDT 113
+ +LAY+H I R+ K +L + + V KL DF + + GE +++
Sbjct: 127 YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-Y 182
Query: 114 VMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG------WDVSDLVKDVHDLVCPF 167
+ + +V+S L ELL G D + ++ ++
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 168 SEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
+ N I + + + + + + ++ +P R + ++
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.8 bits (185), Expect = 6e-17
Identities = 33/232 (14%), Positives = 67/232 (28%), Gaps = 15/232 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ H +I++L LVFE L + ++
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY-----FDSCNGDLDPEIVKSFLFQLL 111
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
L + H R ++ R+ K +L N KL +F L+ + + V+
Sbjct: 112 KGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG-------WDVSDLVKDVHDLVCPFSEYLKN 173
+++ +++S EL DV D +K + L+ +E
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 174 CFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225
+ + + +K +P R S +
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 2e-16
Identities = 31/150 (20%), Positives = 53/150 (35%), Gaps = 9/150 (6%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
H + L V E G L+ + + +IV
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIV 115
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
AL YLH R +V+R+ K ++ +++ K+ DF L T GT Y
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEY 171
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE + + + + V ++E++ G
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 3e-16
Identities = 40/241 (16%), Positives = 81/241 (33%), Gaps = 26/241 (10%)
Query: 1 QMSHNHILKLIGCCLETPIP-----ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKI 55
+ H +I+ + I LV + G ++L + L H
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLM--GADLYKLL-----KTQHLSNDHICYF 114
Query: 56 AMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHIT--DT 113
I+ L Y+H ++ R+ K S +L N K+ DF L+ H
Sbjct: 115 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 114 VMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTG------WDVSDLVKDVHDLVCP 166
+ T Y APE M + + +++S L E+L+ D + + ++
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231
Query: 167 FSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTF--ECIKDSPADRPSMVD 224
S+ NC + + + + ++ + S + + + +P R +
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291
Query: 225 V 225
Sbjct: 292 A 292
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (173), Expect = 4e-15
Identities = 37/149 (24%), Positives = 59/149 (39%), Gaps = 10/149 (6%)
Query: 4 HNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHAL 63
++ L L+ + + G L+ + E +IV AL
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIVLAL 142
Query: 64 AYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAP 123
+LH I++R+ K IL + L DF LS ET GT+ Y AP
Sbjct: 143 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 124 EYMRTGV--FNEKSNVFSFSVFLFELLTG 150
+ +R G ++ + +S V ++ELLTG
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 3e-14
Identities = 34/241 (14%), Positives = 78/241 (32%), Gaps = 19/241 (7%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQY---GTLWDRILGAPQPHFEPLLLKHRLKIAM 57
+ H +++ LI C P + Y + G L ++
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124
Query: 58 DIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET---HITDTV 114
+++ L Y+H I+ R+ K + +L + V KL DF L+ + + +
Sbjct: 125 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 115 MGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGW------DVSDLVKDVHDLVCPF 167
+ TL Y PE + + +++ + E+ T + + L
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 168 SEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVT---FECIKDSPADRPSMVD 224
+ + ++ E ++ + + ++ + + + PA R D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 225 V 225
Sbjct: 302 A 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.2 bits (163), Expect = 1e-13
Identities = 32/239 (13%), Positives = 77/239 (32%), Gaps = 27/239 (11%)
Query: 1 QMSHNHILKLIGCCLETPIP------ILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 54
M H +++ L+ LV + GT +++ E L
Sbjct: 73 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM-----KHEKLGEDRIQF 125
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ ++ L Y+H I+ R+ K + NE+ K+ DF L+ ++ +T V
Sbjct: 126 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYV 179
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG------WDVSDLVKDVHDLVCPFS 168
+ + + + +++S + E++TG D D +K++ +
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 169 EYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTF--ECIKDSPADRPSMVDV 225
+ + + + + + V + + R + +
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 66.0 bits (160), Expect = 3e-13
Identities = 28/150 (18%), Positives = 60/150 (40%), Gaps = 12/150 (8%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
++ ++KL + +V E V G ++ + H A IV
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRFSEPHARFYAAQIV 151
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGY 120
YLH +++R+ K +L +++ ++ DF + + T+ GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEA 204
Query: 121 CAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
APE + + +N+ + ++ V ++E+ G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.4 bits (145), Expect = 2e-11
Identities = 28/151 (18%), Positives = 57/151 (37%), Gaps = 4/151 (2%)
Query: 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVH 61
M NHILKL+ + V + + + + L + +I+ ++
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 62 ALAYLHFGFPRPIVFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDT-VMGTLG 119
L Y+H I+ + K +L + L ++ T + T
Sbjct: 137 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 120 YCAPEYMRTGVFNEKSNVFSFSVFLFELLTG 150
Y +PE + + ++++S + +FEL+TG
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITG 225
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (124), Expect = 1e-08
Identities = 33/193 (17%), Positives = 68/193 (35%), Gaps = 26/193 (13%)
Query: 1 QMSHNHILKLIGCCL------ETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLK 54
++H +I+ L+ E LV E + + +
Sbjct: 72 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH--------ERMSY 123
Query: 55 IAMDIVHALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTV 114
+ ++ + +LH I+ R+ K S I+ + K+ DF L+ + G + +
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY 178
Query: 115 MGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTG-------WDVSDLVKDVHDLVCPF 167
+ T Y APE + + E +++S + E++ + K + L P
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 168 SEYLKNCFEDNRF 180
E++K R
Sbjct: 239 PEFMKKLQPTVRN 251
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 37.1 bits (85), Expect = 9e-04
Identities = 14/103 (13%), Positives = 34/103 (33%), Gaps = 12/103 (11%)
Query: 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIV 60
+ + KL G + + + +++ ++ I+
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMIL 113
Query: 61 HALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISI 103
+A + R IV + +L +EE + + DF S+ +
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 239 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.66 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.49 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 85.11 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=318.09 Aligned_cols=207 Identities=23% Similarity=0.398 Sum_probs=157.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|++.+++..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +++|+|||||
T Consensus 56 ~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlK 128 (263)
T d1sm2a_ 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128 (263)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCS
T ss_pred hcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccc
Confidence 4799999999999999999999999999999999987653 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|||+|+..|+.....
T Consensus 129 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~- 207 (263)
T d1sm2a_ 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS- 207 (263)
T ss_dssp GGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-
T ss_pred hhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-
Confidence 9999999999999999999977644433333455689999999999999999999999999999999996554422111
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
..+....+... .....+...++++.+++.+||+.||++|||++|+++.|+++.++
T Consensus 208 -------------------~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 208 -------------------NSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -------------------HHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------HHHHHHHHHhc-CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11111111111 11111123456789999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=319.14 Aligned_cols=211 Identities=22% Similarity=0.371 Sum_probs=161.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++. .+..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++|+|||||
T Consensus 60 ~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlK 131 (276)
T d1uwha_ 60 KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131 (276)
T ss_dssp TCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccC
Confidence 579999999999875 456899999999999999997653 46899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccC---CcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTG---VFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+|||++.++.+||+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 132 p~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp GGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 999999999999999999987654322 2233456789999999998643 478999999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
........ ..+......+.........++.+.++|.+||+.||.+|||++|+++.|+.+.+++
T Consensus 212 ~~~~~~~~-----------------~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 212 INNRDQII-----------------FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CCCHHHHH-----------------HHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CChHHHHH-----------------HHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 33211100 0000000000000111244577899999999999999999999999999988754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-50 Score=320.31 Aligned_cols=206 Identities=18% Similarity=0.294 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|++.+++..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +++++|||||
T Consensus 83 ~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlK 155 (299)
T d1jpaa_ 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLA 155 (299)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccc
Confidence 5899999999999999999999999999999999887653 46899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc----eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH----ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~ 155 (239)
|+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||.
T Consensus 156 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp GGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence 99999999999999999999766432211 1223457899999999999999999999999999999998 788875
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.... .+....+..+ .....+...++.+.+++.+||+.||.+|||+.||++.|++++++
T Consensus 236 ~~~~---------------------~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 236 DMTN---------------------QDVINAIEQD-YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TCCH---------------------HHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCH---------------------HHHHHHHHcC-CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 4321 1111111111 11111224567789999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-50 Score=319.29 Aligned_cols=207 Identities=22% Similarity=0.368 Sum_probs=168.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|+|.+++..++||||+++|+|.+++..... ..+++..++.++.|++.||.||| +++|+|||||
T Consensus 69 ~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlK 142 (287)
T d1opja_ 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLA 142 (287)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccc
Confidence 37999999999999999999999999999999999976543 57899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++..............|++.|+|||++.+..++.++||||||+++|||++|..|+....+
T Consensus 143 p~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~- 221 (287)
T d1opja_ 143 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID- 221 (287)
T ss_dssp GGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred cCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-
Confidence 9999999999999999999987654443334445688999999999999999999999999999999998776532211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
..... ..+........+...++.+.+||.+||+.||.+|||++|+++.|+.+.+
T Consensus 222 -------------------~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 222 -------------------LSQVY-ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -------------------HHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -------------------HHHHH-HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 01111 1111111111223456789999999999999999999999999988754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=313.58 Aligned_cols=199 Identities=23% Similarity=0.315 Sum_probs=160.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+++..++||||+++|+|.+++... ..+++..++.++.|++.||.||| +++|+|||||
T Consensus 59 ~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiK 130 (271)
T d1nvra_ 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIK 130 (271)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred hCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCccc
Confidence 579999999999999999999999999999999999764 57999999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+|||++.++.+||+|||+++...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 131 p~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 131 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp GGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred HHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998654322 222345679999999999988775 578999999999999999999986433
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... ................++++.+++.+||+.||++|||++|+++
T Consensus 211 ~~~~~~--------------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 211 DSCQEY--------------------SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTSHHH--------------------HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHHHH--------------------HHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 211100 0000000001111234567889999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=312.77 Aligned_cols=205 Identities=21% Similarity=0.318 Sum_probs=165.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|+|.+ +..++||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+|||||
T Consensus 64 ~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlK 134 (277)
T d1xbba_ 64 QLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLA 134 (277)
T ss_dssp TCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCc
Confidence 5899999999999865 4578999999999999999876 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 135 p~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred chhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 99999999999999999999876443322 2234568999999999999999999999999999999998 88888643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
.. .+....+..+. ....+...++++.++|.+||+.||.+|||+++|++.|+..+.++
T Consensus 215 ~~---------------------~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 215 KG---------------------SEVTAMLEKGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CH---------------------HHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CH---------------------HHHHHHHHcCC-CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 21 11111111111 11112245678899999999999999999999999998876553
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=309.86 Aligned_cols=193 Identities=22% Similarity=0.408 Sum_probs=162.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+++..++||||+++|+|.+++... ..+++..++.++.||+.||+||| +++|+|||||
T Consensus 62 ~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiK 133 (263)
T d2j4za1 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIK 133 (263)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred hcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeec
Confidence 479999999999999999999999999999999999875 57899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 134 p~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-- 208 (263)
T d2j4za1 134 PENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-- 208 (263)
T ss_dssp GGGEEECTTSCEEECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred cccceecCCCCEeecccceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--
Confidence 999999999999999999997654322 345679999999999999999999999999999999999999985322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+....+....... +...++++.+++.+||+.||.+|||++|+++
T Consensus 209 -------------------~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 209 -------------------YQETYKRISRVEFTF--PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -------------------HHHHHHHHHTTCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------------HHHHHHHHHcCCCCC--CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111111111111111 1234577899999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=312.69 Aligned_cols=196 Identities=18% Similarity=0.245 Sum_probs=161.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+.+..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +++|+|||||
T Consensus 73 ~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiK 143 (293)
T d1yhwa1 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIK 143 (293)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCc
Confidence 37899999999999999999999999999999998865 45889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 144 p~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 222 (293)
T d1yhwa1 144 SDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (293)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred HHHeEECCCCcEeeccchhheeecccc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH
Confidence 999999999999999999998764322 2234567999999999999999999999999999999999999998532211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhh-hcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIV-VEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+...... ........+...++.++++|.+||+.||.+|||++|+++
T Consensus 223 ---------------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 223 ---------------------RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---------------------HHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---------------------HHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 111111112245677899999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=313.55 Aligned_cols=207 Identities=23% Similarity=0.370 Sum_probs=167.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|++.+ +..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +++++|||||
T Consensus 65 ~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlK 136 (285)
T d1u59a_ 65 QLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLA 136 (285)
T ss_dssp HCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCc
Confidence 4799999999999865 45789999999999999886543 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 137 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987644322 22334568899999999998999999999999999999998 88888643
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhhc
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSLS 237 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~~ 237 (239)
.. .+....+..+. ....+...++++.++|.+||+.||++|||+.++++.|+..+.++.
T Consensus 217 ~~---------------------~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 217 KG---------------------PEVMAFIEQGK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp CT---------------------HHHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CH---------------------HHHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 21 11111111111 111123456788999999999999999999999999998887654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=314.06 Aligned_cols=207 Identities=21% Similarity=0.351 Sum_probs=166.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|++.+ +..++||||+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+|||||
T Consensus 64 ~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiK 136 (272)
T d1qpca_ 64 QLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLR 136 (272)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred hCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccc
Confidence 4799999999998754 567899999999999998765422 35899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++..............|++.|+|||++.+..++.++||||||+++|||+||..|+.....
T Consensus 137 p~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~- 215 (272)
T d1qpca_ 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT- 215 (272)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-
T ss_pred hhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-
Confidence 9999999999999999999987755444444456788999999999988999999999999999999997665432211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
..+....+... .....+...++.+.+++.+||+.||++|||++||++.|+++..+
T Consensus 216 -------------------~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 216 -------------------NPEVIQNLERG-YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -------------------HHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------HHHHHHHHHhc-CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 11111111111 11111234567789999999999999999999999999998765
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=307.09 Aligned_cols=195 Identities=19% Similarity=0.306 Sum_probs=155.4
Q ss_pred CCCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCC--e
Q 044155 1 QMSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRP--I 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~--i 74 (239)
+++|||||++++++.+ ....++||||+++|+|.+++.+. ..+++..++.++.||+.||+||| +++ |
T Consensus 64 ~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~I 135 (270)
T d1t4ha_ 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPI 135 (270)
T ss_dssp TCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCC
T ss_pred hCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCE
Confidence 5899999999999875 34578999999999999999875 56899999999999999999999 777 9
Q ss_pred eeccccCcceeec-CCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 75 VFRNFKTSCILFN-EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 75 ~H~dlk~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 136 iHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~P 211 (270)
T d1t4ha_ 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 211 (270)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred EeCCcChhhceeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCC
Confidence 9999999999996 4789999999999764332 2335679999999998875 689999999999999999999999
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
|....+.. .....+..+..........++++.++|.+||+.||++|||++|+++
T Consensus 212 f~~~~~~~--------------------~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 212 YSECQNAA--------------------QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTCSSHH--------------------HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcccHH--------------------HHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 85332111 1111111111111112234466889999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=317.55 Aligned_cols=220 Identities=19% Similarity=0.257 Sum_probs=163.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCC-CCeeeccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFP-RPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~-~~i~H~dl 79 (239)
+++|||||+++++|.+.+..++||||+++|+|.+++.+. ..+++..+..++.|++.||.||| + ++|+||||
T Consensus 60 ~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDi 131 (322)
T d1s9ja_ 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDV 131 (322)
T ss_dssp GCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCC
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcccc
Confidence 479999999999999999999999999999999999865 56899999999999999999999 6 48999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
||+|||++.++.+||+|||+|...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 132 KP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 132 KPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp SGGGEEECTTCCEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred CHHHeeECCCCCEEEeeCCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999999998765321 23356799999999999999999999999999999999999999965332
Q ss_pred cccccccchh---------------------hhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCC
Q 044155 160 VHDLVCPFSE---------------------YLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPAD 218 (239)
Q Consensus 160 ~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~ 218 (239)
.......... ............+..................+.++.+++.+||..||.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 288 (322)
T d1s9ja_ 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288 (322)
T ss_dssp THHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhH
Confidence 1100000000 0000000000111111111111111111123567899999999999999
Q ss_pred CCCHHHHHH--HHHH
Q 044155 219 RPSMVDVAK--KLRQ 231 (239)
Q Consensus 219 Rps~~ell~--~L~~ 231 (239)
|||++|+++ ++++
T Consensus 289 R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 289 RADLKQLMVHAFIKR 303 (322)
T ss_dssp SCCHHHHHTSHHHHH
T ss_pred CcCHHHHhhCHhhCc
Confidence 999999987 5554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=314.43 Aligned_cols=205 Identities=20% Similarity=0.331 Sum_probs=164.0
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC------------------CCCcCCHHHHHHHHHHHHHHHh
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP------------------HFEPLLLKHRLKIAMDIVHALA 64 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~ 64 (239)
+|||||++++++.+.+..++||||+++|+|.++++..... ....+++..++.++.|++.||+
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 178 (325)
T d1rjba_ 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178 (325)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 7999999999999999999999999999999999865321 1135789999999999999999
Q ss_pred HHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhH
Q 044155 65 YLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVF 143 (239)
Q Consensus 65 ~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 143 (239)
||| +++|+||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||+
T Consensus 179 yLH---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 179 FLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255 (325)
T ss_dssp HHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHH---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHH
Confidence 999 89999999999999999999999999999976543322 22345568999999999999999999999999999
Q ss_pred HHHHhc-CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 044155 144 LFELLT-GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSM 222 (239)
Q Consensus 144 l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 222 (239)
+|||+| |..||....... .+...+........+...++++.+||.+||+.||++|||+
T Consensus 256 l~emlt~g~~Pf~~~~~~~---------------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPVDA---------------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp HHHHTTTSCCSSTTCCCSH---------------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHhCCCCCCCCCCHHH---------------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 999998 888886433111 1111111111111122456779999999999999999999
Q ss_pred HHHHHHHHH
Q 044155 223 VDVAKKLRQ 231 (239)
Q Consensus 223 ~ell~~L~~ 231 (239)
+||++.|..
T Consensus 315 ~ei~~~L~~ 323 (325)
T d1rjba_ 315 PNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhC
Confidence 999999853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=310.72 Aligned_cols=198 Identities=20% Similarity=0.264 Sum_probs=159.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+.+..++||||+++|+|.+++.+.. ..+++..++.++.||+.||.||| +++|+|||||
T Consensus 65 ~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiK 137 (288)
T d2jfla1 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLK 137 (288)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecC
Confidence 4789999999999999999999999999999999876542 46899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccc-----cCCcccccchhhhhhHHHHHhcCCCCcc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMR-----TGVFNEKSNVFSFSVFLFELLTGWDVSD 155 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~~~~g~~p~~ 155 (239)
|+|||++.++.+||+|||++...... ........||+.|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 138 p~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~ 216 (288)
T d2jfla1 138 AGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216 (288)
T ss_dssp GGGEEECTTSCEEECCCTTCEECHHH-HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred hhheeECCCCCEEEEechhhhccCCC-cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC
Confidence 99999999999999999998654221 11233567899999999984 3457899999999999999999999986
Q ss_pred cccccccccccchhhhhhhhhccchhhhhhhhhhcCC-CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 156 LVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV-SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..... +....+..... ....+...++++.+||.+||+.||.+|||++|+++
T Consensus 217 ~~~~~---------------------~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 217 ELNPM---------------------RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp TSCGG---------------------GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCHH---------------------HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 43211 11111111111 11112245678899999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=304.31 Aligned_cols=202 Identities=19% Similarity=0.371 Sum_probs=166.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||++++|+|.+.+..++||||+++|+|.+++.... ..+++..+.+++.|++.||+||| +.+|+|||||
T Consensus 55 ~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk 127 (258)
T d1k2pa_ 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127 (258)
T ss_dssp TCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCS
T ss_pred hcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHh---hcCccccccc
Confidence 5799999999999999999999999999999999876653 56889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||+++..............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+....
T Consensus 128 ~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207 (258)
T ss_dssp GGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred ceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence 999999999999999999997665444333445668999999999999999999999999999999998 7888754321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.+....+... .....+...++.+.++|.+||+.||++|||++++++.|.+
T Consensus 208 ---------------------~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 208 ---------------------SETAEHIAQG-LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---------------------HHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---------------------HHHHHHHHhC-CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1111111111 1111223455789999999999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=307.12 Aligned_cols=206 Identities=22% Similarity=0.281 Sum_probs=159.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|++.+....++||||+.++++.+.+.... ..+++..+..++.|++.||.||| +++|+|||||
T Consensus 65 ~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlK 137 (283)
T d1mqba_ 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLA 137 (283)
T ss_dssp TCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcc---ccccccCccc
Confidence 5799999999999999999999999999999998887653 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|..|+....
T Consensus 138 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 138 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 9999999999999999999976543321 12234457899999999999999999999999999999999766643211
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
. ..+....+..+ .....+...+..+.++|.+||+.||++|||+.||++.|+++.+
T Consensus 218 ~--------------------~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 218 S--------------------NHEVMKAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp C--------------------HHHHHHHHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C--------------------HHHHHHHHhcc-CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1 01111111111 1111122456778999999999999999999999999998765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=308.15 Aligned_cols=203 Identities=19% Similarity=0.257 Sum_probs=147.8
Q ss_pred CCCCcccceeeEEEEe--CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCC--CCCeee
Q 044155 1 QMSHNHILKLIGCCLE--TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGF--PRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~~~i~H 76 (239)
+++|||||++++++.+ ++..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.. ..+|+|
T Consensus 59 ~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiH 137 (269)
T d2java1 59 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137 (269)
T ss_dssp SCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC-------
T ss_pred HCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEe
Confidence 5799999999999875 45678999999999999998653210 056899999999999999999999311 124999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 138 rDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 138 RDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp --CCGGGEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcCchhhcCcCCCCcEEEeeccceeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 9999999999999999999999998764322 223456789999999999999999999999999999999999999854
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .+....+....... .+...++++.++|.+||+.||.+|||++|+++
T Consensus 217 ~~~---------------------~~~~~~i~~~~~~~-~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 217 FSQ---------------------KELAGKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SSH---------------------HHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCH---------------------HHHHHHHHcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 221 11111221111111 11245567899999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=303.76 Aligned_cols=205 Identities=23% Similarity=0.321 Sum_probs=155.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|++. .+..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +++++|||||
T Consensus 64 ~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlK 135 (273)
T d1mp8a_ 64 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIA 135 (273)
T ss_dssp TCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccc
Confidence 579999999999995 467899999999999999877653 46899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 136 p~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 136 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp GGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred hhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999998765443334445568899999999999999999999999999999998 7777754321
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
.+....+..... ...+...++.+.++|.+||+.||.+|||+.||++.|+++.++
T Consensus 216 ---------------------~~~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 216 ---------------------NDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---------------------GGHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------HHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111111111111 111224567899999999999999999999999999998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-48 Score=309.13 Aligned_cols=193 Identities=22% Similarity=0.314 Sum_probs=157.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+.+..++|||||.+|+|..++... ..+++..++.++.||+.||.||| +++|+|||||
T Consensus 71 ~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiK 142 (309)
T d1u5ra_ 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVK 142 (309)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCS
T ss_pred HCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCC
Confidence 579999999999999999999999999998887666554 57899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc---CCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT---GVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+|||++.++.+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 143 p~NILl~~~~~~Kl~DFG~a~~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 143 AGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp GGGEEEETTTEEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cceEEECCCCCEEEeecccccccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999998765332 34579999999999864 35889999999999999999999998532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+....+.............++.+.+||.+||+.||.+|||++|+++
T Consensus 218 ~~---------------------~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 218 NA---------------------MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CH---------------------HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CH---------------------HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 21 11111122221111112245678999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-48 Score=306.36 Aligned_cols=196 Identities=22% Similarity=0.338 Sum_probs=150.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+++..++||||++||+|.+++... ..+++..+..++.||+.||.||| +++|+|||||
T Consensus 63 ~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiK 134 (307)
T d1a06a_ 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLK 134 (307)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEec
Confidence 579999999999999999999999999999999999865 57999999999999999999999 8999999999
Q ss_pred Ccceeec---CCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccc
Q 044155 81 TSCILFN---EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~ 157 (239)
|+||++. .++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 135 p~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 135 PENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp GGGEEESSSSTTCCEEECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccceeecccCCCceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 9999995 46789999999997653322 234567999999999999999999999999999999999999998532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.. .+....+..... ........++.+.++|.+||+.||++|||++|+++
T Consensus 213 ~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 213 ND---------------------AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp SH---------------------HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CH---------------------HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 21 111111221111 11112245677899999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=306.18 Aligned_cols=196 Identities=17% Similarity=0.238 Sum_probs=159.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++|+|.+++... ..+++..++.++.|++.||+||| +++|+|||||
T Consensus 64 ~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiK 135 (288)
T d1uu3a_ 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLK 135 (288)
T ss_dssp HCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred HcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCC
Confidence 379999999999999999999999999999999998875 57899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+||+++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 136 p~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~- 214 (288)
T d1uu3a_ 136 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN- 214 (288)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred ccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-
Confidence 999999999999999999998764322 223345679999999999999999999999999999999999999986322
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+....+....... +...++.+++||.+||+.||++|||++|++.
T Consensus 215 --------------------~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 215 --------------------EYLIFQKIIKLEYDF--PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --------------------HHHHHHHHHTTCCCC--CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --------------------HHHHHHHHHcCCCCC--CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111112222222111 1234567899999999999999999998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=297.48 Aligned_cols=223 Identities=18% Similarity=0.285 Sum_probs=165.2
Q ss_pred CCCCcccceeeEEEEeCC----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhC-----CC
Q 044155 1 QMSHNHILKLIGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFG-----FP 71 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-----~~ 71 (239)
+++|||||++++++.+.+ ..++||||+++|+|.+++++ ..+++..+..++.|++.||.|+|.. ..
T Consensus 53 ~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~ 126 (303)
T d1vjya_ 53 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126 (303)
T ss_dssp TCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred hCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 478999999999998654 46899999999999999986 4588999999999999999999921 02
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCcc---eeecccccccccCccccccCC------cccccchhhhhh
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETH---ITDTVMGTLGYCAPEYMRTGV------FNEKSNVFSFSV 142 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~ 142 (239)
++|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||
T Consensus 127 ~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gv 206 (303)
T d1vjya_ 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp CEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred CCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHH
Confidence 69999999999999999999999999998876443221 233567899999999987543 567899999999
Q ss_pred HHHHHhcCCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCC-----cHHHHHHHHHHHHHHhhhcCCCCC
Q 044155 143 FLFELLTGWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVS-----SIEKEQQLHASAQVTFECIKDSPA 217 (239)
Q Consensus 143 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dp~ 217 (239)
++|||+||..|+............ ..................... ..........+.+++.+||..||+
T Consensus 207 vl~el~tg~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~ 280 (303)
T d1vjya_ 207 VFWEIARRCSIGGIHEDYQLPYYD------LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTT------TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGG
T ss_pred HHHHHhhCCCCCCcccccccchhh------cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHh
Confidence 999999998887654432221110 000011111111111111111 111224567789999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 044155 218 DRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 218 ~Rps~~ell~~L~~l~~~ 235 (239)
+|||+.||++.|.++..+
T Consensus 281 ~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 281 ARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHHh
Confidence 999999999999998765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=304.37 Aligned_cols=206 Identities=23% Similarity=0.313 Sum_probs=158.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|++. .+..++||||+++|+|..++..... ..+++..++.++.||+.||+||| +.+++|||||
T Consensus 68 ~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlK 140 (285)
T d1fmka3 68 KLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLR 140 (285)
T ss_dssp HCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred hcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHh---hhheeccccc
Confidence 479999999999985 4567899999999999988875432 46899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++..............||+.|+|||++....++.++||||||+++|||++|..|+.....
T Consensus 141 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~- 219 (285)
T d1fmka3 141 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV- 219 (285)
T ss_dssp GGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-
T ss_pred ceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-
Confidence 9999999999999999999976644433334456689999999999999999999999999999999998766533221
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
..+....+.... ....+...++++.++|.+||+.||++|||+++|++.|+....
T Consensus 220 -------------------~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 220 -------------------NREVLDQVERGY-RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -------------------HHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -------------------HHHHHHHHHhcC-CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 111111111111 111122456789999999999999999999999999887654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=297.85 Aligned_cols=203 Identities=26% Similarity=0.378 Sum_probs=156.6
Q ss_pred CCCCcccceeeEEEEe-CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLE-TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~-~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||++++|++.+ .+..++||||+++|+|.+++..... ..+++..++.++.||+.||.||| +.+++||||
T Consensus 56 ~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dl 129 (262)
T d1byga_ 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDL 129 (262)
T ss_dssp TCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred hCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccc---cCceecccc
Confidence 5799999999999865 4568999999999999999976422 45899999999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
||+||+++.++.+|++|||+++..... .....+++.|+|||++.+..++.++||||||+++|||+| |..||....
T Consensus 130 kp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 130 AARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp SGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred chHhheecCCCCEeecccccceecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 999999999999999999998754322 224457889999999998999999999999999999998 566654321
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHh
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRS 235 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~ 235 (239)
..+....+..+ .....+...++++.++|.+||+.||.+|||+.++++.|+++...
T Consensus 206 ---------------------~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 206 ---------------------LKDVVPRVEKG-YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ---------------------GGGHHHHHTTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------HHHHHHHHHcC-CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 11111111111 11111224557789999999999999999999999999988653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=298.57 Aligned_cols=203 Identities=24% Similarity=0.438 Sum_probs=162.7
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||++++|++.+ +..++||||++++++.+++.... ..+++..++.++.|++.||.||| +++|+|||||
T Consensus 67 ~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDik 138 (273)
T d1u46a_ 67 SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLA 138 (273)
T ss_dssp HCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred hCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeec
Confidence 4799999999999965 46789999999999999887643 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc--eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCcccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH--ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLV 157 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~ 157 (239)
|+||+++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||+| |..||...
T Consensus 139 p~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 139 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred HHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999876544322 2234457889999999999999999999999999999998 88887532
Q ss_pred cccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 044155 158 KDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQI 232 (239)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l 232 (239)
. ..+....+.........+...+..+.++|.+||+.||++|||+.||++.|+++
T Consensus 219 ~---------------------~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 219 N---------------------GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C---------------------HHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------------------HHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2 12222222222222222234567799999999999999999999999998874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=300.83 Aligned_cols=210 Identities=21% Similarity=0.340 Sum_probs=158.6
Q ss_pred CCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCC
Q 044155 3 SHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGF 70 (239)
Q Consensus 3 ~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 70 (239)
+|+||+.+++++... ...++|||||++|+|.++++..... ....+++..++.++.|++.||.|||
T Consensus 75 ~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--- 151 (299)
T d1ywna1 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 151 (299)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---
T ss_pred CCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---
Confidence 799999999998765 4689999999999999999764320 1135889999999999999999999
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT 149 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 149 (239)
+++|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 152 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence 89999999999999999999999999999976543322 22345578999999999999999999999999999999999
Q ss_pred CC-CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 044155 150 GW-DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKK 228 (239)
Q Consensus 150 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 228 (239)
|. .||....... .+...+........+...++++.+++.+||+.||.+|||++|+++.
T Consensus 232 ~~~~p~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 232 LGASPYPGVKIDE---------------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TSCCSSTTCCCSH---------------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHH---------------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 75 4554322111 0111111111111122445678999999999999999999999999
Q ss_pred HHHHHHhh
Q 044155 229 LRQIYRSL 236 (239)
Q Consensus 229 L~~l~~~~ 236 (239)
|++++++-
T Consensus 291 L~~ilq~n 298 (299)
T d1ywna1 291 LGNLLQAN 298 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhCC
Confidence 99987653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.9e-47 Score=304.80 Aligned_cols=197 Identities=16% Similarity=0.257 Sum_probs=161.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||++++++.+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.||| +++++|||||
T Consensus 79 ~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiK 151 (350)
T d1koaa2 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLK 151 (350)
T ss_dssp HTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeec
Confidence 4799999999999999999999999999999999986543 56999999999999999999999 8999999999
Q ss_pred CcceeecC--CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNE--ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+|||++. ++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 152 p~NIll~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 229 (350)
T d1koaa2 152 PENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 229 (350)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEECCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhHeeeccCCCCeEEEeecchheeccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence 99999964 5789999999998764332 2345678999999999999999999999999999999999999985322
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. .+....+..... ........++.+++||.+||+.||++|||++|+++
T Consensus 230 ~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 230 D---------------------DETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp H---------------------HHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred H---------------------HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111111111111 11111245567899999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=296.87 Aligned_cols=196 Identities=20% Similarity=0.277 Sum_probs=162.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||++++++.+.+..++|||||++|+|.+++... ..+++..++.++.|++.||+||| +++|+|||||
T Consensus 69 ~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiK 140 (293)
T d1jksa_ 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 140 (293)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccc
Confidence 378999999999999999999999999999999999875 56999999999999999999999 8999999999
Q ss_pred CcceeecCCC----ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 81 TSCILFNEEN----VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 81 ~~nil~~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|+||+++.++ .+|++|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 141 p~Nill~~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp GGGEEESCSSSSSCCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceEEEecCCCcccceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence 9999998877 48999999987764332 23345689999999999998999999999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .+....+..... ........+..+.+||.+||+.||++|||++|+++
T Consensus 219 ~~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 219 DTK---------------------QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SSH---------------------HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCH---------------------HHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 221 111112222211 12222345678899999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-46 Score=303.23 Aligned_cols=197 Identities=18% Similarity=0.260 Sum_probs=162.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+|+|||||++++++.+++..++|||||++|+|.+.+.... ..+++.+++.++.||+.||.||| +++|+|||||
T Consensus 82 ~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiK 154 (352)
T d1koba_ 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIK 154 (352)
T ss_dssp TCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccc
Confidence 5799999999999999999999999999999998886543 46999999999999999999999 8999999999
Q ss_pred Ccceeec--CCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFN--EENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+|||++ .++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 155 p~NILl~~~~~~~vkL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 155 PENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp GGGEEESSTTCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cccccccccCCCeEEEeecccceecCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998 56889999999998764432 2345668999999999999999999999999999999999999986432
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. .+....+..... ........++++.+||.+||+.||.+|||++|+++
T Consensus 233 ~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 233 D---------------------LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp H---------------------HHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred H---------------------HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 111112211111 11111245677899999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=297.63 Aligned_cols=208 Identities=22% Similarity=0.351 Sum_probs=167.3
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-----------CCCcCCHHHHHHHHHHHHHHHhHHhhCCC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-----------HFEPLLLKHRLKIAMDIVHALAYLHFGFP 71 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 71 (239)
+|||||+++++|.+++..++||||+++|+|.+++...... ....+++..++.++.|++.||.||| +
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~ 153 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---S 153 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---h
Confidence 7999999999999999999999999999999999765321 1246899999999999999999999 8
Q ss_pred CCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhc-
Q 044155 72 RPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT- 149 (239)
Q Consensus 72 ~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~- 149 (239)
.+++||||||+|||++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++
T Consensus 154 ~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 154 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 9999999999999999999999999999876643322 22345568899999999999999999999999999999998
Q ss_pred CCCCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 044155 150 GWDVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKL 229 (239)
Q Consensus 150 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 229 (239)
|..||..... ......+.. ......+...++++.++|.+||+.||++|||+.||++.|
T Consensus 234 g~~p~~~~~~---------------------~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 234 GGSPYPGVPV---------------------EELFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp SCCSSTTCCH---------------------HHHHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCH---------------------HHHHHHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 5667643221 111111111 111111224556789999999999999999999999999
Q ss_pred HHHHHh
Q 044155 230 RQIYRS 235 (239)
Q Consensus 230 ~~l~~~ 235 (239)
+++++-
T Consensus 292 ~~i~a~ 297 (299)
T d1fgka_ 292 DRIVAL 297 (299)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=298.37 Aligned_cols=195 Identities=19% Similarity=0.274 Sum_probs=162.8
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++||||+++|+|.+++... ..+++..++.++.|++.||.||| +++|+|||||
T Consensus 61 ~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlK 132 (337)
T d1o6la_ 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIK 132 (337)
T ss_dssp SCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCC
T ss_pred hCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccC
Confidence 479999999999999999999999999999999999876 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.+|.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 133 P~NILl~~~g~vkl~DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-- 209 (337)
T d1o6la_ 133 LENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-- 209 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred HHHeEecCCCCEEEeecccccccccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--
Confidence 999999999999999999997653322 23445679999999999999999999999999999999999999886432
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
..+............ +...++++++||.+||+.||.+||+ ++|+++
T Consensus 210 -------------------~~~~~~~i~~~~~~~--p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 210 -------------------HERLFELILMEEIRF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------------------HHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------------------HHHHHHHHhcCCCCC--CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112222222222211 1245667899999999999999995 788875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=300.48 Aligned_cols=204 Identities=19% Similarity=0.318 Sum_probs=161.1
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||+++|+|.++ ..++++|++.+++|.+.+.... ..+++..++.++.||+.||+||| +++|+|||||
T Consensus 67 ~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlK 138 (317)
T d1xkka_ 67 SVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLA 138 (317)
T ss_dssp HCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcch
Confidence 47999999999999765 4678899999999999887753 57899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcc-eeecccccccccCccccccCCcccccchhhhhhHHHHHhc-CCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETH-ITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLT-GWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~-g~~p~~~~~ 158 (239)
|+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |..||....
T Consensus 139 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 139 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp GGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred hhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 99999999999999999999876443322 2334468999999999999999999999999999999998 677775332
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYR 234 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~ 234 (239)
. .+....... ......+...++.+.+++.+||+.||.+|||+.|+++.|..+..
T Consensus 219 ~---------------------~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 219 A---------------------SEISSILEK-GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp G---------------------GGHHHHHHH-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---------------------HHHHHHHHc-CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1 111111111 11111122456778999999999999999999999999988754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=297.93 Aligned_cols=208 Identities=22% Similarity=0.378 Sum_probs=165.1
Q ss_pred CCCCcccceeeEEEEeC-CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 1 QMSHNHILKLIGCCLET-PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
+++||||++++|++.+. +..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+||||
T Consensus 84 ~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDL 156 (311)
T d1r0pa_ 84 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDL 156 (311)
T ss_dssp TCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred hCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCc
Confidence 58999999999998764 57899999999999999988653 46778889999999999999999 899999999
Q ss_pred cCcceeecCCCceeEcccccccccCCCCc---ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 80 KTSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 80 k~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
||+|||+++++.+||+|||+++....... .......||+.|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 157 K~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 157 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp SGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred cHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 99999999999999999999976543221 122345688999999999999999999999999999999998887654
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHhh
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIYRSL 236 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~~~~ 236 (239)
..+..+. ......+. ....+...++.+.++|.+||+.||++|||+.||++.|+++.++.
T Consensus 237 ~~~~~~~--------------------~~~i~~g~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 237 DVNTFDI--------------------TVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp ------C--------------------HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCHHHH--------------------HHHHHcCC-CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 3221111 11111110 01111234567899999999999999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=298.10 Aligned_cols=201 Identities=19% Similarity=0.291 Sum_probs=159.6
Q ss_pred CCCcccceeeEEEEe----CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeec
Q 044155 2 MSHNHILKLIGCCLE----TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFR 77 (239)
Q Consensus 2 l~H~niv~l~~~~~~----~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~ 77 (239)
++|||||+++++|.+ ....++|||||+||+|.+++..... ..+++..++.++.|++.||+||| +++|+||
T Consensus 62 ~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH---~~~iiHR 135 (335)
T d2ozaa1 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHR 135 (335)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHH---HcCCccc
Confidence 479999999999976 3567999999999999999986533 56999999999999999999999 8999999
Q ss_pred cccCcceeecC---CCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 78 NFKTSCILFNE---ENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 78 dlk~~nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 136 DiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred cccccccccccccccccccccccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence 99999999986 4569999999997664332 234567999999999999999999999999999999999999999
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcC--CCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVED--VSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......... .......... .........++++.+||.+||+.||++|||+.|+++
T Consensus 214 ~~~~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 214 YSNHGLAISP-----------------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp EETTCC-------------------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHH-----------------HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 6433211100 0000111111 112223356788999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=298.63 Aligned_cols=210 Identities=20% Similarity=0.295 Sum_probs=166.0
Q ss_pred CC-CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----------CCCCcCCHHHHHHHHHHHHHHHhHHhh
Q 044155 1 QM-SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----------PHFEPLLLKHRLKIAMDIVHALAYLHF 68 (239)
Q Consensus 1 ~l-~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~~i~~~l~~LH~ 68 (239)
++ +|||||+++|++.+++..++||||+++|+|.++++.... .....+++..+..++.||+.||.|+|
T Consensus 66 ~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH- 144 (309)
T d1fvra_ 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS- 144 (309)
T ss_dssp TCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-
T ss_pred hccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh-
Confidence 35 799999999999999999999999999999999975421 11156899999999999999999999
Q ss_pred CCCCCeeeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 69 GFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 69 ~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
+++++||||||+|||++.++.+||+|||+++...... ......||..|+|||.+....++.++||||||+++|||+
T Consensus 145 --~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell 220 (309)
T d1fvra_ 145 --QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 220 (309)
T ss_dssp --HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred --cCCccccccccceEEEcCCCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHH
Confidence 8999999999999999999999999999986543221 123445889999999999999999999999999999999
Q ss_pred cCCC-CcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 149 TGWD-VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 149 ~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
+|.. ||... ...+....+..+. ....+...++++.+||.+||+.||++|||++||++
T Consensus 221 ~~~~~p~~~~---------------------~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~ 278 (309)
T d1fvra_ 221 SLGGTPYCGM---------------------TCAELYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278 (309)
T ss_dssp TTSCCTTTTC---------------------CHHHHHHHGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCCC---------------------CHHHHHHHHHhcC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9865 44321 1122222222211 11112245678999999999999999999999999
Q ss_pred HHHHHHHhhc
Q 044155 228 KLRQIYRSLS 237 (239)
Q Consensus 228 ~L~~l~~~~~ 237 (239)
.|+++.++..
T Consensus 279 ~L~~i~~~~~ 288 (309)
T d1fvra_ 279 SLNRMLEERK 288 (309)
T ss_dssp HHHHHHHSSS
T ss_pred HHHHHHhcCc
Confidence 9999886543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=298.54 Aligned_cols=208 Identities=24% Similarity=0.345 Sum_probs=164.9
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-------------------CCCCcCCHHHHHHHHHHHHH
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-------------------PHFEPLLLKHRLKIAMDIVH 61 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-------------------~~~~~~~~~~~~~~~~~i~~ 61 (239)
+++||||+++++++.+.+..+++|||+++|+|.+++..... .....+++..++.++.|++.
T Consensus 72 ~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 151 (301)
T d1lufa_ 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 151 (301)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHH
T ss_pred hcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHH
Confidence 47999999999999999999999999999999999975422 11135788999999999999
Q ss_pred HHhHHhhCCCCCeeeccccCcceeecCCCceeEcccccccccCCCC-cceeecccccccccCccccccCCcccccchhhh
Q 044155 62 ALAYLHFGFPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGE-THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSF 140 (239)
Q Consensus 62 ~l~~LH~~~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 140 (239)
||+||| +++++||||||+|||++.++.+||+|||+++...... ........+++.|+|||.+.+..++.++|||||
T Consensus 152 gl~ylH---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~ 228 (301)
T d1lufa_ 152 GMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228 (301)
T ss_dssp HHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred Hhhhcc---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccc
Confidence 999999 8999999999999999999999999999987653322 222345568899999999999999999999999
Q ss_pred hhHHHHHhcCCC-CcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCC
Q 044155 141 SVFLFELLTGWD-VSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADR 219 (239)
Q Consensus 141 G~~l~~~~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 219 (239)
|+++|||++|.. ||.... ..+....+..+.. ...+...++++.+++.+||+.||++|
T Consensus 229 Gvvl~ell~~~~~p~~~~~---------------------~~e~~~~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~R 286 (301)
T d1lufa_ 229 GVVLWEIFSYGLQPYYGMA---------------------HEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADR 286 (301)
T ss_dssp HHHHHHHHTTTCCTTTTSC---------------------HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hhhHHHHHccCCCCCCCCC---------------------HHHHHHHHHcCCC-CCCCccchHHHHHHHHHHcCCChhHC
Confidence 999999999964 554322 1122222222221 11123456779999999999999999
Q ss_pred CCHHHHHHHHHHHH
Q 044155 220 PSMVDVAKKLRQIY 233 (239)
Q Consensus 220 ps~~ell~~L~~l~ 233 (239)
||+.||+++|+++.
T Consensus 287 Pt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 287 PSFCSIHRILQRMC 300 (301)
T ss_dssp CCHHHHHHHHHHTT
T ss_pred cCHHHHHHHHHHhc
Confidence 99999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-45 Score=294.18 Aligned_cols=192 Identities=21% Similarity=0.351 Sum_probs=161.5
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+.+..++||||++||+|..++... ..++...++.++.||+.||.||| +++|+|||||
T Consensus 60 ~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiK 131 (316)
T d1fota_ 60 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLK 131 (316)
T ss_dssp SCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCC
T ss_pred hccCcChhheeeeEeeCCeeeeEeeecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhc---cCcEEccccC
Confidence 479999999999999999999999999999999999876 56788999999999999999999 9999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 132 p~NILl~~~g~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-- 205 (316)
T d1fota_ 132 PENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-- 205 (316)
T ss_dssp GGGEEECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred chheeEcCCCCEEEecCccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--
Confidence 99999999999999999999876433 235679999999999999999999999999999999999999985322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
..+....+....... +...++++.+++.+||..||.+|+ |++++++
T Consensus 206 -------------------~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 206 -------------------TMKTYEKILNAELRF--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -------------------HHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------------------HHHHHHHHHcCCCCC--CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 112222222222211 123456789999999999999996 8999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=296.12 Aligned_cols=209 Identities=19% Similarity=0.332 Sum_probs=167.1
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCC-------------CCCcCCHHHHHHHHHHHHHHHhHHhhC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQP-------------HFEPLLLKHRLKIAMDIVHALAYLHFG 69 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~LH~~ 69 (239)
+|||||++++++.+....++||||+++|+|.++++..... ....+++..+..++.||+.||+|||
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH-- 162 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-- 162 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--
Confidence 6999999999999999999999999999999999865321 1136889999999999999999999
Q ss_pred CCCCeeeccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHh
Q 044155 70 FPRPIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 70 ~~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 148 (239)
+++++||||||+||+++.++.++++|||.++....... .......||+.|+|||++....++.++||||||+++|||+
T Consensus 163 -~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 163 -SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (311)
T ss_dssp -HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHH
Confidence 89999999999999999999999999999987654332 2334567899999999999999999999999999999999
Q ss_pred cCCCC-cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 149 TGWDV-SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 149 ~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
|++.| +..... .+.+...+........+...+..+.+||.+||+.||.+|||++++++
T Consensus 242 t~g~p~~~~~~~---------------------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 242 SLGSSPYPGMPV---------------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTTCCSSTTCCS---------------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCCH---------------------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 95544 432211 01111111111111112245677999999999999999999999999
Q ss_pred HHHHHHHh
Q 044155 228 KLRQIYRS 235 (239)
Q Consensus 228 ~L~~l~~~ 235 (239)
.|++...+
T Consensus 301 ~L~~~i~~ 308 (311)
T d1t46a_ 301 LIEKQISE 308 (311)
T ss_dssp HHHHHHHH
T ss_pred HHHHhhcc
Confidence 99987765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.4e-46 Score=300.13 Aligned_cols=195 Identities=18% Similarity=0.232 Sum_probs=158.7
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|||||++++++.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.||| +++++||||||
T Consensus 64 ~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP 135 (364)
T d1omwa3 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKP 135 (364)
T ss_dssp SCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred CCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHH---HCCccceeecc
Confidence 57999999999999999999999999999999999875 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
+|||++.++.+||+|||++....... .....||+.|+|||++.. ..++.++|||||||++|+|++|..||......
T Consensus 136 ~NILl~~~g~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 136 ANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp GGEEECSSSCEEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred ceeEEcCCCcEEEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999998664332 335579999999999875 56899999999999999999999998643211
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
. .............. .+...++++.+||.+||+.||.+||| |+|+++
T Consensus 213 ~------------------~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 213 D------------------KHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C------------------HHHHHHHSSSCCCC--CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred H------------------HHHHHHhcccCCCC--CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 00111111111111 11234567899999999999999999 688875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.7e-46 Score=290.59 Aligned_cols=205 Identities=24% Similarity=0.355 Sum_probs=158.2
Q ss_pred CCCCcccceeeEEEEeCCC----ceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLETPI----PILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~----~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+++||||+++++++..... .++||||+++++|.+++... ..+++..++.++.||+.||.||| +++++|
T Consensus 63 ~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~iiH 134 (277)
T d1o6ya_ 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIH 134 (277)
T ss_dssp TCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred hcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccC
Confidence 4799999999999986543 68999999999999988775 57899999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCC--cceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGE--THITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
|||||+||+++.++..+++|||.+....... ........||+.|+|||++.+..++.++|||||||++|+|+||..||
T Consensus 135 rDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf 214 (277)
T d1o6ya_ 135 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 214 (277)
T ss_dssp CCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCC
Confidence 9999999999999999999999876543222 12334567999999999999989999999999999999999999998
Q ss_pred ccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHH
Q 044155 155 DLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRP-SMVDVAKKLRQ 231 (239)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~ 231 (239)
...... +.....+....... .....++.+.++|.+||+.||.+|| |++++++.|.+
T Consensus 215 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 215 TGDSPV---------------------SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCSSHH---------------------HHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCcCHH---------------------HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 642211 11111111111111 1124557789999999999999999 89999999988
Q ss_pred HHH
Q 044155 232 IYR 234 (239)
Q Consensus 232 l~~ 234 (239)
+.+
T Consensus 274 ~~n 276 (277)
T d1o6ya_ 274 VHN 276 (277)
T ss_dssp HHC
T ss_pred HhC
Confidence 764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-45 Score=288.50 Aligned_cols=194 Identities=24% Similarity=0.320 Sum_probs=159.5
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
.||||+++++++.+++..++||||+++|+|.++++.. ..+++..++.++.||+.||.||| +++|+||||||+
T Consensus 68 ~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~ 139 (277)
T d1phka_ 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPE 139 (277)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred CCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccc
Confidence 3999999999999999999999999999999999865 57999999999999999999999 899999999999
Q ss_pred ceeecCCCceeEcccccccccCCCCcceeecccccccccCcccccc------CCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 83 CILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT------GVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 83 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
||+++.++.+||+|||++....... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|..||..
T Consensus 140 Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 140 NILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eEEEcCCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence 9999999999999999998764432 2345678999999998853 3467899999999999999999999864
Q ss_pred ccccccccccchhhhhhhhhccchhhhhhhhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
... .+....+..+.. ........++++.+++.+||+.||.+|||++|+++
T Consensus 218 ~~~---------------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 218 RKQ---------------------MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp SSH---------------------HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCH---------------------HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 321 111111122111 11112256678999999999999999999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=292.08 Aligned_cols=197 Identities=15% Similarity=0.238 Sum_probs=162.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+.+..++|||||+||+|.+++.... ..+++.++..++.||+.||.||| +++|+|||||
T Consensus 57 ~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlK 129 (321)
T d1tkia_ 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIR 129 (321)
T ss_dssp HSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred hCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCCccccc
Confidence 3789999999999999999999999999999999997653 46899999999999999999999 8999999999
Q ss_pred CcceeecCC--CceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEE--NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+|||++.+ ..++|+|||++....... ......+++.|+|||...+..++.++|||||||++|+|++|..||....
T Consensus 130 p~NIll~~~~~~~ikl~DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 130 PENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp GGGEEESSSSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccceeecCCCceEEEEcccchhhccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 999999854 478999999987764332 2345568999999999999999999999999999999999999985322
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+....+........ .....++++++||.+||..||.+|||++|+++
T Consensus 208 ---------------------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 208 ---------------------NQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---------------------HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------------------HHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222223333322211 12245677899999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=293.96 Aligned_cols=194 Identities=22% Similarity=0.318 Sum_probs=160.9
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
++|||||++++++.+++..++||||+++|+|.+++... ..+++..++.++.||+.||.||| +++++||||||
T Consensus 60 ~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp 131 (320)
T d1xjda_ 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKL 131 (320)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCG
T ss_pred CCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcc
Confidence 68999999999999999999999999999999999876 56889999999999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCcccccccc
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDVH 161 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~~ 161 (239)
+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 132 ~NiL~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--- 207 (320)
T d1xjda_ 132 DNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--- 207 (320)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred cceeecCCCceeccccchhhhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---
Confidence 99999999999999999997653322 22345678999999999999999999999999999999999999986422
Q ss_pred cccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 044155 162 DLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV-DVAK 227 (239)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell~ 227 (239)
..+....+...... .+...++.+.+||.+||+.||++|||+. ++++
T Consensus 208 ------------------~~~~~~~i~~~~~~--~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 208 ------------------EEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------------------HHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------------------HHHHHHHHHcCCCC--CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111122222111 1123467789999999999999999985 6754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-45 Score=293.20 Aligned_cols=192 Identities=18% Similarity=0.255 Sum_probs=161.3
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+....++||||+.+|+|.+++... ..+++..++.++.||+.||.||| +++|+|||||
T Consensus 97 ~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIK 168 (350)
T d1rdqe_ 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLK 168 (350)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred HcCCCcEeecccccccccccccccccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCC
Confidence 479999999999999999999999999999999999875 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDLVKDV 160 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~~~~~ 160 (239)
|+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 169 P~NILl~~~g~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-- 242 (350)
T d1rdqe_ 169 PENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-- 242 (350)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred HHHcccCCCCCEEeeeceeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--
Confidence 99999999999999999999876432 235679999999999999999999999999999999999999985322
Q ss_pred ccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 044155 161 HDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRP-----SMVDVAK 227 (239)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 227 (239)
.......+....... +...++++.++|.+||..||.+|+ |++++++
T Consensus 243 -------------------~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 243 -------------------PIQIYEKIVSGKVRF--PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------------------HHHHHHHHHHCCCCC--CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------------------HHHHHHHHhcCCCCC--CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111222222222111 124567789999999999999994 8999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=289.35 Aligned_cols=216 Identities=19% Similarity=0.178 Sum_probs=156.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+++..++||||+.++++..+.... ..+++..+..++.||+.||.||| +++++|||||
T Consensus 56 ~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiK 127 (299)
T d1ua2a_ 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLK 127 (299)
T ss_dssp HCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred hCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCC
Confidence 378999999999999999999999999977666555433 56888999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+|||++.++.+||+|||++....... .......||+.|+|||++... .++.++|||||||++|||++|..||....+
T Consensus 128 p~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 128 PNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp GGGEEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceEEecCCCccccccCccccccCCCc-ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 999999999999999999997654322 123345689999999998754 579999999999999999999999865433
Q ss_pred cccccccchhhhhhhhhccchhhhhhh---h-hhcCCCcH---HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDH---I-VVEDVSSI---EKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......... ... .....+...... . ........ .....++.+.+|+.+||+.||++||||+|+++
T Consensus 207 ~~~l~~i~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 207 LDQLTRIFET-LGT-PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHHHHHHH-HCC-CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHh-cCC-CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 2111000000 000 000000000000 0 00000000 00133567899999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=286.11 Aligned_cols=208 Identities=19% Similarity=0.342 Sum_probs=164.4
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCC-----CCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQ-----PHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++|||||+++|++...+..++||||+++|+|.+++..... .....+++..+..++.|++.||.||| +++|+
T Consensus 79 ~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~iv 155 (308)
T d1p4oa_ 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFV 155 (308)
T ss_dssp GCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCB
T ss_pred HcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCee
Confidence 47999999999999999999999999999999998874311 11134688899999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCc-ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC-CC
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGET-HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW-DV 153 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~-~p 153 (239)
||||||+|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||+||. .|
T Consensus 156 HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p 235 (308)
T d1p4oa_ 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235 (308)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred eceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976543322 2233446899999999999999999999999999999999985 45
Q ss_pred cccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 044155 154 SDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQIY 233 (239)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~l~ 233 (239)
|.... ..+....+..+.. ...+...+..+.++|.+||+.||.+|||+++|++.|++..
T Consensus 236 ~~~~~---------------------~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 236 YQGLS---------------------NEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTTSC---------------------HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCC---------------------HHHHHHHHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 43221 1122222211111 1112245577999999999999999999999999987653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=283.73 Aligned_cols=217 Identities=17% Similarity=0.194 Sum_probs=158.0
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++|||||++++++.+++..++||||+. +++.+++..... ..+++..+..++.|++.||+||| +++|+|||||
T Consensus 57 ~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiK 129 (298)
T d1gz8a_ 57 ELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLK 129 (298)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCcEEEeccccccccceeEEEeecC-Cchhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccC
Confidence 5799999999999999999999999997 566566654433 56899999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+|||++.++.+||+|||.++...... .......||+.|+|||.+.... .+.++|||||||++|+|++|+.||.....
T Consensus 130 peNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~ 208 (298)
T d1gz8a_ 130 PQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208 (298)
T ss_dssp GGGEEECTTSCEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred chheeecccCcceeccCCcceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence 999999999999999999997664322 2233557899999999877655 57899999999999999999999975432
Q ss_pred cccccccchhhhhhhhhccchhhhhh-----hhhhcCCCcHH---HHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVD-----HIVVEDVSSIE---KEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.......+... .......+..... ........... ....++++.+|+.+||+.||++|||++|+++
T Consensus 209 ~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 209 IDQLFRIFRTL--GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp HHHHHHHHHHH--CCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHhc--CCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11110000000 0000000000000 00000000001 1134567899999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-44 Score=278.43 Aligned_cols=185 Identities=18% Similarity=0.312 Sum_probs=151.8
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccC-CChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQY-GTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
.|||||++++++.+.+..++|||++.+ +++.+++... ..+++..++.++.|++.||.||| +++|+||||||
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp 138 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKD 138 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcc
Confidence 499999999999999999999999975 5788888765 56899999999999999999999 89999999999
Q ss_pred cceeecCC-CceeEcccccccccCCCCcceeecccccccccCccccccCCc-ccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 82 SCILFNEE-NVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVF-NEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 82 ~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
+||+++.+ +.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 139 ~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (273)
T d1xwsa_ 139 ENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215 (273)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred cceEEecCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH
Confidence 99999854 78999999999765332 2345679999999999987665 5778999999999999999999854221
Q ss_pred cccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
. ...... .. ...++++.++|.+||+.||++|||++|+++
T Consensus 216 i-----------------------~~~~~~--~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 I-----------------------IRGQVF--FR----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp H-----------------------HHCCCC--CS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-----------------------hhcccC--CC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 000000 00 123467889999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=280.31 Aligned_cols=217 Identities=18% Similarity=0.192 Sum_probs=153.6
Q ss_pred CCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 2 MSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 2 l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
++||||++++++|... ...+++||++.++++........ ..+++..++.++.|++.||+||| +++|+|
T Consensus 67 ~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH---~~~ivH 139 (305)
T d1blxa_ 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLH---SHRVVH 139 (305)
T ss_dssp TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEe
Confidence 4799999999998642 35789999998766644433322 56889999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCccc
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVSDL 156 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~~~ 156 (239)
|||||+|||++.++.+||+|||++...... .......||+.|+|||++.+..++.++||||+||++|||++|..||..
T Consensus 140 rDiKp~NILi~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 140 RDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCccEEEEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 999999999999999999999998654322 234466799999999999999999999999999999999999999975
Q ss_pred ccccccccccchhh---hhhhhhc-cchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 157 VKDVHDLVCPFSEY---LKNCFED-NRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 157 ~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
.............. ....+.. .......................++.+.+|+.+||+.||++||||+|+++
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 218 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 43221110000000 0000000 00000000000000000011134567889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-42 Score=274.12 Aligned_cols=214 Identities=17% Similarity=0.216 Sum_probs=152.6
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+.+..++++|++.++.+..+.... ..+++..+..++.||+.||+||| +.+|+|||||
T Consensus 56 ~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiK 127 (286)
T d1ob3a_ 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLK 127 (286)
T ss_dssp GCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred hCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCC
Confidence 479999999999999999999999999865555554433 67999999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+|||++.++.+|++|||.+....... .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 128 p~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 128 PQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp GGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CceeeEcCCCCEEecccccceecccCc-cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 999999999999999999987654322 223344688999999998764 578999999999999999999999965432
Q ss_pred cccccccchhhhhhhh--hccchhhhhh------hhhhcCC--CcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCF--EDNRFTEIVD------HIVVEDV--SSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~--~~~~~~~~~~------~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
...... ...... ....+..... ....... ........++.+.+||.+||+.||++|||++|+++
T Consensus 207 ~~~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 207 ADQLMR----IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHH----HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHH----HHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111100 000000 0000000000 0000000 00011234567889999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=276.55 Aligned_cols=219 Identities=19% Similarity=0.213 Sum_probs=150.6
Q ss_pred CCCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||++++++|.... ..++||||++++ +.+.+..... ....+++..++.++.||+.||+||| +++|
T Consensus 69 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH---~~~I 143 (350)
T d1q5ka_ 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGI 143 (350)
T ss_dssp HCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTE
T ss_pred hcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhh-ccCCCCHHHHHHHHHHHHHHHHHHH---hcCC
Confidence 379999999999986432 368999999854 4343332100 0157899999999999999999999 9999
Q ss_pred eeccccCcceeecCCC-ceeEcccccccccCCCCcceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCC
Q 044155 75 VFRNFKTSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWD 152 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~ 152 (239)
+||||||+|||++.++ .+||+|||++....... ......|++.|+|||.+.+ ..++.++||||+||++|||++|..
T Consensus 144 iHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~ 221 (350)
T d1q5ka_ 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221 (350)
T ss_dssp ECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSC
T ss_pred cccCCCcceEEEecCCCceeEecccchhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCC
Confidence 9999999999999775 89999999987664332 2334578999999998765 568999999999999999999999
Q ss_pred Ccccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 044155 153 VSDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDV 225 (239)
Q Consensus 153 p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 225 (239)
||........... +..+........ ......................++++.+|+.+||+.||.+||||.|+
T Consensus 222 pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 300 (350)
T d1q5ka_ 222 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300 (350)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCChHHhhhhhccc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 9975433211110 000000000000 00000000000000000011345678899999999999999999999
Q ss_pred HH
Q 044155 226 AK 227 (239)
Q Consensus 226 l~ 227 (239)
++
T Consensus 301 L~ 302 (350)
T d1q5ka_ 301 CA 302 (350)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=263.86 Aligned_cols=211 Identities=16% Similarity=0.178 Sum_probs=156.2
Q ss_pred CCCcccc-eeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MSHNHIL-KLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~H~niv-~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++|+|++ .+.+++.++...++||||+. +++.+.+.... ..++...+..++.|++.||+||| +++|+|||||
T Consensus 59 l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiK 130 (299)
T d1ckia_ 59 MQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVK 130 (299)
T ss_dssp STTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred ccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCC
Confidence 5566655 44555667778889999995 78877766543 56899999999999999999999 8999999999
Q ss_pred CcceeecC---CCceeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 81 TSCILFNE---ENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 81 ~~nil~~~---~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
|+||+++. +..++++|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|.
T Consensus 131 p~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~ 210 (299)
T d1ckia_ 131 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 210 (299)
T ss_dssp GGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCC
Confidence 99998764 44699999999987643321 1234557999999999999999999999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||........... ............ ........++++.+++..||+.||.+||+++++.+.|+.
T Consensus 211 ~P~~~~~~~~~~~~--------------~~~~~~~~~~~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 211 LPWQGLKAATKRQK--------------YERISEKKMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp CTTCCCC---------------------HHHHHHHHHHSC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CcccccchHHHHHH--------------HHHhhcccCCCC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 99865442211110 000000000000 001112455778999999999999999999999999988
Q ss_pred HHHh
Q 044155 232 IYRS 235 (239)
Q Consensus 232 l~~~ 235 (239)
+...
T Consensus 276 ~~~~ 279 (299)
T d1ckia_ 276 LFHR 279 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-40 Score=261.78 Aligned_cols=212 Identities=12% Similarity=0.060 Sum_probs=164.6
Q ss_pred CCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccCc
Q 044155 3 SHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKTS 82 (239)
Q Consensus 3 ~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~~ 82 (239)
+|+|++.+++++.++...++||||+ +++|.+++.... ..++...+..++.|++.||.||| +++|+||||||+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~ 130 (293)
T d1csna_ 59 GCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPD 130 (293)
T ss_dssp TCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGG
T ss_pred CCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCcc
Confidence 3589999999999999999999999 589999987653 46889999999999999999999 999999999999
Q ss_pred ceeecC-----CCceeEcccccccccCCCCc------ceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCC
Q 044155 83 CILFNE-----ENVAKLFDFSLSISIPEGET------HITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGW 151 (239)
Q Consensus 83 nil~~~-----~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~ 151 (239)
||+++. ++.++|+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|.
T Consensus 131 Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~ 210 (293)
T d1csna_ 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210 (293)
T ss_dssp GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCC
Confidence 999975 56799999999987543211 1234567999999999999999999999999999999999999
Q ss_pred CCcccccccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 044155 152 DVSDLVKDVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAKKLRQ 231 (239)
Q Consensus 152 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 231 (239)
.||........... .. ...... ............++++.+++..||..+|.+||+++.+.+.|++
T Consensus 211 ~Pf~~~~~~~~~~~-----~~---------~i~~~~-~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 211 LPWQGLKAATNKQK-----YE---------RIGEKK-QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CTTSSCCSCCHHHH-----HH---------HHHHHH-HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CcCCCccchhHHHH-----HH---------HHHhcc-CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 99964332111100 00 000000 0000000112345678999999999999999999999999999
Q ss_pred HHHhhc
Q 044155 232 IYRSLS 237 (239)
Q Consensus 232 l~~~~~ 237 (239)
+..+..
T Consensus 276 ~~~~~~ 281 (293)
T d1csna_ 276 VLERLN 281 (293)
T ss_dssp HHHHTT
T ss_pred HHHHcC
Confidence 887654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=269.85 Aligned_cols=199 Identities=21% Similarity=0.295 Sum_probs=158.3
Q ss_pred CCC-cccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 2 MSH-NHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 2 l~H-~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
++| |||+++++++.+....+++|||+.+|+|.+++... ..++...+..++.|++.||.|+| +.+++|||||
T Consensus 85 l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiK 156 (322)
T d1vzoa_ 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIK 156 (322)
T ss_dssp HHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred ccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCC
Confidence 445 89999999999999999999999999999999876 56788999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC--CcccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG--VFNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+||+++.++.++|+|||++...............|++.|+|||.+.+. .++.++|||||||++|+|++|..||....
T Consensus 157 p~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 157 LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp GGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred ccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999876644444444566789999999998764 46789999999999999999999986443
Q ss_pred ccccccccchhhhhhhhhccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 044155 159 DVHDLVCPFSEYLKNCFEDNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKDSPADRPS-----MVDVAK 227 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 227 (239)
..... ............. .+...++.+.+++.+||+.||.+||| ++|+++
T Consensus 237 ~~~~~-----------------~~i~~~~~~~~~~--~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 237 EKNSQ-----------------AEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCCCH-----------------HHHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHH-----------------HHHHHhcccCCCC--CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 21111 1111111111111 11245678899999999999999995 788875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=271.55 Aligned_cols=211 Identities=16% Similarity=0.175 Sum_probs=155.0
Q ss_pred CCCCcccceeeEEEEeCC------CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLETP------IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~------~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++|||||+++++|...+ .+++||||+ +.+|..+++. ..+++..++.++.|++.||.||| +++|
T Consensus 73 ~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~I 142 (346)
T d1cm8a_ 73 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGI 142 (346)
T ss_dssp HCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCC
Confidence 379999999999998654 469999999 4788877765 46899999999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccC-CcccccchhhhhhHHHHHhcCCCC
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
+||||||+|||++.++.+|++|||++...... .....||+.|+|||++.+. .++.++||||+||++|+|++|..|
T Consensus 143 iHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~p 218 (346)
T d1cm8a_ 143 IHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218 (346)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cccccCcchhhcccccccccccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCC
Confidence 99999999999999999999999999765433 2356689999999998764 578999999999999999999999
Q ss_pred cccccccccccc-------cchhhhhhhhhccchhhhhhhhhhc---CCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 154 SDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVE---DVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 154 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
|........... +..+... .... ............ ..........++.+.+||.+||..||.+|||++
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (346)
T d1cm8a_ 219 FKGSDHLDQLKEIMKVTGTPPAEFVQ-RLQS-DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296 (346)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHH-TCSC-HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCChHHHHHHHHhccCCCcHHHHh-hhcc-hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 975432211100 0000000 0000 000000000000 000001123456788999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
|+++
T Consensus 297 eiL~ 300 (346)
T d1cm8a_ 297 EALA 300 (346)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=264.79 Aligned_cols=218 Identities=16% Similarity=0.209 Sum_probs=150.6
Q ss_pred CCCCcccceeeEEEEe--------CCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCC
Q 044155 1 QMSHNHILKLIGCCLE--------TPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPR 72 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~--------~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~ 72 (239)
+++||||+++++++.. .+..++|||++.++.+. ...... ..++...++.++.|++.||.||| ++
T Consensus 65 ~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~----~~~~~~~~~~i~~qil~~l~~lH---~~ 136 (318)
T d3blha1 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RN 136 (318)
T ss_dssp HCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHH-HHTCTT----CCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred HhcCCCccceEeeeecccccccccCceEEEEEeccCCCccc-hhhhcc----cccccHHHHHHHHHHHHHHHHhc---cC
Confidence 3789999999999864 34678999999865554 443322 56889999999999999999999 89
Q ss_pred CeeeccccCcceeecCCCceeEcccccccccCCCCc---ceeecccccccccCccccccC-CcccccchhhhhhHHHHHh
Q 044155 73 PIVFRNFKTSCILFNEENVAKLFDFSLSISIPEGET---HITDTVMGTLGYCAPEYMRTG-VFNEKSNVFSFSVFLFELL 148 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~ 148 (239)
+|+||||||+|||++.++.+|++|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 137 ~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~ 216 (318)
T d3blha1 137 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216 (318)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh
Confidence 999999999999999999999999999876543221 122345689999999998765 6899999999999999999
Q ss_pred cCCCCccccccccccccc------chhhhhhhhhccchhhhhhhhhhcCCCcH----HHHHHHHHHHHHHhhhcCCCCCC
Q 044155 149 TGWDVSDLVKDVHDLVCP------FSEYLKNCFEDNRFTEIVDHIVVEDVSSI----EKEQQLHASAQVTFECIKDSPAD 218 (239)
Q Consensus 149 ~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dp~~ 218 (239)
+|+.||....+....... +.................... ....... .....++.+.+||.+||+.||++
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~ 295 (318)
T d3blha1 217 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV-KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295 (318)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CC-SSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTT
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccc-ccccccchhhhccccCCHHHHHHHHHHCcCChhH
Confidence 999999754322111100 000000000000000000000 0000000 01123456789999999999999
Q ss_pred CCCHHHHHH
Q 044155 219 RPSMVDVAK 227 (239)
Q Consensus 219 Rps~~ell~ 227 (239)
||||+|+++
T Consensus 296 R~sa~elL~ 304 (318)
T d3blha1 296 RIDSDDALN 304 (318)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHc
Confidence 999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=269.67 Aligned_cols=217 Identities=16% Similarity=0.187 Sum_probs=153.1
Q ss_pred CCCCcccceeeEEEEeCC----CceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeee
Q 044155 1 QMSHNHILKLIGCCLETP----IPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVF 76 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~----~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H 76 (239)
+|+||||+++++++.... ..+++++++.+|+|.+++.. ..+++..++.++.|++.||+||| +++|+|
T Consensus 62 ~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH---~~~iiH 132 (345)
T d1pmea_ 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLH 132 (345)
T ss_dssp HCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred HcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcC
Confidence 479999999999997653 23556677778999999975 45899999999999999999999 899999
Q ss_pred ccccCcceeecCCCceeEcccccccccCCCCc--ceeecccccccccCcccccc-CCcccccchhhhhhHHHHHhcCCCC
Q 044155 77 RNFKTSCILFNEENVAKLFDFSLSISIPEGET--HITDTVMGTLGYCAPEYMRT-GVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 77 ~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
|||||+|||++.++.+||+|||++........ .......||+.|+|||++.. ..++.++||||+|+++|+|++|..|
T Consensus 133 RDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~p 212 (345)
T d1pmea_ 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212 (345)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCC
Confidence 99999999999999999999999876533221 12345568999999999854 5578899999999999999999999
Q ss_pred cccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 154 SDLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSI--EKEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 154 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
|........... +......... ................... .....+.++.+|+.+||+.||.+|||+.|
T Consensus 213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 213 FPGKHYLDQLNHILGILGSPSQEDLNCII-NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp CCCSSHHHHHHHHHHHHCSCCHHHHHTCC-CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCHHHHHHHHhhhccCCChhhhhhhh-hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 864332110000 0000000000 0000000000000000000 01133467889999999999999999999
Q ss_pred HHH
Q 044155 225 VAK 227 (239)
Q Consensus 225 ll~ 227 (239)
+++
T Consensus 292 ~L~ 294 (345)
T d1pmea_ 292 ALA 294 (345)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=263.58 Aligned_cols=217 Identities=16% Similarity=0.137 Sum_probs=158.2
Q ss_pred CCCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 1 QMSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
+++||||+++++++.+....+++++++.+++|..++... ..++...+..++.|++.||+||| +++|+|||||
T Consensus 57 ~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiK 128 (292)
T d1unla_ 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLK 128 (292)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred hcCcCCEEeeccccccccceeEEeeeccccccccccccc-----cccchhHHHHHHHHHHHHHHHhh---cCCEeeeccc
Confidence 479999999999999999999999999988888877655 57889999999999999999999 8999999999
Q ss_pred CcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCcccccc
Q 044155 81 TSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSDLVKD 159 (239)
Q Consensus 81 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~~~~~ 159 (239)
|+|||++.++.+||+|||.+....... .......+++.|+|||.+.... ++.++|||||||++|+|++|+.||....+
T Consensus 129 P~NIli~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 207 (292)
T d1unla_ 129 PQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred CcccccccCCceeeeecchhhcccCCC-ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC
Confidence 999999999999999999997754322 2233445678899999887655 68999999999999999999999754332
Q ss_pred cccccccchhhhhhhhhccchhhhhhhh--------hhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 044155 160 VHDLVCPFSEYLKNCFEDNRFTEIVDHI--------VVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 227 (239)
..+...........+. ...+....... .............++.+.+|+.+||+.||.+||||+|+++
T Consensus 208 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 208 VDDQLKRIFRLLGTPT-EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHHHCCCC-TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhhcCCCC-hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2211110000000000 00000000000 0000000111234567889999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-40 Score=265.17 Aligned_cols=212 Identities=16% Similarity=0.155 Sum_probs=152.3
Q ss_pred CCcccceeeEEEEeC--CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeecccc
Q 044155 3 SHNHILKLIGCCLET--PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFK 80 (239)
Q Consensus 3 ~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk 80 (239)
.||||+++++++... ...++||||+.+++|.... ..+++..++.++.||+.||.||| +++|+|||||
T Consensus 88 ~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiK 156 (328)
T d3bqca1 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVK 156 (328)
T ss_dssp TSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred CCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hccccccccc
Confidence 499999999999854 4688999999999987654 46889999999999999999999 8999999999
Q ss_pred CcceeecCCC-ceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCccccc
Q 044155 81 TSCILFNEEN-VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVSDLVK 158 (239)
Q Consensus 81 ~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~~~~~ 158 (239)
|+|||++.++ .++|+|||++....... ......+|+.|+|||.+.+.. ++.++||||+|+++|++++|+.||....
T Consensus 157 p~NILi~~~~~~vkl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 157 PHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp GGGEEEETTTTEEEECCGGGCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccceEEcCCCCeeeecccccceeccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 9999998765 68999999997654332 234556899999999987654 7999999999999999999999986543
Q ss_pred ccccccccchhhhhhhh-------hccchhhhhhhh--------hhcCCCcHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 044155 159 DVHDLVCPFSEYLKNCF-------EDNRFTEIVDHI--------VVEDVSSIEKEQQLHASAQVTFECIKDSPADRPSMV 223 (239)
Q Consensus 159 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 223 (239)
+..............+. ............ .............++++.+||.+||..||.+|||++
T Consensus 235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 314 (328)
T d3bqca1 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314 (328)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 32111000000000000 000000000000 000011111123456789999999999999999999
Q ss_pred HHHH
Q 044155 224 DVAK 227 (239)
Q Consensus 224 ell~ 227 (239)
|+++
T Consensus 315 e~L~ 318 (328)
T d3bqca1 315 EAME 318 (328)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=264.16 Aligned_cols=213 Identities=18% Similarity=0.222 Sum_probs=149.8
Q ss_pred CCCCcccceeeEEEEeC------CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCe
Q 044155 1 QMSHNHILKLIGCCLET------PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPI 74 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~------~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i 74 (239)
+++||||++++++|... +..++||||+. +++.+.+. ..++...++.++.|++.||.||| +.||
T Consensus 72 ~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~-~~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~gi 140 (355)
T d2b1pa1 72 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGI 140 (355)
T ss_dssp HCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred hcCCCCeeEEEEEEecccccccCceeEEEEeccc-hHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hccc
Confidence 37899999999999643 56799999997 45555553 45889999999999999999999 8999
Q ss_pred eeccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCCc
Q 044155 75 VFRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 75 ~H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
+||||||+|||++.++.++++|||++....... ......+|+.|+|||++.+..++.++||||+||++++|++|+.||
T Consensus 141 iHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF 218 (355)
T d2b1pa1 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_dssp CCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccCCccccccccccceeeechhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCC
Confidence 999999999999999999999999876653322 234556899999999999999999999999999999999999999
Q ss_pred ccccccccc-------cccchhhhhhh-------hh------ccchhhhhhhhhhcCCCcHHHHHHHHHHHHHHhhhcCC
Q 044155 155 DLVKDVHDL-------VCPFSEYLKNC-------FE------DNRFTEIVDHIVVEDVSSIEKEQQLHASAQVTFECIKD 214 (239)
Q Consensus 155 ~~~~~~~~~-------~~~~~~~~~~~-------~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 214 (239)
......... ..+..+..... .. ............ ...........++.+.+|+.+||..
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dll~~mL~~ 297 (355)
T d2b1pa1 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL-FPADSEHNKLKASQARDLLSKMLVI 297 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG-SCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred CCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccc-ccccccccccCCHHHHHHHHHHCcC
Confidence 643321110 00111111000 00 001111111111 1112233446778899999999999
Q ss_pred CCCCCCCHHHHHH
Q 044155 215 SPADRPSMVDVAK 227 (239)
Q Consensus 215 dp~~Rps~~ell~ 227 (239)
||++||||+|+++
T Consensus 298 dP~~R~ta~elL~ 310 (355)
T d2b1pa1 298 DPAKRISVDDALQ 310 (355)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=257.70 Aligned_cols=212 Identities=18% Similarity=0.211 Sum_probs=149.5
Q ss_pred CCCCcccceeeEEEEeC-----CCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCee
Q 044155 1 QMSHNHILKLIGCCLET-----PIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIV 75 (239)
Q Consensus 1 ~l~H~niv~l~~~~~~~-----~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~ 75 (239)
+++|||||++++++... ...+++++++.+|+|.+++.. ..+++..++.++.||+.||+||| +++|+
T Consensus 73 ~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~gii 143 (348)
T d2gfsa1 73 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADII 143 (348)
T ss_dssp HCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred hcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCc
Confidence 37899999999998643 344677888889999999864 46899999999999999999999 89999
Q ss_pred eccccCcceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCC-cccccchhhhhhHHHHHhcCCCCc
Q 044155 76 FRNFKTSCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGV-FNEKSNVFSFSVFLFELLTGWDVS 154 (239)
Q Consensus 76 H~dlk~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~g~~p~ 154 (239)
||||||+|||++.++.++++|||.+..... ......|++.|+|||...+.. ++.++|||||||++|+|++|..||
T Consensus 144 HrDiKp~NILi~~~~~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF 219 (348)
T d2gfsa1 144 HRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219 (348)
T ss_dssp CCCCCGGGEEECTTCCEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccCCccccccccccccccccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC
Confidence 999999999999999999999999865422 233556889999999877654 688999999999999999999999
Q ss_pred ccccccccccc-------cchhhhhhhhhccchhhhhhhhhhcCCCcHH---HHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 044155 155 DLVKDVHDLVC-------PFSEYLKNCFEDNRFTEIVDHIVVEDVSSIE---KEQQLHASAQVTFECIKDSPADRPSMVD 224 (239)
Q Consensus 155 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~e 224 (239)
........... +..+..... .................... ....++.+.+||.+||+.||.+||||+|
T Consensus 220 ~~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 220 PGTDHIDQLKLILRLVGTPGAELLKKI--SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHTTC--CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCHHHHHHHHHHhcCCCChHHhhhc--cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 65432111100 000000000 00000000000000000000 1134567889999999999999999999
Q ss_pred HHH
Q 044155 225 VAK 227 (239)
Q Consensus 225 ll~ 227 (239)
+++
T Consensus 298 lL~ 300 (348)
T d2gfsa1 298 ALA 300 (348)
T ss_dssp HHT
T ss_pred Hhc
Confidence 987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-34 Score=231.31 Aligned_cols=214 Identities=16% Similarity=0.177 Sum_probs=143.8
Q ss_pred CCcccceeeEEEEeC--CCceEEEEEccCCCh-hhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccc
Q 044155 3 SHNHILKLIGCCLET--PIPILVFESVQYGTL-WDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNF 79 (239)
Q Consensus 3 ~H~niv~l~~~~~~~--~~~~iv~e~~~~~sL-~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dl 79 (239)
.|+||+++++++... ...+++++++..+.. ......... ..++...+..++.|++.||.|||+ ..+|+||||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDl 152 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDI 152 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCC
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccc---cCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccC
Confidence 589999999998754 345566666544433 233333222 678899999999999999999993 389999999
Q ss_pred cCcceeecCCC------ceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhhHHHHHhcCCCC
Q 044155 80 KTSCILFNEEN------VAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSVFLFELLTGWDV 153 (239)
Q Consensus 80 k~~nil~~~~~------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~g~~p 153 (239)
||+|||++.++ .++++|||.+...... .....||+.|+|||++....++.++||||+|+++++|++|+.|
T Consensus 153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p 228 (362)
T d1q8ya_ 153 KPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228 (362)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred ChhHeeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCC
Confidence 99999998765 3899999998755322 2355689999999999999999999999999999999999999
Q ss_pred cccccccccccc------------cch-hhhh------hhhhccchhhh--------hhhhhhcCCCcHHHHHHHHHHHH
Q 044155 154 SDLVKDVHDLVC------------PFS-EYLK------NCFEDNRFTEI--------VDHIVVEDVSSIEKEQQLHASAQ 206 (239)
Q Consensus 154 ~~~~~~~~~~~~------------~~~-~~~~------~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 206 (239)
|........... ... .... ..+........ ......... ......++.+.+
T Consensus 229 F~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~d 306 (362)
T d1q8ya_ 229 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY--KFSKDEAKEISD 306 (362)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT--CCCHHHHHHHHH
T ss_pred CCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhccccc--ccCcccCHHHHH
Confidence 875433211100 000 0000 00000000000 000000000 011356788999
Q ss_pred HHhhhcCCCCCCCCCHHHHHH
Q 044155 207 VTFECIKDSPADRPSMVDVAK 227 (239)
Q Consensus 207 li~~cl~~dp~~Rps~~ell~ 227 (239)
|+.+||+.||.+||||+|+++
T Consensus 307 ll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 307 FLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.66 E-value=1.6e-17 Score=121.80 Aligned_cols=117 Identities=14% Similarity=0.147 Sum_probs=78.2
Q ss_pred CCCcccceeeEEEEeCCCceEEEEEccCCChhhhhhcCCCCCCCcCCHHHHHHHHHHHHHHHhHHhhCCCCCeeeccccC
Q 044155 2 MSHNHILKLIGCCLETPIPILVFESVQYGTLWDRILGAPQPHFEPLLLKHRLKIAMDIVHALAYLHFGFPRPIVFRNFKT 81 (239)
Q Consensus 2 l~H~niv~l~~~~~~~~~~~iv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~~~i~H~dlk~ 81 (239)
+.|++++..+++. ..+++||++++..+.+ ++......++.|++.++.||| .++++|+||||
T Consensus 71 l~~~~v~~~~~~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP 131 (191)
T d1zara2 71 LQGLAVPKVYAWE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQ 131 (191)
T ss_dssp TTTSSSCCEEEEE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCST
T ss_pred ccCCCcceEEEec----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCCh
Confidence 5678888776552 2479999998655432 233445578999999999999 89999999999
Q ss_pred cceeecCCCceeEcccccccccCCCCcceeecccccccccCccccccCCcccccchhhhhh
Q 044155 82 SCILFNEENVAKLFDFSLSISIPEGETHITDTVMGTLGYCAPEYMRTGVFNEKSNVFSFSV 142 (239)
Q Consensus 82 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 142 (239)
+|||+++++ ++|+|||.+......... ......... -.+ +....++.++|+||+.-
T Consensus 132 ~NILv~~~~-~~liDFG~a~~~~~~~~~--~~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 132 YNVLVSEEG-IWIIDFPQSVEVGEEGWR--EILERDVRN-IIT-YFSRTYRTEKDINSAID 187 (191)
T ss_dssp TSEEEETTE-EEECCCTTCEETTSTTHH--HHHHHHHHH-HHH-HHHHHHCCCCCHHHHHH
T ss_pred hheeeeCCC-EEEEECCCcccCCCCCcH--HHHHHHHHH-HHH-HHcCCCCCcccHHHHHH
Confidence 999999664 889999998665322110 000000000 001 11245788999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.49 E-value=8.3e-05 Score=55.30 Aligned_cols=29 Identities=17% Similarity=0.222 Sum_probs=24.8
Q ss_pred CeeeccccCcceeecCCCceeEccccccc
Q 044155 73 PIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
.++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEEeeccCcceeecCCceEEEeechhcc
Confidence 37999999999999987666799998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.90 E-value=0.00055 Score=50.36 Aligned_cols=29 Identities=7% Similarity=0.019 Sum_probs=25.1
Q ss_pred CeeeccccCcceeecCCCceeEccccccc
Q 044155 73 PIVFRNFKTSCILFNEENVAKLFDFSLSI 101 (239)
Q Consensus 73 ~i~H~dlk~~nil~~~~~~~~l~dfg~~~ 101 (239)
.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 48999999999999987667899998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.79 E-value=0.01 Score=46.46 Aligned_cols=33 Identities=18% Similarity=0.364 Sum_probs=27.3
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccccC
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSISIP 104 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~~~ 104 (239)
...++|+|+.|.|||++.++ ++++||..+...+
T Consensus 222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~ 254 (392)
T d2pula1 222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFYGP 254 (392)
T ss_dssp CCEEECSCCCGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CcceeccCCcCCceeEcCCc-eEEechhhcccCC
Confidence 34699999999999998765 8999998876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.21 E-value=0.003 Score=47.95 Aligned_cols=30 Identities=17% Similarity=0.469 Sum_probs=27.2
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLS 100 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~ 100 (239)
..+++|+|+.++|++++.+...-++||+.+
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccccccCCcchhhhhcccccceeEeccccc
Confidence 678999999999999998877789999976
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.87 E-value=0.11 Score=39.13 Aligned_cols=30 Identities=10% Similarity=0.145 Sum_probs=24.2
Q ss_pred CCCeeeccccCcceeecCCCceeEcccccccc
Q 044155 71 PRPIVFRNFKTSCILFNEENVAKLFDFSLSIS 102 (239)
Q Consensus 71 ~~~i~H~dlk~~nil~~~~~~~~l~dfg~~~~ 102 (239)
..+++|+|+.+.|||++++ ..++||+.+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 5679999999999999743 45899997644
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=85.11 E-value=0.18 Score=39.09 Aligned_cols=15 Identities=13% Similarity=0.350 Sum_probs=13.2
Q ss_pred eeeccccCcceeecC
Q 044155 74 IVFRNFKTSCILFNE 88 (239)
Q Consensus 74 i~H~dlk~~nil~~~ 88 (239)
++|+|+.+.||++..
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 579999999999854
|